Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytoplasmic translation (GO:0002181),-0.48788168006326355,-2.0994013790657133,0.0,0.20415357366072878,0.127,36/91,14.03%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;ETF1;RPS29;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;EIF3I;RPS5;RPL30;RPL6;RPL37A;TMA7;RPL10;RPL15;UBA52;RPS10;RPL14;RPL9;RPL32;RPL36;RPL31;RPL23A;RPL41;RPL3
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.48575997618120725,-2.0939492177219132,0.0,0.10820139404018624,0.134,36/87,14.03%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;RPS29;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;SEC63;RPL9;RPL32;RPL36;SRP72;RPL31;RPL23A;SEC61A1;RPL41;RPL3
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.45205002518830906,-2.0717868699637507,0.0,0.09754004074901484,0.175,58/110,26.15%,PPP2R2A;UPF3A;RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;NCBP1;RPL28;ETF1;RPS29;RBM8A;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;RPL9;RPL32;RPL36;RPL31;RPL23A;RPL41;RPL3;RPL8;UPF3B;HELZ2;UPF2;SMG6;RPL37;MAGOH;MAGOHB;RPL36A;RPL26;RPL11;RPS15;EIF3E;CTIF;PYM1;RPS6;RPS17;RPLP2;RPS18;RPS21
prerank,modulation by symbiont of host process (GO:0044003),-0.8208752837975839,-2.034587811189771,0.0,0.12113112037203241,0.278,6/10,13.39%,MRC1;TLR2;ENO1;UBC;UBA52;B2M
prerank,regulation of phagocytosis (GO:0050764),-0.5188006692885466,-2.0345723287181983,0.0,0.09690489629762594,0.278,18/53,16.30%,FCGR2B;IL15;GAS6;PIP4P2;PTPRC;CD47;TLR2;DOCK2;SYK;IL1B;HCK;DYSF;CYBA;SLC11A1;RACK1;TNF;TUB;FCER1G
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.4520261210208843,-1.9583813267142087,0.0,0.20551459748513362,0.559,36/91,14.03%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;RPS29;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;SEC63;RPL9;RPL32;RPL36;SRP72;RPL31;RPL23A;SEC61A1;RPL41;RPL3
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.7356887834873773,1.9478567385286576,0.0,0.45211261731672603,0.399,7/15,3.78%,YWHAE;KCNJ3;KCNH2;KCNA5;ATP1B1;KCNE2;KCNJ8
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6903049809387957,-1.9471992757341985,0.004796163069544364,0.20045936613734414,0.603,5/15,13.28%,FCGR2B;CD300A;CD300LF;ZC3H12A;NR1H3
prerank,regulation of stem cell proliferation (GO:0072091),-0.6554093571039513,-1.9431072147020128,0.0026246719160104987,0.1839083442727065,0.617,10/17,25.43%,PTPRC;HMGB2;SOX11;YAP1;GJA1;HMGA2;HNRNPU;EIF2AK2;TERT;FBLN1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.550768667165226,-1.927380015935327,0.0,0.1959874307142996,0.683,17/34,25.64%,NEDD9;NRP1;CASS4;CRK;LIMS1;CRKL;CARMIL1;CIB1;S100A10;MYOC;FLNA;MYADM;DOCK1;RREB1;OLFM4;ILK;RAC1
prerank,protein targeting to ER (GO:0045047),-0.43473717232125425,-1.9133950744559927,0.0,0.2076922356041814,0.741,39/99,14.03%,CHMP4B;CHMP4A;RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;RPS29;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;SEC63;RPL9;RPL32;RPL36;SRP72;RPL31;RPL23A;EDEM1;SEC61A1;RPL41;RPL3
prerank,response to interferon-alpha (GO:0035455),-0.664532008503586,-1.8989017113926052,0.0,0.22382655439530807,0.789,8/16,7.08%,IFNAR1;GAS6;AXL;KLHL20;IFITM3;IFNAR2;BST2;RO60
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.7464237197828529,-1.8975945304570287,0.0,0.20846348243801083,0.797,5/11,17.16%,ALOX5;THBS1;SEMA6A;CREB3L1;KLF2
prerank,heterochromatin assembly (GO:0031507),-0.6114412609635415,-1.8970144608945005,0.005319148936170213,0.19337007720582872,0.797,10/20,21.17%,ZNFX1;SMCHD1;MBD2;H3-3A;HDAC1;HMGA2;CDKN2A;POLE3;HMGA1;SIRT2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.7230226034038033,-1.8831910332951174,0.0,0.211736420682413,0.848,7/12,15.86%,PIBF1;ERLIN2;BRCA1;WDTC1;CEACAM1;APOC1;ACADL
prerank,type I interferon signaling pathway (GO:0060337),-0.5178618407864686,-1.8782923916461973,0.0,0.19607249470332494,0.862,14/41,6.74%,SP100;IFNAR1;OAS2;IFIT2;IRF9;IRF7;IFITM3;IFNAR2;STAT2;IFIT1;OASL;IRF4;BST2;IFIT3
prerank,cellular response to type I interferon (GO:0071357),-0.5178618407864686,-1.8782923916461973,0.0,0.19607249470332494,0.862,14/41,6.74%,SP100;IFNAR1;OAS2;IFIT2;IRF9;IRF7;IFITM3;IFNAR2;STAT2;IFIT1;OASL;IRF4;BST2;IFIT3
prerank,ribosome biogenesis (GO:0042254),-0.3859485350075947,-1.873574603848146,0.0,0.19366568419031485,0.876,68/187,19.64%,UTP6;NOL11;EIF2A;RPL39;RPL5;RPS24;CUL4A;URB2;RPS16;MALSU1;WDR43;DHX29;RPL28;RPS14;DDX49;RPL35A;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;RPL30;MRM2;RPF2;RPL6;RPL37A;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;METTL17;UTP11;UTP15;EXOSC10;XPO1;DDX27;RPL14;XRN2;RPL9;MPHOSPH6;RPL32;RPL36;NOP58;RPL31;RPL23A;MDN1;UTP18;RPL41;RPL3;EXOSC9;NPM1;WDR3;TBL3;RPL8;TEX10;FBL;NOP53;GTF3A;RPL37;EMG1;RPL36A;DKC1;RPL26;SDAD1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.6883419615029562,-1.866547671010277,0.0,0.19772651671215025,0.897,7/13,16.34%,OAS2;IL6ST;IL27;OASL;STAT1;EBI3;IL27RA
prerank,toll-like receptor signaling pathway (GO:0002224),-0.432900218509998,-1.8624196955189443,0.0,0.1957725322157094,0.9,39/84,25.13%,RFTN1;MAP3K1;UBE2D3;PIK3C3;SFTPA2;SFTPA1;PIK3R4;TLR2;CD36;MAPKAPK2;TLR7;CD14;HSPD1;TNIP3;RIPK1;CTSL;EPG5;UBC;TLR8;CTSB;TAB1;UBA52;S100A1;MAPKAPK3;BIRC2;IRAK4;LBP;SCIMP;TLR4;TLR1;MYD88;TNIP1;NR1H4;TLR5;TICAM2;FADD;RPS6KA3;TLR9;TAB3
prerank,regulation of macrophage activation (GO:0043030),-0.549181292692316,-1.8493313058227718,0.002777777777777778,0.2159264297418308,0.925,13/30,18.53%,FCGR2B;CD74;PJA2;THBS1;HSPD1;GPR137B;ZC3H12A;SHPK;NR1H3;LBP;WNT5A;TLR4;MMP8
prerank,response to interferon-beta (GO:0035456),-0.5915914354993135,-1.8491896298947732,0.0,0.20590346143496358,0.925,13/22,23.52%,UBE2K;IFITM3;IFNAR2;SHFL;BST2;CDC34;STAT1;ACOD1;AIM2;IFITM1;NDUFA13;XAF1;PLSCR1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5345345604661333,1.84692078323911,0.0,1.0,0.892,20/54,16.51%,KCNMA1;YWHAE;KCNJ3;KCNH2;BIN1;GABBR1;NOS1AP;KCNE2;KCNIP3;KCNIP4;FHL1;NEDD4;STK39;CACNA1D;GABBR2;KCNN4;NEDD4L;KCNJ5;KCNMB3;KCNN3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4883476799930772,-1.8468340386443223,0.002770083102493075,0.20180271432766583,0.929,18/45,14.36%,SP100;OAS2;CD44;TRIM25;IRF9;CIITA;IRF7;OASL;IRF4;TRIM62;MID1;HCK;CAMK2D;STAT1;TRIM5;OAS3;B2M;IRF2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5407531873104425,-1.842435159441402,0.0,0.20119482621637036,0.935,12/26,16.18%,BCL2;PPP2R1B;BCL2L1;MCL1;PF4;IL1B;EYA1;RET;EYA3;EYA2;TNF;MAPK7
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.5599651786569654,-1.8378339807518902,0.0079155672823219,0.20211203792412144,0.939,11/25,19.75%,RBPJ;HIP1;CNOT9;HIP1R;BCAR3;ARAP1;PLAUR;CBL;NUP62;PDE6H;AFAP1L2
prerank,negative regulation of phagocytosis (GO:0050765),-0.6291681643343144,-1.8361136905155406,0.007594936708860759,0.19707624977382351,0.942,8/17,13.54%,FCGR2B;PIP4P2;CD300A;CD47;TLR2;CD300LF;DYSF;RACK1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.5397498964348721,-1.8350244980360717,0.0,0.1912238473288826,0.944,16/31,24.02%,NBR1;NOCT;CDK6;LIMD1;PPARG;NOTCH1;TRPM4;SMAD6;GREM1;RIOX1;BAMBI;PTCH1;SEMA4D;TWIST1;TNN;GDF10
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.6525070184636497,1.8316097650695558,0.0067226890756302525,0.8242704727577773,0.931,11/20,23.15%,LACC1;KCNMA1;ATP1B1;SLC12A2;ATP1B3;SLC8A1;NEDD4L;ATP1A4;ATP1A3;ATP1A1;SLC9A1
prerank,cellular potassium ion homeostasis (GO:0030007),0.7259835950445055,1.8238998805105455,0.0034662045060658577,0.6815222918103353,0.945,7/13,19.85%,KCNMA1;ATP1B1;SLC12A2;ATP1B3;ATP1A4;ATP1A3;ATP1A1
prerank,rRNA metabolic process (GO:0016072),-0.3829893549791072,-1.8067089477165326,0.0,0.25078124171904337,0.987,58/160,19.56%,UTP6;NOL11;RPL39;RPL5;RPS24;RPS16;WDR43;RPL28;RPS14;DDX49;RPL35A;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;RPL30;MRM2;RPL6;RPL37A;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;UTP11;UTP15;EXOSC10;DDX27;RPL14;XRN2;RPL9;MPHOSPH6;RPL32;RPL36;NOP58;RPL31;RPL23A;MDN1;UTP18;RPL41;RPL3;EXOSC9;WDR3;TBL3;RPL8;TEX10;FBL;NOP53;TRIR;RPL37;EMG1;RPL36A;DKC1;RPL26
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5989282677496156,1.8049590545681224,0.0016260162601626016,0.6779322177984833,0.967,11/26,17.90%,YWHAE;ATP1B1;KCNE2;ATP1B3;FHL1;ACTN2;NEDD4;STK39;CACNA1D;NEDD4L;ANK2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6022966577032915,1.804138816577802,0.001644736842105263,0.5691516601939471,0.968,16/25,24.51%,ATP1B1;DMD;ATP1B3;NDUFA4;ACTN2;CFTR;STK39;TRPC6;ANK2;WNK1;COX17;SLC6A9;CTSS;GLRX;PDZK1;ANK3
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.6611894951011872,1.8022644343824734,0.008103727714748784,0.4992288162791771,0.968,7/17,10.81%,SLC4A8;SCAMP5;SYT4;RAB3A;DOC2B;CACNA1G;RAB3D
prerank,cellular sodium ion homeostasis (GO:0006883),0.6851500756169184,1.8005420702046055,0.003430531732418525,0.4470825685638567,0.969,9/15,23.15%,ATP1B1;SLC12A2;ATP1B3;SLC8A1;NEDD4L;ATP1A4;ATP1A3;ATP1A1;SLC9A1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.6092101747432005,-1.7967542195517516,0.0,0.2659829416836923,0.99,6/17,9.44%,APOE;KPNB1;ERLIN2;FGF1;MBTPS1;ABCG1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.7054678095631037,-1.7943212244600646,0.006521739130434782,0.26281839367817955,0.99,6/11,16.34%,STAT4;IL12RB2;IL6ST;STAT1;EBI3;IL27RA
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3715574320069157,-1.790783430544374,0.0,0.2630859052574592,0.992,76/168,26.15%,DIS3L2;PPP2R2A;UPF3A;RPS26;RPL39;RPS23;RPL5;RPS24;CNOT9;RPS16;NCBP1;RPL28;ETF1;RPS29;RBM8A;RPS14;RPS20;SAMD4A;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;TENT2;EXOSC8;UBA52;ZC3H12A;EXOSC10;RPS10;RPL14;DCP1B;XRN2;RPL9;RC3H1;RPL32;RPL36;RPL31;RPL23A;RPL41;RPL3;EXOSC9;RC3H2;RPL8;UPF3B;HELZ2;UPF2;SMG6;RPL37;TENT4B;MAGOH;MAGOHB;RPL36A;RPL26;RPL11;PAN3;CNOT6L;RPS15;EIF3E;CTIF;PYM1;RPS6;EXOSC7;RPS17;CSDE1;RPLP2;TNKS1BP1;RPS18;RPS21
prerank,cellular response to increased oxygen levels (GO:0036295),-0.7001898831234104,-1.7894222741511034,0.004796163069544364,0.25762863876153896,0.993,6/11,12.83%,ATP6V0D1;ATG7;FAS;CAV1;FOXO1;ATP6V1A
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.6235727776612803,-1.788716599401121,0.002512562814070352,0.2516192795368482,0.993,8/16,20.23%,ERLIN2;BRCA1;WDTC1;CEACAM1;APOC1;ACADL;APPL2;NCOR1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.7035750984584189,-1.7879611140939393,0.002352941176470588,0.2460153670477267,0.993,5/11,10.65%,FCGR2B;CD300A;TYROBP;LYN;RC3H1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.4770908820969108,-1.7855041691655484,0.0028735632183908046,0.24434380659315458,0.994,19/48,17.14%,BCL2;FNIP2;BCL2L1;MCL1;AEN;BAX;USP28;BCL3;BRCA1;BAG6;TMEM109;SNW1;EP300;HIPK1;TNFRSF1B;BCL2L11;CRIP1;EPHA2;HIPK2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5647811340947294,1.7853060271497772,0.007987220447284345,0.47832585613342193,0.981,9/31,9.37%,SCAMP5;SYT4;CBARP;SYT13;SYT1;SYT6;DOC2B;ADRA2A;CACNA1G
prerank,positive regulation of histone deacetylation (GO:0031065),0.7044087035185054,1.784118745194084,0.006791171477079796,0.43656878038629054,0.981,8/12,21.73%,CTBP1;AKAP8L;PRKD2;AKAP8;SAP30BP;PRKD1;ZBTB7B;ING2
prerank,natural killer cell mediated immunity (GO:0002228),-0.6368582679184733,-1.7766890806321642,0.002577319587628866,0.25843898105699115,0.996,10/15,28.13%,ULBP1;LYST;SLAMF7;CEBPG;RAET1E;KLRD1;TUBB4B;KLRK1;PLEKHM2;KLRC2
prerank,positive regulation of T cell activation (GO:0050870),-0.44621036483803783,-1.7730612382878466,0.0,0.26018238776539543,0.996,19/62,10.62%,IL15;FLOT2;CD274;CCDC88B;SLC7A1;PTPRC;CD47;CCR2;IL6ST;NCK1;NOD2;HSPD1;TFRC;ZMIZ1;ANXA1;PRKCQ;IL1B;CD28;LCK
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5337160195595849,-1.7715108104116126,0.0025380710659898475,0.25631389212035277,0.996,14/27,22.31%,MAP3K1;TLR2;CD36;CD14;HSPD1;UBC;TAB1;UBA52;IRAK4;TLR4;TLR1;MYD88;TNIP1;TLR5
prerank,positive regulation of phagocytosis (GO:0050766),-0.46417999918661546,-1.7622648023241758,0.0,0.27134517088661075,0.997,18/47,20.05%,FCGR2B;IL15;GAS6;STAP1;PTPRC;CD47;DOCK2;CD300LF;IL1B;C4B;CYBA;SLC11A1;TNF;TUB;FCER1G;RAB31;APPL2;C2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5642678118961799,-1.7601547222305036,0.007792207792207792,0.2693082269982639,0.997,6/21,1.22%,FCGR2B;PTPN22;STAP1;PRKCH;CD300A;SLC39A10
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5931036562813695,1.759395654160925,0.003316749585406302,0.534888749378205,0.992,14/24,22.80%,TPPP;STMN4;STMN3;STMN2;NCKAP5;CKAP5;FGF13;NCKAP5L;KIF2A;KIF14;HDGFL3;PIN1;MAP7D3;TPPP3
prerank,response to copper ion (GO:0046688),0.6091209504486004,1.7555300133933314,0.0016025641025641025,0.5142485136757001,0.995,12/20,18.10%,PRNP;AOC1;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;IL1A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4318206061376806,-1.7544231207101983,0.0,0.2774447066049304,0.999,32/67,26.08%,NEDD9;NRP1;CASS4;CRK;CDK6;CD36;LIMS1;CCL25;UTRN;CRKL;CARMIL1;CIB1;S100A10;SKAP1;EMP2;MYOC;PTK2B;CCL28;FLNA;FN1;MYADM;ECM2;PPM1F;DOCK1;RREB1;CD3E;ARL2;OLFM4;ILK;RAC1;CSF1;ALOX15
prerank,receptor-mediated endocytosis (GO:0006898),-0.382700997646262,-1.7494173063545524,0.0,0.282395845712491,0.999,44/132,18.47%,DAB2;MRC1;FCGR2B;CD163;APOE;AP2A2;DNAJC6;TPCN2;MSR1;CD36;GAK;SNX1;CXCL16;M6PR;FCHO2;AP2B1;HIP1R;LDLRAP1;SYK;TFRC;PICALM;CAV1;LDLR;SNX9;EPS15;CTSL;STAB2;IGF2R;GRB2;DNM2;CLTA;LRP1;DNAJC13;LILRB1;WASF1;RAMP2;CALCRL;CLN3;FCER1G;CLTB;RAB31;FCHO1;HPX;LRP6
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4550396158067397,-1.7474556524372493,0.002702702702702703,0.28043571848570586,0.999,24/47,29.63%,NEDD9;NRP1;CASS4;CRK;CORO1C;LIMS1;CRKL;CARMIL1;CIB1;S100A10;MYOC;SPRY4;FLNA;MYADM;DOCK1;RREB1;OLFM4;FBLN1;PDPN;ILK;RAC1;TESK1;ACTN4;C1QBP
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.655773295410162,-1.7467028611963686,0.014423076923076924,0.2755914985835605,0.999,7/13,19.01%,RBPJ;CPE;NOTCH1;NPY5R;HEY2;SMAD4;NPY2R
prerank,neuromuscular junction development (GO:0007528),0.5760372022665039,1.7450075650771482,0.0050335570469798654,0.5324720085541196,0.998,13/24,24.51%,AGRN;CACNB4;CACNB2;PDZRN3;PPFIBP1;NEDD4;UNC13B;DCTN1;DNAJA3;UNC13C;DOK7;ZC4H2;ANK3
prerank,regulation of multicellular organismal development (GO:2000026),-0.5371241308175264,-1.7400797339343992,0.004889975550122249,0.2849179646952989,1.0,12/25,13.54%,OAS2;CD24;BAG6;RACGAP1;HPSE;MYSM1;TRIP12;CDK1;EHMT1;CCSAP;PTN;SCX
prerank,response to interferon-gamma (GO:0034341),-0.4275954362430332,-1.7385638024669998,0.0,0.2827602607635783,1.0,29/67,25.24%,SP100;CD74;CD47;TLR2;CIITA;IFITM3;CXCL16;CCL25;SHFL;BST2;GBP3;STAT1;ACOD1;DAPK1;SLC11A1;SYNCRIP;GBP4;WNT5A;TLR4;GBP6;CASP1;TRIM21;IFITM1;KYNU;GBP7;MEFV;CCL7;SLC26A6;IL12RB1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.6596573748263587,-1.73818047135586,0.004761904761904762,0.277441747857486,1.0,10/12,28.08%,PTPN22;CD300A;PTPRC;LYN;RC3H1;PAX5;ELF2;BLK;CBFB;CD19
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.616182237235813,-1.7379172214239016,0.0048543689320388345,0.27232059669581465,1.0,10/14,25.12%,DDX60;ANKRD17;TLR2;PUM2;OASL;USP15;PUM1;TLR5;TLR9;DHX58
prerank,negative regulation of macrophage activation (GO:0043031),-0.5992493921599497,-1.7367865085178757,0.009900990099009901,0.2691141066130523,1.0,5/16,13.28%,FCGR2B;PTPRC;LDLR;ZC3H12A;NR1H3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5336609718025485,-1.7359059156415877,0.010810810810810811,0.2658162857051938,1.0,10/24,17.16%,RBPJ;ATF3;CEBPB;HIF1A;HSF1;NOTCH1;CREB3L1;MAPK7;SESN2;KLF2
prerank,regulation of B cell proliferation (GO:0030888),-0.46457476597509834,-1.7334945664501302,0.0028735632183908046,0.2665973467244237,1.0,14/44,10.65%,VAV3;FCGR2B;BCL2;CD74;CD38;CD300A;PTPRC;TYROBP;AHR;GPR183;TFRC;LYN;IKZF3;RC3H1
prerank,negative regulation of viral genome replication (GO:0045071),-0.46797217822217163,-1.7332757844306332,0.0,0.2619570560854527,1.0,21/40,23.52%,OAS2;IFIH1;IFITM3;IFIT1;PROX1;OASL;SHFL;BST2;BANF1;OAS3;INPP5K;TNF;HMGA2;ZC3HAV1;LTF;TNIP1;IFITM1;ILF3;TASOR;EIF2AK2;PLSCR1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.6738245527512682,-1.7327407161809492,0.013986013986013986,0.2580448824001442,1.0,5/11,15.41%,ANXA1;SOCS5;ZC3H12A;RC3H1;RC3H2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.6112945552899757,1.7300671904005565,0.003395585738539898,0.5847255553055387,0.998,6/20,6.31%,STARD3;TSPOAP1;STAR;AKR1C1;FDX2;AKR1B1
prerank,cardiac muscle cell action potential (GO:0086001),0.5602206842957934,1.7299181935041095,0.0047694753577106515,0.5464802770568314,0.998,14/30,22.35%,YWHAE;KCNH2;FGF12;ATP1B1;KCNE2;DMD;CACNA1G;SLC8A1;CACNA1D;CACNA2D1;ANK2;ATP1A1;SCN1B;SCN3B
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5557014423626769,-1.7284662294747069,0.01699029126213592,0.26247216055173694,1.0,8/21,13.37%,APOE;EEPD1;PPARG;PLTP;CAV1;NR1H2;NR1H3;LRP1
prerank,membrane repolarization during action potential (GO:0086011),0.6823470594060548,1.7241339947083771,0.010309278350515464,0.5459082322967013,0.999,4/13,3.05%,YWHAE;KCNH2;ATP1B1;KCNE2
prerank,fatty acid transport (GO:0015908),-0.5822465135916887,-1.7218747356571653,0.01937046004842615,0.2723811938952464,1.0,6/17,5.55%,APOE;PPARG;CD36;FABP4;SLC27A4;PPARD
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.664980417406883,1.7204364591337982,0.0065252854812398045,0.5328254642024448,0.999,5/13,9.37%,SCAMP5;SYT4;SYT1;DOC2B;CACNA1G
prerank,regulation of leukocyte activation (GO:0002694),-0.6258875403422026,-1.719352813087952,0.0023752969121140144,0.272823412073883,1.0,8/14,23.52%,CD74;PJA2;LYN;GPR137B;LCK;SHPK;CD33;PLSCR1
prerank,dendrite morphogenesis (GO:0048813),0.5426324355933304,1.7180822412900008,0.004665629860031105,0.5161553295428009,0.999,25/35,28.99%,MAP6;CTNNA2;SHANK3;KLF7;CTNND2;BTBD3;MINK1;DOCK10;EPHB2;WNT7A;SHANK1;CHRNA7;SDC2;CDC42;MAP2;FARP1;WASL;MEF2A;TAOK2;DLG4;PHACTR1;DIP2A;CELSR2;PTEN;DCDC2
prerank,ncRNA processing (GO:0034470),-0.3520942299501288,-1.7176048365980285,0.0,0.2717429889405486,1.0,67/200,19.56%,UTP6;NOL11;RPL39;RPL5;RPS24;INTS2;RPS16;WDR43;RPL28;RPS14;DDX49;RPL35A;RPL18A;RPL27;RPL21;RPS7;SMAD3;DDX52;RPF1;FARS2;RPL30;MRM2;RPL6;RPL37A;RRP12;SRRT;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;UTP11;UTP15;EXOSC10;RPP21;DDX27;SSB;RPL14;XRN2;RPL9;MPHOSPH6;RPL32;RPL36;NOP58;RPL31;HNRNPA2B1;RPL23A;INTS12;AGO2;MDN1;UTP18;RPL41;RPL3;EXOSC9;WDR3;TBL3;RPL8;TEX10;FBL;NOP53;POP1;RPL37;EMG1;RPL36A;DKC1;RPL26
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.7346307410062928,1.7172298239181298,0.008726003490401396,0.4939725896006664,0.999,5/10,6.94%,YWHAE;CBARP;BIN1;VDAC1;ADRA2A
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.5317646562714676,-1.7159217599875263,0.017948717948717947,0.2713451708866107,1.0,9/22,14.85%,SASH1;XDH;PJA2;RELL1;IL1B;ZC3H12A;GADD45G;BMP2;AGER
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.5253179491286591,-1.7155017255596567,0.0027397260273972603,0.2676758407756245,1.0,8/25,9.84%,FBXL17;VCP;CUL3;YME1L1;UGGT1;BAG6;KLHL15;CLPP
prerank,synapse organization (GO:0050808),0.42153761067391327,1.7124531169153514,0.0,0.4924713614279834,0.999,49/125,23.81%,AGRN;PCDHB9;CACNB4;PCDHB4;OBSL1;CACNB2;PTPRD;PDZRN3;PCDHB5;CNTN2;SPOCK2;NRXN1;CBLN2;DSCAM;PPFIBP1;RYK;SHANK3;ADGRL3;ACHE;SDK1;CX3CR1;CTNND2;NEDD4;PPFIA4;UNC13B;PCDHB3;DCTN1;NRCAM;GPC4;CYFIP1;CHCHD10;SLC6A1;SLC8A3;REST;PTPRS;NTNG1;SNCB;CHRNA7;PIN1;UNC13C;DOK7;LRRC4C;CDC42;GPM6A;FARP1;CAST;ZC4H2;BDNF;LRRC4B
prerank,chloride transmembrane transport (GO:1902476),0.5033278894863783,1.7110663980155232,0.0,0.4761215895152956,0.999,19/48,16.60%,SLC4A8;GABRQ;GLRA3;GABRG1;GABRD;SLC12A2;GABRG2;SLC1A1;GLRB;GABRA2;ANO2;SLC12A6;GLRA2;CFTR;SLC1A3;SLC6A1;GABRB1;GABRR2;ANO3
prerank,positive regulation of macrophage activation (GO:0043032),-0.5682363147033961,-1.7051371580210353,0.014527845036319613,0.28712989054859783,1.0,7/17,18.53%,STAP1;THBS1;HSPD1;LBP;WNT5A;TLR4;MMP8
prerank,B cell receptor signaling pathway (GO:0050853),-0.49509310139060786,-1.7049603275357308,0.008021390374331552,0.2828207507113296,1.0,15/32,20.76%,VAV3;RFTN1;BCL2;CD38;PTPRC;TEC;BAX;SYK;BLNK;LCK;CD79B;BCAR1;CD79A;NFATC2;PIK3CD
prerank,modulation by host of viral genome replication (GO:0044827),0.6646747801043342,1.7041437834747841,0.0034904013961605585,0.4904880338270303,1.0,8/13,16.61%,NUCKS1;YTHDC2;PPIB;PRKN;IFI27;CCNK;EIF2AK4;FBXL2
prerank,cellular response to interferon-gamma (GO:0071346),-0.3971830174411408,-1.7041130141285796,0.0,0.28019241289961005,1.0,28/88,16.41%,SP100;OAS2;CD44;TRIM25;CD47;TLR2;IRF9;CIITA;IRF7;CCL25;OASL;IRF4;TRIM62;MID1;GBP3;HCK;CAMK2D;STAT1;ACOD1;DAPK1;TRIM5;OAS3;SYNCRIP;B2M;GBP4;IRF2;WNT5A;TLR4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5675153578006302,-1.7037950055443436,0.01927710843373494,0.2765732123173679,1.0,8/19,10.41%,AEN;USP28;BCL3;BAG6;TMEM109;SNW1;EP300;HIPK1
prerank,cytosolic transport (GO:0016482),-0.3729436899431841,-1.7001515065915476,0.0,0.2810190144104508,1.0,41/108,17.97%,STX6;RIC1;PIK3C3;KIF16B;VPS26A;KLHL20;PTPN23;STX5;TMEM87B;GAK;RAB7A;SNX1;VPS35;GBF1;LMTK2;EPS15;CLN5;RAB6A;AP4M1;DENND2A;WDR91;VPS26B;AKTIP;WDR81;TBC1D10C;LAMP1;TBC1D10A;DENND5A;EMP2;VPS54;EEA1;YKT6;RBSN;RGP1;CORO7;CLN3;VPS52;DOP1B;GCC2;ERC1;RILP
prerank,synapse assembly (GO:0007416),0.46246537402055066,1.6974801326453985,0.0,0.5018899454695881,1.0,20/67,12.84%,PCDHB9;PCDHB4;PLXNB2;OBSL1;PCDHB5;SPOCK2;NRXN1;DSCAM;GABRG2;RYK;LRRTM3;GABRA2;SHANK3;GRID2;ADGRL3;ACHE;SDK1;FGF13;PCDHB3;NRCAM
prerank,cellular response to copper ion (GO:0071280),0.6292917636220882,1.6973391947583192,0.006734006734006734,0.48166826325678835,1.0,11/16,18.07%,PRNP;AOC1;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6663818984607196,1.6971286186846792,0.00980392156862745,0.4634746097937955,1.0,5/13,10.07%,B3GNT9;B4GAT1;B3GNT6;B3GALT2;B3GALNT1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.4139438863145595,-1.6970230442809706,0.0,0.28343321143231176,1.0,34/69,24.92%,OAS2;PTPRC;IFIH1;TLR2;LILRA5;CCR2;TYROBP;CD14;THBS1;PF4;NOD2;SYK;RIPK1;PSEN1;LPL;CYBA;CD2;OAS3;SPHK2;LBP;AGER;HSPB1;WNT5A;SPN;TLR4;MMP8;ARHGEF2;TLR1;ISL1;TWIST1;APP;TNFRSF8;FADD;TLR9
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.4799025067389493,1.6961946483075168,0.0,0.4498669243591855,1.0,22/57,17.85%,CACNG5;CACNG2;DLG2;NPTXR;CNIH2;GRIA2;MEF2C;NPTX1;GRIA1;ACTN2;GRIN1;GRIA4;GRIN2B;CACNG7;MINK1;CRHBP;DLGAP1;DLGAP2;OPRM1;CACNG3;DLGAP3;SHANK1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5700824431861786,-1.695615769651481,0.014150943396226415,0.28206695290089,1.0,6/18,14.68%,DAB2;PTPN23;MTMR2;MSN;RAB21;DNAJC13
prerank,myelin assembly (GO:0032288),0.7039249526077794,1.695317474119802,0.0034662045060658577,0.43653663483144284,1.0,3/10,5.19%,TPPP;CNTNAP1;GPC1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.6374361422963489,-1.694482721933527,0.00963855421686747,0.28074209614314766,1.0,5/12,12.21%,CCR2;PRKCQ;CLEC6A;IL1B;SLC11A1
prerank,early endosome to Golgi transport (GO:0034498),-0.6537385642532838,-1.6940497693229752,0.013574660633484163,0.27746603608277554,1.0,6/11,14.31%,SNX8;STX5;SNX1;RAB6A;TMED9;RBSN
prerank,negative regulation of immune effector process (GO:0002698),-0.6287735457405109,-1.6929723367712783,0.011990407673860911,0.2760476556792913,1.0,6/13,14.99%,CD300A;CD47;ENPP3;RC3H1;CD55;LILRB1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.47127343554827933,1.6911169078086554,0.001392757660167131,0.43807920398939304,1.0,20/59,15.85%,PLXNB2;OBSL1;ROBO4;CADM1;MYPN;CNTN2;PTPRT;DSCAM;IGSF21;IGSF11;SDK1;NECTIN3;TENM3;BSG;FAT2;CDH4;PKD1;CADM3;DSCAML1;HMCN1
prerank,bicarbonate transport (GO:0015701),0.5648662444638614,1.6897545171197674,0.0064516129032258064,0.42838738398338155,1.0,10/25,13.41%,SLC4A8;CA1;CA3;CA4;CFTR;CYB5R2;SLC26A7;SLC39A8;SLC4A10;SLC4A7
prerank,epidermal cell differentiation (GO:0009913),-0.46167423291645104,-1.6889663705985245,0.005763688760806916,0.2808443074184982,1.0,24/41,36.48%,ST14;ADAM9;CLIC4;ANXA1;TXNIP;CTNNB1;HDAC2;HDAC1;WNT5A;EPHA2;OPN3;BCR;DSP;EVPL;SCEL;SPINK5;KRT10;ASAH1;UGCG;OVOL2;OVOL1;PITX2;GLI1;SPRR1A
prerank,cellular modified amino acid catabolic process (GO:0042219),0.637459349445022,1.685566740729262,0.008403361344537815,0.43151900595203746,1.0,8/15,22.59%,HOGA1;GGT7;GGT5;ABHD12;ALDH4A1;GGACT;CHAC2;PRODH
prerank,positive regulation of potassium ion transport (GO:0043268),0.5137843870677264,1.6811837693920657,0.004608294930875576,0.43648478716233374,1.0,14/38,17.90%,KCNMA1;KCNJ3;KCNH2;GABBR1;NOS1AP;ADRA2A;FHL1;ACTN2;GABBR2;KCNN4;KCNJ5;KCNMB3;KCNN3;ANK2
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.5082707194524719,-1.6789584612262647,0.0076726342710997444,0.3016612090805912,1.0,12/27,18.71%,CD74;GAS6;IGF1;CDK6;NDUFS4;S100A6;BMI1;PDGFC;LIG4;WNT5A;FN1;PDGFRA
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.49844088135887976,-1.677801768109714,0.008356545961002786,0.3003070314524861,1.0,10/30,11.77%,UBE2D3;IRF7;TBK1;CD300LF;CD14;TNIP3;RIPK1;UBC;UBA52;BIRC2
prerank,rRNA processing (GO:0006364),-0.35350041699807183,-1.6763563622598374,0.0,0.29936853204305197,1.0,59/172,19.56%,UTP6;NOL11;RPL39;RPL5;RPS24;RPS16;WDR43;RPL28;RPS14;DDX49;RPL35A;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;RPL30;MRM2;RPL6;RPL37A;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;UTP11;UTP15;EXOSC10;MRPL1;DDX27;RPL14;XRN2;RPL9;MPHOSPH6;RPL32;RPL36;NOP58;RPL31;RPL23A;MDN1;UTP18;RPL41;RPL3;EXOSC9;WDR3;TBL3;RPL8;TEX10;FBL;NOP53;RPL37;EMG1;NAT10;RPL36A;DKC1;RPL26
prerank,retinoic acid metabolic process (GO:0042573),0.6334590494646462,1.6753817815898706,0.01757469244288225,0.44735379668288394,1.0,3/14,4.32%,CYP2S1;CYP26C1;BCO2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.6688542281427383,1.6733081478315028,0.014084507042253521,0.44247692083469947,1.0,6/12,13.14%,STARD3;TSPOAP1;STAR;FDX2;AKR1B1;TSPO
prerank,pentose-phosphate shunt (GO:0006098),-0.6393053324835503,-1.6718859146909577,0.016587677725118485,0.30554052649790164,1.0,4/11,12.61%,RBKS;TALDO1;TKT;SHPK
prerank,positive regulation of viral life cycle (GO:1903902),-0.5340777647970222,-1.6713576146915,0.010471204188481676,0.30227603451478174,1.0,4/22,4.02%,CD74;AXL;LGALS1;KPNA2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6680340530532092,1.6684829557364669,0.01631321370309951,0.4493510219229938,1.0,5/12,10.07%,B3GNT9;B4GAT1;B3GNT6;B3GALT2;B3GALNT1
prerank,transferrin transport (GO:0033572),-0.4743686229660694,-1.6669023711320752,0.005319148936170213,0.30924275988910926,1.0,10/33,12.83%,ATP6V0D1;ATP6V0D2;STEAP3;ATP6V1B2;ATP6V0A1;ATP6V0B;LMTK2;TFRC;DNM2;ATP6V1A
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.6489584158079185,1.6665834615826232,0.020134228187919462,0.4453269829206983,1.0,6/14,17.12%,WRAP53;FUS;TIMELESS;PARP1;ERCC6;MRNIP
prerank,actin filament network formation (GO:0051639),-0.6424765582515425,-1.6646427376145714,0.024608501118568233,0.3115132819147699,1.0,6/11,17.49%,ACTN1;CARMIL1;LCP1;COBL;PLS1;CARMIL2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5220646694820019,1.6639130161608833,0.0046875,0.44402508794936746,1.0,9/35,11.40%,PCDHB9;PCDHGB4;PCDHB4;CDH23;DCHS1;PCDHB5;CDH18;ATP2C1;PCDHB3
prerank,sterol transport (GO:0015918),-0.5481447515233344,-1.6637702477876801,0.021739130434782608,0.3095357040646478,1.0,8/19,9.15%,NPC2;MSR1;OSBP;CD36;LDLRAP1;CAV1;LDLR;OSBPL2
prerank,defense response to symbiont (GO:0140546),-0.38084745411135473,-1.659606057023485,0.0,0.3159320174958252,1.0,32/92,14.99%,BCL2;OAS2;BCL2L1;PTPRC;IFIH1;TLR2;IFIT2;IRF7;LYST;ZBP1;IFITM3;IFNAR2;STAT2;TLR7;IFIT1;ATG7;OASL;SHFL;BST2;IFIT3;TLR8;AGBL5;STAT1;ACOD1;NDUFAF4;NLRC5;TRIM5;OAS3;IRF2;PMAIP1;IFNLR1;LILRB1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6376674390742144,-1.659528811427492,0.016786570743405275,0.3120879313809369,1.0,8/12,35.84%,CAV1;CAMK2D;CALM3;CALM2;PDE4D;CALM1;SRI;IRX3
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.6840874092417398,1.6587377185529968,0.00847457627118644,0.45326417060832086,1.0,4/11,2.48%,YWHAE;KCNJ3;KCNH2;ATP1B1
prerank,regulation of response to stress (GO:0080134),0.6983723975987846,1.657021808131573,0.026223776223776224,0.44937178579813464,1.0,5/10,16.91%,ADCY8;SLC38A2;CORO2B;CRHBP;OPRM1
prerank,homocysteine metabolic process (GO:0050667),-0.6473558848191601,-1.6555367325658854,0.018912529550827423,0.31898995884488873,1.0,6/11,24.23%,MTHFR;MTRR;MPST;CBS;CTH;NOX4
prerank,intracellular cholesterol transport (GO:0032367),-0.5900527782754379,-1.6548231431984246,0.01932367149758454,0.3168497068741039,1.0,7/15,9.44%,NPC2;OSBP;LDLRAP1;LDLR;SERAC1;OSBPL2;ABCG1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3989343109978556,1.6547185904950883,0.0,0.44818771250805167,1.0,44/159,17.81%,PCDHB9;PCDHGB4;PCDHB4;PLXNB2;OBSL1;CDH23;PTPRD;DCHS1;MPZ;CLDN16;ROBO4;CADM1;TENM1;MYPN;PCDHB5;CNTN2;PTPRT;DSCAM;IGSF21;IGSF11;CDH18;GRID2;ADGRL3;SDK1;NECTIN3;TENM3;BSG;IL1RAPL1;FAT2;ATP2C1;CRTAM;ICAM1;PCDHB3;CDH4;MAG;PKD1;CADM3;GPC4;DSCAML1;FAT4;HMCN1;CXADR;PTPRS;NTNG1
prerank,defense response to virus (GO:0051607),-0.37050269513315975,-1.6519800241218368,0.0,0.32047131709279275,1.0,33/100,14.99%,BCL2;OAS2;BCL2L1;PTPRC;ATAD3A;IFIH1;TLR2;IFIT2;IRF7;LYST;ZBP1;IFITM3;IFNAR2;STAT2;TLR7;IFIT1;ATG7;OASL;SHFL;BST2;IFIT3;TLR8;AGBL5;STAT1;ACOD1;NDUFAF4;NLRC5;TRIM5;OAS3;IRF2;PMAIP1;IFNLR1;LILRB1
prerank,chloride transport (GO:0006821),0.44365162702734895,1.647674649524449,0.0,0.4674197460705558,1.0,23/74,16.60%,SLC4A8;GABRQ;GLRA3;GABRG1;NMUR1;GABRD;SLC12A2;GABRG2;SLC1A1;GLRB;GABRA2;ANO2;CLCN6;SLC12A6;GLRA2;CFTR;SLC26A7;SLC1A3;SLC4A10;SLC6A1;GABRB1;GABRR2;ANO3
prerank,stabilization of membrane potential (GO:0030322),0.6070874857275789,1.643958665608016,0.018363939899833055,0.47262732595587936,1.0,7/16,19.18%,KCNK12;KCNK3;KCNK6;KCNN4;CHCHD10;KCNK9;KCNK2
prerank,regulation of neuron projection development (GO:0010975),0.3938898835822973,1.643802733090471,0.0,0.46212574891440794,1.0,55/163,19.61%,CSMD3;ABI3;TANC2;PLXNB2;DCC;ARHGAP44;CHN1;CTNNA2;PAK1;NTRK1;ARSB;STMN2;CRMP1;PLA2G3;PTPRO;NTRK3;FBXO7;ITM2C;RTN4RL1;PTK7;PRKCI;GPC2;PRAG1;RIT2;MINAR1;DAB2IP;SHANK3;TWF2;SRCIN1;CDKL5;TENM3;IL1RAPL1;CFL1;MAG;ARHGAP35;MYLIP;LZTS3;NDRG4;EPHA4;NDNF;STYXL1;NTRK2;PRKD1;TWF1;SETX;ITGA6;PTPRS;SCARB2;ULK4;NTNG2;NTNG1;FES;MAGI2;LRRC4C;ROR1
prerank,sarcomere organization (GO:0045214),0.5373412673055014,1.6437862506580012,0.01652892561983471,0.45141533741664747,1.0,4/27,9.00%,CAPN3;SIX4;MYPN;ACTN2
prerank,response to cytokine (GO:0034097),-0.3492789966596287,-1.6434939581442949,0.0,0.3388129428897974,1.0,55/141,23.52%,PID1;SP100;BCL2;CD74;CD274;BCL2L1;KLHL20;PTPN23;LIFR;CIITA;MCL1;TBK1;IFITM3;IFNAR2;MAPKAPK2;IL6ST;CXCL16;ADAM9;SHFL;SMAD3;LDLRAP1;BST2;RIPK1;ANXA1;IL1B;PTPN7;STAT1;MAPKAPK3;SLC11A1;TIMP4;ASAH2;IFNLR1;RELB;MAPK8;CRNN;IL18R1;MAP2K7;COL3A1;OSMR;MYD88;ALDH1A2;TIMP1;CDK9;CASP1;SETD2;TRIM21;HDAC4;PTPN4;IFITM1;APP;KYNU;MEFV;XAF1;EIF2AK2;PLSCR1
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.519785820565018,-1.6423369959002494,0.008152173913043478,0.33751770578782864,1.0,7/21,14.84%,RBKS;TALDO1;TKT;HK1;SHPK;GPI;PGM2L1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.515703995043484,-1.6402565475780113,0.019656019656019656,0.3397595827064317,1.0,12/22,20.54%,FLOT2;GCNT2;CD44;IL1B;LCK;SKAP1;AGER;TNF;MAPK7;MYADM;BMP7;KLF4
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4662275421534903,-1.6392275089186592,0.011904761904761904,0.33823024622303066,1.0,15/32,17.92%,CLSPN;CDC14B;TOPBP1;NBN;BRCA1;ABRAXAS1;TAOK3;CDK1;TICRR;PLK1;NOP53;UIMC1;BRCC3;DTL;HMGA2
prerank,inorganic anion transmembrane transport (GO:0098661),0.45296901164268927,1.6375446500390447,0.0014641288433382138,0.46674548641598224,1.0,22/63,17.64%,SLC4A8;GABRQ;GLRA3;GABRG1;GABRD;SLC37A4;SLC12A2;GABRG2;SLC1A1;GLRB;SLC20A1;GABRA2;ANO2;SLC12A6;GLRA2;CFTR;SLC1A3;SLC6A1;GABRB1;GABRR2;ANO3;SLC37A1
prerank,lysosome localization (GO:0032418),0.5145144064474305,1.6371988907715327,0.004792332268370607,0.4577234777992295,1.0,13/37,17.26%,MAP6;BLOC1S2;RAB3A;SYTL4;SNAPIN;BORCS6;PIK3CG;S100A13;TFEB;RAB34;FLCN;BORCS5;VPS33B
prerank,sodium ion homeostasis (GO:0055078),0.568457507026712,1.6367405249978082,0.01485148514851485,0.44981414661635266,1.0,10/21,23.15%,ATP1B1;SCNN1A;SLC12A2;ATP1B3;SLC8A1;NEDD4L;ATP1A4;ATP1A3;ATP1A1;SLC9A1
prerank,neuron projection development (GO:0031175),0.3908453036422324,1.6357773301820013,0.0025252525252525255,0.44366834690306467,1.0,76/168,27.76%,CTTN;PLP1;STMN4;STMN3;WHRN;CNTNAP1;SRGAP2;NYAP2;PQBP1;BLOC1S2;PAK1;STMN2;SNAPIN;NCKAP1;NCKAP1L;OMG;IL6;LGI1;MAP1S;RYK;MANF;DAB2IP;SHANK3;SAMD14;ADCYAP1;SH3GL2;GPRIN1;MAP4K4;CTNND2;NEDD4;RASGRF1;BTG2;STX3;EHD1;MINK1;DOCK10;CAMSAP1;ANKRD27;VASH2;MICALL1;IFT88;EPHA4;HMGB1;EPHB2;ERCC6;WNT7A;PPP1R9A;ROCK1;TAOK1;HDGFL3;ALS2;SHANK1;PLXNB1;CDC42;MAP2;GPM6A;ZFYVE27;ULK1;OPHN1;WASL;PTPRM;BDNF;VAPA;TAOK2;RAPGEF2;DCLK1;FLRT3;CNTNAP2;MYO16;MAPT;DLG4;TBC1D24;GRM7;RAB13;DIP2A;EPB41L3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.5554024933429973,-1.6354095100662929,0.018134715025906734,0.34413565619836867,1.0,10/17,14.15%,BUB3;MIS12;BOD1;ZWILCH;CENPA;HASPIN;CTCF;CDK1;RB1;SPDL1
prerank,steroid hormone biosynthetic process (GO:0120178),0.5217695852059421,1.635140405360139,0.007739938080495356,0.43689096651555936,1.0,8/29,13.14%,STARD3;HSD17B2;TSPOAP1;STAR;FDX2;AKR1B1;HSD17B11;TSPO
prerank,protein depolymerization (GO:0051261),0.5364800325219685,1.634948982934231,0.013201320132013201,0.4288121593882684,1.0,12/27,16.38%,STMN4;STMN3;STMN2;NCKAP5;MICAL3;TWF2;CKAP5;CFL1;NCKAP5L;KIF2A;TWF1;KIF14
prerank,purine-containing compound salvage (GO:0043101),0.640167128923885,1.6330230376959907,0.01335559265442404,0.42829977475020103,1.0,6/12,15.26%,ADA;PNP;AMPD3;HPRT1;DCK;GMPR
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.6017381848380444,-1.6309196908426329,0.012437810945273632,0.35227317782351664,1.0,6/13,13.19%,CD74;CD44;DYRK1A;YJU2;PTTG1IP;PSMD10
prerank,regulation of cation channel activity (GO:2001257),0.42317055596569375,1.6308139535131734,0.0068775790921595595,0.42875122210924366,1.0,28/89,17.90%,FGF14;CACNB4;CACNG5;CACNG2;DLG2;FGF12;CACNB2;FGF11;KCNE2;CNIH2;DMD;GRIA2;MEF2C;GRIA1;ACTN2;GRIN1;GRIA4;GRIN2B;FGF13;CACNG7;MINK1;JPH1;CRHBP;HPCA;OPRM1;CACNG3;SHANK1;ANK2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.607049165025868,-1.6297110771378793,0.02546296296296296,0.351388825136796,1.0,8/12,20.01%,GCNT2;CD44;IL1B;LCK;SKAP1;AGER;TNF;BMP7
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.6363323168517896,-1.6291596582251535,0.030162412993039442,0.34896650857740574,1.0,5/11,17.14%,SP100;RPS6KA6;MAD2L2;KAT5;HIPK2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5840193762946798,-1.627199354753392,0.016355140186915886,0.3503365061852682,1.0,4/15,9.55%,IQGAP2;ACTR3;ARPC2;ARPC5
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5448111772574031,-1.626870949754401,0.015306122448979591,0.34765282471211056,1.0,10/18,20.89%,DDX60;ANKRD17;PUM2;OASL;BIRC2;NOP53;NPLOC4;USP15;PUM1;RNF125
prerank,axonal fasciculation (GO:0007413),0.6405844679420544,1.6231711491422305,0.015358361774744027,0.4505952572102797,1.0,5/12,14.92%,MEGF8;ARHGAP35;NRCAM;EPHA4;EPHB2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5340183135332418,-1.6206302009315914,0.030690537084398978,0.36119816139931515,1.0,9/20,16.41%,PTPN22;PRKCE;CD14;LYN;IL1B;HCK;LBP;TNF;TLR4
prerank,regulation of exocytosis (GO:0017157),0.4703078696060114,1.620369867365443,0.004464285714285714,0.45312495417264936,1.0,15/46,14.90%,LGI3;RAB3A;CADPS2;SYTL4;SYT1;RAB26;RAB8A;CLASP2;CFTR;IL1RAPL1;RAB5A;RAB3D;CPLX2;RAB12;HAP1
prerank,negative regulation of cell development (GO:0010721),-0.48874978564479127,-1.618096955833294,0.020833333333333332,0.36440688949597316,1.0,14/25,24.07%,IGF1;PCM1;FBXW7;IL1B;NOTCH1;B2M;LILRB1;TNF;PTHLH;RFLNA;APPL2;LTF;PAX6;HOOK3
prerank,protein heterotetramerization (GO:0051290),0.6357295739528185,1.6179368590951602,0.01794453507340946,0.4545089223144618,1.0,7/13,14.27%,CPSF6;CBR4;PKD2;GRIN1;GRIN2B;PKD1;NUDT21
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.4237080445472103,-1.615987267752357,0.009036144578313253,0.3661440618980523,1.0,18/47,15.86%,FBXW7;PROX1;NFKB1;CAV1;FYN;ERLIN2;BRCA1;WDTC1;ZC3H12A;EP300;PTGIS;C1QTNF3;CRY1;CEACAM1;APOC1;GLA;SIK1;ACADL
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.592327130512032,-1.6156932576768952,0.018561484918793503,0.36315234648052547,1.0,6/14,14.99%,PIBF1;LILRA5;THBS1;TLR8;SLAMF1;LILRB1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.5742255633522622,-1.61453898492041,0.03076923076923077,0.3626076154030387,1.0,4/14,11.91%,IGF1;PTPRC;LDLR;TNFRSF1B
prerank,regulation of aerobic respiration (GO:1903715),-0.5728178908544549,-1.611383365160007,0.03218390804597701,0.36750420858572824,1.0,6/15,16.88%,VCP;ATP7A;CBFA2T3;UQCC2;SLC25A33;NOP53
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5139157308927853,-1.6110630252050588,0.015463917525773196,0.3612429434735375,1.0,10/21,16.18%,BCL2;BCL2L1;MCL1;PF4;IL1B;EYA1;EYA3;EYA2;TNF;MAPK7
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5139157308927853,-1.6110630252050588,0.015463917525773196,0.3612429434735375,1.0,10/21,16.18%,BCL2;BCL2L1;MCL1;PF4;IL1B;EYA1;EYA3;EYA2;TNF;MAPK7
prerank,regulation of interleukin-12 production (GO:0032655),-0.42694938840660396,-1.6093986077386426,0.011235955056179775,0.3623153224433013,1.0,16/47,16.41%,CD47;TLR2;PIBF1;LILRA5;IL16;THBS1;HSPD1;SYK;TLR8;LTB;SLAMF1;FOXP1;AGER;LILRB1;SCIMP;TLR4
prerank,lipoprotein biosynthetic process (GO:0042158),-0.640829708976221,-1.6070087599130785,0.04176334106728538,0.36467432471553707,1.0,3/11,4.87%,APOE;PIK3C3;ATG7
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.36052410143419483,-1.606284747277652,0.0036363636363636364,0.3630630155276494,1.0,49/112,24.92%,GAS6;PTPN22;OAS2;IGF1;PTPRC;CD47;IFIH1;TLR2;LILRA5;RARA;CCR2;MAPKAPK2;TYROBP;CD14;THBS1;PF4;NOD2;SYK;RIPK1;PSEN1;ZC3H12A;LPL;CYBA;CD2;OAS3;SLAMF1;SPHK2;FOXP1;LBP;AGER;LILRB1;HSPB1;WNT5A;SPN;TLR4;MMP8;ARHGEF2;TLR1;CD33;LTF;NLRC3;ISL1;NR1H4;TWIST1;APP;TNFRSF8;GSTP1;FADD;TLR9
prerank,spermatid development (GO:0007286),0.5067916598707469,1.6051744196766324,0.0125,0.4996550959392114,1.0,7/32,6.07%,YTHDC2;TDRD5;ACRBP;DDX25;JAM2;NME5;ZMYND15
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5499679709661549,-1.6046295086636029,0.02195121951219512,0.36410004656338435,1.0,9/17,19.67%,CD300A;PTPRC;PTPA;PPP1R12A;CALM3;CALM2;ITGA1;PPP1R15A;CD33
prerank,membrane organization (GO:0061024),-0.32443784715399854,-1.6021730189085417,0.0,0.3668801745329059,1.0,71/227,16.87%,DAB2;ITSN1;MYOF;RABEP1;TMCC1;HIP1;ACTR3;SYNJ2;CHMP4B;CHMP4A;AP2A2;DNAJC6;REPS2;CORO1C;AGFG1;GAK;SH3GLB1;TOR1AIP1;M6PR;AP3D1;FCHO2;AP2B1;HIP1R;CHRM2;ARPC2;PLEKHA3;LDLRAP1;TFRC;PICALM;LDLR;SNX9;EPS15;FNBP1;CTDNEP1;GAPVD1;UBC;SLC2A8;AMPH;LEMD3;TOR1B;SNAP23;OSBPL2;UBA52;ARPC5;DYSF;SNAP29;IGF2R;GRB2;DNM2;CLTA;CBL;NEMP1;PACSIN2;REEP1;PDCD6IP;CHMP1B;FER1L6;STAM;GCA;TIMM50;EGFR;UBXN2B;WNT5A;CHP1;CLN3;RTP4;KIF20A;CLTB;NAPG;STX18;USO1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.4848056719631627,-1.599461418170352,0.005509641873278237,0.36954364802071915,1.0,8/26,6.28%,ITSN1;AP2A2;DNAJC6;SIGLEC1;GAK;FCHO2;AP2B1;PICALM
prerank,negative regulation of reproductive process (GO:2000242),-0.5470352694381606,-1.5972789557048495,0.015267175572519083,0.3718266208878768,1.0,7/17,20.53%,PAEP;IGF1;ARHGDIB;DUSP1;GJA1;HYAL3;TIMP1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.4469335028001389,-1.5954486177005525,0.014577259475218658,0.37334899835016977,1.0,11/35,14.85%,SASH1;PTPN22;XDH;PJA2;RELL1;IL1B;ZC3H12A;GADD45G;BMP2;DUSP1;AGER
prerank,neurotransmitter biosynthetic process (GO:0042136),0.6258685154985619,1.5948576641365328,0.023728813559322035,0.5374120995292496,1.0,6/14,22.69%,ALDH9A1;ACHE;CHAT;MOXD1;DAGLA;DAGLB
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.4021433690383076,-1.594708915178386,0.005780346820809248,0.3716344228051542,1.0,23/56,19.82%,ALPK1;SFTPA2;SFTPA1;TLR2;CD36;MAPKAPK2;TLR7;CD14;NOD2;CTSL;UBC;TLR8;CTSB;TAB1;UBA52;S100A1;MAPKAPK3;IRAK4;LBP;TLR4;CLEC4E;TLR1;MYD88
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.4752023414666242,-1.5926702668828971,0.02168021680216802,0.3734649374166932,1.0,9/29,11.77%,UBE2D3;IRF7;TBK1;CD300LF;CD14;RIPK1;UBC;UBA52;BIRC2
prerank,regulation of embryonic development (GO:0045995),-0.44918699436095827,-1.5924701906413026,0.014204545454545454,0.3706521548462564,1.0,15/34,21.08%,PHLDB1;B4GALT5;RPS6KA6;BAG6;DAG1;RACGAP1;WDPCP;TRIP12;CDK1;EHMT1;CCSAP;LHX1;NIBAN2;NPHP3;POGLUT1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.6109614201868581,-1.5919489304312342,0.029953917050691243,0.36863087244036946,1.0,3/11,1.54%,BCL2;CD74;CD44
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6435376202863319,-1.5904436394280446,0.02558139534883721,0.3691867457137851,1.0,6/10,28.33%,MAD2L2;NOTCH1;NOTCH4;RGCC;PPM1F;PLG
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5032909338328418,-1.5892636760664156,0.0267639902676399,0.36920755938351096,1.0,9/21,28.41%,OSBPL8;PLA2G4E;PLAAT3;LPCAT4;PLA1A;PLA2G4F;PLA2G2D;MBOAT1;PLA2G12A
prerank,retrograde axonal transport (GO:0008090),0.5925700853241215,1.5886694289865415,0.025848142164781908,0.5573716216973752,1.0,5/16,14.90%,ACTR10;DLG2;DST;KIF1C;HAP1
prerank,clathrin coat assembly (GO:0048268),-0.5627463263706808,-1.584905678029802,0.030226700251889168,0.37729947410458164,1.0,8/15,18.22%,HIP1;FCHO2;HIP1R;PICALM;EPS15;CLTA;CLTB;FCHO1
prerank,calcium ion import (GO:0070509),0.5171057262939426,1.5832169304526507,0.02830188679245283,0.5737724577410951,1.0,11/28,16.41%,ATP2A2;CACNB2;CACNA1S;MICU2;SMDT1;CACNA1G;SLC8A1;CACNA1D;CACNA1B;SLC25A23;CACNA1A
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.5983829676340142,-1.5821947943868135,0.03389830508474576,0.3818962453496012,1.0,6/13,16.30%,PPARG;CD36;SYK;LDLR;LPL;FCER1G
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.634544928453994,-1.5818345431403218,0.0437636761487965,0.3796907489621759,1.0,5/11,12.36%,DAB2;PTPN23;MTMR2;MSN;RAB21
prerank,establishment of protein localization to extracellular region (GO:0035592),0.46852456663034525,1.5807326015673961,0.011747430249632892,0.575147375778402,1.0,15/39,19.24%,LTBP2;RAB3A;TVP23A;RAB8A;COPG1;PPY;TANGO2;ARL4D;RAB3D;MTTP;RAB12;MIA3;COPG2;PREB;OLFM2
prerank,negative regulation of receptor binding (GO:1900121),0.6572369965828521,1.5792104623478165,0.02727272727272727,0.5727943360228225,1.0,3/10,10.34%,ATP2A3;ATP2A2;ADAM15
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.4957303008507348,-1.5783906186402232,0.03816793893129771,0.3856887768158819,1.0,12/24,26.27%,EPC1;RBBP7;PPHLN1;DNMT1;BMI1;H3-3A;PHF19;EED;TASOR;EZH2;MTF2;DNMT3A
prerank,positive regulation of binding (GO:0051099),-0.37102676710877486,-1.5773960230868778,0.0035460992907801418,0.385146867956585,1.0,36/84,21.17%,STK3;APOE;IGF1;HMGB2;PPARG;DTX3L;RARA;MET;NCBP1;CEBPG;TAF1;HIP1R;CAV1;PLAUR;STMN1;CLN5;TXN;PSEN1;AKTIP;SPPL3;LRRK2;PARP9;LRP1;B2M;RALB;BMP2;CDT1;NMD3;HIPK2;MMP8;HES1;DPH3;BAMBI;RPL11;TRIM21;SIRT2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5541416390825696,1.5773138177432287,0.03035413153456998,0.5722258483527778,1.0,10/21,24.33%,KCNH2;KCNA5;NOS1AP;KCNE2;GJA5;CACNA1D;CACNA2D1;ANK2;SCN1B;SNTA1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.4317569314286146,-1.5768918515231742,0.011396011396011397,0.3831282065699677,1.0,10/38,12.18%,UBE2D3;ATG13;FBXW7;TOMM7;SH3GLB1;BAG4;ARIH2;PARL;UBE2L3;LRRK2
prerank,endothelial cell migration (GO:0043542),-0.4433171428704061,-1.5758667604980587,0.020527859237536656,0.38270640166570996,1.0,13/37,15.73%,NRP1;PXN;DPP4;PLEKHG5;PIK3CA;STAT1;EGR3;ADGRA2;ID1;EMP2;CCN3;PRKX;MYH9
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.5944077513903374,-1.5753970713703573,0.02444987775061125,0.3807631487767396,1.0,7/13,24.92%,PIK3C3;PIK3R4;TLR7;EPG5;IRAK4;MYD88;TLR9
prerank,dendritic spine morphogenesis (GO:0060997),0.6050543020643051,1.573598779666388,0.03204047217537943,0.5809149536299215,1.0,11/15,28.40%,SHANK3;CTNND2;DOCK10;EPHB2;WNT7A;SHANK1;CDC42;WASL;DLG4;DIP2A;PTEN
prerank,regulation of Rac protein signal transduction (GO:0035020),0.5896179850445445,1.5733578730936224,0.026058631921824105,0.5728838843541838,1.0,9/16,20.36%,SH3BP1;STMN3;ARHGAP44;PIK3CG;OGT;RASGRF1;CADM4;ALS2;GABARAP
prerank,negative regulation of axonogenesis (GO:0050771),0.5163519590164545,1.5732023997223046,0.023961661341853034,0.5645736583061233,1.0,18/27,29.90%,DIP2B;DCC;THY1;OMG;EFNB3;ARHGDIA;FGF13;GDI1;MAG;PTPRS;ULK2;MAP2;ULK1;RHOA;NGFR;LINGO1;PTEN;RTN4R
prerank,regulation of T cell proliferation (GO:0042129),-0.3956855627886629,-1.5727290034770156,0.01384083044982699,0.384760328635819,1.0,16/61,11.91%,IL15;CD274;CCDC88B;TNFSF8;SLC7A1;PTPRC;DLG5;IL6ST;NCK1;IL27;TFRC;CEBPB;ANXA1;IL1B;CD28;TNFRSF1B
prerank,organophosphate ester transport (GO:0015748),-0.497739766073765,-1.5726354266161782,0.023923444976076555,0.3818330387370662,1.0,8/24,10.11%,OSBPL8;NPC2;PLTP;LDLR;EPG5;PCTP;OSBPL2;SLC25A19
prerank,positive regulation of cellular protein localization (GO:1903829),-0.3818610771187844,-1.5724404288455875,0.010067114093959731,0.37924656662276496,1.0,24/69,16.67%,DTX3L;GNL3L;LAMTOR5;TYROBP;CEP250;TRAPPC12;TFRC;FYN;YAP1;GPR137B;TM9SF4;CDK1;PARP9;SLC5A3;NUMA1;CDT1;ORMDL3;TNF;KAT7;NUP62;NDC80;PARD6A;PLK1;SESN2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.5530940069504646,-1.57181612621178,0.04591836734693878,0.37785693969449485,1.0,8/15,15.15%,APOE;ADAM9;NRDC;SNX9;IL1B;ADAM8;TNFRSF1B;TNF
prerank,inositol phosphate metabolic process (GO:0043647),0.4677792750824528,1.5694317151343955,0.019667170953101363,0.5733800370239106,1.0,14/46,12.24%,PLCH1;INPP4B;ITPK1;IP6K1;INPP5D;NUDT10;PLCD1;INPP5B;PLCG1;NUDT3;PLD4;OCRL;FGF2;IPMK
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.47642980282492164,-1.5679459686238677,0.020887728459530026,0.3850089914611728,1.0,10/27,13.28%,PRKCH;MSR1;PPARG;CD36;NFKB1;PF4;NR1H2;ABCG1;LPL;NR1H3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4863938694960837,-1.5673003578673703,0.0158311345646438,0.3837236544931448,1.0,13/26,22.22%,DAB2;CNOT9;KANK2;SMARCA4;BRCA1;CRY2;PIAS2;CRY1;HDAC1;FOXP1;NCOR1;HEYL;ISL1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.6675237776162923,1.566920727447366,0.032590051457975985,0.5762170406168723,1.0,3/10,5.52%,VSIR;NCKAP1L;PRNP
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.5624826316441149,1.5663882693176996,0.0214168039538715,0.5703960464623382,1.0,7/19,11.80%,MAF1;PRDX5;RPTOR;TENM1;AR;ZC3H8;POLR3F
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.5493929439904234,-1.5656242801224822,0.04081632653061224,0.38515919173429275,1.0,9/16,25.49%,ULBP1;LYST;SLAMF7;CEBPG;RAET1E;TUBB4B;KLRK1;PLEKHM2;VAMP7
prerank,determination of heart left/right asymmetry (GO:0061371),0.45801688145279096,1.5629006032023212,0.007633587786259542,0.5780204812553307,1.0,11/42,13.32%,DNAAF1;VANGL2;CCDC39;MEGF8;MEF2C;DAND5;BBS5;PKD2;TBX2;TBX6;NDRG4
prerank,mitotic sister chromatid segregation (GO:0000070),-0.35626372066488166,-1.5617943915236363,0.0076045627376425855,0.39278100630920826,1.0,37/98,19.83%,DIS3L2;KPNB1;CHMP4B;CHMP4A;MIS12;CUL3;PDS5B;PIBF1;KIF23;PRC1;NCAPD2;NCAPH;BOD1;CDCA8;TEX14;NCAPG2;KIFC1;PDS5A;HASPIN;NUSAP1;SMC2;CDK1;ESPL1;PDCD6IP;CHMP1B;RAD21;RB1;SPDL1;NUP62;NDC80;PLK1;DCTN2;KIF18B;MCPH1;ZWINT;REC8;TENT4A
prerank,phagosome acidification (GO:0090383),-0.47833393128434337,-1.5614121556832912,0.022556390977443608,0.3908943539649496,1.0,6/26,4.11%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;RAB7A;ATP6V0B
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5345689974125192,1.5606827640015166,0.027210884353741496,0.5799350326837586,1.0,9/22,19.75%,FGF10;FGF7;SRSF6;AREG;SNAI2;TGM1;PRKD1;STXBP4;EPB41L4B
prerank,error-prone translesion synthesis (GO:0042276),-0.5156249637678603,-1.5604269622037892,0.0196078431372549,0.39049010816561214,1.0,7/21,17.00%,PCNA;POLI;UBC;UBA52;MAD2L2;RPA1;RPA2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.6376876624529046,1.5589111323205824,0.022336769759450172,0.5800364790451608,1.0,5/12,11.36%,AAAS;BMP4;TGFB1;NEDD4;IFI27
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.6176684262920674,1.5581416559444945,0.042662116040955635,0.5755453740096167,1.0,7/13,22.48%,KCNJ3;KCNA5;CACNB2;KCNJ5;ANK2;SCN3B;KCNN2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.47284220348925415,-1.556959280341698,0.028645833333333332,0.39697892646720057,1.0,12/26,17.29%,NR1H2;PRKAG2;ERLIN2;BRCA1;WDTC1;CEACAM1;APOC1;NR1H3;MID1IP1;PRKAB2;ACADL;ADIPOR2
prerank,peptidyl-proline modification (GO:0018208),0.52310541370463,1.5567866896594698,0.02090032154340836,0.573436516538984,1.0,6/25,7.30%,P3H2;PPIC;PPIB;PPWD1;PPIL1;PPIG
prerank,regulation of cytokinesis (GO:0032465),-0.3667560503037376,-1.5543975903589895,0.006666666666666667,0.4014309299399494,1.0,26/78,16.22%,SVIL;PIK3C3;BCL2L1;PRKCE;CUL3;PIK3R4;GIT1;KIF23;BIRC6;CDC14B;SH3GLB1;PRC1;KIF20B;CIT;UVRAG;RACGAP1;DRD2;KLHL21;CALM3;AHCTF1;CALM2;E2F8;PRPF40A;E2F7;PLK1;KIF20A
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3642475157663539,1.5537320753857264,0.004767580452920143,0.5795999663150473,1.0,59/224,18.41%,PLP1;SNAP25;GABRQ;PCDHB9;CACNB4;GLRA3;PCDHB4;DLG2;HTR1F;KCND2;GABRG1;CACNB2;MPZ;GABRD;GIPC1;SYT1;PCDHB5;GRIA2;NRXN1;GABRG2;SLC1A1;GLRB;GRM3;KCNK3;NPTX1;GRIK2;GRIA1;RIT2;GABRA2;CPNE6;GRIN1;SST;GRIA4;GRIN2B;SLC12A6;GLRA2;ASIC2;UNC13B;SLC1A3;PCDHB3;MINK1;CACNA1B;GAD2;GABBR2;SLC6A1;DLGAP1;GABRB1;NOVA1;HAP1;GABRR2;SPG11;CACNA1A;HTR6;PRKAR1A;MTNR1B;MBP;SNCB;CHRNA7;CHRFAM7A
prerank,protein localization to cilium (GO:0061512),0.49367733926524593,1.553098353665912,0.02748091603053435,0.5743905168353386,1.0,8/32,11.01%,IFT20;WDR19;ODAD4;ROPN1;MAPK15;TMEM107;BBS9;EHD1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.43711501772460915,-1.5521896041143237,0.017341040462427744,0.40433497408578706,1.0,10/35,9.97%,APOE;ALOX5;XDH;PPARG;AIMP1;THBS1;FLT1;CAV1;PDCD10;STAT1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.46550075455179707,1.5520047999451192,0.020895522388059702,0.5713504161455281,1.0,15/44,19.01%,KCNMA1;KCNJ3;KCNH2;GABBR1;NOS1AP;ATP1B1;ATP1B3;ACTN2;GABBR2;KCNN4;KCNJ5;KCNMB3;KCNN3;ANK2;WNK1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6143856302711846,-1.5517109390903976,0.06557377049180328,0.402332653033445,1.0,3/10,9.40%,DIS3L2;UBC;UBA52
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5637312497138818,1.5510409172215638,0.027823240589198037,0.5681515335413297,1.0,11/18,32.94%,HHEX;MCM3AP;DDX25;NUP133;SARNP;NXF1;DDX19A;PCID2;ZC3H11A;POLDIP3;NUP93
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5786175903035831,-1.5501728205611456,0.0387409200968523,0.40343925189110436,1.0,7/13,22.58%,PTPN1;NCK1;DNAJB9;RACK1;WFS1;PPP1R15A;BFAR
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5713187656937382,1.5490928467774256,0.031932773109243695,0.5697494081146683,1.0,8/17,24.33%,KCNH2;NOS1AP;KCNE2;GJA5;CACNA2D1;ANK2;SCN1B;SNTA1
prerank,negative regulation of neuron projection development (GO:0010977),0.43733937922236155,1.5485496109708328,0.010432190760059613,0.5649738620341984,1.0,17/56,13.79%,DCC;THY1;STMN2;CRMP1;PTPRO;OMG;EFNB3;ITM2C;RTN4RL1;PRAG1;MINAR1;ARHGDIA;GDI1;EFNA1;MAG;MYLIP;EPHA4
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6278818633917183,-1.5481198089440855,0.049891540130151846,0.4059697368404144,1.0,5/10,14.99%,BTLA;CD24;LYN;BAG6;LILRB1
prerank,neurotransmitter uptake (GO:0001504),0.6213749653789011,1.5467609010841907,0.04070796460176991,0.5663417909807946,1.0,3/12,11.07%,SNAP25;SLC29A2;SLC1A3
prerank,regulation of catabolic process (GO:0009894),0.561437817119036,1.5466928255823749,0.0423728813559322,0.5594795010887565,1.0,8/18,20.12%,RARRES2;FAF1;CENATAC;ZDHHC2;TMEM9;NEDD4L;HPGD;SNF8
prerank,inner dynein arm assembly (GO:0036159),0.6575365446184208,1.5466910310581754,0.0353356890459364,0.5525820878315539,1.0,4/10,8.59%,DNAAF1;CCDC39;DNAI3;CFAP100
prerank,regulation of cell motility (GO:2000145),0.38538299998964565,1.5456729996764227,0.0,0.5501444426524176,1.0,39/121,19.01%,CCDC25;FGF10;SPOCK3;ABI3;FRMD5;FGF16;PLXNB2;FGF9;LDB2;LDB1;PKN1;PARD6B;ROBO4;NRG4;BEX4;SPOCK2;FGF7;SPINT2;PRAG1;SRCIN1;ENPP2;ERBB4;SST;TGFB1;INPP5F;CAMSAP3;FGF2;MINK1;DOCK10;HACE1;KIF2A;RCC2;SERPINE2;CADM4;KIF14;ROCK1;FES;PIN1;PLXNB1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4691724282116386,1.5445606597571848,0.020440251572327043,0.5483359170597799,1.0,13/38,17.90%,YWHAE;KCNJ3;KCNH2;BIN1;KCNA5;CACNB2;KCNE2;CACNA1G;CACNA1D;CACNA2D1;KCNJ5;CTNNA3;ANK2
prerank,regulation of response to biotic stimulus (GO:0002831),-0.4563284882134081,-1.5438547771563298,0.039473684210526314,0.4143485264556863,1.0,12/28,25.12%,FCGR2B;PTPN22;CD36;ERAP1;BIRC2;TRIM5;CD55;FOXP1;APPL2;XIAP;APPL1;DHX58
prerank,synaptic vesicle endocytosis (GO:0048488),-0.4460370023100906,-1.5431236213276667,0.024793388429752067,0.4134207082617215,1.0,9/33,10.71%,ITSN1;SYNJ2;DNAJC6;GAK;FCHO2;PICALM;AMPH;SNCG;DNM2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.39124654477622883,-1.5426700565643268,0.024615384615384615,0.4115311328345868,1.0,27/57,28.92%,RPL5;RPS24;CUL4A;URB2;RPS16;MALSU1;RPL35A;RPS7;RPF2;BYSL;METTL17;XPO1;RPL14;NPM1;GTF3A;EMG1;RPL26;SDAD1;RPL11;NAF1;RPS15;RPS6;RPS17;LTO1;BOP1;RPS19;WDR74
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.41200543978578064,-1.5421052046983486,0.017721518987341773,0.41007072748829204,1.0,12/40,15.62%,PID1;BCL2;ARL6IP5;BCL2L1;VCP;BAX;MTLN;TUSC2;LRRK2;STOML2;PMAIP1;SLC25A33
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5879283486328293,1.541512217225222,0.04081632653061224,0.5547143400573268,1.0,6/14,21.62%,CARD14;COPS8;ZFP91;MAP3K7;TLR3;TIRAP
prerank,regulation of viral genome replication (GO:0045069),-0.3920270232728214,-1.5408791274305955,0.006153846153846154,0.4106675243036422,1.0,23/56,23.52%,OAS2;IFIH1;IFITM3;IFIT1;PROX1;OASL;SHFL;BST2;CD28;PPIH;BANF1;OAS3;LARP1;TNF;ZC3HAV1;STAU1;LTF;TNIP1;IFITM1;VAPB;ILF3;EIF2AK2;PLSCR1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.4409147043123864,-1.5408434139245366,0.01871657754010695,0.4079196335936756,1.0,16/34,23.84%,IGF1;CUL3;NSMCE2;IL1B;NUSAP1;CD28;CDC27;IGF2;ESPL1;RB1;NUP62;RGCC;DRD3;TGFA;ANAPC7;EGF
prerank,negative regulation of defense response (GO:0031348),-0.3655890607548162,-1.540841291867784,0.003076923076923077,0.40510639474130544,1.0,34/77,25.12%,AOAH;ITCH;APOE;ALOX5;PPARG;METRNL;PTGER4;VPS35;PPARD;ENPP3;PTGIS;ACOD1;C1QTNF3;NR1H3;CCN3;RB1;CXCL17;OTULIN;MAPK7;MUL1;GATA3;TRAF3IP1;KLF4;NLRC3;TRIM21;MVK;SIRT2;FFAR4;ISL1;NR1H4;MEFV;SMPDL3B;FEM1A;DHX58
prerank,positive regulation of transport (GO:0051050),-0.36040290079507237,-1.539597185709683,0.010344827586206896,0.40523086059506297,1.0,22/85,16.30%,DAB2;FCGR2B;IL15;APOE;GAS6;CD47;DOCK2;BAX;HIP1R;ANXA1;IL1B;KCTD7;CYBA;SLC11A1;NR1H3;LRP1;INPP5K;NUMA1;TNF;TUB;CHP1;FCER1G
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.37677405385155427,-1.5376855954231892,0.006666666666666667,0.4073627634432991,1.0,35/73,24.92%,OAS2;PTPRC;IFIH1;TLR2;LILRA5;CCR2;TYROBP;CD14;THBS1;PF4;NOD2;SYK;RIPK1;PSEN1;LPL;ADAM8;CYBA;CD2;OAS3;SPHK2;LBP;AGER;HSPB1;WNT5A;SPN;TLR4;MMP8;ARHGEF2;TLR1;ISL1;TWIST1;APP;TNFRSF8;FADD;TLR9
prerank,negative regulation of B cell activation (GO:0050869),-0.5012910514234785,-1.5375141938737673,0.05614973262032086,0.40509770600580014,1.0,7/21,12.06%,FCGR2B;CD300A;TYROBP;LYN;BANK1;RC3H1;FOXJ1
prerank,regulation of autophagy (GO:0010506),-0.30629315527890955,-1.5363974013490507,0.0,0.4053384711944,1.0,57/216,15.84%,BCL2;ATP6V0D1;PTPN22;ABL2;VPS26A;TRIM65;ATP6V0D2;TPCN2;PSAP;CAPN1;TRIM14;ATP6V1B2;ATG13;PRKAB1;ATP6V0A1;RRAGC;DRAM2;MCL1;FBXW7;PRKACA;MET;EEF1A1;LAMTOR5;SH3GLB1;VPS35;ATP6V0B;EXOC4;ERN1;TPCN1;MTMR4;ITPR1;UBQLN1;GPR137B;PRKAG2;CISD2;DRAM1;CTSA;SMCR8;ZC3H12A;DCAF12;EP300;FOXO1;VPS26B;DAPK1;LRRK2;RRAGA;EXOC8;KAT5;ATP6V1A;TRIM5;GPR137;ORMDL3;PRKAB2;HSPB1;OPTN;FOXK2;MTMR3
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6516567979103098,1.535076872500585,0.036395147313691506,0.5768903157454588,1.0,2/11,0.86%,P3H2;P4HA3
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.619618141066559,-1.5349205283406295,0.04672897196261682,0.4065196693654058,1.0,5/10,16.41%,TLR2;NAMPT;NOD2;KDR;TLR4
prerank,neuron projection fasciculation (GO:0106030),0.6422802402449456,1.5348143572294193,0.030612244897959183,0.5713016065525227,1.0,4/10,14.92%,ARHGAP35;NRCAM;EPHA4;EPHB2
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.5241266561622134,-1.5332271191737317,0.02891566265060241,0.40829813391864694,1.0,12/17,30.86%,CEBPB;CAV1;CD24;CEACAM1;PRKX;AJAP1;MAFG;GATA3;DSPP;FOXN1;APOLD1;DLL1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5365807595654332,-1.5319819143491662,0.04976303317535545,0.40871903611042215,1.0,5/15,12.59%,PLIN2;OSBPL8;PPARG;LPL;PNPLA2
prerank,chemical synaptic transmission (GO:0007268),0.3518386948296797,1.531331885842072,0.0,0.5799622405201499,1.0,74/284,18.41%,PLP1;SNAP25;GABRQ;PCDHB9;CACNB4;GLRA3;PCDHB4;DLG2;HTR1F;KCND2;GABRG1;TSPOAP1;CACNB2;RAB3A;MPZ;GABRD;GIPC1;SYT1;SNAPIN;PCDHB5;NAPB;ERC2;GRIA2;NRXN1;CBLN2;GABRG2;SLC1A1;GLRB;GRM3;KCNK3;FCHSD2;NPTX1;GRIK2;GRIK5;GRIA1;RIT2;GABRA2;GRID2;CPNE6;GRIN1;SST;CHAT;GRIA4;GRIN2B;SLC12A6;GLRA2;ASIC2;UNC13B;SLC1A3;RIMS1;PCDHB3;MINK1;SLC1A4;CRHBP;CACNA1B;GAD2;GABBR2;STXBP2;SLC6A1;DLGAP1;GABRB1;NOVA1;HAP1;GABRR2;SPG11;CACNA1A;HTR6;DLGAP2;PRKAR1A;MTNR1B;MBP;SNCB;CHRNA7;CHRFAM7A
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5676950054486953,-1.5303003462190523,0.03818615751789976,0.4106555805870972,1.0,7/13,20.96%,SOX11;TAF1;PSEN1;MAD2L2;HEY2;PER2;TMSB4X
prerank,positive regulation of cell division (GO:0051781),-0.4178262825838396,-1.5293642941899825,0.014450867052023121,0.41056962848410455,1.0,16/38,22.33%,SVIL;PRKCE;CUL3;KIF23;CDC14B;KIF20B;CIT;FGF1;RACGAP1;DRD2;ECT2;DRD3;MAP10;SIRT2;CDC14A;SHH
prerank,regulation of potassium ion transport (GO:0043266),0.4868802582474754,1.5287158490286112,0.02830188679245283,0.5849292165613845,1.0,9/31,11.87%,KCNH2;KCNA5;KCNE2;KCNIP3;KCNIP4;ADRA2A;FHL1;ACTN2;CACNA1D
prerank,prostanoid metabolic process (GO:0006692),0.5942458851670285,1.5284455497707947,0.05175292153589316,0.5796336065412644,1.0,7/13,21.82%,CYP2S1;PTGS1;AKR1C1;ACOX1;HPGD;PTGR2;HPGDS
prerank,peptide biosynthetic process (GO:0043043),-0.3195239894880493,-1.5278387725829934,0.0,0.41175800127623885,1.0,41/153,14.03%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;EEF1A1;RPS29;RPS14;RPS20;GGTA1;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;DHPS;RPL37A;EIF4EBP2;IGHMBP2;RHD;RPL10;RPL15;YARS2;RPS10;RPL14;RPL9;RPL32;RPL36;RPL31;RPL23A;AGO2;MRPL35;RPL41;RPL3
prerank,regulation of keratinocyte migration (GO:0051547),0.6046352344364186,1.527678360432751,0.0481283422459893,0.576515914577233,1.0,5/12,10.49%,FGF10;FGF7;MAPRE2;MAP4K4;IQSEC1
prerank,N-glycan processing (GO:0006491),-0.5161052060928357,-1.5276011473816091,0.02142857142857143,0.4097292427277267,1.0,8/18,14.94%,MAN2A1;GANAB;ST8SIA6;FUT8;ST8SIA4;GNPTAB;PRKCSH;ST8SIA2
prerank,negative regulation of transport (GO:0051051),-0.40385473299071534,-1.5266274031486375,0.011976047904191617,0.40966817114586235,1.0,21/51,24.76%,FCGR2B;MCTP1;ARL6IP5;PIP4P2;TLR2;MTMR2;RAB7A;BST2;NR1H2;DYSF;NR1H3;RACK1;LILRB1;YRDC;RSC1A1;PPM1F;ITGB3;NDFIP1;PLSCR1;EGF;PRTN3
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.41097786952808824,-1.5264343597688854,0.025936599423631124,0.40760940725957906,1.0,12/41,15.15%,PTPN23;ADAM19;GCNT2;CD44;CD47;AFDN;PLAUR;IL1B;LCK;SKAP1;AGER;TNF
prerank,lipid droplet organization (GO:0034389),0.5286901168379128,1.5255773025746375,0.03289473684210526,0.5797009256959068,1.0,4/22,15.22%,PLA2G4C;HILPDA;PNPLA3;FITM2
prerank,endocytic recycling (GO:0032456),-0.4025904950700597,-1.525226536617977,0.015060240963855422,0.4081787488474571,1.0,11/50,8.48%,DENND1A;EHD4;STX6;VPS26A;PTPN23;DENND1B;RAB7A;VPS35;LMTK2;EPS15;CCDC22
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5738275075087695,-1.5248877848878812,0.05250596658711217,0.4064612587596084,1.0,3/12,1.54%,BCL2;CD74;CD44
prerank,DNA packaging (GO:0006323),-0.5320550002289259,-1.5223369276900656,0.046296296296296294,0.4108009487388454,1.0,8/16,29.73%,NAA10;H1-0;HAT1;BANF1;PRM1;M1AP;AIFM1;BANF2
prerank,keratinocyte differentiation (GO:0030216),-0.4520262075461861,-1.5215556269193955,0.03494623655913978,0.41024786647847933,1.0,17/29,36.48%,ST14;ADAM9;CLIC4;ANXA1;TXNIP;WNT5A;EPHA2;OPN3;BCR;DSP;EVPL;SCEL;KRT10;ASAH1;UGCG;EXPH5;SPRR1A
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.5631159305887035,1.521251198585547,0.03354632587859425,0.5918647817293531,1.0,7/16,23.77%,SRSF12;CWC15;CACTIN;SRSF1;PSIP1;SART1;WBP4
prerank,carbohydrate derivative transport (GO:1901264),-0.49826075970770756,-1.521169578904396,0.02977667493796526,0.40869958977389326,1.0,13/18,27.18%,NPC2;SLC15A3;PLTP;ABCG1;SLC25A19;LBP;CLN3;MFSD2A;SLC15A4;SLC15A2;VLDLR;SLC28A1;CPTP
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6307044089924351,1.5203772568165967,0.048736462093862815,0.5895221380444877,1.0,5/10,10.49%,FGF10;FGF7;MAPRE2;MAP4K4;IQSEC1
prerank,potassium ion import across plasma membrane (GO:1990573),0.4542471824416385,1.5203769964649214,0.03815580286168521,0.5832506259376314,1.0,14/41,19.85%,KCNJ3;KCNH2;ATP1B1;KCNE2;KCNJ8;SLC12A2;ATP1B3;KCNJ13;SLC12A6;KCNJ5;KCNK9;ATP1A4;ATP1A3;ATP1A1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.40994780781513385,-1.5202545634543443,0.008955223880597015,0.40859760972300735,1.0,14/45,17.07%,IQGAP1;KIF16B;REPS2;BRAF;GAB1;PIK3CA;GRB2;CBL;EGFR;SHC1;PTK2B;BCAR1;AAMP;ADAM17
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.43313557093277044,-1.51751878788636,0.0234375,0.4133140652694196,1.0,7/30,9.26%,UBE2D3;ATG13;FBXW7;TOMM7;SH3GLB1;ARIH2;UBE2L3
prerank,regulation of cholesterol storage (GO:0010885),-0.5426483899715246,-1.5151975034021892,0.043689320388349516,0.41717020005749156,1.0,7/15,13.28%,MSR1;PPARG;PPARD;NR1H2;ABCG1;LPL;NR1H3
prerank,negative regulation of blood pressure (GO:0045776),-0.5488700790941777,-1.5148332208746584,0.06993006993006994,0.4157316545312349,1.0,8/13,40.52%,DRD2;PRCP;DRD3;BMPR2;NOS1;NOS2;NPPA;SCPEP1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.40949079807441424,-1.5147046772621238,0.019830028328611898,0.41360541863789074,1.0,15/42,15.58%,NRP1;CDK6;CD36;LIMS1;CCL25;UTRN;CIB1;S100A10;EFEMP2;SKAP1;KDR;EMP2;MYOC;PTK2B;CCL28
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5029346781840806,1.5139085004693813,0.040783034257748776,0.6059480154602072,1.0,15/28,26.62%,STMN4;STMN3;STMN2;MAP1S;CLASP2;MAPRE2;CAMSAP3;CAMSAP1;MAP2;MAPRE3;GBA2;GAS2L1;FKBP4;MAPT;MAP1B
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5388081147971532,-1.5137850103625734,0.05489260143198091,0.4137592960144877,1.0,6/15,9.53%,PRKCH;MSR1;CD36;NFKB1;PF4;LPL
prerank,regulation of histone methylation (GO:0031060),0.5889223430299553,1.5111435604278076,0.045075125208681135,0.6120057030002555,1.0,6/13,18.32%,TET1;CTR9;NSD1;TTLL12;PAF1;CHTOP
prerank,protein localization to chromosome (GO:0034502),-0.4247057553749349,-1.5108673457846766,0.02586206896551724,0.41895515724180143,1.0,14/34,17.00%,ESR1;IFFO1;BOD1;CENPA;HASPIN;CTCF;RPA1;RAD21;RB1;TERF2;MCM9;MCM8;PLK1;RPA2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6194291691858034,1.5108486689298737,0.05457746478873239,0.6070385256201816,1.0,4/11,11.97%,UQCRC1;CYC1;UQCC3;UQCR11
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5865314295417301,-1.5103110707146012,0.05952380952380952,0.41771492603751925,1.0,4/11,14.12%,EP300;C1QTNF3;CRY1;SIK1
prerank,defense response to protozoan (GO:0042832),-0.5725811785072165,-1.5102232788809646,0.059907834101382486,0.41549208704564133,1.0,9/12,22.83%,LYST;IRF4;PF4;SLC11A1;GBP4;BATF2;MYD88;GBP6;GBP7
prerank,regulation of AMPA receptor activity (GO:2000311),0.49763819764374106,1.5087306514588843,0.047697368421052634,0.6106990443439645,1.0,9/25,17.85%,CACNG5;CACNG2;CNIH2;MEF2C;SHANK3;CACNG7;MINK1;CACNG3;SHANK1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.38683434426125274,-1.5074390191300535,0.019169329073482427,0.420871049330559,1.0,19/55,16.34%,IL15;CD274;IGF1;CCDC88B;SLC7A1;PTPRC;CCR2;IL6ST;NCK1;SYK;TFRC;CD24;ANXA1;IL1B;CD28;IGF2;EBI3;AGER;IL27RA
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5026857561555199,-1.5052297868819893,0.03980099502487562,0.4243265541742227,1.0,9/18,17.07%,APOE;ADAM19;LDLRAP1;PSEN1;ABCG1;TMCC2;APH1B;CLN3;ADAM17
prerank,motile cilium assembly (GO:0044458),0.6011769818865151,1.5050938277104693,0.04085257548845471,0.6210600896293805,1.0,4/12,16.65%,DNAAF1;CCDC39;BBS5;DNAAF3
prerank,central nervous system myelination (GO:0022010),0.6202377059463418,1.5050043969898406,0.03664921465968586,0.6153229050862979,1.0,6/11,13.96%,PLP1;CNTNAP1;SOX10;CLU;MYRF;ABCA2
prerank,potassium ion export across plasma membrane (GO:0097623),0.5973727225196981,1.504967448852783,0.043478260869565216,0.6093868421162063,1.0,3/13,3.05%,KCNH2;KCNA5;KCNE2
prerank,ganglion development (GO:0061548),-0.5722153188498726,-1.5049358634176475,0.0378619153674833,0.42257845428021706,1.0,3/11,10.75%,NRP1;NRP2;CTNNB1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.37997425746238916,-1.50489151016256,0.0149812734082397,0.42029343668411395,1.0,15/63,8.08%,VAV3;IL15;BCL2;CD74;CD38;CD274;CCDC88B;SLC7A1;PTPRC;IL6ST;NCK1;GPR183;TFRC;ANXA1;IL1B
prerank,potassium ion transport (GO:0006813),0.3775233224784789,1.5043015894594742,0.00395778364116095,0.6064138591060141,1.0,32/120,19.83%,HCN1;KCNMA1;KCNK12;KCNJ3;KCNH2;KCND2;KCNA5;KCNE2;KCNJ8;KCNH7;KCNC1;KCNK3;ATP1B3;KCNJ13;SLC9A4;PKD2;KCNK6;SLC1A3;KCNN4;SLC9A5;ABCC8;HPN;KCNJ5;KCNC3;SLC24A3;KCNMB3;KCNN3;KCNK9;KCNQ4;SLC24A4;KCNK2;ATP1A4
prerank,natural killer cell activation (GO:0030101),-0.4699394104747962,-1.5041020760880892,0.04145077720207254,0.42001810373144965,1.0,8/23,15.38%,AXL;PTPRC;ULBP1;SLAMF7;TOX;BAG6;CD2;KAT7
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.5974880389318985,-1.5035461961344103,0.07178217821782178,0.4190806448977859,1.0,4/11,16.88%,NOL11;SMARCA4;IPPK;NOP53
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.6090977116338161,-1.5031341523079942,0.057736720554272515,0.41773546878660855,1.0,4/10,17.14%,SP100;RPS6KA6;KAT5;HIPK2
prerank,intracellular sterol transport (GO:0032366),-0.5594414571329345,-1.503059403773095,0.06557377049180328,0.4155810635385546,1.0,5/13,9.44%,NPC2;OSBP;SERAC1;OSBPL2;ABCG1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.5231872414659874,-1.5022172957650364,0.05339805825242718,0.4154205646578498,1.0,6/16,14.78%,KPNB1;DNASE2;HMGB2;H1-0;ENDOG;DFFA
prerank,negative regulation of programmed cell death (GO:0043069),-0.2860218906992998,-1.5016670797366205,0.0,0.4144392326841607,1.0,90/355,16.18%,DAB2;ARHGAP10;BCL2;ITCH;CD74;CD38;GAS6;IGF1;AXL;BCL2L1;KLHL20;RAF1;CD44;TNFAIP8;ATAD3A;YME1L1;BRAF;KANK2;BIRC6;MCL1;MET;NUAK2;SIAH2;RAB7A;IL6ST;BCL3;PIM1;NFKB1;CIAPIN1;RASA1;BAG4;THBS1;VHL;FAS;HSPD1;RIPK1;TFRC;PRDM9;PDCD10;PLAUR;IFIT3;ANXA1;HNRNPK;UBC;CIB1;NAA16;PSEN1;RPL10;HCK;TPT1;RNF157;PIDD1;UBA52;HYPK;GCLC;SH3RF1;ANXA4;CD28;BIRC5;SPRY2;EGR3;CTNNB1;FOXO1;ATF5;BARD1;MIEN1;CDK1;MAD2L1;HDAC2;BIRC2;SMAD6;CBL;FHL2;HDAC1;KDR;CCND2;PSMD10;SCX;PTMA;GREM1;NPM1;EGFR;SHC1;PTK2B;HSPB1;WNT5A;TM7SF3;NUP62;CLN3;PLK1
prerank,regulation of interleukin-6 production (GO:0032675),-0.3498241331209409,-1.501499682315595,0.007017543859649123,0.4126505238977003,1.0,39/96,22.59%,CD74;GAS6;PTPN22;CD47;IFIH1;TLR2;LILRA5;IL16;RAB7B;MAPKAPK2;TYROBP;TLR7;NOD2;HSPD1;SYK;TLR8;IL1B;ZC3H12A;LPL;C1QTNF3;CYBA;FOXJ1;SLAMF1;SPHK2;LBP;AGER;TNF;SCIMP;WNT5A;TLR4;MMP8;ARHGEF2;TLR1;AFAP1L2;MYD88;NLRC3;ISL1;TWIST1;APP
prerank,sulfur amino acid metabolic process (GO:0000096),-0.4677804033626575,-1.4993215121369425,0.0291005291005291,0.4159629063337349,1.0,12/24,24.23%,MSRA;MTHFR;MTHFD1;GCLC;MTRR;MPST;ADI1;CBS;GADL1;CTH;ADO;NOX4
prerank,tryptophan catabolic process (GO:0006569),0.6225879499081912,1.4986334088529918,0.044293015332197615,0.6263191106561533,1.0,4/11,11.65%,IL4I1;IDO2;AFMID;KYAT1
prerank,membrane repolarization (GO:0086009),0.5773897687531171,1.498499029304276,0.035653650254668934,0.6209644499620652,1.0,4/15,7.02%,KCNH2;ATP1B1;KCNE2;ATP1B3
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.4649287449637388,-1.4980959303338592,0.03968253968253968,0.4168190638881409,1.0,11/26,23.05%,CUL3;CDK5RAP2;NSMCE2;CDC27;ESPL1;RB1;DUSP1;PLK1;UBE2C;ANAPC7;CCNB1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.48773816199347036,1.4966617103347213,0.03934426229508197,0.6235569680867933,1.0,13/30,24.33%,KCNH2;FGF12;KCNA5;KCNE2;CACNA1G;CACNA1D;NEDD4L;CACNA2D1;ANK2;ATP1A1;SCN1B;SCN3B;SNTA1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.5953294585794326,-1.4957893085129592,0.07494646680942184,0.42072466038605455,1.0,6/10,25.05%,GAS6;AXL;LYN;LILRB1;CXCL12;BLK
prerank,neutrophil activation involved in immune response (GO:0002283),-0.28006031122463815,-1.4952597144574469,0.0,0.4197339248846427,1.0,126/428,20.25%,IQGAP1;IQGAP2;ADGRE5;CYBB;ATP8B4;CLEC12A;GALNS;PLAU;ITGAX;KPNB1;AP2A2;ERP44;ALOX5;CD300A;RNASE3;FUCA1;CD44;VCP;GMFG;HGSNAT;ANPEP;NPC2;PTPRC;SDCBP;CD47;PSAP;CAPN1;TLR2;PAFAH1B2;C3AR1;CD36;MAGT1;ATP6V0A1;DNASE1L1;DOCK2;EEF1A1;RAB7A;GYG1;TYROBP;IDH1;NFKB1;PLEKHO2;ATG7;CD14;C5AR1;TMEM30A;AGL;PSMD11;MOSPD2;BST2;SYK;PLAUR;ILF2;ITGAL;NHLRC3;CTSB;RAB6A;PSEN1;SLC2A5;CTSA;SNAP23;LAMP2;HPSE;ARPC5;PRCP;GDI2;RAB10;ADAM8;SNAP29;PGAM1;DOK3;IGF2R;STOM;PTGES2;GLIPR1;OLR1;TNFRSF1B;CYBA;CD53;LTA4H;TBC1D10C;PLD1;CEACAM1;SLC11A1;LAMP1;FRK;LCN2;B2M;GLA;CD55;GPI;IMPDH1;CPPED1;VCL;GCA;DNAJC13;GAA;ORMDL3;LILRB3;RAB4B;RAP1B;RAP1A;BST1;FCER1G;FTL;NRAS;PFKL;CRACR2A;GSN;RAB31;GM2A;PTX3;AGPAT2;PLAC8;MMP8;TOM1;MCEMP1;HVCN1;PSMD1;CFP;CD33;CAMP;HSPA1B;PA2G4;LTF;OSCAR
prerank,regulation of inflammatory response (GO:0050727),-0.3099847790698465,-1.4946526763666617,0.0,0.41887680042587827,1.0,66/190,23.96%,AOAH;IL15;APOE;PSMA6;ALOX5;CELF1;CD47;TLR2;LILRA5;PPARG;METRNL;ZBP1;CCR2;IL16;PTGER4;VPS35;TLR7;NFKBIZ;PPARD;USP18;NOD2;RIPK1;ANXA1;ENPP3;IL1B;HCK;LPL;GPSM3;GPRC5B;PTGIS;ACOD1;C1QTNF3;BIRC2;TNFRSF1B;SHPK;NR1H3;CCN3;RB1;CXCL17;FOXP1;TNF;WNT5A;OTULIN;BST1;PDE2A;MAPK7;TLR4;GATA3;MMP8;ADAMTS12;MYD88;KLF4;CASP1;NLRC3;TMSB4X;MVK;TNIP1;FFAR4;ISL1;NR1H4;APP;MEFV;PLA2G7;XIAP;SMPDL3B;BCL6
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6031927209996051,-1.494124903223066,0.07096774193548387,0.4180935567255115,1.0,6/10,21.42%,TYROBP;CD24;LILRB1;FN1;LAPTM4B;CDH3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.37270923358280933,1.493859069372186,0.009102730819245773,0.6295395386240045,1.0,35/124,17.39%,CTTN;PLP1;STMN4;STMN3;ARMC2;CFAP126;PQBP1;BLOC1S2;ROPN1;CATIP;STMN2;SNAPIN;IL6;LGI1;RYK;MANF;SAMD14;ADCYAP1;SH3GL2;PKD2;GPRIN1;NEDD4;RASGRF1;BTG2;STX3;EHD1;CAMSAP1;MICALL1;CYFIP1;HMGB1;ERCC6;CFAP61;PPP1R9A;ROCK1;HDGFL3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.4775925602405569,-1.4937632614575351,0.04466501240694789,0.4167956380157721,1.0,6/22,12.92%,OS9;UGGT1;UBC;UBA52;RNF103;EDEM1
prerank,translesion synthesis (GO:0019985),-0.40978216151945684,-1.4933422660148363,0.0273972602739726,0.41562532254482815,1.0,16/42,19.92%,VCP;TRIM25;PCNA;POLI;UBC;PCLAF;UBA52;MAD2L2;POLD4;RPA1;FAAP20;UBE2L6;RPA2;DTL;USP43;NPLOC4
prerank,neutrophil degranulation (GO:0043312),-0.2809303091804472,-1.4924453325756566,0.0,0.4159416403364785,1.0,125/425,20.25%,IQGAP1;IQGAP2;ADGRE5;CYBB;ATP8B4;CLEC12A;GALNS;PLAU;ITGAX;KPNB1;AP2A2;ERP44;ALOX5;CD300A;RNASE3;FUCA1;CD44;VCP;GMFG;HGSNAT;ANPEP;NPC2;PTPRC;SDCBP;CD47;PSAP;CAPN1;TLR2;PAFAH1B2;C3AR1;CD36;MAGT1;ATP6V0A1;DNASE1L1;DOCK2;EEF1A1;RAB7A;GYG1;TYROBP;IDH1;NFKB1;PLEKHO2;ATG7;CD14;C5AR1;TMEM30A;AGL;PSMD11;MOSPD2;BST2;PLAUR;ILF2;ITGAL;NHLRC3;CTSB;RAB6A;PSEN1;SLC2A5;CTSA;SNAP23;LAMP2;HPSE;ARPC5;PRCP;GDI2;RAB10;ADAM8;SNAP29;PGAM1;DOK3;IGF2R;STOM;PTGES2;GLIPR1;OLR1;TNFRSF1B;CYBA;CD53;LTA4H;TBC1D10C;PLD1;CEACAM1;SLC11A1;LAMP1;FRK;LCN2;B2M;GLA;CD55;GPI;IMPDH1;CPPED1;VCL;GCA;DNAJC13;GAA;ORMDL3;LILRB3;RAB4B;RAP1B;RAP1A;BST1;FCER1G;FTL;NRAS;PFKL;CRACR2A;GSN;RAB31;GM2A;PTX3;AGPAT2;PLAC8;MMP8;TOM1;MCEMP1;HVCN1;PSMD1;CFP;CD33;CAMP;HSPA1B;PA2G4;LTF;OSCAR
prerank,regulation of amyloid-beta formation (GO:1902003),0.46958171065027865,1.4923320196347447,0.03538461538461538,0.6310743225516695,1.0,17/34,18.62%,RTN1;GGA3;BIN1;RELA;PRNP;CLU;LRRTM3;EFNA1;CASP3;EPHA4;ABCA2;HAP1;NTRK2;IFNGR1;ROCK1;CHRNA7;PIN1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5012300499899465,-1.4914568021393417,0.0594059405940594,0.41645213445714463,1.0,10/18,30.11%,THBS1;HSPD1;CD226;CD2;LBP;WNT5A;TLR4;CEBPA;TSLP;IL33
prerank,primary neural tube formation (GO:0014020),0.4738895492141781,1.4913670833086874,0.039936102236421724,0.6297021962342971,1.0,9/30,10.48%,TSC2;VANGL2;PLXNB2;SCRIB;LRP2;MTHFD1L;PRICKLE1;TGFB1;GRHL3
prerank,vascular transport (GO:0010232),0.3980601524651559,1.491172298136287,0.012949640287769784,0.624931302585303,1.0,28/81,21.84%,SLC4A8;ATP2A3;SLC2A3;SLCO2B1;ABCC3;SLC29A2;AVPR1A;KCNJ8;SLC38A2;SLC22A8;LRP2;SLC12A2;SLC1A1;SLC1A3;SLC1A4;ABCA2;SLC6A1;SLC19A1;INSR;SLC24A3;ATP8A1;SLC16A12;SLC13A3;ATP1A4;ABCG2;SLC6A9;SLC22A5;SLC38A3
prerank,neutrophil mediated immunity (GO:0002446),-0.27940778258908555,-1.4906322546049242,0.0,0.4163540252935832,1.0,127/432,20.25%,IQGAP1;IQGAP2;ADGRE5;CYBB;ATP8B4;CLEC12A;GALNS;PLAU;ITGAX;KPNB1;AP2A2;ERP44;ALOX5;CD300A;RNASE3;FUCA1;CD44;VCP;GMFG;HGSNAT;ANPEP;NPC2;PTPRC;SDCBP;CD47;PSAP;CAPN1;TLR2;PAFAH1B2;C3AR1;CD36;MAGT1;ATP6V0A1;DNASE1L1;DOCK2;EEF1A1;RAB7A;GYG1;TYROBP;IDH1;NFKB1;PLEKHO2;ATG7;CD14;C5AR1;TMEM30A;AGL;PSMD11;MOSPD2;BST2;PLAUR;ILF2;ITGAL;NHLRC3;CTSB;RAB6A;PSEN1;SLC2A5;CTSA;SNAP23;LAMP2;HPSE;ARPC5;PRCP;GDI2;RAB10;ADAM8;SNAP29;PGAM1;DOK3;IGF2R;STOM;PTGES2;GLIPR1;OLR1;TNFRSF1B;CYBA;CD53;LTA4H;TBC1D10C;PLD1;CEACAM1;SLC11A1;LAMP1;IRAK4;FRK;LCN2;B2M;GLA;CD55;GPI;IMPDH1;CPPED1;VCL;GCA;DNAJC13;GAA;ORMDL3;LILRB3;RAB4B;RAP1B;RAP1A;BST1;FCER1G;FTL;NRAS;ADAM17;PFKL;CRACR2A;GSN;RAB31;GM2A;PTX3;AGPAT2;PLAC8;MMP8;TOM1;MCEMP1;HVCN1;PSMD1;CFP;CD33;CAMP;HSPA1B;PA2G4;LTF;OSCAR
prerank,neurotransmitter transport (GO:0006836),0.40132093368534316,1.4892281483318828,0.019943019943019943,0.6281015601354769,1.0,17/73,14.15%,SNAP25;TSPOAP1;RAB3A;SLC29A2;SYT1;SNAPIN;SLC38A2;NRXN1;SLC1A1;GABRA2;CHAT;PPFIA4;UNC13B;SLC1A3;RIMS1;GAD2;STXBP2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.5688413963063534,-1.4887127430385851,0.06264501160092807,0.4192023175260523,1.0,7/11,35.20%,NFKBIZ;PRKCQ;CLEC6A;IL12RB1;MALT1;IL23R;IL12B
prerank,cGMP biosynthetic process (GO:0006182),0.6315490108019978,1.4885708303154372,0.06468531468531469,0.6254071709944529,1.0,3/10,10.31%,GUCY2F;GUCY2C;GUCY2D
prerank,polyol metabolic process (GO:0019751),0.4451263725248449,1.4875914165437074,0.02735562310030395,0.6241910078455584,1.0,13/46,12.24%,PLCH1;INPP4B;ITPK1;IP6K1;INPP5D;NUDT10;PLCD1;INPP5B;PLCG1;NUDT3;PLD4;OCRL;IPMK
prerank,regulation of endocytic recycling (GO:2001135),0.6220636168892851,1.486575752032219,0.0549645390070922,0.6233454968122869,1.0,6/11,11.37%,ATP9A;PLA2G3;ACTN2;INPP5F;EHD1;EHD2
prerank,receptor metabolic process (GO:0043112),-0.37638825040275714,-1.486189213489177,0.025078369905956112,0.4235700573522834,1.0,21/53,17.41%,KIF16B;PIK3R4;CD36;SNX1;SH3GLB1;LMTK2;LDLRAP1;SYK;TFRC;PICALM;CAV1;UVRAG;SNX25;GRB2;DNM2;LRP1;LILRB1;RAMP2;CALCRL;FCER1G;RAB31
prerank,microtubule depolymerization (GO:0007019),0.5443730547446526,1.4849523059874294,0.06867671691792294,0.6255394237847643,1.0,8/17,16.38%,STMN4;STMN3;STMN2;NCKAP5;CKAP5;NCKAP5L;KIF2A;KIF14
prerank,positive regulation of synaptic transmission (GO:0050806),0.4007319970897698,1.4844549966467409,0.019287833827893175,0.6223298101691527,1.0,26/72,18.77%,ADCY8;CACNG5;CACNG2;MPP2;SYT1;PRKCZ;NRXN1;LGI1;LGMN;GRIK2;SHANK3;CLSTN2;GRIN2B;CACNG7;ZDHHC2;RIMS1;KCTD13;BAIAP3;HAP1;EPHB2;SLC8A3;EIF2AK4;PLK2;CACNG3;CHRNA7;RIMS3
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4652105347827573,-1.4835328627337983,0.041343669250646,0.4262891590620793,1.0,9/23,17.73%,ZEB2;DAB2;SDCBP;THBS1;SNW1;EP300;ADAM17;HIPK2;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4652105347827573,-1.4835328627337983,0.041343669250646,0.4262891590620793,1.0,9/23,17.73%,ZEB2;DAB2;SDCBP;THBS1;SNW1;EP300;ADAM17;HIPK2;SMAD4
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5016177388742815,-1.4832052927648656,0.047979797979797977,0.424926684473738,1.0,5/18,11.81%,OS9;UGGT1;UBC;UBA52;RNF103
prerank,regulation of anoikis (GO:2000209),-0.4797472922878636,-1.4831882885725458,0.055825242718446605,0.4228156612896133,1.0,7/19,14.12%,BCL2;MCL1;CAV1;PIK3CA;NOTCH1;BRMS1;SIK1
prerank,positive regulation of cytokinesis (GO:0032467),-0.4237073292320095,-1.483006791302393,0.03389830508474576,0.42109129150293206,1.0,9/32,9.19%,SVIL;PRKCE;CUL3;KIF23;CDC14B;KIF20B;CIT;RACGAP1;DRD2
prerank,negative regulation of TOR signaling (GO:0032007),0.4621480178978189,1.4825791287977887,0.03268945022288262,0.6255081586394374,1.0,11/36,16.80%,TSC2;STK11;MINAR1;ITFG2;DDIT4;PDCD6;EPM2A;FLCN;SH3BP4;RNF152;MAPKAPK5
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.4524718311664487,-1.480419009695088,0.04607046070460705,0.42566356995347193,1.0,14/26,29.84%,APOE;ATP7A;HIF1A;IL1B;S100A1;TERF2;TNF;NUS1;POR;DHFR;CDH3;TERT;GCH1;AGTR2
prerank,tube closure (GO:0060606),0.4646504704790058,1.4792367855306503,0.04043545878693624,0.6353287923030897,1.0,9/31,10.48%,TSC2;VANGL2;PLXNB2;SCRIB;LRP2;MTHFD1L;PRICKLE1;TGFB1;GRHL3
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4317730263308305,1.4792248599181752,0.03007518796992481,0.6300115167119917,1.0,10/47,16.81%,GAPDH;SPOCK3;ANXA8;ANXA8L1;BIN1;SPOCK2;SERPINH1;VTN;SERPINE2;AGT
prerank,macroautophagy (GO:0016236),-0.3203453511284914,-1.4787683606788307,0.0,0.4278039812198286,1.0,31/118,17.72%,VIPAS39;VPS37C;PIK3C3;CHMP4B;CHMP4A;MAP1LC3B;NBR1;VCP;PIK3R4;ATG13;PRKAB1;LIX1;MTMR14;TOMM7;ATG7;UBQLN1;EPG5;PRKAG2;UVRAG;LAMP2;SNAP29;TOMM20;ATG3;STAM;PRKAB2;MTMR3;AMBRA1;CLN3;SQSTM1;MAP1LC3A;PGAM5
prerank,negative regulation of gene expression (GO:0010629),-0.2851991033892106,-1.4772932877576024,0.0,0.4297099141287653,1.0,98/302,22.95%,FCGR2B;APOE;FLOT2;PTPN22;MECP2;IGF1;EPC1;DIS3L2;CELF1;SETDB2;PARP14;NOCT;MSR1;RPS26;XDH;ZC3H12D;RBBP7;CNOT9;PPHLN1;MALSU1;FBXW7;NPTN;SOX11;PTGER4;ESR1;NFKB1;SAMD4A;ERN1;TAF1;RPS13;YY1;VHL;CRKL;PICALM;PDCD10;YAP1;SRGN;DNMT1;EIF4ENIF1;HIF1A;BMI1;PSEN1;DDX6;CAPRIN1;H3-3A;SMCR8;HINFP;ZC3H12A;CD28;NOTCH1;ZNF148;DAPK1;SLC11A1;PARP9;AGO2;HDAC1;LSM2;KDR;PAIP2B;SYNCRIP;TYMS;RB1;LARP1;RACK1;LSM5;BMP2;CREB3L1;FOXP1;TERF2;TRIM71;TNF;FXR2;TIPARP;RGCC;HEY2;IGFBP5;MMP8;PHF19;MYADM;RNH1;EED;HSPA1B;NCOR1;NOTCH2;KLF4;PTBP3;DHFR;NDFIP1;CPEB3;FFAR4;ID2;ANXA7;CD3E;APLNR;KAT2B;APP;ILF3;TASOR
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4506423693112569,1.4769860977306097,0.03475513428120063,0.63437791330305,1.0,17/41,24.56%,KCNMA1;KCNJ3;KCNH2;GABBR1;NOS1AP;ACTN2;GABBR2;KCNN4;KCNJ5;KCNMB3;KCNN3;ANK2;CTSS;KCNN2;PDZK1;ANK3;GNG2
prerank,diterpenoid metabolic process (GO:0016101),0.4222403436271305,1.476653052310429,0.03736920777279522,0.6305774320231045,1.0,14/55,15.45%,AGRN;RDH10;AKR1C1;BCO2;RARRES2;LRP2;AWAT2;GPC1;AKR1B1;GPC2;GPC5;RDH5;GPC4;NAPEPLD
prerank,positive regulation of chemotaxis (GO:0050921),0.44170291933132694,1.4763471656313334,0.04094488188976378,0.6266441420233184,1.0,15/43,12.82%,F3;P2RY12;PRSS56;MEGF8;RARRES2;SMOC2;IL6;NTRK3;DSCAM;LGMN;PRKD2;TGFB1;FGF2;STX3;PDGFB
prerank,regulation of mast cell activation (GO:0033003),-0.6009897206971496,-1.4759069019799937,0.08009153318077804,0.43118562585267284,1.0,5/10,26.45%,CD300LF;LYN;CD226;PLSCR1;TSLP
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5700314107482247,-1.475575372927457,0.0767590618336887,0.4298853211588666,1.0,5/11,20.62%,LIMD1;PUM2;AJUBA;WTIP;PUM1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.45086209409413947,1.474510598751546,0.04294478527607362,0.6296372823344185,1.0,20/37,26.97%,TPPP;STMN4;STMN3;MAP6;STMN2;CLASP2;MAPRE2;CAMSAP3;BICD2;PHLDB2;ROCK1;TAOK1;BICD1;CYLD;CDK2AP2;MAPRE3;GAS2L1;MAPT;PRKAA2;EPHA3
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.5941772906736852,-1.4742622621162405,0.07972665148063782,0.43127360248399943,1.0,4/10,15.41%,NFKBIZ;ZC3H12A;RC3H1;RC3H2
prerank,regulation of interleukin-1 production (GO:0032652),-0.5174776420718428,-1.472972373436812,0.08816705336426914,0.43255692757744024,1.0,6/15,16.41%,GAS6;ANXA1;TMED10;CEACAM1;FOXP1;TLR4
prerank,positive regulation of protein sumoylation (GO:0033235),-0.591926288863228,-1.471677053666646,0.07045454545454545,0.4337498271393991,1.0,6/10,24.19%,RWDD3;UBA2;MUL1;HDAC4;PIAS4;PIAS3
prerank,potassium ion transmembrane transport (GO:0071805),0.3632414981895792,1.4709676570360086,0.007978723404255319,0.6404784411066257,1.0,36/135,19.85%,HCN1;KCNK12;KCNJ3;KCNH2;KCND2;KCNA5;ATP1B1;KCNE2;KCNJ8;KCNH7;KCNC1;SLC12A2;KCNK3;ATP1B3;KCNJ13;SLC9A4;PKD2;SLC12A6;KCNK6;SLC1A3;KCNN4;SLC9A5;ABCC8;HPN;KCNJ5;KCNC3;SLC24A3;KCNT2;KCNN3;KCNK9;KCNQ4;SLC24A4;KCNK2;ATP1A4;ATP1A3;ATP1A1
prerank,myoblast fusion (GO:0007520),0.5790687674320725,1.4709276205415642,0.07017543859649122,0.6354341917255375,1.0,4/12,11.81%,JAM2;CD81;ADAMTS15;ADAM12
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.36243164126066624,-1.4708881630443762,0.01892744479495268,0.43349256913877793,1.0,28/66,23.69%,IGF1;GIT1;LILRA5;CD36;TYROBP;NLRC4;NOD2;TLR8;ZC3H12A;LPL;FOXP1;AGER;TNF;HSPB1;WNT5A;TLR4;FFAR1;PYDC1;TRIM16;CD33;MYD88;CASP1;AIM2;FFAR4;ISL1;APP;MEFV;GSTP1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.41303462734372587,-1.4703967084614074,0.026525198938992044,0.4328120265106237,1.0,21/36,26.45%,CD74;GAS6;AXL;PARP14;UBE2K;ZBP1;CD300LF;RIPK1;HIF1A;TRIM44;NLRC5;PARP9;WNT5A;ADAM17;AGPAT2;HSPA1B;CASP1;TICAM2;FADD;CSF1;TSLP
prerank,regulation of regulated secretory pathway (GO:1903305),0.4601623659892924,1.470190438309884,0.04043545878693624,0.6335951982657408,1.0,9/34,11.17%,SYT4;RAB3A;SYT13;SYT1;SNAPIN;SYT6;RAB5A;RAB3D;RIMS1
prerank,positive regulation of protein catabolic process (GO:0045732),-0.34453211582742777,-1.469668709828007,0.02711864406779661,0.4323690213491434,1.0,25/84,17.97%,ITCH;APOE;WWP1;VCP;STX5;RAB7A;SMURF2;VPS35;ADAM9;ATG7;MSN;HECW1;NRDC;SNX9;IL1B;PTTG1IP;ADAM8;FOXO1;BARD1;TNFRSF1B;TNF;WNT5A;TIPARP;DTL;RILP
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.41736927796078843,-1.4694440257533532,0.03978779840848806,0.43097170837856563,1.0,6/33,5.53%,SP100;APOE;PTPN23;MCC;CORO1C;THBS1
prerank,Golgi inheritance (GO:0048313),-0.5632997207644872,-1.4690530639777097,0.07783018867924528,0.43003900904104353,1.0,5/11,11.28%,VCPIP1;STX5;GBF1;PDCD10;CDK1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.46717249151462686,-1.4674368406508433,0.04702970297029703,0.4321915328539205,1.0,5/20,5.95%,BCL2;BCL2L1;MCL1;BAX;FAS
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.45602394130787943,1.467392218850738,0.0328125,0.641015761641726,1.0,15/37,16.52%,PTPRD;DCHS1;CADM1;TENM1;IGSF21;GRID2;NECTIN3;TENM3;IL1RAPL1;CRTAM;ICAM1;CADM3;FAT4;HMCN1;CXADR
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6068733757323501,1.4673283951435496,0.06357388316151202,0.6362355444002963,1.0,4/11,9.35%,DDX5;IL6;BMP4;TGFB1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5895988508841579,-1.4669634992911795,0.0625,0.43142564922766785,1.0,5/11,21.17%,BCL2L1;ZC3H12A;PTGIS;DFFA;SIRT2
prerank,response to molecule of bacterial origin (GO:0002237),-0.3571446572435087,-1.4666912593775174,0.023728813559322035,0.4300898005111261,1.0,20/69,17.07%,FCGR2B;IFNAR1;PTPN22;NOCT;HMGB2;MAPKAPK2;CD14;CD24;IL1B;C4B;ACOD1;MAPKAPK3;SMAD6;SLC11A1;PELI1;FOXP1;LBP;LIAS;TLR4;ADAM17
prerank,synaptic vesicle exocytosis (GO:0016079),0.437344679212905,1.465374140936107,0.03184713375796178,0.6403141105444878,1.0,10/40,11.91%,SNAP25;RAB3A;SYT1;SNAPIN;DOC2B;OTOF;UNC13B;STX3;RIMS1;CPLX2
prerank,potassium ion homeostasis (GO:0055075),0.5026760732564269,1.4638841466520809,0.05564924114671164,0.6424639135478206,1.0,9/23,19.85%,KCNMA1;KCNH2;ATP1B1;SLC12A2;ATP1B3;SLC12A6;ATP1A4;ATP1A3;ATP1A1
prerank,myofibril assembly (GO:0030239),0.43112566732322716,1.4635514449371878,0.03328290468986384,0.6389967574670725,1.0,8/42,12.94%,CAPN3;OBSL1;LMOD1;SIX4;MYPN;TMOD2;ACTN2;LMOD3
prerank,synaptic vesicle cycle (GO:0099504),0.4720648195209162,1.4628021434891127,0.03859060402684564,0.6377086924802232,1.0,8/30,15.54%,SNAP25;RAB3A;SNAPIN;OTOF;RAB5A;RIMS1;CPLX2;WNT7A
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.45690830494739143,1.4618507149837865,0.0452418096723869,0.6367031527146558,1.0,9/34,9.57%,MPP2;GABRG1;GABRG2;MEF2C;ARRB2;GABRA2;GRID2;GRIN1;GRIN2B
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5878871671863235,-1.4610572061176743,0.07603686635944701,0.44252628301670077,1.0,6/10,21.39%,MTRR;MPST;CBS;GADL1;CTH;ADO
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.521638628187975,1.4610291692622674,0.047775947281713346,0.6356534084902733,1.0,4/18,4.80%,PAG1;ADTRP;IL4I1;PPARA
prerank,positive regulation of locomotion (GO:0040017),0.4803251113181157,1.4608707453258367,0.05472636815920398,0.631433781753229,1.0,7/27,12.82%,CCDC25;P2RY12;SPOCK2;RARRES2;TGFB1;STX3;PDGFB
prerank,protein heterooligomerization (GO:0051291),0.543399870846389,1.460842576300989,0.03927986906710311,0.6268616981150298,1.0,8/17,14.27%,CPSF6;MAT2A;CBR4;PKD2;GRIN1;GRIN2B;PKD1;NUDT21
prerank,retinal metabolic process (GO:0042574),0.5694027878463905,1.4597134444901678,0.06304728546409807,0.6268009309832724,1.0,3/12,4.32%,RDH10;AKR1C1;BCO2
prerank,regulation of fibroblast proliferation (GO:0048145),-0.3883225059242979,-1.4588139222463512,0.04335260115606936,0.44621694334369333,1.0,12/45,11.57%,CD74;GAS6;IGF1;CD300A;CDK6;CDC73;NDUFS4;S100A6;BMI1;PDGFC;CTNNB1;LIG4
prerank,inflammatory response (GO:0006954),-0.30140901359495137,-1.4580454478737241,0.00546448087431694,0.44629208496621137,1.0,81/195,29.51%,FCGR2B;ADGRE5;CYBB;ITCH;NRROS;PARP4;HRH1;CD44;TLR2;PJA2;C3AR1;CIITA;SIGLEC1;TBK1;CCR2;MAPKAPK2;PTGER4;NLRC4;NFKB1;CD14;CCL25;C5AR1;THBS1;PF4;CEBPB;GPR68;ITGAL;TUSC2;SCUBE1;ANXA1;BLNK;IL1B;ADAM8;ADCY1;OLR1;CYBA;SLC11A1;CCRL2;BMP2;FOS;TNF;RELB;LIAS;TLR4;HYAL3;TRAF3IP2;LY75;PTX3;TLR1;AFAP1L2;NFATC3;PIK3CD;LTB4R;HDAC4;HPR;HP;MMP25;TLR5;MEFV;PLA2G2D;FPR3;CRH;CCL7;TAC4;CD96;NOX4;NFX1;RAC1;ADORA2A;ALOX15;IL36G;CCL24;FPR2;XCR1;IL10RB;PTGDR;LAT;PTGIR;FOLR2;TBXA2R;MFHAS1
prerank,iron ion transport (GO:0006826),-0.38409531111039213,-1.4573682489338213,0.018867924528301886,0.4458492343511952,1.0,17/47,22.08%,ATP6V0D1;ATP6V0D2;STEAP3;ATP6V1B2;ATP6V0A1;ATP6V0B;LMTK2;TFRC;DNM2;CP;SLC11A1;ATP6V1A;MCOLN1;ATP6V0A4;LTF;HEPH;ATP6V1G2
prerank,positive regulation of protein polymerization (GO:0032273),0.3976341621779174,1.4571182215691199,0.02575107296137339,0.6336752758931745,1.0,12/65,7.35%,TPPP;CTTN;BIN1;PAK1;LMOD1;PSRC1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;NAV3;FCHSD2
prerank,mammary gland epithelium development (GO:0061180),0.5707100921319164,1.4565985429566586,0.06700167504187604,0.631278980169711,1.0,4/14,8.93%,WNT4;SCRIB;WNT3;ERBB4
prerank,oligodendrocyte development (GO:0014003),0.5532476015611761,1.4563334769098129,0.05442176870748299,0.6280486658950103,1.0,7/15,15.19%,TPPP;PLP1;CNTNAP1;SOX10;EIF2B3;MYRF;EIF2B1
prerank,cAMP metabolic process (GO:0046058),-0.5316061877301307,-1.4562815467269672,0.0659090909090909,0.44667943613654765,1.0,8/13,17.38%,ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;ADCY10;EPHA2;PTHLH
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6024730309163768,1.4560087494075618,0.06884057971014493,0.625061755780929,1.0,5/11,15.10%,KCNH2;BIN1;ACTN2;STK39;NEDD4L
prerank,axonemal dynein complex assembly (GO:0070286),0.47331329418861295,1.4543768905380716,0.05237315875613748,0.6275172933380742,1.0,10/27,16.65%,DNAAF1;ODAD4;CCDC39;DNAI3;CCDC65;CFAP100;SPAG1;DNAL1;DNAAF2;DNAAF3
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.49171209845040115,1.4535860634707163,0.05636070853462158,0.6264598580996932,1.0,5/22,4.85%,CACNB4;CBARP;NOS1AP;CACNB2;DMD
prerank,excitatory postsynaptic potential (GO:0060079),0.5264367387009588,1.453056667761631,0.0642504118616145,0.6241867710608456,1.0,6/19,9.57%,MPP2;MEF2C;ARRB2;GRID2;GRIN1;GRIN2B
prerank,sensory perception of sound (GO:0007605),0.3806672005622262,1.4518502237559827,0.012448132780082987,0.6248712307472458,1.0,19/88,15.47%,LHFPL3;LHFPL4;WHRN;LHFPL5;CDH23;LRTOMT;COL2A1;PJVK;LRP2;MARVELD2;GSDME;SLC26A4;SNAI2;HOMER2;POU3F4;CACNA1D;TIMM13;EPS8L2;HPN
prerank,activation of phospholipase C activity (GO:0007202),0.46814977305326577,1.4516108288138638,0.04377104377104377,0.6215575807953988,1.0,8/29,7.23%,P2RY12;ANG;TXK;NMUR1;AVPR1A;CD86;PLCG1;GNA15
prerank,neuron development (GO:0048666),0.3579459180559594,1.451116775684316,0.01034928848641656,0.6194350341177869,1.0,55/141,26.15%,ATP8A2;PLP1;STMN4;STMN3;PQBP1;BLOC1S2;TENM1;STMN2;SNAPIN;PBX2;IL6;LGI1;MEF2C;RYK;MANF;SAMD14;ADCYAP1;SH3GL2;GPRIN1;TENM3;NEDD4;RASGRF1;BTG2;STX3;EHD1;PBX3;CAMSAP1;HS6ST1;MICALL1;HMGB1;ERCC6;NTRK2;PPP1R9A;ROCK1;HDGFL3;XBP1;WNK1;SRF;SRRM4;EPHA5;MAP2;GPM6A;ZFYVE27;ULK1;OPHN1;GBA2;PTPRM;VAPA;RUNX1;TBCD;RAPGEF2;FLRT3;CNTNAP2;LGI4;MAPT
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.5386516146352455,-1.4505563274089524,0.07075471698113207,0.4596598578978812,1.0,4/13,12.26%,GAS6;AXL;TYROBP;LAMP1
prerank,regulation of macroautophagy (GO:0016241),-0.3309045470537548,-1.4503476507976172,0.012448132780082987,0.45814856889106936,1.0,34/105,16.67%,ATP6V0D1;VPS26A;ATP6V0D2;CAPN1;PAFAH1B2;ATP6V1B2;ATG13;PRKAB1;ATP6V0A1;RRAGC;PRKACA;TBK1;LAMTOR5;SH3GLB1;VPS35;ATP6V0B;EXOC4;ERN1;UBQLN1;PRKAG2;SMCR8;PIK3CA;VPS26B;LRRK2;RRAGA;EXOC8;ATP6V1A;KDR;LARP1;PRKAB2;WAC;CLN3;MAPK8;SESN2
prerank,sodium ion export across plasma membrane (GO:0036376),0.5699612738990278,1.4498516733463709,0.06932409012131716,0.6206209278917079,1.0,7/13,28.03%,ATP1B1;ATP1B3;ATP1A4;ATP1A3;ATP1A1;SLC9A1;ATP1B2
prerank,regulation of interferon-gamma production (GO:0032649),-0.34837807940481735,-1.449671803345714,0.003105590062111801,0.45784841452979436,1.0,23/71,16.79%,GAS6;PTPN22;CD274;AXL;CD47;IL12RB2;RARA;CCR2;TLR7;CEBPG;CD14;IL27;HSPD1;TLR8;IL1B;CD226;ZC3H12A;CD2;SLC11A1;EBI3;LILRB1;TLR4;IL18R1
prerank,positive regulation of synapse assembly (GO:0051965),0.47528530603200064,1.4495213989358915,0.055031446540880505,0.6178669848582845,1.0,10/27,15.54%,AGRN;PTPRD;SRPX2;IL1RAP;NRXN1;GRID2;CLSTN2;IL1RAPL1;EPHB2;WNT7A
prerank,early endosome to late endosome transport (GO:0045022),-0.46473504648985575,-1.449119349009496,0.06796116504854369,0.45714742703793276,1.0,10/20,13.64%,PIK3C3;KIF16B;PTPN23;RAB7A;LMTK2;WDR91;AKTIP;WDR81;EMP2;EEA1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.38500148966013925,1.4485009679257417,0.0392156862745098,0.6181631384313186,1.0,24/75,19.85%,KCNJ3;KCNH2;ATP1B1;KCNE2;SLC39A4;KCNJ8;SLC12A2;TRPM2;ATP1B3;KCNJ13;SLC9A4;SLC12A6;SLC8A1;SLC39A8;SLC9A5;SLC6A1;SLC8A3;CACNA2D1;KCNJ5;KCNK9;TRPV6;ATP1A4;ATP1A3;ATP1A1
prerank,defense response to fungus (GO:0050832),0.5375810581649231,1.4482952016887716,0.0595446584938704,0.6148415984605332,1.0,5/17,13.77%,GAPDH;RARRES2;CX3CR1;RNASE7;FAM3A
prerank,myelination (GO:0042552),0.4247291410469807,1.4479577668719792,0.05030487804878049,0.6122903754992546,1.0,20/46,22.68%,TPPP;PLP1;CNTNAP1;MPZ;SOX10;GPC1;NFASC;CMTM8;CXCR4;MYRF;GAL3ST1;SCN2A;MAL2;SLC8A3;ACSBG1;MBP;ABCD2;MAL;EIF2B5;SCN8A
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.4276646278529924,-1.4475981762068415,0.04087193460490463,0.4591506804974628,1.0,9/29,10.77%,IL15;IFNAR1;STAT5B;STAT4;CCR2;IFNAR2;STAT2;STAT1;GHR
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.5044923020328984,-1.4475385437019326,0.06053268765133172,0.45726221918086213,1.0,7/16,11.91%,PTPN22;TNFSF8;SOX11;AHR;IL27;IKZF3;TNFRSF1B
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.6042550530592707,-1.4463110395824832,0.08564814814814815,0.4586412554825263,1.0,8/10,28.26%,SOX11;BMP5;NOTCH1;LRP6;BMP7;LIN7C;DLL4;PHACTR4
prerank,mammary gland development (GO:0030879),0.5040015907905125,1.4448429561791536,0.06724137931034482,0.6212707171203926,1.0,5/21,12.57%,WNT4;PRLR;WNT3;ERBB4;ARHGAP35
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5337494116630783,1.4437198491297512,0.07035175879396985,0.6220938419158044,1.0,11/17,21.35%,RTN1;GGA3;BIN1;PRNP;CLU;HAP1;NTRK2;ROCK1;CHRNA7;PIN1;ABCA7
prerank,receptor catabolic process (GO:0032801),-0.44174716338753883,-1.4435688795548882,0.07046070460704607,0.46419788654538746,1.0,9/24,11.18%,AP2A2;KIF16B;PIK3R4;SH3GLB1;AP2B1;ZNRF3;UVRAG;SNX25;CLTA
prerank,kinetochore organization (GO:0051383),-0.5283942240279255,-1.442673961684351,0.08413461538461539,0.46463939314455216,1.0,6/13,17.05%,MIS12;CENPA;CDT1;CENPW;NDC80;NUF2
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.38640075473454527,-1.442630464874882,0.03910614525139665,0.46273636733364837,1.0,12/44,15.24%,APOE;PTPN22;CD300A;STK38;PTPN1;LYN;IL1B;SPRY2;SPRY1;INPP5K;DUSP1;SPRY4
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.4247731408783929,-1.442555461983888,0.06818181818181818,0.4609606612836266,1.0,11/31,15.82%,FCGR2B;CD274;CD300A;DLG5;SOX11;TYROBP;CEBPB;LYN;RC3H1;LILRB1;SPN
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5111974267430462,-1.4424617869966887,0.05741626794258373,0.459229213914041,1.0,9/14,32.09%,XDH;CAV1;SPRY2;SPRY1;NOTCH4;GDF3;SPRED1;DLL1;MMP9
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5229218162447541,1.4416476257562358,0.0701468189233279,0.6266669651257459,1.0,8/17,22.35%,CACNB2;CACNA1G;SLC8A1;CACNA1D;CACNA2D1;ANK2;SCN1B;SCN3B
prerank,anterior/posterior pattern specification (GO:0009952),0.4092357416407036,1.4416281293690956,0.030257186081694403,0.6226952194254182,1.0,9/53,9.05%,HOXA5;HHEX;HOXD4;CYP26C1;HOXB9;HOXC6;HOXB7;TGFBR1;HEY1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.29962605708040885,-1.4409832444029749,0.0,0.46141024283621557,1.0,48/182,15.57%,APOBEC1;APOE;FLOT2;PTPN22;MECP2;IGF1;CELF1;SETDB2;PARP14;NOCT;MSR1;SDCBP;XDH;FBXW7;MTMR2;SOX11;ESR1;NFKB1;ANKRD13A;TAF1;YY1;VHL;CRKL;PICALM;PDCD10;LDLR;YAP1;DNMT1;HIF1A;PSEN1;SMCR8;HINFP;ZC3H12A;CD28;NOTCH1;ZNF148;PARP9;AGO2;HDAC1;KDR;RB1;RACK1;BMP2;CREB3L1;FOXP1;TERF2;TNF;OPTN
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4529470556840648,-1.4393125756033947,0.05013192612137203,0.4640341524707124,1.0,11/23,23.69%,GAS6;IGF1;GIT1;ZC3H12A;CEACAM1;FFAR1;PYDC1;CD33;FFAR4;MEFV;GSTP1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.5073550256571975,1.4383384003775816,0.056856187290969896,0.6320664680742303,1.0,7/19,15.26%,POLD3;ADA;PNP;AMPD3;HPRT1;DCK;GMPR
prerank,regulation of glucose metabolic process (GO:0010906),0.4491081692756912,1.437189530634943,0.07017543859649122,0.6327646792331901,1.0,13/34,24.41%,SELENOS;GNB3;SLC45A3;DGKQ;OGT;PRKN;IRS1;KHK;RORA;RUBCNL;PDK1;GPLD1;USP7
prerank,regulation of receptor binding (GO:1900120),0.6028706982825057,1.436887507154202,0.07635009310986965,0.6299833311213424,1.0,4/10,12.49%,ATP2A3;ATP2A2;ADAM15;GREM2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.48098871156796136,-1.4368834035151694,0.061381074168797956,0.4687320109517863,1.0,10/19,28.33%,ADAM19;AFDN;MAD2L2;NOTCH1;NOTCH4;RGCC;PPM1F;SERPINF2;TJP1;PLG
prerank,neuron projection morphogenesis (GO:0048812),0.35114420688031267,1.4368602706743947,0.009186351706036745,0.626120420517479,1.0,67/137,28.40%,CTTN;MAP6;CNTNAP1;SRGAP2;DCC;NYAP2;RAB3A;CTNNA2;PAK1;PARD6B;NCKAP1;NCKAP1L;ATL1;LRP2;MAP1S;RYK;RAB8A;DAB2IP;SHANK3;APBB1;MAP4K4;KLF7;CTNND2;BTBD3;MINK1;DOCK10;SLITRK4;ANKRD27;NRCAM;EPHB2;DSCAML1;EIF2AK4;WNT7A;PLPPR4;ROCK1;TAOK1;NTNG2;NTNG1;ALS2;SHANK1;ACTB;PLXNB1;SDC2;CDC42;MAP2;GPM6A;FARP1;IMPACT;WASL;CCK;MEF2A;BDNF;ANK3;TAOK2;DCLK1;FLRT3;CNTNAP2;MYO16;LLGL1;DLG4;MAP1B;DIP2A;BRSK2;EPB41L3;SLITRK1;CELSR2;PTEN
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3540955371847354,-1.4364994494548318,0.021739130434782608,0.4677804572954513,1.0,19/64,15.96%,PEAK1;SLK;PLAU;CDK6;CD36;CORO1C;RASA1;CCL25;UTRN;THBS1;CIB1;SKAP1;EMP2;MYOC;VCL;AJAP1;PTK2B;CCL28;BST1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4984318013071619,-1.43610897627514,0.07637231503579953,0.46691659167616384,1.0,8/17,17.85%,RARA;IRF4;SYK;CEBPB;PRKCQ;CD28;FCER1G;GATA3
prerank,eye photoreceptor cell development (GO:0042462),0.5431745674288495,1.4359904941172048,0.08196721311475409,0.6257035449145234,1.0,3/15,12.44%,NRL;THY1;RPGRIP1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.43586641493996775,-1.4358119431904481,0.05291005291005291,0.4657253399135375,1.0,8/27,13.37%,APOE;EEPD1;PPARG;PLTP;CAV1;NR1H2;NR1H3;LRP1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.529826259188773,-1.435654568706889,0.08293838862559241,0.4622869269356635,1.0,4/13,14.97%,IL15;STAT5B;GRB2;SHC1
prerank,cellular response to interleukin-15 (GO:0071350),-0.529826259188773,-1.435654568706889,0.08293838862559241,0.4622869269356635,1.0,4/13,14.97%,IL15;STAT5B;GRB2;SHC1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.33741244641896495,-1.4352048024130821,0.02622950819672131,0.46149909489500873,1.0,26/80,17.86%,STX6;RIC1;VPS26A;SNX8;STX5;TMEM87B;RAB7A;RAB7B;SNX1;VPS35;GBF1;CLN5;RAB6A;TMED9;DENND2A;VPS26B;TBC1D10C;TBC1D10A;DENND5A;VPS54;YKT6;RBSN;RGP1;VPS52;GCC2;ERC1
prerank,regulation of cholesterol efflux (GO:0010874),-0.4172197190863731,-1.434746136300762,0.05714285714285714,0.4610802883161066,1.0,9/30,13.37%,APOE;EEPD1;PPARG;PLTP;CAV1;NAXE;NR1H2;NR1H3;LRP1
prerank,negative regulation of viral process (GO:0048525),-0.35979348378667164,-1.434675720836699,0.037267080745341616,0.45938720473126443,1.0,34/57,33.16%,OAS2;IFIH1;TRIM14;IFITM3;IFIT1;PROX1;OASL;SHFL;BST2;TRIM62;STAT1;BANF1;TRIM5;OAS3;TNF;ZC3HAV1;PTX3;LTF;TRIM21;TNIP1;IFITM1;ILF3;EIF2AK2;PLSCR1;TRIM13;LARP7;ISG20;BTBD17;SLPI;SRPK1;TRIM11;TRIM32;ISG15;PPIA
prerank,innate immune response (GO:0045087),-0.2879951344860719,-1.4336393021328797,0.0,0.46038567276504666,1.0,65/217,20.88%,SP100;CYBB;CD74;NRROS;ANKRD17;RNASE3;ALPK1;TRIM25;RPL39;ATAD3A;IFIH1;TLR2;PJA2;TRIM14;PPARG;CIITA;IRF7;TBK1;IFITM3;TYROBP;CXCL16;IFIT1;TRIM17;SHFL;BST2;NOD2;SYK;TRIM62;LYN;FYN;TLR8;CLEC6A;HCK;LCK;CYBA;SLC11A1;IRAK4;NLRC5;FRK;KLRD1;TRIM5;LCN2;B2M;IFNLR1;LBP;AGER;PTK2B;OTULIN;RELB;FCER1G;TLR4;ANKHD1;PYDC1;ZAP70;MSRB1;PTX3;CLEC4E;CFP;CAMP;MYD88;CD300E;LTF;SETD2;PIK3CD;TRIM21
prerank,mitochondrial transport (GO:0006839),0.4059023296851241,1.4335927374357669,0.042682926829268296,0.6317314864838569,1.0,27/53,26.73%,SLC25A4;STARD3;FIS1;TMEM14C;FBXO7;TMEM14A;FLVCR1;SLC25A31;BAK1;TOMM34;SLC25A5;PITRM1;TIMM13;TSPO;TIMM22;TOMM70;OXA1L;MFF;BCS1L;MTX2;TIMM23;COX18;TIMM44;TOMM22;TIMM10;SLC25A16;TIMM10B
prerank,positive regulation of lipid kinase activity (GO:0090218),0.45494810473435393,1.4333549134298018,0.06414473684210527,0.6288352403611325,1.0,14/29,19.41%,P2RY12;TNFAIP8L3;CD81;TGFB1;FGF2;IRS1;EEF1A2;PDGFB;TEK;DGKZ;PRKD1;PTK2;FLT3;PDGFRB
prerank,metanephros development (GO:0001656),0.4709713578485217,1.4332692729433187,0.055105348460291734,0.6253549267755886,1.0,6/26,12.51%,FGF10;SIX4;FOXD1;BMP4;PKD2;PKD1
prerank,transport across blood-brain barrier (GO:0150104),0.37985020462369634,1.4327750789793088,0.022857142857142857,0.6235047328329547,1.0,28/83,21.84%,SLC4A8;ATP2A3;SLC2A3;SLCO2B1;ABCC3;SLC29A2;AVPR1A;KCNJ8;SLC38A2;SLC22A8;LRP2;SLC12A2;SLC1A1;SLC1A3;SLC1A4;ABCA2;SLC6A1;SLC19A1;INSR;SLC24A3;ATP8A1;SLC16A12;SLC13A3;ATP1A4;ABCG2;SLC6A9;SLC22A5;SLC38A3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5567819850550632,-1.4327218342302988,0.09948979591836735,0.4610013612193671,1.0,5/11,16.17%,LDLR;NR1H2;CTDNEP1;NR1H3;MFSD2A
prerank,neural tube closure (GO:0001843),0.44049895596165256,1.4325397115743772,0.0581039755351682,0.6207779526108002,1.0,10/34,11.15%,TSC2;VANGL2;PLXNB2;SCRIB;LRP2;MTHFD1L;PRICKLE1;TGFB1;GRHL3;KDM2B
prerank,lipoprotein localization (GO:0044872),-0.5692442718897033,-1.4319389200749921,0.1,0.46136512447607914,1.0,5/11,13.37%,ZDHHC3;PPARG;CD36;ZDHHC17;LRP1
prerank,regulation of mitochondrial translation (GO:0070129),-0.46020844242530035,-1.4309074392199144,0.061124694376528114,0.4619610021823333,1.0,13/21,30.76%,RCC1L;MALSU1;TRUB2;TRMT10C;MTG2;UQCC2;MTG1;MRPS27;RPUSD3;TSFM;C1QBP;SHMT2;MPV17L2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4465703341399842,-1.430754623714003,0.0639386189258312,0.4605323535115207,1.0,7/22,14.21%,NOL11;WDR43;SMARCA4;DHX33;IPPK;UTP15;UBTF
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5668853667971304,-1.43057510935442,0.06733167082294264,0.45560407010472836,1.0,5/12,13.38%,CUL3;NSMCE2;CDC27;ESPL1;RB1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5668853667971304,-1.43057510935442,0.06733167082294264,0.45560407010472836,1.0,5/12,13.38%,CUL3;NSMCE2;CDC27;ESPL1;RB1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5668853667971304,-1.43057510935442,0.06733167082294264,0.45560407010472836,1.0,5/12,13.38%,CUL3;NSMCE2;CDC27;ESPL1;RB1
prerank,Golgi to endosome transport (GO:0006895),-0.505819394765177,-1.430468108648214,0.0681265206812652,0.45407291300744923,1.0,9/16,24.60%,KIF16B;KLHL20;GBF1;EPS15;AP4M1;CORO7;DOP1B;VPS13C;AP2A1
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.5004997046106764,-1.4295962640808455,0.09326424870466321,0.45443784894628575,1.0,9/16,21.84%,HFM1;TOP2A;RMI1;MSH4;EME1;CENPX;SLX4;FANCM;TOP2B
prerank,retinoid metabolic process (GO:0001523),0.38806168907055966,1.4295532410343244,0.042212518195050945,0.6291399130898093,1.0,12/71,8.56%,AGRN;CYP2S1;RDH10;AKR1C1;BCO2;RARRES2;LRP2;AWAT2;GPC1;AKR1B1;GPC2;GPC5
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.35728235012751536,-1.4295237679320658,0.02830188679245283,0.4528594115734603,1.0,29/68,22.59%,CD74;IFIH1;TLR2;LILRA5;IL16;RAB7B;TYROBP;TLR7;NOD2;HSPD1;SYK;TLR8;IL1B;LPL;CYBA;SPHK2;LBP;AGER;TNF;SCIMP;WNT5A;TLR4;MMP8;ARHGEF2;TLR1;MYD88;ISL1;TWIST1;APP
prerank,energy reserve metabolic process (GO:0006112),-0.47852968601824747,-1.428858987955749,0.0654911838790932,0.45280786014820473,1.0,4/19,11.71%,PID1;PHKB;PRKAG2;PPP1R3C
prerank,negative regulation of catalytic activity (GO:0043086),-0.44025405640262827,-1.4262625122458226,0.07692307692307693,0.45771547731903856,1.0,16/24,34.51%,IFIT1;PPP1R12A;NOSIP;NOTCH1;PHPT1;PARP9;CLN3;NES;TIMP1;HP;APBA3;TMBIM1;CAND1;NOS1;HDAC6;GZMA
prerank,sensory perception of mechanical stimulus (GO:0050954),0.37629883899322375,1.4259463412339262,0.02631578947368421,0.640864945767711,1.0,18/85,14.35%,LHFPL3;LHFPL4;WHRN;LHFPL5;CDH23;LRTOMT;COL2A1;PJVK;LRP2;MARVELD2;GSDME;SLC26A4;SNAI2;HOMER2;POU3F4;CACNA1D;TIMM13;EPS8L2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.4160572404257625,-1.4248455081890454,0.064343163538874,0.4597002477179036,1.0,8/31,10.02%,CHST11;IGF1;EXT1;XYLT1;CHST9;FAM20B;UGDH;NDST3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.5556743032570817,-1.4247354279587148,0.07390300230946882,0.4582933646262345,1.0,5/11,36.40%,RTP4;PKD1L3;LPO;RTP2;TAS1R3
prerank,positive regulation of cell cycle process (GO:0090068),-0.33233602021545267,-1.424523099004036,0.007194244604316547,0.45712149222664483,1.0,35/91,23.84%,SVIL;IGF1;PRKCE;CUL3;KIF23;CDC14B;KIF20B;CIT;IL1B;RACGAP1;DRD2;NUSAP1;CD28;RHNO1;MAD2L1;IGF2;RAD21;E2F8;NUMA1;UBXN2B;NUP62;E2F7;NDC80;RGCC;ECT2;CEP295;DRD3;MAP10;SIRT2;MAP3K20;TGFA;CDC14A;CCNB1;PLSCR1;EGF
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3436523011587696,-1.4240973655781144,0.029508196721311476,0.4564728454126097,1.0,20/72,13.52%,ARHGEF3;APOE;NRP1;STARD8;EPS8;ABL2;RAF1;RIPOR2;CUL3;KANK2;MET;CCDC125;ARHGEF18;PDCD10;STMN1;ARHGDIB;GPR65;GPR18;ARHGEF28;MYOC
prerank,T cell activation involved in immune response (GO:0002286),-0.5473971443938794,-1.4239820043887677,0.09070294784580499,0.45507875692210814,1.0,6/12,16.30%,CD74;ITGAL;LCP1;SLC11A1;LILRB1;FCER1G
prerank,regulation of synapse maturation (GO:0090128),0.6092767274197258,1.4238144054609587,0.07950530035335689,0.6458516846412945,1.0,6/10,22.93%,NEUROD2;NRXN1;DAB2IP;ANAPC2;ADGRL1;CAMK2B
prerank,glial cell differentiation (GO:0010001),0.4662319953495197,1.4238115378333347,0.07017543859649122,0.6420394146405217,1.0,6/28,5.19%,TPPP;FGF10;NFIB;SOX10;SOX4;GPC1
prerank,cellular response to alcohol (GO:0097306),-0.38929373066925316,-1.4235923355597384,0.03038674033149171,0.454349964653881,1.0,19/42,21.48%,PTGER4;CTNNA1;AHR;BRCA1;ADCY5;ADCY6;KLF9;CTNNB1;ADCY1;ADCY3;LARP1;GRAMD1C;SPHK2;GRAMD1B;MAP4K1;LRP6;CDH1;MLC1;PTCH1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.5276284896946364,-1.4234894534041211,0.08847184986595175,0.4528870974944167,1.0,5/13,13.89%,APOE;NFKB1;ERLIN2;BMP5;BMP2
prerank,filopodium assembly (GO:0046847),-0.4867014488742525,-1.4232570139879759,0.08188585607940446,0.451803626762306,1.0,5/16,7.77%,FGD4;FGD6;S1PR2;SPEF1;FGD1
prerank,positive chemotaxis (GO:0050918),0.5197057901816845,1.423212293809316,0.07419354838709677,0.6406019459467389,1.0,4/17,5.55%,FGF10;TSC2;SCRIB;FGF7
prerank,diacylglycerol metabolic process (GO:0046339),0.4831755819080007,1.4227120314575397,0.07,0.6390382497235505,1.0,11/23,21.81%,DGKI;ANG;DGAT2;DGKQ;DGKZ;DGKE;DAGLA;PGS1;PLA2G15;DGKH;LIPE
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.5095383267391514,1.4224350612435062,0.06807131280388978,0.6364192919578853,1.0,6/19,10.16%,FBXW8;OBSL1;PTPRD;CDKL5;IL1RAPL1;SS18L1
prerank,chromatin assembly (GO:0031497),-0.38996064568853644,-1.422055891681475,0.037142857142857144,0.45310369177415377,1.0,10/38,10.50%,LIN54;HMGB2;KAT6B;PADI4;PRDM9;ANP32B;H3-3A;H1-0;CTCF;GRWD1
prerank,magnesium ion transport (GO:0015693),-0.5371166215790297,-1.4217860137003864,0.06896551724137931,0.45216461652877227,1.0,7/12,28.01%,MAGT1;MRS2;NIPAL4;NIPAL3;MMGT1;SLC41A1;NIPAL1
prerank,negative regulation of anoikis (GO:2000811),-0.5128292600568132,-1.4207508997099345,0.07710843373493977,0.4530691464832039,1.0,5/14,10.94%,BCL2;MCL1;CAV1;PIK3CA;NOTCH1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5197663537324342,-1.4187732651541423,0.09490740740740741,0.4565781256270165,1.0,5/13,15.77%,MDFIC;SP100;NUP153;BARD1;CHP1
prerank,negative regulation of endocytosis (GO:0045806),-0.44803674403368765,-1.418678808025134,0.060759493670886074,0.45519466918361157,1.0,9/24,14.99%,MCTP1;CD300A;MTMR2;PICALM;CAV1;NR1H2;APOC1;NR1H3;LILRB1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.4600913527588335,-1.4183349600174526,0.06297229219143577,0.45434678044038806,1.0,12/21,29.66%,RPL5;RAB1A;CDC14B;RPS7;MAD2L2;MAD2L1;PLK1;UBE2C;RPL11;GORASP1;CDC20;RPL23
prerank,regulation of cell aging (GO:0090342),0.5866046676219843,1.4178015244844744,0.0919931856899489,0.6520694550574466,1.0,4/11,21.73%,VASH1;NEK4;NUAK1;ING2
prerank,regulation of immune response (GO:0050776),-0.3042749369671041,-1.4177213516723366,0.022321428571428572,0.45424793318918927,1.0,53/135,25.12%,ITGA4;FCGR2B;IL15;PTPN22;CD300A;CSK;ULBP1;DENND1B;IRF7;SLAMF7;CD300LF;TYROBP;AHR;IRF4;SYK;ITGB7;LYN;ITGAL;PDCD1;CD226;ERAP1;HCST;JAML;RAET1E;BIRC2;KLRD1;B2M;FOXP1;LILRB1;SPN;GPR108;CLEC2D;TREML2;CD247;COL3A1;CD33;PILRA;APPL2;CD300E;OSCAR;CD300LG;IFITM1;CD3E;KLRK1;TREML4;PLSCR1;XIAP;BCL6;CD96;FCRLB;CD300C;APPL1;DHX58
prerank,regulation of interleukin-10 production (GO:0032653),-0.38002174798159477,-1.41695471766121,0.03672316384180791,0.4544081039429958,1.0,10/44,6.17%,FCGR2B;CD274;CD47;PIBF1;LILRA5;TYROBP;IRF4;NOD2;HSPD1;SYK
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5422935756192289,1.4164751763525922,0.08482871125611746,0.6538360509623354,1.0,4/14,6.02%,SRSF12;RNPS1;SRSF6;PTBP1
prerank,organic anion transport (GO:0015711),0.37499084206013567,1.4151424913888553,0.02857142857142857,0.6558214197399321,1.0,16/76,14.50%,SLC25A4;SLC4A8;SLC35A1;SLCO2B1;CA1;CA3;CA4;SLC2A2;CFTR;CYB5R2;SLC26A7;MFSD10;SLC39A8;SLC4A10;SLC4A7;SLC19A1
prerank,negative regulation of insulin secretion (GO:0046676),0.52528119328797,1.4150508825933992,0.08173076923076923,0.6524851921914986,1.0,9/17,27.12%,ADRA2A;PRKN;KLF7;IRS1;SFRP1;REST;MIDN;CHGA;KCNB1
prerank,dendritic spine organization (GO:0097061),0.4705589130311184,1.4144988155296212,0.07085346215780998,0.6511703747206273,1.0,16/26,28.40%,PRNP;LGMN;SHANK3;CTNND2;DOCK10;INSR;EPHB2;WNT7A;SHANK1;CHRNA7;CDC42;ARF1;WASL;DLG4;DIP2A;PTEN
prerank,neuron projection extension (GO:1990138),-0.4080958533854868,-1.4141948415716923,0.056338028169014086,0.45974394952887454,1.0,8/32,12.38%,IQGAP1;ALCAM;NRP1;NRP2;CDKL3;USP9X;CTNNB1;SEMA5B
prerank,cellular response to cytokine stimulus (GO:0071345),-0.2674648874892933,-1.4141552254217782,0.0,0.45817190425037757,1.0,105/416,16.94%,F13A1;PID1;BCL2;IFNAR1;GAS6;POU2F1;ITGAX;AXL;BCL2L1;ALOX5;ABL2;CSK;CRK;PTPN23;RIPOR2;CD47;STAT5B;LIFR;TEC;TLR2;STAT4;UBE2K;CD36;IL12RB2;MCL1;PRKACA;TBK1;CCR2;IL16;IFNAR2;STAT2;IL6ST;JUNB;IFIT1;PIM1;GRAP2;NFKB1;CCL25;IRF4;BAG4;PF4;SMAD3;LDLRAP1;CRKL;SYK;RIPK1;CDC34;CCND1;FYN;RO60;ANXA1;GBP3;UBC;CIB1;GAB2;HIF1A;BRCA1;IL1B;HCK;PTPN7;SOCS5;PIK3CA;UBA52;ZC3H12A;VIM;STAT1;BIRC5;PTGIS;LCK;RC3H1;GRB2;GHR;FOXO1;ACOD1;TNFRSF1B;DAPK1;CBL;IRAK4;TCF7;SHPK;ASAH2;SYNCRIP;LCN2;GBP4;INPP5K;HAS2;FOS;DUSP1;IFNLR1;LBP;EBI3;SHC1;TNF;BCL2L11;WNT5A;RBMX;PDE2A;IL27RA;SDC1;TLR4;HMOX1;MAPK8;CRNN;IL18R1;HYAL3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5854951522498789,1.4140684838092068,0.07719298245614035,0.6491477942852582,1.0,5/10,21.22%,ALOX12;SH2B3;PRKG1;SERPINE2;RDX
prerank,cellular response to purine-containing compound (GO:0071415),0.594504421402171,1.4140050937614763,0.09608540925266904,0.6458254204658952,1.0,4/10,12.15%,CACNA1S;TRPM2;SLC8A1;P2RY1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.5203157938533849,-1.4138310462442867,0.07692307692307693,0.4573777066511735,1.0,5/14,12.44%,TFRC;CD226;MAD2L2;PAXIP1;SHLD1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5834186746866524,-1.4124792779705777,0.07228915662650602,0.45919866766206363,1.0,5/10,13.84%,NBR1;FAS;LYN;RNF13;GREM1
prerank,heart development (GO:0007507),0.3389014978250354,1.412291725868553,0.016414141414141416,0.6491327229781335,1.0,36/150,16.67%,TSC2;ZFPM1;FGF12;KDM6B;ADAP2;TNNI3;SOX4;MEGF8;MYBPC3;TCF25;ZFPM2;NTRK3;MEF2C;DAND5;TGFBR3;TGFBR1;BMP4;ERBB4;PKD2;FOXC1;TGFB1;LDB3;TBX2;SGCZ;CRELD1;SGCG;PKD1;AKAP13;PDGFB;TEK;NDRG4;INSR;BORCS8;CXADR;PTK2;SGCD
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.5679611625545582,-1.4119853046053665,0.1016548463356974,0.45878210614266574,1.0,2/10,8.06%,DNMT1;BRCA1
prerank,neuron differentiation (GO:0030182),0.3395031717245628,1.4119679535409686,0.009987515605493134,0.646923882589808,1.0,49/165,26.23%,ATP8A2;WNT4;LDB1;PTPRD;NEUROG2;ATOH7;NEUROD2;TENM1;SOX4;PBX2;WNT3;MEF2C;ITM2C;RYK;TGFBR1;MANF;NRBP2;LHX3;TENM3;WNT8B;IL1RAPL1;DDIT4;CASP3;PBX3;HS6ST1;LHX5;LMX1B;ERCC6;NTRK2;WNT7A;LHX2;EN2;XBP1;PIN1;WNK1;SRF;IRX5;EPHA5;LHX4;OPHN1;ACSL3;ERCC2;NIF3L1;RUNX1;RNF112;VXN;WNT5B;FZD5;PHOX2A
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6045391972766115,1.4118992189533024,0.09694793536804308,0.6401382434295546,1.0,4/10,20.77%,CDC42EP5;CDC42EP4;CDC42EP1;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.6045391972766115,1.4118992189533024,0.09694793536804308,0.6401382434295546,1.0,4/10,20.77%,CDC42EP5;CDC42EP4;CDC42EP1;CDC42
prerank,protein-containing complex disassembly (GO:0032984),-0.35392546292846905,-1.4116240783696268,0.031791907514450865,0.458135201692794,1.0,21/54,25.50%,VIPAS39;MAP1LC3B;VCP;DVL3;LIX1;CAV1;UBQLN1;EPG5;UVRAG;LAMP2;SNAP29;CTNNB1;FZD2;CLN3;MAP1LC3A;LRP6;LIX1L;PYM1;GABARAPL2;VAMP7;FZD1
prerank,response to fatty acid (GO:0070542),-0.4845046943881911,-1.411434364689181,0.08478802992518704,0.4570327689353824,1.0,7/17,22.71%,PID1;CD36;LPL;FOXO1;FFAR1;NR1H4;GLDC
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.508048052248368,-1.4112255688377136,0.09534883720930233,0.455947807501246,1.0,6/13,17.52%,FCGR2B;ALOX5;NR1H2;NR1H3;AQP11;WFS1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.4982448738361085,1.4101670544773546,0.0664451827242525,0.6434946086556504,1.0,5/20,7.30%,PPIC;PPIB;PPWD1;PPIL1;PPIG
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5095032718576262,-1.4089607012776926,0.08788598574821853,0.4598577281475907,1.0,5/15,11.37%,RPL5;DTX3L;RPS7;MAD2L2;MAD2L1
prerank,body fluid secretion (GO:0007589),0.5419776860707407,1.4087189807660085,0.08247422680412371,0.6460512516700694,1.0,6/15,22.66%,PRLR;ERBB4;SLC22A4;ZBTB7B;GUCA1B;NPR1
prerank,inositol lipid-mediated signaling (GO:0048017),0.4069143817755767,1.4086878921518875,0.04437869822485207,0.642700878222409,1.0,12/50,11.46%,PLCH1;PIK3C2G;PLCL1;ADAP2;NTRK1;PLCD1;PIK3CG;RPS6KB1;TNFAIP8L3;OGT;INPP5F;IRS1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5561982306495955,-1.408565291295253,0.07990314769975787,0.459297617362541,1.0,7/11,30.00%,PJA2;LYN;ACOD1;CYBA;TLR1;MFHAS1;TNFAIP3
prerank,actomyosin structure organization (GO:0031032),0.37404443417353916,1.4066306668792048,0.03488372093023256,0.6475846261867502,1.0,14/75,9.00%,EPB41L2;FRMD5;CAPN3;F11R;LMOD1;SIX4;MYPN;MYH10;ITGB5;TMOD2;FRMD3;EPB41;CDC42BPA;ACTN2
prerank,calcium-mediated signaling (GO:0019722),0.3653129010132006,1.4066043219927367,0.02888583218707015,0.6442575418088944,1.0,27/93,16.32%,ACKR4;P2RY12;ATP2A2;ACKR3;KSR2;ATP1B1;NMUR1;TNNI3;FIS1;PRNP;TRPM2;PLCG1;CCR1;SAMD14;RCAN3;CXCR6;CX3CR1;SLC8A1;BTK;CXCR4;PPP3CC;CCR6;RCAN2;ACKR2;CCR9;DMPK;PPP1R9A
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.52781623142419,-1.405967016435065,0.07363420427553444,0.46419508352149286,1.0,7/13,18.13%,CD74;GAS6;AXL;IFIH1;TRIM44;WNT5A;AGPAT2
prerank,regulation of protein localization (GO:0032880),-0.35998074434898963,-1.4054674672961522,0.022222222222222223,0.4639378064378658,1.0,20/58,20.88%,STX6;TRIM25;TRIM14;DVL3;AFDN;FBXW7;BORA;TRIM17;PICALM;USP8;TMEM231;WDPCP;TRIM5;RACK1;DNAJB6;MAPK8;PPM1F;ITGB3;ZDHHC7;TRIM21
prerank,regulation of hippo signaling (GO:0035330),-0.47266321174304193,-1.4032706244419515,0.08685446009389672,0.46773694023937284,1.0,8/17,19.61%,LIMD1;DLG5;SOX11;CIT;MOB3B;AJUBA;NEK8;WTIP
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.513436007117152,-1.4030044677790066,0.09090909090909091,0.46682172021653023,1.0,4/13,4.02%,CBLB;KPNB1;RANBP2;KPNA2
prerank,nervous system development (GO:0007399),0.30887830362368174,1.4025008710567444,0.0,0.658019507731932,1.0,98/429,15.59%,NAV2;ROGDI;STMN3;PCDHB9;FUT10;PCDHB4;GDF11;LSAMP;MERTK;OBSL1;ECRG4;LDB2;LDB1;FGF12;WWTR1;FGF11;DCHS1;ACAN;MPZ;CNTFR;NEUROD2;SOX10;CYP26C1;TENM1;MAB21L2;NCKAP1;PCDHB5;CRMP1;SPOCK2;NFASC;LY6H;EFNB3;GSS;NRXN1;NAV3;DSCAM;TMOD2;LGI1;GLRB;MEF2C;MAP1S;RYK;DPF2;SEMA6B;NDP;NPTX1;TGFBR1;ADAM22;SHANK3;LIMK1;ADGRL3;CPNE6;COX7B;ACHE;ERBB4;SH3GL2;PKD2;RAPGEFL1;SDK1;PCDHA5;TGFB1;RAPGEF5;APLP1;WNT8B;PRKN;ASIC2;PCDH1;FGF2;FGF13;BTBD3;FEZ2;PCDHB3;CXCR4;LRCH4;ACVR1B;HAPLN2;SH3GL3;SEMA4F;PKD1;VCAN;DCTN1;NRCAM;MYLIP;TBX6;GFRA1;EVL;RBFOX2;RBFOX3;ALDH5A1;HAPLN1;SCN2A;DPYSL2;HAP1;EPHB2;DSCAML1;ERCC6;FAT4;APC2
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.5311275527374326,-1.4020730667227947,0.07981220657276995,0.4674904912705781,1.0,9/13,32.58%,SYK;GAB2;LAMP1;SPHK2;CD177;KLRC2;FGR;ITGB2;STX4
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5892717457260024,1.4016771604240235,0.08996539792387544,0.6578867727375131,1.0,4/11,10.96%,PRDX5;PRDX2;PXDN;PRDX4
prerank,cellular response to zinc ion (GO:0071294),0.5295085818178698,1.40163406271528,0.08754208754208755,0.6546612841081736,1.0,10/15,18.07%,GLRA2;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.364361273839294,-1.4014433982339005,0.036414565826330535,0.4674318995278451,1.0,17/48,16.79%,PTPN22;IL12RB2;CCR2;TLR7;CEBPG;CD14;IL27;HSPD1;TLR8;IL1B;CD226;CD2;SLC11A1;EBI3;LILRB1;TLR4;IL18R1
prerank,positive regulation of secretion by cell (GO:1903532),0.377068411866089,1.4013208406925834,0.04297994269340974,0.6525173211422374,1.0,21/70,18.10%,FRMD4A;MYOM1;ANG;RAB3A;CADPS2;SYTL4;MYH10;SLC12A2;CLASP2;APBB1;ACHE;TGFB1;CFTR;RAB5A;UNC13B;DNM1L;BAIAP3;APBB3;IER3IP1;STXBP5;IL1A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.37575752693230313,1.4012146615620487,0.03125,0.6496188128261198,1.0,37/75,28.99%,MAP6;DCC;RAB3A;CTNNA2;PARD6B;ATL1;MEF2C;MAP1S;RYK;RAB8A;APBB1;KLF7;BTBD3;MINK1;SLITRK4;NRCAM;DSCAML1;WNT7A;PLPPR4;NTNG2;NTNG1;ACTB;SDC2;MAP2;FARP1;OPHN1;CCK;MEF2A;ANK3;TBCD;TAOK2;LLGL1;MAP1B;BRSK2;SLITRK1;CELSR2;DCDC2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.3505590730916345,-1.4008945045708903,0.03571428571428571,0.4671492117023424,1.0,20/57,17.92%,CLSPN;CDC14B;TOPBP1;MDC1;CCND1;NBN;BRCA1;ABRAXAS1;TAOK3;CDK1;TICRR;EME1;WAC;PLK1;NOP53;RPA2;UIMC1;BRCC3;DTL;HMGA2
prerank,mRNA splice site selection (GO:0006376),0.44952130381130784,1.4007850585875035,0.07075471698113207,0.6480964129540938,1.0,12/30,18.37%,SRSF12;SRSF5;ISY1;SRSF6;SF3A1;SRSF1;YTHDC1;CELF6;SETX;SRSF9;PUF60;PSIP1
prerank,regulation of viral life cycle (GO:1903900),-0.4515331101480156,-1.4006126460062014,0.08997429305912596,0.4662765079520165,1.0,5/21,6.61%,AXL;TRIM25;TRIM14;KPNA2;TRIM62
prerank,positive regulation of response to external stimulus (GO:0032103),-0.30783493488876923,-1.399892974514971,0.0196078431372549,0.46668717266316484,1.0,46/128,25.12%,SASH1;IL15;DDX60;ANKRD17;CD47;TLR2;LILRA5;ZBP1;CCR2;IL16;PTGER4;TLR7;NFKBIZ;PUM2;OASL;THBS1;RIPK1;TLR8;IL1B;LPL;GPSM3;GPRC5B;ADAM8;ACOD1;CYBA;PTN;TNF;SCIMP;WNT5A;OPTN;PDE2A;TLR4;POLR3G;PPM1F;USP15;PUM1;SLC15A4;TNIP1;APOH;SERPINF2;APP;PLA2G7;PLSCR1;FEM1A;TLR9;DHX58
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5157323745078818,1.3997105357523554,0.08047945205479452,0.6492642275206922,1.0,7/17,24.33%,KCNH2;KCNE2;KCNJ8;NEDD4L;ANK2;SCN3B;SNTA1
prerank,regulation of ion transmembrane transport (GO:0034765),0.446829218772296,1.399378109308533,0.06774193548387097,0.6473324526281669,1.0,9/33,15.91%,YWHAE;KCNJ3;KCNH2;KCNE2;KCNJ8;KCNJ13;NEDD4;NEDD4L;KCNJ5
prerank,maintenance of blood-brain barrier (GO:0035633),0.4501134089485657,1.3990094805106221,0.05546218487394958,0.6454363105214613,1.0,6/30,5.93%,F11R;JAM2;DMD;IL6;SLC12A2;SLC1A1
prerank,protein polyglutamylation (GO:0018095),0.5774889107551533,1.3988504031993851,0.09706959706959707,0.6427503691792856,1.0,8/11,30.23%,TTLL6;TTLL7;TPGS1;TTLL1;TTLL5;TTLL11;CFAP20;CEP41
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2602979551087582,-1.3987065942259105,0.0,0.46805331561318914,1.0,132/532,18.00%,F13A1;SP100;IL15;BCL2;IFNAR1;PSMA6;POU2F1;ITGAX;OAS2;BCL2L1;ALOX5;ABL2;CSK;CRK;TNFSF8;CD44;TRIM25;STAT5B;LIFR;TEC;TALDO1;MAP3K8;STAT4;IFIT2;IRF9;CIITA;IRF7;CD36;PSMB2;IL12RB2;MCL1;PRKACA;SMARCA4;CCR2;IL16;IFITM3;CD300LF;IFNAR2;STAT2;IL6ST;PSME2;JUNB;IFIT1;PIM1;LIMS1;GRAP2;NFKB1;MSN;CCL25;IL27;OASL;IRF4;LMNB1;BAG4;PF4;PSMD11;BST2;CRKL;NOD2;SYK;RIPK1;CCND1;PSMC6;TRIM62;IFIT3;MID1;FYN;YAP1;ANXA1;UBC;GAB2;HIF1A;PSMA3;IL1B;HCK;IL1RL1;TAB1;SOCS5;PIK3CA;UBA52;LCP1;CAMK2D;VIM;STAT1;BIRC5;LCK;GRB2;LTB;GHR;FOXO1;BIRC2;HNRNPA2B1;TNFRSF1B;CBL;CEACAM1;IRAK4;PELI1;TRIM5;OAS3;PSMD10;LCN2;EDA;B2M;TNFRSF17;FOS;IRF2;AIP;IFNLR1;LBP;EBI3;SHC1;PSMB5;TNF;BCL2L11;PTK2B;RAP1B;TRAF1;FCER1G;IL27RA;SDC1;HMOX1;IL18R1;SQSTM1;ADAM17;TRAF3IP2;ADIPOR2;PYDC1;TNFRSF9;TNFRSF25;SMAD4;GATA3;PSMD5
prerank,membrane raft organization (GO:0031579),-0.4959174065551337,-1.398554415358438,0.09324009324009325,0.4668173308506183,1.0,7/15,18.83%,RFTN1;FLOT2;NAXE;S100A10;EMP2;CLN3;MYADM
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.36936579305655637,-1.3985538928896648,0.03254437869822485,0.4652402452734202,1.0,19/49,19.87%,CD74;TLR2;RAB1A;LAMTOR5;TLR7;CD14;NOD2;SYK;RIPK1;TLR8;IL1B;CD2;LBP;TNF;TLR4;TLR1;AFAP1L2;MYD88;HSPA1B
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3429476954671715,-1.397858421740476,0.023890784982935155,0.46558929481324457,1.0,20/67,16.70%,VAV3;CYBB;NRP1;NRP2;PXN;AXL;CRK;MAPKAPK2;NCK1;FLT1;FYN;PIK3CA;MAPKAPK3;CYBA;KDR;PTK2B;HSPB1;ELMO2;BCAR1;AAMP
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3411584009881888,-1.3977083950512494,0.015873015873015872,0.4644790668394285,1.0,20/72,16.08%,CD74;GAS6;AXL;PTPRC;LIFR;ZBP1;PTPN1;IFNAR2;USP18;SYK;RIPK1;CD24;STAT1;HIPK1;TRIM44;BIRC2;RACK1;TNF;OTULIN;TRAF1
prerank,cellular protein metabolic process (GO:0044267),-0.26534330214200635,-1.3969658463127308,0.0,0.4649239176490416,1.0,111/396,19.56%,MSRA;APOE;PARP4;GAS6;UBE2D3;IGF1;ABL2;STK38;RPN2;RPS26;RPL39;SFTPA2;SFTPA1;RPS23;YME1L1;RPL5;RPS24;IGFBP4;RPS16;LGALS1;RPL28;EEF1A1;SIAH2;RPS29;NAGPA;RPS14;SHISA5;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;UBL4A;RPS5;PADI4;RIPK1;CDC34;RPL30;PARL;RPL6;DHPS;RPL37A;CPE;EIF4EBP2;CLN5;IGHMBP2;ST8SIA4;PSEN1;RPL10;RPL15;CDKL3;MBTPS1;SERPINC1;GOLM1;UBE2L3;UBA52;LOX;SERPIND1;YARS2;RPS10;PPP4R2;RPL14;ICMT;RPL9;RPL32;RPL36;CP;CCN1;SPPL3;RPL31;IGF2;RPL23A;LTA4H;RPN1;PRKCSH;AGO2;ATG3;MRPL35;PNPLA2;STOML2;FAM20C;APH1B;FBXO2;RPL41;MXRA8;RPL3;UBE2L6;ST8SIA2;MAGEC2;CDH2;RPL8;ADPRH;ADAM17;WFS1;CCDC59;IGFBP7;GNMT;MSRB1;ANO8;MFGE8;RPL37;IGFBP5;FN1;SRBD1;NAPSA;MRPS33;RPL36A;RPL26
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.36983828334530444,-1.3969507202249498,0.04672897196261682,0.46342407546377296,1.0,15/43,17.92%,CLSPN;CDC14B;TOPBP1;NBN;BRCA1;ABRAXAS1;TAOK3;CDK1;TICRR;PLK1;NOP53;UIMC1;BRCC3;DTL;HMGA2
prerank,cellular response to leucine (GO:0071233),0.5897883344863872,1.3963970853436067,0.11148648648648649,0.6465170976266414,1.0,2/10,2.41%,KLHL22;RPTOR
prerank,response to leucine (GO:0043201),0.5897883344863872,1.3963970853436067,0.11148648648648649,0.6465170976266414,1.0,2/10,2.41%,KLHL22;RPTOR
prerank,autophagosome maturation (GO:0097352),-0.3921367046985778,-1.3960275316943083,0.043478260869565216,0.4642990344231365,1.0,9/32,10.26%,VIPAS39;MAP1LC3B;VCP;LIX1;UBQLN1;EPG5;UVRAG;LAMP2;SNAP29
prerank,positive regulation of inflammatory response (GO:0050729),-0.33353024742647486,-1.3952024596655954,0.032490974729241874,0.46506905152138867,1.0,32/86,26.45%,IL15;CD47;TLR2;LILRA5;ZBP1;CCR2;IL16;IL6ST;PTGER4;TLR7;NFKBIZ;RIPK1;IL1B;LPL;GPSM3;GPRC5B;ADAM8;LBP;TNF;WNT5A;PDE2A;TLR4;MMP8;OSMR;TNIP1;APP;PLA2G7;FEM1A;TLR9;VAMP7;CEBPA;TSLP
prerank,heart contraction (GO:0060047),0.419113965681357,1.3942572710383454,0.06222222222222222,0.6518699802177205,1.0,9/41,12.27%,KCNH2;ATP1B1;TNNC1;TNNI3;DMD;MYBPC3;SLC8A1;SGCZ;SGCG
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5038499107695475,-1.3942387156139409,0.09501187648456057,0.4662247750174188,1.0,5/13,12.18%,CHMP4B;CHMP4A;SMCR8;MTM1;LRRK2
prerank,megakaryocyte differentiation (GO:0030219),0.5693141096703526,1.3937504065005173,0.09106529209621993,0.6506974968320642,1.0,3/11,14.64%,ZFPM1;SH2B3;THPO
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.39398181457276177,-1.3934550329322692,0.07880434782608696,0.4666207503243302,1.0,14/33,23.84%,HIP1;CNOT9;FBXW7;HIP1R;BCAR3;ARAP1;PLAUR;CBL;NUP62;ADAM17;PDE6H;AFAP1L2;TGFA;EGF
prerank,primary alcohol metabolic process (GO:0034308),-0.4333629011002994,-1.3927138832218993,0.08585858585858586,0.46720601111922705,1.0,11/25,24.41%,IGF1;GPD2;RDH11;GDPD3;GDE1;CYP1A1;ALDH3A2;DHRS9;DHRS3;CYP1B1;RDH12
prerank,heterochromatin organization (GO:0070828),-0.5000626065569681,-1.3909913176885433,0.10473815461346633,0.4702203879610511,1.0,7/14,22.27%,SETDB2;SETD7;SMCHD1;HP1BP3;HMGA2;POLE3;MECOM
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.38356845801648265,1.3898317043274866,0.05991440798858773,0.6638906421202331,1.0,13/62,6.88%,POLR2L;CDK7;CTR9;RTF1;POLR2F;NELFB;ELP2;GTF2H2;NELFCD;ELOC;SSRP1;GTF2H4;GTF2F1
prerank,aminoglycan biosynthetic process (GO:0006023),0.40649876754650516,1.3891869329733293,0.06564885496183206,0.6633437226919301,1.0,13/49,13.21%,AGRN;B3GNT9;HS3ST5;HS3ST6;B4GAT1;B3GNT6;B3GALT2;GPC1;GPC2;GPC5;B3GALNT1;HS6ST1;GPC4
prerank,regulation of cilium movement (GO:0003352),0.5872878145232174,1.3890666491401829,0.11313868613138686,0.6605967116613827,1.0,4/10,6.86%,DNAAF1;CFAP43;CCDC39;CCDC65
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4258498494778401,-1.3885150817605714,0.06958762886597938,0.47503278113617253,1.0,14/26,24.92%,PTPN22;TLR2;PJA2;CAV1;CYBA;NR1H3;LBP;TLR1;LTF;SLC15A4;TLR5;TICAM2;TREML4;TLR9
prerank,regulation of mast cell degranulation (GO:0043304),-0.5071476605880443,-1.387207593403263,0.08552631578947369,0.4768355806619463,1.0,5/14,14.06%,CD300A;SYK;LYN;GAB2;SPHK2
prerank,fat cell differentiation (GO:0045444),-0.3550159925508488,-1.3871176451448248,0.04746835443037975,0.4754421801097386,1.0,21/57,22.09%,PID1;OSBPL8;PPARG;METRNL;BBS7;EGR2;ERAP1;EP300;TMEM120B;FOXO1;ATF5;C1QTNF3;SMAD6;ALOXE3;TMEM120A;HMGA2;PER2;TFAP2B;KLF4;FFAR4;CLIP3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.46885053523974507,1.3847287908034764,0.09628378378378379,0.6753881794343822,1.0,6/23,9.60%,KCNH2;SCNN1A;OTC;SLC12A2;SLC26A4;SLC12A6
prerank,steroid metabolic process (GO:0008202),0.37522090233625993,1.3843384999016384,0.05263157894736842,0.673775911908455,1.0,16/72,17.85%,STARD3;STAR;NR1I2;AKR1C1;CYP26C1;PRLR;LRP2;FDX2;LGMN;CYP39A1;LSS;RDH5;TSPO;CYP27A1;AMACR;HSD17B10
prerank,monoacylglycerol metabolic process (GO:0046462),0.5350895984536946,1.3839239013964835,0.10362694300518134,0.672395370770061,1.0,3/13,7.16%,DGAT2;AWAT2;ABHD12
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.5054330521146019,-1.3832949181541225,0.09068627450980392,0.48376933278555656,1.0,5/14,19.70%,IL6ST;IL1B;ADAM8;TNF;OSMR
prerank,nucleosome assembly (GO:0006334),-0.39622586685003597,-1.3832794871691483,0.07466666666666667,0.482275072337827,1.0,9/31,14.13%,HMGB2;KAT6B;CABIN1;PADI4;ANP32B;H3-3A;GRWD1;HAT1;NPM1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5396059398256814,1.3828812397608075,0.12724014336917563,0.6735423570687065,1.0,3/13,5.80%,GCHFR;FPGS;MTHFD1L
prerank,ether lipid biosynthetic process (GO:0008611),0.5747476378248302,1.3828417511759599,0.11015490533562823,0.6705078470528849,1.0,3/10,11.35%,PLA2G4C;DHRS7B;LPCAT2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.39166761239333425,-1.3823833226982707,0.07541899441340782,0.482954069383047,1.0,22/36,31.51%,APOE;CAV1;HIF1A;IL1B;NOSIP;DNM2;S100A1;GLA;TERF2;EGFR;TNF;NUS1;DHFR;NOSTRIN;TERT;CYGB;HSP90AA1;ZDHHC21;GCH1;AGTR2;CALM1;DDAH1
prerank,cAMP biosynthetic process (GO:0006171),-0.5505098957483922,-1.3819899881974056,0.12195121951219512,0.48255469301383125,1.0,6/10,14.26%,ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;ADCY10
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4501020893752428,1.3816605059383384,0.0768,0.6722549610256138,1.0,6/29,9.35%,ZFPM1;TNNC1;TNNI3;MYBPC3;TGFBR3;TGFB1
prerank,mismatch repair (GO:0006298),-0.4133399032643318,-1.3807541583213268,0.07,0.4839913415823914,1.0,12/27,20.71%,PCNA;MSH5;POLD4;RPA1;MSH4;MCM9;RNASEH2A;PMS1;RPA2;MUTYH;XPC;SETD2
prerank,mitotic cytokinesis (GO:0000281),-0.3625510040052775,-1.3806019403489962,0.05730659025787966,0.4828523665038608,1.0,18/47,17.83%,CHMP4B;KIF23;RASA1;SNX9;STMN1;CIT;RACGAP1;USP8;CENPA;NUSAP1;ESPL1;PDCD6IP;KIF4A;CKAP2;INCENP;PLK1;KIF20A;ECT2
prerank,cilium-dependent cell motility (GO:0060285),0.47436936952529746,1.3802477672252276,0.09427609427609428,0.6748862748466903,1.0,8/22,21.60%,CCDC39;DNAH3;DNAI3;CCDC65;DNAAF2;CFAP44;CFAP54;DNAH2
prerank,cellular response to interferon-beta (GO:0035458),-0.5008574998918266,-1.380204281913927,0.09601873536299765,0.4823063572173432,1.0,7/14,27.78%,UBE2K;CDC34;STAT1;ACOD1;AIM2;NDUFA13;IRGC
prerank,embryonic heart tube morphogenesis (GO:0003143),0.4024154355587825,1.3796062887776666,0.06287425149700598,0.6744886509601019,1.0,10/43,13.32%,DNAAF1;VANGL2;CCDC39;MEGF8;MEF2C;BBS5;PKD2;TBX2;TBX6;NDRG4
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4576431799453999,1.3791126702789587,0.08169934640522876,0.6734126401834808,1.0,10/25,15.26%,ADA;PNP;GART;PRPSAP2;AMPD3;HPRT1;DCK;ADSL;PRPSAP1;GMPR
prerank,circulatory system development (GO:0072359),0.3423192896046032,1.3786772908865854,0.024161073825503355,0.6720824064262454,1.0,25/118,12.97%,TSC2;ZFPM1;FGF12;KDM6B;ADAP2;FLT4;TNNI3;SOX4;STK11;TCF25;ZFPM2;NTRK3;NXN;MEF2C;TGFBR1;ERBB4;PKD2;FOXC1;HEY1;TGFB1;LDB3;PKD1;AKAP13;PDGFB;TEK
prerank,immunoglobulin mediated immune response (GO:0016064),-0.559882106923904,-1.3784704488915944,0.09662921348314607,0.4853144763893614,1.0,3/10,7.51%,FCGR2B;CD74;TLR8
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4931571282264753,1.3779949561364728,0.10413223140495868,0.6715717814233955,1.0,7/18,15.29%,DNAAF1;ODAD4;CCDC39;ROPN1L;SPA17;SPEF2;DNAAF2
prerank,cytosolic calcium ion transport (GO:0060401),0.44751515217049365,1.3777395668517525,0.08709677419354839,0.6695132606231741,1.0,10/28,15.58%,ATP2A3;ATP2A2;MICU2;SMDT1;SLC8A1;ITPR3;JPH1;ATP2B3;CACNA2D1;SLC25A23
prerank,B cell mediated immunity (GO:0019724),-0.5490458336558512,-1.3771016893491335,0.12053571428571429,0.4873364080687396,1.0,3/10,7.51%,FCGR2B;CD74;TLR8
prerank,neuropeptide signaling pathway (GO:0007218),0.3918441781852695,1.3769917511599412,0.05997001499250375,0.6695041037305348,1.0,14/58,18.97%,GLRA3;NMUR1;NXPH3;LTB4R2;GLRB;PPY;SORCS1;NXPH2;ADCYAP1;GLRA2;SORT1;GAL;OPRM1;OPRD1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.4124866684077097,-1.3766799354703858,0.056716417910447764,0.48701613638923447,1.0,7/29,6.20%,VAV3;BCL2;CD74;CD38;PTPRC;GPR183;TFRC
prerank,sodium ion transport (GO:0006814),0.36746818410060395,1.3766761570466919,0.05955678670360111,0.6677476413353365,1.0,34/85,29.35%,HCN1;SLC4A8;ATP1B1;SCNN1A;SLC5A12;SLC12A2;ATP1B3;SLC38A7;PKD2;SLC8A1;ASIC1;ASIC2;FGF13;SCN2A;SLC6A1;SLC8A3;NEDD4L;SLC24A3;ASIC3;SLC24A4;ATP1A4;SLC6A9;SCN1B;SCN3B;SCN8A;SLC6A7;SCN7A;SLC6A2;SLC6A5;KCNK1;SCN1A;NALCN;SLC6A15;NDUFA9
prerank,heart looping (GO:0001947),0.40952279724792084,1.375692348149232,0.08006042296072508,0.6688404719243131,1.0,9/39,13.32%,DNAAF1;VANGL2;CCDC39;MEF2C;BBS5;PKD2;TBX2;TBX6;NDRG4
prerank,response to glucagon (GO:0033762),-0.4619442424598218,-1.3749796618985919,0.09523809523809523,0.48996432358629777,1.0,8/19,15.05%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;CRY1;ADCY3;PRKACB
prerank,axon development (GO:0061564),0.3659039537318078,1.3749504825937207,0.047619047619047616,0.6689915750253946,1.0,25/78,19.68%,PLP1;DCC;RAB3A;CTNNA2;PARD6B;ATL1;MAP1S;RYK;RAB8A;RTN4RL1;APBB1;KLF7;SLITRK4;ARHGAP35;NRCAM;VASH2;EPHB2;DSCAML1;WNT7A;PLPPR4;MTR;NTNG2;NTNG1;ACTB;NREP
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3588618589724988,-1.3744624875166271,0.07246376811594203,0.4897692991541384,1.0,13/47,14.01%,PID1;XDH;CD36;TYROBP;THBS1;DHRS4;SYK;RIPK1;ZC3H12A;GRB2;ACOD1;CYBA;SLC5A3
prerank,negative regulation of nervous system development (GO:0051961),-0.46595400390389824,-1.3744241628007217,0.10148514851485149,0.48835394603754206,1.0,10/17,24.07%,PCM1;TLR2;SLIT1;IL1B;NOTCH1;B2M;TNF;APPL2;PAX6;HOOK3
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3923113690496498,-1.3737040004911818,0.055248618784530384,0.4888098103717821,1.0,10/29,16.17%,APOE;LDLR;NR1H2;CTDNEP1;SORBS1;NR1H3;ZBTB20;MID1IP1;CHP1;MFSD2A
prerank,cholesterol transport (GO:0030301),-0.36678166831942605,-1.373562244981296,0.06027397260273973,0.48775481272568316,1.0,13/45,9.44%,APOE;NPC2;MSR1;OSBP;CD36;STX12;LDLRAP1;CAV1;LDLR;SERAC1;OSBPL2;ABCG4;ABCG1
prerank,cGMP metabolic process (GO:0046068),0.55324973068937,1.3733438265144151,0.11205432937181664,0.6726492893644506,1.0,3/12,10.31%,GUCY2F;GUCY2C;GUCY2D
prerank,response to lipid (GO:0033993),-0.31138386578159766,-1.3724410941401213,0.029304029304029304,0.48937810183423797,1.0,30/105,18.58%,IFNAR1;PTPN22;NOCT;STAT5B;HMGB2;PPARG;CD36;RARA;MAPKAPK2;ESR1;PPARD;ANXA1;IL1B;ABCG1;CTNNB1;FOXO1;MAPKAPK3;OVCA2;SMAD6;SLC11A1;RXRB;PELI1;FOXP1;LBP;LIAS;TLR4;ADAM17;FFAR1;PAQR7;TRIM16
prerank,microtubule polymerization (GO:0046785),0.45011922425670803,1.3723700616655499,0.09584664536741214,0.6737160524286291,1.0,13/28,26.15%,TPPP;CLASP2;CCDC57;CKAP5;FGF13;TUBGCP2;HDGFL3;PIN1;TUBGCP6;MAP7D3;TPPP3;TUBGCP5;MAPT
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5848005495628035,1.372337078407247,0.13636363636363635,0.6708598565337698,1.0,3/10,8.76%,SELENOS;DGKQ;OGT
prerank,cell junction assembly (GO:0034329),0.3547928217894731,1.3721191306267515,0.036535859269282815,0.6687479405461855,1.0,41/100,28.43%,SH3BP1;PCDHB9;PCDHB4;FSCN1;OBSL1;DCHS1;PARD6B;PCDHB5;SPOCK2;PKP4;NRXN1;DSCAM;RYK;CDH18;SHANK3;ADGRL3;ACHE;SDK1;CTNND2;PCDHB3;NRCAM;FLCN;ITGA6;ACTB;CDC42;GRHL2;GPM6A;FARP1;VMP1;OPHN1;LIMS2;BDNF;RHOA;FLRT3;FZD5;CDH10;CDHR3;MYO9A;SLITRK1;PTEN;CLDN5
prerank,myotube differentiation (GO:0014902),0.4952024067227785,1.3719788324516535,0.1097770154373928,0.666193866303153,1.0,6/17,13.97%,SIX4;JAM2;MEF2C;ADAMTS15;ADAM12;SORT1
prerank,error-free translesion synthesis (GO:0070987),-0.4382659770019387,-1.3701429194380415,0.06940874035989718,0.493621631529167,1.0,7/22,19.92%,VCP;PCNA;UBC;UBA52;RPA1;RPA2;NPLOC4
prerank,regulation of NMDA receptor activity (GO:2000310),0.4335883102082923,1.3699472875829264,0.09470304975922954,0.6715004291055167,1.0,14/32,22.93%,DLG2;GRIA2;MEF2C;GRIA1;ACTN2;GRIN1;GRIA4;GRIN2B;CRHBP;EPHB2;OPRM1;SLC6A9;NEFL;CAMK2B
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3501684487559325,-1.3694722268692465,0.04833836858006042,0.493980891668704,1.0,21/51,22.59%,LILRA5;CD36;IL16;TYROBP;NLRC4;NOD2;TLR8;LPL;TMED10;AGER;TNF;HSPB1;WNT5A;TLR4;PYDC1;TRIM16;MYD88;CASP1;AIM2;ISL1;APP
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.46526804076820505,-1.3687986242439998,0.10945273631840796,0.4941844310711006,1.0,7/19,9.97%,IFIH1;IRF7;TBK1;TLR7;HSPD1;TLR8;STAT1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5326820373006383,-1.3687069893349895,0.1201923076923077,0.4929677934200758,1.0,5/10,19.18%,THBS1;IL1B;INPP5K;RSC1A1;IRS2
prerank,regulation of defense response (GO:0031347),-0.32794459310392315,-1.3686486394002377,0.02702702702702703,0.491643048521229,1.0,23/76,20.96%,FCGR2B;APOE;PSMA6;PTPN22;ALOX5;CELF1;ZBP1;CCR2;USP18;NOD2;ANXA1;HCK;ERAP1;BIRC2;SHPK;FOXP1;WNT5A;BST1;ADAMTS12;MYD88;APPL2;CASP1;TMSB4X
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.48955948016109463,1.368500778055274,0.1018363939899833,0.6745041020127301,1.0,9/18,18.40%,RELA;CLU;LRRTM3;EFNA1;CASP3;EPHA4;ABCA2;IFNGR1;CHRNA7
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.4743354939275869,-1.368030027341228,0.10407239819004525,0.4919093720882236,1.0,8/16,32.73%,VCP;ATP7A;UQCC2;SLC25A33;PPIF;ABCD1;SHMT2;PDE12
prerank,intracellular pH reduction (GO:0051452),-0.3883890052516292,-1.367693386359257,0.07161125319693094,0.49139519211976374,1.0,6/33,4.11%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;RAB7A;ATP6V0B
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5778340947454709,1.367252995747387,0.11038961038961038,0.6765857031635856,1.0,3/10,13.64%,WHRN;STRC;IFT88
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2676299761508108,-1.367193544482023,0.0,0.4913336877687858,1.0,79/306,15.59%,APOE;B4GALT5;EPC1;EXT1;RBBP8;RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RRAGC;CLSPN;RPL28;EEF1A1;POLR2E;RPS29;TOPBP1;RPS14;BCL3;RPS20;RPL35A;RPS12;EEFSEC;ORC5;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;DHPS;RPL37A;NBN;EIF4EBP2;IGHMBP2;PCLAF;BRCA1;RPL10;RPL15;RMI1;ATRIP;EEF1D;ORC2;ALAS1;YARS2;RPS10;RPL14;GRWD1;RPL9;RHNO1;BARD1;RPL32;RPL36;RPA1;CDK1;RPL31;RPL23A;RMI2;MCM2;AGO2;MRPL35;KAT5;TICRR;ORC4;POLR2B;TYMS;SCX;PTMA;RPL41;RPL3;POLR2H;POLR2J;MCM9;MCM8;KAT7;RPL8
prerank,positive regulation of defense response (GO:0031349),-0.31710899721634667,-1.3660571946146367,0.041044776119402986,0.49287399590790676,1.0,24/89,17.45%,IL15;CD47;TLR2;LILRA5;ZBP1;CCR2;IL16;PTGER4;TLR7;NFKBIZ;RIPK1;TLR8;IL1B;LPL;GPSM3;GPRC5B;ADAM8;CYBA;TNF;WNT5A;OPTN;PDE2A;TLR4;POLR3G
prerank,negative regulation of ossification (GO:0030279),-0.42718775279264487,-1.3655096631859733,0.09819121447028424,0.49292220162259187,1.0,8/23,15.28%,RBPJ;BCOR;SRGN;NOTCH1;TRPM4;SMAD6;GREM1;PTK2B
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5327100267405985,1.3647683606575989,0.10758377425044091,0.6837401445085314,1.0,5/13,15.53%,HHEX;DAB2IP;NEDD4;PDCD6;CADM4
prerank,regulation of cardiac conduction (GO:1903779),0.390161609865384,1.3634059772230414,0.05417276720351391,0.686720136943807,1.0,20/54,22.82%,ATP2A3;ATP2A2;ITPR2;ATP1B1;ASPH;ATP1B3;SLC8A1;GJA5;ITPR3;ATP2B3;SLC8A3;DMPK;AGT;ANK2;TMEM65;ATP1A4;ATP1A3;ATP1A1;NPR1;RYR3
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5410637333948072,-1.3625123320867618,0.11358574610244988,0.4994106795675578,1.0,5/10,14.99%,FCGR2B;PTPRC;CEACAM1;KLRD1;LILRB1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3622554045636023,-1.3624692874637407,0.0641399416909621,0.498057985451277,1.0,19/45,22.59%,LILRA5;CD36;TYROBP;NLRC4;NOD2;TLR8;LPL;AGER;TNF;HSPB1;WNT5A;TLR4;PYDC1;TRIM16;MYD88;CASP1;AIM2;ISL1;APP
prerank,protein secretion (GO:0009306),0.3846085830544186,1.3623251790883757,0.05433186490455213,0.6882358254399256,1.0,18/56,19.24%,LTBP2;PTPRN;RAB3A;TVP23A;RAB8A;COPG1;PPY;ADCYAP1;TANGO2;ARL4D;RAB3D;MTTP;RAB12;GAL;MIA3;COPG2;PREB;OLFM2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.37435604455383503,1.3615727371700928,0.06886657101865136,0.68822817688506,1.0,13/64,6.88%,POLR2L;CDK7;CTR9;RTF1;POLR2F;NELFB;ELP2;GTF2H2;NELFCD;ELOC;SSRP1;GTF2H4;GTF2F1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.48575776008773397,-1.3615310370547433,0.11538461538461539,0.4989118723893088,1.0,4/15,12.73%,CD36;C5AR1;DRD2;ADCY3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5195303146273621,-1.3612319538993147,0.11943793911007025,0.49821501612299857,1.0,7/12,21.64%,DAB2;SMARCA4;PIAS2;HDAC1;FOXP1;NCOR1;HEYL
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.5116302998635991,-1.3610551006991267,0.11031175059952038,0.497202018111336,1.0,6/12,13.38%,CTCF;CTNNB1;ESPL1;BUB1;RAD21;RB1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.45127367730658097,-1.3610023084299427,0.10465116279069768,0.49587166838778657,1.0,6/18,15.08%,RIC1;VPS35;MSN;PTTG1IP;WDR91;RGP1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.36149255993038887,1.3608798297083868,0.047142857142857146,0.6882138498797632,1.0,38/84,25.49%,SRSF12;RNPS1;PRDX6;SMU1;DDX5;TRA2B;CWC22;ZC3H10;SRSF6;PTBP1;CIRBP;RBM5;SON;YTHDC1;METTL16;KHDRBS2;CELF6;QKI;RBFOX2;RBFOX3;NOVA1;HNRNPA1;RBMXL1;REST;RBM3;SRSF9;PUF60;TRA2A;SRRM4;TIA1;RBFOX1;FXR1;RBM39;RBM15B;CELF4;SRSF3;ZBTB7A;SF1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.4475239815064702,-1.3608366259170435,0.09158415841584158,0.49492716066062764,1.0,10/20,15.86%,FBXW7;ERLIN2;BRCA1;WDTC1;BMP5;CEACAM1;APOC1;BMP2;SIK1;ACADL
prerank,nucleotide catabolic process (GO:0009166),-0.4730393605967392,-1.360729189879157,0.10178117048346055,0.4937976962917278,1.0,4/16,5.65%,GDA;VCP;XDH;NT5E
prerank,positive regulation of developmental growth (GO:0048639),0.3904384991317515,1.3606641820475278,0.09226190476190477,0.6861951798215531,1.0,13/49,15.10%,AGRN;SYT4;SEMA7A;PPIB;SYT1;LIMK1;TWF2;CPNE6;CDKL5;RIMS1;MAP3K13;INSR;NEDD4L
prerank,thymus development (GO:0048538),0.5362965210817181,1.3604771363681887,0.1289134438305709,0.6839528969571189,1.0,3/13,7.62%,FGF10;RIPK3;TGFBR1
prerank,membrane protein proteolysis (GO:0033619),-0.3793953547094204,-1.360207678798757,0.07202216066481995,0.4938023909887965,1.0,16/37,17.07%,ADAM19;NFKB1;ADAM9;PARL;PRKCQ;PSEN1;DAG1;ERAP1;MBTPS1;RET;CLPP;SPPL3;APH1B;MYH9;RBMX;ADAM17
prerank,histone modification (GO:0016570),-0.3017415524626064,-1.3598654123035339,0.036734693877551024,0.49320741898817333,1.0,26/109,14.94%,BAZ1B;KAT6B;SIN3B;ATXN7;RCOR1;PADI4;PHF20;HLCS;TBL1X;EYA1;TRRAP;EYA3;EP300;EYA2;PRMT2;BRMS1;BRMS1L;CCNA2;HDAC2;RCOR3;EHMT1;KAT5;HDAC1;MIDEAS;MSL3;INCENP
prerank,response to iron ion (GO:0010039),-0.5219296920648925,-1.359283003859295,0.11804008908685969,0.4933081988288696,1.0,3/12,13.39%,BCL2;HIF1A;B2M
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.339056293927258,-1.3591289672732547,0.058823529411764705,0.49232977661944277,1.0,15/59,11.28%,MED13;MECP2;MITF;MED26;MED7;CDK8;BAX;MED16;NFKB1;CEBPB;CCND1;MED10;MED15;CTNNB1;CDK1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.4855255074174799,1.3587290475557343,0.1111111111111111,0.6881383019926068,1.0,6/19,14.62%,FSCN1;DLG2;SCRIB;PRKCI;MTCL1;PATJ
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.509167975024608,-1.3582318574021752,0.12293144208037825,0.4932381627547216,1.0,3/13,3.64%,PID1;VCP;ENO1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.33718551041491224,-1.3577267885074222,0.05454545454545454,0.4931780971510361,1.0,16/60,12.11%,MED13;MECP2;MED26;MED7;CDK8;BAX;MED16;NFKB1;CEBPB;CCND1;MED10;MED15;CTNNB1;PAXIP1;CDK1;ATF7IP
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.4420262392411115,-1.3574128653053845,0.104,0.49116286549776245,1.0,6/20,13.90%,MGST3;GSTA3;GSTO2;GSTZ1;GSTM1;GSTM5
prerank,glutathione derivative metabolic process (GO:1901685),-0.4420262392411115,-1.3574128653053845,0.104,0.49116286549776245,1.0,6/20,13.90%,MGST3;GSTA3;GSTO2;GSTZ1;GSTM1;GSTM5
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.45350319630165103,-1.3566518126798401,0.10714285714285714,0.4916621234763437,1.0,8/18,18.31%,FCGR2B;BAX;NCK1;ERN1;BAG6;PMAIP1;BCL2L11;RNFT1
prerank,negative regulation of coagulation (GO:0050819),0.5313468871865982,1.356350775350678,0.12093862815884476,0.6951197510028833,1.0,6/14,15.41%,ADTRP;HS3ST5;CD34;THBD;VTN;SERPINE2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5382867135905207,1.356346849384594,0.11443661971830986,0.692224505638944,1.0,6/12,19.10%,SYT1;DOC2B;UNC13B;RIMS1;RIMS3;UNC13C
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.49279487853659243,-1.3562193565652672,0.12614678899082568,0.4914298459909882,1.0,7/14,19.14%,PPP2R2A;NCK1;PPP2R2C;PPP3CA;DUSP1;PPP2CB;PPM1F
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.3571530245837633,-1.3555984176393772,0.061971830985915494,0.4917025365168411,1.0,17/47,21.95%,NOCT;PPARG;METRNL;ASXL2;PIM1;PPARD;CEBPB;ZC3H12A;LPL;AAMDC;TRPM4;BMP2;GDF3;BMP7;HNRNPU;ID2;RREB1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.557656291761513,1.3552948392016995,0.11130742049469965,0.6937094752919605,1.0,3/11,2.39%,BIN1;NOS1AP;CACNB2
prerank,cGMP-mediated signaling (GO:0019934),-0.4988701027923515,-1.3552056370802747,0.13768115942028986,0.4913449360898655,1.0,8/13,35.50%,APOE;CD36;IRAG1;PDE2A;AQP1;HTR2C;PDE3A;NPPA
prerank,alpha-amino acid catabolic process (GO:1901606),0.4418946462902462,1.3551296869985334,0.09177215189873418,0.6914890811136775,1.0,9/29,17.85%,HOGA1;IL4I1;IDO2;OTC;ACADSB;KYAT1;ALDH4A1;DAO;HSD17B10
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.32993449171451295,-1.3550441641400732,0.03374233128834356,0.49037382545256625,1.0,22/66,19.90%,CCT6A;DTX3L;ZPR1;LAMTOR5;SMAD3;TFRC;YAP1;PSEN1;ZC3H12A;CDK1;CCT3;PARP9;NMD3;ORMDL3;KAT7;PLK1;SESN2;FLNA;ECT2;CDH1;DKC1;CHP2
prerank,defense response to bacterium (GO:0042742),-0.30267988841543264,-1.3537525489185842,0.021739130434782608,0.4923818207096938,1.0,32/105,20.24%,ANKRD17;OAS2;MPEG1;RNASE3;RPL39;TLR2;HMGB2;LYST;RAB1A;NLRC4;NOD2;SYK;CEBPB;RPL30;LYZL4;STAB2;SLC11A1;OAS3;LCN2;GBP4;LBP;SHC1;OPTN;SPN;FCER1G;TLR4;ADAM17;CFP;CAMP;MYD88;GBP6;LTF
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.4414284511469655,-1.353116407761418,0.10052910052910052,0.49267921920698,1.0,9/21,23.05%,RAD51B;MECP2;CCND1;CDK1;NPM1;CDC25A;DTL;CDC25C;CCNB1
prerank,positive regulation of immune effector process (GO:0002699),-0.41144094311147783,-1.353053215757428,0.09018567639257294,0.4914509174970089,1.0,11/27,26.05%,DDX60;ANKRD17;PTPRC;CCR2;IL1B;LBP;LILRB1;APPL2;DHX58;IL12RB1;MYB
prerank,regulation of protein secretion (GO:0050708),0.33854824650678916,1.352810509446568,0.03633916554508748,0.6984130178283158,1.0,35/119,19.97%,FRMD4A;MYOM1;SNAP25;ADTRP;ANG;ITPR2;KCNA5;SYTL4;DISP1;MYH10;IL6;SLC12A2;RFX6;SLC2A2;ADRA2A;APBB1;RAPGEF3;PRKCA;ACHE;TGFB1;CACNA2D2;UNC13B;ITPR3;CACNA1D;DNM1L;ABCC8;APBB3;IER3IP1;CACNA1A;MTNR1B;STXBP5;IL1A;CCL5;LLGL2;ERP29
prerank,mitotic metaphase plate congression (GO:0007080),-0.35278105376682267,-1.3521849582381957,0.05,0.492305001017644,1.0,17/51,17.43%,KPNB1;CHMP4B;CHMP4A;MIS12;CUL3;PIBF1;BOD1;CDCA8;KIFC1;PDCD6IP;CHMP1B;SPDL1;CDT1;NUP62;NDC80;NUF2;DCTN2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.4620591208912495,-1.3521705026403932,0.13189448441247004,0.49099028719132726,1.0,8/17,22.58%,RBPJ;SNW1;STAT1;EP300;NOTCH1;NOTCH4;HEYL;KAT2B
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.446316329762144,-1.3518720307090963,0.095,0.49035958915519134,1.0,9/19,24.04%,GNL3L;EXOSC10;TERF2;TENT4B;NAT10;HNRNPC;HNRNPU;TINF2;PIF1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2972672280855686,-1.3503657405844036,0.019138755980861243,0.4927956069885074,1.0,44/125,23.72%,MECP2;KPNB1;BUB3;MIS12;TACC3;KIF11;PMF1;RANBP2;PTPA;ZWILCH;CDCA8;STMN1;CENPA;NUP43;MAPRE1;NUSAP1;XPO1;BIRC5;MAD2L1;AHCTF1;ESPL1;BUB1;DYNC1LI2;BUB1B;KNTC1;SPDL1;KIF4A;INCENP;NDC80;PLK1;WDR62;NUF2;DCTN2;ERCC6L;PAFAH1B1;ZWINT;SETD2;MAP4;B9D2;RCC1;NUP98;CCNB1;NDE1;SPC24
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3956930551870406,-1.3501813394999662,0.08923884514435695,0.4918642885411701,1.0,10/29,16.27%,UBE2K;ZBP1;PTPN1;IFNAR2;STAT2;USP18;NLRC5;OAS3;WNT5A;MUL1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.40969404673267407,-1.3498961685950088,0.07349081364829396,0.4912214644706806,1.0,10/27,15.15%,CCDC88B;CD44;CD47;CCR2;HSPD1;PRKCQ;LCK;SKAP1;HAS2;TNF
prerank,mitochondrial protein processing (GO:0034982),-0.5173647259855807,-1.349819874008683,0.13470319634703196,0.49008385475994726,1.0,3/11,15.36%,YME1L1;STOML2;IMMP2L
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5294826835183114,-1.3487011280074555,0.13566739606126915,0.49167449220598397,1.0,5/11,21.89%,P2RX4;FOXO1;NOTCH1;SMAD4;LMNA
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.43905068144910586,-1.348214532035768,0.10421836228287841,0.4915626019713971,1.0,8/21,14.22%,STAP1;PRKCH;SLC39A10;PTPRC;TESPA1;CD226;LCK;FOXP1
prerank,regulation of interleukin-8 production (GO:0032677),-0.3319463379574618,-1.3479277917012638,0.04560260586319218,0.4909865783454665,1.0,27/69,20.96%,CD74;PTPN22;PTPRC;TLR2;RAB1A;LAMTOR5;BCL3;TLR7;CD14;NOD2;SYK;RIPK1;ANXA1;TLR8;IL1B;ANXA4;CD2;LBP;TNF;TLR4;TLR1;CD33;AFAP1L2;MYD88;HSPA1B;KLF4;TMSB4X
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.48725893001065407,-1.3472218636775415,0.112565445026178,0.49135534970953454,1.0,7/14,13.61%,CPSF1;NCBP1;ERN1;FIP1L1;CPSF4;CSTF2;CPSF2
prerank,protein modification process (GO:0036211),-0.32278513580980367,-1.3466528555309194,0.04794520547945205,0.49146166761198296,1.0,24/76,15.71%,MSRA;PARP4;UBE2D3;ABL2;STK38;RPN2;NAGPA;UBL4A;PADI4;CDC34;CPE;ST8SIA4;CDKL3;UBE2L3;UBA52;LOX;PPP4R2;ICMT;RPN1;ATG3;FBXO2;UBE2L6;ST8SIA2;ADPRH
prerank,lung development (GO:0030324),0.4220603026125122,1.3448496770206473,0.07861635220125786,0.7290481958423276,1.0,8/33,12.51%,FGF10;DNAAF1;FGF9;CCDC39;FGF7;BMP4;FGF2;PKD1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3517253008171813,-1.3447413333432126,0.06481481481481481,0.4952004694440796,1.0,19/48,23.25%,APOE;FLOT2;NFKB1;LDLR;PFDN5;EDNRB;MAD2L2;AGAP2;MAD2L1;EGFR;FLNA;RILP;PTX3;ITGB3;FMN2;PFDN2;SIRT2;ADGRB1;EIF2AK1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.5235915202953114,-1.3446986868200514,0.12408759124087591,0.4939823199676401,1.0,3/11,8.25%,VCP;UGGT1;BAG6
prerank,indolalkylamine catabolic process (GO:0046218),0.5653678699717966,1.3441692039904691,0.12203389830508475,0.7289577049609879,1.0,3/10,11.65%,IL4I1;IDO2;KYAT1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5713637762743371,1.344083639360603,0.1384083044982699,0.7263720502382802,1.0,6/10,17.41%,CACNG5;NPTXR;NPTX1;DLGAP1;DLGAP2;DLGAP3
prerank,regulation of endocytosis (GO:0030100),-0.3418480128151698,-1.3439335665784653,0.04838709677419355,0.49464846084506625,1.0,10/61,6.28%,DAB2;MCTP1;APOE;HIP1;ABL2;PTPN1;MTMR2;ZFYVE16;HIP1R;PICALM
prerank,heterocycle biosynthetic process (GO:0018130),-0.47405958708370743,-1.3424419390330566,0.1136890951276102,0.4972418881033686,1.0,4/14,7.09%,ALOX5;MOCS2;MOCS1;PYCR2
prerank,regulation of chemokine production (GO:0032642),-0.3797391234138862,-1.3423086893787046,0.07669616519174041,0.4962560724851939,1.0,19/36,30.41%,CD74;TLR2;TLR7;HIF1A;LPL;FOXP1;AGER;TNF;WNT5A;TLR4;HMOX1;ADAM17;APP;EIF2AK2;TLR9;TSLP;SIGIRR;IL33;EGR1
prerank,protein tetramerization (GO:0051262),0.3702986455687059,1.3422207250310003,0.06321839080459771,0.7311428046311641,1.0,20/67,20.88%,HCN1;CPSF6;KCNC1;TRPM2;ALDH9A1;CBR4;PKD2;GRIN1;ACOT13;GRIN2B;HPRT1;PKD1;NUDT21;OXA1L;KCNC3;ACACB;TK1;HSD17B10;ALDOA;SSBP1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.508470766287332,-1.3420678776702095,0.1191588785046729,0.4956401110778977,1.0,7/12,35.20%,CCR2;IL1B;SLC11A1;IL18R1;IL12RB1;IL23R;IL12B
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.46682622121834627,1.3416782176097395,0.10097719869706841,0.730422016377604,1.0,5/23,9.35%,TNNC1;TNNI3;MYBPC3;TGFBR3;TGFB1
prerank,negative regulation of mRNA processing (GO:0050686),0.5048875362495454,1.3415726541451582,0.12171052631578948,0.7278903693083224,1.0,4/15,6.02%,SRSF12;RNPS1;SRSF6;PTBP1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.47723588145078477,-1.341509178834097,0.1037037037037037,0.4957583289276618,1.0,7/15,25.35%,SDCBP;RAB7A;PDCD6IP;STAM;SDC1;SDC4;ATP13A2
prerank,negative regulation of hippo signaling (GO:0035331),-0.5106463496190655,-1.3405079956455004,0.13425925925925927,0.4971004852693059,1.0,6/12,24.26%,LIMD1;DLG5;CIT;AJUBA;WTIP;MAP2K3
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.4454027527096318,-1.3397825590569468,0.1163895486935867,0.49773715750978625,1.0,12/18,28.08%,C3AR1;C5AR1;LYN;BAG6;SPG21;FCER1G;BCAR1;LAX1;FPR3;BLK;FPR2;CD19
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.5227881326870198,1.3396208218599586,0.1567291311754685,0.7331140588834301,1.0,7/13,18.40%,ADCY8;LGMN;SHANK3;ZDHHC2;EPHB2;EIF2AK4;CHRNA7
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4846619730518642,1.339536499055958,0.12,0.7305319307492725,1.0,6/18,20.51%,ADCY8;CRTC1;PRKD2;PRKD1;OPRD1;EPHA5
prerank,protein deacetylation (GO:0006476),-0.35871873391017767,-1.3393176823211124,0.0875,0.49774177322119517,1.0,14/41,22.85%,SIN3B;RCOR1;TBL1X;BRMS1;BRMS1L;HDAC2;RCOR3;HDAC1;MIDEAS;MSL3;FLNA;SIRT2;HDAC4;TBL1XR1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.41666247282532276,1.3388414959437103,0.10703363914373089,0.730548075944426,1.0,8/34,9.35%,ZFPM1;WWTR1;E2F1;IL6;ZFPM2;TRIB2;ZFP36L2;TGFB1
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.4306523120779345,-1.3383885097316062,0.11538461538461539,0.4988686749882709,1.0,6/21,12.06%,FCGR2B;PTPN22;PIBF1;SOX11;BANK1;FOXJ1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3124694963688577,-1.3378565035274685,0.052083333333333336,0.49901245572337405,1.0,34/88,26.00%,MYO5A;RABEP1;DNAJC6;KIF16B;KLHL20;GOLGB1;EXOC4;GBF1;AP1S3;CLINT1;EPS15;CCDC22;AP4M1;SNAP23;RAB10;DNM2;CLTA;EXOC8;STXBP6;CORO7;FTL;DOP1B;EXOC6;GOPC;CCDC93;NAPA;DTNBP1;PUM1;VPS13C;APP;AP2A1;BLOC1S3;VAMP7;EXOC1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.45422270402756454,-1.3369459824243357,0.10869565217391304,0.5002187874632981,1.0,3/18,3.58%,AOAH;FUCA1;BPGM
prerank,collagen fibril organization (GO:0030199),0.35170149381255544,1.3367851994515916,0.060393258426966294,0.7364755352971759,1.0,27/88,23.86%,P3H2;PLOD3;P4HA3;COL5A1;DST;PPIB;LAMB3;COL2A1;TGFBR1;SERPINH1;PXDN;COL4A5;COL28A1;ADAMTS14;COL4A2;COL15A1;COL18A1;PLOD1;ITGA6;ADAMTS3;P4HA2;COL4A4;LAMC2;COL6A1;COL20A1;COL13A1;COL27A1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4276236212591604,1.3362166472561647,0.09180327868852459,0.7361780226674836,1.0,9/31,13.79%,ABI3;TANC2;ARHGAP44;SHANK3;SRCIN1;EFNA1;CFL1;LZTS3;EPHA4
prerank,fluid transport (GO:0042044),-0.518188515168946,-1.3361279189260515,0.15081206496519722,0.5010087778341032,1.0,5/12,36.43%,AQP11;SLC26A6;PDPN;AQP1;SLC4A11
prerank,translation (GO:0006412),-0.273005080656949,-1.3357694909754385,0.022099447513812154,0.5005852678097983,1.0,49/208,14.33%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;EEF1A1;ETF1;RPS29;AIMP1;RPS14;RPS20;RPL35A;RPS12;EEFSEC;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;FARS2;RPL30;RPL6;DHPS;RPL37A;TMA7;EIF4EBP2;IGHMBP2;IARS2;RPL10;RPL15;EEF1D;UBA52;YARS2;RPS10;RPL14;RPL9;RPL32;RPL36;RPL31;RPL23A;AGO2;MRPL35;RPL41;RPL3;QARS1;NARS1
prerank,renal filtration (GO:0097205),0.5612343815777643,1.3355876938696207,0.13793103448275862,0.7361282587717763,1.0,3/10,6.44%,TMEM63C;CD34;XPNPEP3
prerank,negative regulation of potassium ion transport (GO:0043267),0.5281344874395014,1.3353022092824132,0.12609457092819615,0.7343337425457666,1.0,5/13,15.10%,KCNH2;BIN1;ACTN2;STK39;NEDD4L
prerank,regulation of cation transmembrane transport (GO:1904062),0.43705494701486214,1.335040607228285,0.10112359550561797,0.7325624923909212,1.0,11/29,25.03%,KCNH2;FGF12;KCNE2;KCNIP3;KCNIP4;CACNA1D;WNK1;KCNN2;PDZK1;SNTA1;CD63
prerank,prostaglandin metabolic process (GO:0006693),0.43967178165791915,1.3343883584368899,0.09744408945686901,0.7324414135489641,1.0,11/26,22.69%,CYP2S1;PTGS1;PTGDS;AKR1C1;PRXL2B;ACOX1;HPGD;PTGR2;HPGDS;PNPLA8;DAGLB
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.43137997683743706,-1.3333689768592873,0.0835509138381201,0.5055025360425869,1.0,9/21,17.31%,GAS6;BCOR;SRGN;NOTCH1;TRPM4;GREM1;PTK2B;ASPN;HEY2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.37925306509132034,1.3333432043046833,0.08836524300441827,0.7338565123809243,1.0,17/52,15.66%,SRSF12;RNPS1;SMU1;DDX5;TRA2B;ZC3H10;SRSF6;PTBP1;RBM5;YTHDC1;KHDRBS2;CELF6;RBFOX2;RBFOX3;NOVA1;HNRNPA1;REST
prerank,regulation of protein sumoylation (GO:0033233),-0.45743670069883346,-1.333183378144747,0.12045454545454545,0.5046907855255098,1.0,9/17,24.19%,RWDD3;GNL3L;ZMIZ1;UBA2;CTNNB1;MUL1;HDAC4;PIAS4;PIAS3
prerank,transepithelial transport (GO:0070633),0.5024821954531348,1.3331575891541259,0.1259124087591241,0.7317603273748018,1.0,6/15,23.60%,SLC12A2;SLC1A1;SLC1A3;CXADR;ABCG2;GPLD1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.458389072695529,-1.3330616841394876,0.12378640776699029,0.5037782452559958,1.0,7/17,8.71%,ARL6IP5;NOD2;PDCD10;LYN;MID1;RNF13;TAOK3
prerank,cellular metal ion homeostasis (GO:0006875),0.34420049988599805,1.3326949079176624,0.0644718792866941,0.731076238166657,1.0,28/102,19.85%,ATP2A3;KCNMA1;ATP13A4;ATP2A2;ATP1B1;SLC24A5;CLDN16;TNNI3;ATP13A5;SLC12A2;ATP1B3;CCR1;SLC8A1;RMDN3;ATP2C1;ATP2B3;SLC8A3;NEDD4L;SLC24A3;DMPK;ANK2;CHRNA7;SLC24A4;CCL15;CCL5;ATP1A4;ATP1A3;ATP1A1
prerank,regulation of T cell cytokine production (GO:0002724),-0.4681820639295109,-1.3326058694324263,0.13902439024390245,0.5037428358496618,1.0,5/15,13.47%,CCR2;TRPM4;TNFRSF1B;B2M;CD55
prerank,positive regulation of protein processing (GO:0010954),-0.44448488950692466,-1.332310582138571,0.12009237875288684,0.5032133226984357,1.0,11/19,31.11%,CCBE1;ENO1;NLRC4;ADAM8;MYH9;GSN;NKD2;KLKB1;RHBDD1;CLEC3B;F12
prerank,insulin receptor signaling pathway (GO:0008286),-0.32858151953705494,-1.3319378833874718,0.04513888888888889,0.503012879102813,1.0,15/69,12.83%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;NAMPT;ATP6V0B;GAB1;BCAR3;AP3S1;PIK3CA;GRB2;FOXO1;IGF2;SORBS1;ATP6V1A
prerank,synaptic membrane adhesion (GO:0099560),0.5089853588183579,1.3314611003418073,0.1396551724137931,0.7337500010834228,1.0,9/14,32.02%,PTPRD;GPC4;PTPRS;NTNG1;LRRC4C;LRRC4B;SLITRK1;LRFN5;PTPRF
prerank,regulation of cellular respiration (GO:0043457),-0.4588559758710055,-1.3310084919443081,0.10565110565110565,0.5043372481533209,1.0,10/17,34.75%,IFNAR1;VCP;CBFA2T3;IFNLR1;NOP53;NOA1;IL10RB;SHMT2;TRAP1;NOS2
prerank,bile acid and bile salt transport (GO:0015721),0.44651023209718194,1.330630804473589,0.12227805695142378,0.7344428316755028,1.0,7/24,17.78%,SLCO2B1;ABCC3;AKR1C1;SLC10A2;STARD5;ATP8B1;SLC10A1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5292871886524445,1.3305903553861742,0.15120274914089346,0.7318062787690497,1.0,6/12,14.21%,ADA;GART;PRPSAP2;HPRT1;ADSL;PRPSAP1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.42550223662727843,1.3301185177618142,0.12032520325203253,0.7281977201564205,1.0,9/29,15.55%,ACSF2;ACSL6;ACOT13;OXSM;DBI;ACOT4;ACBD6;ACOT11;ACLY
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.42550223662727843,1.3301185177618142,0.12032520325203253,0.7281977201564205,1.0,9/29,15.55%,ACSF2;ACSL6;ACOT13;OXSM;DBI;ACOT4;ACBD6;ACOT11;ACLY
prerank,sulfur compound transport (GO:0072348),-0.3945402349305773,-1.3299828303811099,0.07631578947368421,0.5058448851536799,1.0,7/27,12.72%,LRRC8D;SLC26A11;SLC6A6;RACGAP1;SLC25A19;SLC13A4;SLC25A11
prerank,pinocytosis (GO:0006907),-0.5349193941400326,-1.3295014787627377,0.15990453460620524,0.5058391482672903,1.0,4/10,11.25%,DOCK2;MAPKAPK2;CARMIL1;MAPKAPK3
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.45077597594978824,-1.329185601498513,0.11917098445595854,0.5053728918892404,1.0,8/18,23.05%,RAD51B;MECP2;CCND1;CDK1;CDC25A;DTL;CDC25C;CCNB1
prerank,regulation of macrophage migration (GO:1905521),0.567056234886248,1.3284549108244454,0.13333333333333333,0.7323952690393404,1.0,3/10,9.53%,P2RY12;CD81;CX3CR1
prerank,mitochondrial genome maintenance (GO:0000002),0.5363037233785459,1.32761387747583,0.14214876033057852,0.7331215713941867,1.0,2/11,0.37%,TOP3A;SLC25A4
prerank,positive regulation of endocytosis (GO:0045807),-0.35695229204093176,-1.3271249006978467,0.08908045977011494,0.5094137332895887,1.0,16/45,22.09%,DAB2;APOE;HIP1;STAP1;AXL;LDLRAP1;HNRNPK;CBL;RAB21;LRP1;B2M;CLN3;RAB31;APPL2;ABCA13;CLIP3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4876645105170966,-1.3271241126535336,0.14628297362110312,0.508140638602049,1.0,8/13,28.84%,NRP1;CTNNB1;KDR;NOTCH4;SHH;SEMA3E;DLL4;NRARP
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4199983419840887,-1.3268614920514188,0.11351351351351352,0.5075902536701489,1.0,5/23,5.92%,CD74;DPP4;RIPOR2;MPP1;MOSPD2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.4573652008646065,-1.3263160198814845,0.1368909512761021,0.5077265351346715,1.0,7/17,15.05%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;PRKACB
prerank,metanephric mesenchyme development (GO:0072075),0.5609762882792151,1.3262057572420107,0.13993174061433447,0.7361506527172655,1.0,3/10,8.98%,WNT4;SIX4;PKD2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.44114089067784906,-1.3260579389308578,0.1187648456057007,0.5071086523798751,1.0,6/18,6.95%,ABL2;RIPOR2;CUL3;MET;CCDC125;STMN1
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.2879650872512778,-1.325328284388874,0.011904761904761904,0.5079191944897156,1.0,35/132,15.91%,ITCH;APOE;IGF1;TRIM65;TRIM14;DTX3L;PTPN1;SH3GLB1;VPS35;ADAM9;MSN;MTLN;TPCN1;NRDC;SNX9;HIF1A;IL1B;PSEN1;ZC3H12A;PTTG1IP;ADAM8;RC3H1;FOXO1;TNFRSF1B;DAPK1;LRRK2;KAT5;PNPLA2;TRIM5;ENTPD5;ZBTB20;ORMDL3;TNF;OPTN;ZC3H18
prerank,transport along microtubule (GO:0010970),0.5114691629013374,1.3246956242175738,0.1319796954314721,0.7395267945292968,1.0,8/13,26.77%,COPG1;CAMSAP3;BORCS5;SPG11;COPG2;CDC42;APBA1;DYNC1I1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4916937220051382,-1.3246104295221883,0.14187643020594964,0.508519703007724,1.0,3/13,0.72%,PLXNC1;NRP1;NRP2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.47996452178283155,1.324315726576927,0.13982300884955753,0.7384827538388334,1.0,8/17,22.29%,CTNNA2;NCKAP1;DNAI3;FCHSD2;WASF3;CYFIP1;WASF2;ARF1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.41723245600369574,-1.3242610655470115,0.09560723514211886,0.5081436350349179,1.0,9/22,15.15%,APOE;ADAM9;NRDC;SNX9;IL1B;ADAM8;TNFRSF1B;TIMP4;TNF
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.42686150914677895,-1.323710138868945,0.0975,0.5083844053233753,1.0,6/22,14.02%,APOE;PPARG;PPARD;IL1B;SORBS1;ZBTB20
prerank,regulation of microtubule depolymerization (GO:0031114),0.44418734180338515,1.3235687117565147,0.10847457627118644,0.7388905419307892,1.0,10/25,17.39%,STMN2;NAV3;MAP1S;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,positive regulation of histone modification (GO:0031058),0.4123938679488254,1.3234100912782574,0.10869565217391304,0.7368702331048836,1.0,14/33,21.92%,TET1;PPARGC1A;CTBP1;AKAP8L;UBE2N;AKAP8;SAP30BP;MAPK3;PAF1;CHTOP;ZBTB7B;ARRB1;ING2;BRD7
prerank,protein autoubiquitination (GO:0051865),-0.3335332653046546,-1.3229375952389533,0.06748466257668712,0.5091536490691702,1.0,14/61,10.60%,ITCH;UBE2D3;CUL3;DTX3L;RNF213;OBI1;TRIM17;UHRF2;RNF146;RNF13;BRCA1;RNF157;SH3RF1;RNF220
prerank,basement membrane organization (GO:0071711),0.5097374424191135,1.3226755738331673,0.1386986301369863,0.7372520383103796,1.0,8/14,23.48%,LAMB3;PXDN;HPN;NTNG2;NTNG1;CTSS;FLRT2;LAMB2
prerank,icosanoid biosynthetic process (GO:0046456),-0.5410547392122383,-1.3215568419816757,0.14108910891089108,0.5116580129653311,1.0,4/10,18.56%,ALOX5;MGST3;LTA4H;LTC4S
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.3911473814486913,-1.3212119631978778,0.11671087533156499,0.5113313134805743,1.0,8/30,12.16%,RPN2;MAGT1;UGGT1;MGAT2;MCFD2;ST6GAL1;FUT8;RPN1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.3087764039025699,-1.3202686759981832,0.057971014492753624,0.5124470998514087,1.0,30/88,20.62%,FNIP2;VCP;SDCBP;GNL3L;RAB7A;BAX;SH3GLB1;SYNPO2;MTLN;SMAD3;SYK;TFRC;AJUBA;PDCD6IP;SYNPO;STAM;RACK1;CDT1;TNF;BCL2L11;ICE1;PFN2;SDC1;STX18;RGCC;SLX4;HAS3;BMP7;SDC4;WARS1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4474507925370063,1.3202430220141588,0.10294117647058823,0.744432817117082,1.0,6/23,17.90%,CBARP;NOS1AP;PRNP;UBASH3B;CACNA2D1;ANK2
prerank,positive regulation of immune response (GO:0050778),-0.32257171563711806,-1.3199514021859626,0.06329113924050633,0.5120038844598941,1.0,14/64,14.99%,FCGR2B;IL15;CD74;PTPRC;IL6ST;NOD2;TLR8;CD226;ADAM8;SKAP1;CYBA;SASH3;SPHK2;LILRB1
prerank,cellular response to misfolded protein (GO:0071218),-0.4254416588124473,-1.3193579193529796,0.11518324607329843,0.5122185015453019,1.0,5/20,8.29%,VCP;CUL3;UGGT1;BAG6;KLHL15
prerank,regulation of exit from mitosis (GO:0007096),-0.3627867269553412,-1.3182418198992851,0.08055555555555556,0.5138261351834478,1.0,15/38,22.35%,BUB3;CDC14B;UBC;UBA52;CDC27;MAD2L1;BUB1B;KNTC1;UBE2C;MAD2L1BP;RGCC;SIRT2;ANAPC10;CDC14A;ANAPC7
prerank,lung epithelium development (GO:0060428),0.5586705164019434,1.3182401811643523,0.14583333333333334,0.7502157219587898,1.0,3/10,12.51%,FGF10;BMP4;PKD1
prerank,sodium ion transmembrane transport (GO:0035725),0.35473619490446273,1.3181955712473272,0.07323943661971831,0.7476948058669801,1.0,35/84,29.34%,HCN1;SLC4A8;ATP1B1;SCNN1A;SLC12A2;ATP1B3;SLC9A4;PKD2;SLC8A1;ASIC1;ASIC2;SLC9A5;SCN2A;SLC6A1;SLC8A3;SLC24A3;ASIC3;SLC24A4;ATP1A4;ATP1A3;ATP1A1;SLC6A9;SCN1B;SCN3B;SCN8A;SLC6A7;SLC9A1;SCN7A;SLC6A2;SLC6A5;KCNK1;ATP1B2;SCN1A;NALCN;SLC6A15
prerank,chromosome condensation (GO:0030261),-0.37249279507826266,-1.3179871328020927,0.0997229916897507,0.5133333683475662,1.0,20/36,27.05%,TOP2A;NCAPD2;NCAPH;NCAPG2;H1-0;NUSAP1;SMC2;CDK1;BANF1;RB1;INCENP;PLK1;MCPH1;TENT4A;ACIN1;NCAPH2;CCNB1;ERN2;AIFM1;CDCA5
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4570500578229331,-1.317406462381559,0.15035799522673032,0.5135070564542003,1.0,3/15,1.54%,BCL2;CD74;CD44
prerank,regulation of membrane repolarization (GO:0060306),0.5282804003104029,1.3172854747446174,0.14385964912280702,0.7486900172183324,1.0,5/13,15.57%,YWHAE;KCNH2;KCNE2;NEDD4L;CACNA2D1
prerank,epithelial tube morphogenesis (GO:0060562),0.4145777253816061,1.3168065018085253,0.1125,0.7480177056665063,1.0,9/32,12.51%,FGF10;SCRIB;PAK1;MEGF8;MEF2C;BMP4;PRKD2;PKD2;PKD1
prerank,negative regulation of lipid storage (GO:0010888),-0.4346690206815506,-1.3163641979102285,0.10831234256926953,0.5148539955317348,1.0,8/19,15.15%,OSBPL8;PPARG;PPARD;NR1H2;ABCG1;PNPLA2;NR1H3;TNF
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.46081623437840125,-1.3153599420560875,0.13648293963254593,0.5161682854055426,1.0,6/16,16.17%,LDLR;NR1H2;CTDNEP1;PNPLA2;NR1H3;MFSD2A
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3661863593781428,-1.315309995874285,0.07692307692307693,0.5150544979233408,1.0,14/38,21.09%,SASH1;DDX60;ANKRD17;PUM2;OASL;TLR8;ADAM8;ACOD1;CYBA;SCIMP;POLR3G;USP15;PUM1;SLC15A4
prerank,regulation of monocyte differentiation (GO:0045655),-0.47612285654387243,-1.315127622945501,0.14603960396039603,0.5142325708993016,1.0,3/14,2.83%,CD74;CDK6;IRF7
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3193706912797026,-1.314934604320867,0.06188925081433225,0.5135055186273663,1.0,16/66,13.39%,MTSS1;APOE;ALOX5;CDK6;MCC;CDC73;XDH;RUNX3;FBXW7;AIMP1;THBS1;CAV1;STAT1;KLF9;CEACAM1;B2M
prerank,establishment of protein localization to membrane (GO:0090150),-0.3190507406060718,-1.31489056044897,0.08108108108108109,0.5123671402959548,1.0,19/66,17.10%,RFTN1;VPS37C;SDCBP;ZDHHC14;ZDHHC3;AFDN;BRAF;ZDHHC4;RABGEF1;RAB10;ICMT;SEC63;ATG3;REEP1;NACAD;EGFR;RTP4;RAB3GAP2;AQP11
prerank,regulation of T cell activation (GO:0050863),-0.35557809386897626,-1.314038548788853,0.07692307692307693,0.5134648265619355,1.0,11/42,12.09%,PTPN22;CCDC88B;TNFSF8;CD47;CCR2;IL27;HSPD1;PRKCQ;LCK;TNFRSF1B;CD2
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.32096566860861897,-1.3129511162201388,0.07516339869281045,0.5148637021425764,1.0,10/70,6.29%,PEAK1;ITGA4;NRP1;PXN;ATRNL1;RILPL2;ACTN1;PROX1;ARL13B;ITGB7
prerank,regulation of interferon-alpha production (GO:0032647),-0.422497096803163,-1.3129403410389375,0.13399503722084366,0.5136754882236095,1.0,10/23,20.73%,IFIH1;IRF7;TBK1;TLR7;HSPD1;TLR8;STAT1;TLR4;SETD2;NLRC3
prerank,positive regulation of axon extension (GO:0045773),0.44820979521359544,1.3126059413831397,0.13680781758957655,0.7630006681441494,1.0,7/22,13.98%,SEMA7A;MEGF8;DSCAM;LIMK1;TWF2;CDKL5;MAP3K13
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5309442144456702,-1.312229366137422,0.1650943396226415,0.5141684791729854,1.0,5/10,13.54%,BCL2;LRRK2;KDR;MYOC;RACK1
prerank,negative regulation of inflammatory response (GO:0050728),-0.27507284889698363,-1.3120800306726796,0.004629629629629629,0.5132564950235657,1.0,74/182,30.00%,AOAH;CD163;APOE;IGF1;ALOX5;GIT1;PPARG;METRNL;PRKACA;ADCY9;PTGER4;VPS35;PPARD;SYK;LYN;FYN;ENPP3;HCK;ADCY5;VIPR1;ADCY6;PTGIS;ACOD1;ADCY1;C1QTNF3;TNFRSF1B;ADCY3;NR1H3;CCN3;RB1;CXCL17;NPSR1;PRKACB;RAMP2;CALCRL;GPR27;MYH9;OTULIN;MAPK7;ADAM17;PTHLH;GATA3;CD247;KLF4;NLRC3;MVK;FFAR4;ISL1;VIPR2;NR1H4;MEFV;RXFP2;PTH1R;CRH;CALCA;GSTP1;SMPDL3B;GLP1R;FEM1A;RAMP3;SCTR;ADORA2A;VIP;FPR2;CREB1;GPR83;PTGDR;RPS19;PTGIR;MFHAS1;GPR15;RHBDF2;FGR;TNFAIP3
prerank,proteoglycan metabolic process (GO:0006029),-0.3954123627530422,-1.3117280480232436,0.13262599469496023,0.5128535853637115,1.0,6/26,9.54%,CHST11;IGF1;XYLT1;CHST9;FAM20B;HPSE
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.472315535326303,1.311548270692925,0.13321799307958476,0.7650013754265823,1.0,6/18,15.10%,CBARP;KCNH2;BIN1;COMMD1;STK39;NEDD4L
prerank,regulation of dendrite morphogenesis (GO:0048814),0.40928740224357135,1.310951389310795,0.11278195488721804,0.7648847060939848,1.0,12/32,19.82%,FBXW8;OBSL1;PTPRD;CDKL5;HECW2;IL1RAPL1;SS18L1;NEDD4;NEDD4L;SARM1;NSMF;SDC2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.29792041701959016,-1.310377346272697,0.043010752688172046,0.5152192342492977,1.0,27/93,18.72%,FCGR2B;SASH1;ARL6IP5;SDCBP;XDH;PJA2;NOD2;RIPK1;PDCD10;MID1;RELL1;IL1B;TAOK3;ZC3H12A;SH3RF1;MAP3K11;TNFRSF19;GADD45G;SLAMF1;BMP2;AGER;PTK2B;SCIMP;TRAF1;HIPK2;MMP8;TRAF4
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.49585611715427524,1.3103456223349057,0.14259927797833935,0.764729692637594,1.0,5/15,9.35%,FSCN1;CST3;IL6;CLASP2;TGFB1
prerank,regulation of nervous system process (GO:0031644),0.4753164785603333,1.3099886966746677,0.1423785594639866,0.7635971578394515,1.0,8/18,18.40%,CACNG5;NPTXR;NPTX1;DLGAP1;SLC8A3;DLGAP2;DLGAP3;CHRNA7
prerank,sphingolipid catabolic process (GO:0030149),-0.4652734087665801,-1.3091776855972321,0.13064133016627077,0.5171031942942693,1.0,5/15,13.46%,ACER3;SGPL1;SMPDL3A;ASAH2;GLA
prerank,positive regulation of nervous system development (GO:0051962),0.38939862319930807,1.307935554109465,0.11332312404287902,0.7697933268703542,1.0,17/42,23.81%,PTPRD;SRPX2;NUMB;LRP2;IL1RAP;NRXN1;GRID2;CLSTN2;CX3CR1;IL1RAPL1;EPHB2;WNT7A;OPRM1;GHRL;NAP1L1;BDNF;LRRC4B
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.40827348066999386,-1.3076779708470985,0.13385826771653545,0.5197588185367086,1.0,12/24,33.18%,RTEL1;ZRANB3;H1-0;TERF2;DFFA;DACH1;NIBAN2;KMT2A;BMPR2;RPS3;MSH6;MSH3
prerank,cardiac muscle contraction (GO:0060048),0.4119954582178376,1.3070881015511462,0.12519561815336464,0.7707910359450207,1.0,7/34,9.63%,KCNH2;ATP1B1;TNNC1;TNNI3;DMD;MYBPC3;SLC8A1
prerank,protein homooligomerization (GO:0051260),0.33129433080993914,1.3069795036160439,0.052700922266139656,0.7685622057709282,1.0,35/114,23.06%,HCN1;ADCY8;GLRA3;MPP2;IKZF4;NACC2;FUS;C9;DISP1;ATL1;TRPM2;TRMT61B;ALDH9A1;CBR4;PKD2;ACOT13;SIGMAR1;HPRT1;ASIC1;EHD1;CHMP2A;RNF135;ACACB;TK1;EHD3;ALS2;HSD17B10;ALAD;ALDOA;SSBP1;ALOX5AP;STEAP4;SPAST;RYR3;ATL2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.48026382978598203,-1.306802848181693,0.135632183908046,0.5210410672140804,1.0,5/14,14.72%,PTPN22;CCR2;SYK;CD55;EBI3
prerank,cellular response to ketone (GO:1901655),-0.36882415910712646,-1.3066883968792098,0.08743169398907104,0.5201321488755755,1.0,12/35,14.06%,NR3C1;PTGER4;AHR;MSN;ADCY5;ADCY6;KLF9;ACOD1;ADCY1;ADCY3;LARP1;SPHK2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.4690012828470458,-1.3062436072119605,0.16083916083916083,0.5199993154297933,1.0,7/14,17.07%,ADAM19;DYRK1A;PSEN1;ABCG1;APH1B;CLN3;ADAM17
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.47443671144695404,1.3062314614343014,0.14096185737976782,0.769109128296214,1.0,6/18,9.35%,DDX5;ZC3H10;IL6;NCOR2;BMP4;TGFB1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.5053295406369537,-1.306198569209343,0.14988290398126464,0.5189241229068058,1.0,6/12,20.05%,PCGF3;SMCHD1;CDYL;BRCA1;PCGF5;HNRNPU
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3968814782777004,-1.3060887843675237,0.129973474801061,0.518020093166628,1.0,4/26,3.75%,IQGAP1;STAT5B;EEF1A1;ZPR1
prerank,negative regulation of bone mineralization (GO:0030502),-0.47976830747612254,-1.3060774794465195,0.13316582914572864,0.5168636590721494,1.0,6/13,19.84%,BCOR;SRGN;TRPM4;GREM1;PTK2B;RFLNA
prerank,positive regulation of phospholipase C activity (GO:0010863),0.3918384440715245,1.3050474837452617,0.08025682182985554,0.7715097544120487,1.0,15/40,19.67%,P2RY12;ANG;TXK;NMUR1;AVPR1A;CD86;NTRK3;PLCG1;GNA15;FGF2;NTRK2;HRAS;ITK;PDGFRB;PLCB2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.31040099497282636,-1.3050134711952441,0.05521472392638037,0.5185032528841087,1.0,20/71,16.68%,VAV3;FCGR2B;ACTR3;CRK;PRKCE;NCK1;WIPF1;ARPC2;SYK;LYN;FYN;HCK;PIK3CA;ARPC5;GRB2;MYO10;WIPF3;ELMO2;FCER1G;PLD2
prerank,negative regulation of cytokine production (GO:0001818),-0.27355332916164804,-1.3048943900726153,0.02553191489361702,0.5176624528649435,1.0,49/163,20.96%,FCGR2B;ITCH;GAS6;PTPN22;CD274;AXL;TRIM25;PTPRC;IFIH1;PIBF1;LILRA5;RARA;TBK1;NPTN;PTGER4;TYROBP;BCL3;RNF216;THBS1;HOMER3;ANXA1;TLR8;SRGN;ZC3H12A;ANXA4;ACOD1;C1QTNF3;FOXJ1;CEACAM1;SLC11A1;NLRC5;KAT5;SLAMF1;AGER;UBE2L6;LILRB1;TNF;TLR4;RGCC;FN1;MMP8;TRAF3IP1;CD33;NPLOC4;APPL2;KLF4;NLRC3;RNF125;TMSB4X
prerank,axon extension (GO:0048675),-0.4041824451824436,-1.304727176335821,0.11375661375661375,0.5168565657185693,1.0,6/23,12.38%,ALCAM;NRP1;NRP2;SLIT1;USP9X;SEMA5B
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4945833320466544,1.3039889938611187,0.14597315436241612,0.773325885990358,1.0,9/16,31.75%,C3;MRAP;PRKCA;PRMT5;GRP;CHGA;NECAB2;SLC39A14;PDE6G
prerank,regulation of establishment of cell polarity (GO:2000114),-0.4634270024012928,-1.3035149793878955,0.12626262626262627,0.5187205926115592,1.0,8/16,20.17%,RIPOR2;KIF20B;SHTN1;RACK1;PTK2B;RAP1B;GSN;BCAS3
prerank,protein oxidation (GO:0018158),-0.5137228778769365,-1.3030605702941533,0.16379310344827586,0.5186274079973651,1.0,5/11,35.38%,SUMF1;LOX;LOXL1;PRDX3;APOA2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.515012987348055,-1.3030398948609134,0.14757709251101322,0.517500761678075,1.0,4/11,19.34%,CIITA;PF4;HDAC2;TAF7
prerank,regulation of adaptive immune response (GO:0002819),-0.4420865706375099,-1.3025506480393447,0.13411764705882354,0.517613988314045,1.0,6/18,13.74%,FCGR2B;IRF7;IL6ST;AHR;SKAP1;SASH3
prerank,negative regulation of phosphatase activity (GO:0010923),-0.3992122965641642,-1.3022643150622104,0.12432432432432433,0.5171798364082182,1.0,13/25,30.91%,PTPA;BOD1;CRY2;PPP1R35;CHP1;PPP1R15A;BOD1L1;SEMA4D;SH2D4A;MASTL;PPP1R26;TGFB2;FKBP1A
prerank,positive regulation of cell projection organization (GO:0031346),0.32540307717668016,1.3016194314743388,0.058900523560209424,0.7806145923398159,1.0,55/115,29.11%,MAP6;FBXW8;PLXNB2;OBSL1;PTPRD;NTRK1;ARSB;STMN2;PLA2G3;NTRK3;PTK7;PRKCI;GPC2;RIT2;DAB2IP;TWF2;ARHGDIA;CDKL5;TENM3;IL1RAPL1;SS18L1;ARHGAP35;NDRG4;MAP3K13;NDNF;STYXL1;NTRK2;PRKD1;TWF1;SETX;ITGA6;SCARB2;FES;PLXNB1;DVL2;MAGI2;ROR1;SCN1B;CAMK2B;SERPINI1;BDNF;TIAM1;RHOA;RAPGEF2;CAMK1;DLG4;NGFR;EPHA3;CUX1;SLITRK1;ATP1B2;ROR2;ROBO1;MDK;CUL7
prerank,muscle cell differentiation (GO:0042692),0.4086356497379102,1.3015242876889035,0.10990712074303406,0.7783279373121239,1.0,13/32,27.69%,NEBL;DUSP29;LBX2;DMD;MEF2C;SGCZ;RORA;NRAP;MRTFA;POPDC3;TMEM204;WNT5B;SEMA4C
prerank,zinc ion homeostasis (GO:0055069),0.42585585257145225,1.3013424180216566,0.13015873015873017,0.7764406493403062,1.0,13/28,18.07%,SLC39A4;TMC8;PRKN;SLC39A8;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.492866638021938,-1.3013176677178986,0.17412935323383086,0.5184887697187733,1.0,5/12,12.11%,APOBEC1;SETDB2;PPHLN1;DNMT1;ATF7IP
prerank,activation of protein kinase A activity (GO:0034199),-0.4594080890240934,-1.2999952410751106,0.1308641975308642,0.5208684053204957,1.0,7/16,15.05%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;PRKACB
prerank,regulation of nervous system development (GO:0051960),-0.36100604516070683,-1.2999936915024628,0.09782608695652174,0.5197066421867027,1.0,16/37,21.64%,HMGB2;DOCK7;ZPR1;YAP1;IL1B;CTNNB1;TNFRSF1B;PTN;HEY2;PER2;NPHP3;HES1;PTPRZ1;BHLHE40;SIRT2;HEYL
prerank,regulation of cellular catabolic process (GO:0031329),-0.32233618258012187,-1.2999694523872893,0.0759493670886076,0.5186170626108616,1.0,20/62,15.84%,ABL2;TPCN2;PSAP;RRAGC;DRAM2;MTMR4;ITPR1;GPR137B;CISD2;DRAM1;SMCR8;DCAF12;EP300;WDR91;DAPK1;LRRK2;RRAGA;GPR137;HSPB1;MTMR3
prerank,lymphocyte differentiation (GO:0030098),-0.3159792237395269,-1.2999052140671064,0.05263157894736842,0.5176234872177968,1.0,25/68,22.46%,ITGA4;PTPN22;AXL;PTPRC;KLF6;CEBPG;LYL1;TOX;DNAJB9;BLNK;LFNG;LCK;CD79B;NHEJ1;KAT7;RELB;IKZF1;ADAM17;ZAP70;GATA3;CD79A;PIK3CD;HDAC4;GPR89B;GPR89A
prerank,DNA methylation or demethylation (GO:0044728),-0.4270332256518186,-1.2995776898503462,0.14360313315926893,0.516039744266571,1.0,6/19,14.04%,DNMT1;ATF7IP;EHMT1;MTRR;GATAD2A;FOS
prerank,DNA alkylation (GO:0006305),-0.4270332256518186,-1.2995776898503462,0.14360313315926893,0.516039744266571,1.0,6/19,14.04%,DNMT1;ATF7IP;EHMT1;MTRR;GATAD2A;FOS
prerank,positive regulation of biosynthetic process (GO:0009891),-0.34573010578838936,-1.298845555925287,0.09722222222222222,0.5167816514638802,1.0,17/40,22.15%,SUCO;APOE;CD36;LARP6;VIM;HDAC2;SORBS1;CYBA;SCX;CREB3L1;SLC5A3;ZBTB20;TLR4;RGCC;MMP8;SERPINF2;ADGRB1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.4473022790888656,1.2982534482036352,0.14072847682119205,0.7870506478249929,1.0,4/22,6.80%,IL2RA;IL4I1;VSIR;IL2
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.44135261012987226,-1.2979990126998406,0.15144230769230768,0.5178846207593274,1.0,8/18,16.30%,DOCK2;TYROBP;SYK;ENPP3;DYSF;SLAMF1;LBP;FCER1G
prerank,membrane depolarization during action potential (GO:0086010),0.4224719960955042,1.2977150848431553,0.13312693498452013,0.7866870112477429,1.0,14/26,34.04%,KCNH2;CACNA1G;SLC8A1;CACNA1D;SCN2A;SCN1B;SCN3B;SCN8A;SCN7A;CACNA1H;SCN1A;CACNA1I;SCN4B;KCNJ2
prerank,regulation of biosynthetic process (GO:0009889),-0.4972981133986105,-1.2971639463607587,0.16216216216216217,0.5189616891599365,1.0,6/11,24.20%,ALOX5;SPHK2;MID1IP1;SLC25A33;GSTP1;CCN6
prerank,action potential (GO:0001508),0.3825786819441369,1.297055293852127,0.09767441860465116,0.7869543871388394,1.0,17/44,28.45%,KCNH2;KCND2;KCNE2;DMD;GNA15;CACNA1G;SCN2A;GNA11;KCNMB3;SCN3B;SCN8A;SCN7A;ANK3;GNAQ;KCNB1;CACNA1H;SCN1A
prerank,apical protein localization (GO:0045176),0.5511204344213695,1.2968860522337684,0.16751269035532995,0.7850074813619479,1.0,6/10,21.63%,VANGL2;INSC;JAM3;ATP8B1;ACTB;MAL
prerank,skeletal muscle contraction (GO:0003009),0.4673319710863896,1.296797662311776,0.15025041736227046,0.7827522305131919,1.0,2/19,4.01%,TNNC1;TNNI3
prerank,cell projection assembly (GO:0030031),0.449773253914474,1.295909093762404,0.1440677966101695,0.7838959304497964,1.0,8/22,20.77%,RHOV;NCKAP1;NCKAP1L;CYFIP1;RHOQ;RHOU;CAPG;CDC42
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.5332381640079027,1.2955235418020998,0.17304189435336975,0.7828892038605846,1.0,6/11,26.73%,TIMM29;TIMM13;TIMM22;TOMM70;TIMM10;TIMM10B
prerank,establishment of apical/basal cell polarity (GO:0035089),0.49599709907235934,1.2939128601906835,0.15306122448979592,0.7871546306660169,1.0,9/14,27.15%,SH3BP1;FSCN1;SCRIB;CAMSAP3;PATJ;CDC42;OPHN1;RHOA;MYO9A
prerank,arachidonic acid secretion (GO:0050482),-0.5227508865964251,-1.2936406018936562,0.16428571428571428,0.5254060476598684,1.0,3/10,19.73%,ANXA1;DRD2;DRD3
prerank,arachidonate transport (GO:1903963),-0.5227508865964251,-1.2936406018936562,0.16428571428571428,0.5254060476598684,1.0,3/10,19.73%,ANXA1;DRD2;DRD3
prerank,acyl-CoA metabolic process (GO:0006637),0.39733837259229005,1.29290924879916,0.12225705329153605,0.7888332752294741,1.0,9/35,16.35%,ACSF2;ACSL6;ACOT13;OXSM;DBI;ACOT4;ACBD6;ACOT11;ACACB
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.236656457207012,-1.2918259407038282,0.0,0.5288353580168896,1.0,152/476,22.48%,MDFIC;SP100;MED13;CD74;CREB5;APOE;CD38;IGF1;EPC1;MITF;SP3;ARID1B;CDK5RAP2;HMGB2;KAT6B;RUNX3;PPARG;DVL3;CIITA;IRF7;DTX3L;SMARCA4;RARA;SOX11;MED16;BCL3;ESR1;AHR;NFKB1;SETD3;KLF6;IRF4;LYL1;VHL;PPARD;NCOA1;SMAD3;SP1;MLLT3;DYRK1A;JMJD6;CEBPB;HNRNPAB;PICALM;EGR2;ZMIZ1;PCBD2;ILF2;KDM8;NR1H2;YAP1;TBL1X;NAA16;HIF1A;SMARCA1;BRCA1;IL1B;FOXE1;PSEN1;RNF14;HINFP;RNF6;RET;MAD2L2;CTCF;STAT1;PBX4;EP300;DNM2;CTNNB1;FOXO1;PRMT2;ATF5;NOTCH1;TRIM44;HDAC2;SKAP1;NFE2;ATF7IP;FZD2;RXRB;PARP9;KAT5;HDAC1;NR1H3;RYBP;SCX;INPP5K;BMP2;FOS;NPM1;TESC;ZNF318;EGFR;NOTCH4;LHX1;BICRAL;SHC1;TNF;TRIM45;ING1;WNT5A;PHF5A;NUP62;FOXK2;WAC;DEAF1;EDRF1;TNNI2;HIPK2;KLF2;MAP2K7;HEY2;NAT14;SMAD4;GATA3;HMGA2;HNRNPD;GLIS2;RNF20;NIBAN2;LRP6;TRIM16;XPC;HAS3;CDH1;HES1;TFAP2B;AFAP1L2;ACVR1;BMP7;EHF;ESRRB;BAMBI;HMGA1;ELF2;NFATC2;EPO;KLF4;KMT2B;POU3F1;MAP3K2;ZFP90;HDAC4;ID2;RREB1;HMGN5;FZD4;MECOM;NR1H4;SHH;CAND2
prerank,signal release from synapse (GO:0099643),0.38481220268193433,1.291738600841041,0.10832025117739404,0.7913551470226441,1.0,10/43,14.15%,SNAP25;RAB3A;SYT1;SNAPIN;NRXN1;OTOF;RIMS1;CPLX2;GAD2;STXBP2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.42383712885730035,-1.2916297343150775,0.12686567164179105,0.5281338291046731,1.0,6/20,6.28%,DAB2;PID1;BCL2L1;CSK;PPP2R5A;PICALM
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4403363872002899,-1.2914562917556451,0.13658536585365855,0.5274918253245267,1.0,3/17,5.94%,PLBD1;PLA2G4E;PLAAT3
prerank,peptidyl-asparagine modification (GO:0018196),-0.3772664608707782,-1.2910548777548745,0.13172043010752688,0.5274308316823307,1.0,7/31,7.74%,RPN2;MAGT1;UGGT1;MGAT2;MCFD2;ST6GAL1;FUT8
prerank,response to ATP (GO:0033198),0.47027041994121044,1.2903766382563089,0.1346153846153846,0.7946520041030769,1.0,6/18,16.10%,P2RY12;TRPC3;DGKQ;HSP90B1;P2RY1;SSH1
prerank,negative regulation of apoptotic process (GO:0043066),-0.24476861379055898,-1.2902620579011441,0.0,0.5284441285521856,1.0,106/444,16.18%,DAB2;ARHGAP10;BCL2;ITCH;CD74;APOE;CD38;GAS6;IGF1;AXL;PRKCH;BCL2L1;KLHL20;RAF1;CD44;TNFAIP8;ATAD3A;YME1L1;BRAF;BIRC6;MCL1;NUAK2;SIAH2;RNF213;IL6ST;LAMTOR5;BCL3;PIM1;NFKB1;CIAPIN1;RASA1;BAG4;THBS1;VHL;FAS;HSPD1;RIPK1;TFRC;PRDM9;CAV1;PDCD10;PLAUR;IFIT3;YAP1;ANXA1;HNRNPK;UBC;CIB1;NAA16;PSEN1;RPL10;HCK;TPT1;CPEB4;RNF157;PIK3CA;PIDD1;UBA52;HYPK;ZC3H12A;GCLC;SH3RF1;ANXA4;ADAM8;CD28;BIRC5;SPRY2;EGR3;AGAP2;CTNNB1;FOXO1;ATF5;BARD1;NOTCH1;MIEN1;CDK1;MAD2L1;HDAC2;LIG4;BIRC2;SMAD6;CBL;FHL2;HDAC1;KDR;CCND2;ASAH2;PSMD10;RB1;SCX;PTMA;GREM1;NPM1;QARS1;EGFR;DFFA;SHC1;TNF;PTK2B;HSPB1;WNT5A;DNAJB6;NUP62;GPX1;CLN3;PLK1
prerank,response to organonitrogen compound (GO:0010243),0.3942554246090581,1.2901651474463813,0.12713178294573643,0.7929152909721753,1.0,11/38,15.20%,UBXN6;GLRA3;IL6;INAVA;TRPM2;GLRB;PRKN;GLRA2;CCDC47;DERL1;IRF5
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4406573936370854,-1.2901463873863817,0.14588235294117646,0.5276019188458114,1.0,5/15,23.84%,RBPJ;CEACAM1;EGFR;WDR54;EGF
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.5112703192024565,-1.289876163532317,0.1724137931034483,0.5270815164823993,1.0,4/11,12.11%,SETDB2;PPHLN1;DNMT1;ATF7IP
prerank,regulation of GTPase activity (GO:0043087),0.30855664490479906,1.2897777937736812,0.04114713216957606,0.7919220799380817,1.0,58/177,20.51%,AGRN;SH3BP1;STMN3;SRGAP2;PLXNB2;ARHGAP44;CHN1;F11R;SGSM2;CHN2;NTRK1;SGSM3;THY1;FGD2;PKP4;TMED2;DAB2IP;MAPRE2;RAPGEF3;ADCYAP1;EPHA1;CDKL5;MAP4K4;RGS10;ITGB1BP1;OCRL;RASGRF1;RAP1GAP;SFRP1;DOCK10;RAP1GDS1;VAV1;PRKG1;DOCK9;RALBP1;ARFGEF1;EPHA4;FLCN;RCC2;NTRK2;SH3BP4;RSU1;RRP1B;HRAS;PTK2;ITGA6;ALS2;ZC3H15;ARHGAP12;ASAP3;PIN1;CCL15;WNK1;PLXNB1;CCL5;CAV2;GMIP;EPHA5
prerank,negative regulation of developmental growth (GO:0048640),0.4135151140699101,1.2891034334694091,0.12680577849117175,0.7921885214143453,1.0,14/30,30.40%,DIP2B;DCC;FGF13;MAG;WWC1;PTPRS;ULK2;MAP2;ULK1;NKD1;PTEN;DUSP10;RTN4R;FGFR3
prerank,determination of left/right symmetry (GO:0007368),0.397631031675432,1.288671422755834,0.09937888198757763,0.7914508797878732,1.0,7/36,8.98%,DNAAF1;ODAD4;CCDC39;PKD1L1;MEGF8;DAND5;PKD2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4626923346550123,1.288144117964949,0.15057283142389524,0.7910971710089499,1.0,8/18,18.40%,PRKCZ;NRXN1;SHANK3;GRIN1;RIMS1;WNT7A;SHANK1;CHRNA7
prerank,cholesterol efflux (GO:0033344),-0.4186533533803076,-1.2877260593904598,0.1451990632318501,0.5317134997455188,1.0,6/20,12.97%,APOE;NPC2;STX12;ABCG4;ABCG1;APOC1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.42080698182270526,-1.2875786812275702,0.14615384615384616,0.5308784890249184,1.0,10/21,17.07%,ADAM19;ADAM9;PRKCQ;PSEN1;DAG1;ERAP1;SPPL3;MYH9;RBMX;ADAM17
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.4454030838070913,-1.2873970920051918,0.1546134663341646,0.5302490281222214,1.0,6/17,13.19%,CD74;CD44;DYRK1A;YJU2;PTTG1IP;PSMD10
prerank,vacuolar acidification (GO:0007035),-0.4170540596243658,-1.2873128127008067,0.15347721822541965,0.5292951557462885,1.0,7/21,19.82%,ATP6V0D1;ATP6V0D2;ATP6V0A1;CLN5;SLC11A1;CLN3;ATP6V0A4
prerank,photoreceptor cell development (GO:0042461),-0.46471335893134486,-1.287249461352698,0.15422885572139303,0.5283482828748016,1.0,10/14,44.83%,MFSD2A;RP1;DCX;TH;CDHR1;AHI1;CEP290;MYO7A;TOPORS;VEGFA
prerank,response to exogenous dsRNA (GO:0043330),-0.4271528302902726,-1.2871070818559809,0.13012048192771083,0.5275857630436055,1.0,7/18,17.50%,RFTN1;IFIH1;IFIT1;CAV1;RALB;MUL1;SLC3A2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.49972247749038046,1.2870370438048335,0.1644295302013423,0.7932149728238238,1.0,7/13,20.17%,NFIB;RELA;PPARA;BMP4;PDGFB;REST;SRF
prerank,positive regulation of cellular respiration (GO:1901857),-0.5067023568949345,-1.2868112902283175,0.19854721549636803,0.5271573194504574,1.0,2/11,1.55%,IFNAR1;VCP
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.44576984464982494,1.2866823243922503,0.15081967213114755,0.7920993711495037,1.0,6/20,12.55%,ATP2A2;ATP1B1;TNNI3;DMD;SLC8A1;GSTO1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.30331448494595836,-1.286625763372879,0.06501547987616099,0.5264961395964786,1.0,20/73,16.68%,VAV3;FCGR2B;ACTR3;CRK;PRKCE;NCK1;WIPF1;ARPC2;SYK;LYN;FYN;HCK;PIK3CA;ARPC5;GRB2;MYO10;WIPF3;ELMO2;FCER1G;PLD2
prerank,mitochondrion localization (GO:0051646),-0.4201528432172623,-1.2864561777272736,0.13192612137203166,0.5257684157678123,1.0,6/19,16.27%,TRAK1;MARK2;MTM1;BRAT1;LRRK2;MUL1
prerank,regulation of viral entry into host cell (GO:0046596),-0.37407108958886787,-1.2863639530965914,0.12064343163538874,0.5248419287610718,1.0,7/30,6.61%,CD74;TRIM25;TRIM14;CIITA;LGALS1;IFITM3;TRIM62
prerank,regulation of mitochondrial fusion (GO:0010635),-0.49720721761550235,-1.2862571845684145,0.16122004357298475,0.5239855401094577,1.0,2/11,6.20%,PID1;TFRC
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.43644383587256275,-1.2860327266576173,0.16009852216748768,0.5234486143227968,1.0,6/16,18.53%,FCGR2B;CD274;TYROBP;AGER;LILRB1;MMP8
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4311170626087249,1.2853780523607559,0.13253012048192772,0.7951694900311754,1.0,4/25,5.88%,CAPN3;CACNB2;THY1;PLCG1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.42540781563963725,-1.2853770611704958,0.15113350125944586,0.5240056336491286,1.0,10/18,29.51%,ENSA;PTPA;PPP1R35;INPP5K;ARPP19;CHP1;PPP1R15A;SH2D4A;PPP1R26;MFHAS1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.3304941237730173,-1.285364145970428,0.06936416184971098,0.5229362337088331,1.0,14/55,15.96%,PID1;ALOX5;XDH;THBS1;DHRS4;RIPK1;PARL;BRCA1;ZC3H12A;GRB2;ACOD1;SPHK2;SLC25A33;BST1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.39429835128152885,-1.2849295974649062,0.14652956298200515,0.5228813856211998,1.0,10/25,18.41%,IGF1;SOX11;DOT1L;H1-0;MAD2L2;RB1;HEY2;GATA3;PER2;NIBAN2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.40822604865378564,-1.2844633732163173,0.13850415512465375,0.5229406602305362,1.0,8/23,21.35%,GIT1;CBFA2T3;EP300;C1QTNF3;CRY1;SIK1;NCOR1;HDAC4
prerank,ion transport (GO:0006811),0.32762149462153983,1.2828206428319522,0.06429548563611491,0.8035053997010604,1.0,37/111,23.42%,TMEM63C;SLC24A5;SLC5A12;TRPM3;VDAC1;SLC12A2;SLC1A1;GLRB;SLC20A1;CNGB1;SLC25A18;SLC9A4;SLC26A4;GRIN1;SLC12A6;SLC8A1;SLC26A7;SLC1A3;CTNS;TRPC6;PANX1;TSPO;KCNN4;SLC9A5;GABRB1;SLC8A3;SLC24A3;KCNN3;CHRNA7;SLC24A4;WNK1;ATP1A4;PANX2;SLC25A10;KCNN2;SLC9A1;SLC25A26
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4802643376671116,1.2823305157478735,0.1541038525963149,0.8030230359326102,1.0,4/16,13.55%,DDX5;AR;TADA3;RBFOX2
prerank,negative regulation of hemostasis (GO:1900047),0.5194185255758443,1.2818173956927834,0.16393442622950818,0.8026794371301661,1.0,5/12,15.41%,ADTRP;CD34;THBD;VTN;SERPINE2
prerank,regulation of neuron migration (GO:2001222),0.42859060767612395,1.2818008324161958,0.13344316309719934,0.800193869651606,1.0,13/26,26.70%,SRGAP2;PLXNB2;CTNNA2;DAB2IP;IGSF10;ULK4;NTNG2;NTNG1;NSMF;CAMK2B;SEMA3A;RAPGEF2;PHACTR1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.27718688754822096,-1.2807947105268693,0.06896551724137931,0.531214133852682,1.0,48/136,21.75%,SP100;ITCH;GAS6;RWDD3;ESR1;PROX1;PIM1;CEBPG;TAF1;ID3;ZC3H12A;MAD2L2;ANXA4;PTGIS;PAXIP1;NFKBIE;PRMT2;ACOD1;BRMS1;HDAC2;ID1;FOXJ1;NLRC5;PSMD10;RB1;SIK1;SFRP5;CHP1;OTULIN;PYDC1;WFS1;FLNA;GLIS2;NWD1;HES1;TRIM37;CDKN2A;BMP7;BHLHE40;KLF4;NLRC3;TRIM21;TMSB4X;HDAC4;AIM2;PTCH1;HEYL;ID2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.307742563022644,-1.280609222185494,0.06031746031746032,0.5305866315453316,1.0,15/70,10.70%,VAV3;FCGR2B;ACTR3;CRK;PRKCE;NCK1;WIPF1;ARPC2;SYK;LYN;FYN;HCK;PIK3CA;ARPC5;GRB2
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5211235313116791,1.2799442953869025,0.17229729729729729,0.8055144292985384,1.0,2/12,0.46%,IDH3B;IREB2
prerank,negative regulation of protein transport (GO:0051224),-0.3968533682814325,-1.2794347651733762,0.1348314606741573,0.5323583853375353,1.0,10/25,21.30%,APOE;CSK;DRD2;RSC1A1;PKDCC;DPH3;PPM1F;DRD3;SERGEF;NDFIP1
prerank,response to nutrient levels (GO:0031667),0.4783552770981887,1.2790520344647924,0.17152658662092624,0.8068861530086799,1.0,8/17,30.39%,RPTOR;RPS6KB1;ULK1;MEAK7;ATF4;PRKAA2;KCNB1;FAM107A
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4459998325328617,1.2789623345383634,0.15924657534246575,0.8046564461742617,1.0,9/21,17.39%,STMN2;NAV3;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3794397003428442,-1.2788720045136965,0.1514360313315927,0.5327024659113572,1.0,8/28,10.73%,PRPF19;CLSPN;USP28;DOT1L;NBN;ATRIP;HINFP;RHNO1
prerank,B cell proliferation (GO:0042100),-0.4401786915916806,-1.2788157356429273,0.1632183908045977,0.5317517264095073,1.0,3/17,6.06%,BCL2;PTPRC;HSPD1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.34610463645163736,-1.2788054924150931,0.09946236559139784,0.5306896222427878,1.0,14/42,18.45%,VCP;TRIM25;PCNA;POLI;UBC;PCLAF;UBA52;POLD4;RPA1;FAAP20;UBE2L6;RPA2;DTL;USP43
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3550269475377892,-1.2785859971910392,0.10755813953488372,0.530187532355585,1.0,11/39,14.73%,NOL11;RPS24;RPS16;RPS14;RPS7;DDX52;RPS5;UTP4;METTL17;NPM1;WDR3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.44623049930998326,-1.2778070920631002,0.1641025641025641,0.5311297458620919,1.0,10/16,29.84%,APOE;HIF1A;S100A1;TERF2;TNF;NUS1;DHFR;TERT;GCH1;AGTR2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.4885276849367789,-1.2777907218340432,0.16705882352941176,0.5300782563090725,1.0,5/12,10.08%,APOE;FLOT2;RANBP9;PICALM;TMED10
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3553112207812971,-1.2770664457136387,0.12427745664739884,0.5309164288142576,1.0,12/39,14.82%,RBPJ;IL6ST;NOD2;PDCD10;ZMIZ1;YAP1;SNW1;EP300;NOTCH1;TSPAN5;CCN3;NOTCH4
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5011408044695504,1.2768482754962773,0.16987740805604204,0.8113228405550096,1.0,4/12,12.23%,NELFB;NELFCD;RNF168;RNF8
prerank,myelin maintenance (GO:0043217),0.5319729452493743,1.2760867648170682,0.1551094890510949,0.8120323312659106,1.0,6/10,28.40%,CLU;CXCR4;MYRF;ABCD2;EPB41L3;PTEN
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.24256174741875308,-1.2760276578658851,0.00909090909090909,0.5325026587582542,1.0,126/417,21.84%,RBPJ;MDFIC;NR3C1;WWP1;CD38;GAS6;MECP2;POU2F1;EPC1;SETDB2;SP3;LIMD1;ZHX2;HMGB2;KAT6B;PPARG;CIITA;CBFA2T3;SMARCA4;RARA;ENO1;SMURF2;PATZ1;BCL3;AHR;PROX1;LIMS1;NAB1;PPARD;ATXN1;MBD2;RCOR1;CIART;BCL7A;DPF3;BCOR;PFDN5;KDM8;NR1H2;ID4;BRCA1;FOXE1;CRY2;HINFP;SNW1;ID3;GCLC;MBD1;L3MBTL4;CTCF;BIRC5;ZBTB18;CTNNB1;FOXO1;PRMT2;ATF5;SPEN;NOTCH1;L3MBTL3;BRMS1;HDAC2;ID1;RCOR3;ZNF148;CRY1;ATF7IP;DEPDC1;EHMT1;KAT5;HDAC1;MIDEAS;RB1;GATAD2A;INPP5K;BMP2;FOXP2;CREB3L1;L3MBTL2;QARS1;FOXP1;ZNF318;RIOX1;THAP7;LHX1;DACH1;SHC1;TNF;KDM5C;KAT7;WNT5A;FOXK2;DEAF1;SAP18;IKZF1;ARID5B;UIMC1;HEY2;SMAD4;GATA3;HMGA2;GLIS2;PER2;NIBAN2;LANCL2;HES1;TFAP2B;PPM1F;CDKN2A;TAF7;EED;YEATS2;PA2G4;BMP7;NCOR1;HMGA1;BHLHE40;KLF4;SCMH1;RBAK;BASP1;SIRT2;TRIM33;HDAC4;HEYL;ID2;PSPC1
prerank,calcium ion transport into cytosol (GO:0060402),0.44028556802506313,1.275850484039187,0.14735099337748345,0.8105694200433464,1.0,7/21,15.57%,TRPM2;GRIN1;GRIN2B;SLC8A1;ITPR3;JPH1;CACNA2D1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.37061134361993064,-1.2755132743195157,0.13866666666666666,0.5327325008684781,1.0,12/30,25.39%,GNL3L;EXOSC10;TERF2;DACH1;NIBAN2;TENT4B;NAT10;HNRNPC;HNRNPU;TINF2;PIF1;BMPR2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3394722293722863,-1.274578248785286,0.10734463276836158,0.5340424643784929,1.0,19/46,24.60%,MAP3K1;PTGER4;TLR7;NFKB1;FAS;TLR8;IL1B;PIEZO2;PDE2A;TLR4;MAPK8;MAP2K4;TMEM150C;MYD88;CASP1;MAP3K2;TLR5;TNFRSF8;FADD
prerank,metal ion export (GO:0070839),0.41180924680939834,1.2744591113553914,0.14516129032258066,0.8141193022303288,1.0,9/31,19.85%,KCNH2;KCNA5;ATP1B1;KCNE2;ATP1B3;KCNT2;ATP1A4;ATP1A3;ATP1A1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.37564992979481554,-1.2740848014170099,0.13279132791327913,0.5342212152390101,1.0,8/32,14.02%,PID1;IGF1;VCP;ENO1;HIF1A;PSEN1;ENTPD5;ZBTB20
prerank,intestinal lipid absorption (GO:0098856),0.5141974563783295,1.2738375566776157,0.1810344827586207,0.814178415169714,1.0,3/11,5.57%,ABCG8;AKR1C1;SOAT2
prerank,lipid droplet formation (GO:0140042),0.5527058523828492,1.2738091430474485,0.19434628975265017,0.8117726706760898,1.0,2/10,15.22%,PLA2G4C;FITM2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.38367797507637624,-1.273378608512171,0.12162162162162163,0.534824388345445,1.0,7/26,9.40%,ITCH;ALPK1;IFIH1;NOD2;UBC;TAB1;UBA52
prerank,regulation of protein polymerization (GO:0032271),0.39616094062942214,1.2731558865509833,0.14009661835748793,0.8121906677930184,1.0,11/35,23.08%,TPPP;CTTN;FCHSD2;CAMSAP3;CAMSAP1;PLEKHG2;MAP2;LATS1;MAPRE3;TPPP3;GBA2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5160169012367941,1.27206907446233,0.1815068493150685,0.8144503912116166,1.0,9/12,32.39%,ATP1B1;DMD;ATP1B3;WNK1;GLRX;ANK3;ATP1B2;WNK4;WNK3
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5232468647702438,1.2717565499276409,0.17035775127768313,0.813318195350918,1.0,4/11,20.42%,GTF2H2;ARRB2;ADM;ARRB1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.49168445644337533,-1.2716859639989992,0.18854415274463007,0.537932268605717,1.0,2/11,4.12%,STAP1;TYROBP
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.33552433076814336,-1.271578228003807,0.10601719197707736,0.5371919791779782,1.0,13/48,13.52%,NEDD9;NRP1;CASS4;CRK;LIMS1;CRKL;CARMIL1;CIB1;CDKL3;CAPRIN1;S100A10;CUX2;MYOC
prerank,regulation of apoptotic process (GO:0042981),-0.234696063270297,-1.271413937104416,0.0,0.5365040667818821,1.0,149/676,16.53%,VAV3;DAB2;ARHGEF3;FGD4;ITSN1;ARHGAP10;BCL2;STK3;ITCH;CD74;ARL6IP5;SLK;DDX42;CD38;GAS6;HIP1;IGF1;AXL;BCL2L1;KLHL20;RAF1;STK17B;CD44;VCP;TNFAIP8;STEAP3;ATAD3A;YME1L1;IFIT2;ACTN1;BRAF;BIRC6;MCL1;NUAK2;LGALS1;ZBP1;SIAH2;BAX;TOP2A;IL6ST;PTPA;NLRC4;BCL3;PIM1;NFKB1;CIAPIN1;ARHGEF18;RASA1;ATG7;ARHGEF6;SLC27A4;HIP1R;BAG4;THBS1;VHL;FAS;HSPD1;RIPK1;TFRC;PRDM9;PDCD10;PLAUR;IFIT3;PLEKHG5;ANXA1;TMEM219;HNRNPK;UBC;ANP32B;CIB1;NAA16;FGD1;CTSB;PSEN1;RPL10;HCK;TPT1;IKZF3;RNF157;PIDD1;PNMA2;ABR;UBA52;HYPK;GNA13;GCLC;SH3RF1;UTP11;MAP3K11;STAT1;ANXA4;CD28;BIRC5;SPRY2;EGR3;DNM2;CTNNB1;FOXO1;PRMT2;ATF5;BARD1;MIEN1;CDK1;BRMS1;STPG1;MAD2L1;HDAC2;BIRC2;SMAD6;GRM4;DAPK1;CBL;ARHGEF26;GADD45G;FHL2;RPS6KA2;HDAC1;KDR;CCND2;APH1B;PSMD10;RYBP;RACK1;SCX;PTMA;GREM1;BMP2;SPHK2;NPM1;HS1BP3;PMAIP1;EGFR;DFFA;SHC1;LILRB1;TNF;BCL2L11;PTK2B;HSPB1;WNT5A;NUP62;SAP18;DDX20;CLN3;ARHGEF5;PLK1;KLF11;BCAR1;MAPK8
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.4050556488701438,-1.2713085420931998,0.13010204081632654,0.5356874756759685,1.0,7/22,15.77%,MDFIC;SP100;BAG4;BARD1;LRRK2;INPP5K;CHP1
prerank,cell projection organization (GO:0030030),0.41106682941422207,1.271151816211323,0.15270935960591134,0.8133211158758339,1.0,10/30,21.34%,P2RY12;RHOV;NCKAP1;NCKAP1L;CYFIP1;RHOQ;RHOU;CAPG;CDC42;KIF17
prerank,development of primary male sexual characteristics (GO:0046546),0.40053499025367095,1.2711192220905885,0.15458937198067632,0.8109857159903605,1.0,6/34,9.12%,WNT4;FGF9;SIX4;LRP2;AR;MEA1
prerank,respiratory system development (GO:0060541),0.4002986581881539,1.2703425210660004,0.13665594855305466,0.8119927304661629,1.0,8/32,12.88%,DNAAF1;FGF9;CCDC39;DISP1;FGF7;BMP4;FGF2;SPEF2
prerank,regulation of cell division (GO:0051302),-0.3043488931757237,-1.2695707396143763,0.08852459016393442,0.539110282381379,1.0,25/72,22.33%,PIK3C3;BCL2L1;PIK3R4;GIT1;BIRC6;SH3GLB1;PRC1;MLLT3;CIB1;TXNIP;FGF1;UVRAG;KLHL21;CALM3;AHCTF1;CALM2;RACK1;PRPF40A;PLK1;KIF20A;KIF18B;ESRRB;SETD2;SIRT2;SHH
prerank,modification-dependent protein catabolic process (GO:0019941),-0.2598408499451079,-1.2695420493617773,0.028169014084507043,0.538133546154818,1.0,42/193,12.04%,ITCH;RNF149;BUB3;TRIM25;CUL3;ARIH1;UBE2K;UBA6;DTX3L;BIRC6;FBXL14;SIAH2;RNF213;OS9;SMURF2;TAF1;RNF146;PSMD11;CDC34;UBL7;ARIH2;UBQLN1;RNF13;UBC;ZNRF3;FBXW4;BAG6;KLHL15;RNF14;TTC3;RNF150;RNF6;UBE2L3;UBA52;CDC27;SPSB2;RC3H1;TRIP12;WDR91;MAD2L1;WDR81;CBL
prerank,regulation of cell cycle process (GO:0010564),-0.28930027797396485,-1.2693614894925473,0.07434944237918216,0.5375744681157821,1.0,29/104,17.92%,PIK3C3;BCL2L1;PIK3R4;GIT1;BIRC6;KIF11;MKI67;SH3GLB1;BORA;PRC1;CEP250;KIF20B;UVRAG;RACGAP1;KLHL21;CTNNB1;ATF5;CALM3;AHCTF1;RMI2;BUB1;CALM2;PRPF40A;NUMA1;PLK1;KIF20A;CUL9;ECT2;HMGA2
prerank,nucleoside salvage (GO:0043174),0.527349257997418,1.2693258111610513,0.17269736842105263,0.8138994921567149,1.0,5/10,19.73%,HPRT1;DCK;TK1;TK2;UCK1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.35712784042808654,-1.269325222668201,0.10904255319148937,0.5366345792919899,1.0,12/36,24.31%,ITCH;PTPN22;TAOK3;FOXO1;DUSP1;QARS1;NCOR1;DUSP19;MECOM;GSTP1;DUSP3;FKTN
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5040440813129696,1.2690273210673826,0.17235494880546076,0.8127456047749846,1.0,3/13,7.53%,DDX5;HIC1;EEF1E1
prerank,epithelial cell migration (GO:0010631),-0.3513948814396591,-1.2688946447148988,0.11830985915492957,0.5366744680666703,1.0,10/37,13.74%,ZEB2;NRP1;PXN;DPP4;KANK2;PLEKHG5;PIK3CA;STAT1;ADGRA2;PRKX
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.3997539838362574,1.268703641914392,0.15609756097560976,0.8116649922818826,1.0,5/31,7.62%,HOXD4;COL2A1;MEGF8;HOXB9;TGFBR1
prerank,positive regulation of signaling (GO:0023056),0.39205474684218233,1.2683827931095528,0.12558139534883722,0.8105932128793245,1.0,10/37,14.44%,CD80;SCRIB;SYT1;LGI1;GRIK2;CLSTN2;INPP5F;RIMS1;KCTD13;VAMP3
prerank,arachidonic acid metabolic process (GO:0019369),0.39278446829230407,1.2683177361861189,0.1465648854961832,0.8084726554123106,1.0,6/35,5.38%,CYP2S1;CYP2U1;PTGS1;PTGDS;ALOX12;PLA2G4C
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.42725616143237855,1.2676716703944693,0.16229508196721312,0.8087036225323943,1.0,6/25,9.57%,MPP2;MEF2C;ARRB2;GRID2;GRIN1;GRIN2B
prerank,cation transport (GO:0006812),0.30558999035830464,1.2674471349744754,0.07769423558897243,0.8071491276263102,1.0,33/167,16.26%,KCNMA1;TMEM63C;KCNJ3;KCNA5;ATP1B1;SLC5A12;KCNJ8;LRP2;TRPM3;KCNC1;SLC12A2;TRPM2;SLC1A1;KCNK3;CNGB1;KCNJ13;SLC38A7;GRIN1;SLC8A1;ASIC1;KCNK6;FGF13;TRPC6;PANX1;SLC66A1;KCNN4;SCN2A;ABCC8;SLC22A4;SLC8A3;NEDD4L;KCNJ5;KCNMB3
prerank,cellular response to glucose starvation (GO:0042149),-0.33813139746575843,-1.2655268451816806,0.12742382271468145,0.5442715333105623,1.0,13/41,16.67%,PIK3C3;PIK3R4;NUAK2;SH3GLB1;PRKAG2;CPEB4;ZC3H12A;SZT2;SIK2;SIK1;PMAIP1;MTMR3;SESN2
prerank,actin nucleation (GO:0045010),-0.4143266007966572,-1.2648673315206955,0.16097560975609757,0.5449010105874229,1.0,4/21,9.55%,IQGAP2;ACTR3;ARPC2;ARPC5
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3223705292614349,-1.2647349810407793,0.1167192429022082,0.5441750563506103,1.0,18/56,17.76%,RAD51B;ANKRD17;MECP2;CUL3;NSMCE2;CCND1;ANXA1;CDC27;CDK1;ESPL1;CCND2;RB1;EGFR;CDC25A;UBE2C;ADAM17;RGCC;DTL
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3037914718084724,-1.2642377466533838,0.09090909090909091,0.5443880115987116,1.0,19/73,16.11%,FNIP2;GAS6;RAF1;CD44;CNOT9;BRAF;DOCK7;TBK1;TFRC;BCAR3;CAV1;PDCD10;TXN;MAD2L2;SPRY2;MTCP1;EGFR;TNF;PFN2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.37042343901304436,1.264043269837968,0.12848297213622292,0.8192180526700051,1.0,10/44,13.24%,CTTN;BIN1;LMOD1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;FCHSD2;LMOD3;EVL
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.34269473817665846,1.2638809015580885,0.10526315789473684,0.8175672323583263,1.0,12/69,11.46%,PLCH1;TPTE;PIK3C2G;PLCL1;NYAP2;NTRK1;PLCD1;PIK3CG;RPS6KB1;OGT;INPP5F;IRS1
prerank,neuron projection organization (GO:0106027),0.47391435349512223,1.2634544092886404,0.19063545150501673,0.8170725329430215,1.0,8/15,22.29%,PRNP;LGMN;DCTN1;INSR;ABCD2;CHRNA7;ATP1A3;ARF1
prerank,purine nucleotide catabolic process (GO:0006195),-0.4675757245720115,-1.2632805393090343,0.1828978622327791,0.5457088108881997,1.0,3/13,5.65%,GDA;XDH;NT5E
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.43416014624016036,-1.2631991919589745,0.18032786885245902,0.544854273767556,1.0,11/16,35.20%,PTPRC;CEACAM1;KLRD1;AGER;LILRB1;FADD;IL12RB1;KLRC1;IL12A;IL23R;IL12B
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.42812186263983165,1.262460153774952,0.1598639455782313,0.8188622038286194,1.0,10/22,26.15%,NTRK1;STMN2;NTRK3;SH3GL2;EHD1;NTRK2;MAGI2;BDNF;RAPGEF2;MAPT
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.24626259796459107,-1.2624380746491792,0.0,0.5457972927577511,1.0,85/336,18.84%,VAV3;BCL2;VCPIP1;FNIP2;RAD51B;PARP4;BCL2L1;RBBP8;VCP;SETD7;ETAA1;BAZ1B;PDS5B;CUL4A;IRF7;UBA6;DTX3L;MCL1;BAX;TOP2A;MAPKAPK2;TOPBP1;USP28;DOT1L;BCL3;RTEL1;ZBTB40;ZRANB3;TAF1;YY1;CHD1L;CCND1;POLI;LYN;YAP1;NBN;IGHMBP2;CIB1;USP45;PCLAF;BRCA1;UVRAG;PSEN1;PDS5A;TAOK3;ATRIP;HINFP;PIDD1;ZC3H12A;TRRAP;ALKBH8;GRB2;FOXO1;BARD1;TRIP12;RPA1;CDK1;AKTIP;CRY1;TNFRSF1B;RMI2;BRAT1;ALKBH7;TICRR;NPM1;FOXP1;FAAP20;MNAT1;MCM9;BCL2L11;MCM8;CRIP1;EPHA2;WAC;NOP53;MUTYH;NUPR2;DTL;PPP1R15A;SLX4;MAPK12;XPC;WDHD1;HPF1;RBBP5
prerank,negative regulation of histone methylation (GO:0031061),-0.4868143514369978,-1.2624222784321613,0.18850574712643678,0.5447751381226169,1.0,5/10,24.48%,BCOR;DNMT1;BRCA1;AASS;MTF2
prerank,positive regulation of B cell activation (GO:0050871),-0.32880623141015264,-1.2623375576135145,0.10749185667752444,0.5438795028714218,1.0,15/50,16.53%,VAV3;BCL2;CD74;CD38;PTPRC;NOD2;GPR183;SYK;TFRC;MAD2L2;PAXIP1;SHLD1;SASH3;BST1;CHRNB2
prerank,negative regulation of response to external stimulus (GO:0032102),-0.28313980140967476,-1.2618687876930292,0.06872852233676977,0.5440453495589288,1.0,42/105,25.12%,AOAH;ITCH;APOE;ALOX5;CRK;PPARG;METRNL;PTGER4;VPS35;PPARD;ENPP3;DRD2;PTGIS;ACOD1;C1QTNF3;NR1H3;CCN3;RB1;CXCL17;AJAP1;OTULIN;MAPK7;MUL1;CERS2;KLK8;GATA3;TRAF3IP1;DRD3;LTF;KLF4;NLRC3;TRIM21;MVK;SIRT2;FFAR4;ISL1;NR1H4;MEFV;SMPDL3B;DUSP3;FEM1A;DHX58
prerank,negative regulation of cell projection organization (GO:0031345),0.3706631662872132,1.2616500812992337,0.1386748844375963,0.819930822853341,1.0,13/48,13.79%,DCC;STMN2;CRMP1;PTPRO;PRNP;ITM2C;RTN4RL1;PRAG1;MINAR1;GRIN2B;MAG;MYLIP;EPHA4
prerank,positive regulation of cytokine production (GO:0001819),-0.2499784957223786,-1.2615623910974774,0.01282051282051282,0.5438417732348036,1.0,84/292,18.59%,IL15;RFTN1;PAEP;CD74;PTPN22;CD274;CCDC88B;PTPRC;CCBE1;IFIH1;TLR2;PIBF1;LILRA5;IRF7;IL12RB2;RAB1A;RARA;ZBP1;TBK1;CCR2;IL16;POLR2E;RAB7B;IL6ST;LAMTOR5;PTGER4;TYROBP;DHX33;TLR7;NFKB1;CEBPG;CD14;IL27;IRF4;NOD2;HSPD1;SYK;RIPK1;CEBPB;DDX41;ANXA1;TLR8;PRKCQ;HIF1A;CLEC6A;BRCA1;IL1B;CD226;DRD2;LPL;HPSE;TMED10;EP300;CD28;CTNNB1;LTB;C1QTNF3;CYBA;CD2;SLC11A1;STOML2;LRRFIP1;CXCL17;SPHK2;POLR2H;FOXP1;LBP;EBI3;AGER;LILRB1;TNF;SCIMP;WNT5A;FCER1G;TLR4;HMOX1;IL18R1;ADAM17;RGCC;POLR3G;GATA3;AGPAT2;MMP8;ARHGEF2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5289084564883655,1.2610266159775434,0.19529837251356238,0.820144373961811,1.0,5/10,30.08%,DIP2B;FLCN;PRKAA2;DIP2A;SETD5
prerank,protein deneddylation (GO:0000338),0.5345636416933948,1.2608437437994986,0.18998272884283246,0.8184666879754349,1.0,4/10,20.13%,COPS8;COPS3;COPS6;COPS5
prerank,mRNA processing (GO:0006397),0.2880353205653147,1.260558711252569,0.03290246768507638,0.8173750606566573,1.0,80/287,20.23%,POLR2L;SRSF12;DHX35;RNPS1;CDK7;SMU1;CWC15;PQBP1;SRSF5;FUS;DHX15;POLR2F;DDX5;TRA2B;BCAS2;HNRNPH1;CWC22;CASC3;XAB2;PPARGC1A;PPWD1;CTNNBL1;GTF2H2;CPSF6;SF3B2;CWF19L2;PPIL1;ISY1;PRPF40B;SRRM2;SRSF6;SF3B6;PTBP1;SRSF11;GTF2H4;RBM5;GTF2F1;CACTIN;DDX46;AKAP8L;PRMT9;SNRNP70;SON;SF3B5;SF3A1;SRSF1;SNRPD2;YTHDC1;CPSF3;GPKOW;POLR2G;LSM8;RAMAC;TBRG4;SF3B3;CRNKL1;IK;CSTF1;NUDT21;NOVA1;CDC40;DDX39B;HNRNPA1;THOC5;SARNP;GEMIN5;GEMIN6;SRSF9;ELAVL2;PUF60;CHTOP;UBL5;GCFC2;TRA2A;SNRPD3;SNRNP27;ALYREF;SRSF2;SRRM4;RBM10
prerank,regulation of microtubule-based process (GO:0032886),0.38659433468703713,1.2602598667118443,0.15503875968992248,0.8162441348105112,1.0,17/36,26.97%,TPPP;MAP6;CLASP2;CAMSAP3;BICD2;PHLDB2;ROCK1;TAOK1;BICD1;KLHL42;CYLD;CDK2AP2;MEMO1;AURKA;MAPT;PRKAA2;EPHA3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.26489728277942154,-1.26020525524287,0.03773584905660377,0.5464272343420923,1.0,52/163,21.10%,VAV3;RFTN1;BCL2;CD38;PSMA6;PTPN22;CSK;PTPRC;DENND1B;TEC;PSMB2;PSME2;GRAP2;NFKBIZ;NFKB1;NCK1;PSMD11;SYK;PSMC6;FYN;BLNK;PRKCQ;THEMIS;PSMA3;EIF2B2;PIK3CA;ZC3H12A;CD28;LCP2;LCK;RC3H1;SPPL3;SKAP1;STOML2;PSMD10;CD79B;PSMB5;EIF2B4;RC3H2;SPG21;BCAR1;ZAP70;GATA3;PSMD5;CD247;THEMIS2;PSMD1;CD79A;NFATC2;PRAM1;PIK3CD;LAX1
prerank,triglyceride metabolic process (GO:0006641),-0.32667787170785256,-1.2588749608256256,0.10982658959537572,0.5488493744706815,1.0,11/48,16.52%,APOE;FABP4;PLAAT3;CAV1;LPL;FABP7;PNPLA2;APOC1;GK;GK5;GPAM
prerank,covalent chromatin modification (GO:0016569),-0.4583948262271266,-1.2588399969116806,0.1691542288557214,0.5478885809720015,1.0,3/14,12.77%,MBD2;HLCS;HDAC1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4110163302315921,1.258255612384918,0.16927899686520376,0.8221300184166493,1.0,12/26,20.37%,VSIR;USP50;GRIN1;GRIN2B;EFNA1;PSME3;PSENEN;EFNA3;EPHA4;PRELID1;MBP;PSME1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4432465786370855,-1.258241649480991,0.1941031941031941,0.5483425463841113,1.0,2/16,1.02%,MCTP1;MCTP2
prerank,positive regulation of hydrolase activity (GO:0051345),0.30915085181110336,1.258147355453014,0.09114249037227215,0.8201915646187591,1.0,38/137,19.54%,AGRN;SH3BP1;SRGAP2;F11R;SGSM2;NTRK1;SGSM3;THY1;MTMR9;PKP4;RIPK3;MAPRE2;RAPGEF3;ADCYAP1;CDKL5;MAP4K4;RGS10;RASGRF1;RAP1GAP;SFRP1;DOCK10;MTCL1;RAP1GDS1;DOCK9;RALBP1;FLCN;RSU1;HRAS;ITGA6;ALS2;ZC3H15;WRN;ASAP3;PIN1;CCL15;PLXNB1;CCL5;CAV2
prerank,positive regulation of insulin secretion (GO:0032024),0.3889269794455767,1.258111114732119,0.16436251920122888,0.8180042247842795,1.0,7/36,9.94%,ADCY8;NNAT;SOX4;RFX6;DOC2B;TCF7L2;CFTR
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.3345847176627793,-1.2565219272306507,0.11869436201780416,0.5518951607961702,1.0,5/46,1.66%,PEAK1;ITGA4;NRP1;PXN;ATRNL1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3657429236734206,1.2564816070840177,0.1458966565349544,0.8227840956995998,1.0,10/46,7.90%,DGKI;CACNG5;CACNG2;SYT1;NRXN1;MEF2C;ATAD1;GRM3;TPRG1L;SHANK3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3581864032389254,1.2562325148289601,0.1358609794628752,0.8215122492753928,1.0,12/51,12.11%,CTTN;CNTNAP1;SRGAP2;NYAP2;PAK1;NCKAP1;NCKAP1L;MAP1S;DAB2IP;MAP4K4;MINK1;ANKRD27
prerank,negative regulation of type I interferon production (GO:0032480),-0.3418156654209352,-1.2559555839738052,0.128686327077748,0.5525048680007445,1.0,15/40,20.89%,ITCH;TRIM25;IFIH1;TBK1;RNF216;YY1;ACOD1;NLRC5;UBE2L6;LILRB1;RELB;TRAF3IP1;NPLOC4;NLRC3;RNF125
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.48369703791311286,1.2551547846502369,0.19405594405594406,0.8237175559311103,1.0,4/13,12.23%,NELFB;NELFCD;RNF168;RNF8
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4223344241660233,1.254858496418835,0.15833333333333333,0.8226246170381619,1.0,8/24,15.53%,HHEX;DAB2IP;PRKD2;NEDD4;ITGA5;PDCD6;VTN;CADM4
prerank,inorganic anion transport (GO:0015698),-0.3237703927353249,-1.2537071039539243,0.09717868338557993,0.557430863466586,1.0,21/53,28.54%,SLC26A11;CLIC4;CLCN1;ENPP3;RACGAP1;FXYD1;SLC13A4;SLC11A1;SLC25A11;ANO5;ANO8;ANO1;CLIC5;PACC1;SLC26A6;CLIC1;GLRA1;ANO10;ANO4;SLC4A1;SLC5A5
prerank,response to glucocorticoid (GO:0051384),-0.37861248839492323,-1.2521254462639853,0.15263157894736842,0.5605458909200024,1.0,12/26,29.14%,NR3C1;ADAM9;GOT1;ANXA1;UBE2L3;TNF;BCL2L11;HNRNPU;ISL1;HSD3B2;SLIT2;SLIT3
prerank,T cell activation (GO:0042110),-0.3026342996075097,-1.2518448788535854,0.07717041800643087,0.5602281725639823,1.0,26/69,22.46%,CD74;PTPN22;CD44;DPP4;PTPRC;NCK1;MSN;IRF4;HSPD1;KIF13B;JAML;LFNG;LCP1;CD28;LCK;PPP3CA;CD2;NHEJ1;ZAP70;GATA3;TREML2;NLRC3;PIK3CD;CD3E;GPR89B;GPR89A
prerank,regulation of lymphocyte differentiation (GO:0045619),0.455447830866074,1.2516453165944117,0.19210977701543738,0.8339951222354638,1.0,7/18,16.94%,IL4I1;NCKAP1L;XRCC6;ZFP36L2;CRTAM;PRDM1;PRELID1
prerank,regulation of cell cycle (GO:0051726),-0.24501548293927972,-1.2516358804115861,0.017857142857142856,0.5597164936914832,1.0,87/271,24.47%,IQGAP1;ANKRD17;FBXL17;CDK6;BRINP1;LIN54;PTPRC;SDCBP;RUNX3;PRCC;PRKACA;RARA;FBXL8;CDC14B;JUNB;PROX1;GBF1;ERN1;UHRF2;THBS1;SMAD3;CCND1;KIF20B;LIN52;NBN;PCLAF;BRCA1;MYBL2;CDKN2C;LIN37;EP300;UHMK1;BIRC5;CDKN3;BARD1;NOTCH1;BIRC2;GADD45G;RPS6KA2;ASAH2;RB1;RACK1;BMP2;PRR11;DUSP1;SIK1;LILRB1;CDC25A;PLK1;MLF1;NOP53;NUDT6;HIPK2;RGCC;NUPR2;DTL;PPP1R15A;GATA3;HMGA2;RNF20;PER2;LRP6;MAPK12;CDKN2A;FBXL12;AFAP1L2;BMP7;HNRNPU;NOTCH2;CDK9;PUM1;TRIM21;SIRT2;DHCR24;MAP3K20;ID2;CDC14A;MECOM;RPRM;KAT2B;CCNB1;XIAP;MASTL;DDIAS;RPRD1B;PLAGL1;PIM2
prerank,striated muscle contraction (GO:0006941),0.3613948810750168,1.251348409196147,0.1344165435745938,0.8329149516455218,1.0,9/53,12.94%,KCNH2;ATP1B1;TNNC1;TNNI3;DMD;MYBPC3;PGAM2;SLC8A1;LMOD3
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5187397473306198,-1.2513450759171134,0.17841409691629956,0.5594301419309001,1.0,4/10,10.77%,STAT5B;PTPN1;LYN;GHR
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.46238582939661976,-1.2506092948691585,0.20353982300884957,0.5603762835419616,1.0,3/13,12.04%,CBLB;SOCS5;CBL
prerank,regulation of axonogenesis (GO:0050770),0.35957312973038824,1.2505596460148745,0.1543026706231454,0.8339331014775803,1.0,23/51,28.40%,MAP6;PLXNB2;CHN1;PAK1;THY1;OMG;EFNB3;ARHGDIA;GDI1;MAG;ARHGAP35;EPHA4;NTRK2;PLXNB1;LRRC4C;TIAM1;RHOA;NGFR;LINGO1;BRSK2;SLITRK1;PTEN;ROBO1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.31779567513886653,-1.249448038175154,0.11594202898550725,0.5623460642691193,1.0,14/54,12.78%,ITCH;UBE2D3;CUL3;UBE2K;DTX3L;RNF216;RNF146;CDC34;ARIH2;TTC3;RNF6;UBE2Q2;PELI1;UBE2E3
prerank,brain morphogenesis (GO:0048854),0.5111299612777958,1.2485840166358413,0.18275862068965518,0.8398896761571414,1.0,3/12,12.88%,CTNNA2;SHANK3;SPEF2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.420290441043314,-1.2480866040228644,0.1770573566084788,0.5648352174796246,1.0,7/18,22.22%,NR3C1;ANXA1;UBE2L3;KLF9;BCL2L11;HNRNPU;ISL1
prerank,negative regulation of peptidase activity (GO:0010466),0.36788938524772813,1.2478439703792408,0.13271604938271606,0.8407195605113458,1.0,14/47,26.07%,GAPDH;SPOCK3;CST3;SPOCK2;SERPINH1;VTN;SERPINE2;UBXN1;AGT;TIMP2;SERPINI1;CST7;SERPINF1;SERPINB8
prerank,central nervous system development (GO:0007417),0.2881758524753758,1.2474746026282866,0.07407407407407407,0.8399799541287282,1.0,58/250,18.13%,TPPP;ZFHX3;ROGDI;PLXNB2;C3;DNAJC30;ECRG4;BPTF;NNAT;ACAN;NFIB;SOX10;CYP26C1;ABCB6;NCKAP1;SOX4;PBX2;MAP1S;UBE3A;SEMA6B;NPTX1;ADAM22;ADGRL3;COX7B;SH3GL2;PKD2;GRIN1;CX3CR1;GRIN2B;PRKN;ASIC2;DDIT4;CTNS;CXCR4;PBX3;HAPLN2;SH3GL3;PKD1;PHF8;VCAN;NRCAM;TBX6;NDRG4;MYRF;ALDH5A1;HAPLN1;APOD;NKX2-2;HAP1;DSCAML1;SLC8A3;IER3IP1;TUBGCP2;AATK;ZIC5;IL1RAPL2;POU3F3;MBP
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.4781640214751576,-1.2473622748523159,0.21577726218097448,0.5656059292090668,1.0,4/11,13.18%,CDC73;NCBP1;BARD1;AHCYL1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.46549780611183217,-1.2473025419163986,0.19714964370546317,0.5646911002870539,1.0,4/13,9.00%,UBA5;UBA6;ATG7;UBA2
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.4170119473234665,-1.2470707591269456,0.16037735849056603,0.5642933174456544,1.0,9/18,20.92%,TCTA;FBXW7;GPR137B;GPR137;LILRB3;LILRB1;TLR4;LTF;TMEM178A
prerank,neurotransmitter secretion (GO:0007269),0.37079774195348103,1.2464767500080525,0.1484375,0.8420498869117102,1.0,10/44,14.15%,SNAP25;RAB3A;SYT1;SNAPIN;NRXN1;OTOF;RIMS1;CPLX2;GAD2;STXBP2
prerank,cellular response to interleukin-12 (GO:0071349),-0.31919919189673523,-1.2463936832223297,0.11598746081504702,0.5650478797320148,1.0,11/48,15.34%,CD47;TALDO1;STAT4;IL12RB2;PSME2;MSN;LMNB1;LCP1;HNRNPA2B1;AIP;RAP1B
prerank,sodium-independent organic anion transport (GO:0043252),0.5332381633827189,1.2462941552708031,0.2115732368896926,0.8404866949642649,1.0,2/10,10.41%,SLCO2B1;MFSD10
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.2720579450648855,-1.246109031647447,0.036585365853658534,0.5647506959796934,1.0,40/122,19.56%,IGF1;UPF3A;NIBAN1;TLR2;RPL5;CIITA;NAMPT;PCNA;BCL3;NFKB1;SAMD4A;THBS1;NOD2;BCAR3;IL1B;LARP6;VIM;CD28;PIWIL2;IGF2;SORBS1;PLD1;NLRC5;PPP1R3E;KDR;NPM1;CDT1;NMD3;ZCCHC4;EGFR;KAT7;LARP4B;FXR2;TLR4;UPF3B;RGCC;HNRNPD;IRS2;NAT10;RPL26
prerank,histone H2A ubiquitination (GO:0033522),0.45798274785642873,1.2459321484749695,0.19463087248322147,0.8396928314588437,1.0,6/17,14.08%,UBE2B;KDM2B;RNF168;RNF8;DDB2;RNF2
prerank,mesonephric tubule development (GO:0072164),0.47015468268237026,1.2458442187624856,0.1918032786885246,0.8377578394780514,1.0,5/15,12.51%,BMP4;PKD2;FOXC1;NPNT;PKD1
prerank,muscle filament sliding (GO:0030049),0.38031955006885604,1.2453195948327798,0.16174183514774496,0.8354609688998936,1.0,6/38,9.15%,TNNC1;TNNI3;DMD;MYBPC3;ACTN2;MYL6
prerank,actin-myosin filament sliding (GO:0033275),0.38031955006885604,1.2453195948327798,0.16174183514774496,0.8354609688998936,1.0,6/38,9.15%,TNNC1;TNNI3;DMD;MYBPC3;ACTN2;MYL6
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2459009160323067,-1.2452914812573317,0.024539877300613498,0.565795223062864,1.0,52/259,12.93%,FGD4;EHD4;MTSS1;ATP6V0D1;FGD6;RAB8B;NRP1;ACTR3;KIF3A;PTPN23;EMP1;PCM1;FXYD5;SDCBP;RILPL2;FAM161A;PIBF1;RAB1A;MKS1;RPGR;SCLT1;CDC14B;EXOC4;CPLANE1;GBF1;CEP250;ARL13B;S1PR2;ARHGEF6;TCTN1;SSX2IP;SPEF1;BBS7;FHDC1;ASAP1;CARMIL1;DNAH5;FGD1;TMEM231;KIF24;CEP164;WDPCP;SNAP29;CCDC28B;TMEM138;NOTCH1;SHTN1;FOXJ1;IFT52;EXOC8;PMP22;EMP2
prerank,male gonad development (GO:0008584),0.3887405960176149,1.2449386324371805,0.15323854660347552,0.8348986267711259,1.0,6/34,9.12%,WNT4;FGF9;SIX4;LRP2;AR;MEA1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3507765932053711,-1.244225249609662,0.12972972972972974,0.567434790491669,1.0,15/34,16.74%,NRP1;MAPKAPK2;GAB1;ERN1;FLT1;ANXA1;PIK3CA;SPRY2;EGR3;NOTCH1;SEMA6A;KDR;RAMP2;HSPB1;NUS1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.33536544516969313,-1.2441291479031744,0.11590296495956873,0.5666056659636862,1.0,7/41,3.44%,NEDD9;GAS6;STAP1;CASS4;LILRA5;FBXW7;PTPN1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4112236850408084,-1.2438904711272065,0.17401960784313725,0.5662417738705869,1.0,11/19,30.00%,IGF1;GIT1;ZC3H12A;FFAR1;PYDC1;CD33;FFAR4;MEFV;GSTP1;CPTP;TNFAIP3
prerank,mucosal immune response (GO:0002385),-0.45180705740942506,-1.2438590697257843,0.18446601941747573,0.5652734927461162,1.0,5/15,20.24%,RNASE3;RPL39;IFNLR1;CAMP;LTF
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.36932418497470537,-1.2435637103258572,0.1343669250645995,0.5649943826600519,1.0,8/30,10.22%,CD274;PIBF1;LILRA5;IRF4;NOD2;HSPD1;SYK;CD28
prerank,negative regulation of GTPase activity (GO:0034260),0.43030360351074004,1.243440917527246,0.18370883882149047,0.8389488163037544,1.0,12/22,23.16%,F11R;TMED2;DAB2IP;ARFGEF1;RCC2;SH3BP4;RRP1B;HRAS;WNK1;GMIP;RDX;GPSM1
prerank,Notch signaling pathway (GO:0007219),-0.3123906782443416,-1.2433267710068383,0.09281437125748503,0.5645370268015187,1.0,19/59,22.58%,RBPJ;ITCH;DTX3L;PSEN1;SNW1;STAT1;EP300;NOTCH1;APH1B;GMDS;BMP2;NOTCH4;ADAM17;DTX4;HEY2;HES1;NOTCH2;HEYL;KAT2B
prerank,mitochondrion transport along microtubule (GO:0047497),0.4927808801600473,1.243324471533505,0.1929530201342282,0.8371793588865534,1.0,8/13,26.15%,MAP1S;RHOT1;LRPPRC;SYBU;UXT;NEFL;SPAST;MAPT
prerank,defense response to tumor cell (GO:0002357),0.5184057435496444,1.243166506007669,0.22372881355932203,0.8356097994112514,1.0,3/10,8.89%,ABI3;DLEC1;PRDX2
prerank,positive regulation of lipid storage (GO:0010884),-0.4062528830038279,-1.2430859639172642,0.16795865633074936,0.5640612015376557,1.0,5/21,9.53%,PLIN2;MSR1;NFKB1;ZC3H12A;LPL
prerank,protein stabilization (GO:0050821),-0.26308499408096786,-1.242670043223274,0.054455445544554455,0.564107896758413,1.0,44/168,17.78%,STK3;FLOT2;HIP1;IGF1;RPL5;CCT6A;DVL3;STX12;FBXW7;TYROBP;TAF1;HIP1R;BAG4;VHL;SEC16A;RPS7;HSPD1;PDCD10;TBL1X;NAA16;BAG6;LAMP2;HYPK;EP300;USP9X;CCNH;TRIM44;CCT3;WDR81;ATF7IP;LAMP1;RAB21;NLK;GET1;TESC;MCM8;CHP1;PFN2;MUL1;NAPG;NOP53;DNLZ;WFS1;FLNA
prerank,negative regulation of defense response to virus (GO:0050687),-0.49182842844314056,-1.2423791669903146,0.2184873949579832,0.5638078859308133,1.0,5/10,29.63%,ITCH;MUL1;TRAF3IP1;RNF26;C1QBP
prerank,superoxide metabolic process (GO:0006801),-0.36311083805849387,-1.2423509602695126,0.164804469273743,0.5628447603853278,1.0,10/29,24.23%,CYBB;NRROS;ATP7A;SH3PXD2B;CYBA;CYB5R4;SOD3;TAFA4;NOXO1;NOX4
prerank,cellular response to alkaloid (GO:0071312),0.4575461887881235,1.2422902258556034,0.18874172185430463,0.8370918102395656,1.0,5/17,12.72%,CACNA1S;SLC8A1;CASP3;CASP7;CRHBP
prerank,DNA replication initiation (GO:0006270),-0.34476664147038477,-1.2422221200598926,0.15542521994134897,0.5621378658276287,1.0,16/37,26.29%,POLE4;TOPBP1;ORC5;CDC34;ORC2;RPA1;MCM2;ORC4;CDT1;PRIM2;MCM8;RPA2;POLE3;CDC45;PURA;POLE
prerank,inorganic ion transmembrane transport (GO:0098660),0.5124438239342947,1.242207764256633,0.21299638989169675,0.8351821596529965,1.0,4/12,14.40%,KCNJ8;PKD2;ASIC2;ABCC8
prerank,hydrogen peroxide metabolic process (GO:0042743),0.44596136541655707,1.242058251590444,0.18344155844155843,0.8335309378031189,1.0,5/19,13.92%,PRDX5;PRDX2;PXDN;PRDX4;ACOX1
prerank,protein polyubiquitination (GO:0000209),-0.24475919768491297,-1.2412629584931132,0.03164556962025317,0.5637485545255971,1.0,76/297,18.11%,SASH1;BCL2;ITCH;WWP1;HECTD2;PSMA6;UBE2D3;HERC6;KLHL20;FBXL17;UNKL;CUL3;ARIH1;PRPF19;TRIM14;UBE2K;PSMB2;DTX3L;FBXL14;FBXO30;FBXW7;SIAH2;RNF213;FBXL8;SMURF2;PSME2;TAF1;RNF216;UBE2Q1;RNF146;HECW1;PSMD11;CDC34;ARIH2;PSMC6;TRIM62;UBC;NHLRC3;PSMA3;FBXW4;BRCA1;RNF14;TTC3;LMO7;RNF6;UBE2L3;UBA52;CDC27;RC3H1;UBE2Q2;CTNNB1;BARD1;TRIP12;AKTIP;BIRC2;PELI1;UBE2E3;TRIM5;FBXO32;PSMD10;FBXO2;UBE2L6;PSMB5;TRIM71;RC3H2;MKRN1;TRAF1;MUL1;UBE2C;LONRF1;TRAF3IP2;TRIM3;DTL;PSMD5;RNF20;RNF144A
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.3514419350405406,-1.2407207454176619,0.16566265060240964,0.5641194480395427,1.0,10/35,16.18%,APOE;ADGRG6;PDE7B;CD36;AHR;ADCY1;IRAG1;RIMS2;PDE2A;MAPK7
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2711406675773291,-1.2402997401779725,0.07116104868913857,0.5642376812366825,1.0,23/121,12.50%,NEDD9;IL15;CD74;NRP1;GAS6;IGF1;CASS4;PARP14;CD44;PTPRC;TEC;PIBF1;LILRA5;PTPN1;IL6ST;LYN;CLEC6A;BANK1;GPRC5B;GHR;CSPG4;IGF2;PARP9
prerank,apoptotic cell clearance (GO:0043277),-0.36160043863142793,-1.240250502278058,0.1462140992167102,0.5633545840184402,1.0,13/30,27.84%,GAS6;RARA;TYROBP;THBS1;ANXA1;NR1H3;LRP1;ITGB3;ADGRB1;XKR7;RAC1;ALOX15;XKR9
prerank,establishment of mitotic spindle localization (GO:0040001),-0.36892717304872813,-1.2400684435264575,0.15591397849462366,0.5628440892487824,1.0,13/28,19.14%,KPNB1;CDK5RAP2;CENPA;NUSAP1;MAD2L1;ESPL1;SPDL1;NUMA1;UBXN2B;GJA1;NDC80;PLK1;PAFAH1B1
prerank,positive regulation of leukocyte migration (GO:0002687),0.4062909012998177,1.2399255461565226,0.168,0.8403647954596635,1.0,7/27,15.93%,PRSS56;THY1;NCKAP1L;IL6;ICAM1;MIA3;JAM3
prerank,acylglycerol biosynthetic process (GO:0046463),0.4260335471554181,1.2395786576143417,0.18032786885245902,0.8395608645698269,1.0,4/23,6.60%,ANG;DGAT2;AWAT2;PNPLA3
prerank,organic cation transport (GO:0015695),0.4376804765533318,1.2395447116738687,0.18823529411764706,0.8374503840311781,1.0,10/20,29.51%,SLC44A2;RALBP1;SLC22A4;SEC14L1;SLC22A18;SLC22A5;SLC25A26;PDZK1;SLC5A7;SLC25A29
prerank,negative regulation of immune response (GO:0050777),-0.2654864665896518,-1.2389852144912707,0.05240174672489083,0.5646417675589145,1.0,61/154,30.00%,FCGR2B;ITCH;CD163;CD300A;PRKACA;ADCY9;CCR2;PTGER4;SYK;LYN;FYN;ENPP3;PDCD1;HCK;ADCY5;VIPR1;ADCY6;RC3H1;ACOD1;ADCY1;ADCY3;NPSR1;LILRB1;PRKACB;RAMP2;CALCRL;GPR27;MYH9;MUL1;ADAM17;PTHLH;CD247;TRAF3IP1;COL3A1;NLRC3;TRIM21;SIRT2;VIPR2;RXFP2;PTH1R;CRH;CALCA;GLP1R;RAMP3;FCRLB;DHX58;SCTR;ADORA2A;VIP;ALOX15;RNF26;SPINK5;CREB1;GPR83;PTGDR;PTGIR;C1QBP;GPR15;RHBDF2;FGR;TNFAIP3
prerank,regulation of interferon-beta production (GO:0032648),-0.32327078316676766,-1.238801228769678,0.12569832402234637,0.564066567138738,1.0,14/46,17.45%,OAS2;IFIH1;TLR2;IRF7;TBK1;TLR7;RNF216;YY1;TLR8;OAS3;LILRB1;RELB;TLR4;POLR3G
prerank,histone deacetylation (GO:0016575),-0.3273276613842901,-1.238741435351021,0.12779552715654952,0.5631778510506568,1.0,15/43,22.85%,SIN3B;RCOR1;TBL1X;BRMS1;BRMS1L;HDAC2;RCOR3;HDAC1;MIDEAS;MSL3;ELK4;PER2;SIRT2;HDAC4;TBL1XR1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4030541558334264,-1.2382824429120458,0.16010498687664043,0.5633211157777244,1.0,8/20,17.73%,RBPJ;SMAD9;HIF1A;EP300;NOTCH1;BMP2;SESN2;SMAD4
prerank,negative regulation of MAPK cascade (GO:0043409),-0.28639030749496536,-1.2381651200911288,0.10921501706484642,0.5626113808720798,1.0,31/87,25.52%,APOE;CD300A;STK38;PTPRC;PTPN1;RANBP9;RPS6KA6;CAV1;LYN;IL1B;DAG1;SPRY2;FOXO1;SEMA6A;SPRY1;PSMD10;INPP5K;DUSP1;QARS1;SPRY4;PEBP1;TLR4;SMAD4;BMP7;TNIP1;GSTP1;DUSP3;TIMP3;DUSP7;FBLN1;PIK3R2
prerank,calcium ion transport (GO:0006816),0.31251380133016404,1.2380788158769709,0.12550066755674233,0.84153743889108,1.0,33/113,19.31%,ATP2A3;TRPC3;ATP2A2;CDH23;CACNB2;SLC24A5;NMUR1;CACNA1S;TRPM3;TRPM2;CCR1;PKD2;CACNA1G;SLC8A1;CACNG7;ATP2C1;TRPC6;PANX1;CACNA1D;PKD1;CACNA1B;KCNN4;SLC8A3;CACNA2D1;SLC24A3;CACNA1A;CACNG3;ANK2;CHRNA7;SELENOK;SLC24A4;TRPV6;CCL5
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.514153049539259,1.237337412401055,0.2229965156794425,0.8423567075897862,1.0,3/11,8.31%,SOX4;ZFPM2;BMP4
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.38635073166214484,-1.237138813478874,0.1859903381642512,0.5643270712066573,1.0,6/24,11.53%,ITGA4;MSN;NT5E;SYK;ITGAL;OLR1
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.2627304082208825,-1.2364056224742204,0.06842105263157895,0.5652165486602192,1.0,32/170,9.89%,APOE;NOVA2;IGF1;KIF16B;AFF1;CDK6;PTPRC;ZUP1;TRIM14;PEG3;MTMR2;AHR;PROX1;NFKBIZ;TRIM17;RASA1;TAPBP;MTMR4;PRDM9;ZFP64;HNRNPAB;LDLR;SLC8A2;RO60;HNRNPK;HIF1A;BMI1;PSEN1;KDM6A;HINFP;ZC3H12A;CTCF
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.29102794456424264,-1.2362101362918991,0.08304498269896193,0.5646978256578743,1.0,23/79,17.97%,FCGR2B;CD74;KIF3A;AP2A2;KIF23;KIF11;RAB7A;AP2B1;AP1S3;OSBPL1A;CTSL;RACGAP1;SEC23A;DNM2;DCTN4;CLTA;MFSD6;DYNC1LI2;KIF4A;CAPZB;FCER1G;DCTN2;RILP
prerank,regulation of oxidoreductase activity (GO:0051341),-0.45707571206987874,-1.2361774610519893,0.18028846153846154,0.5637541174883859,1.0,4/13,11.69%,ABL2;ATP7A;NOD2;SZT2
prerank,negative regulation of platelet activation (GO:0010544),0.45270679893113613,1.2361567886532125,0.18466898954703834,0.845048190482048,1.0,6/16,15.41%,ALOX12;THBD;SH2B3;PRKG1;PDGFB;SERPINE2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3756877125741421,1.2358606686331621,0.1544461778471139,0.8440697134107671,1.0,7/35,11.71%,HOXA5;ANKRD54;ZFPM1;LDB1;NCKAP1L;HSPA9;ACVR1B
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4036670976770267,1.2352064007104508,0.1779935275080906,0.8445270172160129,1.0,10/27,23.97%,SYT4;SYT13;SYT1;SYT6;DOC2B;RIMS1;SDF4;RIMS3;SYT11;SYT12
prerank,peptidyl-methionine modification (GO:0018206),0.4803797194443385,1.2350070114598626,0.17699115044247787,0.8431967721978361,1.0,4/12,21.27%,NAA30;METAP1D;NAA60;METAP2
prerank,regulation of protein targeting to membrane (GO:0090313),0.4022700242648831,1.234921352088608,0.18019480519480519,0.8414087506288274,1.0,14/28,27.57%,FIS1;PRNP;MYO1C;ITGB1BP1;GDI1;MTCL1;HRAS;MFF;ITGAM;PDZK1;ANK3;DMTN;KCNB1;CEMIP
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.2967016510360916,-1.2346619462871884,0.11147540983606558,0.5668165105419039,1.0,25/76,20.96%,SASH1;PTPN22;TLR2;BCL3;TLR7;LIMS1;CD14;UACA;NOD2;IL1B;ZC3H12A;EP300;TRIM44;C1QTNF3;CCN3;EGFR;AGER;TNF;TLR4;NR3C2;MMP8;PTP4A3;BMP7;NLRC3;TMSB4X
prerank,monosaccharide transmembrane transport (GO:0015749),0.46066252244319816,1.2346365009127274,0.20853858784893267,0.8403902515150742,1.0,3/16,6.69%,SLC50A1;SLC45A3;SLC2A2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.36829362208238103,-1.2344818367119461,0.17922077922077922,0.5662539621436414,1.0,12/27,24.65%,CHST11;XYLT1;CHST9;UGDH;CSPG4;CHST7;CHPF;XYLT2;PXYLP1;CHST12;CHSY3;CHST3
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5223098706459848,1.2344696204437926,0.20665499124343256,0.83890857215134,1.0,5/10,25.34%,ENPP2;LIPC;PLA2G15;PNPLA8;PLA2G4A
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.44536436194974,1.2343599754562273,0.21739130434782608,0.8371620167714124,1.0,5/18,16.91%,AGRN;GNA15;RGS10;GNA11;OPRM1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.4165862246079864,-1.2339139761274662,0.19554455445544555,0.566811836347602,1.0,6/16,10.80%,BCOR;DNMT1;BRCA1;SNW1;CTNNB1;PAXIP1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4986589200718432,1.233889572232715,0.2200328407224959,0.8369024039209654,1.0,5/11,19.92%,DONSON;TIMELESS;LIG3;SMARCAL1;FBXO5
prerank,lipoprotein transport (GO:0042953),-0.5067203853053952,-1.2338620993105713,0.2038369304556355,0.565934048892389,1.0,4/10,13.37%,PPARG;CD36;ZDHHC17;LRP1
prerank,apoptotic nuclear changes (GO:0030262),-0.38608688565397575,-1.2332144004299168,0.15,0.5665074316782575,1.0,7/24,14.78%,KPNB1;DNASE2;HMGB2;TOP2A;H1-0;ENDOG;DFFA
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4552098625346487,1.2328142948061898,0.20770519262981574,0.8369972654718967,1.0,4/15,9.77%,BLOC1S2;SNAPIN;AP3M1;AP3B2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4552098625346487,1.2328142948061898,0.20770519262981574,0.8369972654718967,1.0,4/15,9.77%,BLOC1S2;SNAPIN;AP3M1;AP3B2
prerank,protein sumoylation (GO:0016925),-0.31062888587862225,-1.232552600846463,0.10736196319018405,0.5672452894256724,1.0,12/49,11.40%,IFIH1;NSMCE2;RANBP2;EGR2;EYA1;NUP153;NDC1;UBA2;NUP43;NUP210;PIAS2;TRPM4
prerank,regulation of defense response to virus (GO:0050688),-0.4427383815313659,-1.232410766669826,0.16210045662100456,0.5665737425200834,1.0,7/14,30.00%,ITCH;RNF216;IFNLR1;TRAF3IP1;RNF26;C1QBP;TNFAIP3
prerank,regulation of cellular metabolic process (GO:0031323),0.3603004269711041,1.2322914108207452,0.14733542319749215,0.8369773949832156,1.0,15/45,16.35%,MKLN1;GNB3;BCO2;PPARA;CNDP1;NCOR2;EIF6;PRKN;TBC1D16;COQ7;AGPAT1;ABCA2;ACLY;SSH1;ACACB
prerank,respiratory tube development (GO:0030323),0.402802844646312,1.2317854129301549,0.1859706362153344,0.8369050245774532,1.0,6/28,10.73%,DNAAF1;FGF9;CCDC39;FGF7;BMP4;FGF2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.31419756776592234,1.2312772554709766,0.1278295605858855,0.8368289884077542,1.0,31/107,19.31%,ATP2A3;ATP13A4;ATP2A2;ATP1B1;SLC24A5;SLC39A4;TNNI3;ATP13A5;CCR1;SLC8A1;RMDN3;SLC39A8;ATP2C1;ATP2B3;SLC8A3;SLC24A3;DMPK;MT2A;ANK2;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;CHRNA7;SLC24A4;CCL15;CCL5
prerank,negative regulation of developmental process (GO:0051093),0.33887000929033995,1.231043644568071,0.15080527086383602,0.8356583635784324,1.0,15/69,11.53%,DCC;CST3;NEUROD2;NFIB;THY1;BMP4;RAPGEF3;FOXC1;VASH1;HEY1;TGFB1;TBX2;PRKN;KLF7;SFRP1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4973600746671859,-1.2306248534731146,0.22857142857142856,0.5703290983189399,1.0,5/10,22.58%,BAG6;EP300;KAT5;KAT7;KAT2B
prerank,embryonic eye morphogenesis (GO:0048048),0.5065493898235045,1.2306126512883724,0.2119205298013245,0.8353028004121273,1.0,6/11,24.90%,MFAP2;FBN2;TBX2;KDM2B;MFAP5;FBN1
prerank,membrane fusion (GO:0061025),-0.356328531413571,-1.230246454480028,0.13368983957219252,0.5702761836098919,1.0,12/33,19.28%,MYOF;RABEP1;SNAP23;DYSF;SNAP29;DNM2;GCA;UBXN2B;CHP1;NAPG;USO1;NAPA
prerank,DNA geometric change (GO:0032392),-0.37969554110309667,-1.230112234616646,0.17480719794344474,0.5696100360317777,1.0,8/24,15.21%,ASCC3;HMGB2;RTEL1;ZRANB3;NBN;ANXA1;HNRNPA2B1;MCM9
prerank,mitotic spindle organization (GO:0007052),-0.2602854641573496,-1.2300388120746792,0.041025641025641026,0.5688170642157697,1.0,51/153,23.72%,MECP2;KPNB1;BUB3;VCP;MIS12;PIBF1;KIF23;KIF11;PMF1;RANBP2;PTPA;PRC1;KIFC2;ZWILCH;CDCA8;STMN1;KIFC1;ABRAXAS1;CENPA;NUP43;MAPRE1;XPO1;BIRC5;MAD2L1;AHCTF1;BUB1;DYNC1LI2;BUB1B;KNTC1;SPDL1;KIF4A;INCENP;NDC80;PLK1;WDR62;NUF2;MZT1;DCTN2;FLNA;TPX2;ERCC6L;PAFAH1B1;ZWINT;MAP4;B9D2;RCC1;OFD1;NUP98;CCNB1;NDE1;SPC24
prerank,cyclooxygenase pathway (GO:0019371),0.5159437881700301,1.22996968556859,0.21367521367521367,0.8358181736802267,1.0,2/10,2.13%,PTGS1;PTGDS
prerank,peptide metabolic process (GO:0006518),-0.29478326866463095,-1.2293923232573396,0.07796610169491526,0.5695048988750927,1.0,17/75,13.90%,NLN;ANPEP;CPQ;CPD;PARL;GSTA3;CPE;CLN5;RHD;PSEN1;ERAP1;CPM;GSTZ1;SPPL3;LTA4H;GSTM1;GSTM5
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.450029903577048,1.2288325984745674,0.20349761526232116,0.83844632952271,1.0,6/17,19.85%,ATP1B1;GJC3;SLC8A1;GJA5;ATP1A3;ATP1A1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4816519273118391,-1.2287453712811574,0.20243902439024392,0.5703095032750488,1.0,3/11,13.98%,ATF3;CEBPB;CREB3L1
prerank,determination of bilateral symmetry (GO:0009855),-0.38592640526783395,-1.2280704797463167,0.19363395225464192,0.5710541884781769,1.0,14/24,35.84%,BBS7;DNAH5;ODAD2;NOTCH1;FOXJ1;ODAD3;NPHP3;GALNT11;KIF3B;DLL1;TBX1;DNAAF4;LEFTY1;PITX2
prerank,regulation of ossification (GO:0030278),-0.34265234251751897,-1.2280099901658912,0.12359550561797752,0.5702404793088942,1.0,18/36,31.16%,RBPJ;NBR1;SOX11;ANKH;NOTCH1;SMAD6;PTN;BMP2;WNT5A;LRP6;ACVR1;TWIST1;BMPR2;KREMEN2;NOTUM;LRP4;TGFB2;DDR2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4683277169549903,1.2279298265733631,0.2037351443123939,0.8401586124905482,1.0,4/14,15.04%,SLC45A3;PPARGC1A;IRS1;PTPN2
prerank,autophagy of peroxisome (GO:0030242),-0.4610718098378156,-1.227713770250438,0.20099255583126552,0.5701006327888191,1.0,4/12,2.33%,PIK3C3;MAP1LC3B;NBR1;PIK3R4
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.4748154731775479,-1.2272436978380377,0.20823798627002288,0.570323423378612,1.0,5/11,14.99%,PTPRC;AHR;CEACAM1;KLRD1;LILRB1
prerank,response to sterol (GO:0036314),0.49584697150325746,1.2269077528628036,0.22959183673469388,0.8422736765060495,1.0,5/11,20.58%,TGFBR1;TGFB1;ABCA2;RORA;SMAD2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.4620431814780901,-1.2267579755585225,0.2127659574468085,0.5706848508164261,1.0,5/14,10.77%,PXN;STAT5B;PTPN1;LYN;GHR
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.22898471316907923,-1.2267061839407505,0.0,0.5698090177016167,1.0,144/497,21.84%,RBPJ;MDFIC;NR3C1;WWP1;CD38;GAS6;MECP2;POU2F1;EPC1;SETDB2;SP3;LIMD1;ZHX2;HMGB2;CNOT9;KAT6B;PPARG;CIITA;CBFA2T3;MALSU1;SMARCA4;RARA;ENO1;SMURF2;PATZ1;BCL3;AHR;PROX1;LIMS1;SAMD4A;NAB1;PPARD;ATXN1;MBD2;RCOR1;CIART;BCL7A;DPF3;BCOR;PFDN5;KDM8;NR1H2;EIF4ENIF1;ID4;BRCA1;FOXE1;CRY2;DDX6;PDS5A;CAPRIN1;HINFP;SNW1;ID3;GCLC;MBD1;L3MBTL4;CTCF;BIRC5;ZBTB18;CTNNB1;FOXO1;PRMT2;ATF5;SPEN;NOTCH1;L3MBTL3;BRMS1;HDAC2;ID1;RCOR3;ZNF148;CRY1;DAPK1;ATF7IP;DEPDC1;EHMT1;KAT5;HDAC1;MIDEAS;PAIP2B;SYNCRIP;TYMS;RB1;LARP1;RACK1;GATAD2A;INPP5K;BMP2;FOXP2;CREB3L1;L3MBTL2;QARS1;FOXP1;ZNF318;RIOX1;THAP7;LHX1;DACH1;SHC1;TRIM71;TNF;KDM5C;KAT7;WNT5A;FOXK2;DEAF1;SAP18;IKZF1;FXR2;ARID5B;UIMC1;HEY2;SMAD4;GATA3;HMGA2;GLIS2;PER2;IGFBP5;NIBAN2;LANCL2;HES1;TFAP2B;PPM1F;CDKN2A;TAF7;EED;YEATS2;PA2G4;BMP7;NCOR1;HMGA1;BHLHE40;KLF4;SCMH1;RBAK;DHFR;BASP1;SIRT2;TRIM33;HDAC4;CPEB3;HEYL;ID2;PSPC1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.29185170548884287,-1.2264867856559383,0.10443037974683544,0.5693930293760187,1.0,17/74,10.46%,BCL2;IGF1;BCL2L1;BIRC6;MCL1;SIAH2;THBS1;PF4;FAS;RIPK1;BRCA1;IL1B;EYA1;BMP5;SH3RF1;EYA3;EYA2
prerank,thyroid hormone generation (GO:0006590),-0.5017930416578062,-1.226442701514248,0.2171837708830549,0.568510699488408,1.0,7/10,37.10%,CPQ;FOXE1;TG;SLC5A5;TPO;DUOX1;DIO2
prerank,endothelial cell proliferation (GO:0001935),0.4471552562316825,1.2260191139847996,0.19895287958115182,0.8438547371963145,1.0,5/17,12.97%,CD34;BMP4;ITGB1BP1;THAP1;TEK
prerank,positive regulation of protein secretion (GO:0050714),0.3332632041625111,1.2259734082424323,0.13314447592067988,0.8419434967705125,1.0,19/69,19.56%,FRMD4A;MYOM1;ANG;NNAT;SYTL4;SOX4;MYH10;DOC2B;APBB1;TCF7L2;ACHE;TGFB1;UNC13B;DNM1L;APBB3;IER3IP1;IL1A;GHRL;HCAR2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.49251926611046576,1.2253824291262934,0.20921985815602837,0.8423457721324672,1.0,4/12,14.58%,ADCY8;RFX6;CFTR;BAIAP3
prerank,regulation of gastrulation (GO:0010470),-0.44113054846060573,-1.224699911403639,0.20745920745920746,0.572068819103771,1.0,6/14,21.08%,PHLDB1;DAG1;RACK1;SCX;LHX1;POGLUT1
prerank,signal transduction by p53 class mediator (GO:0072331),0.393543867494145,1.2246357751313872,0.17080745341614906,0.8432871446128708,1.0,8/30,15.31%,FHIT;USP10;DDX5;STK11;MYO6;PPP1R13B;NDRG1;BATF
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.4573092920276841,-1.2236910737636668,0.1773049645390071,0.573745332434959,1.0,3/12,12.69%,CLSPN;TOPBP1;TICRR
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.39866752788848353,-1.2235294838535615,0.2033898305084746,0.573159404155815,1.0,9/20,23.64%,IGF1;LAMTOR5;H1-0;EP300;RB1;GATA3;NIBAN2;TWIST1;PAX6
prerank,sensory perception of pain (GO:0019233),-0.39823214906322557,-1.2233242990098476,0.19444444444444445,0.5727692508920811,1.0,8/21,24.58%,P2RX4;CCR2;KCNA2;ALOXE3;CHRNB2;OPRK1;CHRNA4;SCN9A
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.28185346943349965,1.2229285229738907,0.07446808510638298,0.84808849699583,1.0,86/241,26.08%,POLR2L;SRSF12;DHX35;RNPS1;SMU1;CWC15;PQBP1;SRSF5;FUS;DHX15;POLR2F;DDX5;TRA2B;BCAS2;HNRNPH1;CWC22;CASC3;XAB2;PPWD1;CTNNBL1;SF3B2;CWF19L2;PPIL1;ISY1;PRPF40B;SRRM2;SRSF6;SF3B6;PTBP1;SRSF11;RBM5;GTF2F1;CACTIN;DDX46;SNRNP70;SF3B5;SF3A1;SRSF1;SNRPD2;YTHDC1;CPSF3;GPKOW;POLR2G;LSM8;SF3B3;CRNKL1;IK;CSTF1;NUDT21;NOVA1;CDC40;DDX39B;HNRNPA1;GEMIN5;GEMIN6;SRSF9;ELAVL2;PUF60;UBL5;GCFC2;TRA2A;SNRPD3;SNRNP27;ALYREF;SRSF2;RBM10;USP49;POLR2C;LSM4;LSM3;SART1;SNRPB2;RBM15B;POLR2D;SNU13;WBP4;PRPF38A;PNN;ESS2;SRSF3;HNRNPH3;SF1;METTL14;DHX16;NONO;USP39
prerank,positive regulation of DNA binding (GO:0043388),-0.3579466390635675,-1.222654180925539,0.17307692307692307,0.5735270497313172,1.0,15/31,23.84%,IGF1;HMGB2;PPARG;CEBPG;PLAUR;TXN;H1-0;RB1;GATA3;NIBAN2;MMP8;HES1;SIRT2;TWIST1;EGF
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.4299342972119144,-1.2224844168629658,0.20698254364089774,0.5729863770015414,1.0,7/15,16.17%,FBXW7;LDLR;NR1H2;CTDNEP1;NR1H3;SIK1;MFSD2A
prerank,response to zinc ion (GO:0010043),0.4068206695558304,1.2224765327812182,0.2091917591125198,0.8479536903503917,1.0,12/25,18.07%,GLRA2;SLC30A3;KHK;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,protein K48-linked deubiquitination (GO:0071108),0.40968006628040127,1.2224352577840405,0.1938610662358643,0.8460559579666066,1.0,7/23,15.26%,OTUD7A;USP50;USP33;OTUB1;BAP1;OTUD7B;OTUD5
prerank,hemidesmosome assembly (GO:0031581),0.5125210072815811,1.2222239422174592,0.2375,0.8448709028765244,1.0,6/11,25.03%,DST;LAMB3;ITGA6;LAMC2;LAMC1;ITGB4
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4294207150474383,1.2221255595642042,0.22434782608695653,0.8432291522775912,1.0,5/18,11.12%,CACNG5;CACNG2;NRXN1;SHANK3;CACNG7
prerank,brain development (GO:0007420),0.30379411047982424,1.2220704132066953,0.1102257636122178,0.8413725254300887,1.0,30/136,16.00%,ZFHX3;ROGDI;PLXNB2;DNAJC30;BPTF;CTNNA2;NNAT;NFIB;ABCB6;PBX2;MAP1S;UBE3A;SHANK3;ADGRL3;GRIN1;CX3CR1;GRIN2B;DDIT4;CTNS;CXCR4;PBX3;PHF8;SPEF2;NDRG4;APOD;NKX2-2;HAP1;DSCAML1;IER3IP1;TUBGCP2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4344074538671158,1.2220652995732226,0.18971061093247588,0.8393374123324044,1.0,5/20,10.24%,GATM;FPGS;GSS;GGCT;PTDSS2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4280495718858993,1.2217199227524052,0.2,0.8386510893115166,1.0,7/19,10.73%,ZFPM2;MEF2C;TGFBR3;TGFBR1;ERBB4;TBX2;FGF2
prerank,regulation of postsynapse organization (GO:0099175),0.3953558329083309,1.2217097691867862,0.19001610305958133,0.8366421635274682,1.0,12/28,18.86%,ABI3;TANC2;ARHGAP44;SHANK3;SRCIN1;CDKL5;IL1RAPL1;CFL1;LZTS3;EPHA4;ARHGAP22;ABHD17C
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3970813322975619,1.2215340337186933,0.18137254901960784,0.8353168543327062,1.0,8/27,17.90%,YWHAE;CACNB4;CACNB2;DMD;ADRA2A;JPH1;HPCA;ANK2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3471661690272332,-1.2215192911338995,0.15846994535519127,0.5746075361867078,1.0,12/35,17.80%,CD300A;PPP6R1;PTPA;PPP6R3;PPP1R12A;BOD1;CRY2;CALM3;CALM2;PPP1R2;ITGA1;PPP1R15A
prerank,external encapsulating structure organization (GO:0045229),0.28359689789762654,1.221359962458602,0.09135802469135802,0.8339941484483295,1.0,55/205,19.79%,AGRN;COL5A1;MMP16;F11R;LAMB3;ACAN;COL2A1;ICAM5;ITGB6;JAM2;SPOCK2;ADAMTS20;SMOC2;ITGB5;MFAP2;FBN2;ADAMTSL1;ADAMTS15;APLP1;BSG;PXDN;ADAM15;ITGA10;COL4A5;ITGA5;FGF2;NPNT;SLC39A8;ICAM1;ADAM12;ADAMTS19;COL28A1;THSD4;VCAN;PDGFB;ADAMTS14;COL4A2;MMP1;VTN;HAPLN1;NDNF;TGM1;COL15A1;COL18A1;JAM3;ADAMTS4;LAMA1;ITGA6;POSTN;MMP17;ADAMTS3;DCN;MFAP5;COL4A4;ITGAD
prerank,innate immune response in mucosa (GO:0002227),-0.5027878575447884,-1.2208149522738627,0.26024096385542167,0.5754881725938391,1.0,4/10,20.24%,RNASE3;RPL39;CAMP;LTF
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.32047046558856207,-1.2204713432092449,0.1529745042492918,0.5754191150945146,1.0,16/46,17.72%,RBPJ;IL15;NOVA2;DOCK7;NRDC;NR1H2;PCTP;NOTCH1;ID1;ALDH1A1;NR1H3;RB1;TLR4;IL18R1;ADAM17;PGAM5
prerank,maturation of SSU-rRNA (GO:0030490),-0.3485118128067454,-1.2203854818412843,0.15877437325905291,0.5746986643804475,1.0,8/34,14.73%,UTP6;NOL11;RPS16;RPS14;DDX52;UTP4;TSR1;WDR3
prerank,phagosome maturation (GO:0090382),-0.34634262346061484,-1.2203645312236076,0.16966580976863754,0.5737753488885092,1.0,6/35,4.11%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;RAB7A;ATP6V0B
prerank,acute inflammatory response (GO:0002526),0.418502152503092,1.2203477721029898,0.20833333333333334,0.8360269151799358,1.0,3/23,5.65%,F3;MBL2;IL6
prerank,regulation of astrocyte differentiation (GO:0048710),0.4948460711494259,1.21999260541031,0.20640569395017794,0.8354331119717797,1.0,5/12,15.41%,BIN1;IL6;CLCF1;EPHA4;SERPINE2
prerank,regulation of defense response to virus by host (GO:0050691),-0.3587081527924453,-1.2199072554059913,0.16883116883116883,0.574052674715817,1.0,11/30,17.17%,PTPN22;DTX3L;RNF216;ZC3H12A;STAT1;TRIM44;PARP9;IFNLR1;LILRB1;MUL1;TRAF3IP2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3929920650357557,1.2196514731265555,0.16823899371069181,0.8348630844412748,1.0,14/30,25.24%,FHIT;GIPC1;SGTA;OGT;STYX;TAF9;CCAR2;UBXN1;HSP90AB1;TLK2;CAMLG;USP7;TRIM39;HFE
prerank,response to estrogen (GO:0043627),-0.3515624892190804,-1.2195828631573151,0.17539267015706805,0.5739267339537237,1.0,11/31,20.17%,TRIM25;RARA;ESR1;CAV1;CD24;BRCA1;EP300;KMT2D;GATA3;RBBP5;BCAS3
prerank,regulation of receptor internalization (GO:0002090),0.37812426045175307,1.2191810630891846,0.17701863354037267,0.8347718691611408,1.0,14/35,26.40%,MKLN1;RIN3;ANKRD13D;ATAD1;ARRB2;INSR;ATXN2;RSPO1;MAGI2;ARRB1;ARF1;CD63;SCYL2;DLG4
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4547187182937635,1.2188800920806937,0.20623916811091855,0.832099082894213,1.0,4/15,20.27%,NANOS1;ZFP36L2;TOB1;DHX36
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4547187182937635,1.2188800920806937,0.20623916811091855,0.832099082894213,1.0,4/15,20.27%,NANOS1;ZFP36L2;TOB1;DHX36
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.35016965896601226,-1.218535268058525,0.16414141414141414,0.5758875091071586,1.0,10/30,14.22%,DAB2;SMARCA4;RNF14;H3-3A;RNF6;EP300;PRMT2;PIAS2;HDAC1;FOXP1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.3951543817144376,-1.2184016447107395,0.18717948717948718,0.5752685682587189,1.0,3/21,3.17%,PEAK1;SLK;CORO1C
prerank,modulation of chemical synaptic transmission (GO:0050804),0.30959975747093577,1.2181552798867983,0.12108843537414966,0.8331468724538262,1.0,31/107,19.50%,DGKI;SLC4A8;CACNG5;NPTXR;SYT1;SLC12A2;LGI1;MEF2C;GRM3;NPTX1;TPRG1L;GRIK2;GRIK5;GRID2;CLSTN2;CX3CR1;NRG3;RIMS1;KCTD13;CPLX2;CACNA1B;DLGAP1;BAIAP3;SLC8A3;DGKZ;CACNA1A;DLGAP2;DLGAP3;CHRNA7;RIMS3;LRRC4C
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3798804984580717,1.2180102226170066,0.19938650306748465,0.8317868966831667,1.0,15/32,27.54%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;POLR1E;RRN3;MAPK3;POLR1F;POLR1G;GTF2H3;ERCC2;TAF1A;POLR1A;GTF2H1
prerank,protein K63-linked ubiquitination (GO:0070534),0.36164227063726045,1.2178942100320413,0.15458937198067632,0.8303265536868215,1.0,13/41,15.88%,UBE2B;UBE2V1;RNF126;UBE2G1;ZFP91;PRKN;PELI3;NEDD4;UBE2N;RNF168;RNF8;RNF135;RNF152
prerank,regulation of histone deacetylation (GO:0031063),0.4719117955969573,1.217400252462957,0.2224168126094571,0.8304399678610396,1.0,6/13,21.73%,CTBP1;AKAP8L;AKAP8;SAP30BP;ZBTB7B;ING2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.46275546469564616,-1.2170554081020195,0.20823244552058112,0.5767384127856005,1.0,7/12,20.56%,IGF1;CIB1;SPPL3;TNF;CAMTA1;CHP2;STIMATE
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.46275546469564616,-1.2170554081020195,0.20823244552058112,0.5767384127856005,1.0,7/12,20.56%,IGF1;CIB1;SPPL3;TNF;CAMTA1;CHP2;STIMATE
prerank,eye morphogenesis (GO:0048592),0.4391862630537862,1.2166002162066065,0.19543973941368079,0.8317820868412353,1.0,4/19,9.37%,COL5A1;MFAP2;FBN2;TENM3
prerank,regulation of axon extension (GO:0030516),0.37487857583883455,1.2165071933544038,0.17546583850931677,0.8301869365640256,1.0,9/37,13.98%,CTTN;DIP2B;SEMA7A;LIMK1;TWF2;CDKL5;MAG;NRCAM;MAP3K13
prerank,multivesicular body assembly (GO:0036258),-0.3565002624264088,-1.216174542464373,0.19106699751861042,0.5781547134283431,1.0,6/30,13.40%,VPS37C;CHMP4B;CHMP4A;PDCD6IP;CHMP1B;STAM
prerank,regulation of B cell differentiation (GO:0045577),0.4496711811642742,1.2160772940848232,0.20563847429519072,0.8299415674778136,1.0,7/17,17.88%,IL4I1;NCKAP1L;ZFP36L2;BTK;SFRP1;INHA;XBP1
prerank,ventricular septum morphogenesis (GO:0060412),0.39672053253809914,1.215158544066345,0.1986970684039088,0.8317495620937201,1.0,7/27,9.05%,ZFPM1;SOX4;ZFPM2;TGFBR3;TGFBR1;BMP4;HEY1
prerank,negative regulation of phosphorylation (GO:0042326),-0.28253709530472587,-1.2148961317388476,0.12131147540983607,0.5805290081788416,1.0,27/85,21.35%,PID1;STAP1;NIBAN1;XDH;GIT1;CBFA2T3;CORO1C;CRKL;LYN;CIB1;CDKN2C;ZC3H12A;DNAJC10;LRRK2;INPP5K;PRKRIP1;CHP1;LRP6;TRAF3IP1;MYADM;CDKN2A;IRS2;BMP7;HNRNPU;NCOR1;WARS1;HDAC4
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.44462543875598054,1.2148875666369787,0.1875,0.830936243996981,1.0,9/18,27.12%,ADRA2A;PRKN;IRS1;SFRP1;CRHBP;REST;MIDN;CHGA;KCNB1
prerank,detection of mechanical stimulus (GO:0050982),0.4383923453369085,1.2148344086920821,0.23130434782608697,0.8291883739451468,1.0,6/19,18.79%,LHFPL5;PKD1L1;PKD2;PKD1;PTK2;PKD2L2
prerank,protein N-linked glycosylation (GO:0006487),-0.29797122791479835,-1.2143623429756898,0.11419753086419752,0.5809913053427751,1.0,12/66,8.49%,TMEM165;RPN2;MPDU1;MAGT1;UGGT1;MGAT2;MCFD2;ALG12;ST6GAL1;MGAT4C;FUT8;ALG13
prerank,extracellular structure organization (GO:0043062),0.2816980246495186,1.2143088086239044,0.10442260442260443,0.8293596065935795,1.0,55/204,19.79%,AGRN;COL5A1;MMP16;F11R;LAMB3;ACAN;COL2A1;ICAM5;ITGB6;JAM2;SPOCK2;ADAMTS20;SMOC2;ITGB5;MFAP2;TGFBR1;FBN2;ADAMTSL1;ADAMTS15;APLP1;BSG;PXDN;ADAM15;ITGA10;COL4A5;ITGA5;FGF2;NPNT;SLC39A8;ICAM1;ADAM12;ADAMTS19;COL28A1;THSD4;VCAN;PDGFB;ADAMTS14;COL4A2;MMP1;VTN;HAPLN1;NDNF;COL15A1;COL18A1;JAM3;ADAMTS4;LAMA1;ITGA6;POSTN;MMP17;ADAMTS3;DCN;MFAP5;COL4A4;ITGAD
prerank,ribosome assembly (GO:0042255),-0.31718432188748635,-1.2142810015719268,0.11242603550295859,0.5802634340428487,1.0,16/47,22.19%,EIF2A;RPL5;DHX29;RPS14;RPS5;RPF2;RPL6;RPL10;RPL23A;MDN1;RPL3;NPM1;NOP53;EFL1;RPL11;RPS15
prerank,purine-containing compound catabolic process (GO:0072523),-0.4583760971651944,-1.2138716758260824,0.21359223300970873,0.5803962678544852,1.0,3/13,5.65%,GDA;XDH;NT5E
prerank,glycerolipid metabolic process (GO:0046486),0.5024105830076704,1.2133189116207816,0.24210526315789474,0.8313631549694537,1.0,5/11,20.34%,PNPLA3;DGKQ;GAL3ST1;DGKZ;PLA2G15
prerank,regulation of DNA binding (GO:0051101),-0.3219601245245814,-1.2131127251334088,0.16470588235294117,0.5813923000603067,1.0,9/44,8.19%,SP100;IGF1;HMGB2;PPARG;DOT1L;BCL3;CEBPG;PLAUR;TXN
prerank,ceramide transport (GO:0035627),-0.46089344434788004,-1.2128247602151307,0.25,0.581213600210941,1.0,8/12,28.68%,PSAP;PLEKHA3;PLTP;SGPP1;ABCA13;CERT1;CPTP;GLTP
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.23492493074977966,-1.2126006130300366,0.007692307692307693,0.5808529706760159,1.0,70/341,13.26%,PPP2R5C;ITCH;WWP1;VPS37C;PSMA6;RNF149;UBE2D3;KLHL20;PTPN23;BUB3;FBXL17;VCP;TRIM25;CUL3;ARIH1;CUL4A;UBE2K;UBA6;PSMB2;DTX3L;BIRC6;FBXL14;FBXW7;SIAH2;RNF213;OS9;SMURF2;PSME2;TAF1;RNF216;RNF146;HECW1;RMND5B;PSMD11;CDC34;UBL7;ARIH2;PSMC6;UBQLN1;RNF13;NHLRC3;TBL1X;ZNRF3;PSMA3;FBXW4;BAG6;KLHL15;RNF14;TTC3;RNF150;SPOPL;RNF6;UBE2L3;KCTD17;RAD23B;CDC27;USP9X;SPSB2;RC3H1;CTNNB1;TRIP12;WDR91;MAD2L1;BIRC2;WDR81;CBL;KAT5;PELI1;PSMD10;BUB1B
prerank,positive regulation of cellular component movement (GO:0051272),0.39622926094540695,1.212362432061918,0.19306930693069307,0.8333738823442752,1.0,4/24,7.62%,CCDC25;SPOCK2;STK11;TGFBR1
prerank,protein mannosylation (GO:0035268),0.4203155927597279,1.2123265572925914,0.22772277227722773,0.8315854129376037,1.0,6/22,10.08%,B4GAT1;TMTC4;DPY19L4;FKRP;DPY19L3;SDF2L1
prerank,protein localization to cell junction (GO:1902414),-0.38495232328903034,-1.2110540907508962,0.19651741293532338,0.5839692057159258,1.0,10/22,29.91%,KIF3A;CGNL1;ARHGEF18;NECTIN1;MPP4;NLGN2;DSP;TJP1;NPHS1;MARVELD3
prerank,tRNA processing (GO:0008033),0.3357545631998188,1.2110524034508379,0.17518248175182483,0.8348783033870831,1.0,13/61,10.21%,ZBTB8OS;TYW5;ADAT2;RPP40;TSEN54;ELP5;CTU1;DDX1;METTL1;ELAC2;ADAT1;DTWD2;FTSJ1
prerank,cellular response to interleukin-6 (GO:0071354),0.40263538392105813,1.2109966442601507,0.21775544388609716,0.8331873291596591,1.0,6/26,5.65%,SELPLG;CTR9;RELA;PTPRT;SOCS3;IL6
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4762803068223964,1.2107001730419908,0.23240589198036007,0.8325035640498301,1.0,8/14,30.58%,ATP1B1;ATP1B3;ACTN2;GAL;ANK2;LRRC55;ATP1B2;KCNIP2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.4647045107529655,-1.2105615856571625,0.20919540229885059,0.5842520423773596,1.0,2/11,3.17%,CD44;CORO1C
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2768026694195731,1.2103330441735511,0.0885478158205431,0.8320057147267218,1.0,91/264,26.08%,POLR2L;SRSF12;DHX35;RNPS1;SMU1;CWC15;PQBP1;SRSF5;FUS;DHX15;POLR2F;DDX5;TRA2B;BCAS2;HNRNPH1;CWC22;CASC3;XAB2;PPWD1;CTNNBL1;SF3B2;CWF19L2;PPIL1;ISY1;PRPF40B;SRRM2;SRSF6;SF3B6;PTBP1;DDX1;SRSF11;RBM5;GTF2F1;CACTIN;DDX46;SNRNP70;SF3B5;SF3A1;SNUPN;SRSF1;SNRPD2;YTHDC1;CPSF3;GPKOW;POLR2G;LSM8;SF3B3;CRNKL1;IK;CSTF1;NUDT21;NOVA1;CDC40;DDX39B;HNRNPA1;GEMIN5;GEMIN6;SRSF9;ELAVL2;PUF60;UBL5;GCFC2;TRA2A;SNRPD3;SNRNP27;ALYREF;SRSF2;RBM10;PRMT5;USP49;POLR2C;LSM4;LSM3;SART1;SNRPB2;RBM15B;POLR2D;SNU13;WBP4;PRPF38A;PNN;ESS2;COIL;CELF4;SRSF3;HNRNPH3;SF1;METTL14;DHX16;NONO;USP39
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4410911256326538,1.2098494248026366,0.2170418006430868,0.8320843101767214,1.0,5/16,11.06%,FOXD1;BMP4;PKD2;FGF2;NPNT
prerank,response to ionizing radiation (GO:0010212),-0.2896418440959834,-1.2097538994842112,0.14332247557003258,0.5854667080958434,1.0,28/70,25.73%,AEN;TOPBP1;USP28;ANXA1;BRCA1;EYA1;ABRAXAS1;EEF1D;EYA3;GRB2;RHNO1;PAXIP1;LIG4;BRAT1;KAT5;TICRR;SWI5;NHEJ1;UIMC1;BRCC3;ECT2;XRRA1;BABAM2;BRSK1;NET1;RAD51AP1;TRIM13;TNKS1BP1
prerank,protein localization to chromatin (GO:0071168),-0.4013781711390188,-1.2096902892097678,0.17473118279569894,0.5846716588832358,1.0,11/18,33.23%,PPHLN1;ESR1;RAD21;MCM9;MCM8;PLK1;TASOR;FAM47E;RUVBL2;WAPL;SGF29
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.45891120291737075,-1.2096832947657352,0.23130841121495327,0.5837250159999242,1.0,5/12,19.22%,PPARG;NR1H2;ABCG1;NR1H3;ITGB3
prerank,regulation of microglial cell activation (GO:1903978),-0.42156855865825954,-1.2093079844707455,0.21674876847290642,0.5837966667655811,1.0,3/15,6.67%,STAP1;PTPRC;LDLR
prerank,epiboly involved in wound healing (GO:0090505),-0.4219490824567851,-1.2090259430799448,0.20046620046620048,0.5835985512721802,1.0,7/16,17.78%,CD44;PDCD10;LCP1;CCN1;CEACAM1;CARMIL2;FLNA
prerank,multivesicular body organization (GO:0036257),-0.35187383592532906,-1.2089552996315949,0.17223650385604114,0.5828362138500014,1.0,6/31,13.40%,VPS37C;CHMP4B;CHMP4A;PDCD6IP;CHMP1B;STAM
prerank,regulation of response to external stimulus (GO:0032101),-0.26709362742092047,-1.2073588208997434,0.09019607843137255,0.5861327919286907,1.0,34/121,20.96%,FCGR2B;PSMA6;PTPN22;ALOX5;CELF1;P2RX4;CD36;ZBP1;CCR2;CAMKMT;STK24;USP18;NOD2;CAV1;ANXA1;HCK;ERAP1;FNTB;ADGRA2;BIRC2;SHPK;TRIM5;CD55;FOXP1;WNT5A;BST1;PDE6B;PDGFRA;ADAMTS12;PPEF1;MYD88;APPL2;CASP1;TMSB4X
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.44628309655247606,-1.2059253468432338,0.23056994818652848,0.5888556025683632,1.0,6/13,13.61%,CPSF1;NCBP1;FIP1L1;CPSF4;CSTF2;CPSF2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3065937557254719,-1.2057980118924874,0.15714285714285714,0.5882898230795036,1.0,10/52,9.26%,BCL2;UBE2D3;ATG13;FBXW7;TOMM7;SH3GLB1;PPP3R1;ARIH2;YWHAG;UBE2L3
prerank,bile acid biosynthetic process (GO:0006699),-0.3709038242482633,-1.2055018910027382,0.19230769230769232,0.5880948593985227,1.0,5/24,9.15%,ACOT8;OSBP;OSBPL9;OSBPL1A;OSBPL2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4304954134114579,1.2051856399354357,0.23214285714285715,0.8491662642394334,1.0,11/19,21.35%,RTN1;GGA3;BIN1;PRNP;CLU;HAP1;NTRK2;ROCK1;CHRNA7;PIN1;ABCA7
prerank,base conversion or substitution editing (GO:0016553),0.5015741990314362,1.204459523241624,0.2486865148861646,0.8501921449349354,1.0,3/11,6.35%,ADARB2;APOBEC2;ADAR
prerank,positive regulation of cell population proliferation (GO:0008284),-0.22650453098660225,-1.2042068631398948,0.009259259259259259,0.5907483101173289,1.0,91/423,15.62%,PID1;RBPJ;IL15;BCL2;CD74;GAS6;MECP2;ITGAX;ACER3;IGF1;PRKCH;GCNT2;CDK6;DPP4;PTPRC;SDCBP;NDUFS4;CUL3;CD47;LIFR;CAPN1;FAM98B;IL12RB2;MEIS1;RARA;FAM98A;NAMPT;CDCA7L;SOX11;IL6ST;DOT1L;KITLG;PROX1;S100A6;PIM1;PRC1;S1PR2;C5AR1;THBS1;TOX;BST2;CRKL;NOD2;PDGFD;FLT1;KIF20B;PDCD10;LYN;DHPS;YAP1;CIB1;GAB2;IL1B;FGF1;BMI1;HSF1;HCK;BMP5;VIPR1;KRAS;HPSE;PDGFC;STAT1;BIRC5;NOTCH1;TRPM4;CCN1;HDAC2;LIG4;IGF2;HDAC1;KDR;EMP2;CCND2;PTN;SLAMF1;SCX;GREM1;BMP2;HAS2;NPM1;KMT2D;FOXP1;CIAO1;EGFR;SHC1;TNF;PTK2B;GJA1;WNT5A;SLC25A33
prerank,positive regulation of neurogenesis (GO:0050769),0.32935536030226875,1.2036551482876119,0.17478510028653296,0.8514518639567349,1.0,14/68,11.22%,MAP6;FBXW8;PLXNB2;OBSL1;PTPRD;NUMB;LRP2;SHANK3;ARHGDIA;CDKL5;CX3CR1;IL1RAPL1;SS18L1;SMARCD3
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.49424364480797267,-1.2032355399900168,0.24780701754385964,0.5923845184202531,1.0,3/10,7.41%,ATP5MG;ATP5PO;ATP5MC1
prerank,axon guidance (GO:0007411),0.28120564901035394,1.2032256181448175,0.1067484662576687,0.8512852630719738,1.0,50/201,16.83%,SEMA7A;PLXNB2;DCC;CHN1;EFNA4;ROBO4;NFIB;SEMA6C;MYPN;CNTN2;PTPRO;GPC1;EFNB3;NRXN1;DOK4;DSCAM;PLCG1;LGI1;RYK;SEMA6B;SHANK3;SEMA3D;PRKCA;EPHA1;BSG;KLF7;EFNA1;RAP1GAP;FEZ2;SPTAN1;CXCR4;SEMA4F;USP33;EFNA3;ARHGAP35;SPTBN2;GFRA1;EVL;EPHA4;CYFIP1;SPTBN1;ENAH;EPHB2;DSCAML1;MAPK3;SEMA4B;SIAH1;SEMA3C;PTK2;LAMA1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.27378766201290705,-1.2030839425933075,0.10600706713780919,0.5918452777227033,1.0,29/101,16.53%,PTPN22;STAP1;CD274;AXL;PRKCE;CDC73;HMGB2;GIT1;NFKB1;ADAM9;CD14;PF4;NOD2;TNIP3;LYN;IL1B;HCK;ZC3H12A;VIM;ACOD1;TNFRSF1B;SHPK;NR1H3;LBP;LILRB1;TNF;WNT5A;TLR4;MAPK8
prerank,positive regulation of interferon-beta production (GO:0032728),-0.34458755051320167,-1.203077229825398,0.1875,0.5909126405622539,1.0,7/33,7.51%,OAS2;IFIH1;TLR2;IRF7;TBK1;TLR7;TLR8
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.28341015220946897,-1.203069120067481,0.1103448275862069,0.5890301050469335,1.0,22/78,17.97%,FCGR2B;CD74;KIF3A;AP2A2;KIF23;KIF11;RAB7A;AP2B1;AP1S3;OSBPL1A;CTSL;RACGAP1;SEC23A;DNM2;DCTN4;CLTA;DYNC1LI2;KIF4A;CAPZB;FCER1G;DCTN2;RILP
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.28341015220946897,-1.203069120067481,0.1103448275862069,0.5890301050469335,1.0,22/78,17.97%,FCGR2B;CD74;KIF3A;AP2A2;KIF23;KIF11;RAB7A;AP2B1;AP1S3;OSBPL1A;CTSL;RACGAP1;SEC23A;DNM2;DCTN4;CLTA;DYNC1LI2;KIF4A;CAPZB;FCER1G;DCTN2;RILP
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2527284813096918,-1.2029366287160062,0.06280193236714976,0.5884603875393103,1.0,52/166,19.73%,ZEB2;IGF1;UPF3A;NIBAN1;RPL5;ATP7A;P2RX4;CD36;PCNA;BCL3;SAMD4A;THBS1;SMAD3;SP1;BCAR3;LDLR;NR1H2;CTDNEP1;HIF1A;IL1B;LARP6;VIM;CD28;PIWIL2;IGF2;SORBS1;PLD1;PPP1R3E;NR1H3;NPM1;CDT1;NMD3;MID1IP1;ARPP19;ZCCHC4;EGFR;TNF;KAT7;CHP1;LARP4B;MFSD2A;FXR2;TLR4;UPF3B;KLF2;RGCC;HNRNPD;MMP8;IRS2;NAT10;RPL26;OPN3
prerank,protein modification by small protein conjugation (GO:0032446),-0.23049626354418157,-1.2028870134371241,0.016666666666666666,0.5876722021290434,1.0,79/361,13.71%,ITCH;VCPIP1;WWP1;UBE2D3;MSL2;KLHL20;FBXL17;VCP;CDC73;CUL3;TRIM7;IFIH1;ARIH1;NSMCE2;UBA5;PJA2;TRIM14;CUL4A;UBE2K;UBA6;DTX3L;PEX10;BIRC6;FBXW7;RNF213;RANBP2;OS9;PCNA;SMURF2;TRIM17;UHRF2;ATG7;HECW1;VHL;EGR2;CDC34;ARIH2;TRIM62;UBC;ZNRF3;HIF1A;BRCA1;EYA1;NUP153;NDC1;RNF14;CCDC22;LMO7;UBA2;NUP43;RNF6;RNF157;UBE2L3;UBA52;PEX13;NUP210;CDC27;USP9X;SPSB2;RNF220;UFC1;KLHL21;UBE2Q2;BARD1;TRIM44;PIAS2;TRPM4;DCUN1D1;RNF103;CBL;RRAGA;RNF38;ATG3;UBE2E3;TRIM5;FBXO32;RACK1;FBXO2;UCHL3
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.3075933253861271,-1.2027996481171255,0.15789473684210525,0.5869540456937797,1.0,18/56,17.83%,CHMP4B;KIF23;RASA1;SNX9;STMN1;CIT;RACGAP1;USP8;CENPA;NUSAP1;ESPL1;PDCD6IP;KIF4A;CKAP2;INCENP;PLK1;KIF20A;ECT2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.2633367584672016,-1.20235398432418,0.11284046692607004,0.587220903765707,1.0,47/128,23.79%,PPP2R2A;PCM1;FBXL17;ENSA;PPP1R12B;CDK5RAP2;PRKACA;FBXL8;BORA;TUBA4A;CEP250;PPP1R12A;KDM8;YWHAG;HAUS2;CEP164;MAPRE1;WEE1;CCNH;DNM2;CDK1;CCNA2;AJUBA;HAUS8;MNAT1;ARPP19;CDK14;CDC25A;OPTN;PLK1;DCTN2;ODF2;FBXL15;PAFAH1B1;NES;FBXL12;MELK;AKAP9;CDC25C;CEP78;CCNY;OFD1;TUBB4B;CCNB1;NDE1;BRSK1;MASTL
prerank,negative regulation of T cell differentiation (GO:0045581),0.5014601997760468,1.2018630246905568,0.22495606326889278,0.8548628326764498,1.0,6/10,28.92%,BMP4;ZC3H8;LAG3;GLI3;IRF1;MDK
prerank,lymphocyte proliferation (GO:0046651),-0.3839099072321386,-1.201772505154978,0.22055137844611528,0.5878103437095523,1.0,4/22,6.06%,BCL2;PTPRC;MSN;HSPD1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.38389791518959543,-1.2012525855172198,0.20380434782608695,0.588350227277562,1.0,9/22,21.75%,PROX1;TOX;LRRK2;TRIM71;NES;SHCBP1;PTPRZ1;APPL2;ID2
prerank,regulation of MAP kinase activity (GO:0043405),-0.27635150110745604,-1.201163236862809,0.11746987951807229,0.5876463788227668,1.0,25/92,15.24%,APOE;CD300A;STK38;PTPN1;NOD2;PDGFD;FLT1;PDCD10;CD24;LYN;IL1B;FGF1;PDGFC;ADAM8;SPRY2;LRRK2;PIK3R6;SPRY1;PIK3R5;INPP5K;DUSP1;CDK12;EGFR;TNF;SPRY4
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.31643429059655703,-1.2008148079368726,0.1416184971098266,0.5876468802724812,1.0,13/48,17.34%,GAS6;STAP1;PARP14;PTPRC;PPARG;STAT2;USP18;NR1H2;NLRC5;OAS3;NR1H3;MUL1;PYDC1
prerank,cytoplasmic translational initiation (GO:0002183),-0.40713969040636355,-1.2004215350160068,0.22277227722772278,0.5876818910380293,1.0,4/17,5.90%,EIF4B;DHX29;EIF2S2;EIF3I
prerank,positive regulation of myoblast differentiation (GO:0045663),0.44421098898170996,1.2004165878445898,0.24054982817869416,0.8586166095142646,1.0,7/16,27.68%,BOC;MEF2C;SMYD1;BTG1;RANBP3L;HIF1AN;PLCB1
prerank,epithelial cell morphogenesis (GO:0003382),-0.4057904035343301,-1.2000865552701678,0.21601941747572814,0.5875789658126076,1.0,3/17,4.18%,RILPL2;MET;CCDC88C
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.42152403434036123,1.2000743066851878,0.22240802675585283,0.8580849110794865,1.0,7/20,15.10%,YWHAE;ADRA2A;ACTN2;HECW2;NEDD4;STK39;NEDD4L
prerank,V(D)J recombination (GO:0033151),0.5019820346932935,1.1999160185464322,0.2288135593220339,0.8567984907544481,1.0,5/11,21.44%,DCAF1;LIG3;HMGB1;TCF3;XRCC4
prerank,regulation of programmed cell death (GO:0043067),-0.2535837739987346,-1.1996355263047007,0.08866995073891626,0.5878289849120725,1.0,38/161,17.63%,SLK;DDX42;HIP1;ACER3;RAF1;VCP;STEAP3;ACTN1;KANK2;LGALS1;BAX;NLRC4;BCL3;FAS;RIPK1;TMEM219;ANP32B;CTSB;TPT1;IKZF3;PIDD1;STAT1;BIRC5;BRMS1;BIRC2;DAPK1;LRRK2;HS1BP3;PMAIP1;DFFA;TNF;BCL2L11;TM7SF3;NUP62;BCAR1;NOP53;WFS1;TNFRSF25
prerank,phasic smooth muscle contraction (GO:0014821),-0.47876597648323593,-1.1992373325500263,0.23389021479713604,0.5879000371099213,1.0,7/10,37.77%,EDNRB;DRD2;HTR1D;EDN3;EDN2;EDN1;GDNF
prerank,protein localization to centrosome (GO:0071539),-0.4098875236810383,-1.1992161512169162,0.22646310432569974,0.5870320805841717,1.0,4/17,5.75%,PCM1;GOLGB1;PIBF1;CCDC14
prerank,positive regulation of protein deacetylation (GO:0090312),0.46228682290534207,1.1991495903493345,0.2508650519031142,0.8579291488816407,1.0,6/14,21.73%,CTBP1;AKAP8L;AKAP8;SAP30BP;ZBTB7B;ING2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4251765200673506,-1.1990224349497,0.22401847575057737,0.5866226680641607,1.0,5/16,6.59%,PARP14;PIBF1;BCL3;VHL;CAV1
prerank,organic hydroxy compound transport (GO:0015850),0.3672012026723869,1.1987972727462153,0.20367534456355282,0.857441390392175,1.0,10/36,18.81%,SLCO2B1;ABCC3;ABCG8;AKR1C1;SLC10A2;STARD5;RALBP1;ATP8B1;SLC10A1;GHRL
prerank,mitotic cell cycle phase transition (GO:0044772),-0.24383239988317235,-1.1986501995738086,0.05392156862745098,0.5867145089192687,1.0,70/203,23.79%,CHMP4B;EPS8;PPP2R2A;PCM1;FBXL17;CDK6;ENSA;PPP1R12B;CUL3;CDK5RAP2;CUL4A;TACC3;PRKACA;FBXL8;GPR132;BORA;TUBA4A;CEP250;PPP1R12A;CDC34;CCND1;KDM8;YWHAG;CDKN2C;HAUS2;HINFP;CEP164;MAPRE1;WEE1;CDC27;CCNH;DNM2;CDKN3;CDK1;CCNA2;AJUBA;HAUS8;CCND2;RB1;MNAT1;ARPP19;TRIM71;CDK14;CDC25A;OPTN;PLK1;UBE2C;DCTN2;ODF2;FBXL15;PAFAH1B1;CDKN2A;NES;FBXL12;ACVR1;CUL5;MELK;AKAP9;CDC25C;CEP78;CCNY;RCC1;OFD1;ANAPC7;TUBB4B;CCNB1;NDE1;BRSK1;MASTL;CTDP1
prerank,copper ion transport (GO:0006825),-0.4640358257029399,-1.1978901707823713,0.2631578947368421,0.5877532320570186,1.0,3/11,3.73%,STEAP3;ATP7A;SLC31A2
prerank,cilium movement (GO:0003341),0.3439712872092802,1.197532049451646,0.18701700154559506,0.860518760595915,1.0,12/47,15.88%,DNAAF1;ODAD4;CCDC39;ROPN1L;DNAH9;DNAI3;CFAP100;CAMSAP3;SPA17;SPEF2;DNAAF2;CFAP61
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4354726621158512,1.1974987191623903,0.2224168126094571,0.858735792468545,1.0,6/17,15.47%,THY1;SLA2;PRNP;PVRIG;PTPN2;DGKZ
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.45270489064413055,1.1970274277408028,0.25752508361204013,0.8588210995726933,1.0,4/15,12.26%,SELENOS;HSP90B1;HERPUD1;DERL1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.46423043650536633,-1.1969262030051433,0.2330316742081448,0.589412772932288,1.0,2/11,4.74%,NOVA2;RASA1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.37590485620087843,1.1968870021389668,0.20421393841166938,0.8575221690422701,1.0,5/32,9.09%,TRPC3;CAPN3;THY1;PLCG1;GRIN1
prerank,granulocyte differentiation (GO:0030851),-0.3994874427097728,-1.1963924528757741,0.22193877551020408,0.5898804850954195,1.0,4/18,10.19%,CBFA2T3;RARA;DEK;EP300
prerank,positive regulation of protein transport (GO:0051222),0.3242478615329505,1.1963407508217625,0.16594516594516595,0.857875120288081,1.0,19/67,18.61%,FRMD4A;MYOM1;ANG;SYTL4;TENM1;MYH10;APBB1;ACHE;OAZ1;TGFB1;PLK3;UNC13B;ATP2C1;DNM1L;APBB3;IER3IP1;B3GAT3;IL1A;RIPOR1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3890684682094795,1.1962541724582547,0.19575856443719414,0.8563035858994542,1.0,12/26,30.49%,ADCY8;RFX6;ADRA2A;CFTR;KLF7;BAIAP3;STXBP4;EPHA5;GPLD1;BRSK2;CDK16;LRP5
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.4848164414770869,-1.196233678508735,0.23094688221709006,0.5893763980197376,1.0,4/10,12.45%,PPARG;RARA;SNW1;RXRB
prerank,regulation of steroid biosynthetic process (GO:0050810),0.48927147000154025,1.1957711779655675,0.26595744680851063,0.8564004504643379,1.0,3/11,8.50%,WNT4;STAR;DGKQ
prerank,amino acid transport (GO:0006865),-0.30733238751261927,-1.1957080452842554,0.13538461538461538,0.5898596695928091,1.0,12/49,17.50%,SLC38A6;SLC1A5;SLC7A1;SLC43A2;SLC6A6;SLC7A11;SLC6A17;SLC25A47;SLC16A10;SLC7A6;SLC38A11;SLC3A2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.36785463560376414,1.1956465382431427,0.21525423728813559,0.854958719634437,1.0,13/34,19.41%,P2RY12;TNFAIP8L3;DAB2IP;TGFB1;FGF2;IRS1;PDGFB;TEK;PIK3IP1;PRKD1;PTK2;FLT3;PDGFRB
prerank,regulation of glucose import (GO:0046324),-0.34725164390578916,-1.1952974143170383,0.1875,0.5900620365189636,1.0,3/30,0.97%,PID1;OSBPL8;IGF1
prerank,positive regulation of type I interferon production (GO:0032481),-0.2882405993426796,-1.1951786755166909,0.11824324324324324,0.5894416658650781,1.0,21/73,14.18%,PTPN22;OAS2;IFIH1;TLR2;IRF7;ZBP1;TBK1;POLR2E;DHX33;TLR7;NFKB1;CD14;HSPD1;DDX41;TLR8;STAT1;EP300;CTNNB1;OAS3;LRRFIP1;POLR2H
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2934996319287515,-1.1951084674741286,0.16233766233766234,0.5887324839195,1.0,22/65,24.01%,HIP1;CNOT9;HIP1R;BCAR3;ARAP1;PLAUR;EPS15;SPRY2;GRB2;CBL;CEACAM1;SPRY1;STAM;EGFR;ITGA1;NUP62;PDE6H;AFAP1L2;TGFA;WDR54;EGF;DUSP3
prerank,hexose transmembrane transport (GO:0008645),0.4229173350827965,1.1945371778051483,0.22617124394184168,0.8574511452328452,1.0,5/21,13.03%,SLC2A3;SLC50A1;SLC45A3;SLC2A2;SLC45A1
prerank,cardiac muscle tissue development (GO:0048738),0.3415166851607665,1.1944085570379226,0.19161676646706588,0.8560652209336924,1.0,10/50,12.51%,ZFPM1;KDM6B;BMP4;HEY1;CACNA1G;TBX2;SGCZ;GJA5;SGCG;AKAP13
prerank,Fc receptor signaling pathway (GO:0038093),-0.26467584916089526,-1.1942122248197002,0.0970464135021097,0.5902229400741472,1.0,30/110,18.00%,VAV3;MAP3K1;PSMA6;TEC;PSMB2;PSME2;GRAP2;NFKB1;PPP3R1;PSMD11;SYK;PSMC6;LYN;GAB2;PRKCQ;PSMA3;TAB1;PIK3CA;LCP2;GRB2;PPP3CA;PSMD10;FOS;SHC1;PSMB5;FCER1G;MAPK8;MAP2K4;MAP2K7;PSMD5
prerank,cellular response to insulin stimulus (GO:0032869),-0.2631671030257531,-1.1937650202009589,0.11297071129707113,0.5904487375222598,1.0,36/124,22.58%,ATP6V0D1;MYO5A;RAB8B;ATP6V0D2;DENND4C;PPARG;ATP6V1B2;ATP6V0A1;NAMPT;ATP6V0B;GAB1;SLC27A4;BCAR3;GOT1;AP3S1;RAB15;RAB10;GRB2;FOXO1;IGF2;SORBS1;CEACAM1;ATP6V1A;INPP5K;SHC1;SLC25A33;BCAR1;CPEB2;RAB31;IRS2;ATP6V0A4;ZDHHC7;INSIG1;ATP6V1G2;CAPN10;KAT2B
prerank,axonogenesis (GO:0007409),0.27536346913691023,1.193037518511057,0.08737864077669903,0.8595349376223437,1.0,59/237,16.83%,SEMA7A;DCC;RAB3A;CTNNA2;EFNA4;PARD6B;ROBO4;SEMA6C;MYPN;ATL1;CNTN2;PTPRO;GPC1;EFNB3;NRXN1;DOK4;DSCAM;PLCG1;LGI1;MAP1S;RYK;RAB8A;SEMA6B;SHANK3;APBB1;SEMA3D;PRKCA;EPHA1;BSG;KLF7;EFNA1;RAP1GAP;FEZ2;SPTAN1;CXCR4;SLITRK4;SEMA4F;USP33;EFNA3;ARHGAP35;NRCAM;SPTBN2;GFRA1;EVL;EPHA4;CYFIP1;SPTBN1;ENAH;EPHB2;DSCAML1;SPG11;WNT7A;MAPK3;SEMA4B;SIAH1;SEMA3C;PLPPR4;PTK2;LAMA1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.38185836302274334,-1.193006959667361,0.2367758186397985,0.5915874883171625,1.0,8/21,18.30%,IGF1;MEF2D;ERN1;LDLRAP1;DNMT1;HTR1B;GJA1;IGFBP5
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4047447572448665,1.1926522411658191,0.23128119800332778,0.8591991106695384,1.0,12/24,27.57%,FIS1;PRNP;MYO1C;ITGB1BP1;MTCL1;HRAS;MFF;ITGAM;PDZK1;ANK3;KCNB1;CEMIP
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.49653372070978385,1.1925048668200389,0.24561403508771928,0.8579573624902644,1.0,4/10,19.01%,PDE3B;SNAI2;JAM3;WNK1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.21284171444792796,-1.192464910065548,0.0,0.5921565103999247,1.0,239/807,22.97%,ZEB2;DAB2;RBPJ;TRPS1;MDFIC;SP100;FNIP2;NR3C1;WWP1;CD38;GAS6;UBE2D3;MECP2;POU2F1;EPC1;GATAD2B;SETDB2;MITF;SP3;IRF2BP2;TGIF1;SDCBP;LIMD1;CDC73;ZHX2;ATF3;HMGB2;KAT6B;SIN3B;RUNX3;PPARG;CIITA;PEG3;CBFA2T3;ETV6;IRF7;KANK2;TFEC;MNT;SMARCA4;RARA;ERF;ENO1;SOX11;SMURF2;N4BP2L2;RPS14;PATZ1;BCL3;ESR1;AHR;PROX1;LIMS1;NFKB1;ETV5;NAB1;TAF1;ZNF8;LCOR;YY1;VHL;PPARD;ATXN1;MBD2;SMAD3;RCOR1;CIART;BCL7A;CEBPB;DPF3;CCND1;CAV1;BCOR;PFDN5;KDM8;NR1H2;WWOX;YAP1;UBC;TBL1X;ID4;ZMYM5;BRCA1;FOXE1;BMI1;EDNRB;PSEN1;HSF1;RPL10;CRY2;HINFP;LIN37;SNW1;UBA52;ID3;H1-0;GCLC;ORC2;MAD2L2;MBD1;MZF1;L3MBTL4;CTCF;STAT1;EP300;NFIC;FOXP4;BIRC5;ZBTB18;USP9X;CTNNB1;FOXO1;PRMT2;ATF5;SPEN;NOTCH1;L3MBTL3;BRMS1;BRMS1L;HDAC2;ID1;CUX2;RCOR3;ZNF148;IGF2;CRY1;ZBTB5;FOXJ1;ATF7IP;DEPDC1;EHMT1;FHL2;PARP9;KAT5;FRK;HDAC1;MIDEAS;CBX8;PSMD10;NR1H3;LRRFIP1;RB1;GATAD2A;E2F8;INPP5K;BMP2;MOSPD1;FOXP2;CREB3L1;L3MBTL2;QARS1;FOXP1;IRF2;ELK4;ZNF318;RIOX1;THAP7;NOTCH4;LHX1;DACH1;SHC1;TNF;KDM5C;KAT7;WNT5A;ZBTB2;FOXK2;DEAF1;SAP18;DDX20;E2F7;IKZF1;PDE2A;PLK1;KLF11;ARID5B;NOP53;UIMC1;KLF2;DNAJB1;HEY2;SATB1;WFS1;NUPR2;SMAD4;NRIP1;FLNA;GATA3;HMGA2;HIVEP1;GLIS2;PER2;NIBAN2;MCPH1;LANCL2;HES1;TFAP2B;TRIM37;MYT1L;PPM1F;CDKN2A;TAF7;EED;MXI1;YEATS2;PA2G4;BMP7;HNRNPU;NCOR1;HMGA1;BHLHE40;EPO;KLF4;SCMH1;RBAK;BASP1;SIRT2;TRIM33;ZFP90;HDAC4;PTCH1;CPEB3;HEYL;ID2;PSPC1;RREB1;SEMA4D;ISL1;MECOM;NR1H4;SHH;TWIST1;HOXD9;AASS;ILF3;NDUFA13;TBL1XR1;TFAP2C;ZNF3
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4244188018601055,-1.1924354980988547,0.24757281553398058,0.5913145985165483,1.0,9/15,27.18%,CD36;DHX33;TLR4;PYDC1;MYD88;NLRC3;MEFV;EIF2AK2;CPTP
prerank,epithelium development (GO:0060429),0.3025634806467009,1.192368555904579,0.14504881450488144,0.8565994810381674,1.0,19/107,13.32%,FGF10;WNT4;CD34;AKR1C1;CDHR2;SOX10;MEOX2;WNT3;VDAC1;TIMELESS;ALDOC;PKD2;TGFB1;TBX2;SNAI2;UPK1B;PPP2R3A;PKD1;NDRG4
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.39393327079554663,-1.1922804993086586,0.24427480916030533,0.5908118704419216,1.0,3/19,5.92%,CD74;RIPOR2;MOSPD2
prerank,vasodilation (GO:0042311),0.4628399636523186,1.1917524332081681,0.24874791318864775,0.8571790575702852,1.0,1/13,0.54%,KCNMA1
prerank,cellular response to oxygen levels (GO:0071453),-0.4764937499074867,-1.191686393296246,0.25721153846153844,0.59146922469658,1.0,3/10,12.83%,ATP6V0D1;CPEB4;ATP6V1A
prerank,glycerol metabolic process (GO:0006071),-0.48526017193713755,-1.1916233042577298,0.2463768115942029,0.5907051824230165,1.0,4/10,14.07%,GOT1;COQ3;GK;GK5
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4225645681287081,-1.191481364135499,0.23703703703703705,0.590178638278971,1.0,4/15,8.20%,APOE;LDLR;PFDN5;PSEN1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.45492908012437344,1.1909496763113903,0.2504201680672269,0.8586082118013488,1.0,4/14,13.32%,TRIB1;MEF2C;PRKG1;NDRG4
prerank,aorta morphogenesis (GO:0035909),-0.4054208593235433,-1.1907183250032314,0.24532710280373832,0.5912474504121875,1.0,7/17,19.19%,RBPJ;PROX1;EFEMP2;LRP1;HEY2;TFAP2B;MYLK
prerank,bicellular tight junction assembly (GO:0070830),0.34535405560940746,1.1903450550501893,0.17996870109546165,0.8592115698135723,1.0,6/46,6.81%,F11R;CLDN16;PARD6B;MARVELD2;PARD6G;PRKCI
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3689902339128166,1.1900219814447497,0.2071097372488408,0.8586194592741033,1.0,16/36,25.24%,FHIT;GIPC1;PSMF1;OGT;TAF9;CCAR2;UBXN1;PRKCG;ALAD;HSP90AB1;TLK2;CAMLG;OPHN1;USP7;TRIM39;HFE
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.42865241978136837,-1.189994399660955,0.2366412213740458,0.5922134168627244,1.0,5/15,9.47%,VCP;ATF3;GSTO2;HSF1;ZC3H12A
prerank,neutrophil activation (GO:0042119),-0.4490281270365991,-1.189899804572918,0.24817518248175183,0.5915709732724472,1.0,3/12,6.17%,IL15;TYROBP;SYK
prerank,negative regulation of wound healing (GO:0061045),0.38808098659677537,1.189771768236004,0.21510673234811165,0.8577301950798739,1.0,9/28,15.95%,ADTRP;CD34;SLC12A2;CLASP2;THBD;FGF2;VTN;SERPINE2;PHLDB2
prerank,metal ion transport (GO:0030001),0.31327724137997864,1.1897084208823512,0.1820689655172414,0.856155396427839,1.0,26/86,19.86%,ATP2A3;TRPC3;CDH23;NMUR1;CACNA1S;LRP2;TRPM2;CCR1;PKD2;SLC8A1;CACNG7;SLC39A8;ATP2C1;PANX1;CACNA1D;CACNA1B;KCNN4;SLC8A3;CACNA2D1;CACNA1A;CACNG3;CHRNA7;SELENOK;TRPV6;CCL5;CNNM4
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.39710649864371567,-1.1897055018580451,0.228643216080402,0.5911869671311164,1.0,10/20,22.88%,C3AR1;P2RX4;NT5E;TXNIP;IL1B;TXN;ENTPD5;CASP1;APP;MEFV
prerank,autophagy of nucleus (GO:0044804),-0.40496127223725825,-1.188782947721846,0.2315270935960591,0.5928384336442947,1.0,5/16,16.23%,ATG13;ATG7;ATG2B;ATG3;ATG9B
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.43762746337957015,1.1875499773766345,0.23168654173764908,0.8630828583249986,1.0,7/18,11.60%,NAPB;GRIA2;GRIK2;GRIK5;GRID2;UNC13B;SLC1A4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.45289097842502013,-1.1874433256277774,0.28169014084507044,0.5955365959414428,1.0,7/12,20.54%,CD74;LPL;OAS3;FOXP1;TNF;TLR4;KLF4
prerank,positive regulation of actin nucleation (GO:0051127),0.48036581039448456,1.186849364795007,0.2513274336283186,0.8641513983381729,1.0,5/11,17.93%,NCKAP1;FCHSD2;WASF3;CYFIP1;WASF2
prerank,T cell differentiation (GO:0030217),-0.3187802826684213,-1.1868171695544876,0.1897018970189702,0.596214914666673,1.0,17/40,22.46%,PTPN22;PTPRC;ANXA1;LFNG;CD28;LCK;LIG4;TCF7;NHEJ1;FCER1G;ADAM17;ZAP70;GATA3;PIK3CD;SHH;GPR89B;GPR89A
prerank,regulation of insulin secretion (GO:0050796),0.3067766260544595,1.186772098995415,0.1644021739130435,0.8626233528996664,1.0,26/101,19.31%,SNAP25;ITPR2;KCNA5;NNAT;SOX4;IL6;RFX6;SLC2A2;DOC2B;ADRA2A;TCF7L2;RAPGEF3;PRKCA;PRKN;CACNA2D2;IRS1;SFRP1;ITPR3;CACNA1D;ABCC8;REST;CACNA1A;STXBP4;MTNR1B;GHRL;CCL5
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.39077227201747794,-1.1864869107903344,0.22982885085574573,0.5962661822135502,1.0,5/20,6.28%,DAB2;PID1;BCL2L1;PPP2R5A;PICALM
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4554462249277489,-1.1862237988348563,0.2457831325301205,0.5961345935681714,1.0,3/12,6.87%,APOE;LDLR;PFDN5
prerank,receptor signaling pathway via STAT (GO:0097696),-0.36196371080014234,-1.186210402555751,0.1994750656167979,0.5952613973216725,1.0,8/25,10.77%,IFNAR1;STAT5B;STAT4;CCR2;IFNAR2;STAT2;STAT1;GHR
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2983414715261642,1.1859427303638381,0.17871759890859482,0.864241152827204,1.0,30/113,17.95%,FGF10;F3;ANG;FGF9;PTPRN;FLT4;FGF7;SRSF6;AREG;TGFBR1;EGFL7;NME1;BMP4;TCF7L2;PRKCA;PRKD2;FGF2;PDCD6;SFRP1;PDGFB;VASH2;TEK;TGM1;HPN;WNT7A;PRKD1;HRAS;STXBP4;XBP1;AKT3
prerank,7-methylguanosine RNA capping (GO:0009452),0.38421359152942586,1.1858969771474057,0.20440251572327045,0.8607636783735315,1.0,8/31,12.29%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;GTF2F1;POLR2G;RAMAC
prerank,7-methylguanosine mRNA capping (GO:0006370),0.38421359152942586,1.1858969771474057,0.20440251572327045,0.8607636783735315,1.0,8/31,12.29%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;GTF2F1;POLR2G;RAMAC
prerank,endodermal cell fate commitment (GO:0001711),0.5097846468504903,1.1853137045603888,0.23498233215547704,0.8612615353494089,1.0,2/10,1.94%,CTR9;RTF1
prerank,negative regulation of metabolic process (GO:0009892),-0.2953840671165214,-1.184872384622489,0.18028169014084508,0.5979172092585459,1.0,18/54,17.72%,RBPJ;IL15;NOVA2;DOCK7;NRDC;NR1H2;IL1B;PCTP;NOTCH1;ID1;APOC1;ALDH1A1;NR1H3;RB1;TLR4;IL18R1;ADAM17;PGAM5
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.37941665858943247,1.184578386757223,0.21303656597774245,0.8623602790194776,1.0,8/31,9.35%,TNNC1;TNNI3;LRP2;MYBPC3;ZFPM2;TGFBR3;TGFBR1;TGFB1
prerank,lipid phosphorylation (GO:0046834),0.49326801470712417,1.1842762865107404,0.2495511669658887,0.8617271657832084,1.0,5/10,20.69%,DGKI;DGKQ;DGKZ;DGKE;DGKH
prerank,receptor internalization (GO:0031623),-0.31474838183882564,-1.1841351084788272,0.17757009345794392,0.5990589278283619,1.0,16/44,17.41%,CD36;SNX1;LDLRAP1;SYK;TFRC;PICALM;CAV1;GRB2;DNM2;CEACAM1;LRP1;LILRB1;RAMP2;CALCRL;FCER1G;RAB31
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.47640744734565915,1.1833038761608399,0.23454545454545456,0.8637367228320848,1.0,5/12,16.05%,FGF9;MEF2C;PRKG1;PDGFB;DOCK4
prerank,regulation of interleukin-2 production (GO:0032663),0.350040633820791,1.183279151789644,0.21879815100154082,0.8620370367416366,1.0,11/43,14.31%,CD80;CD34;IL17F;CD86;PRNP;NAV3;PNP;PRKD2;HOMER2;MAP3K7;SPTBN1
prerank,negative regulation of immune system process (GO:0002683),-0.4149610684971172,-1.183247264065209,0.24528301886792453,0.6005543131629925,1.0,8/16,28.01%,FCGR2B;LYN;PDCD1;HMOX1;COL3A1;FADD;FCRLB;SPINK5
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.43003587069705634,1.1822846422770668,0.2621035058430718,0.8642236941971904,1.0,5/17,15.39%,SELENOS;HSP90B1;HERPUD1;DERL1;HM13
prerank,regulation of cell adhesion (GO:0030155),0.2915393750411771,1.1814646761788863,0.1447721179624665,0.8656220761653528,1.0,34/129,19.75%,ZFHX3;FRMD5;PLXNB2;ARHGDIG;SIPA1;PKP4;DSCAM;PIK3CG;PDE3B;ADAM22;ARHGDIA;PRKCA;PRKD2;ITGB1BP1;EFNA1;STX3;ZDHHC2;MINK1;CXCR4;EPHA4;FLCN;CBLL1;EPHB2;RSU1;MIA3;KIF14;PTK2;ROCK1;PPP2R1A;IL18;FES;PLXNB1;CCL5;EPB41L4B
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2630328933783619,-1.1810112389031056,0.13135593220338984,0.6055985529573427,1.0,30/109,18.00%,VAV3;MAP3K1;PSMA6;TEC;PSMB2;PSME2;GRAP2;NFKB1;PPP3R1;PSMD11;SYK;PSMC6;LYN;GAB2;PRKCQ;PSMA3;TAB1;PIK3CA;LCP2;GRB2;PPP3CA;PSMD10;FOS;SHC1;PSMB5;FCER1G;MAPK8;MAP2K4;MAP2K7;PSMD5
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.38874500709237414,1.1809268665790609,0.23176661264181522,0.8661534392707372,1.0,9/24,16.53%,SEMA7A;SEMA6C;MEGF8;DSCAM;SEMA6B;SEMA3D;SEMA4F;SEMA4B;SEMA3C
prerank,amyloid fibril formation (GO:1990000),-0.30739871324883444,-1.180495699266753,0.18028169014084508,0.6060340031028216,1.0,20/51,23.38%,TGFBI;ITM2B;CD36;SIAH2;RIPK1;GGA2;UBC;H3-3A;UBA52;USP9X;TSPAN5;APH1B;B2M;UBE2L6;GSN;MFGE8;LTF;SERF1A;APP;CALCA
prerank,epithelial cell-cell adhesion (GO:0090136),0.4866635518421024,1.180259247540984,0.2550091074681239,0.8669543372271128,1.0,3/11,10.47%,PLEKHA7;ITGB5;CAMSAP3
prerank,regulation of Golgi organization (GO:1903358),-0.40222238037256064,-1.1801166047329559,0.21204819277108433,0.6061675093284457,1.0,8/17,20.30%,MYO5A;STX5;PDCD10;USP6NL;RBSN;RAB33B;STX18;AKAP9
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.39380779855468984,1.1799331267095037,0.2479740680713128,0.8664679117494934,1.0,4/25,1.74%,B3GNT9;B4GAT1;B3GNT6;B3GALT2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.36356424962863887,-1.1797767727903115,0.226775956284153,0.6062073134551517,1.0,11/26,25.07%,FLOT2;TLR2;IRF7;CD36;BIRC2;GPR108;APPL2;TLR5;SMPDL3B;TLR9;APPL1
prerank,glycoprotein metabolic process (GO:0009100),-0.3055699577004943,-1.1792791118676291,0.17543859649122806,0.6066399137331692,1.0,12/53,14.94%,B4GALT5;ERP44;MAN2A1;GANAB;ST8SIA6;FUT8;HIF1A;ST8SIA4;HPSE;PRKCSH;FBXO2;ST8SIA2
prerank,histone H3-K4 methylation (GO:0051568),-0.3494072650833584,-1.1791436160629691,0.20149253731343283,0.6060843344764678,1.0,14/26,25.77%,TET2;PRDM9;WDR82;KMT2C;KDM6A;PAXIP1;TET3;DPY30;KMT2D;RBBP5;KMT2B;SETD1A;KMT2A;DYDC2
prerank,cellular response to sterol (GO:0036315),-0.4190086711423582,-1.1785483385026987,0.25235849056603776,0.6067399784086863,1.0,8/13,31.15%,GRAMD1C;GRAMD1B;LRP6;MLC1;INSIG1;PTCH1;RORC;INSIG2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3142272244834638,1.1784954620222003,0.18876080691642652,0.8702416351188468,1.0,26/72,26.13%,FGF10;POLR2L;FGF16;FGF9;POLR2F;KLB;HNRNPH1;FGF7;PTBP1;GTF2F1;FGF2;POLR2G;RBFOX2;HNRNPA1;MAPK3;SETX;CEP57;TIA1;POLR2C;FLRT2;POLR2D;ESRP1;MAPK1;FRS3;FLRT3;GALNT3
prerank,regulation of vacuole organization (GO:0044088),0.4166154561711478,1.1782639241641364,0.23267326732673269,0.8693014241372818,1.0,7/20,20.72%,IFT20;RAB1B;RAB5A;IFT88;UBQLN2;SCARB2;ENO3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.39876976843263506,1.1777360552749074,0.23310810810810811,0.8695957050930008,1.0,10/25,22.17%,LDB1;HTATSF1;EAF2;CCNK;ERCC6;DDX39B;CCAR2;THOC5;ALYREF;SCAF8
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.36283058945755275,-1.1776823659326074,0.21105527638190955,0.6082223919764099,1.0,7/23,16.41%,GAS6;CD274;AXL;RARA;ZC3H12A;LILRB1;TLR4
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4604994696753224,1.1776253447940639,0.2568306010928962,0.8682135122418501,1.0,3/13,9.35%,PRICKLE1;BMP4;TGFB1
prerank,tight junction assembly (GO:0120192),0.3350056825564681,1.1772417702602935,0.20588235294117646,0.8679542337742049,1.0,6/49,6.81%,F11R;CLDN16;PARD6B;MARVELD2;PARD6G;PRKCI
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.41835881056352225,1.1771502652308052,0.2465986394557823,0.8665907321716293,1.0,8/20,25.82%,DGAT2;CBR4;PPT2;FITM2;ACLY;ACSL3;SLC25A1;FASN
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.3288016743298371,-1.177119991367002,0.19889502762430938,0.6088407197450858,1.0,7/38,6.59%,NEDD9;GAS6;CASS4;PTPRC;LILRA5;PTPN1;CAV1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3766032669406929,1.177021786732849,0.21870047543581617,0.8653873808133783,1.0,13/30,27.54%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;POLR1E;POLR1F;POLR1G;GTF2H3;ERCC2;TAF1A;POLR1A;GTF2H1
prerank,heme biosynthetic process (GO:0006783),0.41330991715532617,1.176975552189256,0.24869565217391304,0.8638209326348437,1.0,10/22,25.44%,ABCB6;FLVCR1;TSPO;PGRMC1;UROD;ALAD;ABCG2;SLC25A38;COX10;CPOX
prerank,vitamin D metabolic process (GO:0042359),0.4683960333767382,1.176655117891596,0.29180887372013653,0.8633337367534384,1.0,2/13,6.71%,LRP2;LGMN
prerank,regulation of mitotic nuclear division (GO:0007088),-0.2980870271504364,-1.1763896789805346,0.16379310344827586,0.6098351713297894,1.0,21/55,23.84%,IGF1;CDK5RAP2;MKI67;BORA;KIF20B;IL1B;NUSAP1;CD28;IGF2;DUSP1;NUP62;CUL9;RGCC;NME6;DRD3;BMP7;CDC25C;TGFA;RCC1;CCNB1;EGF
prerank,regulation of mRNA metabolic process (GO:1903311),-0.46202180784730296,-1.1760085301958818,0.2723112128146453,0.6099193402127223,1.0,2/11,4.75%,NCBP1;SLTM
prerank,cortical actin cytoskeleton organization (GO:0030866),0.42170650474374494,1.1757820704236963,0.23578595317725753,0.8650379479249429,1.0,10/20,27.54%,NCKAP1;NCKAP1L;FMNL3;FMNL1;RHOQ;ROCK1;LLGL2;FHOD1;LLGL1;RAB13
prerank,regulation of synapse assembly (GO:0051963),0.3461105965124373,1.1757033782355648,0.20763358778625954,0.8636158865214562,1.0,14/46,18.81%,LHFPL4;PTPRD;SRPX2;IL1RAP;NRXN1;MEF2C;GRID2;CLSTN2;IL1RAPL1;GPC4;EPHB2;WNT7A;IL1RAPL2;GHRL
prerank,positive regulation of neuron projection development (GO:0010976),0.3053894092938887,1.175192756287834,0.1782312925170068,0.8638381971206136,1.0,32/85,23.80%,PLXNB2;NTRK1;ARSB;STMN2;PLA2G3;NTRK3;PTK7;PRKCI;GPC2;RIT2;DAB2IP;TWF2;TENM3;ARHGAP35;NDRG4;NDNF;STYXL1;NTRK2;PRKD1;TWF1;SETX;ITGA6;SCARB2;FES;MAGI2;ROR1;DHX36;SCN1B;ZDHHC15;CAMK2B;SERPINI1;BDNF
prerank,neuromuscular synaptic transmission (GO:0007274),0.42912298153481176,1.1751681278817738,0.2568659127625202,0.8621936254783876,1.0,4/18,9.33%,TSPOAP1;ERC2;FCHSD2;CHAT
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4618196772531995,-1.1751503282528304,0.2413793103448276,0.611374307266682,1.0,3/11,6.64%,ARL6IP5;STK24;PDCD10
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.44108935110224545,-1.174442094736148,0.2528216704288939,0.6123426321503629,1.0,5/13,19.49%,MET;TXN;LRRK2;RACK1;GPR37
prerank,positive regulation of nuclear division (GO:0051785),-0.3647963480178432,-1.1743982616049642,0.1994949494949495,0.6115373832334711,1.0,11/25,23.84%,IGF1;IL1B;NUSAP1;CD28;IGF2;NUP62;RGCC;DRD3;SIRT2;TGFA;EGF
prerank,negative regulation of protein kinase activity (GO:0006469),0.3039424659885361,1.1743068903783442,0.20516499282639886,0.8637863971116663,1.0,16/88,10.22%,TSC2;PPM1E;WWTR1;THY1;PTPRT;PTPRO;TRIB1;ADAR;TRIB2;UBASH3B;DAB2IP;SRCIN1;EPHA1;MVP;SLC8A1;ITGB1BP1
prerank,negative regulation of T cell activation (GO:0050868),-0.32649085464014627,-1.174239757990645,0.2046783625730994,0.6110877233411445,1.0,6/35,6.21%,FCGR2B;PTPN22;CD274;RIPOR2;DLG5;CEBPB
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4001925505213437,-1.1741300264982633,0.2611764705882353,0.6104879338867825,1.0,3/17,2.80%,PID1;GIT1;CBFA2T3
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.2680003860621361,-1.1731848103250904,0.12408759124087591,0.6121025568178693,1.0,26/95,16.53%,FCGR2B;STAP1;CD274;AXL;CDC73;TLR2;HMGB2;GIT1;NFKB1;ADAM9;CD14;PF4;NOD2;TNIP3;IL1B;ZC3H12A;VIM;ACOD1;TNFRSF1B;SHPK;NR1H3;LBP;LILRB1;WNT5A;TLR4;MAPK8
prerank,inorganic cation transmembrane transport (GO:0098662),0.2704064292083439,1.1728748922506964,0.13116726835138387,0.8676257776080858,1.0,67/268,23.15%,HCN1;SLC4A8;ATP2A3;KCNK12;TRPC3;ATP2A2;KCNH2;KCND2;KCNA5;ATP1B1;SLC24A5;SCNN1A;KCNE2;SLC39A4;KCNJ8;TRPM3;KCNH7;KCNC1;SLC12A2;TRPM2;KCNK3;ATP1B3;SLC9A4;PKD2;CACNA1G;SLC8A1;ASIC1;ASIC2;KCNK6;SLC1A3;SLC39A8;ATP2C1;TRPC6;CACNA1D;SLC30A3;PKD1;KCNN4;SLC9A5;SCN2A;SLC6A1;ABCC8;ATP6V0E1;SLC8A3;HPN;KCNC3;SLC24A3;CACNA1A;KCNN3;ASIC3;SLC39A3;KCNK9;KCNQ4;SLC24A4;TRPV6;KCNK2;ATP1A4;ATP1A3;ATP1A1;ABCB7;SLC6A9;SCN1B;SCN3B;KCNN2;SCN8A;RYR3;SLC6A7;SLC9A1
prerank,sphingoid biosynthetic process (GO:0046520),-0.4683906854242047,-1.1728490681878163,0.25301204819277107,0.611198897144983,1.0,5/11,20.33%,ACER3;ASAH2;SPHK2;SPTLC2;SPTLC3
prerank,sphingosine biosynthetic process (GO:0046512),-0.4683906854242047,-1.1728490681878163,0.25301204819277107,0.611198897144983,1.0,5/11,20.33%,ACER3;ASAH2;SPHK2;SPTLC2;SPTLC3
prerank,blood vessel morphogenesis (GO:0048514),-0.3040727933705555,-1.1728341806710363,0.1871345029239766,0.6103508368875848,1.0,21/54,23.52%,RBPJ;NRP1;CCBE1;PROX1;RASA1;FLT1;SYK;AGGF1;CAV1;LOX;ID1;KDR;HAS2;CDH2;RAMP2;HEY2;HES1;SERPINF2;SHH;APLNR;CYP1B1
prerank,regulation of muscle contraction (GO:0006937),-0.35867535957193963,-1.1728033864318526,0.22074468085106383,0.6095527194969027,1.0,4/26,6.59%,PPP1R12B;ENO1;CHRM2;CAV1
prerank,heart process (GO:0003015),0.4568670962068958,1.172645061169355,0.26288659793814434,0.8668231290260423,1.0,5/14,16.67%,TNNI3;SGCZ;SGCG;PPCS;SGCD
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3436111379973167,-1.172491359942015,0.2268041237113402,0.609499654635622,1.0,9/30,13.19%,CD74;BCL2L1;CD44;RTEL1;DYRK1A;YJU2;TPT1;PTTG1IP;PSMD10
prerank,positive regulation of neutrophil migration (GO:1902624),-0.39391771076553667,-1.1716405133137047,0.2416452442159383,0.6109261173077123,1.0,4/18,10.17%,CD74;RIPOR2;MOSPD2;ADAM8
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2735970207648412,-1.1712693752233172,0.14705882352941177,0.6109815185333758,1.0,23/88,16.37%,APOE;RIC1;DNAJC1;CNOT9;MALSU1;NFKB1;SAMD4A;CLN8;EIF4ENIF1;EDNRB;BAG6;DDX6;CAPRIN1;DAPK1;PAIP2B;SYNCRIP;TYMS;LARP1;RACK1;RGP1;TRIM71;CLN3;FXR2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.304400892630345,1.1704312273602246,0.1829608938547486,0.8736378040524743,1.0,31/87,26.13%,FGF10;POLR2L;FGF16;FGF9;POLR2F;KLB;HNRNPH1;FGF7;PTBP1;GTF2F1;ZFP36L2;ITGB1BP1;FGF2;SFRP1;POLR2G;RBFOX2;NDNF;HNRNPA1;MAPK3;SETX;CCL5;CEP57;TIA1;POLR2C;FLRT2;POLR2D;ESRP1;MAPK1;FRS3;FLRT3;GALNT3
prerank,response to unfolded protein (GO:0006986),-0.3041077054507284,-1.1701401477536002,0.20588235294117646,0.6132317055763578,1.0,18/48,19.87%,ERP44;HSPA4;PTPN1;BAX;ERN1;HSPD1;HSF1;PACRG;TOR1B;HSPB3;HSPB1;HSPB8;TM7SF3;OPTN;DNAJB5;DNAJB1;HSPA13;HSPA1B
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3449154054215172,-1.170046084868162,0.2222222222222222,0.6125530270712873,1.0,8/29,15.15%,PPP2R1B;THBS1;RIPK1;CAV1;WWOX;RET;PMAIP1;TNF
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.39829358641536494,1.1697823477630467,0.2687296416938111,0.8744863091587758,1.0,10/22,18.40%,RELA;CLU;LRRTM3;EFNA1;CASP3;EFNA3;EPHA4;ABCA2;IFNGR1;CHRNA7
prerank,ethanol metabolic process (GO:0006067),-0.4424453829311852,-1.1695090965106578,0.26018099547511314,0.6130431764228899,1.0,4/12,22.42%,ACSS2;ALDH1A1;ALDH2;ALDH1B1
prerank,positive regulation of reproductive process (GO:2000243),-0.33680572386013463,-1.169070156419381,0.2231404958677686,0.6132949600457784,1.0,14/31,34.52%,SMURF2;PRDM9;PGAM4;AGO2;HYAL3;SIRT2;TAC4;VIP;GLRA1;INHBB;C1QBP;SYDE1;PDE3A;PLA2G10
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.2769293015060916,-1.1689431556145404,0.16382252559726962,0.6127090687202601,1.0,23/86,20.01%,ZEB2;DAB2;RBPJ;SDCBP;SOX11;THBS1;BMP5;SNW1;EP300;NOTCH1;CCN1;RBPMS;BMP2;NUMA1;BMP3;ADAM17;HIPK2;SMAD4;FBXL15;ACVR1;ACVR2A;GDF3;BMP7
prerank,response to lipopolysaccharide (GO:0032496),-0.25176020265405497,-1.1688638989354105,0.13793103448275862,0.6120174607122582,1.0,35/138,17.07%,IFNAR1;PTPN22;STAP1;CD274;AXL;NOCT;CDC73;HMGB2;GIT1;MAPKAPK2;NFKB1;ADAM9;CD14;PF4;NOD2;TNIP3;IL1B;ZC3H12A;VIM;ACOD1;MAPKAPK3;SMAD6;TNFRSF1B;SLC11A1;SHPK;PELI1;NR1H3;FOXP1;LBP;LILRB1;WNT5A;LIAS;TLR4;MAPK8;ADAM17
prerank,regulation of cholesterol esterification (GO:0010872),-0.47174974554387866,-1.168561039988526,0.2682926829268293,0.6120044465195634,1.0,3/10,12.97%,APOE;ABCG1;APOC1
prerank,snRNA processing (GO:0016180),0.4346645563596959,1.1676426590660078,0.25950413223140495,0.8813230112515102,1.0,6/16,20.65%,INTS6L;INTS10;INTS8;INTS5;INTS9;INTS11
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.47662960882036587,1.167381669076937,0.26750448833034113,0.8805810838980215,1.0,3/11,9.35%,TGFBR3;TGFBR1;TGFB1
prerank,peptidyl-arginine modification (GO:0018195),-0.4070798170389879,-1.1662280414908561,0.26303317535545023,0.6173012148698408,1.0,2/15,6.12%,NDUFAF5;PADI4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.417539677501251,1.1660677831446298,0.2521150592216582,0.8840580737139181,1.0,6/18,11.13%,SELPLG;ADD2;JAM2;PODXL2;CX3CR1;SLC39A8
prerank,sensory perception of light stimulus (GO:0050953),0.3062276790162586,1.164969641853767,0.19099590723055934,0.886722891436514,1.0,10/87,8.46%,GUCY2F;WHRN;ROM1;RDH10;CDH23;COL2A1;CRYGN;CNGB1;CRYBA4;CABP1
prerank,regulation of cartilage development (GO:0061035),-0.3908789750289146,-1.1647450634363925,0.26119402985074625,0.6205393695399037,1.0,5/18,17.38%,TRPS1;SOX6;SCX;BMP2;PTHLH
prerank,methylguanosine-cap decapping (GO:0110156),0.4937732522027762,1.1646125850463056,0.27629233511586454,0.8864612059912176,1.0,2/10,5.33%,PATL1;LSM1
prerank,regulation of cell development (GO:0060284),-0.32680275066258047,-1.164068543291237,0.2236842105263158,0.621510267409506,1.0,13/36,21.64%,HMGB2;DOCK7;YAP1;IL1B;CTNNB1;FOXO1;ADGRA2;HEY2;PER2;HES1;BHLHE40;NOTCH2;HEYL
prerank,cellular response to estrogen stimulus (GO:0071391),0.45047382667898656,1.1636905390712697,0.25585284280936454,0.8883139631172402,1.0,4/14,12.72%,WBP2;AR;SFRP1;CRHBP
prerank,phosphate ion transport (GO:0006817),0.44065830609979983,1.1636120243907164,0.24668874172185432,0.8868837202515509,1.0,6/16,25.30%,SLC37A4;SLC20A1;SLC37A1;SLC25A10;XPR1;SLC37A3
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.281678648531786,-1.1634284192826805,0.17667844522968199,0.6224473787022852,1.0,14/71,10.41%,PSMA6;CHMP4B;FBXL17;VCP;YME1L1;PRPF19;CAPN2;CTSL;UBC;CTSB;BAG6;UBA52;CLPP;USP9X
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2460014785459787,-1.1629057303149637,0.09387755102040816,0.6229830033230689,1.0,27/159,9.33%,HIP1;PXN;CHMP4B;CHMP4A;MIS12;OTUD6B;HSPA4;EIF4B;PSMG1;FCHO2;NCK1;HIP1R;SMAD3;PSMD11;HSPD1;TBCA;PICALM;SNX9;EPS15;UVRAG;TESPA1;NUP153;HSF1;NDC1;CENPA;TBCEL;CCDC40
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.3345279054109114,-1.1626961477360251,0.1994535519125683,0.6226471336679664,1.0,10/31,17.63%,RAB1A;FBXW7;CDC14B;BMI1;UBE2L3;DCUN1D1;MAGEC2;PLK1;UBE2C;ARRDC4
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3990178329388119,-1.1617272941853471,0.2692307692307692,0.6244435222276913,1.0,4/18,9.95%,APOE;VPS35;MSN;PTTG1IP
prerank,protein ubiquitination (GO:0016567),-0.21870041217130304,-1.1616244543678196,0.06060606060606061,0.6238096547701062,1.0,111/471,16.57%,SASH1;BCL2;ITCH;VCPIP1;WWP1;HECTD2;PSMA6;UBE2D3;MSL2;HERC6;KLHL20;FBXL17;VCP;UNKL;TRIM25;CDC73;CUL3;TRIM7;ARIH1;PRPF19;PJA2;TRIM14;CUL4A;UBE2K;UBA6;PSMB2;DTX3L;PEX10;BIRC6;FBXL14;FBXO30;FBXW7;SIAH2;RNF213;OBI1;FBXL8;OS9;PCNA;SMURF2;PSME2;TRIM17;UHRF2;TAF1;UBE2Q1;RNF146;HECW1;VHL;PSMD11;CDC34;ARIH2;PSMC6;TRIM62;RNF13;UBC;NHLRC3;ZNRF3;HIF1A;PSMA3;FBXW4;BRCA1;RNF14;CCDC22;LMO7;RNF6;RNF157;UBE2L3;UBA52;SH3RF1;PEX13;CDC27;USP9X;SPSB2;RNF220;RC3H1;KLHL21;UBE2Q2;CTNNB1;KBTBD8;BARD1;TRIM44;TRIP12;AKTIP;BIRC2;RNF103;CBL;RRAGA;RNF38;ATG3;PELI1;UBE2E3;TRIM5;FBXO32;PSMD10;RACK1;FBXO2;UCHL3;UBE2L6;PSMB5;TRIM71;RC3H2;KLHL41;WAC;OTULIN;MKRN1;PLK1;MUL1;UBE2C;LONRF1;ASB4;USP5;CUL9
prerank,cellular response to amyloid-beta (GO:1904646),-0.3196010861984758,-1.1614665315284376,0.19786096256684493,0.6233835628204794,1.0,10/35,16.41%,ITGA4;FCGR2B;IGF1;CD36;FYN;PSEN1;LRP1;AGER;GJA1;TLR4
prerank,regulation of interleukin-13 production (GO:0032656),-0.4438292214692537,-1.161424536637518,0.2548076923076923,0.6226068844641197,1.0,7/13,26.45%,LILRA5;RARA;IRF4;SPHK2;GATA3;LEF1;TSLP
prerank,cellular response to lipid (GO:0071396),-0.23984845456900086,-1.1613116524887004,0.0797872340425532,0.6220262805266282,1.0,50/191,17.76%,PID1;NR3C1;STAP1;CD274;AXL;ABL2;BRINP1;CDC73;HMGB2;GIT1;ESR1;AHR;NFKB1;ADAM9;CD14;MSN;LCOR;PF4;NOD2;TNIP3;LYN;IL1B;ADCY5;RET;UBE2L3;SNW1;ZC3H12A;LPL;ADCY6;VIM;ACOD1;ADCY1;TNFRSF1B;KAT5;SHPK;ADCY3;NR1H3;SPHK2;TESC;LBP;EGFR;LILRB1;PTK2B;WNT5A;FAM210B;TLR4;MAPK8;ADNP2;MAP4K1;NRIP1
prerank,positive regulation of chemokine production (GO:0032722),-0.31262924735000724,-1.1607163990764857,0.21529745042492918,0.6226664827302588,1.0,14/44,17.07%,CD74;TLR2;TLR7;SYK;HIF1A;IL1B;LPL;OAS3;AGER;TNF;WNT5A;TLR4;HMOX1;ADAM17
prerank,extracellular matrix organization (GO:0030198),0.2638737641021299,1.1606375651703962,0.1346153846153846,0.8973270592182917,1.0,75/276,21.54%,P3H2;AGRN;PLOD3;P4HA3;COL5A1;DST;MMP16;PPIB;F11R;LAMB3;ACAN;COL2A1;ICAM5;ITGB6;JAM2;SPOCK2;ADAMTS20;SMOC2;ITGB5;MFAP2;TGFBR1;SERPINH1;FBN2;TGFB1;ADAMTSL1;ADAMTS15;APLP1;BSG;CAPNS1;PXDN;ADAM15;ITGA10;COL4A5;ITGA5;FGF2;NPNT;SLC39A8;ICAM1;ADAM12;ADAMTS19;COL28A1;THSD4;VCAN;PDGFB;ADAMTS14;COL4A2;MMP1;VTN;HAPLN1;NDNF;KLK2;COL15A1;COL18A1;JAM3;PLOD1;ADAMTS4;LAMA1;ITGA6;POSTN;TMPRSS6;MMP17;QSOX1;ADAMTS3;P4HA2;DCN;CTSK;MFAP5;COL4A4;ITGAD;CAPG;ITGAM;KIF9;LAMC2;COL6A1;CTSS
prerank,cardiac muscle cell contraction (GO:0086003),0.41121093178331236,1.16059798411774,0.2541528239202658,0.8957377767454885,1.0,8/19,22.35%,FGF12;KCNE2;CACNA1G;CACNA1D;CACNA2D1;ATP1A1;SCN1B;SCN3B
prerank,regulation of organelle organization (GO:0033043),-0.2729414998376166,-1.1601089851597084,0.1893687707641196,0.6234235668926879,1.0,24/80,16.84%,ZEB2;MYO5A;MARK2;STX5;VPS35;CAPN2;CLIC4;MSN;SPEF1;PARL;PDCD10;TMED9;EP300;MTM1;USP6NL;CDT1;RBSN;CLN3;ARHGEF5;PDE2A;MUL1;RAB33B;STX18;SQSTM1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.36825401261145324,-1.1597522746289899,0.2512437810945274,0.6234980125020089,1.0,12/22,30.00%,PTPN22;RAB7B;LYN;ACOD1;NR1H3;LBP;APPL2;LTF;TICAM2;APPL1;MFHAS1;TNFAIP3
prerank,heart morphogenesis (GO:0003007),0.33155452257240764,1.159547876723489,0.2191780821917808,0.8981801432348153,1.0,12/50,22.12%,ZFPM1;MEGF8;MYBPC3;TGFBR3;TGFBR1;HEY1;TBX2;INSR;PTK2;ENG;MDM4;FLRT2
prerank,mononuclear cell differentiation (GO:1903131),-0.36335517613597224,-1.159481936193621,0.258974358974359,0.6233680002706146,1.0,8/24,16.08%,GAS6;AXL;PPARG;LYN;LILRB1;MYH9;RELB;IKZF1
prerank,negative regulation of autophagy (GO:0010507),-0.28967639432699105,-1.1589319806145266,0.17666666666666667,0.6240370482729577,1.0,10/54,12.27%,BCL2;PTPN22;MCL1;MET;ATG7;CTSA;SMCR8;PIK3CA;LRRK2;RRAGA
prerank,xenobiotic transport (GO:0042908),0.42259821420085175,1.1587456121484794,0.28046744574290483,0.8996467190560088,1.0,7/17,27.08%,ABCC3;NR1I2;SLC22A4;ABCG2;SLC22A18;ABCC5;ABCA3
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.4318731164718678,-1.1581176453398716,0.2564102564102564,0.6253799778999986,1.0,5/12,20.47%,FCGR2B;GPR183;LFNG;PTK2B;NOTCH2
prerank,histone H3 deacetylation (GO:0070932),-0.4059739660068544,-1.1580784194159677,0.2831168831168831,0.6246224953237258,1.0,6/15,21.35%,HDAC2;HDAC1;ELK4;PER2;SIRT2;HDAC4
prerank,regulation of protein binding (GO:0043393),-0.2567349618808339,-1.1575261816707363,0.127208480565371,0.6252072690726725,1.0,29/114,17.14%,DAB2;STK3;CRK;MARK2;BTBD1;IFIT2;DTX3L;GNL3L;PRKACA;BAX;IFIT1;TAF1;HIP1R;LDLRAP1;CAV1;PSEN1;AKTIP;SPPL3;LRRK2;LRP1;B2M;RACK1;RALB;BMP2;NMD3;CFHR2;PLK1;MAPK8;HIPK2
prerank,cell cycle G2/M phase transition (GO:0044839),-0.25453516362835626,-1.1574984748814943,0.16194331983805668,0.6244066431846924,1.0,47/129,23.79%,PPP2R2A;PCM1;FBXL17;ENSA;PPP1R12B;CDK5RAP2;PRKACA;FBXL8;BORA;TUBA4A;CEP250;PPP1R12A;KDM8;YWHAG;HAUS2;CEP164;MAPRE1;WEE1;CCNH;DNM2;CDK1;CCNA2;AJUBA;HAUS8;MNAT1;ARPP19;CDK14;CDC25A;OPTN;PLK1;DCTN2;ODF2;FBXL15;PAFAH1B1;NES;FBXL12;MELK;AKAP9;CDC25C;CEP78;CCNY;OFD1;TUBB4B;CCNB1;NDE1;BRSK1;MASTL
prerank,positive regulation of protein binding (GO:0032092),-0.2950904209364575,-1.157425870804009,0.20552147239263804,0.6237369642672763,1.0,20/56,20.88%,STK3;APOE;DTX3L;TAF1;HIP1R;CAV1;PSEN1;AKTIP;SPPL3;LRRK2;LRP1;B2M;RALB;BMP2;NMD3;PPP2CB;HIPK2;BAMBI;RPL11;TRIM21
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2231244927001242,-1.1572261401280672,0.08661417322834646,0.6233300084687529,1.0,75/348,16.37%,IQGAP1;DAB2;IL15;CD74;FNIP2;NRP1;GAS6;IGF1;RAF1;CD44;PTPRC;SDCBP;TEC;NIBAN1;CNOT9;DVL3;UBE2K;FAM20A;BRAF;DOCK7;TBK1;NPTN;S1PR2;FAS;CRKL;PDGFD;RIPK1;TFRC;BCAR3;CCND1;CAV1;PDCD10;PLAUR;SNX9;LYN;NBN;PRKAG2;CIB1;CLEC6A;IL1B;FGF1;TXN;BANK1;BMP5;KRAS;MAD2L2;PDGFC;SPRY2;LCP2;AGAP2;GHR;CALM3;AKTIP;CCN1;CSPG4;IGF2;RBPMS;BRAT1;LRRK2;KDR;CCND2;CALM2;RACK1;RALB;MTCP1;BMP2;EGFR;AGER;TNF;PTK2B;RAP1A;BMP3;PFN2;PLK1;FXR2
prerank,positive regulation of catalytic activity (GO:0043085),-0.32274571326947005,-1.1569843536152602,0.21081081081081082,0.6231091750646659,1.0,11/37,16.53%,ABL2;ATP7A;NOD2;CAV1;CIB1;PSEN1;IGF2;SLC5A3;MID1IP1;NHEJ1;MAPK8
prerank,cell cycle checkpoint signaling (GO:0000075),-0.4261748952215929,-1.1568389736014293,0.26715686274509803,0.6226627444415757,1.0,6/12,19.40%,PRCC;ZWILCH;WEE1;BUB1;BUB1B;ZWINT
prerank,camera-type eye morphogenesis (GO:0048593),0.4959351398204819,1.1559447557509033,0.3089983022071307,0.9091716511114484,1.0,3/10,11.15%,TENM3;TBX2;KDM2B
prerank,regulation of cellular senescence (GO:2000772),0.3842704357357418,1.1557276454154461,0.24673202614379086,0.9082348439544238,1.0,11/28,21.73%,ABI3;EEF1E1;VASH1;NEK4;CGAS;RBL1;AKT3;ARG2;FBXO5;NUAK1;ING2
prerank,protein dephosphorylation (GO:0006470),-0.24957785455167733,-1.1555527154289686,0.11836734693877551,0.6253800937441373,1.0,35/135,15.84%,PPP2R5C;PTPN22;DUSP16;PPP2R1B;PPP2R2A;PTPRC;PPP2R5A;PPP4R1;PTPN1;MTMR2;CDC14B;PTPN21;NCK1;PPM1H;PPP1R12A;MTMR4;CTDNEP1;EYA1;PTPN7;TAB1;DUSP18;EYA3;PPP2R2C;PPP4R2;EYA2;PHPT1;PPP3CA;MTM1;CTDSP1;DUSP1;TIMM50;PPP2CB;RPAP2;TNS2;MTMR3
prerank,embryonic appendage morphogenesis (GO:0035113),-0.43876077160407023,-1.1552465176978468,0.28708133971291866,0.6253190123619228,1.0,7/12,30.84%,MBNL1;FBXW4;LRP6;PTCH1;SHH;CYP26B1;TGFB2
prerank,protein hydroxylation (GO:0018126),0.44209149217317467,1.1550698179886898,0.2736318407960199,0.909108011066087,1.0,3/15,5.43%,P3H2;PLOD3;ASPH
prerank,RNA export from nucleus (GO:0006405),0.2997348997824692,1.1550151064427245,0.18421052631578946,0.9075602509976435,1.0,35/100,24.22%,HHEX;RNPS1;AAAS;SRSF5;MCM3AP;CASC3;DDX25;SRSF6;SRSF11;NUP54;SRSF1;YTHDC1;CPSF3;NUP88;RAE1;FYTTD1;UPF1;CDC40;DDX39B;HNRNPA1;THOC5;NUP133;SARNP;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;ALKBH5;RBM15B;GLE1;EIF4E
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.41527953336703405,-1.1547864848873282,0.2608695652173913,0.6256110270372981,1.0,6/15,22.22%,NR3C1;ANXA1;UBE2L3;BCL2L11;HNRNPU;ISL1
prerank,postreplication repair (GO:0006301),-0.31085054638054344,-1.1547602272945372,0.21910112359550563,0.6248074192019252,1.0,15/45,18.45%,VCP;TRIM25;PCNA;POLI;UBC;PCLAF;BRCA1;UBA52;POLD4;RPA1;FAAP20;UBE2L6;RPA2;DTL;USP43
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3939406848114478,-1.1547026415337256,0.26262626262626265,0.6240902670581189,1.0,3/17,5.92%,CD74;RIPOR2;MOSPD2
prerank,digestive tract morphogenesis (GO:0048546),-0.40817727607539317,-1.1542865784186582,0.25934579439252337,0.6243173323755593,1.0,7/14,37.50%,SOX11;BBS7;PDGFRA;ID2;GLI1;SOX17;STRA6
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.36046211050013666,-1.154093938327656,0.23218997361477572,0.6240079532921232,1.0,3/24,5.49%,PID1;NDUFS4;MTLN
prerank,regulation of dopamine secretion (GO:0014059),0.3809015216339088,1.1537907509097027,0.27823240589198034,0.9107785867310956,1.0,5/25,9.79%,SYT4;SYT13;SYT1;SYT6;PRKN
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.3632205479736737,-1.1533551976746395,0.24484536082474226,0.6252618025963832,1.0,4/24,1.54%,BCL2;CD74;BCL2L1;CD44
prerank,positive regulation of receptor internalization (GO:0002092),0.3989197029248735,1.1532782750437762,0.2736156351791531,0.9111117061034262,1.0,7/22,25.14%,ATAD1;ARRB2;INSR;MAGI2;ARRB1;CD63;SCYL2
prerank,dendrite self-avoidance (GO:0070593),0.424471862289616,1.1531931851979862,0.2764227642276423,0.9096952154904012,1.0,6/16,14.95%,ROBO4;MYPN;CNTN2;DSCAM;BSG;DSCAML1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3638749854164471,-1.1530830804413277,0.24050632911392406,0.6251716780946514,1.0,10/21,27.70%,CHST11;CHST9;UGDH;CSPG4;CHST7;CHPF;CHST12;CHSY3;CHST3;NCAN
prerank,regulation of innate immune response (GO:0045088),-0.29040023567170303,-1.1527186346547251,0.18618618618618618,0.6253458235820848,1.0,21/57,25.12%,FCGR2B;PTPN22;PTPN1;IFNAR2;USP18;TLR8;ERAP1;ADAM8;ACOD1;BIRC2;PARP9;MUL1;POLR3G;APPL2;NLRC3;TRIM21;SLC15A4;PLSCR1;XIAP;APPL1;DHX58
prerank,neuromuscular process controlling balance (GO:0050885),0.4668112091906465,1.1526758458493798,0.2791519434628975,0.9100731404836959,1.0,5/12,25.50%,CDH23;NRXN1;SHANK1;CLRN1;TPP1
prerank,Golgi to lysosome transport (GO:0090160),-0.462796029308422,-1.152189455073428,0.27546296296296297,0.6257924413904086,1.0,5/11,16.03%,GAK;AP4M1;LAMP1;RBSN;CLN3
prerank,cellular lipid catabolic process (GO:0044242),-0.34360304811426945,-1.1519821339341336,0.2445054945054945,0.6255054111793091,1.0,4/27,5.55%,AOAH;ACOT8;PLBD1;PPARD
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.38018373684217277,-1.1516383872400058,0.2698019801980198,0.6256061742195334,1.0,13/19,30.61%,NFKB1;TNF;MAPK7;MAPK8;KLF2;WFS1;GATA3;KLF4;APP;EGF;MTPN;TMEM106A;PAX8
prerank,regulation of leukocyte migration (GO:0002685),0.43157666286827195,1.1516072829483899,0.281505728314239,0.9126122460348718,1.0,4/16,15.73%,ADTRP;NCKAP1L;CD81;MIA3
prerank,response to alcohol (GO:0097305),0.3759711214718109,1.1514197535096915,0.24,0.9116136737601969,1.0,8/27,20.58%,TGFBR3;TGFBR1;GRIN1;TGFB1;GRIN2B;ABCA2;SDF4;SMAD2
prerank,calcium ion transmembrane transport (GO:0070588),0.3052313827204246,1.1513997397066882,0.22916666666666666,0.9099475680551543,1.0,23/86,16.41%,ATP2A3;TRPC3;ATP2A2;SLC24A5;TRPM3;TRPM2;MICU2;SMDT1;PKD2;GRIN1;CACNA1G;GRIN2B;SLC8A1;ATP2C1;TRPC6;CACNA1D;PKD1;ATP2B3;SLC8A3;CACNA2D1;SLC25A23;SLC24A3;CACNA1A
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4436484521479051,1.1513546080109642,0.2736318407960199,0.9083887086049184,1.0,6/13,10.73%,ZFPM2;MEF2C;TGFBR3;ERBB4;TBX2;FGF2
prerank,Rho protein signal transduction (GO:0007266),0.3260082358974528,1.151351332422883,0.24492753623188407,0.9066764793067458,1.0,22/53,24.68%,RHOV;EPS8L3;ARHGDIG;CDC42EP5;ADRA2A;CTNNAL1;LIMK1;ARHGDIA;ARHGAP5;CFL1;EPS8L2;ROCK1;RIPOR1;RHOU;CDC42EP4;CDC42EP1;CDC42;ARHGAP1;ARHGAP4;EPS8L1;ARHGEF1;RHOA
prerank,L-amino acid transport (GO:0015807),0.37387628242357746,1.150937567187606,0.2601626016260163,0.9066073169176707,1.0,7/28,11.60%,SLC38A2;SLC1A1;SLC25A18;SFXN1;SLC1A3;CTNS;SLC1A4
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4451718535606761,-1.1506819479093775,0.2698412698412698,0.6273006886327963,1.0,5/11,22.66%,PARP4;PARP14;PARP9;TIPARP;PARP16
prerank,negative regulation of interleukin-2 production (GO:0032703),0.41452131028258876,1.1504712548362144,0.25874125874125875,0.9066042940428531,1.0,4/18,10.35%,CD34;PRNP;NAV3;HOMER2
prerank,gene expression (GO:0010467),-0.22063297346217584,-1.149420774938423,0.0546875,0.6298825646177839,1.0,76/348,14.19%,APOBEC1;SRSF4;EPC1;RPS26;RPL39;CPSF1;RPS23;RPL5;RPS24;LMF2;RPS16;RRAGC;AGFG1;NCBP1;RPL28;EEF1A1;POLR2E;RANBP2;RPS29;RBM8A;RPS14;BCL3;SNRNP40;RPS20;RPL35A;FIP1L1;RPS12;RPL18A;RPS13;RPL27;RPL21;ATXN1;RPS7;RPS5;HSPD1;RPL30;RPL6;DHX38;DHPS;RPL37A;HNRNPK;RNGTT;EIF4EBP2;IGHMBP2;NUP153;RPL10;RPL15;NDC1;NUP43;NUP210;YARS2;RPS10;RPL14;XRN2;RPL9;RPL32;RPL36;RPL31;RBPMS;HNRNPA2B1;RPL23A;CPSF4;PRPF4;TSPAN5;AGO2;MRPL35;NXT1;POLR2B;SYNCRIP;SCX;CPSF2;PTMA;RPL41;RPL3;POLR2H;TESC
prerank,positive regulation of catabolic process (GO:0009896),-0.2818188585870405,-1.149361263218561,0.1861198738170347,0.6291821342828352,1.0,16/65,17.97%,ITCH;WWP1;VCP;STX5;RAB7A;SMURF2;ATG7;HECW1;IL1B;FOXO1;BARD1;TNF;WNT5A;TIPARP;DTL;RILP
prerank,positive regulation of cell killing (GO:0031343),-0.42410874946905047,-1.1492316353891454,0.284688995215311,0.6286935545252235,1.0,8/13,34.75%,SYK;CYBA;WNT5A;MAPK8;NOXO1;RAC1;FZD7;NOS2
prerank,pyruvate metabolic process (GO:0006090),0.33030387046747534,1.149178286998586,0.25181950509461426,0.9100712092981058,1.0,15/52,20.72%,HOGA1;GAPDH;VDAC1;PGAM2;ALDOC;BSG;PFKM;HK2;DLD;DLAT;PDHX;PFKFB2;PGM1;ALDOA;ENO3
prerank,regulation of platelet aggregation (GO:0090330),0.4112583553560161,1.14909959653431,0.27504244482173174,0.9086700384537718,1.0,6/17,15.41%,F11R;ALOX12;PRKCA;SH2B3;PRKG1;SERPINE2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.42852835855435956,1.1489051558657057,0.2706270627062706,0.9078175417413095,1.0,2/15,1.44%,WHRN;LHFPL5
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2671093232965929,-1.1480463660609783,0.17028985507246377,0.6310791590557678,1.0,14/82,9.55%,VAV3;ITSN1;ACTR3;AP2A2;CRK;SDCBP;GIT1;RASA1;AP2B1;ARPC2;LYN;FYN;PSEN1;ARPC5
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.41854722055028815,1.147597694739935,0.2800658978583196,0.9112596132150651,1.0,7/17,23.98%,NDUFA4;COX7B;COX6C;COX7C;COX4I1;COX6B1;COX10
prerank,mesenchyme development (GO:0060485),0.4334615101181368,1.147592846576299,0.2857142857142857,0.9095645168125259,1.0,4/15,10.44%,TGFBR1;BMP4;PKD2;CRELD1
prerank,DNA replication (GO:0006260),-0.25587224628015554,-1.1474559914008138,0.16342412451361868,0.6319062799956469,1.0,28/105,17.00%,BAZ1A;RBBP8;CLSPN;TOPBP1;ORC5;NBN;IGHMBP2;PCLAF;BRCA1;RMI1;ATRIP;ORC2;POLD4;GRWD1;RHNO1;BARD1;RPA1;CDK1;RMI2;MCM2;KAT5;TICRR;ORC4;MCM9;MCM8;KAT7;RNASEH2A;RPA2
prerank,establishment of melanosome localization (GO:0032401),-0.37439676524714915,-1.147117196508874,0.258974358974359,0.6318819073067128,1.0,6/19,26.38%,MYO5A;BBS7;MLPH;SHROOM2;BLOC1S3;MREG
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.40125237783323076,1.146695641229982,0.28205128205128205,0.9114537901454294,1.0,3/22,6.71%,LRP2;VKORC1L1;LGMN
prerank,gonad development (GO:0008406),0.34340061799754074,1.1466915300934435,0.24924012158054712,0.9097587684748254,1.0,6/41,9.12%,WNT4;FGF9;SIX4;LRP2;AR;MEA1
prerank,iron ion transmembrane transport (GO:0034755),0.49034146089628466,1.1466430111785268,0.291044776119403,0.9082485362270974,1.0,5/10,31.31%,ABCB6;SLC39A8;ABCB7;ABCC5;SLC39A14
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.3977107766114561,-1.1464701889479905,0.2695852534562212,0.6328412742396944,1.0,5/16,14.84%,AOAH;PHKB;AGL;GAA;PGM2L1
prerank,positive regulation of proteolysis (GO:0045862),-0.2929595925502422,-1.1463169997013092,0.22028985507246376,0.6323931344105671,1.0,21/55,24.60%,APOE;CCBE1;NLRC4;ADAM9;NRDC;SNX9;IL1B;ZC3H12A;ADAM8;HDAC2;TNFRSF1B;TBC1D10A;TNF;PLK1;MAPK12;NKD2;TNIP1;NDUFA13;PERP;FGFR4;FADD
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4582569566951026,-1.146028665995947,0.30837004405286345,0.6323426300841972,1.0,4/11,7.83%,SYK;PLAUR;LYN;PRKCQ
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3699333656590509,-1.1457987924632782,0.2715736040609137,0.6303705572169684,1.0,10/20,19.40%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;PLK1;TRIP13;ZWINT
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3699333656590509,-1.1457987924632782,0.2715736040609137,0.6303705572169684,1.0,10/20,19.40%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;PLK1;TRIP13;ZWINT
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3699333656590509,-1.1457987924632782,0.2715736040609137,0.6303705572169684,1.0,10/20,19.40%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;PLK1;TRIP13;ZWINT
prerank,organic substance transport (GO:0071702),0.28430465167930064,1.1456354313137862,0.20193637621023514,0.9104947627687959,1.0,34/121,22.66%,SCAMP5;SLCO2B1;ABCA9;SLC48A1;SLC50A1;ABCG8;DISP1;ABCB6;LRP2;FLVCR1;LRP1B;SLC18A1;HSP90B1;SCAMP2;RAB38;CHMP1A;ARRDC1;ABCA2;CHMP2A;SPNS2;SLC19A1;SLC22A4;MIA3;ATP8A1;VPS33B;ABCD2;LMAN2L;ABCG2;SLC22A18;SCAMP3;ABCA7;SLC22A5;SLC19A2;PEX3
prerank,phosphorylation (GO:0016310),-0.21671612556884517,-1.145386788493198,0.0660377358490566,0.6306355678335847,1.0,90/384,18.06%,PEAK1;MAP3K1;STK3;FNIP2;GAS6;PRKCH;CSK;STK38;PRKCE;STK17B;CDK6;GMFG;MARK2;LIMD1;TEC;CDK17;PIK3R4;CDK8;RUNX3;FAM20A;BRAF;PRKAB1;PPP4R1;BIRC6;PRKACA;RARA;NUAK2;TBK1;MKNK1;MAPKAPK2;DGKK;NADK;PIM1;LMTK2;ERN1;STK24;TAF1;TESK2;DYRK1A;SYK;FAM20B;CERKL;LYN;FYN;PRKAG2;CDKL3;HCK;TAOK3;HCST;PIK3CA;RET;HASPIN;CAMK2D;MAP3K11;GNPTAB;BIRC5;HIPK1;LCK;CERK;CDK1;DAPK1;HK1;LRRK2;PANK3;SHPK;FRK;FAM20C;SIK2;NLK;GK;BMP2;SPHK2;GK5;SIK1;CDK12;PRKACB;CDK14;PTK2B;DGKA;PI4KA;POMK;PLK1;MAPK8;HIPK2;ZAP70;MAP4K1;TBCK;PKN3;SGK3;SGK2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.46709029086247283,-1.1452579976369923,0.31873479318734793,0.6292859475944029,1.0,2/10,3.91%,ASCC3;ASCC1
prerank,DNA dealkylation (GO:0035510),-0.46709029086247283,-1.1452579976369923,0.31873479318734793,0.6292859475944029,1.0,2/10,3.91%,ASCC3;ASCC1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2713343705174583,-1.1448885806932025,0.19141914191419143,0.6294355114730017,1.0,29/76,25.19%,CUL3;RWDD3;FBXW7;CAV1;UBQLN1;BRCA1;UBA2;UBE2L3;ZC3H12A;PTTG1IP;PAXIP1;DCUN1D1;BIRC2;CRY1;LRRK2;PSMD10;FANCI;MUL1;WFS1;CENPX;NDFIP1;TNIP1;HDAC4;PHF23;XIAP;PIAS4;PIAS3;ANGPT1;DCUN1D4
prerank,chemical homeostasis (GO:0048878),0.3215149348433188,1.1446780162851447,0.2460431654676259,0.9125959762977734,1.0,24/61,25.79%,TLCD3A;SLC4A8;USF2;TLCD3B;PNPLA3;ABCB4;TLCD2;SLC66A1;USF1;SLC4A10;SLC4A7;ACOX1;ABHD5;NEDD4L;FITM2;ANGPTL3;ABHD8;WNK1;EIF5A2;PNPLA8;THADA;VGF;DDX3X;KLHL3
prerank,platelet degranulation (GO:0002576),-0.25044414458572756,-1.1441015335764322,0.15151515151515152,0.6307830297577401,1.0,54/118,32.54%,F13A1;GAS6;IGF1;OLA1;PSAP;ACTN1;CD36;TUBA4A;THBS1;PF4;LYN;SRGN;LAMP2;SERPING1;IGF2;FAM3C;TAGLN2;VCL;FLNA;FN1;F8;ITGB3;F5;TIMP1;TLN1;PHACTR2;TMSB4X;APOH;SERPINF2;APP;VEGFB;ANXA5;EGF;TIMP3;BLK;PDGFA;CTSW;TOR4A;CLEC3B;ITIH3;PLG;ACTN4;PLEK;VEGFC;CD109;CALM1;TGFB2;VWF;PROS1;HGF;RAB27B;BRPF3;ABCC4;TTN
prerank,selective autophagy (GO:0061912),-0.2906653545084422,-1.1440422533047307,0.20298507462686566,0.6301034887006652,1.0,15/56,13.02%,MAP1LC3B;NBR1;UBA5;ATG13;RAB7A;ARL13B;UBQLN1;UBC;WDFY3;UBA52;VIM;UFC1;ATG2B;WDR81;DYNC1LI2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.42385992407729345,-1.1438901200080567,0.30424528301886794,0.6296564908643028,1.0,5/12,19.18%,IGF1;IGF2;SORBS1;PPP1R3E;IRS2
prerank,positive regulation of growth (GO:0045927),-0.2756660063494567,-1.1436558873735563,0.22145328719723184,0.629466317602991,1.0,18/64,17.52%,RFTN1;BCL2;SDCBP;NCBP1;ZPR1;CXCL16;DDX49;CIB1;H3-3A;BRAT1;PSMD10;EXOSC9;EGFR;SLC25A33;MFSD2A;ADAM17;ADNP2;WFS1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4097499488920202,1.1436462836484302,0.29152542372881357,0.9150970915924199,1.0,4/18,9.64%,POLD3;GINS3;MCM3;LIG3
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.21068218020872936,-1.1434848390143375,0.05714285714285714,0.629041119540524,1.0,168/572,22.51%,ZEB2;DAB2;RBPJ;TRPS1;SP100;FNIP2;NR3C1;UBE2D3;MECP2;EPC1;GATAD2B;MITF;IRF2BP2;TGIF1;SDCBP;CDC73;ZHX2;ATF3;SIN3B;RUNX3;PPARG;CIITA;PEG3;ETV6;IRF7;KANK2;TFEC;MNT;SMARCA4;RARA;ERF;ENO1;SOX11;SMURF2;N4BP2L2;RPS14;ESR1;PROX1;NFKB1;ETV5;TAF1;ZNF8;LCOR;YY1;VHL;PPARD;ATXN1;MBD2;SMAD3;CEBPB;CCND1;CAV1;BCOR;NR1H2;WWOX;YAP1;UBC;TBL1X;ID4;ZMYM5;FOXE1;BMI1;EDNRB;PSEN1;HSF1;RPL10;CRY2;LIN37;SNW1;UBA52;ID3;H1-0;ORC2;MAD2L2;MZF1;CTCF;STAT1;EP300;NFIC;FOXP4;ZBTB18;USP9X;SPEN;NOTCH1;BRMS1;BRMS1L;HDAC2;ID1;CUX2;ZNF148;IGF2;CRY1;ZBTB5;FOXJ1;FHL2;PARP9;KAT5;FRK;HDAC1;CBX8;PSMD10;NR1H3;LRRFIP1;RB1;GATAD2A;E2F8;BMP2;MOSPD1;FOXP2;FOXP1;IRF2;ELK4;THAP7;NOTCH4;DACH1;TNF;ZBTB2;DEAF1;DDX20;E2F7;PDE2A;PLK1;KLF11;ARID5B;NOP53;KLF2;DNAJB1;HEY2;SATB1;WFS1;NUPR2;SMAD4;NRIP1;GATA3;HMGA2;HIVEP1;GLIS2;PER2;MCPH1;HES1;TFAP2B;TRIM37;MYT1L;TAF7;EED;MXI1;YEATS2;HNRNPU;NCOR1;BHLHE40;NFATC3;EPO;KLF4;SIRT2;TRIM33;ZFP90;HDAC4;PTCH1;CPEB3;ID2;RREB1;SEMA4D;ISL1;NR1H4;SHH;TWIST1;HOXD9;AASS
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.32779051355067496,-1.1431645953606893,0.24585635359116023,0.629067725404245,1.0,14/32,22.44%,CDK17;ZPR1;PCNA;HINFP;TYMS;RB1;CDT1;CDK14;E2F7;KLF11;ESRRB;DHFR;ID2;CDC45
prerank,negative regulation of centrosome duplication (GO:0010826),-0.4484944426123295,-1.1428479585586002,0.2776470588235294,0.6291337111262131,1.0,6/11,25.89%,CDK5RAP2;BRCA1;NPM1;TRIM37;KAT2B;CCNF
prerank,cellular calcium ion homeostasis (GO:0006874),0.28313288703656836,1.1428281505489604,0.21721854304635763,0.9166081317633649,1.0,32/133,19.54%,ATP2A3;YWHAE;ATP13A4;ADCY8;TRPC3;ATP2A2;CDH23;ATP1B1;SLC24A5;TNNI3;ATP13A5;CCR1;MICU2;SMDT1;BAK1;SLC8A1;CCDC47;HERPUD1;RMDN3;ATP2C1;TRPC6;ATP2B3;SLC8A3;SLC24A3;DMPK;ANK2;CHRNA7;SELENOK;SLC24A4;CCL15;CCL5;CAV2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3054202707645395,1.142664142865809,0.23281907433380084,0.9155492369093379,1.0,23/75,23.21%,GUCY2F;C3;MRAP;RGS11;CNGB1;GNG4;DGKQ;ADCYAP1;MGRN1;GUCY2D;USP33;RIC8B;RGS2;RGS20;NMT1;ROCK1;CCL5;YWHAB;METAP2;GUCA1B;GIT2;TULP3;RGS5
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.46272080361826623,-1.1424998026154645,0.2818181818181818,0.6292908550634453,1.0,2/10,3.29%,APOE;PRKACA
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.44549537246922155,-1.1421683845236597,0.3010989010989011,0.629325970212328,1.0,4/11,23.23%,FAS;PLAUR;GSN;CAAP1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3005272524278001,1.14184484216292,0.22720897615708274,0.9170698982894325,1.0,14/86,8.07%,CTTN;BIN1;PAK1;LMOD1;PSRC1;TENM1;STMN2;NCKAP1;NCKAP1L;CDC42EP5;NAV3;CLU;FCHSD2;LIMK1
prerank,T cell receptor signaling pathway (GO:0050852),-0.2436160440244748,-1.141832155304245,0.1111111111111111,0.6294217212926175,1.0,40/138,19.16%,RFTN1;PSMA6;PTPN22;CSK;PTPRC;DENND1B;TEC;PSMB2;PSME2;GRAP2;NFKBIZ;NFKB1;NCK1;PSMD11;PSMC6;FYN;PRKCQ;THEMIS;PSMA3;EIF2B2;PIK3CA;ZC3H12A;CD28;LCP2;LCK;RC3H1;SPPL3;SKAP1;STOML2;PSMD10;PSMB5;EIF2B4;RC3H2;BCAR1;ZAP70;GATA3;PSMD5;CD247;THEMIS2;PSMD1
prerank,negative regulation of axon extension (GO:0030517),0.3671137347894496,1.1418146426694291,0.2889983579638752,0.9154943489944857,1.0,10/30,17.31%,DIP2B;SEMA7A;SEMA6C;SEMA6B;SEMA3D;MAG;SEMA4F;SEMA4B;SEMA3C;PTPRS
prerank,prostanoid biosynthetic process (GO:0046457),0.43261136894876023,1.1417365248434261,0.28209459459459457,0.9141788933796059,1.0,3/15,4.38%,PTGS1;PTGDS;PRXL2B
prerank,protein methylation (GO:0006479),-0.3142304454557018,-1.1415891974858716,0.25,0.6291765194861154,1.0,13/40,14.03%,FAM98B;FAM98A;ETF1;CAMKMT;SETD3;RAB6A;SNRPB;VCPKMT;ICMT;PRMT2;EEF2KMT;EHMT1;ETFBKMT
prerank,ventricular septum development (GO:0003281),0.3501900916947615,1.1407019824995486,0.2727272727272727,0.9166553147407445,1.0,8/37,9.90%,ZFPM1;SOX4;ZFPM2;DAND5;TGFBR3;TGFBR1;HEY1;GJA5
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4277181110455917,1.1406442250126572,0.2832764505119454,0.915206467168948,1.0,6/16,18.26%,PQBP1;DDX5;SRSF6;SRSF1;SRSF9;PUF60
prerank,positive regulation of MAPK cascade (GO:0043410),-0.2287303162697413,-1.140147908121776,0.09146341463414634,0.6322525726695396,1.0,52/245,15.67%,IQGAP1;CD74;ARL6IP5;APOE;NRP1;GAS6;PTPN22;IGF1;GCNT2;CD44;PTPRC;LILRA5;BRAF;CD36;FBXW7;DHX33;CCL25;C5AR1;CRKL;NOD2;GPR183;PDGFD;FLT1;BCAR3;PDCD10;CD24;MID1;GLIPR2;CIB1;FGF1;TAOK3;RET;PDGFC;ADAM8;SPRY2;NOTCH1;IGF2;GRM4;LRRK2;PIK3R6;KDR;TRIM5;PIK3R5;SLAMF1;BMP2;EGFR;AGER;SHC1;TNF;PTK2B;SCIMP;RAP1A
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.35424079824007904,1.1399832588265395,0.25960061443932414,0.9160996612950413,1.0,8/35,11.92%,GGT7;HMGCLL1;ALOX12;AWAT2;GGT5;CBR4;PPT2;ACSS3
prerank,stress fiber assembly (GO:0043149),-0.4094034815804486,-1.1395931791097031,0.27802690582959644,0.6320374318141612,1.0,5/15,11.85%,PDLIM1;CUL3;FHDC1;PDCD10;SORBS1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4094034815804486,-1.1395931791097031,0.27802690582959644,0.6320374318141612,1.0,5/15,11.85%,PDLIM1;CUL3;FHDC1;PDCD10;SORBS1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2605346134603726,-1.1393901660447439,0.18218623481781376,0.6308894797712308,1.0,28/104,19.16%,PSMA6;RAF1;PSMB2;PRKACA;TYROBP;PSME2;NFKB1;CLEC10A;PSMD11;SYK;PSMC6;LYN;FYN;PSMA3;CLEC6A;TAB1;KRAS;EP300;KLRD1;PSMD10;PSMB5;PRKACB;RELB;FCER1G;NRAS;PSMD5;CLEC4E;PSMD1
prerank,cellular response to lectin (GO:1990858),-0.2605346134603726,-1.1393901660447439,0.18218623481781376,0.6308894797712308,1.0,28/104,19.16%,PSMA6;RAF1;PSMB2;PRKACA;TYROBP;PSME2;NFKB1;CLEC10A;PSMD11;SYK;PSMC6;LYN;FYN;PSMA3;CLEC6A;TAB1;KRAS;EP300;KLRD1;PSMD10;PSMB5;PRKACB;RELB;FCER1G;NRAS;PSMD5;CLEC4E;PSMD1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.29756842571901915,1.139274604379747,0.21171770972037285,0.9172001892255758,1.0,34/96,24.22%,HHEX;RNPS1;AAAS;SRSF5;MCM3AP;CASC3;DDX25;SRSF6;SRSF11;NUP54;SRSF1;YTHDC1;CPSF3;NUP88;RAE1;FYTTD1;UPF1;CDC40;DDX39B;THOC5;NUP133;SARNP;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;ALKBH5;RBM15B;GLE1;EIF4E
prerank,monocarboxylic acid transport (GO:0015718),0.3251735019854536,1.1392530382822437,0.2400611620795107,0.9156056569442231,1.0,7/51,8.66%,SLC16A6;SLCO2B1;ABCC3;AKR1C1;SLC10A2;ABCB4;STARD5
prerank,mRNA export from nucleus (GO:0006406),0.2958159967776098,1.1389707962381164,0.22340425531914893,0.9150775931128023,1.0,50/102,31.41%,HHEX;RNPS1;AAAS;SRSF5;MCM3AP;CASC3;DDX25;SRSF6;SRSF11;NUP54;SRSF1;YTHDC1;CPSF3;NUP88;RAE1;FYTTD1;UPF1;CDC40;DDX39B;THOC5;NUP133;SARNP;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;DDX19A;ALKBH5;RBM15B;POLR2D;GLE1;EIF4E;SRSF3;PCID2;NUP107;NUP155;THOC7;SRRM1;NUP85;ZC3H11A;TPR;SRSF7;SEC13;POLDIP3;U2AF1;U2AF2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4356320723867145,-1.138802741876544,0.29764453961456105,0.6316654927879303,1.0,2/12,6.73%,IQGAP1;CD24
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.41059559426501024,-1.1386271829855639,0.28633405639913234,0.6313559738171056,1.0,4/14,17.30%,ITGA4;THBS1;ECSCR;RGCC
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2605225533266401,-1.138364466898287,0.18548387096774194,0.6312149584795627,1.0,28/105,19.16%,PSMA6;RAF1;PSMB2;PRKACA;TYROBP;PSME2;NFKB1;CLEC10A;PSMD11;SYK;PSMC6;LYN;FYN;PSMA3;CLEC6A;TAB1;KRAS;EP300;KLRD1;PSMD10;PSMB5;PRKACB;RELB;FCER1G;NRAS;PSMD5;CLEC4E;PSMD1
prerank,positive regulation of cell adhesion (GO:0045785),0.30464680067042865,1.1382492829984359,0.22142857142857142,0.9162399678399491,1.0,15/74,15.62%,ZFHX3;FRMD5;P2RY12;NCKAP1L;MAGI1;PRKCA;PRKD2;STX3;NPNT;PDGFB;EPHA4;FLCN;NDNF;FBLN2;RSU1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.2558352969121258,-1.1381005900266006,0.1647940074906367,0.6311712725992961,1.0,55/110,36.93%,ADGRE5;ADGRG6;ADCY9;PTGER4;S1PR2;PF4;ADCY5;DRD2;GNA13;ADCY6;ADCY1;GPR65;ADCY3;RAMP2;CALCRL;PTHLH;ADRA1A;ADGRG5;S1PR3;DRD3;LPAR2;ADGRL2;ADGRB1;GPR101;RXFP2;PTH1R;CALCA;GLP1R;RAMP3;S1PR4;ADORA2A;VIP;LPAR3;ADGRG7;GPR4;PTGIR;TBXA2R;ADGRG1;GPR26;ADGRG2;LGR4;PTGFR;MC2R;CXCL9;ADGRD1;DRD1;GPER1;GPR3;CALCR;FSHR;LHCGR;ADRA2C;GHRH;CALCB;ADCY4
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.30477879939536584,-1.137681802176663,0.25471698113207547,0.6314111730159114,1.0,14/47,15.37%,ARL6IP5;NBR1;FAS;NOD2;PDCD10;MID1;TAOK3;FOXO1;MAPK8IP3;GREM1;QARS1;EGFR;AGER;SCIMP
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3888998856717518,-1.137619772051695,0.2793733681462141,0.6307642054631039,1.0,9/18,27.64%,BRAF;PRKAG2;IL1B;INPP5K;RSC1A1;FFAR4;CLIP3;APPL1;TRIB3
prerank,peptide cross-linking (GO:0018149),-0.3461033474155635,-1.1368706964966484,0.26857142857142857,0.6318926288751409,1.0,15/25,36.48%,F13A1;THBS1;ANXA1;CD247;FN1;COL3A1;DSP;EVPL;KRT10;TGM6;TGM5;EPB42;TGM7;CD3G;SPRR1A
prerank,nuclear membrane reassembly (GO:0031468),-0.2827862055737616,-1.1364957580660475,0.2057877813504823,0.6321131332920528,1.0,15/54,23.05%,KPNB1;CHMP4B;CHMP4A;PPP2R2A;NDC1;NUP43;CDK1;AHCTF1;BANF1;UBXN2B;SIRT2;LMNA;RCC1;NUP98;CCNB1
prerank,negative regulation of protein depolymerization (GO:1901880),0.38436073446516755,1.1363776948721853,0.2830820770519263,0.9220349115387396,1.0,9/24,17.39%,STMN2;NAV3;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,regulation of RNA metabolic process (GO:0051252),-0.2841424836176712,-1.135748514440576,0.22364217252396165,0.6332474259039527,1.0,10/59,6.91%,AHNAK;HNRNPLL;OAS2;NOVA2;CELF1;MITF;MBNL1;RASA1;OASL;MBNL3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.41742826186454707,1.1349675662621321,0.31711409395973156,0.9259749424548956,1.0,2/17,3.05%,NOS1AP;KCNE2
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.3376525820347742,-1.134924053700678,0.24653739612188366,0.6345869797624853,1.0,8/27,15.38%,KAT6B;PHF20;BAG6;TRRAP;EP300;KAT5;MSL3;KAT7
prerank,muscle contraction (GO:0006936),0.2855700718757615,1.1339195072034505,0.22148541114058357,0.9284353873799505,1.0,17/126,9.79%,MYOM1;LMOD1;NMUR1;CACNA1S;TNNC1;TNNI3;DMD;MYBPC3;ITGB5;ASPH;TMOD2;MYL12B;PGAM2;ACTN2;MYL6;SLC8A1;EMD
prerank,mitotic nuclear membrane organization (GO:0101024),-0.28335043914274366,-1.1338762365106323,0.24922118380062305,0.6357900652543568,1.0,9/51,12.77%,KPNB1;CHMP4B;CHMP4A;PPP2R2A;NDC1;NUP43;CDK1;AHCTF1;BANF1
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.28335043914274366,-1.1338762365106323,0.24922118380062305,0.6357900652543568,1.0,9/51,12.77%,KPNB1;CHMP4B;CHMP4A;PPP2R2A;NDC1;NUP43;CDK1;AHCTF1;BANF1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.3951396491583709,-1.1337462591467145,0.29292929292929293,0.6353280124339669,1.0,9/16,19.58%,PDS5B;BOD1;PDS5A;HASPIN;MAU2;RAD21;RB1;DSCC1;REC8
prerank,regulation of isotype switching (GO:0045191),-0.4050381853063336,-1.133662244285061,0.27078384798099764,0.6347418296778781,1.0,4/14,12.44%,TFRC;MAD2L2;PAXIP1;SHLD1
prerank,oligodendrocyte differentiation (GO:0048709),0.40341250553743296,1.1333934168643387,0.3191489361702128,0.9289101089832025,1.0,6/19,15.19%,TPPP;SOX10;EIF2B3;MYRF;SLC8A3;EIF2B1
prerank,cellular response to starvation (GO:0009267),-0.24149271220871926,-1.1332346026915756,0.18446601941747573,0.6350279908573437,1.0,35/147,17.56%,ATP6V0D1;PIK3C3;ATP6V0D2;MAP1LC3B;PIK3R4;ATP6V1B2;RRAGC;NUAK2;LAMTOR5;SH3GLB1;ATP6V0B;STK24;ATG7;FAS;CEBPB;PRKAG2;CPEB4;LAMP2;ZC3H12A;EIF2S1;FOXO1;SZT2;LRRK2;RRAGA;ATP6V1A;SIK2;RALB;SIK1;PMAIP1;MTMR3;MFSD2A;MAPK8;SESN2;MAP1LC3A;NUPR2
prerank,nuclear migration (GO:0007097),-0.41459320716755166,-1.1330589898695742,0.27577937649880097,0.6346450621200304,1.0,6/13,24.07%,PCM1;DOCK7;TMEM201;PAFAH1B1;SYNE2;HOOK3
prerank,B cell activation (GO:0042113),-0.27393812813694907,-1.132609475002089,0.19933554817275748,0.6350086379712121,1.0,22/68,21.35%,ITGA4;BCL2;PTPRC;KLF6;CEBPG;LYL1;GPR183;HSPD1;DNAJB9;BLNK;BANK1;FCRL1;CD79B;NHEJ1;CHRNB2;ADAM17;ZAP70;CD79A;PIK3CD;CHRNA4;LAX1;HDAC4
prerank,regulation of interleukin-17 production (GO:0032660),0.35978996248900663,1.1324178375495177,0.2644230769230769,0.9310692213641862,1.0,7/31,9.35%,VSIR;NCKAP1L;SLAMF6;PRNP;IL6;IL2;TGFB1
prerank,protein catabolic process (GO:0030163),-0.28591370289485973,-1.1319805151028568,0.23353293413173654,0.6359271266670905,1.0,14/59,14.96%,APOE;VCP;PRPF19;SIAH2;RIPK1;CLN8;CLN5;BAG6;LAMP2;CEACAM1;FBXO2;UCHL3;PMAIP1;MAGEC2
prerank,regulation of neuron apoptotic process (GO:0043523),0.29254860773288516,1.1313165872938222,0.226775956284153,0.9338790359425104,1.0,22/96,16.74%,FAIM2;NTRK1;SIX4;PPARGC1A;PLA2G3;PRNP;BACE1;MEF2C;LGMN;PRKCI;NRBP2;GRID2;SIGMAR1;PRKN;CLCF1;KDM2B;MAG;NDNF;SNX6;NTRK2;KIF14;PRKCG
prerank,negative regulation of viral release from host cell (GO:1902187),0.4462355704254465,1.131311664810164,0.307426597582038,0.9322208282555752,1.0,3/13,13.44%,MID2;TRIM26;TRIM8
prerank,regulation of T cell mediated immunity (GO:0002709),-0.45158850988665133,-1.1313093948350461,0.29508196721311475,0.636922832794393,1.0,5/10,14.85%,CCR2;IL1B;TRPM4;TNFRSF1B;AGER
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3842099432124322,-1.131291828682706,0.3014705882352941,0.6361594619652562,1.0,4/18,6.08%,ITGA4;PPARG;SP1;FLT1
prerank,cell-cell junction organization (GO:0045216),0.3003477447078087,1.130990357052484,0.24495677233429394,0.9318963356370081,1.0,18/79,16.52%,FSCN1;ANG;DCHS1;PARD6B;CADM1;PKP4;MARVELD2;PRKCI;CDH18;SDK1;NECTIN3;TGFB1;CTNND2;CDH4;CADM3;FLCN;CADM2;CXADR
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.28957193469313397,-1.1308408758427873,0.21450151057401812,0.6366555500837103,1.0,10/46,15.34%,TALDO1;STAT4;IL12RB2;PSME2;MSN;LMNB1;LCP1;HNRNPA2B1;AIP;RAP1B
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4384466696991113,1.1307262601038395,0.2897822445561139,0.9312638859814375,1.0,2/14,3.31%,AVPR2;AVPR1A
prerank,organelle assembly (GO:0070925),-0.2135016183119078,-1.1305999537865024,0.08196721311475409,0.6364578106659019,1.0,72/384,13.40%,EHD4;ATP6V0D1;RAB8B;VPS37C;ACTR3;EIF2A;PIK3C3;KIF3A;CHMP4B;CHMP4A;PTPN23;PCM1;MAP1LC3B;MIS12;LIMD1;RILPL2;FAM161A;RPS23;PIBF1;ATG13;STX12;RAB1A;DHX29;TMOD1;MKS1;RAB7A;RPGR;SCLT1;CDC14B;SH3PXD2B;EXOC4;CPLANE1;GBF1;CEP250;ARL13B;ATG7;TCTN1;SSX2IP;BBS7;UBAP2L;FHDC1;ASAP1;UBQLN1;HPS1;DNAH5;EIF4ENIF1;DDX6;HAUS2;TMEM231;KIF24;CEP164;CENPA;WDPCP;MAPRE1;TUBGCP4;EIF2S1;SNAP29;CCDC28B;TMEM138;RC3H1;NOTCH1;ATG2B;HAUS8;FOXJ1;IFT52;ATG3;EXOC8;PGM5;PDCD6IP;CHMP1B;SYNPO;STAM
prerank,amide biosynthetic process (GO:0043604),0.33378242660510504,1.1305515781043143,0.2697160883280757,0.9302997674683539,1.0,12/47,18.94%,OTC;SLC25A2;PM20D1;DMD;TLCD3B;CERS4;SPTSSA;CERS5;CERS6;CERS1;ASMT;ARG2
prerank,cellular glucan metabolic process (GO:0006073),-0.4380038618385888,-1.130228784532261,0.30210772833723654,0.6365892128780514,1.0,5/11,25.79%,PHKB;PRKAG2;PPP1R3C;GBE1;PHKA1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3037210259983303,1.1296732134863712,0.2360335195530726,0.9321773338720735,1.0,22/72,21.80%,PSMB1;CARD14;RELA;COPS8;PSMF1;BTRC;PSMA1;PSMD7;ZFP91;PSMA8;PSME3;MAP3K7;PSMD14;PSMC4;TLR3;PSMB4;REL;PSME1;PSMD2;PSMD4;TIRAP;PSMD8
prerank,B cell differentiation (GO:0030183),-0.29740583693132283,-1.129275778263172,0.22530864197530864,0.6384009414738421,1.0,8/46,7.82%,ITGA4;IRF2BP2;PTPRC;KLF6;CEBPG;LYL1;DNAJB9;BLNK
prerank,nuclear export (GO:0051168),0.30288734509576054,1.1291244693058986,0.25105782792665726,0.9326807584972873,1.0,38/80,31.41%,RNPS1;STRADB;SRSF5;CASC3;SRSF6;SRSF11;TGFB1;SRSF1;RAE1;PKD1;CDC40;DDX39B;HNRNPA1;THOC5;XPO6;SARNP;SRSF9;NXF1;CHTOP;STRADA;ALYREF;SRSF2;RANBP3L;POM121;RANBP17;EIF4E;CCHCR1;SRSF3;NUP155;THOC7;SRRM1;ZC3H11A;TPR;SRSF7;POLDIP3;RITA1;U2AF1;U2AF2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3584775515374866,1.12841182153746,0.30082644628099175,0.9339994514006889,1.0,13/30,22.05%,THY1;SOCS3;PRKCZ;SRCIN1;MVP;INPP5F;SH2B3;SFRP1;PTPN2;CADM4;PPP2R1A;SH3BP5L;SFRP2
prerank,proton transmembrane transport (GO:1902600),-0.309741412705172,-1.1281829636920753,0.2473404255319149,0.6405462113511158,1.0,8/36,19.82%,ATP6V0D1;ATP5PO;SLC46A1;UCP2;ATP6V1A;HVCN1;SLC25A27;ATP6V0A4
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.28216009545197773,1.1281399787867972,0.2188365650969529,0.9334961872287196,1.0,33/118,19.82%,BCL9L;ABI3;TANC2;ARHGAP44;CHN1;PAK1;FLT4;IL6;MEF2C;CLASP2;SHANK3;SRCIN1;VASH1;HECW2;TGFB1;NEDD4;FGF2;CFL1;SFRP1;CAMSAP1;ARHGAP35;VASH2;LZTS3;EPHA4;NEDD4L;FITM2;SARM1;PHLDB2;ZMYM6;NSMF;ZMYM3;LRRC4C;SDC2
prerank,digestive tract development (GO:0048565),0.35158018720562323,1.1273837359325884,0.2874806800618238,0.9348785943767751,1.0,4/32,4.97%,DNAAF1;CCDC39;MEGF8;RARRES2
prerank,proteasome assembly (GO:0043248),-0.425823093719567,-1.1268247965585816,0.29411764705882354,0.6434180135121004,1.0,5/11,18.00%,OTUD6B;PSMG1;PSMD11;PSMD10;PSMD5
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4256978650093226,1.1265350280221764,0.3247422680412371,0.9365823223083222,1.0,6/15,15.93%,FGF16;SMOC2;LGMN;PRKD2;FGF2;PRKD1
prerank,regulation of protein localization to membrane (GO:1905475),0.3671249618629507,1.1259509422778406,0.288961038961039,0.9373448972037851,1.0,11/28,23.64%,GPC1;AR;GPC2;GPC5;PRKN;ZDHHC2;GPC4;SPTBN1;ACTB;VTI1B;PDZK1
prerank,positive regulation of exocytosis (GO:0045921),0.34639893259416743,1.1256461217351554,0.2750759878419453,0.9368684590586595,1.0,11/35,21.97%,RAB3A;CADPS2;SYTL4;CLASP2;CFTR;RAB5A;RAB3D;CHMP2A;STXBP5;SNF8;RAB2B
prerank,RNA stabilization (GO:0043489),-0.318226009193577,-1.125397964858999,0.2566137566137566,0.6464880285719611,1.0,16/33,28.82%,NOCT;ZCCHC17;EIF4ENIF1;TENT2;TRDMT1;TENT5A;SLC11A1;NSUN2;LARP1;DKC1;HNRNPU;NAF1;TENT5C;VIP;PAIP1;PHAX
prerank,positive regulation of protein maturation (GO:1903319),-0.4436659123090948,-1.1253576429472127,0.2925170068027211,0.6457716081016027,1.0,4/11,19.35%,CCBE1;NLRC4;ADAM8;NKD2
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.4135748921256878,-1.1253426283853945,0.2718676122931442,0.64500404723273,1.0,8/14,30.76%,RCC1L;TRUB2;TRMT10C;UQCC2;MRPS27;RPUSD3;C1QBP;MPV17L2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.34792967338148706,-1.1247141820463569,0.30117647058823527,0.6459610091513094,1.0,3/25,6.29%,ITGA4;ITGAX;ITGB7
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.35667584372713135,1.1246033954220889,0.27414330218068533,0.9394208423102366,1.0,12/31,27.15%,SH3BP1;DLG2;SCRIB;PRKCI;CAMSAP3;MTCL1;LIN7A;CDC42;OPHN1;RHOA;PARD3B;MYO9A
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.21035336379831232,-1.124545604365292,0.07368421052631578,0.6455920268453584,1.0,107/509,15.43%,IQGAP1;OSBPL8;SASH1;BCL2;CD74;DDX60;GAS6;HIP1;ANKRD17;IGF1;AXL;BCL2L1;CASS4;GCNT2;ALPK1;TRIM25;PTPRC;DLG5;TLR2;TRIM14;LILRA5;P2RX4;FRS2;RRAGC;MET;LGALS1;TBK1;BAX;SOX11;LAMTOR5;SHISA5;DHX33;TLR7;ESR1;KITLG;GAB1;RPS20;LIMS1;PUM2;CD14;OASL;THBS1;BST2;NOD2;PDGFD;FLT1;RIPK1;TFRC;BCAR3;LITAF;CAV1;TRIM62;LYN;FYN;PLEKHG5;RNF13;GAB2;CLEC6A;IL1B;FGF1;TXN;CCDC22;NRG2;S100A4;SMCR8;EEF1D;HCST;PIK3CA;RET;HPSE;GPRC5B;PDGFC;ADAM8;EP300;CD28;SPRY2;TNFRSF19;LCK;GRB2;TRIM44;F7;GPR61;BIRC2;IGF2;GRM4;CBL;RRAGA;IRAK4;PELI1;KDR;TRIM5;ZDHHC17;PIK3R5;MYOC;RACK1;BMP2;SPHK2;CHD5;PMAIP1;EGFR;AGER;SHC1;DDX21;TNF;BCL2L11;GJA1;WNT5A
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.38560223395977117,1.124475597453184,0.2962328767123288,0.9382876796728343,1.0,10/24,25.44%,ABCB6;FLVCR1;TSPO;PGRMC1;UROD;ALAD;ABCG2;SLC25A38;COX10;CPOX
prerank,dendritic cell chemotaxis (GO:0002407),0.43368478739672484,1.124389971942451,0.30664395229982966,0.9369415381320776,1.0,7/14,19.31%,TRPM2;PIK3CG;CCR1;CXCR4;CCR6;HMGB1;CCL5
prerank,translational termination (GO:0006415),0.2889599264763302,1.1240284061049726,0.2719665271966527,0.9366953614931233,1.0,33/95,26.26%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;GSPT1;N6AMT1;DAP3;MRPS5;MRPL58;APEH;MRPL19;MRPL15;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;TRMT112;MRPS25;MRPS9
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.4717033873972471,1.1238429899016,0.3244206773618538,0.9358551753933761,1.0,4/10,13.30%,ADTRP;CST3;TGFB1;CHADL
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.4498958918334504,1.1233906596479628,0.3333333333333333,0.9361327270572009,1.0,4/12,14.81%,IFT20;F3;NDRG4;APOD
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.4128639168820707,-1.1228597604241937,0.30641330166270786,0.6492951295099234,1.0,9/13,27.14%,PRPF19;PRPF6;LSM2;CD2BP2;DDX20;PRPF3;USP4;PRPF31;AAR2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.3790185113637617,-1.1221294986119015,0.29539951573849876,0.6504895277412439,1.0,6/18,13.89%,SOX6;FRS2;NOTCH1;HDAC1;CCN3;BMP2
prerank,embryonic heart tube development (GO:0035050),0.4345928555274894,1.1219658456541106,0.31282952548330406,0.9401541052889002,1.0,3/14,13.32%,MEGF8;TBX2;NDRG4
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.2413890105193072,-1.1219203101417103,0.1694915254237288,0.6502333747023901,1.0,26/140,12.14%,VAV3;ARHGAP15;ARHGEF3;FGD4;ITSN1;ARHGAP10;STARD8;ARHGAP17;ARHGAP19;CGNL1;ARHGEF18;ARHGEF6;ARHGAP18;ARAP1;ARHGAP30;PLEKHG5;FGD1;RACGAP1;ARHGAP24;ABR;GNA13;RHOJ;ARHGDIB;ARHGAP39;ARHGEF26;ARHGAP28
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3636332724573227,1.1217395625183424,0.30615640599001664,0.9394122886407925,1.0,11/27,19.41%,P2RY12;TNFAIP8L3;TGFB1;FGF2;IRS1;PDGFB;TEK;PRKD1;PTK2;FLT3;PDGFRB
prerank,nucleotide biosynthetic process (GO:0009165),0.40840678331323316,1.1214986122894224,0.282793867120954,0.938735946666935,1.0,8/18,18.89%,PNP;GART;PRPSAP2;HPRT1;ADSL;PRPSAP1;NMNAT2;RRM2B
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.23181524042839727,-1.1214324089501988,0.1693121693121693,0.650801592628341,1.0,47/199,17.85%,RBPJ;FCGR2B;IL15;PAEP;GAS6;NOVA2;PTPN23;MCC;DOCK7;CORO1C;NPTN;PTGER4;RPS6KA6;NRDC;NR1H2;SRGN;IL1B;PCTP;BMP5;RAB11FIP1;MAD2L2;SPRY2;ARHGDIB;NOTCH1;ID1;SMAD6;SLC11A1;PROCR;SPRY1;ALDH1A1;NR1H3;RB1;BMP2;RAB11FIP5;EGFR;AGER;TNF;TRPV3;GJA1;PFN2;TLR4;IL18R1;ADAM17;RGCC;HEY2;PGAM5;GATA3
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.44533008391761,-1.1214097874778781,0.325635103926097,0.6500463080136055,1.0,2/10,2.62%,ZEB2;ATP7A
prerank,modulation by symbiont of entry into host (GO:0052372),-0.3890361597303213,-1.1208940283409532,0.3097560975609756,0.6506792843991699,1.0,5/16,13.02%,TRIM25;TRIM14;CAV1;TRIM62;TRIM5
prerank,dendritic cell differentiation (GO:0097028),-0.3574190463517742,-1.1208563924687105,0.29925187032418954,0.649971618296491,1.0,5/22,14.99%,GAS6;AXL;LYN;BATF2;LILRB1
prerank,cellular response to dsRNA (GO:0071359),-0.392368391528249,-1.1206745624514942,0.2780373831775701,0.6496165027361683,1.0,6/15,16.27%,IFIH1;IFIT1;CAV1;RALB;NPM1;MUL1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4043471172185278,-1.1206457484188792,0.3118811881188119,0.6488933748164099,1.0,10/14,38.91%,ETNPPL;PISD;ETNK2;ALOX15;LPIN3;CHKA;LPIN1;ETNK1;CEPT1;SLC27A1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.3852331640514087,-1.1200985741849883,0.27828054298642535,0.649696246699804,1.0,7/18,24.69%,CCT6A;EXOSC10;CCT3;NOP10;DKC1;NAF1;NHP2
prerank,endochondral bone morphogenesis (GO:0060350),0.46180418872798207,1.1198960546456345,0.3304042179261863,0.9433557991224946,1.0,6/11,23.76%,MEF2C;BMP4;FOXC1;BMPR1B;INPPL1;COL13A1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3707354102289059,-1.1190129582127546,0.2676767676767677,0.6518211939287094,1.0,5/20,11.64%,APOE;DLG5;PSEN1;CAPRIN1;CUX2
prerank,negative regulation of cell growth (GO:0030308),0.2809271973427919,1.1188795906998203,0.24234354194407456,0.9457098075305629,1.0,39/121,24.48%,WFDC1;DIP2B;DCC;CDHR2;PSRC1;SIPA1;STK11;MINAR1;APBB1;FHL1;GNG4;TGFB1;ADAM15;FGF13;MAG;SFRP1;CGRRF1;ACVR1B;DCBLD2;FLCN;EI24;CCAR2;SH3BP4;NDRG3;PTPRS;PPP2R1A;BTG1;TCHP;ULK2;MAP2;FRZB;SFRP2;ULK1;NPR1;JADE1;PRDM11;SMARCA2;CDKN2AIP;CRLF3
prerank,regulation of endothelial cell migration (GO:0010594),-0.2595932716825499,-1.1186936538327015,0.22184300341296928,0.651868318324572,1.0,33/85,25.64%,SASH1;SP100;APOE;NRP1;NRP2;PROX1;THBS1;FGF1;ZC3H12A;PRCP;RHOJ;CEACAM1;KDR;EMP2;PTN;GPI;FOXP1;PTK2B;WNT5A;EPHA2;BCAR1;AAMP;GATA3;ITGB3;BCAS3;PIK3CD;APOH;ADGRB1;EGF;ANXA3;ANGPT1;BMPR2;RAC1
prerank,sympathetic nervous system development (GO:0048485),-0.39315612526848354,-1.1186196252276301,0.28978622327790976,0.6512800704565909,1.0,6/15,19.00%,NRP1;NRP2;SOX11;CTNNB1;GATA3;TFAP2B
prerank,cortical cytoskeleton organization (GO:0030865),0.3374380334991682,1.1183190491642896,0.3108108108108108,0.9462803873437164,1.0,15/41,27.76%,NCKAP1;NCKAP1L;RHOBTB1;FMNL3;FMNL1;RHOQ;ROCK1;RHOBTB2;LLGL2;RHOBTB3;RHOA;FHOD1;LLGL1;RAB13;EPB41L3
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.31142969329058723,-1.1180540506893486,0.2732732732732733,0.6520107675400765,1.0,10/39,17.85%,ITGA4;GAS6;THBS1;KDR;TNF;RAMP2;MAPK7;ECSCR;RGCC;GATA3
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.43872496378177367,-1.1178608800778298,0.30528846153846156,0.6509401209354829,1.0,5/10,25.48%,AP2A2;AP2B1;CLTA;AP2A1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.43872496378177367,-1.1178608800778298,0.30528846153846156,0.6509401209354829,1.0,5/10,25.48%,AP2A2;AP2B1;CLTA;AP2A1;VLDLR
prerank,protein insertion into ER membrane (GO:0045048),0.3448054755229224,1.117853368717227,0.2822966507177033,0.9464836874816273,1.0,10/37,15.21%,SGTA;PRNP;EMC6;EMC2;OTOF;EMD;TRAM2;CCDC47;GET3;TRAM1
prerank,positive regulation of rRNA processing (GO:2000234),0.4764154540339436,1.1178049982624374,0.3379549393414211,0.9450716301257235,1.0,3/10,8.15%,RIOK1;WDR75;DIMT1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3050829834108724,1.1173083899304161,0.26732673267326734,0.9454157055024737,1.0,15/68,16.93%,ACSF2;GTPBP1;ACSL6;ACOT13;AMPD3;HPRT1;OXSM;DBI;ACOT4;ACBD6;TPST2;ACOT11;ACLY;GNAI3;RHOQ
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.3166080749948119,-1.1170653912349153,0.23919308357348704,0.6523106979585109,1.0,13/37,22.31%,APOE;SDCBP;MTMR2;NFKB1;ANKRD13A;BRCA1;EDNRB;OPTN;PTX3;ITGB3;NCOR1;SIRT2;WDR54
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4384847696450501,-1.116830210044666,0.3103448275862069,0.6521919550238704,1.0,3/11,11.98%,DAB2;MLLT3;PLEKHA4
prerank,positive regulation of signal transduction (GO:0009967),-0.2256116228483287,-1.1167967760329607,0.12345679012345678,0.6515094595334793,1.0,51/238,15.37%,RBPJ;SASH1;CD74;NRP1;GAS6;IGF1;AXL;PTPRC;CDC73;CCBE1;RWDD3;DLG5;TLR2;SMARCA4;ASXL2;BAX;NPTN;IL6ST;VPS35;LIMS1;ERN1;TUBD1;FAS;NOD2;PDCD10;ZMIZ1;YAP1;TEDC2;HIF1A;CLEC6A;IL1B;FGF1;CD226;SNW1;EP300;PTGIS;NOTCH1;TRIM44;CUX2;F7;IGF2;SORBS1;LRRK2;TSPAN5;EMP2;CCN3;BMP2;RIMS2;NOTCH4;PTK2B;SCIMP
prerank,lipid translocation (GO:0034204),0.38898183358986105,1.1167752763460395,0.3073322932917317,0.9459720722415393,1.0,6/21,16.69%,ATP8A2;ATP9A;ABCB4;ATP11A;ATP8B1;ATP8A1
prerank,ESCRT III complex disassembly (GO:1904903),0.4674415611381715,1.116373748390125,0.31514084507042256,0.944399647974645,1.0,6/10,28.97%,CHMP1A;CHMP2A;CHMP5;VTA1;CHMP7;CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.4674415611381715,1.116373748390125,0.31514084507042256,0.944399647974645,1.0,6/10,28.97%,CHMP1A;CHMP2A;CHMP5;VTA1;CHMP7;CHMP2B
prerank,negative regulation of RNA splicing (GO:0033119),0.3965180850082548,1.116329755575572,0.3089171974522293,0.9429776294746781,1.0,4/19,6.02%,SRSF12;RNPS1;SRSF6;PTBP1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.4181915391257188,1.1151522811759627,0.31864406779661014,0.9460020807914035,1.0,5/16,20.74%,GNB3;PRKN;SCARB2;RORA;PDK1
prerank,glycogen metabolic process (GO:0005977),-0.34025683568827614,-1.1150901973552008,0.29081632653061223,0.655325493298058,1.0,8/27,18.14%,PHKB;GYG1;AGL;PRKAG2;PPP1R3C;GAA;PGM2L1;PER2
prerank,second-messenger-mediated signaling (GO:0019932),0.294957129133485,1.1150661751106803,0.26490984743411927,0.9447375644405093,1.0,23/82,18.39%,ACKR4;P2RY12;ACKR3;KSR2;NMUR1;PLCG1;CCR1;SAMD14;RCAN3;CXCR6;CX3CR1;BTK;CXCR4;CCR6;NDNF;RCAN2;ACKR2;CCR9;DDAH2;PPP1R9A;AGT;PPP2R1A;INPP5A
prerank,protein localization to organelle (GO:0033365),0.2728877730571447,1.1145343974621706,0.2242503259452412,0.9451797611892169,1.0,23/133,13.34%,IFT20;HHEX;YWHAE;LAMP5;OBSL1;ROPN1;SIX4;SGTA;PRNP;SYS1;DDX1;MTCH2;BMP4;OTOF;ARFRP1;BBS9;EMD;TRAM2;CCDC47;EHD1;SCG3;BICD2;MICALL1
prerank,regulation of B cell activation (GO:0050864),-0.3414343365446242,-1.1141376191106636,0.2759493670886076,0.6571305187702448,1.0,6/25,12.06%,FCGR2B;AHR;NOD2;BANK1;IKZF3;FOXJ1
prerank,kidney development (GO:0001822),0.3032765357334707,1.1140596272539132,0.26600284495021337,0.9453587874886071,1.0,13/65,17.15%,FGF10;WNT4;VANGL2;SOX4;TGFBR1;BMP4;FOXC1;C1GALT1;PKD1;IFT27;IFT88;AGT;PYGO2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.34112128518033175,1.1138716338455683,0.27821939586645467,0.9445375967371313,1.0,12/35,22.96%,POLG;POLD3;OGG1;XRCC1;LIG3;ADPRS;PARP1;APEX1;FEN1;UNG;MPG;RFC4
prerank,striated muscle cell development (GO:0055002),0.42671748639416507,1.1137831377468355,0.3392857142857143,0.9433226661195645,1.0,4/14,12.94%,CAPN3;LMOD1;TMOD2;LMOD3
prerank,mRNA transport (GO:0051028),0.288827251163265,1.1136454247845746,0.2546419098143236,0.9422938072111194,1.0,34/101,24.22%,HHEX;RNPS1;AAAS;SRSF5;MCM3AP;CASC3;DDX25;SRSF6;SRSF11;NUP54;SRSF1;YTHDC1;CPSF3;NUP88;RAE1;FYTTD1;UPF1;CDC40;DDX39B;THOC5;NUP133;SARNP;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;ALKBH5;RBM15B;GLE1;EIF4E
prerank,sulfate transport (GO:0008272),-0.3914902411158127,-1.113567204580561,0.3140096618357488,0.6579895374419367,1.0,4/14,12.72%,SLC26A11;RACGAP1;SLC13A4;SLC25A11
prerank,negative regulation of T cell proliferation (GO:0042130),0.3606698763235338,1.112297700489334,0.3110419906687403,0.9460529618407031,1.0,5/28,5.52%,CD80;IL4I1;SCRIB;CD86;PRNP
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.44107918990612094,-1.1122412601928025,0.3097949886104784,0.6609409856763155,1.0,4/10,21.17%,NCK1;VHL;DNAJB1;SIRT2
prerank,histone ubiquitination (GO:0016574),0.3854131416366498,1.1120124285429998,0.30870279146141216,0.9456425461832658,1.0,6/21,16.18%,CTR9;UBE2B;PHC1;UBE2N;RNF8;PAF1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4139527383352414,1.1117921978280165,0.31724137931034485,0.9449427416399612,1.0,5/16,31.43%,CLDN16;CLDN14;CLDN18;CLDN5;CLDN10
prerank,protein complex oligomerization (GO:0051259),0.2928941819090248,1.1116747305459656,0.26933701657458564,0.9438164584195619,1.0,23/85,18.87%,ADCY8;GLRA3;MPP2;IKZF4;NACC2;FUS;C9;CPSF6;ATL1;KCNC1;TRMT61B;MAT2A;PKD2;EHD1;DNM1L;CHMP2A;NUDT21;RNF135;OXA1L;KCNC3;EHD3;ALS2;ALAD
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.39652970575417007,-1.1116010640975145,0.30787037037037035,0.6618941646749081,1.0,4/15,12.97%,APOE;PLTP;ABCG1;APOC1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.43346685190829626,1.1111582594029052,0.31793960923623443,0.9442548661240923,1.0,6/14,16.67%,SEC31A;SEC24D;SEC24B;MIA3;SEC24C;SCAP
prerank,cellular protein catabolic process (GO:0044257),-0.28339561923204976,-1.110339513017258,0.23870967741935484,0.6645314443612678,1.0,12/59,11.18%,PSMA6;AP2A2;YME1L1;SIAH2;RAB7A;CAPN2;AP2B1;RIPK1;CTSL;CTSB;CLPP;CLTA
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.2394042160170171,-1.1101738182025396,0.20161290322580644,0.664179626309571,1.0,43/149,20.24%,PSMA6;FLOT2;PRKCH;TRIM25;TLR2;TRIM14;CD36;RAB7B;LAMTOR5;NLRC4;DHX33;NFKB1;NOD2;RIPK1;TFRC;CAV1;TRIM62;UBC;CIB1;PRKCQ;IL1B;TAB1;PIDD1;UBA52;ADAM8;EP300;TRIM5;EDA;NPM1;RIPK4;AGER;TNF;WNT5A;TRAF1;TLR4;CRNN;IL18R1;ERC1;ARHGEF2;TRIM37;MYD88;HSPA1B;LTF
prerank,acyl-CoA biosynthetic process (GO:0071616),0.41453545607701003,1.1101346167524933,0.32666666666666666,0.9467972001959719,1.0,11/16,32.63%,CBR4;PPT2;ACLY;PPCS;ACSS1;SLC25A1;FASN;DIP2A;ACAT1;MLYCD;GCDH
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.4473909168804127,-1.1100035538032376,0.34192037470725994,0.6638237169317603,1.0,4/10,16.06%,STOML2;E2F8;CDT1;E2F7
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3942471671899843,-1.1096015639206709,0.3069544364508393,0.6641384829049638,1.0,7/16,21.74%,SMCHD1;KLHL15;MAD2L2;RMI2;SHLD1;PARPBP;FBH1
prerank,negative regulation of organelle assembly (GO:1902116),-0.3132533266024641,-1.1094914855286606,0.2694610778443114,0.6636782829926101,1.0,16/35,29.83%,CHMP4B;CHMP4A;CDK5RAP2;YAP1;BRCA1;SMCR8;MTM1;LRRK2;SMAD4;TRIM37;KAT2B;PHF23;CEP97;TESK1;CCP110;SCFD1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3967207936515531,-1.1094241617091023,0.3287671232876712,0.6630615838193179,1.0,5/13,19.18%,IGF1;IGF2;SORBS1;PPP1R3E;IRS2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.34336212945920574,-1.1093634180379668,0.3012658227848101,0.6624004566114032,1.0,8/25,19.91%,RBPJ;SOX11;NOTCH1;CCN1;NUMA1;SMAD4;FBXL15;ACVR2A
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.43808832963331606,1.109356783788163,0.3316412859560068,0.9482217094776416,1.0,4/13,12.83%,RAB3A;GRIK2;SYNGR1;SLC4A10
prerank,peptidyl-glutamic acid modification (GO:0018200),0.37619314459256714,1.1092034693786368,0.32825719120135366,0.9472337734326584,1.0,12/24,26.77%,VKORC1L1;TTLL6;PARP1;AGBL4;TTLL7;TPGS1;TTLL1;TTLL10;TTLL5;TTLL8;TTLL11;CFAP20
prerank,tRNA modification (GO:0006400),0.3051144996242289,1.109058756377536,0.3064748201438849,0.9462608906503419,1.0,11/62,10.21%,TYW5;ADAT2;ELP5;CTU1;METTL2B;METTL2A;TRMT44;METTL1;TRMT61B;DTWD2;FTSJ1
prerank,cell-cell junction assembly (GO:0007043),0.30494760151012656,1.1088474928599068,0.3019145802650957,0.9454858734749993,1.0,12/63,15.93%,CNTNAP1;FSCN1;DCHS1;PARD6B;PKP4;CDH18;PRKCA;GJA5;CTNND2;FLCN;PATJ;JAM3
prerank,positive regulation of cell junction assembly (GO:1901890),0.31201470614848203,1.1088278397852596,0.2948148148148148,0.943993512480477,1.0,16/56,18.81%,PTPRD;SRPX2;THY1;IL1RAP;NRXN1;GRID2;MAP4K4;CLSTN2;IL1RAPL1;SFRP1;TEK;EPHB2;WNT7A;AGT;ROCK1;GHRL
prerank,mitochondrial translational elongation (GO:0070125),0.28688231649684937,1.1087325979610692,0.2839160839160839,0.9428315830632271,1.0,29/88,26.26%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,ribosomal large subunit assembly (GO:0000027),-0.34408591819950596,-1.1086456796584403,0.2849604221635884,0.663617855946429,1.0,9/24,20.36%,RPL5;RPF2;RPL6;RPL10;RPL23A;MDN1;RPL3;NOP53;RPL11
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.34713123507446025,-1.1084680826865918,0.30612244897959184,0.663296269500462,1.0,7/23,14.78%,KPNB1;DNASE2;HMGB2;DNASE1L1;H1-0;ENDOG;DFFA
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.29877421031028184,1.1084418875752726,0.277037037037037,0.9424430111319787,1.0,15/72,15.16%,POLR2L;CDK7;POLR2F;COPS8;XAB2;GTF2H2;ISY1;POLD3;GTF2H4;XRCC1;LIG3;COPS3;POLR2G;COPS6;ERCC6
prerank,peptidyl-lysine methylation (GO:0018022),0.37016388764167546,1.1081782870708181,0.3223570190641248,0.9418389944510899,1.0,9/26,17.00%,SMYD2;METTL21C;EEF1AKMT2;METTL21A;SETD6;SETD4;SUV39H2;SMYD1;N6AMT1
prerank,protein localization to condensed chromosome (GO:1903083),-0.4196068446179255,-1.1078287026509726,0.33753148614609574,0.664238446066688,1.0,5/12,14.15%,BUB3;MIS12;ZWILCH;CDK1;SPDL1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3363786158789388,-1.1074203360796495,0.3012658227848101,0.6646137178410958,1.0,12/24,30.08%,GNL3L;EXOSC10;TERF2;SLX4;TENT4B;NAT10;HNRNPC;HNRNPU;TINF2;PIF1;TNKS;PINX1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.4610992781872959,1.1073970054820352,0.3361921097770154,0.9433138262491687,1.0,2/10,2.39%,NOS1AP;CACNB2
prerank,protein alkylation (GO:0008213),-0.35829674299725534,-1.1073114842171692,0.2923433874709977,0.6641046477515797,1.0,9/22,14.03%,FAM98B;FAM98A;ETF1;CAMKMT;SNRPB;VCPKMT;PRMT2;EEF2KMT;ETFBKMT
prerank,DNA metabolic process (GO:0006259),-0.2177201683127005,-1.1072482983664271,0.14838709677419354,0.6634942303405824,1.0,62/270,17.04%,SP100;RAD51B;PARP4;RBBP8;VCP;DNASE2;HMGB2;PDS5B;DNASE1L1;POLE4;TOP2A;PCNA;KPNA2;TOPBP1;DOT1L;RTEL1;UHRF2;ORC5;ZRANB3;NT5E;CDC34;CHD1L;POLI;NBN;UBC;IGHMBP2;DNMT1;USP45;BRCA1;UVRAG;PDS5A;ATRIP;HINFP;UBA52;TRRAP;ORC2;POLD4;BARD1;RPA1;CDK1;LIG4;RMI2;MCM2;KAT5;TICRR;ORC4;RAD21;TYMS;ENDOG;NPM1;CDT1;PRIM2;MNAT1;TERF2;DDX21;MCM8;RNASEH2A;NTHL1;CBS;NOP53;RPA2;MUTYH
prerank,regulation of protein transport (GO:0051223),-0.33145612933491325,-1.1072245491592536,0.29292929292929293,0.6627746984908304,1.0,13/27,30.20%,DNAJC1;PTPN1;GAPVD1;LCP1;TNF;CHP1;PPM1F;NDFIP1;ATP13A2;SNX3;RHBDF2;SCFD1;NDFIP2
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.38383347140763724,-1.1070804983329732,0.30066815144766146,0.6623589727210771,1.0,4/17,12.84%,ATP5MG;ATP5PO;ATP5MC1;STOML2
prerank,RNA processing (GO:0006396),0.2668644472342478,1.106912880492923,0.26878980891719745,0.9435705314421383,1.0,41/176,17.48%,ADARB2;RNPS1;IVNS1ABP;SMU1;SRSF5;FUS;DHX15;TSEN54;BCAS2;HNRNPH1;PPARGC1A;CPSF6;SF3B2;LSM1;PTBP1;SRSF11;MTPAP;ADAR;RBM5;PPIG;AKAP8L;PRMT9;SON;RNASEL;SF3A1;SRSF1;SNRPD2;MPHOSPH10;DROSHA;SF3B3;NUDT21;NOVA1;RP9;DDX39B;DDX47;CCAR2;RBM3;SETX;BICD1;SRSF9;PPP2R1A
prerank,atrial septum morphogenesis (GO:0060413),0.4825667462625131,1.106393453861861,0.3644524236983842,0.9440213932720513,1.0,2/10,4.45%,ZFPM1;SOX4
prerank,Notch signaling involved in heart development (GO:0061314),-0.4387776015701777,-1.1063123526432457,0.3441108545034642,0.6636183459242979,1.0,7/11,27.05%,RBPJ;NOTCH1;HEY2;NOTCH2;HEYL;GALNT11;DLL4
prerank,neutral amino acid transport (GO:0015804),-0.32498658654155577,-1.1061529786809197,0.29155313351498635,0.6632528338958095,1.0,4/28,3.14%,SLC38A6;SLC1A5;SLC43A2;SLC6A6
prerank,leukocyte tethering or rolling (GO:0050901),0.40616830943680915,1.1056875070048187,0.3184931506849315,0.9452133955846814,1.0,5/17,9.53%,SELPLG;ADD2;JAM2;PODXL2;CX3CR1
prerank,histone H4-K5 acetylation (GO:0043981),0.423349055003883,1.105645015997571,0.3048780487804878,0.9422964422345268,1.0,9/15,30.69%,JADE2;MEAF6;OGT;KAT8;WDR5;JADE1;MCRS1;ING4;KANSL3
prerank,histone H4-K8 acetylation (GO:0043982),0.423349055003883,1.105645015997571,0.3048780487804878,0.9422964422345268,1.0,9/15,30.69%,JADE2;MEAF6;OGT;KAT8;WDR5;JADE1;MCRS1;ING4;KANSL3
prerank,response to progesterone (GO:0032570),-0.37438302955663005,-1.1055971454202922,0.3208020050125313,0.6641068010157561,1.0,7/18,13.28%,THBS1;CATSPER3;CAV1;YAP1;CATSPER2;ACOD1;NR1H3
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.26210848864958225,-1.1052602739259896,0.23426573426573427,0.664190941234477,1.0,19/78,17.21%,DAB2;PID1;PRKCH;BCL2L1;PRKCE;PPP2R5A;LDLRAP1;PICALM;CIB1;SORBS1;LRP1;EGFR;TNF;EPHA2;PLS1;CLN3;SQSTM1;RSC1A1;AKAP5
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.4304314692419714,-1.1051189443492062,0.3270588235294118,0.6637598562095173,1.0,4/12,9.48%,EML2;DYRK1A;STMN1;MAPRE1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2608034903699898,-1.1045033749034425,0.24742268041237114,0.6647424193364871,1.0,32/82,24.56%,SUCO;IGF1;NBR1;NOCT;CDK6;LIMD1;PPARG;PRKACA;SOX11;IL6ST;YAP1;NOTCH1;TRPM4;CCN1;SMAD6;GREM1;BMP2;SMOC1;RIOX1;ACVR1;ACVR2A;BMP7;LTF;BAMBI;PTCH1;IFITM1;FFAR4;SEMA4D;TWIST1;TNN;GDF10;TMEM119
prerank,regulation of interleukin-4 production (GO:0032673),-0.35800743184952283,-1.1041053853927427,0.3053435114503817,0.6651073774608812,1.0,8/21,17.85%,RARA;IRF4;SYK;CEBPB;PRKCQ;CD28;FCER1G;GATA3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.38832848425166033,-1.1039067618212348,0.3230088495575221,0.6648794435242471,1.0,4/16,12.84%,ATP5MG;ATP5PO;ATP5MC1;STOML2
prerank,regulation of vasculogenesis (GO:2001212),-0.39586140989519025,-1.1037811947829004,0.3367088607594937,0.6644431539449929,1.0,7/14,17.31%,XDH;CEACAM1;KDR;EMP2;RAP1A;ASB4;HEY2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4175239733046083,-1.1037529148499716,0.3277511961722488,0.6637398615361193,1.0,8/13,31.01%,CAV1;CAMK2D;CALM3;CALM2;PDE4D;CASQ2;CALM1;SRI
prerank,limb morphogenesis (GO:0035108),-0.35443783454963695,-1.103535795373867,0.3121951219512195,0.6635031221235888,1.0,7/20,22.33%,MBNL1;FBXW4;IQCE;LRP6;TFAP2B;PTCH1;SHH
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.21437716587154945,-1.103471888485639,0.14035087719298245,0.6628890554831353,1.0,110/348,25.35%,PID1;RBPJ;ITCH;CD74;GAS6;PTPN22;STAP1;ITGAX;IGF1;CELF1;SETDB2;ADAM19;MITF;MED26;TLR2;RPL5;FAM98B;PPHLN1;AFDN;BRAF;CD36;PRKAB1;DTX3L;FAM98A;PTPN1;ZPR1;SOX11;LAMTOR5;VPS35;TYROBP;LIMS1;MSN;RPS7;PF4;SMAD3;SP1;TFRC;PDCD10;YAP1;DNMT1;HIF1A;BRCA1;IL1B;FGF1;PSEN1;HINFP;ZC3H12A;KRAS;CTCF;CD28;SPRY2;NOTCH1;CUX2;ATF7IP;SLC11A1;AGO2;SCX;GREM1;BMP2;TESC;RIMS2;TERF2;LILRB1;TNF;RAMP2;GJA1;WNT5A;PDE2A;MAPK7;TLR4;MAPK8;KLF2;GSN;RGCC;HEY2;WFS1;HMGA2;FN1;NWD1;MMP8;PPM1F;MYD88;HSPA1B;BMP7;DTNBP1;RPL11;KLF4;WARS1;PIK3CD;POU3F1;CDH3;ID2;HMGN5;CD3E;FGF18;TWIST1;APP;TASOR;PLSCR1;MAPK11;PAX6;EGF;FGFR4;TMEM119;RAMP3;ANGPT1;TLR9;RNF207;MTPN;ATP13A2
prerank,myeloid leukocyte differentiation (GO:0002573),-0.27005015762696816,-1.1032043647715386,0.25874125874125875,0.6628425923293095,1.0,13/65,15.76%,IL15;PPARG;CBFA2T3;RARA;TYROBP;GPR183;GAB2;DEK;EP300;FOXP1;BATF2;MYH9;EPHA2
prerank,membrane depolarization (GO:0051899),0.34847132800195285,1.1030702646087434,0.3073248407643312,0.950957458659791,1.0,17/32,32.39%,CACNB4;CACNG2;KCNH2;CACNA1G;CACNA1B;SCN2A;CACNA1A;SCN1B;SCN3B;SCN8A;SCN7A;CACNA1H;SCN1A;ATP5IF1;CACNA1I;P2RX7;CACNA1E
prerank,icosanoid secretion (GO:0032309),-0.417167846019973,-1.1028984802599362,0.3088235294117647,0.6628984747753306,1.0,5/12,34.75%,ANXA1;DRD2;DRD3;ABCC4;NOS2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.3319007448450143,-1.1028711271259353,0.2905759162303665,0.6621979245628994,1.0,12/26,27.88%,ALOX5;CD36;CYBA;SLC5A3;SPHK2;SLC25A33;TLR4;MMP8;ADGRB1;CCN6;ABCD1;SLC30A10
prerank,sulfation (GO:0051923),0.4499800784634622,1.102799413620242,0.33687943262411346,0.9504063850627749,1.0,1/11,1.10%,HS3ST5
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3428699497614943,-1.102767563520293,0.2989949748743719,0.661685478434637,1.0,12/23,24.26%,CDK5RAP2;CENPA;MAD2L1;SPDL1;NUMA1;UBXN2B;GJA1;NDC80;PLK1;PAFAH1B1;NDE1;PKHD1
prerank,cellular response to cadmium ion (GO:0071276),0.37478974898557166,1.102429584483374,0.3252818035426731,0.950330258356641,1.0,10/24,18.07%,MAPK3;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of cell death (GO:0010942),-0.27265820812981595,-1.1022701725444894,0.2727272727272727,0.6622726011146739,1.0,15/59,15.43%,FCGR2B;CELF1;CD36;SLC6A6;TYROBP;RIPK1;PICALM;FYN;ZC3H12A;EIF2S1;LRRK2;LRP1;FOS;TNF;WNT5A
prerank,positive regulation of programmed cell death (GO:0043068),-0.21835085245219385,-1.102182867009938,0.14285714285714285,0.6617469552215576,1.0,60/272,16.84%,VAV3;ARHGEF3;FGD4;ITSN1;STK3;ARL6IP5;STK17B;TNFAIP8;IFIT2;ZBP1;BAX;TOP2A;PTPA;NLRC4;ARHGEF18;ATG7;ARHGEF6;SLC27A4;HIP1R;FAS;HSPD1;SYK;RIPK1;PLEKHG5;UBC;FGD1;PSEN1;PIDD1;PNMA2;ABR;UBA52;GNA13;UTP11;MAP3K11;DNM2;CTNNB1;FOXO1;PRMT2;BARD1;STPG1;DAPK1;ARHGEF26;LRRK2;GADD45G;RPS6KA2;APH1B;RYBP;RACK1;BMP2;SPHK2;PMAIP1;LILRB1;TNF;BCL2L11;SAP18;DDX20;ARHGEF5;KLF11;MAPK8;SQSTM1
prerank,amino acid import (GO:0043090),0.3849936221004549,1.1019905814414301,0.32450331125827814,0.9505288777885537,1.0,7/21,15.54%,SLC1A1;SFXN1;SLC1A3;SFXN2;SLC6A1;SLC22A4;SH3BP4
prerank,histone methylation (GO:0016571),0.3668152537952766,1.1019580353991494,0.3134087237479806,0.9491271313976384,1.0,7/26,17.00%,SMYD2;NSD1;SETD6;SUV39H2;SMYD1;FBLL1;N6AMT1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.4052473386155211,1.1018761629696874,0.3494983277591973,0.9479411624537719,1.0,9/15,26.78%,NTRK1;DDIT4;CASP3;SORT1;HAP1;NTRK2;ZFYVE27;BDNF;NGFR
prerank,signal transduction in response to DNA damage (GO:0042770),-0.28756173060048223,-1.1017528058174217,0.2796610169491525,0.6621849402845388,1.0,12/49,10.80%,PRPF19;CLSPN;USP28;DOT1L;BCL3;NBN;ATRIP;HINFP;MAD2L2;GRB2;RHNO1;PAXIP1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3063629158048597,-1.1016547541525148,0.281767955801105,0.661695519888804,1.0,10/37,15.24%,BCL2;BCL2L1;BAX;NCK1;RPS7;CAV1;LCK;RACK1;PMAIP1;BCL2L11
prerank,regulation of centriole replication (GO:0046599),-0.37064551036407234,-1.101462614042742,0.3188405797101449,0.6613973703891345,1.0,7/17,22.58%,CDK5RAP2;BRCA1;NPM1;NUP62;CEP295;TRIM37;KAT2B
prerank,long-chain fatty acid transport (GO:0015909),-0.32024320918485366,-1.1012243344110617,0.31382978723404253,0.6612391818145195,1.0,10/30,16.27%,APOE;PPARG;CD36;FABP4;SLC27A4;PRKAG2;MID1IP1;PRKAB2;MFSD2A;ACACA
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.250533336036691,-1.1011664534662826,0.21201413427561838,0.660622943841614,1.0,20/98,14.55%,PID1;APOE;IFNAR1;CHCHD2;XDH;PPARG;RAB1A;THBS1;PPARD;DHRS4;RIPK1;NR1H2;ZC3H12A;GRB2;ACOD1;CDK1;APOC1;NR1H3;GREM1;IFNLR1
prerank,regulation of RNA splicing (GO:0043484),0.29835256955634143,1.1011605468465382,0.28715728715728717,0.9491769178332914,1.0,29/69,25.49%,PQBP1;FUS;FAM50A;TRA2B;HNRNPH1;CWC22;SLC38A2;PTBP1;SNRNP70;SON;YTHDC1;METTL16;KHDRBS2;METTL4;QKI;SETX;RRP1B;SRRM4;RBM20;TIA1;RBM38;CLK3;FASTK;RBM39;TMBIM6;ESRP1;SRSF3;HNRNPH3;SF1
prerank,artery morphogenesis (GO:0048844),0.3487666923004143,1.1009941842543698,0.34299516908212563,0.9482801020789848,1.0,10/30,19.41%,LRP2;TGFBR1;BMP4;PKD2;TBX2;GJA5;ANGPTL3;ENG;HPGD;PDGFRB
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3449689779220376,1.1009116542636985,0.3295269168026101,0.9470923381838547,1.0,6/32,14.90%,CAPN3;THY1;PLCG1;PKD2;GSTO1;HAP1
prerank,transcription by RNA polymerase I (GO:0006360),0.34045293687401734,1.100829343488059,0.3237518910741301,0.9459033233572643,1.0,15/34,27.54%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;POLR1E;RRN3;MAPK3;POLR1F;POLR1G;GTF2H3;ERCC2;TAF1A;POLR1A;GTF2H1
prerank,ketone body metabolic process (GO:1902224),0.4551858019781898,1.1001119134319184,0.3362369337979094,0.9471243308960411,1.0,3/10,14.63%,HMGCLL1;ACSS3;OXCT1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.39323132328899824,-1.1000726676826846,0.3176178660049628,0.6627696561527339,1.0,10/15,39.09%,TACC3;CDC27;PLK1;UBE2C;ANAPC7;CDC23;CENPE;ANAPC1;PTTG1;CDC16
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.29015730283947316,-1.099938768017348,0.27044025157232704,0.6623344375789179,1.0,11/49,15.24%,BCL2;BCL2L1;MCL1;BAX;CAV1;UBQLN1;PLAUR;LCK;RACK1;PMAIP1;BCL2L11
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.312839460837856,1.0998424450832183,0.3026706231454006,0.9467406952569025,1.0,12/53,15.46%,FGF10;WRAP53;NACC2;DDX5;HIC1;NSMCE4A;EEF1E1;UBE2N;RNF168;RNF8;ERCC6;CCAR2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4486509568076307,1.0996004964377253,0.3339191564147627,0.946194689168135,1.0,2/12,7.46%,MCM5;MCM3
prerank,gluconeogenesis (GO:0006094),0.3327492692048354,1.0994079891177642,0.30884557721139433,0.9454732677436557,1.0,15/39,27.24%,GAPDH;PPARGC1A;SLC37A4;PGAM2;ALDOC;MDH1;PGM1;ALDOA;ENO3;SLC25A10;RBP4;SLC25A1;CRTC2;ATF4;PFKFB1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.42120158564392596,1.099363903902472,0.3396551724137931,0.9441181516043676,1.0,6/14,16.21%,PELI3;CCDC3;RFFL;TRAIP;PTPN2;CARD16
prerank,negative regulation of double-strand break repair (GO:2000780),-0.32606185170351665,-1.0991679045319371,0.2887700534759358,0.6636503392667468,1.0,12/30,22.48%,SMCHD1;CYREN;HSF1;KLHL15;MAD2L2;TRIP12;RMI2;SHLD1;PARPBP;HMGA2;FBH1;TWIST1
prerank,negative regulation of histone modification (GO:0031057),-0.3951087312563262,-1.0989393177979976,0.31143552311435524,0.6635124886199205,1.0,6/14,22.51%,BRCA1;SPHK2;THAP7;TAF7;TWIST1;AASS
prerank,lipid catabolic process (GO:0016042),-0.3604775616720066,-1.0988708539265974,0.3433583959899749,0.6629490470318469,1.0,6/18,22.02%,PLAAT3;LPL;ACADL;HSD11B1;SIRT2;PLA1A
prerank,pancreas development (GO:0031016),0.4421585160937544,1.0988604677820633,0.3404255319148936,0.9445933719263208,1.0,3/12,8.64%,DNAAF1;CCDC39;TCF7L2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.43524551930464134,1.0987420330330366,0.33943427620632277,0.9435740613710406,1.0,4/12,14.92%,MYCBP2;NFIB;EPHA4;EPHB2
prerank,phospholipid transport (GO:0015914),-0.2872764155529548,-1.0987127334951905,0.2742382271468144,0.6626066783602588,1.0,12/52,12.97%,OSBPL8;ATP8B4;APOE;NPC2;TMEM30A;PLTP;LDLR;PCTP;OSBPL2;ABCG1;ATP11C;APOC1
prerank,positive regulation of cellular senescence (GO:2000774),0.4657632119912395,1.0987023786601726,0.34797297297297297,0.9422608428004704,1.0,4/10,18.94%,ABI3;EEF1E1;CGAS;ARG2
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4105400045910701,-1.0985214659400404,0.32338308457711445,0.6623874025407982,1.0,4/14,5.98%,CD74;DENND1B;RARA;NOD2
prerank,nucleotide-excision repair (GO:0006289),0.2779344438439049,1.0983733654116998,0.2857142857142857,0.9420162746457166,1.0,31/101,24.41%,POLR2L;CDK7;POLR2F;COPS8;XAB2;GTF2H2;ISY1;POLD3;GTF2H4;COMMD1;OGG1;XRCC1;LIG3;COPS3;FAN1;POLR2G;PARP1;DDB2;COPS6;ERCC6;BRIP1;HUS1;COPS5;POLR2C;GTF2H3;POLA1;RFC4;POLR2D;ERCC2;ERCC4;USP7
prerank,regulation of lymphocyte migration (GO:2000401),0.45701184801235833,1.0981177850229378,0.3530405405405405,0.9415173508899571,1.0,4/10,15.73%,ADTRP;JAM2;CCR6;MIA3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.29762105257960597,-1.0979131645845321,0.2747875354107649,0.6632320780773903,1.0,15/43,23.69%,GAS6;PTPN22;CD274;IGF1;RARA;ZC3H12A;SLAMF1;LBP;LILRB1;TLR4;CD33;LTF;NLRC3;NR1H4;GSTP1
prerank,osteoclast differentiation (GO:0030316),-0.34669917224860386,-1.0976558044948905,0.30985915492957744,0.6631893641476763,1.0,9/22,31.53%,TYROBP;GPR183;GAB2;FOXP1;EPHA2;OSCAR;CSF1;GLO1;DCSTAMP
prerank,amino acid transmembrane transport (GO:0003333),-0.289829703691565,-1.0976468332448595,0.2787878787878788,0.6624607672890825,1.0,10/45,17.51%,SLC38A6;LRRC8D;SLC7A1;SLC6A6;SLC7A11;SFXN3;SLC7A6;SLC38A11;SLC3A2;SLC25A22
prerank,protein targeting to peroxisome (GO:0006625),0.35757308821331485,1.0974117494448679,0.3211009174311927,0.9426241468730495,1.0,16/29,27.86%,PEX5;FIS1;ATAD1;PEX26;PEX14;PEX2;PEX6;ABCD2;PEX11B;PEX3;ZFAND6;HACL1;PXMP4;ABCD3;ACBD5;LONP2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3955630104823241,-1.0974000734505382,0.30788804071246817,0.6624065494007132,1.0,6/14,10.80%,PRDM9;DNMT1;BRCA1;SNW1;CTNNB1;PAXIP1
prerank,positive regulation of axonogenesis (GO:0050772),0.3329709784634386,1.0971256348762275,0.3295638126009693,0.9422312880418013,1.0,18/43,28.40%,MAP6;SEMA7A;PLXNB2;LIMK1;TWF2;ARHGDIA;CDKL5;MAP3K13;NTRK2;PLXNB1;ZFYVE27;BDNF;TIAM1;RHOA;MAPT;NGFR;SLITRK1;ROBO1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.30481979787456615,-1.0967177288958625,0.3076923076923077,0.6634437692132146,1.0,8/37,11.79%,IGF1;PPARG;MEF2D;ERN1;LDLRAP1;DNMT1;EFEMP2;HTR1B
prerank,DNA conformation change (GO:0071103),0.3933459167314177,1.096660031056528,0.33614864864864863,0.9425196877362213,1.0,5/17,15.27%,TOP3A;HHEX;TOP1MT;HMGB1;HMGB3
prerank,regulation of cell migration (GO:0030334),0.2423136517955506,1.0964998548456795,0.23094425483503983,0.9416656909477592,1.0,86/382,17.88%,FGF10;ABI3;FRMD5;SEMA7A;F3;FGF16;SRGAP3;SRGAP2;PLXNB2;FGF9;LDB2;LDB1;STK26;LDLRAD4;CTNNA2;PAK1;ELP5;PARD6B;LRRC15;ROBO4;VSIR;SLURP1;ARSB;THY1;NUMB;SEMA6C;BEX4;PTPRT;DNAI3;PTPRU;FGF7;NTRK3;NAV3;MAPK15;TRIP6;SEMA6B;ADRA2A;CCR1;MAZ;TGFBR1;SEMA3D;SRCIN1;ENPP2;PRKCA;EPHA1;ERBB4;MAP4K4;SST;IGSF10;TGFB1;MYO1C;SNAI2;ADAM15;CAMSAP3;FGF2;MINK1;SFRP1;DOCK10;SCAI;SEMA4F;PDGFB;HACE1;EPHA4;FLCN;RFFL;KIF2A;CBLL1;INSR;EPHB2;RCC2;SERPINE2;ADORA3;MIA3;SEMA4B;KIF14;HRAS;SEMA3C;PTK2;ITGA6;ANGPTL3;ROCK1;ENG;ULK4;NTNG2;NTNG1;XBP1
prerank,embryonic limb morphogenesis (GO:0030326),-0.3063384739408389,-1.0964104600849773,0.30133333333333334,0.6635006716328655,1.0,11/34,22.48%,MBNL1;FBXW4;WDPCP;CTNNB1;HDAC2;HDAC1;LRP6;MAP3K20;PTCH1;SHH;TWIST1
prerank,protein import into peroxisome matrix (GO:0016558),0.44112511753589334,1.0963185302126195,0.36019736842105265,0.940850175824371,1.0,5/12,18.22%,PEX5;PEX26;PEX14;PEX2;PEX6
prerank,presynapse assembly (GO:0099054),0.401686541487168,1.0959444979711972,0.3424190800681431,0.9407806208028952,1.0,9/16,32.25%,PTPRD;LRRTM3;IL1RAPL1;WNT7A;PCLO;PTEN;CEL;NLGN3;NLGN1
prerank,hexose biosynthetic process (GO:0019319),0.3284722183680642,1.0958677660749192,0.3278443113772455,0.9396132916757549,1.0,16/42,27.24%,GAPDH;PPARGC1A;SLC37A4;AKR1B1;PGAM2;ALDOC;MDH1;PGM1;ALDOA;ENO3;SLC25A10;RBP4;SLC25A1;CRTC2;ATF4;PFKFB1
prerank,regulation of peptide hormone secretion (GO:0090276),0.3001209772152113,1.0957096873986156,0.30029154518950435,0.9387580817064768,1.0,16/67,17.28%,SNAP25;ITPR2;KCNA5;IL6;RFX6;SLC2A2;ADRA2A;RAPGEF3;PRKCA;CACNA2D2;ITPR3;CACNA1D;CRHBP;ABCC8;CACNA1A;MTNR1B
prerank,positive regulation of chromosome organization (GO:2001252),-0.3933304970817125,-1.0957020272979479,0.3154034229828851,0.664641596681969,1.0,4/15,13.25%,RTEL1;NBN;LIG4;RAD21
prerank,positive regulation of vasoconstriction (GO:0045907),0.4339229090810647,1.095665543522272,0.3389830508474576,0.9374588662923938,1.0,2/13,3.31%,AVPR2;AVPR1A
prerank,regulation of spindle assembly (GO:0090169),-0.33726269367102435,-1.0956147973622876,0.3189873417721519,0.6641252475038013,1.0,8/25,20.05%,CHMP4B;PDCD6IP;CHMP1B;CCSAP;NUMA1;PLK1;HSPA1B;HNRNPU
prerank,protein acetylation (GO:0006473),-0.3214225670943324,-1.0952842855846778,0.3046875,0.6642277354755419,1.0,12/30,26.14%,NAA10;NAA16;EP300;HAT1;FOXO1;KAT5;DSCC1;NAT10;ESCO2;KAT2B;NAA40;NAT9
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.43607418832336137,1.0950459897086062,0.3656093489148581,0.9383776177746608,1.0,4/13,14.65%,GTPBP1;CNOT8;NUDT21;UPF1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.37574139028064846,1.0949790836497681,0.3275316455696203,0.9371894477341834,1.0,7/22,23.15%,ATP1B1;PKD2;GSTO1;HAP1;ANK2;VMP1;SLC9A1
prerank,actin filament organization (GO:0007015),-0.2312616624028881,-1.0949391384755527,0.2157676348547718,0.6643935457717212,1.0,33/151,18.89%,NEDD9;MYO5A;SVIL;HIP1;EPS8;CASS4;ACTN1;ARHGAP17;CORO1C;TMOD1;CGNL1;MYO1F;PROX1;HIP1R;MYO15A;CARMIL1;SHROOM4;GAS2L3;LCP1;MAD2L2;NEB;COBL;EMP2;VILL;CORO7;ELMO2;PLS1;BCAR1;GSN;CARMIL2;FLNA;ARHGEF2;TPM4
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.348110992608436,-1.0947769277076267,0.3123425692695214,0.6640526593543932,1.0,9/22,15.43%,CCR2;NOD2;TRPM4;TNFRSF1B;SPHK2;LILRB1;TNF;SCIMP;WNT5A
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.24618393356724913,-1.094561203605213,0.2379182156133829,0.6638641162411862,1.0,34/112,21.53%,NR3C1;NRROS;PXN;SOX6;GCNT2;LIMS1;ARHGEF18;ADAM9;SMAD3;CRKL;SMAD9;ZMIZ1;WWOX;UBC;UBA52;USP9X;ID1;SMAD6;CBL;NLK;FOS;WNT5A;PDE2A;PARD6A;MAPK7;SMAD4;COL3A1;ACVR1;APPL2;USP15;CGN;BAMBI;USP9Y;ZMIZ2
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.28077219593867564,-1.0940117700026726,0.29476584022038566,0.6646554439462528,1.0,14/49,14.21%,HMGB2;RAB7B;THBS1;PF4;KMT2C;CIB1;PRKCQ;H3-3A;EP300;NFE2;HDAC1;DPY30;TESC;KMT2D
prerank,cognition (GO:0050890),-0.29427293100207663,-1.0934285933704504,0.32122905027932963,0.6655267621357676,1.0,14/42,22.59%,MAGT1;C5AR1;SLC8A2;SHROOM4;CBR3;CUX2;TNF;DGCR2;MFSD2A;CHRNB2;DOP1B;CHRNA4;SOBP;APP
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3197538073948415,-1.093220609172947,0.2876712328767123,0.665380348347183,1.0,6/29,8.06%,UBA5;CNOT9;KANK2;ESR1;YAP1;BRCA1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.30509948935074704,-1.0930766877134928,0.30512820512820515,0.6650156398125708,1.0,14/38,20.54%,CD47;P2RX4;CD36;SMAD3;CAV1;IL1B;ZC3H12A;PTGIS;GLA;TNF;TLR4;KLF2;MMP8;KLF4
prerank,cellular zinc ion homeostasis (GO:0006882),0.3633395970526302,1.0930725553545073,0.33014354066985646,0.9430048249700272,1.0,11/26,18.07%,SLC39A4;SLC39A8;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,DNA duplex unwinding (GO:0032508),-0.28314197218008547,-1.0930411329189407,0.28353658536585363,0.664371861313018,1.0,11/50,12.47%,ASCC3;CUL4A;RTEL1;CHD1L;NBN;ANXA1;UBC;UBA52;RAD23B;RPA1;MCM2
prerank,regulation of intracellular signal transduction (GO:1902531),-0.20539897096841378,-1.0930215534256464,0.09565217391304348,0.6636650179786729,1.0,92/420,17.21%,VAV3;ARHGAP15;ARHGEF3;FGD4;ITSN1;PPP2R5C;ARHGAP10;STK3;PTPN22;STARD8;CRK;RBBP8;AKAP12;RBBP7;RPL5;PJA2;PRKAB1;ARHGAP17;RRAGC;ARHGAP19;TTI1;TOPBP1;BCL3;ARHGEF18;TAF1;ARHGEF6;ARHGAP18;PHF20;ARAP1;RPF2;CD24;LYN;TAF12;ARHGAP30;GNA12;NBN;PLEKHG5;PRKAG2;FGD1;MOB3B;CLEC6A;BRCA1;IL1B;FGF1;RACGAP1;RMI1;ARHGAP24;TAOK3;ATRIP;PIDD1;ABR;GNA13;RHOJ;EP300;HIPK1;RHNO1;ARHGDIB;BARD1;ARHGAP39;RPA1;CDK1;HDAC2;BIRC2;RMI2;ARHGEF26;ARHGAP28;LRRK2;CEACAM1;EHMT1;KAT5;HDAC1;MYOC;ENTPD5;SPHK2;EGFR;AGER;TNF;PRKAB2;ARAP2;HSPB1;WNT5A;OPTN;BST1;ARHGEF5;TRAF1;PDE2A;CRNN;SQSTM1;NOP53;RPA2;HIPK2;AKAP5
prerank,mRNA metabolic process (GO:0016071),0.2841545506255949,1.0927287261914727,0.2976190476190476,0.9428546431968703,1.0,20/90,14.28%,NUDT12;SRSF5;DHX15;DDX5;PPARGC1A;CPSF6;SF3B2;PTBP1;SRSF11;AKAP8L;PRMT9;ZFP36L2;SON;SF3A1;SRSF1;CPSF3;METTL16;TBRG4;NUDT21;AGO4
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2076276905097528,-1.0922563136643395,0.09016393442622951,0.6650158810833033,1.0,83/390,16.74%,VAV3;NEDD9;ITSN1;MTSS1;CYBB;ATP6V0D1;NRP1;NRP2;ACTR3;PXN;STAP1;IGF1;AXL;AP2A2;CASS4;KIF16B;CRK;ATP6V0D2;SDCBP;HNRNPM;GIT1;ATP6V1B2;ATP6V0A1;FRS2;MET;NCBP1;NAMPT;POLR2E;MAPKAPK2;ATP6V0B;SHOC2;GAB1;LMTK2;NCK1;RASA1;AP2B1;RASGRP4;ARPC2;PDGFD;FLT1;SYK;BCAR3;LYN;STMN1;FYN;AP3S1;BLNK;FGF1;PSEN1;HCK;PIK3CA;RET;ARPC5;PDGFC;LCP2;LCK;GRB2;GHR;FOXO1;MAPKAPK3;IGF2;SORBS1;CYBA;CBL;FRK;ATP6V1A;KDR;APH1B;POLR2B;ARHGEF28;POLR2H;EGFR;SHC1;POLR2J;TRIM71;PTK2B;ELMO2;EPHA2;GFRA2;BCAR1;AAMP;EPHB4;NUS1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.3454252326171353,1.0921427541049116,0.3310924369747899,0.9436412859961083,1.0,10/33,15.47%,RELA;THY1;SLA2;PRNP;CD81;PRKD2;KCNN4;PVRIG;PTPN2;DGKZ
prerank,lipid homeostasis (GO:0055088),0.3040726182639612,1.09211683949019,0.31054977711738485,0.9422882012136707,1.0,17/57,18.15%,TLCD3A;DGAT2;USF2;TLCD3B;PNPLA3;ABCB4;ORMDL2;TLCD2;USF1;ACOX1;ABCA2;ABHD5;FITM2;ANGPTL3;FABP3;XBP1;ABHD8
prerank,supramolecular fiber organization (GO:0097435),0.2445914579929429,1.091409705413983,0.25319396051103366,0.943579486354242,1.0,79/333,21.50%,TPPP;P3H2;STMN4;SH3BP1;LTBP2;LTBP3;PLOD3;STMN3;P4HA3;COL5A1;DST;GGA3;CAPN3;PPIB;LAMB3;CST3;COL2A1;LMOD1;STMN2;BFSP2;RHOBTB1;NCKAP5;TMOD2;BACE1;TSPAN15;RIPK3;TGFBR1;SERPINH1;MYO6;SAMD14;FSD1;CKAP5;PLK3;MYO1C;PRKN;PXDN;COL4A5;CAMSAP3;FGF13;MYO1H;CAMSAP1;COL28A1;PSENEN;NCKAP5L;DCTN1;ADAMTS14;COL4A2;CORO1A;LMOD3;EVL;KIF2A;HOOK2;TCHH;COL15A1;COL18A1;TUBGCP2;SIAH1;PPP1R9A;CLIP1;KIF14;PLOD1;ITGA6;RHOBTB2;HDGFL3;ARHGAP12;ADAMTS3;PIN1;HOOK1;P4HA2;COL4A4;INPPL1;ALDOA;CCDC13;CALB1;HSP90AB1;CDC42;TUBGCP6;LAMC2;COL6A1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.260051171557985,-1.0913870873628952,0.2662337662337662,0.666570614109201,1.0,34/73,30.55%,DAB2;NEDD9;NRP1;CUL3;CD47;TEC;ADAM9;SYK;ITGB7;HCK;ADAM11;CEACAM1;PTN;PTK2B;MYH9;BCAR1;FN1;ITGB3;COL3A1;PRAM1;DOCK1;LAMA5;ITGA11;ITGA2;LAMA3;FBLN1;ILK;FYB2;PLEK;LAT;ITGB8;PLPP3;FGR;ITGB2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.4507849430277091,1.0913221344652748,0.37545126353790614,0.9424379094517923,1.0,3/11,11.46%,TSC2;GIGYF1;IRS1
prerank,response to cadmium ion (GO:0046686),0.3621988009516615,1.0912891095374186,0.358695652173913,0.9411183096436708,1.0,15/26,31.57%,MAPK3;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;MAPK1;SUMO1;CHUK;HAAO;NCF1
prerank,cellular amino acid catabolic process (GO:0009063),0.2865009983112252,1.090994809826386,0.3092926490984743,0.9408346493082704,1.0,22/87,20.91%,HOGA1;HMGCLL1;IL4I1;IDO2;OTC;ACADSB;BCAT1;KYAT1;BCKDHB;AMT;ALDH6A1;ALDH5A1;ALDH4A1;SLC25A44;DAO;DLD;HSD17B10;BCKDHA;ABAT;ECHS1;QDPR;ASPA
prerank,membrane assembly (GO:0071709),-0.31197044468711393,-1.090947669746549,0.30498533724340177,0.6669430098900555,1.0,9/34,14.84%,RFTN1;FLOT2;CHMP4B;GAK;PICALM;NRXN2;S100A10;EMP2;UBXN2B
prerank,neurotrophin signaling pathway (GO:0038179),0.36916433866913284,1.0906344578274134,0.3355263157894737,0.9407774651462978,1.0,11/21,26.78%,NTRK1;DDIT4;CASP3;SORT1;HAP1;NTRK2;MAGI2;ZFYVE27;BDNF;RAPGEF2;NGFR
prerank,positive regulation of cell communication (GO:0010647),0.35879137733008926,1.0905608263847526,0.3247172859450727,0.9396459329790579,1.0,7/28,11.21%,CD80;SYT1;LGI1;GRIK2;CLSTN2;RIMS1;KCTD13
prerank,regulation of cytoskeleton organization (GO:0051493),0.2760184078623689,1.0904906865676989,0.28769017980636236,0.9384829698269538,1.0,30/108,20.54%,TPPP;SH3BP1;STMN3;MAP6;FSCN1;ARHGAP44;F11R;PAK1;CORO2B;RHOBTB1;TWF2;CAMSAP3;GRHL3;BICD2;ARHGAP35;CORO1A;MAPK3;PHLDB2;PTK2;RHOQ;CDK10;ROCK1;TAOK1;RHOBTB2;BICD1;PLXNB1;PDGFRB;CYLD;EPHA5;IQGAP3
prerank,mesenchymal cell differentiation (GO:0048762),-0.2858698723696349,-1.0902487943708798,0.29411764705882354,0.6681005983160586,1.0,18/51,22.22%,RBPJ;FBXL17;DLG5;LIMS1;HNRNPAB;HIF1A;S100A4;CTNNB1;NOTCH1;BMP2;NOTCH4;WNT5A;HEY2;HMGA2;LRP6;BMP7;HEYL;ISL1
prerank,negative regulation of hormone secretion (GO:0046888),-0.4389810242564589,-1.0901800844139031,0.35799522673031026,0.6675050459119608,1.0,4/10,15.39%,IL1B;RAB11FIP1;RAB11FIP5;GJA1
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23344304002297753,-1.0899565838012972,0.24299065420560748,0.6673609432085442,1.0,25/144,9.47%,BCL2;GAS6;UBE2D3;PCM1;ATG13;FBXW7;ZPR1;TOMM7;SH3GLB1;PPP3R1;SEC16A;TMEM30A;SMAD3;ARIH2;KIF20B;PDCD10;FYN;ANP32B;CIB1;YWHAG;IL1B;PSEN1;TM9SF4;UBE2L3;ZC3H12A
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.24626920014799028,-1.089556805947343,0.24615384615384617,0.6676728699887825,1.0,30/101,17.92%,ETAA1;PROX1;NOD2;PDGFD;FLT1;CCND1;PDCD10;CD24;SLC8A2;CIB1;IL1B;FGF1;PDGFC;ADAM8;CALM3;LRRK2;PIK3R6;CCND2;PSMD10;CALM2;PIK3R5;RALB;MTCP1;EGFR;INCENP;TNF;WNT5A;ADAM17;RGCC;HMGA2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.26446382542016605,-1.089398415262807,0.27639751552795033,0.6673644829545988,1.0,18/73,16.27%,HIP1;VCP;XDH;PPARG;BAX;NLRC4;HIP1R;SMAD3;FAS;HSPD1;RIPK1;ANP32B;PIDD1;LCK;SENP1;RACK1;TNF;MUL1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3573735213878102,1.0892250583294518,0.3281004709576138,0.9418007061181627,1.0,5/26,8.96%,SMOC2;LGMN;RPS6KB1;PRKCA;CCDC57
prerank,chordate embryonic development (GO:0043009),-0.27709866065800115,-1.0888960164775146,0.2966360856269113,0.6680254690491462,1.0,19/55,22.22%,XYLT1;MBNL1;PROX1;FUT8;BRCA1;BMP5;HINFP;LIG4;IGF2;BMP2;TRIM71;WNT5A;DEAF1;EGFL8;GATA3;BMP7;ALDH1A2;PTCH1;ISL1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.37467816632197337,1.0883313346442571,0.3627287853577371,0.9438192938195757,1.0,7/20,16.53%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;SEMA4F;SEMA4B;SEMA3C
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3479900148313887,1.0880924997772672,0.32436708860759494,0.9432252115508759,1.0,10/29,17.85%,SHANK3;TWF2;PRKN;CORO1A;ARFGEF1;TWF1;SSH1;SSH2;SSH3;SHANK1
prerank,macromolecule catabolic process (GO:0009057),-0.3345384187313729,-1.088084198937417,0.3266832917705736,0.6695022016228684,1.0,7/26,8.34%,KIF16B;PIK3R4;SH3GLB1;CLN8;CLN5;UVRAG;SNX25
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.35271476495017456,-1.0880812199855014,0.35844155844155845,0.6687618915823722,1.0,8/19,22.78%,PRKCE;CD14;TNIP3;LBP;SCIMP;TLR4;NR1H4;TICAM2
prerank,positive regulation of glucose import (GO:0046326),-0.35166921835445086,-1.087857008669117,0.328042328042328,0.668614320864369,1.0,7/21,25.07%,OSBPL8;IGF1;SORBS1;ARPP19;IRS2;CAPN10;APPL1
prerank,regulation of hemopoiesis (GO:1903706),-0.4336436714092173,-1.0878418685026352,0.3365617433414044,0.6679099518972612,1.0,3/10,13.42%,PURB;MYSM1;PTN
prerank,negative regulation of DNA recombination (GO:0045910),-0.2955036084029514,-1.0876836226269704,0.3072289156626506,0.667554965394095,1.0,14/43,17.15%,POLR2E;SMCHD1;RTEL1;ZRANB3;KLHL15;H1-0;MAD2L2;RMI2;SHLD1;POLR2B;POLR2H;TERF2;POLR2J;PARPBP
prerank,response to peptide (GO:1901652),-0.3077211448070951,-1.0875831116470143,0.3109919571045576,0.6670904952436755,1.0,11/33,15.38%,STAT5B;STAT4;STAT2;NOD2;FYN;ANXA1;EIF2B2;STAT1;AGER;EIF2B4;KAT7
prerank,positive regulation of gene expression (GO:0010628),-0.20325118041063267,-1.0875160579514496,0.1326530612244898,0.6665184144778942,1.0,128/442,22.59%,PID1;RBPJ;IL15;CD74;HNRNPLL;GAS6;PTPN22;STAP1;ITGAX;IGF1;CCDC88B;CELF1;ADAM19;MITF;MED26;UPF3A;NIBAN1;TLR2;RPL5;BAZ1B;FAM98B;AFDN;BRAF;CD36;PRKAB1;FAM98A;POLR2E;ZPR1;SOX11;LAMTOR5;PTGER4;VPS35;TYROBP;BCL3;LIMS1;SAMD4A;ERN1;MSN;THBS1;RPS7;PF4;SMAD3;SP1;DYRK1A;RIPK1;TFRC;PDCD10;YAP1;DNMT1;HIF1A;CLEC6A;BRCA1;IL1B;FGF1;PSEN1;DEK;HINFP;LARP6;ZC3H12A;KRAS;VIM;CTCF;EP300;CD28;SPRY2;NOTCH1;C1QTNF3;PIWIL2;CUX2;PLD1;SLC11A1;AGO2;SCX;BMP2;SPHK2;NPM1;POLR2H;TESC;RIMS2;TERF2;ZCCHC4;EGFR;LILRB1;DDX21;TNF;RAMP2;GJA1;WNT5A;LARP4B;PDE2A;FXR2;TLR4;UPF3B;MAPK8;GSN;RGCC;HEY2;HMGA2;HNRNPD;AGPAT2;FN1;NWD1;MMP8;TENT4B;PPM1F;NAT10;RPL26;MYD88;TENT4A;HSPA1B;BMP7;DTNBP1;RPL11;KLF4;WARS1;PIK3CD;POU3F1;POLR1B;CDH3;CPEB3;ID2;HMGN5;CD3E;FGF18;EIF3E;TWIST1;KAT2B;APP
prerank,cell junction organization (GO:0034330),0.29440196068231056,1.0873974801220563,0.31008902077151335,0.9443544435431526,1.0,22/71,23.04%,AGRN;SH3BP1;CBLN2;MARVELD2;PPFIBP1;PRKCI;SDK1;TGFB1;CTNND2;PPFIA4;SLC6A1;SLC8A3;CXADR;SNCB;CHRNA7;PIN1;ACTB;CDC42;GRHL2;VMP1;OPHN1;LIMS2
prerank,cellular response to peptide (GO:1901653),-0.2761653059995038,-1.0873704626356886,0.2961876832844575,0.66617519169552,1.0,14/56,16.41%,ITGA4;FCGR2B;PTPN22;IGF1;CD36;NOD2;CAV1;FYN;PSEN1;VIM;LRP1;AGER;GJA1;TLR4
prerank,regulation of dendrite development (GO:0050773),0.33201582039490396,1.0869100399779787,0.325434439178515,0.9447783707092089,1.0,10/37,19.82%,CSMD3;DCC;DAB2IP;CDKL5;HECW2;NEDD4;NEDD4L;SARM1;NSMF;SDC2
prerank,mitochondrial translational termination (GO:0070126),0.2827498392282533,1.0868699750153192,0.31408450704225355,0.943488279717753,1.0,29/88,26.26%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,RNA polyadenylation (GO:0043631),-0.33615689849410746,-1.0868543846276177,0.3253333333333333,0.6660775401950946,1.0,11/26,26.21%,CDC73;CPSF1;FIP1L1;TENT2;AHCYL1;CPSF2;PCF11;TENT4B;APP;LEO1;WDR33
prerank,mRNA polyadenylation (GO:0006378),-0.33615689849410746,-1.0868543846276177,0.3253333333333333,0.6660775401950946,1.0,11/26,26.21%,CDC73;CPSF1;FIP1L1;TENT2;AHCYL1;CPSF2;PCF11;TENT4B;APP;LEO1;WDR33
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.35531271904933737,-1.0867676345804391,0.3275,0.6655932283170378,1.0,7/20,18.74%,MCUB;YME1L1;PARL;MICU3;STOML2;MICU1;SLC8B1
prerank,microtubule nucleation (GO:0007020),0.39217920148521884,1.086767489022513,0.3425774877650897,0.9424400976750956,1.0,3/19,8.96%,TPPP;CLASP2;CCDC57
prerank,nuclear pore complex assembly (GO:0051292),-0.4390158241144982,-1.0864287121028917,0.358974358974359,0.6657597344541115,1.0,3/10,11.63%,NUP153;NDC1;AHCTF1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3465220083060178,-1.0862956678877795,0.34102564102564104,0.6653832630177174,1.0,10/21,19.40%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;PLK1;TRIP13;ZWINT
prerank,regulation of trophoblast cell migration (GO:1901163),-0.3908661972969848,-1.0861561904056465,0.33726415094339623,0.665046549075611,1.0,7/14,29.71%,SMURF2;ARHGDIB;AGO2;GJA1;TIMP1;C1QBP;SYDE1
prerank,embryonic organ morphogenesis (GO:0048562),0.32276865196255494,1.0856375313607693,0.3211567732115677,0.9452546519117586,1.0,13/42,26.03%,HOXD4;MEGF8;HOXB9;MFAP2;FBN2;RBPMS2;DSCAML1;MFAP5;HOXB3;RBP4;HOXC9;FBN1;FUZ
prerank,cellular response to pH (GO:0071467),-0.3666937047855336,-1.085549376966872,0.36363636363636365,0.6658637063384499,1.0,6/17,18.98%,GPR68;RAB11FIP5;CHP1;PKD1L3;MCOLN1;HVCN1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.33092931748529264,-1.0853950052742083,0.33756345177664976,0.6655720238994122,1.0,6/27,8.08%,PID1;PTPN1;NCK1;SLC27A4;PRKCQ;IL1B
prerank,regulation of synapse organization (GO:0050807),0.3593203477216198,1.0843083793175827,0.3408,0.9487951892500601,1.0,9/26,18.86%,CTNNA2;MEF2C;CDKL5;IL1RAPL1;NEDD4;SLITRK4;EPHA4;ARHGAP22;ABHD17C
prerank,substantia nigra development (GO:0021762),0.33176875902778546,1.0842484460511361,0.32142857142857145,0.9476063322449025,1.0,5/37,6.85%,PLP1;YWHAE;FGF9;NDRG2;SYNGR3
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.39583123339956194,-1.0841589424139906,0.35308056872037913,0.6681119703636355,1.0,3/14,7.75%,ACOT8;ACOX3;CROT
prerank,regulation of blood coagulation (GO:0030193),0.35040385066953017,1.0840963293498067,0.33068362480127184,0.9467558147109216,1.0,7/27,15.41%,ADTRP;CD34;THBD;ENPP4;VTN;EPHB2;SERPINE2
prerank,tryptophan metabolic process (GO:0006568),0.45002478941895346,1.0838084708815443,0.36904761904761907,0.9464051197960595,1.0,3/11,11.65%,IL4I1;IDO2;KYAT1
prerank,microtubule bundle formation (GO:0001578),0.31769867297054183,1.0838009891571883,0.3586626139817629,0.9450187693242096,1.0,10/42,16.37%,TPPP;AAAS;PSRC1;NCKAP5;MAP1S;NCKAP5L;LRGUK;MTCL1;SPAG16;CLIP1
prerank,synaptonemal complex assembly (GO:0007130),-0.3820163839191263,-1.0836226110350784,0.3358395989974937,0.6681108110977863,1.0,6/15,19.58%,STAG3;BAG6;RAD21;TEX11;TRIP13;REC8
prerank,synaptonemal complex organization (GO:0070193),-0.3820163839191263,-1.0836226110350784,0.3358395989974937,0.6681108110977863,1.0,6/15,19.58%,STAG3;BAG6;RAD21;TEX11;TRIP13;REC8
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.35704881709368064,-1.0833348636355313,0.3238095238095238,0.6681570882838426,1.0,6/20,13.04%,FLOT2;SDCBP;RIPK1;BIRC2;PELI1;PDCD6IP
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3763436144957382,-1.0833012791017627,0.32180851063829785,0.6675331533528917,1.0,11/16,31.47%,RTEL1;HNRNPA2B1;TERF2;SLX4;SMG6;NAF1;TINF2;TNKS;PINX1;SMG5;ATM
prerank,regulation of cytokine production (GO:0001817),-0.2349076240149503,-1.0830219491629665,0.26229508196721313,0.6676022227534942,1.0,18/126,8.04%,FCGR2B;IL15;CCDC88B;ALOX5;PTPRC;CD47;IFIH1;IRF7;ZBP1;TBK1;CCR2;MAPKAPK2;NPTN;PTGER4;LYN;ANXA1;SRGN;CLEC6A
prerank,calcium ion homeostasis (GO:0055074),0.2814488454396072,1.0826920094406332,0.3226256983240223,0.9478266452336824,1.0,22/95,19.31%,ATP2A3;ATP13A4;ATP2A2;ATP1B1;SLC24A5;TNNI3;ATP13A5;CCR1;GRIN1;SLC8A1;RMDN3;ATP2C1;ATP2B3;SLC8A3;SLC24A3;DMPK;ANK2;CHRNA7;SLC24A4;CCL15;TRPV6;CCL5
prerank,negative regulation of cell adhesion (GO:0007162),0.2893885621438811,1.08246779655641,0.3249258160237389,0.9473136485199873,1.0,18/72,16.64%,PLXNB2;ARHGDIG;CORO2B;PTPRO;SIPA1;DSCAM;PDE3B;SPINT2;ADAM22;ARHGDIA;TGFB1;SNAI2;ITGB1BP1;CBLL1;EPHB2;MIA3;JAM3;PTK2
prerank,positive regulation of viral transcription (GO:0050434),0.3577351876085376,1.0822019062091937,0.343042071197411,0.9468996328414435,1.0,5/25,6.88%,POLR2L;POLR2F;NELFB;NELFCD;GTF2F1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.3895043490642647,-1.0814768895766775,0.337995337995338,0.671207134945387,1.0,5/15,13.38%,RIC1;NOTCH1;EFEMP2;LRP1;RB1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.25150622190597777,-1.08146227833857,0.2977346278317152,0.670518235633241,1.0,33/84,25.64%,SASH1;NRP1;NRP2;P2RX4;MET;PROX1;THBS1;SP1;HIF1A;FGF1;ZC3H12A;KDR;GPI;FOXP1;PTK2B;HSPB1;WNT5A;BCAR1;AAMP;NUS1;ADAM17;GATA3;ITGB3;BCAS3;PIK3CD;TMSB4X;FGF18;EGF;MAP2K3;ANXA3;ANGPT1;BMPR2;RAC1
prerank,phosphate ion transmembrane transport (GO:0035435),0.4407218138848248,1.0813437541974569,0.3583617747440273,0.9486311727073216,1.0,6/12,25.30%,SLC37A4;SLC20A1;SLC37A1;SLC25A10;XPR1;SLC37A3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.24775586506242986,-1.0811324004617628,0.2779783393501805,0.6706178607484948,1.0,22/93,16.11%,FNIP2;GAS6;RAF1;CD44;CNOT9;BRAF;DOCK7;TBK1;NCK1;TFRC;BCAR3;CAV1;PDCD10;TXN;MAD2L2;SPRY2;RACK1;MTCP1;INPP5K;EGFR;TNF;PFN2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3214803213954627,-1.0811155077705665,0.3399503722084367,0.6699355305398174,1.0,9/26,23.84%,CBLB;FBXW7;SOCS5;CBL;SHC1;ADAM17;TGFA;APP;EGF
prerank,lymphocyte chemotaxis (GO:0048247),-0.30853654821416326,-1.0810605541116936,0.3136729222520107,0.669355059637514,1.0,5/34,10.17%,GAS6;CXCL16;CCL25;GPR183;ADAM8
prerank,regulation of protein catabolic process (GO:0042176),-0.24526288842509786,-1.0808312464209808,0.2518248175182482,0.6692698259215379,1.0,24/99,17.97%,ITCH;WWP1;VCP;STX5;EEF1A1;RAB7A;SMURF2;ATG7;HECW1;CTSA;MAD2L2;AGAP2;FOXO1;BARD1;WDR91;MAD2L1;EGFR;TNF;WNT5A;ODC1;TIPARP;DTL;FLNA;RILP
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.38469923476426265,1.0803879424709841,0.35845896147403683,0.9508972503847511,1.0,6/20,18.40%,AGRN;LY6H;RGS10;LY6G6D;GNA11;CHRNA7
prerank,regulation of pH (GO:0006885),0.4500092374185392,1.0801849821219498,0.36254295532646047,0.9502775409728664,1.0,4/11,23.15%,LACC1;SLC26A4;ATP1A4;SLC9A1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3923177192911636,1.0801771540542777,0.35714285714285715,0.9489149913685397,1.0,4/18,11.17%,SLC4A8;SNAPIN;RAB5A;RIMS1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.22547850313404402,-1.0801477275627032,0.2446351931330472,0.6704603682871275,1.0,36/153,18.64%,CSNK1G1;GAS6;PRKCH;STK38;PRKCE;MARK2;PRKACA;CLSPN;TBK1;MKNK1;MAPKAPK2;LMTK2;ERN1;TAF1;RPS6KA6;DYRK1A;RIPK1;PRKCQ;CAMK2D;UHMK1;HIPK1;MAPKAPK3;CDK1;LRRK2;RPS6KA2;NLK;PRKX;PLK1;MAPK8;HIPK2;MAP4K1;CAMK1G;PKN3;SGK3;SGK2;MAPK12
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3141418646590737,1.08011925047511,0.33748055987558323,0.947761590798409,1.0,13/46,19.46%,TOMM40L;TIMM21;FIS1;FBXO7;TOMM34;PITRM1;TIMM13;TSPO;TIMM22;TOMM70;HK2;MFF;TIMM23
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.3925260908710765,-1.0800844649786316,0.33569739952718675,0.6699150542744684,1.0,7/13,39.81%,IDH1;GOT1;PHYH;GPT2;TAT;GOT2;ADHFE1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.42201080244422706,1.080005944567638,0.34655172413793106,0.9468094312821869,1.0,7/14,24.38%,SELENOS;PRKN;HERPUD1;TXNDC12;XBP1;CREB3;TMBIM6
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.35552576938583486,1.0798934641793394,0.34838709677419355,0.94583218732547,1.0,5/26,12.55%,YWHAE;CBARP;ADRA2A;PKD2;GSTO1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.4589969854134946,1.0795539150792635,0.3829787234042553,0.945706021915188,1.0,4/10,10.49%,SMYD2;EEF1AKMT2;SETD6;SETD4
prerank,regulation of chemotaxis (GO:0050920),0.34790010607099553,1.0794028756834306,0.3504983388704319,0.9448514485566007,1.0,8/30,15.04%,P2RY12;MYCBP2;RARRES2;TGFB1;STX3;CXCR4;PDGFB;PTPN2
prerank,RNA catabolic process (GO:0006401),-0.28487754790515885,-1.0791893309949134,0.3371104815864023,0.6717313978104265,1.0,14/46,19.87%,DIS3L2;RNASE3;ZC3H12D;NCBP1;ZPR1;ERN1;XRN2;LSM2;LSM5;RNASEH2A;HNRNPD;RNH1;RNASEH1;HSPA1B
prerank,nucleotide metabolic process (GO:0009117),0.3687270339702422,1.0790948320025808,0.34627831715210355,0.9446542044842987,1.0,8/23,23.34%,FHIT;REXO2;PNP;DCK;NMNAT2;AK5;AK1;AK4
prerank,regulation of protein localization to cell periphery (GO:1904375),0.39277535937068964,1.0790005228321085,0.3639344262295082,0.9436234564731686,1.0,7/18,21.43%,MISP;AR;ZDHHC2;ABCA2;SPTBN1;ACTB;VTI1B
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3995278385282949,-1.0788518997080836,0.3543123543123543,0.6719625683734006,1.0,4/13,12.06%,TOX;TESPA1;ADAM8;FOXJ1
prerank,glycoprotein biosynthetic process (GO:0009101),0.2851348240453255,1.0786986749607714,0.33053221288515405,0.9433247650722791,1.0,19/79,19.53%,ST3GAL5;B3GNT9;FUT10;B3GNT6;B3GALT2;DDOST;ALG1;SERP2;CHST10;ST6GALNAC2;B3GALNT1;GAL3ST4;CSGALNACT1;ST3GAL6;ALG5;CANT1;ALG3;BMPR1B;ST3GAL3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.4171782739647376,1.0781448906270537,0.3257042253521127,0.9439691710110685,1.0,6/13,24.16%,NCKAP1L;PNP;NKAP;ZBTB7B;GLI3;RUNX1
prerank,sodium ion import across plasma membrane (GO:0098719),0.3962675805900051,1.077930556686745,0.3553299492385787,0.9433683476861356,1.0,5/17,14.19%,SLC12A2;SLC9A4;SLC8A1;SLC9A5;SLC6A1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.27217281695072804,-1.0778985643089347,0.29545454545454547,0.6737698577619237,1.0,18/58,17.31%,NSD2;HMGB2;PRPF19;NSMCE2;IFFO1;MDC1;NBN;BRCA1;UVRAG;CYREN;ABRAXAS1;PAXIP1;BARD1;LIG4;KAT5;NHEJ1;UIMC1;BRCC3
prerank,atrial septum development (GO:0003283),0.42626489559286673,1.0778333061604055,0.3613013698630137,0.9423489183512919,1.0,5/13,21.45%,ZFPM1;DAND5;GJA5;ANK2;MDM4
prerank,protein O-linked glycosylation (GO:0006493),0.27965693887304344,1.0776206878021344,0.3233695652173913,0.9417808676727161,1.0,28/96,23.50%,PLOD3;TET1;B4GAT1;B3GNT6;TMTC4;ST6GALNAC2;GALNTL6;POFUT1;GXYLT1;OGT;FKRP;SDF2L1;C1GALT1;SLC35C1;MGAT5B;POMGNT1;PLOD1;DPM3;GCNT4;ST3GAL3;GALNT4;GALNT2;GCNT1;OGA;LARGE1;ST6GALNAC4;GALNT9;PGM3
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2949607049720331,1.0775481716452822,0.3468795355587808,0.9406670710918162,1.0,18/69,16.74%,NTRK1;SIX4;PPARGC1A;PLA2G3;MEF2C;LGMN;PRKCI;NRBP2;CX3CR1;PRKN;CLCF1;KDM2B;MAG;NDNF;SNX6;NTRK2;KIF14;PRKCG
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2478419556570575,-1.0775183459492028,0.2968197879858657,0.6740525429432247,1.0,26/103,16.68%,IGF1;RRAGC;SIAH2;USP28;CCDC88C;SHOC2;GRAP2;ARHGEF18;ARHGAP18;CRKL;ARHGAP30;DNMT1;USP8;RASGRP2;ABR;KRAS;GRB2;CCNA2;SHTN1;PLD1;RB1;RALB;SHC1;CHP1;NRAS;PLD2
prerank,pre-miRNA processing (GO:0031054),0.4237018924869068,1.0773759568493753,0.38054607508532423,0.9399555906055248,1.0,4/14,21.33%,ADAR;DROSHA;AGO4;LIN28B
prerank,midbody abscission (GO:0061952),-0.37740119985273934,-1.0772859834485986,0.34549878345498786,0.6739438746498173,1.0,5/17,16.22%,CHMP4B;CHMP4A;PDCD6IP;CHMP1B;KIF20A
prerank,protein homotetramerization (GO:0051289),0.31490881232275636,1.0768416571526185,0.3287878787878788,0.9405341907342979,1.0,13/49,22.82%,HCN1;TRPM2;ALDH9A1;CBR4;PKD2;ACOT13;HPRT1;ACACB;TK1;HSD17B10;ALDOA;SSBP1;RYR3
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.35997854101082694,-1.0766837699729122,0.36683417085427134,0.674874846824443,1.0,7/19,20.05%,CHMP4B;PDCD6IP;CHMP1B;CCSAP;PLK1;HSPA1B;HNRNPU
prerank,cardiac myofibril assembly (GO:0055003),0.41632859682552176,1.076662633933382,0.34982935153583616,0.9397907521897254,1.0,2/15,1.81%,NEBL;OBSL1
prerank,regulation of urine volume (GO:0035809),-0.4378359241369278,-1.076306231576708,0.378021978021978,0.6751758810282067,1.0,4/10,19.00%,ADCY6;INPP5K;HAS2;TFAP2B
prerank,RNA splicing (GO:0008380),0.27961499946012064,1.076186439468987,0.3157162726008345,0.9402472321873167,1.0,21/95,15.46%,RNPS1;IVNS1ABP;SMU1;FUS;DHX15;TRA2B;BCAS2;PPARGC1A;SF3B2;LSM1;PTBP1;SRSF11;PPIG;SNRPD2;MPHOSPH10;SF3B3;NOVA1;RP9;DDX39B;DDX47;CCAR2
prerank,positive regulation of protein kinase activity (GO:0045860),-0.23144259977033402,-1.0756328343807948,0.26905829596412556,0.676183768915174,1.0,32/148,15.67%,IQGAP1;NEDD9;STK3;GAS6;CASS4;PTPRC;MARK2;ETAA1;LILRA5;CLSPN;PTPN1;BORA;PDCD10;SLC8A2;SNX9;PRKAG2;CIB1;TAOK3;GPRC5B;LCP2;AGAP2;CALM3;CCN1;SLC11A1;EMP2;CALM2;RALB;MTCP1;INCENP;TNF;PTK2B;RAP1A
prerank,protein-DNA complex assembly (GO:0065004),-0.23716524293369598,-1.0756261099574018,0.27555555555555555,0.6754831186071174,1.0,29/116,15.34%,PSMA6;HMGB2;KAT6B;CUL4A;PSMB2;PSME2;ORC5;PSMD11;PADI4;CHD1L;PSMC6;UBC;ANP32B;PSMA3;H3-3A;UBA52;ORC2;RAD23B;CCNH;GRWD1;RPA1;MCM2;ORC4;PSMD10;NPM1;CDT1;MNAT1;PSMB5;MCM8
prerank,cellular response to calcium ion (GO:0071277),0.2964655992790489,1.075247472596913,0.3270893371757925,0.9423861853912209,1.0,12/67,8.98%,SYT4;ADCY8;CAPN3;NEUROD2;SYT13;SYT1;SYT6;TRPM2;MEF2C;LGMN;CPNE6;PKD2
prerank,cellular response to estradiol stimulus (GO:0071392),-0.35008462837942844,-1.074991133951328,0.3341584158415842,0.676584594257783,1.0,6/18,17.76%,ESR1;LCOR;KAT5;EGFR;FAM210B;NRIP1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.26239077939834926,-1.0744738497871535,0.30670926517571884,0.6772285876345807,1.0,26/73,26.48%,RBPJ;UBE2D3;PPARG;SOX11;SMURF2;SMAD9;LEMD3;NOTCH1;CCN1;SMAD6;GREM1;BMP2;NUMA1;HIPK2;SMAD4;FBXL15;TFAP2B;ACVR2A;GDF3;BAMBI;TRIM33;SKIL;XIAP;BMPR2;FST;UBE2O
prerank,regulation of protein kinase activity (GO:0045859),-0.2418995313165538,-1.0744496313436855,0.27898550724637683,0.6765871668731422,1.0,36/106,21.50%,IQGAP1;GAS6;PTPRC;C5AR1;SNX9;PRKAG2;YWHAG;UVRAG;SMCR8;TAB1;LCP2;AGAP2;CCN1;CEACAM1;RB1;INPP5K;QARS1;DEPTOR;PRKRIP1;TNF;PTK2B;HSPB1;RAP1A;CHP1;PYDC1;ECT2;LRP6;TRAF4;PPM1F;TAF7;DBNDD1;DTNBP1;PLCE1;WARS1;GSKIP;DUSP19
prerank,ncRNA catabolic process (GO:0034661),-0.31816133451106965,-1.0744470441484282,0.32904884318766064,0.6758702115475559,1.0,10/28,25.45%,DIS3L2;EXOSC8;EXOSC10;EXOSC9;RBM7;POP1;TRIR;TENT4B;EXOSC7;ERN2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.3143106867430975,-1.0739679744512167,0.3116531165311653,0.6764621778409946,1.0,10/27,23.54%,MAP3K8;CCDC88C;NFKB1;UBC;UBA52;KAT7;MAPK8;MAP2K7;MAP3K20;MAPK11
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3278623263845075,1.0733704916929288,0.35736196319018404,0.9479691327283728,1.0,9/41,9.35%,TNNC1;TNNI3;SOX4;MYBPC3;MEF2C;TGFBR3;BMP4;HEY1;TGFB1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.3977583959740862,1.0727709785076187,0.36065573770491804,0.9487746657449025,1.0,3/15,16.81%,SIX4;BMP4;AGT
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.25195288667725496,-1.0727348653854987,0.2975778546712803,0.6791508883780244,1.0,30/85,20.52%,DENND1A;STARD8;IGF1;EPS8;RAF1;DENND4C;KANK2;ARHGAP17;SHOC2;ARHGEF18;RASGRP4;CRKL;PDCD10;LYN;SPRY2;GRB2;ARHGDIB;NOTCH1;SPRY1;ARHGEF28;SHC1;SPRY4;NUP62;SQSTM1;ARHGEF2;IRS2;MYO9B;PLCE1;NOTCH2;EPO
prerank,positive regulation of GTPase activity (GO:0043547),0.2533172739492982,1.0727294183583984,0.3084455324357405,0.9475685281096634,1.0,48/188,20.57%,AGRN;SH3BP1;SRGAP2;F11R;SGSM2;SCRIB;NTRK1;SGSM3;THY1;SIPA1;PKP4;NTRK3;MAPRE2;RAPGEF3;ADCYAP1;EPHA1;CDKL5;MAP4K4;RGS10;RASGRF1;RAP1GAP;TBC1D16;SFRP1;DOCK10;RAP1GDS1;TBC1D8;DOCK9;RALBP1;FLCN;SYDE2;APC2;RSU1;TBC1D25;HRAS;ITGA6;ARHGAP22;ALS2;ZC3H15;ASAP3;PIN1;CCL15;PLXNB1;CCL5;CAV2;SIPA1L2;GMIP;ARHGAP45;GARNL3
prerank,myoblast differentiation (GO:0045445),-0.3876924052123324,-1.0725392986458586,0.36231884057971014,0.678967200784295,1.0,7/14,18.64%,IGF1;MBNL1;HINFP;RB1;PLEKHM3;SDC1;MAPK12
prerank,mesonephros development (GO:0001823),0.4553659497757626,1.0722270180788536,0.3710247349823322,0.9481100714633622,1.0,2/11,8.31%,FGF10;BMP4
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3763789511155662,1.072038366901048,0.33613445378151263,0.9474614448791596,1.0,3/21,2.72%,GUCY2F;ADCY8;GUCY2C
prerank,neuron fate commitment (GO:0048663),-0.3892142311685403,-1.0718472324913486,0.3835294117647059,0.6801319235975264,1.0,8/14,30.86%,MYT1L;ID2;ISL1;SHH;PAX6;DLL4;EPOP;DLL1
prerank,regulation of actin filament polymerization (GO:0030833),0.2914290463101311,1.071424692698555,0.3265895953757225,0.9484321773872406,1.0,19/69,21.56%,CTTN;BIN1;LMOD1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;FCHSD2;TWF2;EVL;ARFGEF1;TWF1;SSH1;PLEKHG2;SSH2;SSH3;CDC42EP4;CDC42EP1;LATS1
prerank,protein transport (GO:0015031),-0.2056368816044258,-1.0708616885060263,0.20689655172413793,0.6821601510226523,1.0,79/332,18.65%,ATP6V0D1;VIPAS39;CD74;STX6;ARL6IP5;APOE;RAB8B;RIC1;TBC1D1;KIF3A;VPS26A;GOLPH3L;ATP6V0D2;STEAP3;SNX8;PPARG;ATP6V1B2;CD36;ATP6V0A1;STX12;STX5;RAB1A;RAB7A;SNX1;RPGR;AP3B1;VPS35;ATP6V0B;AP3D1;LMTK2;DNAJC27;ARF3;RABGAP1;TBC1D2;TFRC;GGA2;SNX9;TXNIP;RAB6A;NDC1;CTSA;AP4M1;TMED9;LAMP2;RAB15;VPS45;ABCG1;RAB10;TMED10;HIKESHI;DNM2;VPS26B;TBC1D10C;RAB21;TBC1D10A;ATP6V1A;CHMP1B;ZDHHC17;LRP1;USP6NL;NPM1;RAMP2;CALCRL;OPTN;ADPRH;MYH9;NAPG;SEC23IP;USO1;RAB3GAP2;RAB31;MCOLN1;ARRDC4;GCC2;TBCK;RILP;STX19;ARHGEF2;TOM1
prerank,activation of protein kinase activity (GO:0032147),0.2696320082539514,1.0705758234236544,0.32694938440492477,0.9501734095521133,1.0,29/106,19.00%,ADCY8;STRADB;ANG;PAK1;CARD14;COPS8;PRLR;STK11;CD86;NTRK3;ADRA2A;RIPK3;MAP4K4;ZFP91;PRR5;ITGB1BP1;MINK1;MAP3K7;PAK5;PDGFB;TOM1L1;INSR;KIF14;PAK6;PRKAR1A;TAOK1;TLR3;IL18;STRADA
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.36285693471375446,-1.0704994394059808,0.35809018567639256,0.6824006211112962,1.0,10/16,37.71%,SLC2A5;DRD2;PRCP;KLK3;KLK1;BMPR2;SPX;DDAH1;NPPA;GSK3A
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.4402619819689884,1.070391606636767,0.3786231884057971,0.9495133759438512,1.0,3/12,9.35%,SELENOS;AR;TGFB1
prerank,regulation of platelet activation (GO:0010543),-0.34049802016262876,-1.0697825001195702,0.330188679245283,0.6836833137488202,1.0,8/21,18.71%,APOE;TEC;SYK;LYN;PRKCQ;FCER1G;TLR4;PDGFRA
prerank,regulation of neurogenesis (GO:0050767),-0.275223921996713,-1.0692314375451628,0.30606060606060603,0.6844309702338021,1.0,21/55,24.07%,PCM1;HMGB2;DOCK7;SOX11;YAP1;IL1B;SNW1;CTNNB1;SPEN;NOTCH1;LIG4;B2M;TNF;HEY2;PER2;HES1;APPL2;BHLHE40;HEYL;PAX6;HOOK3
prerank,carbohydrate catabolic process (GO:0016052),0.3262612203651805,1.0692306707635506,0.3522388059701492,0.9525085397515031,1.0,14/38,24.43%,GAPDH;PGAM2;NEU1;NAGA;ALDOC;MAN2B2;PFKM;HK2;PFKFB2;PGM1;ALDOA;ENO3;MANBA;PKM
prerank,intraciliary retrograde transport (GO:0035721),0.4296247981553075,1.0691075037125273,0.3808724832214765,0.9515971309430616,1.0,2/12,6.47%,WDR19;DYNC2I2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.45769430051559523,1.069012192083004,0.38917975567190227,0.9506144413101714,1.0,3/10,7.87%,GABRG1;GABRG2;GABRA2
prerank,lipid transport (GO:0006869),-0.24546194822931364,-1.0689788626973202,0.31329113924050633,0.684344911716355,1.0,17/97,9.44%,OSBPL8;APOE;NPC2;OSBP;CD36;ABCA6;SLC27A4;PPARD;PLEKHA3;NCOA1;PLTP;CLN8;LDLR;PCTP;OSBPL2;ABCG4;ABCG1
prerank,positive regulation of cell migration (GO:0030335),-0.21506492391594786,-1.0685135151063858,0.20441988950276244,0.684935239631745,1.0,75/253,22.37%,DAB2;NEDD9;NRP1;PLAU;ITGAX;IGF1;CASS4;PRKCE;GCNT2;PTPRC;SDCBP;CCR2;SMURF2;CXCL16;GAB1;ADAM9;THBS1;CRKL;PDGFD;FLT1;KIF20B;CAV1;PDCD10;CARMIL1;GLIPR2;CIB1;HIF1A;IL1B;FGF1;SEMA6D;RET;MAPRE1;PDGFC;SPRY2;ELP6;NOTCH1;MIEN1;SEMA6A;CCN1;PPP3CA;F7;SHTN1;SEMA3B;SEMA5B;AGO2;FAM83H;KDR;MYOC;RACK1;BMP2;HAS2;FAM89B;EGFR;PTK2B;BCAR1;ADAM17;SEMA4A;CLDN1;CARMIL2;FN1;ARHGEF2;PDGFRA;MYADM;PPM1F;MYLK;F10;ACVR1;SYNE2;DOCK1;PIK3CD;CXCL12;RREB1;SEMA4D;SEMA4G;CCAR1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.44706006079751237,1.068346084033253,0.37037037037037035,0.9517322751015894,1.0,3/10,15.04%,NDRG4;APOD;PTPN2
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.3433512826646958,-1.0682522554130212,0.3407960199004975,0.6849105002629663,1.0,4/20,8.86%,APOE;KPNB1;LDLRAP1;MBTPS1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.40000801481500914,1.0679162547516339,0.39865996649916247,0.9519273449241349,1.0,3/17,4.82%,CTR9;CPSF6;ZC3H14
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3350220999222309,-1.0678677325192378,0.3573200992555831,0.6851924015017247,1.0,5/24,6.28%,DAB2;PID1;BCL2L1;PPP2R5A;PICALM
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3032352640268149,-1.0674555595214608,0.34710743801652894,0.6855724592508999,1.0,9/36,17.07%,NRP1;FBXW7;CCR2;TAF1;HIF1A;HDAC2;HDAC1;GREM1;ADAM17
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4140700694275518,-1.0668942498652676,0.3349282296650718,0.6864020573248536,1.0,4/11,16.33%,ATG7;AGTPBP1;ICMT;AGBL1
prerank,receptor clustering (GO:0043113),0.3550013750312309,1.0664753576950294,0.38688524590163936,0.9558485687046634,1.0,6/27,10.22%,AGRN;DLG2;SCRIB;THY1;NRXN1;ITGB1BP1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3165843408633944,-1.0663677665336508,0.3464566929133858,0.6870842434090517,1.0,11/31,24.92%,TLR2;IL16;HSPD1;SYK;LTB;AGER;SCIMP;TLR4;ISL1;MAPK11;TLR9
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2327844057940169,-1.066156954777055,0.27385892116182575,0.6869689287949411,1.0,27/113,17.00%,FNIP2;VCP;CUL4A;CD36;GNL3L;BAX;SH3GLB1;DHX33;ESR1;MTLN;SYK;TFRC;CHD1L;ASAP1;PSMC6;LCP1;RPA1;AJUBA;SKAP1;RACK1;CDT1;TNF;BCL2L11;ICE1;RAP1B;TLR4;RPA2
prerank,cellular response to metal ion (GO:0071248),0.2684962898622076,1.0660596321607088,0.32297297297297295,0.9560639914480557,1.0,48/123,28.39%,SYT4;ADCY8;DLG2;CAPN3;NEUROD2;SYT13;SYT1;SYT6;PRNP;SLC12A2;TRPM2;MEF2C;LGMN;CPNE6;PKD2;PRKN;GLRA2;CRHBP;AOC1;MAPK3;HPCA;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;ALOX5AP;RYR3;GPLD1;CPNE5;MEF2A;SYT11;SYT12;ANK3;MAPK1;HFE;PLCG2;DLG4;ADD1;PRKAA2;DMTN;CACNA1H;KCNH1;SUMO1
prerank,negative regulation of response to stimulus (GO:0048585),-0.2722220998738279,-1.065775511199813,0.31399317406143346,0.6874110916097004,1.0,21/60,22.48%,FCGR2B;MCTP1;ALOX5;CDK6;PTPN1;LYN;NR1H2;PDCD1;SOCS5;NR1H3;TERF2;MAPK7;AQP11;WFS1;HMGA2;COL3A1;ACVR1;APPL2;KLF4;VPS13C;TWIST1
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.3416008210337875,-1.065662106503328,0.3569553805774278,0.687029450976619,1.0,4/22,7.83%,IL15;RFTN1;NOD2;PRKCQ
prerank,regulation of gluconeogenesis (GO:0006111),0.3520958365582443,1.0656478437963708,0.39461172741679873,0.9562576925529427,1.0,4/27,8.76%,SELENOS;PPARGC1A;DGKQ;OGT
prerank,positive regulation of epithelial cell migration (GO:0010634),0.276479451583638,1.0649079323462922,0.35319148936170214,0.9576005425106215,1.0,18/92,10.77%,FGF10;INSL3;FLT4;SMOC2;FGF7;PLCG1;PIK3CG;CLASP2;MAPRE2;BMP4;ENPP2;PRKCA;PRKD2;MAP4K4;ITGB1BP1;IQSEC1;FGF2;PDCD6
prerank,spliceosomal complex assembly (GO:0000245),0.31223967713862705,1.0647453632157047,0.3483483483483483,0.9568872630064645,1.0,15/46,18.71%,SRSF5;SRSF6;DDX1;RBM5;SF3A1;SRSF1;SNRPD2;YTHDC1;CELF6;CRNKL1;DDX39B;SETX;SRSF9;PUF60;GCFC2
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.3609016745704818,-1.064676905213276,0.3871794871794872,0.6889994672536812,1.0,3/18,5.98%,ABL2;ATP7A;NOD2
prerank,UV-damage excision repair (GO:0070914),0.42630515971942684,1.0641351145587623,0.3647260273972603,0.9577971973706088,1.0,4/12,23.37%,POLD3;DDB2;POLA1;ACTR5
prerank,blood vessel diameter maintenance (GO:0097746),-0.30850699305815016,-1.0637528469292965,0.3333333333333333,0.6908758671074745,1.0,20/34,40.52%,EDNRB;GCLC;ADCY6;EDNRA;KLF2;PER2;SERPINF2;ACE2;AGTR2;KEL;NOS1;EDN3;CRP;EDN2;GPER1;AGTR1;EDN1;KCNMB4;ECE1;SCPEP1
prerank,response to interleukin-4 (GO:0070670),-0.4320534288409841,-1.0635036969385763,0.34894613583138173,0.6908693176982653,1.0,7/10,36.28%,TCF7;SHPK;GATA3;LEF1;DCSTAMP;CITED1;RUFY4
prerank,DNA strand elongation (GO:0022616),0.38160381699254653,1.0632582616981536,0.3641025641025641,0.9597135211120756,1.0,3/18,7.46%,POLD3;GINS3;MCM3
prerank,sphingosine metabolic process (GO:0006670),-0.3621418454863327,-1.0632494941180852,0.36175710594315247,0.6908514400684549,1.0,6/17,20.33%,ACER3;SGPP1;ASAH2;SPHK2;SPTLC2;SPTLC3
prerank,regulation of cellular component movement (GO:0051270),-0.27523710892541947,-1.0630066890998053,0.340625,0.6907953606821418,1.0,9/49,8.61%,SP100;ABL2;RAF1;CDK6;ACTN1;ARHGAP18;ARAP1;LYN;NRG2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.3238334528853221,-1.06247243068275,0.31926121372031663,0.6914765012244019,1.0,10/27,20.62%,LIMD1;PUM2;RIPK1;EIF4ENIF1;DDX6;AJUBA;AGO2;EGFR;WTIP;PUM1
prerank,axoneme assembly (GO:0035082),0.3352861718107759,1.0623721875854375,0.35566188197767146,0.9615626865685316,1.0,8/30,16.65%,DNAAF1;CCDC39;CCDC65;SPAG1;LRGUK;SPAG16;DNAAF2;DNAAF3
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3338302105531254,1.062207162964668,0.3805031446540881,0.960780636549545,1.0,6/32,15.02%,GAPDH;ANG;DEFA6;RNASE7;FAM3A;GALP
prerank,cellular response to radiation (GO:0071478),-0.2896991193849482,-1.062163571802574,0.3323529411764706,0.6916530864576562,1.0,21/40,35.08%,EEF1D;GRB2;RHNO1;LIG4;SWI5;GPR88;ECT2;OPN3;TRPM1;RRH;NET1;RAD51AP1;TNKS1BP1;GPR52;FIGNL1;CLOCK;SPIDR;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,cellular protein localization (GO:0034613),-0.20800756385998243,-1.0619949208449477,0.23717948717948717,0.6914297516569136,1.0,75/285,19.28%,ITSN1;VIPAS39;CD74;STX6;RIC1;TBC1D1;VPS26A;SNX8;PRPF19;ATG13;STX12;RRAGC;STX5;TM9SF3;RAB1A;SNX1;RPGR;AP3B1;VPS35;SH3PXD2B;AP3D1;CEP250;DNAJC27;ARF3;RABGAP1;TBC1D2;GGA2;SNX9;TM9SF2;CPE;TM9SF1;RAB6A;CTSA;AP4M1;TMED9;TM9SF4;VPS45;TMED10;CTNNB1;VPS26B;ID1;FOXJ1;TBC1D10C;LRRK2;RRAGA;RAB21;TBC1D10A;EMP2;REEP1;CEP68;USP6NL;NPM1;VCL;EGFR;GJA1;WNT5A;ADPRH;RTP4;ATG9B;NAPG;SEC23IP;USO1;RAB3GAP2;HEY2;RAB31;FLNA;TBCK;STX19;ARHGEF2;RAP2A;USP4;TBC1D22A;FBLN5;HPS6;NAPA
prerank,microtubule anchoring at centrosome (GO:0034454),-0.42400361372692175,-1.0619338600695694,0.3854875283446712,0.6908768490786482,1.0,2/10,1.48%,KIF3A;PCM1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.399719755692202,-1.0619127804394883,0.3877551020408163,0.6902137859652159,1.0,5/13,23.05%,CDK5RAP2;MAD2L1;DUSP1;NDC80;CCNB1
prerank,sprouting angiogenesis (GO:0002040),-0.2749554022288383,-1.061864747653852,0.3303834808259587,0.6896463947467802,1.0,16/51,16.71%,NRP1;CCBE1;RNF213;THBS1;JMJD6;NAXE;EGR3;ADGRA2;KDR;E2F8;GREM1;PTK2B;RAMP2;OTULIN;E2F7;EPHB4
prerank,negative regulation of cellular component movement (GO:0051271),-0.3667878214784486,-1.061328126338223,0.381294964028777,0.6904299515178753,1.0,4/15,3.71%,SP100;CRK;ACTN1;CCDC125
prerank,mitotic chromosome condensation (GO:0007076),-0.3206893828293997,-1.061321173834674,0.34285714285714286,0.689744120249708,1.0,12/26,23.05%,NCAPD2;NCAPH;NCAPG2;NUSAP1;SMC2;CDK1;RB1;PLK1;MCPH1;TENT4A;NCAPH2;CCNB1
prerank,NAD biosynthetic process (GO:0009435),-0.34916006884568085,-1.0612175374684771,0.3491271820448878,0.6892940236632025,1.0,9/20,24.61%,NAMPT;NAXE;PTGIS;PARP9;NMNAT3;NAXD;PARP16;KYNU;NMNAT1
prerank,lamellipodium assembly (GO:0030032),0.3489315878466359,1.0611745316717265,0.38064516129032255,0.9632141007365084,1.0,4/26,8.02%,P2RY12;SRGAP2;PTPRO;ABLIM2
prerank,amide transport (GO:0042886),-0.32558599628432044,-1.0610308701486018,0.3629441624365482,0.6890705233989441,1.0,12/26,29.22%,PLEKHA3;PLTP;SLC46A1;SLC14A2;AQP11;ABCA13;PDPN;CERT1;CPTP;GLTP;FOLR2;FOLR1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3281346888826554,1.0608306404526724,0.3714733542319749,0.9631846918815693,1.0,8/37,15.70%,IFT20;WDR19;IFT81;DYNC2I2;IFT27;IFT88;CLUAP1;DYNLRB1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3712060257964198,1.0599928582815903,0.37702265372168287,0.9649068078072309,1.0,4/21,9.57%,BEX3;USP50;GRIN1;GRIN2B
prerank,regulation of cell differentiation (GO:0045595),-0.2266416660592544,-1.0598704296725727,0.2838983050847458,0.6915401258248702,1.0,41/148,22.33%,TRPS1;PHLDB1;MOSMO;FLOT2;ALOX5;RAF1;CDK6;CDK5RAP2;RUNX3;SLC6A6;PRKACA;PURB;VHL;CEBPB;CD24;ST7;ANP32B;YWHAG;DAG1;BIRC2;IGF2;UQCC2;NSUN2;EMP2;GREM1;SMOC1;SIK1;NOTCH4;TNF;KLHL41;HEY2;PTHLH;GATA3;TFAP2B;PA2G4;KLF4;CDK9;ID2;SERPINF2;ISL1;SHH
prerank,hyaluronan metabolic process (GO:0030212),-0.3307080205385064,-1.0597604640268652,0.3688118811881188,0.691128737307499,1.0,10/23,18.72%,LYVE1;CD44;IL1B;HMMR;CEMIP2;STAB2;HAS2;CHP1;HYAL3;HAS3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.2403852082676726,-1.0597253262470858,0.30324909747292417,0.6905169744023664,1.0,23/108,15.15%,ARL6IP5;HIP1;VCP;XDH;PPARG;BAX;NLRC4;GRAMD4;HIP1R;UACA;SMAD3;FAS;HSPD1;SYK;RIPK1;ANP32B;PIDD1;LCK;DAPK1;SENP1;RACK1;PMAIP1;TNF
prerank,pigment granule transport (GO:0051904),-0.3516875414075224,-1.0596642013583581,0.37468354430379747,0.6892776865469057,1.0,2/18,5.65%,MYO5A;BBS7
prerank,melanosome transport (GO:0032402),-0.3516875414075224,-1.0596642013583581,0.37468354430379747,0.6892776865469057,1.0,2/18,5.65%,MYO5A;BBS7
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.32559207717111194,1.0596392542254216,0.37318255250403876,0.9648707461767612,1.0,11/35,16.53%,SH3BP1;SEMA7A;PLXNB2;SEMA6C;SEMA6B;SEMA3D;ARHGDIA;FARP2;SEMA4F;SEMA4B;SEMA3C
prerank,negative regulation of secretion (GO:0051048),-0.42019051759353143,-1.0595073195233093,0.375,0.6890291073533108,1.0,4/10,26.53%,CD74;NR1H3;EGF;SPX
prerank,positive regulation of ERAD pathway (GO:1904294),0.4135391437414474,1.0592176724106575,0.40816326530612246,0.9650985232311744,1.0,5/13,16.99%,TMEM259;SGTA;NFE2L2;HERPUD1;UBQLN2
prerank,histone H3-K36 demethylation (GO:0070544),-0.4272410875808015,-1.058991285709565,0.38461538461538464,0.6896730776789703,1.0,4/10,14.60%,RIOX2;KDM7A;KDM8;RIOX1
prerank,regulation of chromosome organization (GO:0033044),-0.33912549824222976,-1.0587775365324998,0.3790322580645161,0.689539990563701,1.0,9/22,18.12%,LIG4;RMI2;BUB1;YLPM1;RB1;CDT1;TERF2;HNRNPD;SMG6
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.35282582437086935,1.0581613486321169,0.36741214057507987,0.9675878388790364,1.0,12/25,27.64%,HSPA2;SDF2;SDF2L1;HSPA9;DNAJC7;HSPE1;HSPA14;DNAJB4;DNAJB13;ST13;HSPA8;PTGES3
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3625897194431985,-1.0581343111871995,0.3880597014925373,0.690655706093708,1.0,7/17,20.05%,PTPRC;SOX11;N4BP2L2;KAT7;GJA1;HMGA2;HNRNPU
prerank,in utero embryonic development (GO:0001701),-0.3210602809674099,-1.0580944528712672,0.3756218905472637,0.690061277119227,1.0,7/25,16.23%,MBNL1;FUT8;HINFP;LIG4;IGF2;BMP2;EGFL8
prerank,positive regulation of apoptotic process (GO:0043065),-0.2070757765869167,-1.0580403904183076,0.2191780821917808,0.689486076421392,1.0,62/293,16.84%,VAV3;ARHGEF3;FGD4;ITSN1;STK3;ARL6IP5;STK17B;TNFAIP8;IFIT2;ZBP1;BAX;TOP2A;PTPA;NLRC4;ARHGEF18;ATG7;ARHGEF6;SLC27A4;HIP1R;FAS;HSPD1;RIPK1;PLEKHG5;UBC;FGD1;PSEN1;PIDD1;PNMA2;ABR;UBA52;GNA13;ZC3H12A;UTP11;MAP3K11;PTGIS;DNM2;CTNNB1;FOXO1;PRMT2;BARD1;BRMS1;STPG1;DAPK1;ARHGEF26;GADD45G;RPS6KA2;APH1B;RYBP;RACK1;BMP2;SPHK2;SIK1;PMAIP1;LILRB1;TNF;BCL2L11;SAP18;DDX20;ARHGEF5;KLF11;MAPK8;SQSTM1
prerank,protein neddylation (GO:0045116),0.41348607849016805,1.05801082721208,0.3884007029876977,0.9667962964392748,1.0,7/13,32.71%,UBE2M;DCUN1D2;UBA3;NAE1;RBX1;RNF7;NEDD8
prerank,cell part morphogenesis (GO:0032990),-0.39174644607887715,-1.057655955984108,0.3875,0.6898064726634971,1.0,4/13,15.02%,PID1;MTM1;PACSIN2;WASF1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4165176743529597,1.0574642912287313,0.39636363636363636,0.9674716541598345,1.0,4/12,19.01%,ADTRP;PPARA;MIA3;WNK1
prerank,positive regulation of ion transport (GO:0043270),0.3072412472921287,1.0572438161226951,0.3757309941520468,0.9669577988444906,1.0,9/48,11.87%,CACNB2;PLA2G3;CNKSR3;ADRA2A;CCR1;FHL1;ACTN2;TRPC6;CACNA1D
prerank,alcohol catabolic process (GO:0046164),-0.42361965893196385,-1.0571931178716223,0.3869346733668342,0.6903392234548646,1.0,1/10,0.52%,APOE
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.31983265302080327,-1.056965295317197,0.3743455497382199,0.690246341484594,1.0,6/28,8.08%,PID1;PTPN1;NCK1;SLC27A4;PRKCQ;IL1B
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.3533216417562086,1.0564788123803972,0.38412698412698415,0.9683646733412435,1.0,8/24,25.47%,BOC;CTNNA2;MEF2C;TCF3;OLFM2;CDC42;MEF2A;CAMK1
prerank,cellular response to hydroxyurea (GO:0072711),0.43985997352419176,1.0564572849460634,0.390625,0.967118412653254,1.0,2/10,14.43%,TIMELESS;NSMCE3
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.39387904333368373,-1.0563846075158898,0.4081145584725537,0.6910522549236823,1.0,4/12,18.53%,STAP1;IL1B;TNF;MMP8
prerank,regulation of TOR signaling (GO:0032006),0.294642691832188,1.056163747402222,0.3624454148471616,0.9668716142853806,1.0,18/67,18.75%,TSC2;RPTOR;SLC38A9;MINAR1;DGKQ;ITFG2;DDIT4;PDCD6;EPM2A;FLCN;RFFL;WDR59;SH3BP4;HTR6;WDR24;MAPKAPK5;FBXO9;HDAC3
prerank,protein import into peroxisome membrane (GO:0045046),0.3644391762425315,1.0560852612620184,0.3653250773993808,0.9658353834076698,1.0,12/22,27.71%,PEX5;FIS1;ATAD1;PEX26;PEX14;PEX2;ABCD2;PEX11B;PEX3;PXMP4;ABCD3;ACBD5
prerank,vesicle organization (GO:0016050),0.3081033594844612,1.0557205643215921,0.37925925925925924,0.9658147566395762,1.0,14/46,20.45%,ANXA8;ANXA8L1;CD34;USP50;PI4K2A;CORO1A;SORT1;HOOK2;VPS33B;ALS2;SNX33;HOOK1;CAV2;SNX11
prerank,RNA transport (GO:0050658),0.2854621363169723,1.0554786802197649,0.33951497860199714,0.9653581165231567,1.0,33/71,31.94%,RNPS1;SRSF5;CASC3;SRSF6;SRSF11;CKAP5;SRSF1;RAE1;CDC40;DDX39B;HNRNPA1;THOC5;SARNP;SRSF9;NXF1;ATXN2;CHTOP;ALYREF;SRSF2;POM121;RBFOX1;EIF4E;SRSF3;NUP155;THOC7;SRRM1;ZC3H11A;TPR;SRSF7;POLDIP3;U2AF1;U2AF2;YBX1
prerank,regulation of intracellular transport (GO:0032386),0.3225693637543045,1.0548890109107683,0.3676923076923077,0.9661444718690302,1.0,8/38,14.90%,DNAJC30;AAAS;ATP9A;PLA2G3;MYBPC3;INPP5F;WWC1;HAP1
prerank,positive regulation of autophagy (GO:0010508),0.2776769441278367,1.0543311307701915,0.3664772727272727,0.9668608661947417,1.0,22/81,17.73%,TSC2;MID2;STK11;FBXO7;SCOC;PLK3;PRKN;EPM2A;MAP3K7;TFEB;TRIM8;FLCN;HMGB1;EIF2AK4;SH3BP4;GNAI3;RNF152;PRKD1;PLK2;ROCK1;TRIM68;TMEM59
prerank,response to calcium ion (GO:0051592),0.27029878538544116,1.0542971979516365,0.3663101604278075,0.9656779881848291,1.0,19/102,12.72%,KCNMA1;SYT4;ADCY8;TRPC3;CAPN3;NEUROD2;SYT13;SYT1;SYT6;TRPM2;MEF2C;LGMN;SEC31A;CPNE6;PKD2;NEDD4;PDCD6;ITPR3;CRHBP
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.24699434273308699,-1.0539924224530113,0.3322475570032573,0.6969724404617208,1.0,26/87,21.53%,NRROS;PXN;GCNT2;ARHGEF18;ADAM9;SMAD3;SMAD9;ZMIZ1;UBC;UBA52;USP9X;ID1;SMAD6;CBL;NLK;FOS;PARD6A;SMAD4;COL3A1;ACVR1;APPL2;USP15;CGN;BAMBI;USP9Y;ZMIZ2
prerank,cell differentiation in spinal cord (GO:0021515),0.4416817690910656,1.0539719597883062,0.39198606271777003,0.9655460712051798,1.0,2/10,4.45%,MDGA2;SOX4
prerank,extracellular transport (GO:0006858),0.4231440752900795,1.0534401874540904,0.39473684210526316,0.9661810269450088,1.0,5/12,15.29%,ROPN1L;SPA17;SPEF2;ARRDC1;DNAAF2
prerank,cation transmembrane transport (GO:0098655),0.30869139685053015,1.053265011729829,0.3669724770642202,0.9655177711275638,1.0,9/44,14.40%,ATP1B1;KCNJ8;TRPM3;TRPM2;PKD2;SFXN1;ASIC2;SFXN2;ABCC8
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.29903870309232594,-1.0530987536276746,0.3392330383480826,0.6987521110475149,1.0,9/34,16.65%,CD300A;RAB7B;CD300LF;CD14;GRAMD4;LYN;ACOD1;TLR4;GPR108
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.37325776102358865,1.0530449592543563,0.40439932318104904,0.9650466201381505,1.0,4/19,12.43%,VDAC1;FBXO7;PRKN;DNM1L
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3053404134136431,1.0530254360781874,0.3930197268588771,0.9638240186574731,1.0,17/49,25.30%,LDLRAD4;TMC8;PEX5;PRKCZ;CLU;PPM1A;ANKRD27;HMGB1;JAM3;KIF14;OPRD1;CDC42;ULK1;IMPACT;AIDA;CRYAB;DDX3X
prerank,regulation of protein kinase B signaling (GO:0051896),0.24921365181982724,1.0529365179762906,0.36594663278271916,0.9628286346451539,1.0,38/193,15.21%,FGF10;TPTE;TSC2;F3;FGF16;P2RY12;CD80;FGF9;NTRK1;KLB;NRG4;PPARA;LRP2;CD86;FGF7;NTRK3;AREG;PIK3CG;ARRB2;TNFAIP8L3;MAZ;TGFBR1;TCF7L2;ERBB4;TGFB1;CX3CR1;ITGB1BP1;SH2B3;FGF2;PDCD6;IRS1;VAV1;PDGFB;TEK;FLCN;THPO;INSR;NTRK2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.33395296866171875,-1.0519259240244943,0.3686746987951807,0.7011680978488569,1.0,3/22,1.21%,FCGR2B;PTPN22;CD300A
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.3501780639193752,1.0515223004935355,0.38740157480314963,0.9667159802945126,1.0,7/25,17.90%,ATP2A2;NOS1AP;GJA5;FGF13;CXADR;CTNNA3;ANK2
prerank,triglyceride catabolic process (GO:0019433),-0.3505731371052605,-1.051476067508875,0.3817733990147783,0.70170951457465,1.0,4/19,12.59%,FABP4;LPL;FABP7;PNPLA2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.33890061023859436,1.0511246738435942,0.36306729264475746,0.9668816550375674,1.0,13/31,21.38%,YWHAE;E2F1;ZNF205;BAK1;PPP3CC;PPP1R13B;CHCHD10;BBC3;YWHAQ;NMT1;CASP8;YWHAB;TFDP2
prerank,double-strand break repair (GO:0006302),-0.22218700770279134,-1.0510187779083604,0.3130841121495327,0.7022388515587207,1.0,42/158,18.69%,NSD2;RAD51B;RBBP8;VCP;BAZ1B;HMGB2;PRPF19;NSMCE2;DTX3L;KPNA2;IFFO1;YY1;MDC1;NBN;CIB1;BRCA1;EYA1;CYREN;ABRAXAS1;RMI1;MAD2L2;EYA3;PAXIP1;BARD1;RPA1;LIG4;PARP9;KAT5;RAD21;SWI5;NHEJ1;MCM9;MCM8;EME1;MMS22L;MAPK8;RPA2;UIMC1;BRCC3;SLX4;TRIP13;HPF1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.35718963029843454,-1.0506263292961702,0.37755102040816324,0.7025915053537873,1.0,6/16,21.42%,IGF1;IGFBP4;BMP5;BMP2;IGFBP5;CDH3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.27980919727026216,1.0506025935245713,0.38472622478386165,0.9675268842489034,1.0,19/85,16.50%,FGF10;MAGED1;FGF16;FGF9;SIX4;FGF7;SRSF6;TGFBR3;DAB2IP;NME1;BMP4;TCF7L2;TGFB1;FGF2;SFRP1;HPN;PRKD1;PEX2;HRAS
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2597810440207323,-1.050373079029815,0.35873015873015873,0.7025953118588352,1.0,20/59,25.13%,TLR2;TBK1;BCL3;TLR7;CD14;RIPK1;UBC;TLR8;TAB1;UBA52;BIRC2;TNF;RELB;TLR4;ERC1;NKIRAS1;NLRC3;TICAM2;TLR9;TAB3
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.3737540865784149,-1.0501826348935477,0.37755102040816324,0.702363601552205,1.0,5/15,15.15%,ORMDL1;RACK1;SPHK2;ORMDL3;TNF
prerank,nuclear envelope organization (GO:0006998),-0.3373398218641263,-1.0501723255132123,0.34974093264248707,0.7016850657481205,1.0,5/20,12.43%,TOR1AIP1;CTDNEP1;LEMD3;TOR1B;NEMP1
prerank,positive regulation of protein metabolic process (GO:0051247),-0.23474514061520704,-1.0500584960863775,0.33840304182509506,0.7012770909530881,1.0,27/110,17.97%,PAEP;ITCH;APOE;WWP1;VCP;STX5;RAB1A;RAB7A;SMURF2;RANBP9;ATG7;HECW1;NR1H2;IL1B;PSEN1;FOXO1;BARD1;NR1H3;TNF;WNT5A;MAPK7;MAPK8;TIPARP;KLF2;WFS1;DTL;RILP
prerank,negative regulation of locomotion (GO:0040013),0.4169921600952992,1.0498756420294968,0.4126984126984127,0.9688385068909509,1.0,5/12,18.62%,SPOCK3;FRMD5;SPINT2;PTPN2;PIN1
prerank,regulation of MAPK cascade (GO:0043408),-0.21996175775975255,-1.0495610194031872,0.3256880733944954,0.7019538391933291,1.0,36/157,16.35%,IQGAP1;STK3;CD74;IGF1;NBR1;PTPRC;LILRA5;DHX33;FAS;FLT1;SYK;BCAR3;CAV1;CD24;LYN;IL1B;DAG1;TAOK3;RET;CCN1;IGF2;GRM4;CEACAM1;KDR;TRIM5;PSMD10;ZDHHC17;MYOC;GREM1;BMP2;DUSP1;EGFR;SHC1;EPHA2;ARHGEF5;PEBP1
prerank,ncRNA metabolic process (GO:0034660),0.32320685255231596,1.049544659312242,0.39546191247974066,0.9688100280007318,1.0,7/37,17.31%,NIFK;DTD1;MEPCE;EXD1;DROSHA;TDRKH;DTD2
prerank,negative regulation of catabolic process (GO:0009895),-0.2710628862956993,-1.0493887994862592,0.34226190476190477,0.7016718777930763,1.0,17/47,22.15%,GIT1;CBFA2T3;IL1B;MAD2L2;AGAP2;MAD2L1;APOC1;EGFR;TNF;FLNA;RILP;ZDHHC7;FMN2;NCOR1;SIRT2;HDAC4;ADGRB1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.2975579565974428,1.0490999537831274,0.37410071942446044,0.9691338319976612,1.0,13/57,14.36%,PPARGC1A;FIS1;MLLT11;PDCD5;FBXO7;ZNF205;BAK1;PRKN;DNM1L;RALBP1;CHCHD10;BIK;BBC3
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4314375314347782,1.0488895734741976,0.40867992766726946,0.9686043661109722,1.0,4/11,24.39%,MEF2C;TGFB1;DHX36;EFNB2
prerank,regulation of rRNA processing (GO:2000232),0.3905789175053045,1.0488634195867612,0.3976510067114094,0.9674054317715685,1.0,3/16,8.15%,RIOK1;WDR75;DIMT1
prerank,regulation of cellular component size (GO:0032535),-0.30858979465312597,-1.048741991984626,0.36363636363636365,0.7026970092560916,1.0,13/30,25.64%,VAV3;EPS8;LAMTOR5;MSN;PICALM;NEB;HP1BP3;PPP1R15A;LARS1;LAMTOR4;MTPN;ATP13A2;RAC1
prerank,liver development (GO:0001889),0.3318748420665895,1.0487162117890345,0.403125,0.9666805869539556,1.0,6/32,8.98%,WNT4;DNAAF1;CCDC39;IL6;TGFBR3;PKD2
prerank,intracellular protein transmembrane transport (GO:0065002),0.30816691137129215,1.048703643914537,0.3939393939393939,0.9654400731763452,1.0,11/42,19.46%,TOMM40L;PEX5;TIMM21;SEC62;PEX26;PEX14;SEC61A2;TOMM70;PEX2;PEX6;TIMM23
prerank,epithelial cell differentiation (GO:0030855),-0.24131448139504197,-1.048394522482583,0.3469387755102041,0.7029279745903771,1.0,25/88,21.78%,DAB2;PPARG;PCNA;PROX1;SCUBE1;ANXA1;CTSB;ANXA4;RAB10;CDK1;HDAC2;MAF;HDAC1;KDR;TAGLN2;E2F8;E2F7;TAGLN;GATA3;CASP6;ZDHHC7;EHF;DHRS9;BASP1;ANXA7
prerank,peroxisome organization (GO:0007031),0.35106871244250565,1.048198874842893,0.40345368916797486,0.9659868420979931,1.0,12/25,22.95%,SEC16B;FIS1;PEX11G;PEX14;DNM1L;PEX2;MFF;PEX6;ABCD2;PEX11B;PEX3;PEX11A
prerank,regulation of microtubule nucleation (GO:0010968),-0.4213215908015959,-1.048155288371943,0.4008810572687225,0.7028838262950942,1.0,3/10,4.83%,MECP2;GIT1;EML2
prerank,mRNA destabilization (GO:0061157),-0.296255693917318,-1.0481088698670742,0.3489010989010989,0.7023168178443167,1.0,12/38,25.86%,DIS3L2;CELF1;ZC3H12D;ZC3H12A;RC3H1;TRIM71;RC3H2;MEX3D;PUM1;CPEB3;RIDA;GIGYF2
prerank,regulation of ion transport (GO:0043269),0.27918200654818254,1.0479197193931482,0.3710144927536232,0.9657284402544245,1.0,15/76,15.91%,SYT4;KCNJ3;KCNA5;KCNJ8;SYT13;SYT1;SYT6;KCNJ13;PRKN;NKAIN2;NEDD4;VAMP3;SNX6;NEDD4L;KCNJ5
prerank,chromatin remodeling (GO:0006338),-0.2349637087338484,-1.047613796344217,0.3418181818181818,0.7029057069922132,1.0,30/100,22.63%,BAZ1A;GATAD2B;ARID1B;BAZ1B;SMARCA4;ESR1;INO80C;MBD2;PADI4;CHD1L;INO80B;SMARCA1;SATB2;KDM6A;MYSM1;HDAC2;NUDT5;HDAC1;RB1;NPM1;TADA2B;KDM5C;SATB1;HMGA2;TADA2A;POLE3;HNRNPC;HDAC4;KAT2B;TAF6L
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.40853679620101,-1.047534011780601,0.3695150115473441,0.7024224979333612,1.0,4/11,5.98%,GAS6;AXL;IRF7;NOD2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.33278022795326834,1.0475041348589664,0.3973941368078176,0.9659380635895729,1.0,9/31,19.46%,TOMM40L;PEX5;TIMM21;PEX26;PEX14;TOMM70;PEX2;PEX6;TIMM23
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.25589672286785675,-1.047499250410221,0.32646048109965636,0.7018332645322103,1.0,17/62,15.65%,LIMD1;PPARG;POLR2E;RANBP2;PUM2;NUP153;NDC1;H3-3A;NUP43;NUP210;AJUBA;AGO2;POLR2B;POLR2H;POLR2J;TRIM71;NUP62
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.39014781365207274,1.0471936820556944,0.39712918660287083,0.9657735463718953,1.0,6/16,18.84%,PRDX6;TRA2B;CIRBP;RBMXL1;RBM3;TRA2A
prerank,Golgi ribbon formation (GO:0090161),-0.3822106585854982,-1.047178866175098,0.37236533957845436,0.7019703603921762,1.0,4/13,17.70%,STX6;FHDC1;OPTN;GCC2
prerank,regulation of DNA replication (GO:0006275),-0.2716939518854954,-1.0462108444831668,0.35795454545454547,0.7039642313693341,1.0,10/49,15.38%,ANKRD17;OBI1;PCNA;ORC5;BCAR3;PDS5A;CCNA2;CDT1;EGFR;KAT7
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3136965628553578,1.0455693832835529,0.3812405446293495,0.9703404932858921,1.0,10/42,17.12%,WRAP53;PPP4C;FUS;USP51;TIMELESS;CGAS;PARP1;ERCC6;SHLD3;MRNIP
prerank,protein deubiquitination (GO:0016579),-0.20845902424319118,-1.045558336074294,0.2931937172774869,0.705098105474838,1.0,62/242,18.66%,VCPIP1;PSMA6;VCP;OTUD6B;IFIH1;PSMB2;ASXL2;CLSPN;SIAH2;ATXN7;SMURF2;PSME2;USP28;ESR1;YY1;INO80C;USP18;SMAD3;PSMD11;TNIP3;RIPK1;INO80B;PSMC6;UBC;USP45;HIF1A;PSMA3;BRCA1;ABRAXAS1;USP8;TAB1;UBA52;ZC3H12A;TRRAP;MYSM1;RAD23B;EP300;USP9X;USP38;NFRKB;BARD1;JOSD1;TOMM20;CDK1;CCNA2;BIRC2;PSMD10;STAM;UCHL3;TADA2B;PSMB5;CDC25A;FOXK2;OTULIN;USP5;UIMC1;BRCC3;SMAD4;GATA3;PSMD5;INO80E;USP4
prerank,establishment of spindle orientation (GO:0051294),-0.3124053733816878,-1.0455091327985486,0.3712121212121212,0.7045436272228424,1.0,13/28,24.26%,CDK5RAP2;CENPA;MAD2L1;SPDL1;NUMA1;UBXN2B;GJA1;NDC80;PLK1;PAFAH1B1;MAP4;NDE1;PKHD1
prerank,plasma membrane organization (GO:0007009),0.29097415308070207,1.0453953428411824,0.3699851411589896,0.9696539629906215,1.0,21/61,24.89%,COL5A1;BIN1;RAB3A;SYTL4;OTOF;BIN2;EHD2;CXCR4;TLCD2;MICALL1;SPTBN1;ANK2;ABCD2;SNX33;ABCA7;PACSIN3;PLSCR4;FA2H;SYT11;ANK3;FNBP1L
prerank,response to amino acid starvation (GO:1990928),-0.25157310517880616,-1.044723918473947,0.3381818181818182,0.705992703782302,1.0,14/72,13.48%,ATP6V0D1;ATP6V0D2;ATP6V1B2;RRAGC;LAMTOR5;SH3GLB1;ATP6V0B;FAS;CEBPB;EIF2S1;SZT2;RRAGA;ATP6V1A;LARP1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.34241679781658085,1.044474894773496,0.41412520064205455,0.9717459553754677,1.0,5/28,5.97%,FGF10;THY1;NCKAP1L;IL6;XRCC6
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.39025373279300124,-1.0444276405598745,0.4172494172494173,0.706077889897061,1.0,6/13,22.66%,NAMPT;NAXE;PTGIS;PARP9;NAXD;PARP16
prerank,negative regulation of kinase activity (GO:0033673),-0.26212480294621426,-1.0441343906276868,0.35014836795252224,0.7061723218562282,1.0,25/62,21.50%,PTPRC;PPP2R5A;PRKAG2;YWHAG;SMCR8;TAB1;CEACAM1;RB1;INPP5K;QARS1;DEPTOR;PRKRIP1;HSPB1;CHP1;PYDC1;LRP6;PPM1F;IRS2;TAF7;DBNDD1;HNRNPU;DTNBP1;WARS1;GSKIP;DUSP19
prerank,metal ion homeostasis (GO:0055065),0.31270184140065005,1.044013696208229,0.39717425431711145,0.9721211340498016,1.0,7/40,9.63%,KCNH2;SCNN1A;CLDN16;SLC12A2;GRIN1;SLC12A6;SLC8A1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.30520816218333785,1.043911344949555,0.4012251148545176,0.9712332963271049,1.0,12/48,17.42%,GUCY2F;ADCY8;NUDT2;GUCY2C;PPCDC;AMPD3;GUCY2D;COASY;DCAKD;ADSL;PPCS;AK5
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.32675227723723627,1.0438977406743295,0.3913738019169329,0.9699989619171019,1.0,4/33,6.57%,TPTE;PIK3C2G;NYAP2;PIK3CG
prerank,endothelial tube morphogenesis (GO:0061154),-0.4248066534362398,-1.0435700141476862,0.411214953271028,0.7070055240419547,1.0,2/10,10.75%,RBPJ;CTNNB1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.404230529010405,-1.0434739828223265,0.40232558139534885,0.7065982021701891,1.0,4/11,13.89%,SOX6;FRS2;GREM1;BMP2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.3979233650526935,-1.043435422275135,0.4,0.706002614568869,1.0,4/12,15.38%,NBN;TICRR;CDT1;KAT7
prerank,positive regulation of developmental process (GO:0051094),-0.2196760430865599,-1.0431566843554485,0.3386243386243386,0.7061088051519647,1.0,47/164,22.33%,APOE;PHLDB1;DDHD1;B4GALT5;SOX6;DLG5;DVL3;SLC6A6;CORO1C;SMURF2;VPS35;VHL;TFRC;CEBPB;PSEN1;DAG1;BMP5;MAD2L2;PAXIP1;TRPM4;COBL;SHLD1;AGO2;KDR;PTN;SCX;BMP2;NUMA1;LHX1;TNF;GJA1;WNT5A;MUL1;MIEF1;NIBAN2;ACVR1;PA2G4;BMP7;ESRRB;BASP1;CPEB3;LMNA;RREB1;SERPINF2;FZD4;ISL1;SHH
prerank,erythrocyte differentiation (GO:0030218),0.30545743850969825,1.0430846226867299,0.39457831325301207,0.9716512943480372,1.0,11/44,17.39%,ZFPM1;NCKAP1L;TGFBR3;FLVCR1;SH2B3;HSPA9;CASP3;SLC25A5;INHA;PTPN2;KMT2E
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.33044401652457733,-1.0429146951335402,0.3759213759213759,0.7060568706687418,1.0,7/23,13.28%,PARP14;PPARG;NR1H2;STAT1;NLRC5;PARP9;NR1H3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.2716421672275499,-1.042834202735306,0.37183098591549296,0.7055732005997467,1.0,17/51,24.04%,CCT6A;GNL3L;PKIB;PRKCQ;EXOSC10;CTNNB1;CCT3;TERF2;MAP2K7;SMG6;TENT4B;NAT10;HNRNPC;HNRNPU;NAF1;TINF2;PIF1
prerank,sister chromatid segregation (GO:0000819),-0.3008117831176798,-1.042764190766889,0.35714285714285715,0.7050410609121399,1.0,13/31,21.84%,MIS12;TOP2A;CDCA8;NCAPG2;KIFC1;NUSAP1;ESPL1;RB1;NDC80;PLK1;KIF18B;ZWINT;TOP2B
prerank,neural crest cell development (GO:0014032),0.3081568744884106,1.0427037071272938,0.38699690402476783,0.9717616187224636,1.0,12/44,16.53%,SEMA7A;SOX10;CYP26C1;SEMA6C;SEMA6B;SEMA3D;ERBB4;SNAI2;PDCD6;SEMA4F;SEMA4B;SEMA3C
prerank,negative regulation of blood coagulation (GO:0030195),0.32151544201731885,1.0426095605064627,0.37662337662337664,0.9708137576041326,1.0,8/38,15.41%,ADTRP;F3;PLAT;CD34;THBD;PDGFB;VTN;SERPINE2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.31920288127790336,1.0424121449817172,0.39001560062402496,0.9703000707200605,1.0,16/40,26.95%,SMYD2;UBE2V1;NSMCE4A;USP51;NEK4;UBE2N;WRNIP1;RFWD3;SMG1;FBXO5;ING2;NPAS2;FXR1;MAPT;FEM1B;RADX
prerank,protein ADP-ribosylation (GO:0006471),-0.3141149439833338,-1.0421067970729398,0.3716577540106952,0.706235262483681,1.0,8/28,22.66%,PARP4;PARP14;PARP9;TIPARP;ZC3HAV1;HPF1;SIRT2;PARP16
prerank,defense response to Gram-positive bacterium (GO:0050830),0.3145397177778278,1.042084997073772,0.4086687306501548,0.9701910074054142,1.0,9/40,11.55%,ANG;MBL2;RARRES2;DEFA6;IL6;MR1;PGLYRP2;RNASE7;DROSHA
prerank,positive regulation of translation (GO:0045727),-0.23649380774536416,-1.0419692801813174,0.356401384083045,0.7058821427862424,1.0,27/94,19.56%,RCC1L;UPF3A;NIBAN1;RPL5;TRUB2;BCL3;SAMD4A;TRMT10C;THBS1;LARP6;VIM;UHMK1;CD28;PIWIL2;JMJD4;PLD1;UQCC2;AGO2;LARP1;NPM1;ZCCHC4;LARP4B;FXR2;UPF3B;HNRNPD;NAT10;RPL26
prerank,glucose homeostasis (GO:0042593),0.2751465950466906,1.0418419123558533,0.38115330520393814,0.9697639397888432,1.0,15/83,15.04%,NUCKS1;ADCY8;PPARGC1A;SOX4;STK11;IL6;RFX6;ADRA2A;TCF7L2;KLF7;IRS1;USF1;HK2;INSR;PTPN2
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3724347356299265,-1.0418199475690497,0.36633663366336633,0.7056255983869957,1.0,3/15,8.06%,CELF1;STOX2;BRCA1
prerank,ERBB signaling pathway (GO:0038127),-0.2575319471514218,-1.041743030038876,0.35451505016722407,0.7051753136264931,1.0,15/64,17.07%,IQGAP1;KIF16B;REPS2;BRAF;GAB1;NRG2;PIK3CA;GRB2;CBL;EGFR;SHC1;PTK2B;BCAR1;AAMP;ADAM17
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.30398071827488,1.0416496742571417,0.37183544303797467,0.9692248267187445,1.0,15/46,20.69%,ANG;IL6;XRCC6;TRIB1;CCN4;BMP4;TCF7L2;RBPMS2;PDGFB;NDRG4;APOD;IL18;CCL5;PDGFRB;XRCC5
prerank,tRNA methylation (GO:0030488),0.3181311147150991,1.0415474129003393,0.40458015267175573,0.9683213705799414,1.0,8/34,12.45%,DALRD3;METTL2B;METTL2A;TRMT44;METTL1;TRMT61B;FTSJ1;PRORP
prerank,organophosphate biosynthetic process (GO:0090407),-0.2882614583698145,-1.041368686319272,0.3687315634218289,0.7054715473572132,1.0,11/37,18.87%,MOCS2;MOCS1;AGPAT4;AGPAT5;TKT;IPPK;GK;GK5;ITPKA;GPAM;IP6K3
prerank,positive regulation of innate immune response (GO:0045089),-0.30221006458851407,-1.041275296959462,0.37398373983739835,0.7050368976041441,1.0,14/30,28.78%,UBE2K;ZBP1;TRIM62;TLR8;ADAM8;NLRC5;LBP;WNT5A;POLR3G;SLC15A4;PLSCR1;FADD;FPR2;RPS19
prerank,protein targeting to lysosome (GO:0006622),-0.3398967185578564,-1.041249006601249,0.38498789346246975,0.704426666107274,1.0,7/20,10.27%,RAB7A;NAGPA;M6PR;ZFYVE16;AP4M1;LAMP2;GNPTAB
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3803011041618646,1.0409725958015283,0.40728476821192056,0.9692271262863301,1.0,4/18,12.54%,POLR2L;MAF1;WDR75;PHF8
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.2505425338209618,-1.0407540589991904,0.34285714285714286,0.7051892487498906,1.0,14/74,10.94%,RBPJ;PSMA6;LIMD1;PSMB2;PSME2;VHL;PSMD11;PSMC6;UBC;HIF1A;PSMA3;UBA52;EP300;NOTCH1
prerank,regulation of secretion by cell (GO:1903530),0.2997071398232256,1.0407435671467098,0.38244047619047616,0.9687533181711524,1.0,13/54,14.90%,LGI3;RAB3A;DISP1;SYT1;RAB26;MEF2C;RAB8A;RAB3D;RIMS1;CPLX2;RAB12;VAMP3;HAP1
prerank,substrate-dependent cell migration (GO:0006929),-0.3771128521864946,-1.0402966441410983,0.3740648379052369,0.7057318955011531,1.0,3/14,1.93%,NRP1;PTPRC;SDCBP
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3225617578208838,-1.040180351448553,0.3859223300970874,0.7053449756652098,1.0,6/24,11.57%,PCNA;UBC;UBA52;POLD4;RPA1;LIG4
prerank,nitric oxide metabolic process (GO:0046209),0.401651699376529,1.0400569736855312,0.4290718038528897,0.969979552676098,1.0,4/14,18.94%,GCHFR;DDAH2;CYB5B;ARG2
prerank,establishment of endothelial barrier (GO:0061028),0.33255523797762715,1.0399018292939208,0.376271186440678,0.9692719465665746,1.0,6/29,11.30%,RAB1B;F11R;ROBO4;MARVELD2;RAPGEF3;ICAM1
prerank,positive regulation of organelle assembly (GO:1902117),-0.28146725285368124,-1.0395922669717323,0.3916913946587537,0.7062339411013272,1.0,17/44,23.41%,SDCBP;SH3GLB1;ASAP1;KCTD17;LCP1;PDCD6IP;RALB;NUMA1;TNF;NUP62;SDC1;STX18;RAB3GAP2;SDC4;CNOT6L;G3BP1;MARK4
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.23929831497619172,-1.0395682929117918,0.35611510791366907,0.7056057064586,1.0,15/94,8.25%,BCL2;ARL6IP5;FNIP2;BCL2L1;CUL3;CUL4A;MCL1;BAX;ERN1;STK24;CEBPB;ITPR1;CD24;BRCA1;BAG6
prerank,protein localization to membrane (GO:0072657),0.24487288026253046,1.0394014729228866,0.3592592592592593,0.9698135080097798,1.0,37/187,12.64%,AGRN;WDR19;DLG2;CAPN3;F11R;CACNB2;SCRIB;ATP1B1;RAB3A;RAB40B;KCNIP3;THY1;ARL5A;MRAP;NRXN1;TMED2;KCNIP4;RAB8A;CLASP2;ATP1B3;TSPAN15;ZDHHC22;TSPAN32;SHANK3;NUP54;CD81;ACTN2;BSG;ITGB1BP1;RAB38;FGF13;RAB3D;EHD1;ZDHHC2;EHD2;P2RY1;RAB34
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.3223560239710437,-1.039228917933062,0.3803827751196172,0.7059031832210986,1.0,8/24,13.79%,MET;CGNL1;ARHGEF18;ARAP1;STMN1;ARHGAP28;MYOC;INPP5K
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.36987792739763875,-1.0391511910962814,0.3933649289099526,0.7054200974883671,1.0,3/14,7.92%,CMPK1;ENPP3;SMPDL3A
prerank,negative regulation of cell motility (GO:2000146),0.26705878980471437,1.03913072572951,0.39444444444444443,0.9695024584954847,1.0,43/108,29.25%,SPOCK3;FRMD5;SRGAP3;SRGAP2;STK26;LDLRAD4;SLURP1;THY1;PTPRT;DNAI3;PTPRU;NAV3;MAPK15;SPINT2;EPHA1;ADAM15;SFRP1;SCAI;EPHA4;FLCN;ADORA3;MIA3;ENG;PIN1;MAGI2;ARHGAP4;RAP2C;SFRP2;SINHCAF;TMIGD3;TMEFF2;ARID2;FUZ;NGFR;SULF1;CHRD;PTEN;ROBO1;CLDN5;DUSP10;KANK1;DLC1;NKX2-1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3905580669563927,-1.0388162829611483,0.4019607843137255,0.7056434672114833,1.0,3/12,4.76%,PTPN1;BAX;ERN1
prerank,phagosome-lysosome fusion (GO:0090385),-0.4276873207151999,-1.038733860401762,0.41594827586206895,0.7052036458747482,1.0,3/10,16.03%,RAB7A;RAB7B;CLN3
prerank,T cell homeostasis (GO:0043029),0.43452346394581753,1.038687806741407,0.4027072758037225,0.9696717366409306,1.0,3/10,9.80%,NCKAP1L;RIPK3;ZC3H8
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3172230623491665,1.038527905979061,0.4150326797385621,0.9689773257450303,1.0,7/38,10.18%,OTUD7A;USP10;MAPKBP1;CACTIN;DAB2IP;PPM1A;PPM1N
prerank,protein kinase A signaling (GO:0010737),0.4255499804004088,1.0382443940335548,0.4032846715328467,0.9687497916892109,1.0,2/12,3.21%,MYOM1;TCP11
prerank,positive regulation of T cell differentiation (GO:0045582),0.31342762341470154,1.0381086865779559,0.4107692307692308,0.9679873587610083,1.0,6/36,10.56%,IL4I1;VSIR;NCKAP1L;SOX4;PNP;NKAP
prerank,negative regulation of lymphocyte migration (GO:2000402),0.43289093204468765,1.0380229021441882,0.4253731343283582,0.967051656449854,1.0,4/10,23.06%,ADTRP;APOD;MIA3;WASL
prerank,generation of neurons (GO:0048699),0.24308902483146497,1.0378141625262194,0.3888213851761847,0.9666109896232875,1.0,36/190,16.62%,WNT4;PLXNB2;LDB1;PTPRD;NEUROG2;SIX4;ATOH7;NEUROD2;WNT3;MEF2C;ITM2C;RYK;NRBP2;LHX3;ADGRL3;CDKL5;HEY1;CX3CR1;WNT8B;IL1RAPL1;FGF13;DDIT4;CASP3;NRCAM;LHX5;TUBB2A;NDNF;LMX1B;ERCC6;NTRK2;TAFA1;WNT7A;TUBGCP2;LHX2;BHLHE41;EN2
prerank,tyrosine metabolic process (GO:0006570),0.43132732818486147,1.0375455677074277,0.40683760683760684,0.966338147163925,1.0,2/11,13.17%,IL4I1;DCT
prerank,protein localization to cell surface (GO:0034394),0.34670895890007125,1.037459323359355,0.38513513513513514,0.9654081434698174,1.0,7/26,17.90%,FGF10;GGA3;PTPRU;FGF7;UNC50;JAM3;ANK2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.27944893482514815,1.0371998458321934,0.38243626062322944,0.9651143570822289,1.0,14/75,12.97%,WNT4;HOXA5;HHEX;IL17F;YJEFN3;PDE3B;GTF2I;MINAR1;DAB2IP;FOXC1;VASH1;EFNA3;COL4A2;TEK
prerank,folic acid-containing compound metabolic process (GO:0006760),0.37637841370876884,1.0370870422533975,0.41459369817578773,0.9642577292530309,1.0,6/19,14.50%,FPGS;MTHFD1L;MTHFD2L;GGH;ALDH1L1;SLC19A1
prerank,regulation of telomere capping (GO:1904353),-0.3224121957467087,-1.0369524783164252,0.376657824933687,0.7093075504332498,1.0,8/23,18.12%,RTEL1;PKIB;NBN;PRKCQ;TERF2;MAP2K7;HNRNPD;SMG6
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.2795176689793731,-1.0367777846163395,0.425414364640884,0.7091117869927921,1.0,12/38,16.88%,PPP2R5C;XDH;CIB1;DAG1;BANK1;DRD2;RACK1;INPP5K;SFRP5;EPHA2;MUL1;NOP53
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.21696583599345245,-1.0364922709620426,0.3537117903930131,0.7091681508174273,1.0,23/161,7.94%,DAB2;STK3;APOE;PSMA6;MCC;LIMD1;CUL3;DVL3;IGFBP4;PSMB2;SIAH2;PSME2;CCDC88C;DKK2;HECW1;PSMD11;MLLT3;TMEM131L;PSMC6;CAV1;PFDN5;ZNRF3;PSMA3
prerank,positive regulation of cell aging (GO:0090343),0.4297414491309899,1.0359556103320122,0.4204152249134948,0.9669725014740412,1.0,3/11,10.40%,ABI3;EEF1E1;CGAS
prerank,cell-substrate junction assembly (GO:0007044),0.3244266547183701,1.0358893243860292,0.40716612377850164,0.9659470422610867,1.0,6/33,9.00%,CTTN;DST;LAMB3;THY1;TRIP6;ACTN2
prerank,positive regulation of protein modification process (GO:0031401),-0.21161730865559417,-1.0354340920789609,0.3865979381443299,0.7113831811819763,1.0,48/203,17.07%,DAB2;CD74;GAS6;NIBAN1;FAM161A;PPP2R5A;DVL3;FAM20A;NPTN;PTPA;ATG7;FAS;CRKL;DYRK1A;RIPK1;TFRC;CCND1;PLAUR;LYN;CIB1;IL1B;FGF1;TXN;KRAS;CDCA2;BRMS1;CALM3;AKTIP;CCN1;SPPL3;IGF2;BRAT1;LRRK2;KAT5;KDR;CCND2;CALM2;RACK1;RALB;BMP2;EGFR;AGER;TNF;CHP1;FXR2;CAMTA1;RAB3GAP2;ADAM17
prerank,peptidyl-lysine modification (GO:0018205),-0.23477913486394117,-1.035156204836241,0.3794466403162055,0.7114856736216737,1.0,21/99,14.03%,VIPAS39;IFIH1;NSMCE2;ATP7A;RANBP2;EGR2;EYA1;NUP153;NDC1;UBA2;NUP43;NUP210;LOX;USPL1;EP300;VCPKMT;PIAS2;TRPM4;KAT5;SENP1;ETFBKMT
prerank,positive regulation of integrin activation (GO:0033625),0.4193214269814159,1.0350214593626954,0.41254125412541254,0.9677815304384491,1.0,1/11,1.15%,P2RY12
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4377195478803861,1.0347530725037042,0.45233968804159447,0.967494606694277,1.0,6/10,27.15%,SH3BP1;CAMSAP3;CDC42;OPHN1;RHOA;MYO9A
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.28413472963889896,1.0346200025094916,0.4032023289665211,0.9667213934369642,1.0,17/69,17.21%,NDUFA6;UQCRC1;COA6;NDUFA4;CYC1;SDHC;COX7B;UQCC3;COX6C;NDUFS1;UQCR11;NDUFA8;NDUFS6;SDHAF2;COX7C;NDUFAB1;NDUFS2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2616312676487797,1.0344566702071953,0.3956343792633015,0.9660989542145402,1.0,18/107,12.41%,SELENOS;TMEM117;ATP2A3;SCAMP5;TMEM259;UBXN6;ATP2A2;DAB2IP;BAK1;PRKN;CFTR;HSP90B1;RASGRF1;CCDC47;HERPUD1;CASP4;DERL1;ERP27
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.313883539208291,-1.034331173157008,0.3709677419354839,0.7131163426856265,1.0,10/26,20.56%,IGF1;HOMER3;CIB1;SPPL3;FHL2;TNF;CHP1;CAMTA1;CHP2;STIMATE
prerank,skeletal muscle organ development (GO:0060538),0.3382687790505583,1.0341421403200564,0.42671009771986973,0.965983824343454,1.0,9/26,23.99%,SIX4;DISP1;MEF2C;MYL6;IGSF8;LARGE1;FXR1;CFLAR;POPDC3
prerank,apical junction assembly (GO:0043297),0.2932722316466862,1.0341413021505172,0.37248840803709427,0.9647671365371694,1.0,6/53,6.81%,F11R;CLDN16;PARD6B;MARVELD2;PARD6G;PRKCI
prerank,regulation of muscle cell differentiation (GO:0051147),0.32744630426011545,1.0341101413012594,0.4030075187969925,0.9636450564018872,1.0,4/31,6.21%,BOC;CTNNA2;PTBP1;MEF2C
prerank,protein localization to kinetochore (GO:0034501),-0.37475975082908863,-1.0340314804746258,0.391304347826087,0.7132391799032816,1.0,5/14,14.15%,BUB3;MIS12;ZWILCH;CDK1;SPDL1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.25085749283357445,-1.0336463793918966,0.3540983606557377,0.7135836167141423,1.0,12/63,16.17%,BCL2;RIC1;PTPN22;MCL1;MET;MTMR2;TIMP4;RRAGA;APOC1;RGP1;FOXK2;MFSD2A
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.35096509907248585,-1.0335414181086044,0.4166666666666667,0.7132182011934917,1.0,7/17,20.23%,PPARG;PPARD;CAV1;PRKAG2;PRKAB2;ADIPOR2;NCOR1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.39674132327972894,1.0335120512291427,0.4228855721393035,0.9646504125792162,1.0,5/15,28.15%,SAT2;MOXD1;ASMT;AANAT;SRM
prerank,phosphate-containing compound metabolic process (GO:0006796),0.24653314093124729,1.0331145287556769,0.3915211970074813,0.9648145879475805,1.0,52/198,21.51%,PLCH1;INPP4B;TPTE;ITPK1;IP6K1;PTPRD;PAK1;INPP5D;PLA2G3;NUDT10;PLCD1;INPP5B;PFKFB4;PLA2G4C;PLCG1;PIK3CG;TNFAIP8L3;SLC20A1;NUDT3;LIMK2;PLD4;ALDOC;PPM1A;TGFB1;ALPL;PPA1;OCRL;IPMK;AGPAT1;COQ8A;PFKM;HK2;EPHB2;MAPK3;PLPPR4;PRKCG;ANGPTL3;TAOK1;INPP5A;PFKFB2;PLCB2;FRA10AC1;NT5C;INPPL1;ALDOA;PFKP;PLA2G15;PLPP1;PSPH;PIP4P1;INPP5J;TOP1
prerank,protein localization to plasma membrane (GO:0072659),0.25657829365046714,1.032863217959599,0.38756613756613756,0.964412352620539,1.0,29/129,14.31%,F11R;CACNB2;ATP1B1;RAB3A;RAB40B;KCNIP3;MRAP;TMED2;KCNIP4;RAB8A;CLASP2;ATP1B3;TSPAN15;ZDHHC22;TSPAN32;CD81;ACTN2;NECTIN3;BSG;ITGB1BP1;FGF13;RAB3D;EHD1;ZDHHC2;EHD2;P2RY1;RAB34;RAB12;SPTBN1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3392548379244856,1.0327530302025674,0.3952755905511811,0.9635824581580982,1.0,7/28,11.82%,LACC1;RELA;UBE2V1;INAVA;NOD1;UBE2N;MAP3K7
prerank,cardiac muscle cell differentiation (GO:0055007),0.35848692287892836,1.0321275937419985,0.40916530278232405,0.9645442919176024,1.0,5/21,16.52%,KDM6B;MEF2C;SLC8A1;AKAP13;CXADR
prerank,nucleic acid-templated transcription (GO:0097659),0.31536492575608926,1.0320173173963318,0.40683229813664595,0.9637271723605891,1.0,9/42,13.49%,POLR2L;RNPS1;POLR2F;XAB2;E2F1;FUBP3;POLR2G;THAP1;PPP5C
prerank,electron transport chain (GO:0022900),0.38264991422858885,1.031889918895359,0.40842787682333875,0.9629712726466197,1.0,3/15,4.43%,CYB561;PPARGC1A;NDOR1
prerank,maturation of LSU-rRNA (GO:0000470),0.33235065888580406,1.0318461161495491,0.4230769230769231,0.9619493259738143,1.0,6/26,13.46%,RPL7A;NIFK;RRP15;EIF6;NOP2;NSA2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.24605142462834467,-1.0317156390378115,0.38392857142857145,0.7174458008268052,1.0,27/76,24.92%,ITCH;RWDD3;CCDC22;ZC3H12A;ANXA4;PTGIS;PRMT2;ACOD1;BRMS1;FOXJ1;NLRC5;PSMD10;CHP1;OTULIN;PYDC1;NWD1;TRIM37;CDKN2A;BMP7;KLF4;NLRC3;TRIM21;TMSB4X;AIM2;CYP1B1;PKHD1;TLR9
prerank,protein monoubiquitination (GO:0006513),-0.2873433372026163,-1.0316960714684238,0.4098360655737705,0.7168041459598865,1.0,6/36,3.74%,UBE2D3;TRIM25;CDC73;CUL3;DTX3L;OBI1
prerank,positive regulation of calcium ion transport (GO:0051928),0.31925116996465747,1.031525527884779,0.4097331240188383,0.9618537390093893,1.0,10/36,19.41%,TRPC3;CACNB2;CCR1;GRIN1;TRPC6;CACNA1D;PDGFB;ANK2;CCL5;PDGFRB
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.38842085239777036,1.0304017490721857,0.43211920529801323,0.9645646937824668,1.0,5/16,13.84%,PFAS;NUDT2;GART;AMPD3;ADSL
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4175408730181509,-1.0303458016077833,0.41445783132530123,0.7190660288771498,1.0,8/10,37.82%,PPP3R1;PPP3CA;NFATC3;NFATC2;NFAT5;PPP3CB;NFATC4;NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),-0.4175408730181509,-1.0303458016077833,0.41445783132530123,0.7190660288771498,1.0,8/10,37.82%,PPP3R1;PPP3CA;NFATC3;NFATC2;NFAT5;PPP3CB;NFATC4;NFATC1
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.32420398607778383,-1.0302076405040796,0.4040920716112532,0.7188048170198601,1.0,10/22,25.85%,PDGFD;NBN;PDGFC;CALM3;CALM2;GREM1;RAP2A;GPNMB;TNKS1BP1;PDGFA
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.25587587237714554,-1.0302031907250462,0.4055727554179567,0.7181344993484778,1.0,18/66,16.04%,SASH1;DVL3;NOD2;PDGFD;FLT1;PDCD10;CD24;FGF1;TAOK3;MAP3K11;PDGFC;ADAM8;LRRK2;PIK3R6;PIK3R5;EGFR;TNF;ARHGEF5
prerank,regulation of catecholamine secretion (GO:0050433),0.3343012413996319,1.0301553698740202,0.4064516129032258,0.9642747231007862,1.0,5/29,9.79%,SYT4;SYT13;SYT1;SYT6;PRKN
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.32824968764928614,1.029613513356575,0.41809672386895474,0.9648793770131981,1.0,9/33,16.87%,MN1;SUSD2;E2F1;TCIM;PSME3;PKD1;PAF1;KIF14;STXBP4
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3170443268532882,-1.0295877834572005,0.39892183288409705,0.7191023117906925,1.0,3/26,2.77%,OSBPL8;IGF1;BRAF
prerank,response to amyloid-beta (GO:1904645),-0.26626030040717485,-1.0293925314161638,0.42178770949720673,0.7189750664795742,1.0,10/44,16.41%,ITGA4;FCGR2B;IGF1;CD36;FYN;PSEN1;LRP1;AGER;GJA1;TLR4
prerank,glutamine family amino acid catabolic process (GO:0009065),0.412040969033676,1.0293484101714883,0.42105263157894735,0.9645975669719339,1.0,6/13,29.44%,ALDH4A1;DAO;PRODH;GLUL;GLS2;GAD1
prerank,response to UV-B (GO:0010224),0.4089437968488652,1.0292273595211057,0.4109347442680776,0.9638129249400577,1.0,2/12,5.03%,RELA;STK11
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.2864766795947648,-1.0291934836056813,0.37950138504155123,0.7187950695196633,1.0,5/36,5.53%,SP100;APOE;MECP2;PPARG;THBS1
prerank,glycogen catabolic process (GO:0005980),-0.3679311207739079,-1.02907536820121,0.40232558139534885,0.718428176487059,1.0,4/15,14.84%,PHKB;AGL;GAA;PGM2L1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3708685896510899,-1.028883447815958,0.39408866995073893,0.7182580696225825,1.0,4/15,16.78%,CDC73;CUL3;NPM1;CRNN
prerank,protein K63-linked deubiquitination (GO:0070536),0.32403920368640915,1.0287851135628527,0.40683229813664595,0.964151268766112,1.0,11/31,25.02%,OTUD7A;USP50;USP33;PSMD14;OTUD7B;OTUD5;ABRAXAS2;STAMBP;CYLD;USP7;BABAM1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.35916901198121925,1.028739800065602,0.4009584664536741,0.9631272408540658,1.0,6/21,15.22%,NUDT10;PNP;NUDT3;AMPD3;HPRT1;FITM2
prerank,amino acid import across plasma membrane (GO:0089718),-0.3139717002296316,-1.0285063682740692,0.41333333333333333,0.7185999577126683,1.0,3/24,3.14%,SLC1A5;SLC7A1;SLC6A6
prerank,regulation of cell size (GO:0008361),-0.3267897489035342,-1.0284369930057988,0.4267352185089974,0.7181068153255595,1.0,3/23,5.05%,VAV3;LAMTOR5;MSN
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.295448001447199,-1.028241627126012,0.4131578947368421,0.7179645092002771,1.0,8/32,10.41%,AEN;USP28;BCL3;BAG6;TMEM109;SNW1;EP300;HIPK1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.36033227167747317,1.028145640681769,0.3979763912310287,0.9628379929548876,1.0,9/20,19.93%,ACADSB;BCAT1;BCKDHB;ALDH6A1;SLC25A44;DLD;HSD17B10;BCKDHA;ECHS1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.36033227167747317,1.028145640681769,0.3979763912310287,0.9628379929548876,1.0,9/20,19.93%,ACADSB;BCAT1;BCKDHB;ALDH6A1;SLC25A44;DLD;HSD17B10;BCKDHA;ECHS1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.32472430819936626,-1.0280449333937474,0.39950372208436724,0.7178417497885137,1.0,7/24,19.00%,MCL1;FBXW7;BAX;TYROBP;CTNNB1;TNF;TFAP2B
prerank,maintenance of protein location in nucleus (GO:0051457),-0.34062276556258164,-1.0279108340709109,0.4088541666666667,0.7175240563178015,1.0,6/20,24.57%,SP100;BCL3;BARD1;HNRNPU;SYNE1;ARL2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4146945746011444,-1.0278377424404113,0.43990384615384615,0.7170491804310094,1.0,3/10,18.58%,PRKCH;NUMA1;TRIM16
prerank,protein prenylation (GO:0018342),0.43428246497801104,1.0277911867415963,0.44346289752650175,0.9628746411005503,1.0,6/10,30.97%,CHM;PGGT1B;RABGGTB;RCE1;FNTA;RABGGTA
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.2647828430318719,-1.0275452233696483,0.40509915014164305,0.7172134190605332,1.0,14/51,17.30%,NRP1;PXN;ARHGEF10L;CD47;SYNPO2;CARMIL1;SORBS3;S100A10;GPR65;SYNPO;MYOC;ARHGEF5;PFN2;RGCC
prerank,telomere organization (GO:0032200),-0.27383809476108295,-1.0275290087335875,0.3871951219512195,0.7165732819243134,1.0,8/43,11.08%,SP100;PCNA;DOT1L;RTEL1;NBN;H3-3A;POLD4;RPA1
prerank,polyamine metabolic process (GO:0006595),0.4055557777288422,1.027374888537992,0.4341216216216216,0.9631945889538037,1.0,3/13,14.70%,SMS;SAT2;AOC1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.36655737342867983,-1.0270035978364922,0.44680851063829785,0.717326071663305,1.0,11/16,36.46%,THBS1;PDCD10;HMOX1;FGFBP1;APLNR;DLL4;JCAD;GATA2;IL12A;IL12B;AGTR1
prerank,cellular response to amino acid starvation (GO:0034198),-0.246877869631966,-1.0269821727288122,0.38545454545454544,0.7167010884085295,1.0,13/71,12.83%,ATP6V0D1;ATP6V0D2;ATP6V1B2;RRAGC;LAMTOR5;SH3GLB1;ATP6V0B;FAS;CEBPB;EIF2S1;SZT2;RRAGA;ATP6V1A
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.26557386097731167,-1.0264029790396962,0.39710144927536234,0.7176591806555805,1.0,18/57,19.73%,AKAP12;PSAP;ADCY9;CHRM2;ADCY5;DRD2;NPY1R;ADCY6;ADCY1;HTR1B;GRM4;ADCY3;PDE2A;AKAP5;FLNA;OPRK1;GPR37;DRD3
prerank,regulation of protein export from nucleus (GO:0046825),-0.32398314167675485,-1.0263541314438112,0.40540540540540543,0.7171154170432181,1.0,6/23,10.93%,SP100;GAS6;ANP32B;IL1B;UHMK1;BARD1
prerank,DNA repair (GO:0006281),-0.20212095841471042,-1.0259054778375445,0.3790322580645161,0.7176699015956847,1.0,70/284,18.69%,ASCC3;VCPIP1;NSD2;RAD51B;PARP4;RBBP8;VCP;BAZ1B;PDS5B;DTX3L;PCNA;ASCC1;KPNA2;TOPBP1;DOT1L;ZRANB3;APEX2;MDC1;ERCC6L2;CHD1L;POLI;NBN;UBC;IGHMBP2;CIB1;USP45;BRCA1;UVRAG;EYA1;ABRAXAS1;PDS5A;ATRIP;HINFP;UBA52;TRRAP;MAD2L2;EYA3;RAD23B;POLD4;RHNO1;BARD1;RPA1;CDK1;LIG4;RMI2;PARP9;KAT5;TICRR;RAD21;NPM1;FAAP20;MNAT1;FANCI;EME1;RNASEH2A;MAPK8;PMS1;NOP53;RPA2;MUTYH;UIMC1;BRCC3;CENPX;HMGA2;SLX4;TRIP13;FANCM;XPC;WDHD1;HPF1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.33586096055214554,1.0258578924412742,0.42164781906300486,0.9672446670406489,1.0,7/25,14.99%,LDB1;NELFB;NELFCD;RNF168;RNF8;EAF2;BRD4
prerank,positive regulation of DNA replication (GO:0045740),-0.3616187920275606,-1.0256832326294256,0.4014962593516209,0.7176262297938475,1.0,5/16,15.38%,PCNA;BCAR3;CDT1;EGFR;KAT7
prerank,entry into host (GO:0044409),-0.3873166397005778,-1.0254749128230687,0.43658536585365854,0.717502504573941,1.0,5/13,18.75%,MET;GRB2;CTNNB1;CBL;CDH1
prerank,ncRNA 3'-end processing (GO:0043628),0.3985330718535546,1.0253325780683906,0.44243421052631576,0.9678924731533503,1.0,6/14,22.14%,INTS6L;ELAC2;PTCD1;INTS8;INTS5;TRNT1
prerank,cellular response to unfolded protein (GO:0034620),-0.31221519191454916,-1.025297266859047,0.40168539325842695,0.7173002209724537,1.0,11/26,19.87%,PTPN1;BAX;ERN1;HSPD1;HSF1;PACRG;HSPB8;TM7SF3;OPTN;HSPA13;HSPA1B
prerank,negative regulation of growth (GO:0045926),0.256411071408755,1.0252749635494938,0.41160949868073876,0.9669006863949829,1.0,39/121,24.48%,WFDC1;PSRC1;SIPA1;STK11;MINAR1;APBB1;FHL1;GNG4;TGFB1;ADAM15;SFRP1;CGRRF1;ACVR1B;DCBLD2;FLCN;EI24;CCAR2;SH3BP4;NDRG3;MT2A;PPP2R1A;BTG1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;TCHP;FRZB;SFRP2;NPR1;JADE1;PRDM11;SMARCA2;CDKN2AIP;CRLF3
prerank,epithelial to mesenchymal transition (GO:0001837),-0.2759250170980114,-1.0251733441430835,0.3871866295264624,0.716980240870531,1.0,16/47,22.95%,RBPJ;DLG5;LIMS1;HNRNPAB;HIF1A;S100A4;CTNNB1;NOTCH1;BMP2;NOTCH4;WNT5A;HEY2;HMGA2;BMP7;HEYL;TASOR
prerank,positive regulation of secretion (GO:0051047),0.42326217073502487,1.0246716194631456,0.41952983725135623,0.9677124729594413,1.0,4/11,23.60%,XBP1;NPR1;ACSL3;GPLD1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3910288148786947,-1.0242531518491045,0.40497737556561086,0.7188717281368671,1.0,4/12,16.03%,TMEM165;CLN5;LRRK2;CLN3
prerank,hippo signaling (GO:0035329),0.3434946826582325,1.024228444367814,0.42197452229299365,0.968080496619156,1.0,12/26,22.76%,YWHAE;WWTR1;DCHS1;CASP3;WWC1;FAT4;TEAD3;DVL2;YWHAB;TEAD2;LATS1;AMOT
prerank,regulation of gene expression (GO:0010468),-0.183460286459607,-1.0240622010076377,0.4,0.7187067521163608,1.0,235/903,22.63%,PID1;RBPJ;AHNAK;CD74;NR3C1;APOE;NSD2;HNRNPLL;NFXL1;FLOT2;GAS6;PTPN22;MECP2;STAP1;ITGAX;NOVA2;IGF1;CELF1;SETDB2;AFF1;ADAM19;SOX6;PARP14;MITF;GCNT2;NOCT;CDK6;SP3;LIN54;MED26;MSR1;MBNL1;PTPRC;LIMD1;XDH;TLR2;RPL5;ZUP1;FAM98B;TRIM14;KAT6B;RUNX3;AFDN;PEG3;BRAF;CD36;PRKAB1;FBXW7;FAM98A;ZPR1;SOX11;ASCC1;LAMTOR5;VPS35;TYROBP;PATZ1;ESR1;AHR;PROX1;LIMS1;NFKBIZ;NFKB1;TRIM17;PUM2;NAB1;MSN;TAF1;LYL1;YY1;VHL;ATXN1;RPS7;PF4;TAPBP;SMAD3;SP1;CRKL;TFRC;CEBPB;PRDM9;ZFP64;HNRNPAB;PICALM;PDCD10;RPL6;SLC8A2;LYN;PFDN5;MBNL3;YAP1;RO60;SRRT;HNRNPK;DNMT1;PRKCQ;HIF1A;BRCA1;IL1B;FGF1;BMI1;PSEN1;UTP4;MYBL2;RNF14;KDM6A;SMCR8;HINFP;RNF6;UBE2L3;ZC3H12A;KRAS;TRRAP;MZF1;CTCF;EP300;CD28;SPRY2;RC3H1;DNM2;ATF5;NOTCH1;TRIM44;AJUBA;CUX2;ZNF148;IGF2;CPSF4;ZNHIT3;SLC11A1;PARP9;AGO2;TCF7;HDAC1;KDR;TRIM5;RYBP;ZBTB11;PRDM4;RB1;LARP1;RACK1;SCX;NLK;BMP2;CREB3L1;TESC;KMT2D;FOXP1;IRF2;MSL3;RIMS2;TERF2;THAP7;LHX1;LILRB1;TRIM71;TNF;RAMP2;KAT7;GJA1;CRIP1;WNT5A;FOXK2;GPX1;PDE2A;HP1BP3;ZKSCAN5;TLR4;MAPK8;TIPARP;MLF1;CRNN;ADNP2;TESMIN;GSN;RGCC;HEY2;PTHLH;RFXANK;CLK4;GATA3;ERC1;HMGA2;HNRNPD;RNF20;TRAPPC2;FN1;NWD1;FOXN2;MMP8;PHF19;SBNO1;CDH1;MYADM;PPM1F;PTP4A3;WTIP;MYD88;HSPA1B;BMP7;ESRRB;LTF;DTNBP1;HMGA1;BHLHE40;RPL11;NFATC2;NOTCH2;KLF4;PUM1;WARS1;PTBP3;PIK3CD;TRIM21;RBAK;ZC3H7A;POU3F1;NDFIP1;HDAC4;CDH3;ID2;ANXA7;PSPC1;RREB1;HMGN5;SPIN4;CD3E;FGF18;SHH;CCAR1;TWIST1;APLNR;APP;PRDM8;TAF6L
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.35473997789266426,1.0237004714921427,0.41185897435897434,0.9687395327465779,1.0,6/20,18.07%,ZC3H7B;SPOUT1;DROSHA;TSN;AGO4;TSNAX
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.19990856006758367,-1.0234909462889077,0.32167832167832167,0.7196283699501618,1.0,59/314,13.86%,PPP2R5C;ITCH;WWP1;PSMA6;UBE2D3;KLHL20;BUB3;FBXL17;VCP;TRIM25;CUL3;CUL4A;UBE2K;PSMB2;FBXL14;FBXW7;SIAH2;FBXL8;OS9;SMURF2;PSME2;TAF1;RNF216;HECW1;RMND5B;PSMD11;CDC34;PSMC6;UBQLN1;DNAJB9;UBC;NHLRC3;TBL1X;PSMA3;ERLIN2;FBXW4;BAG6;KLHL15;SPOPL;KCTD17;UBA52;DCAF12;DNAJC10;RAD23B;CDC27;SPSB2;CTNNB1;CDK1;MAD2L1;BIRC2;RNF103;KAT5;PELI1;EDEM1;PSMD10;BUB1B;RB1;FBXO2;KCTD2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.24746244176751508,-1.0233639498050697,0.36893203883495146,0.7192985614139074,1.0,27/73,24.74%,MECP2;EPC1;RBBP7;BAZ1B;PPHLN1;POLR2E;DNMT1;BMI1;H3-3A;DEK;CTCF;EP300;IGF2;SPHK2;POLR2H;DDX21;GPX1;PHF19;EED;POLR1B;HDAC4;KAT2B;TFAP2C;TASOR;EZH2;MTF2;TDG
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.29448137379916095,-1.0228792324383977,0.41818181818181815,0.719931054407314,1.0,10/32,17.80%,CD300A;PPP2R5A;PTPA;CDCA2;CALM3;SPPL3;CALM2;ITGA1;CAMTA1;PPP1R15A
prerank,glutamate receptor signaling pathway (GO:0007215),0.31622308655804776,1.022456221517038,0.4206471494607088,0.9717601943214265,1.0,19/37,29.64%,GRIA2;GRM3;GRIK2;GRID2;GRIN1;GRIA4;GRIN2B;HOMER2;DAGLA;DAGLB;GRIK3;GRIK4;GRM8;GNAQ;GRM7;KCNB1;PLCB1;GRM1;GRIN2A
prerank,prostaglandin biosynthetic process (GO:0001516),0.3690900142172465,1.022111711279597,0.4288079470198676,0.9717980669733522,1.0,3/18,4.38%,PTGS1;PTGDS;PRXL2B
prerank,female gamete generation (GO:0007292),-0.3032386146203586,-1.0218282459669203,0.39425587467362927,0.7220610152055271,1.0,10/29,20.22%,PRDM9;DIAPH2;USP9X;PIWIL2;PTN;KMT2D;MCM9;MCM8;TRIP13;FMN2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.33835542116832434,1.0217854665808035,0.4245901639344262,0.9717149016940394,1.0,10/24,25.08%,UBE2B;TCP11;PDE3B;MGRN1;CGAS;PRKAR1A;PRKAR2B;PDE11A;GNAI1;RAPGEF2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3583477094767911,1.0211025383461179,0.4397905759162304,0.9728389680611988,1.0,12/22,27.34%,MAP1S;AEBP1;CAMSAP3;CAMSAP1;AKAP13;CHRNA7;MAP2;MAPRE3;GBA2;MAPT;MAP1B;HSPA8
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3462646960233657,1.0210547862829829,0.42387543252595156,0.9718316561257104,1.0,4/23,8.93%,OCIAD2;PRLR;IL6;ERBB4
prerank,response to interleukin-6 (GO:0070741),0.4252067525381738,1.0208082987929297,0.43617021276595747,0.9714589643595053,1.0,3/10,4.59%,SELPLG;RELA;PTPRT
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.386473199320668,-1.0206393426507543,0.4231678486997636,0.7246285092909927,1.0,5/12,17.05%,MIS12;BOD1;CDT1;NDC80;NUF2
prerank,calcium ion import across plasma membrane (GO:0098703),0.3900530501620089,1.0204912250587348,0.41156462585034015,0.9714291504879108,1.0,5/14,18.76%,TRPM2;SLC8A1;SLC8A3;CACNA2D1;TRPV6
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.37513741501012043,-1.0204504282371418,0.43884892086330934,0.7244502980002994,1.0,3/13,8.49%,MPDU1;ALG12;ALG13
prerank,protein targeting to membrane (GO:0006612),0.26724524130394683,1.0201411150638096,0.418732782369146,0.9714661945795784,1.0,29/83,22.66%,CHM;PEX5;FIS1;SGTA;ATAD1;PRKCI;SEC62;ZDHHC22;SSR1;PEX26;MYO1C;ZDHHC1;PEX14;ZDHHC2;SGTB;SRP14;GET3;MICALL1;TRAM1;SRP19;ZDHHC23;PEX2;SRPRA;ABCD2;GOLGA7;SSR2;PEX11B;ZDHHC15;PEX3
prerank,regulation of G0 to G1 transition (GO:0070316),-0.2810019920894625,-1.0197303424217492,0.4157608695652174,0.7257505311059362,1.0,9/38,14.00%,EPC1;RBBP8;RBBP7;BRCA1;BMI1;RHNO1;EHMT1;RYBP;L3MBTL2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.2971206886664843,-1.0196969945420118,0.41361256544502617,0.7251665755724592,1.0,12/33,22.23%,ALOX5;THBS1;FGF1;CEMIP2;RHOJ;S100A1;SEMA6A;CEACAM1;CREB3L1;KLF2;KLF4;FGF18
prerank,negative regulation of proteolysis (GO:0045861),0.318260026709743,1.0196702959018602,0.4267716535433071,0.971991050104286,1.0,12/34,24.12%,PLAT;CST3;PRNP;PTPN3;EFNA1;EPHA4;SERPINE2;ROCK1;TMEM59;TIMP2;CST7;ACP4
prerank,regulation of biomineral tissue development (GO:0070167),-0.3115980840603554,-1.0195354583470098,0.412532637075718,0.7249255252941117,1.0,5/26,10.94%,GAS6;NBR1;CEBPB;ANKH;NOTCH1
prerank,response to growth factor (GO:0070848),0.30695055054881937,1.0192749209588519,0.4195046439628483,0.972187226392696,1.0,10/41,14.72%,LRP2;RPS6KB1;TGFBR1;TWF2;MAP2K5;EMD;SFRP1;ACVR1B;PDGFB;AMHR2
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.34191449351511866,-1.019195094915259,0.41025641025641024,0.7251632869877706,1.0,7/19,20.54%,LIFR;IFIH1;CD24;PARP9;WNT5A;MAPK7;KLF4
prerank,B cell activation involved in immune response (GO:0002312),-0.3861701917517978,-1.0189502007635067,0.41451990632318503,0.7251534936429085,1.0,3/13,11.57%,FCGR2B;GPR183;LIG4
prerank,organelle transport along microtubule (GO:0072384),0.3274564241669916,1.0187406770696,0.44075829383886256,0.9728458893326478,1.0,11/31,17.34%,MAP1S;COPG1;RHOT1;LRPPRC;PEX14;BICD2;BORCS5;HAP1;UXT;COPG2;BICD1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4262925391820692,1.0186951870199856,0.43243243243243246,0.9718451552645075,1.0,3/10,13.17%,CX3CR1;SMARCD3;DCT
prerank,regulation of phosphorylation (GO:0042325),-0.22500770845854887,-1.0182662245899858,0.39330543933054396,0.726320515176321,1.0,32/120,16.88%,FNIP2;NRP1;STAP1;SDCBP;NDUFS4;CORO1C;RANBP2;STAT2;CCDC88C;KCTD20;THBS1;CD24;LYN;PRKAG2;HIF1A;PSEN1;NUP153;NDC1;CDKN2C;NUP43;NUP210;EP300;PGAM1;BARD1;NLRC5;EMP2;PRKRIP1;EGFR;HSPB1;NUP62;SESN2;NOP53
prerank,regulation of vasculature development (GO:1901342),-0.3073816891777925,-1.018220915362966,0.38734177215189874,0.7257737799378581,1.0,11/26,26.35%,SP100;CTNNB1;ADGRA2;EMP2;EPHA2;HMOX1;RNH1;WARS1;HTATIP2;GPNMB;EGLN1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.31666900426546546,1.0181506895468364,0.42542372881355933,0.9725130778739991,1.0,18/33,32.25%,SLC4A8;GRIK2;GRIK5;GRID2;CX3CR1;NRG3;CACNA1B;CACNA1A;LRRC4C;GRIK3;BDNF;GRIK4;PSMC5;FABP5;CEL;GRID1;NLGN3;NLGN1
prerank,positive regulation of cell motility (GO:2000147),-0.20952719091376962,-1.0179119045720428,0.39565217391304347,0.7258935503474288,1.0,71/205,25.85%,DAB2;NEDD9;PLAU;ITGAX;IGF1;CASS4;GCNT2;SDCBP;CXCL16;ADAM9;THBS1;PDGFD;FLT1;CAV1;PDCD10;CARMIL1;CIB1;IL1B;FGF1;SEMA6D;RET;MAPRE1;PDGFC;SPRY2;ELP6;NOTCH1;MIEN1;SEMA6A;PHPT1;CCN1;PPP3CA;F7;SEMA3B;SEMA5B;FAM83H;KDR;MYOC;RACK1;BMP2;HAS2;FAM89B;EGFR;PTK2B;BCAR1;ADAM17;SEMA4A;CLDN1;CARMIL2;PDGFRA;MYADM;PPM1F;MYLK;F10;ACVR1;SYNE2;PIK3CD;CXCL12;SEMA4D;SEMA4G;CCAR1;TWIST1;GTSE1;EGF;CCL7;SEMA3F;SEMA3E;TJP1;PDPN;GPNMB;CSF1;PDGFA
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.40224277994890906,1.0178772539679157,0.43392857142857144,0.9722539711033013,1.0,4/12,18.37%,PPARGC1A;PPARA;IRS1;ABCD2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3026656424541304,-1.0175183828101648,0.4186666666666667,0.7263430459625307,1.0,7/26,9.54%,CCBE1;CCR2;IL6ST;HIF1A;BRCA1;IL1B;HPSE
prerank,negative regulation of cell population proliferation (GO:0008285),0.2269987368448034,1.0173565102102733,0.43857634902411025,0.9729075028070645,1.0,69/351,18.10%,ATP8A2;P3H2;MN1;TPTE;TSC2;MAGED1;SMYD2;AVPR2;ANG;NACC2;PAK1;NTRK1;SLURP1;COPS8;TENM1;SOX4;IGFBP6;PTPRU;STK11;E2F1;IL6;PDCD5;CTBP1;TRIB1;GSDME;AR;RBM5;EEF1E1;TGFBR3;MINAR1;DAB2IP;NME1;BMP4;ERBB4;PKD2;SST;TGFB1;NMI;EMD;BTG3;ITGB1BP1;SH2B3;THAP12;BTG2;KDM2B;SFRP1;CGRRF1;NDRG4;FLCN;BAP1;ZBTB49;APOD;PTPN2;IFI35;HPN;SH3BP4;ADORA3;REST;COL18A1;MED25;PEX2;DNAJA3;HRAS;OPRM1;CDK10;BTG1;FABP3;UTP20;IL1A
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.3547808429107102,-1.0171868414945757,0.4172661870503597,0.7266031713127564,1.0,3/16,3.64%,PID1;VCP;ENO1
prerank,negative regulation of protein binding (GO:0032091),0.27449070572799855,1.0171278823457974,0.41799709724238027,0.9725304264335994,1.0,24/71,25.47%,ATP2A3;ZFPM1;ATP2A2;TMC8;EFHB;ARRB2;GTF2F1;STYX;ITGB1BP1;ADAM15;PEX14;USP33;PDGFB;MITD1;CARD16;ROCK1;PIN1;ACTB;MAP2;PPP1CA;AURKA;TMBIM6;HFE;CAMK1
prerank,neuron apoptotic process (GO:0051402),-0.34133666220212977,-1.0170973219022337,0.41794871794871796,0.7261617241240121,1.0,5/19,11.57%,BCL2;TRPC5;FAS;CIT;LIG4
prerank,protein localization to cell periphery (GO:1990778),0.25139793638012137,1.0169288313242977,0.42181340341655715,0.9720570394685621,1.0,29/133,14.31%,WDR19;F11R;CACNB2;ATP1B1;RAB3A;RAB40B;KCNIP3;MRAP;TMED2;KCNIP4;RAB8A;CLASP2;ATP1B3;TSPAN15;ZDHHC22;TSPAN32;CD81;ACTN2;BSG;ITGB1BP1;FGF13;RAB3D;EHD1;ZDHHC2;EHD2;P2RY1;RAB34;RAB12;SPTBN1
prerank,glycerophospholipid metabolic process (GO:0006650),0.2723502819965348,1.0168652728968333,0.41630901287553645,0.9711464351799778,1.0,11/75,8.83%,PRDX6;PLA2G3;PLCD1;PLA2G4C;PIGQ;PLCG1;PNPLA3;ABHD12;PIGB;PIGP;CPNE6
prerank,regulation of lamellipodium organization (GO:1902743),-0.36187527368068684,-1.01663855219988,0.405,0.7266870135271097,1.0,7/14,25.64%,CD44;CARMIL1;EPHA2;CAPZB;CARMIL2;PDPN;RAC1
prerank,organelle disassembly (GO:1903008),-0.28826103728733654,-1.0165588966462786,0.3930635838150289,0.7262076956280331,1.0,7/33,11.32%,VCP;UBA5;STX5;GBF1;UFC1;CDK1;ATG2B
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.28268244458478947,1.0162616500427795,0.4442815249266862,0.9708825204881578,1.0,17/56,19.07%,NDUFA6;DMAC1;NDUFAF8;TIMM21;FOXRED1;NDUFS1;NDUFA8;NDUFS6;NDUFAF2;OXA1L;ECSIT;NDUFAB1;TIMMDC1;NDUFS2;NDUFAF6;BCS1L;NDUFB6
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.28268244458478947,1.0162616500427795,0.4442815249266862,0.9708825204881578,1.0,17/56,19.07%,NDUFA6;DMAC1;NDUFAF8;TIMM21;FOXRED1;NDUFS1;NDUFA8;NDUFS6;NDUFAF2;OXA1L;ECSIT;NDUFAB1;TIMMDC1;NDUFS2;NDUFAF6;BCS1L;NDUFB6
prerank,skeletal system development (GO:0001501),-0.21583062322346086,-1.0162044789381206,0.46017699115044247,0.7265080482498666,1.0,36/148,20.01%,TRPS1;IGF1;EXT1;XYLT1;SOX6;CD44;PAPSS2;ATP7A;SOX11;PTGER4;SH3PXD2B;TCOF1;COL11A2;DYM;WWOX;ANKH;BMP5;IGF2;MYOC;BMP2;GJA1;WNT5A;DEAF1;BMP3;ANKRD11;RAB33B;HYAL3;PTHLH;COL9A2;TRAPPC2;BPNT2;TEAD4;PKDCC;RFLNA;GDF3;BMP7
prerank,nitric oxide biosynthetic process (GO:0006809),0.40166358269009916,1.016123294810216,0.44148936170212766,0.970212335453073,1.0,4/13,18.94%,GCHFR;DDAH2;CYB5B;ARG2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.3724848867442222,-1.0158806749804943,0.4462242562929062,0.7267718069026119,1.0,4/13,12.92%,SEC16A;TMEM30A;TM9SF4;EDEM1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.21548947908250016,-1.0154913994875685,0.40086206896551724,0.7271915523113514,1.0,32/151,15.67%,CD74;APOE;NRP1;GAS6;PTPN22;GCNT2;CD44;PTPRC;BRAF;CD36;FBXW7;CCL25;C5AR1;CRKL;NOD2;GPR183;PDGFD;GLIPR2;CIB1;PDGFC;SPRY2;NOTCH1;KDR;SLAMF1;BMP2;EGFR;AGER;SHC1;TNF;PTK2B;SCIMP;RAP1A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2317221393048077,-1.015456077636777,0.4152823920265781,0.7266217120511134,1.0,23/95,17.73%,ZEB2;DAB2;SDCBP;SOX11;SMURF2;THBS1;SMAD3;MTMR4;CAV1;UBC;LEMD3;SNX25;SNW1;UBA52;EP300;SPRY2;SMAD6;SPRY1;FAM89B;ASPN;ADAM17;HIPK2;SMAD4
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.33142549267767535,-1.0153660253947927,0.43107769423558895,0.7262004159763261,1.0,3/20,0.97%,NRP1;PLAU;IGF1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.2858281821704712,-1.0153495937178327,0.44011976047904194,0.7255817393558106,1.0,17/33,37.34%,CD74;PF4;RIPK1;HSF1;TESC;TNF;ACIN1;ID2;FADD;CSF1;LEF1;CD4;DCSTAMP;IL23R;IL12B;POU4F2;POU4F1
prerank,barbed-end actin filament capping (GO:0051016),-0.3375260991415686,-1.0149452501601126,0.4148681055155875,0.7253700707310428,1.0,6/18,17.28%,SVIL;EPS8;ADD3;VILL;CAPZB;GSN
prerank,actin filament capping (GO:0051693),-0.3375260991415686,-1.0149452501601126,0.4148681055155875,0.7253700707310428,1.0,6/18,17.28%,SVIL;EPS8;ADD3;VILL;CAPZB;GSN
prerank,alpha-amino acid metabolic process (GO:1901605),-0.2714204787180765,-1.014923121139804,0.42813455657492355,0.7247785328143338,1.0,11/45,19.37%,ATP7A;MTHFR;KMO;RIMKLA;PYCR2;GOT1;MTHFD1;MTRR;CBS;GNMT;GADL1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3506036925169218,-1.0148557057354182,0.41475826972010177,0.7243003550461783,1.0,6/16,18.71%,NRP1;PTPN1;PDGFD;PDGFC;BCAR1;PDGFRA
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.3821068736906002,-1.0147197257284102,0.40375586854460094,0.7240054996344976,1.0,5/12,16.27%,IFIH1;IFIT1;CAV1;RALB;MUL1
prerank,non-motile cilium assembly (GO:1905515),-0.28818852570966447,-1.0145679817687665,0.4128205128205128,0.7237850796438916,1.0,5/30,5.60%,PCM1;PIBF1;CEP250;ARL13B;TBC1D32
prerank,MAPK cascade (GO:0000165),0.23041399626547043,1.014391424582035,0.43478260869565216,0.9749918788863589,1.0,72/295,21.40%,FGF10;YWHAE;IL5RA;FGF16;PSMB1;DLG2;FGF9;IL2RA;PAK1;KLB;RGL2;NRG4;FGF7;MEF2C;AREG;IL2;PSMF1;BTRC;LYPLA1;RIT2;DAB2IP;SHANK3;RASGEF1A;PPP1CC;PSMA1;ZFP36L2;PSMD7;ERBB4;ACTN2;GRIN1;MAP4K4;TGFB1;GRIN2B;PTPN3;PSMA8;RASGRF1;FGF2;FGF13;SPTAN1;PSME3;IRS1;MINK1;MAP3K7;PSMD14;PDGFB;TEK;SPTBN2;GFRA1;PPP5C;PSMC4;SPTBN1;RASAL3;MAPK3;SETX;HRAS;PTK2;TAOK1;FLT3;IL18;MBP;PSMB4;GOLGA7;ABHD17C;IL17RD;CCL5;PDGFRB;TNIP2;PSME1;YWHAB;PSMD2;PSMD4;SHC3
prerank,positive regulation of translational initiation (GO:0045948),0.3639873991042124,1.0138778923136698,0.4497444633730835,0.9756143965897822,1.0,7/18,25.30%,RPS6KB1;CDC123;POLR2G;CCL5;EIF2B5;POLR2D;DDX3X
prerank,cardiolipin metabolic process (GO:0032048),0.39377851533545005,1.0137095241724778,0.4438687392055268,0.97502990107814,1.0,7/13,34.02%,PTPMT1;PGS1;PNPLA8;TAMM41;PLA2G4A;CRLS1;LCLAT1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.40999629625786405,-1.0136920772285383,0.4224343675417661,0.7254355430647472,1.0,3/10,8.28%,CDC73;NCBP1;HSF1
prerank,regulation of presynapse organization (GO:0099174),0.3709979269156857,1.0136622953536976,0.4570446735395189,0.9728883472903251,1.0,9/18,30.71%,PTPRD;IL1RAPL1;GPC4;WNT7A;IL1RAPL2;LRRC4B;SLITRK1;LRFN5;MDGA1
prerank,regulation of presynapse assembly (GO:1905606),0.3709979269156857,1.0136622953536976,0.4570446735395189,0.9728883472903251,1.0,9/18,30.71%,PTPRD;IL1RAPL1;GPC4;WNT7A;IL1RAPL2;LRRC4B;SLITRK1;LRFN5;MDGA1
prerank,establishment of vesicle localization (GO:0051650),0.3653009762952777,1.0135739550406784,0.4521452145214521,0.9720265518702464,1.0,6/18,23.96%,SNAPIN;LIMK2;SPG11;TMEM230;CCDC186;SYT11
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.2616751824894692,-1.0135367093909389,0.43636363636363634,0.7252216063076531,1.0,22/50,32.09%,GAS6;RAF1;CD44;SIAH2;LAMTOR5;THBS1;PLAUR;SH3RF1;TNF;DNAJB6;GPX1;KLF4;DHCR24;CAAP1;XIAP;RPS6KA3;AQP1;FNIP1;CDKN2D;USP47;HGF;MMP9
prerank,aromatic amino acid family catabolic process (GO:0009074),0.38663680995102107,1.0134701001166697,0.4461028192371476,0.9712385211367113,1.0,3/15,11.65%,IL4I1;IDO2;KYAT1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.32616509572312785,-1.0133881572175667,0.4381443298969072,0.7250006855528761,1.0,9/23,23.84%,IGF1;NFKB1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;APP;EGF
prerank,lipid oxidation (GO:0034440),0.4024511007862025,1.0131829494167073,0.4353146853146853,0.9710813376745027,1.0,3/12,13.92%,ALOX12;PPARGC1A;ACOX1
prerank,aminoglycan metabolic process (GO:0006022),-0.4211069144887587,-1.013180157623131,0.4206896551724138,0.7249225245863233,1.0,2/10,4.06%,XYLT1;CHST9
prerank,cell chemotaxis (GO:0060326),0.2808452063447145,1.0131214184729875,0.4176470588235294,0.970144790843253,1.0,14/60,16.07%,ACKR4;ACKR3;HOXB9;ARRB2;CCR1;BIN2;CXCR6;CX3CR1;CXCR4;PDGFB;CCR6;DOCK4;ACKR2;CCR9
prerank,regulation of multicellular organism growth (GO:0040014),-0.35974297277231904,-1.0129771878489868,0.42080378250591016,0.7247611264142513,1.0,6/15,22.59%,IGF1;STAT5B;GHR;MFSD2A;PTCH1;APP
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.42963675685570685,1.0127662722666562,0.4517857142857143,0.9702482505592339,1.0,5/10,15.10%,COMMD1;HECW2;NEDD4;STK39;NEDD4L
prerank,regulation of lipid catabolic process (GO:0050994),0.3654717510720191,1.0126923343286505,0.4462809917355372,0.9693445533789231,1.0,6/19,20.22%,RARRES2;PDE3B;ADRA2A;ANGPTL3;HCAR2;TYSND1
prerank,positive regulation of bone mineralization (GO:0030501),0.3143564526937531,1.012612730332436,0.432348367029549,0.9684726123799879,1.0,6/35,9.63%,WNT4;MEF2C;FBN2;BMP4;TGFB1;SLC8A1
prerank,macrophage migration (GO:1905517),-0.3690599934515416,-1.0125798852819594,0.4346793349168646,0.7251071869817363,1.0,4/13,13.59%,P2RX4;CCR2;EDNRB;CXCL17
prerank,intestinal absorption (GO:0050892),0.3924772923519446,1.0125492120516242,0.4432809773123909,0.9675342655957089,1.0,3/13,6.94%,F11R;SLC2A2;ADRA2A
prerank,mitotic spindle assembly (GO:0090307),-0.2718605478426195,-1.0124258112610163,0.4257142857142857,0.7248614610129599,1.0,9/42,8.47%,KPNB1;PIBF1;KIF23;KIF11;PRC1;KIFC2;KIFC1;RACGAP1;ABRAXAS1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4246992535247051,1.0123075657525489,0.4444444444444444,0.9672661101453738,1.0,2/10,6.40%,WNT3;RYK
prerank,regulation of translation (GO:0006417),-0.20901475177082532,-1.0122761408058474,0.3953488372093023,0.7245807141646056,1.0,59/173,25.15%,EIF2A;UPF3A;NIBAN1;RPL5;CNOT9;MALSU1;EIF4B;NCBP1;ETF1;BCL3;TCOF1;SAMD4A;THBS1;SHFL;MTG2;EIF4ENIF1;RPL10;DDX6;CAPRIN1;EIF2B2;LARP6;VIM;CD28;PIWIL2;DAPK1;PLD1;PAIP2B;SYNCRIP;TYMS;LARP1;RACK1;MIF4GD;NPM1;ZCCHC4;TRIM71;EIF2B4;HSPB1;LARP4B;FXR2;UPF3B;HNRNPD;EIF1B;IGFBP5;NAT10;RPL26;DHFR;CPEB3;EIF3E;APP;ILF3;CTIF;PYM1;EIF2AK2;RIDA;MTG1;CSDE1;RPS6KA3;EIF4A2;MTPN
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.30720650835642965,1.0122203727118955,0.44019138755980863,0.9664384187498948,1.0,7/39,9.65%,RNF126;AREG;LGMN;DAB2IP;SH3GL2;MVP;PTPN3
prerank,positive regulation of RNA metabolic process (GO:0051254),0.30034979573008086,1.0117749165777836,0.4264264264264264,0.9667869844877213,1.0,9/45,9.35%,DDX5;RELA;SLC38A2;RIOK1;IL6;WDR75;DIMT1;BMP4;TGFB1
prerank,snRNA metabolic process (GO:0016073),0.36655165323029293,1.0115036497437568,0.4494195688225539,0.9665694360292096,1.0,6/17,20.65%,MEPCE;INTS10;INTS8;INTS5;INTS9;INTS11
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.20332021957822768,-1.0111910848196548,0.42528735632183906,0.7268160441099194,1.0,49/214,17.73%,CD74;APOE;NRP1;GAS6;PTPN22;GCNT2;CD44;PTPRC;BRAF;CD36;FBXW7;PTPN1;RANBP9;CCL25;C5AR1;RPS6KA6;CRKL;NOD2;GPR183;PDGFD;SYK;LYN;GLIPR2;CIB1;IL1B;PDGFC;SPRY2;NOTCH1;SEMA6A;CCN1;CEACAM1;KDR;SPRY1;ZDHHC17;SLAMF1;BMP2;EGFR;AGER;SHC1;TNF;PTK2B;SCIMP;RAP1A;EPHA2;ARHGEF5;TLR4;MAP2K7;ADRA1A;SMAD4
prerank,ureteric bud morphogenesis (GO:0060675),0.3732400414144992,1.0109780672069548,0.45234248788368336,0.9672057947850146,1.0,4/16,11.06%,BMP4;PKD2;FGF2;NPNT
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3168924198768456,-1.0109427436590683,0.41309823677581864,0.7268257830056303,1.0,7/24,20.65%,TRPS1;SOX6;GREM1;PTHLH;ADAMTS12;PKDCC;WNT9A
prerank,protein modification by small protein removal (GO:0070646),-0.203726744647033,-1.010803036850795,0.41040462427745666,0.7264915898258271,1.0,64/252,18.66%,VCPIP1;PSMA6;VCP;OTUD6B;IFIH1;PSMB2;ASXL2;CLSPN;SIAH2;ATXN7;SMURF2;PSME2;USP28;ESR1;YY1;INO80C;USP18;SMAD3;PSMD11;TNIP3;RIPK1;INO80B;PSMC6;UBC;USP45;HIF1A;PSMA3;BRCA1;ABRAXAS1;USP8;TAB1;UBA52;ZC3H12A;TRRAP;MYSM1;USPL1;RAD23B;EP300;USP9X;USP38;NFRKB;BARD1;JOSD1;TOMM20;CDK1;CCNA2;BIRC2;SENP1;PSMD10;STAM;UCHL3;TADA2B;PSMB5;CDC25A;FOXK2;USP5;UIMC1;BRCC3;SMAD4;GATA3;PSMD5;COPS4;INO80E;USP4
prerank,mRNA 3'-end processing (GO:0031124),0.27568071567493707,1.0105851013949503,0.4183098591549296,0.9674208983915674,1.0,22/78,20.11%,RNPS1;SRSF5;CPSF4L;CASC3;CPSF6;SRSF6;SRSF11;MTPAP;SRSF1;CPSF3;CSTF1;NUDT21;CDC40;DDX39B;THOC5;PAF1;SARNP;SRSF9;CHTOP;ALYREF;SSU72;SRSF2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.36279924469923863,-1.0104998717810318,0.41797752808988764,0.7266465989199236,1.0,3/14,12.05%,FTSJ3;RPF2;ZNHIT3
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4065828687543058,1.0103149317185385,0.45045045045045046,0.9671813523485712,1.0,4/12,9.35%,ZC3H10;IL6;NCOR2;TGFB1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.26237477608766846,-1.0102692455375577,0.42388059701492536,0.7265882903150406,1.0,16/50,19.56%,SASH1;TLR2;TLR7;LIMS1;CD14;NOD2;IL1B;EP300;TRIM44;EGFR;AGER;TNF;TLR4;NR3C2;MMP8;PTP4A3
prerank,protein localization to cell-cell junction (GO:0150105),0.38424558810569914,1.0101530685208542,0.4448462929475588,0.9665620534381125,1.0,2/15,2.48%,F11R;SCRIB
prerank,actin filament depolymerization (GO:0030042),0.41130277040753394,1.0098914631724225,0.44991212653778556,0.9662947684912508,1.0,4/11,16.03%,MICAL3;TWF2;CFL1;TWF1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2486882703089041,1.0097709787857336,0.43958868894601544,0.9655782751553517,1.0,21/138,9.70%,POLR2L;CDK7;WWTR1;POLR2F;ESRRG;NR1I2;NR1I3;PPARGC1A;GTF2H2;PPARA;NR2F6;AR;GTF2H4;RXRG;GTF2F1;MAZ;NCOR2;GTF2E2;HDAC5;TAF9;MAML3
prerank,regulation of small molecule metabolic process (GO:0062012),0.326569932288203,1.0094418135589192,0.4317817014446228,0.9654990456578747,1.0,10/28,25.70%,GNB3;PPARA;NCOR2;DGKQ;PRKN;TTC39B;RORA;PDK1;FMO5;PANK2
prerank,vesicle transport along microtubule (GO:0047496),-0.32050956678375775,-1.0094171637701082,0.43869209809264303,0.7282109929188595,1.0,12/23,33.52%,TRAK1;KIF3A;RAB1A;CLN3;PAFAH1B1;NDE1;TRAK2;KIF3B;BICDL2;KIF5A;DYNC1H1;HTT
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4003723525873348,1.0092985182722864,0.45878136200716846,0.9648818189099208,1.0,2/12,2.48%,VANGL2;SCRIB
prerank,neuron remodeling (GO:0016322),0.4236036141020867,1.0092570243970354,0.4597495527728086,0.9639015708586814,1.0,2/10,12.14%,C3;FARP2
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.29339541503861777,-1.009218738584147,0.4412532637075718,0.7281076444617731,1.0,8/28,19.90%,ZPR1;SMAD3;PSEN1;ZC3H12A;FLNA;ECT2;CDH1;CHP2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.41491075222624535,1.0089764251839413,0.46830985915492956,0.9637462837473969,1.0,4/11,18.53%,COMMD1;ACTN2;NEDD4L;SNX33
prerank,response to amino acid (GO:0043200),0.3173688698708898,1.0087712564518694,0.4330708661417323,0.9633531918357903,1.0,10/31,19.03%,GLRA3;RPTOR;GLRB;SLC38A9;GRIN1;GLRA2;IPO5;SH3BP4;XBP1;NSMF
prerank,double-strand break repair via homologous recombination (GO:0000724),0.26083469824974953,1.0086300571724922,0.44308943089430897,0.9627222081125214,1.0,22/95,19.41%,NUCKS1;MCM5;RNF138;RAD21L1;SMC5;MCM3;XRCC1;LIG3;UBE2N;RECQL;FAN1;RAD52;PSMD14;PARP1;FEN1;XRCC3;RFWD3;TONSL;HUS1;WRN;SEM1;RECQL4
prerank,GPI anchor metabolic process (GO:0006505),0.33467419902170786,1.0085123135398317,0.45768025078369906,0.9619647980955076,1.0,11/26,28.05%,PIGQ;PIGB;PIGP;MPPE1;DPM3;PGAP2;GPLD1;PGAP3;DPM1;DPM2;PIGZ
prerank,aromatic amino acid family metabolic process (GO:0009072),0.42736493222477717,1.008497762160464,0.45869947275922673,0.960904749343977,1.0,3/10,20.14%,IL4I1;KYAT1;QDPR
prerank,translational elongation (GO:0006414),0.2573249889152397,1.0084294885734488,0.44241573033707865,0.9600489129496096,1.0,33/101,26.75%,MRPS6;GADD45GIP1;MRPL45;GTPBP1;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;EEF1A2;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;LTN1;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9;EEF2K
prerank,RNA modification (GO:0009451),0.28684929851076346,1.008389460055238,0.4366812227074236,0.9590947141811813,1.0,10/54,11.37%,TYW5;ADAT2;ELP5;CTU1;ADAR;METTL1;MEPCE;DTWD2;FTSJ1;NOP2
prerank,protein O-linked mannosylation (GO:0035269),0.36941492662495606,1.0081529522509514,0.4761092150170648,0.9588261012592499,1.0,8/18,27.31%,B4GAT1;TMTC4;FKRP;SDF2L1;DPM3;LARGE1;DPM1;DPM2
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4086324026947435,-1.0080642387256902,0.42857142857142855,0.7299697226914086,1.0,2/10,2.80%,GIT1;CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),-0.4086324026947435,-1.0080642387256902,0.42857142857142855,0.7299697226914086,1.0,2/10,2.80%,GIT1;CBFA2T3
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.27272143010179056,1.007902005547575,0.45427728613569324,0.9585788424547095,1.0,22/72,24.18%,DNASE1;RNASE1;GTF2H2;DNASE1L2;POLD3;DDX1;GTF2H4;OGG1;FAN1;PARP1;DDB2;FEN1;PNRC2;DXO;REXO4;HORMAD1;IHO1;EXD2;GTF2H3;RFC4;ERCC2;ERCC4
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.20399214576331182,-1.0074814989501149,0.4467005076142132,0.7309291794288246,1.0,53/234,17.30%,STK3;PSMA6;FLOT2;PRKCH;TRIM25;TLR2;TRIM14;PPARG;CD36;SMARCA4;RAB7B;LAMTOR5;NLRC4;DHX33;ESR1;NFKB1;CEBPG;TAF1;SMAD3;NOD2;RIPK1;TFRC;CAV1;TRIM62;TAF12;UBC;CIB1;PRKCQ;IL1B;HSF1;TAB1;PIDD1;UBA52;ADAM8;EP300;CTNNB1;ADCY1;FZD2;TRIM5;EDA;NPM1;RIPK4;AGER;TNF;WNT5A;ARHGEF5;TRAF1;TLR4;ARID5B;CRNN;IL18R1;HIPK2;RGCC
prerank,cellular response to heat (GO:0034605),-0.2803737941184905,-1.007407972142671,0.41046831955922863,0.7304677831095884,1.0,8/35,10.57%,VCP;RBBP7;PRKACA;IER5;THBS1;FGF1;HSF1;HIKESHI
prerank,ncRNA transcription (GO:0098781),0.38990418349409073,1.0070716455178692,0.4341880341880342,0.9602191482821001,1.0,5/13,22.39%,ANG;NIFK;SPIN1;SNAPC3;POLR1G
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3567950446191808,-1.0069216394898177,0.41204819277108434,0.7310633615382133,1.0,4/15,11.99%,RIPOR2;TYROBP;ADAM9;CD53
prerank,regulation of response to oxidative stress (GO:1902882),-0.39695284112574875,-1.0065944369792312,0.4216589861751152,0.7313025170883014,1.0,2/11,1.17%,MCTP1;ALOX5
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3183087414282847,-1.0062493022453063,0.4209245742092457,0.731648729257087,1.0,5/23,12.04%,CBLB;PTPRC;CAV1;SOCS5;CBL
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.41213408381679717,-1.0061244271875942,0.4392935982339956,0.7313343275461855,1.0,5/10,19.03%,XYLT1;DSEL;DSE;XYLT2;PXYLP1
prerank,polarized epithelial cell differentiation (GO:0030859),0.3908902821798154,1.0060988534123867,0.4429530201342282,0.9623235516706403,1.0,7/13,27.15%,SH3BP1;SCRIB;CAMSAP3;CDC42;OPHN1;RHOA;MYO9A
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.30938891577634026,1.0060124083097437,0.4428794992175274,0.9615007051261714,1.0,9/39,11.27%,FGF14;FGF12;FGF11;DMD;HECW2;PTPN3;NEDD4;FGF13;STK39
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3466515479630017,1.0059292388143597,0.45394736842105265,0.9595737033526363,1.0,10/23,21.38%,YWHAE;E2F1;PPP3CC;PPP1R13B;BBC3;YWHAQ;NMT1;CASP8;YWHAB;TFDP2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3466515479630017,1.0059292388143597,0.45394736842105265,0.9595737033526363,1.0,10/23,21.38%,YWHAE;E2F1;PPP3CC;PPP1R13B;BBC3;YWHAQ;NMT1;CASP8;YWHAB;TFDP2
prerank,rRNA transcription (GO:0009303),0.36287042233177247,1.005903761310435,0.45187601957585644,0.9585624339631503,1.0,4/17,12.53%,ANG;NIFK;SPIN1;POLR1E
prerank,camera-type eye development (GO:0043010),0.33682852744610864,1.005556253990026,0.43833333333333335,0.9586457505346214,1.0,4/25,9.37%,PRSS56;FBN2;CRYBA4;TENM3
prerank,response to ethanol (GO:0045471),0.3885339727126385,1.0054060842633106,0.4700854700854701,0.9580301022738972,1.0,4/14,17.44%,GRIN1;GRIN2B;GLRA2;SDF4
prerank,ion homeostasis (GO:0050801),0.3284853759613231,1.0053384920625872,0.4416,0.9571864577370373,1.0,8/30,19.01%,SLC4A8;FHL1;SLC30A3;UNC80;SLC4A10;SLC4A7;NEDD4L;WNK1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.30680162230819485,-1.0053059813954401,0.44607843137254904,0.7329890850103725,1.0,9/26,14.21%,TET2;SETD3;PRDM9;WDR82;VCPKMT;EEF2KMT;TET3;ETFBKMT;KMT2D
prerank,protein localization to microtubule organizing center (GO:1905508),-0.35716616728487893,-1.0049691973768407,0.45885286783042395,0.7332329164872518,1.0,3/15,5.75%,PCM1;PIBF1;CCDC14
prerank,carbohydrate transport (GO:0008643),0.4108020098180428,1.0048687858035952,0.46234676007005254,0.9576517411611036,1.0,2/11,6.69%,SLC50A1;SLC2A2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.31339657423201406,1.0045529168913734,0.49047619047619045,0.9576341867612495,1.0,8/35,16.16%,DDX5;WBP2;AR;UBE3A;TADA3;NEDD4;RBFOX2;CALCOCO1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.30212987764620614,-1.0043660917065547,0.44854881266490765,0.7341610405310034,1.0,8/27,14.20%,FXYD5;UTRN;CAMK2D;SCN2B;FXYD1;SLMAP;FXYD2;FXYD6
prerank,protein targeting to mitochondrion (GO:0006626),0.28565084685004133,1.0042711791426855,0.450229709035222,0.9574965832400055,1.0,11/52,14.52%,TOMM40L;TIMM21;FIS1;FBXO7;TIMM29;TOMM34;PITRM1;TIMM13;TSPO;TIMM22;TOMM70
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.36227226391408307,-1.004054869887625,0.42857142857142855,0.7343757526029042,1.0,5/14,15.24%,PTPN1;BAX;DNAJB9;FICD;BCL2L11
prerank,maturation of 5.8S rRNA (GO:0000460),-0.3439230942108565,-1.0040216441876524,0.4541284403669725,0.7338356964613274,1.0,4/17,10.83%,FTSJ3;RPF1;EXOSC10;MPHOSPH6
prerank,renal water homeostasis (GO:0003091),-0.3193428095582019,-1.0037270780422545,0.44711538461538464,0.7339627023434084,1.0,9/23,19.00%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;PRKACB;WFS1;TFAP2B
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3538199407145556,-1.0035695939669276,0.44976076555023925,0.7337357381462262,1.0,4/15,5.83%,PRKCE;PPARG;PPARD;LDLRAP1
prerank,acute-phase response (GO:0006953),0.4045042272249414,1.0035303429742677,0.45840407470288624,0.9588751460528528,1.0,2/12,5.65%,MBL2;IL6
prerank,positive regulation of cell differentiation (GO:0045597),-0.20028324768307187,-1.0031900715844346,0.46994535519125685,0.73412618697542,1.0,63/237,22.48%,DAB2;SUCO;IGF1;PRKCH;SOX6;GCNT2;NOCT;BRINP1;RIPOR2;MSR1;SDCBP;PPARG;CD36;SLC6A6;ASXL2;SOX11;IL6ST;CTNNA1;KITLG;NFKB1;VHL;PPARD;PF4;SMAD3;CEBPB;YAP1;GLIPR2;IL1B;ZC3H12A;LPL;GPRC5B;CTNNB1;AAMDC;TRPM4;CCN1;CEACAM1;KDR;PTN;BMP2;CDH2;GJA1;RAP1A;ASB4;RGCC;SMAD4;ECT2;ARHGEF2;MAPK12;PKDCC;ACVR1;ACVR2A;GDF3;PA2G4;BMP7;LTF;BAMBI;IFITM1;HEYL;FFAR4;ID2;SERPINF2;ISL1;TWIST1
prerank,carbohydrate homeostasis (GO:0033500),0.27423283210852567,1.0029710290571852,0.4449213161659514,0.9596852415009252,1.0,12/67,15.04%,ADCY8;SOX4;STK11;IL6;RFX6;ADRA2A;TCF7L2;KLF7;IRS1;USF1;INSR;PTPN2
prerank,negative regulation of telomere maintenance (GO:0032205),-0.35339782307786166,-1.0026469078601823,0.4444444444444444,0.734980396883075,1.0,9/15,32.63%,RTEL1;NBN;TERF2;SLX4;SMG6;TNKS;PINX1;ATM;RAD50
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.34703620633741733,1.0026457441668002,0.4405940594059406,0.9596583887855844,1.0,5/21,9.35%,WWTR1;SH2B1;TGFBR1;BMP4;TGFB1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.3244467359073838,-1.0025556347443052,0.4549763033175355,0.7345569962103652,1.0,3/20,6.06%,HSPA4;PSMG1;HSPD1
prerank,tRNA transport (GO:0051031),-0.27803709153269884,-1.0024262373944495,0.45614035087719296,0.7342598065147475,1.0,8/35,11.15%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB;TOMM20
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3014014144345725,-1.002321468822416,0.44297082228116713,0.733875984924577,1.0,6/26,14.07%,B4GALT5;RRM1;ST8SIA6;TKT;GK;GK5
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3556307594898792,1.0022764705020832,0.4597315436241611,0.9597582303496441,1.0,3/20,1.96%,HOXA5;CTR9;LDB1
prerank,aggrephagy (GO:0035973),-0.30700558277111245,-1.0020745093538144,0.44054054054054054,0.7338912427389038,1.0,9/27,16.84%,ARL13B;UBQLN1;UBC;WDFY3;UBA52;VIM;WDR81;DYNC1LI2;SQSTM1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.29989731321990865,-1.0014924762483068,0.42933333333333334,0.7348324944200729,1.0,8/27,16.41%,GAS6;PTPN22;ZC3H12A;C1QTNF3;FOXJ1;SLAMF1;TNF;TLR4
prerank,integrated stress response signaling (GO:0140467),0.38753795202992286,1.0012565569150176,0.4663299663299663,0.961979022222231,1.0,8/14,31.07%,NFE2L2;HERPUD1;EIF2AK4;OMA1;IMPACT;ATF4;DDIT3;CCL2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2794909531662822,-1.001182552290685,0.4463768115942029,0.734980252359692,1.0,9/36,18.63%,PPP2R5C;PPP2R5A;PDGFD;NBN;PDGFC;CALM3;CALM2;CHP1;RAP2A
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.36098098727483696,-1.0009959375976618,0.4634760705289673,0.7348850519286313,1.0,2/15,5.30%,DAB2;HIP1R
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.3778106563985184,1.0007769339881505,0.43500866551126516,0.9625213603373911,1.0,3/15,4.80%,SLC45A3;PPARGC1A;PPARA
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.27249992416648666,1.0005593002755429,0.47384615384615386,0.9621322449812187,1.0,20/67,19.41%,ABI3;TXK;NTRK1;FLT4;PRLR;EPHA1;ERBB4;BTK;PDGFB;TEK;EPHA4;INSR;EPHB2;MAPK3;PTK2;ITK;AATK;FLT3;FES;PDGFRB
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.25543261450349536,-1.0004613857391158,0.4411764705882353,0.7356910274449602,1.0,14/52,19.35%,PRKCH;PRKCE;CIB1;SORBS1;LRP1;RACK1;EGFR;TNF;EPHA2;PLS1;CLN3;SQSTM1;AKAP5;NKD2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.37331205444109894,1.0002879151425794,0.45183887915936954,0.9619123837440235,1.0,5/16,15.46%,NACC2;ACKR3;CLU;SNAI2;CCAR2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.3971485695067545,-1.0000321351524208,0.43107769423558895,0.7361951260166056,1.0,5/10,19.94%,PID1;IL1B;INPP5K;RSC1A1;APPL2
prerank,positive regulation of response to stimulus (GO:0048584),-0.27997139626271117,-0.9999312577203553,0.4447513812154696,0.7358000936098572,1.0,14/40,21.55%,FCGR2B;IL15;IFIH1;IER5;B2M;WNT5A;ECHDC3;FXR2;GATA3;HMGA2;CDKN2A;HMGA1;HOMER1;SELENON
prerank,cytoplasmic microtubule organization (GO:0031122),0.2813966076184262,0.9998970611225755,0.4771048744460857,0.96210866155482,1.0,16/54,22.44%,TPPP;STMN3;DST;LIMK2;FSD1;PLK3;CAMSAP3;CAMSAP1;DCTN1;HOOK2;TUBGCP2;CLIP1;HOOK1;CCDC13;TUBGCP6;SPAST
prerank,regulation of protein import into nucleus (GO:0042306),-0.27439652797847525,-0.999732921841649,0.4423076923076923,0.7356713150371508,1.0,10/36,19.90%,MDFIC;ZPR1;SMAD3;PSEN1;ZC3H12A;CHP1;FLNA;ECT2;CDH1;CHP2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.3084425904702695,-0.9996895117427917,0.4725848563968668,0.7351423898190977,1.0,9/26,16.41%,CDK6;TCTA;RARA;GPR137B;CEACAM1;GPR137;LILRB3;C1QC;TLR4
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.3655272423958971,0.9996389213141708,0.4686971235194585,0.9618585298069932,1.0,3/18,5.65%,CTR9;SOCS3;IL6
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.21275900494442265,-0.9995843458678372,0.484304932735426,0.7347930928166283,1.0,40/175,19.16%,PID1;PSMA6;TNFSF8;PSMB2;PSME2;LIMS1;CCL25;BAG4;PSMD11;RIPK1;PSMC6;GBP3;CIB1;PSMA3;BRCA1;ZC3H12A;STAT1;LTB;ACOD1;BIRC2;TNFRSF1B;PSMD10;EDA;INPP5K;TNFRSF17;HAS2;PSMB5;TNF;PTK2B;TRAF1;HYAL3;ADAM17;PYDC1;TNFRSF9;TNFRSF25;GATA3;PSMD5;ARHGEF2;ADAMTS12;PSMD1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3092632320834754,-0.9993923078482864,0.45524296675191817,0.7346950865567988,1.0,5/22,10.80%,MED13;MED16;ESR1;PSMC6;PAXIP1
prerank,carboxylic acid metabolic process (GO:0019752),0.3197457986809974,0.9993387711453684,0.47086614173228347,0.9617662334068319,1.0,7/33,16.80%,SLC2A3;CYP2S1;GSTO1;CSGALNACT1;ACOT4;DAO;AGXT
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.3721615147742863,-0.9991778411239427,0.4492753623188406,0.7346409638855307,1.0,6/12,22.15%,CD36;CYBA;SLC5A3;TLR4;MMP8;ADGRB1
prerank,positive regulation of neuron death (GO:1901216),-0.2701553843201415,-0.9989617372349079,0.45896656534954405,0.7345621462836731,1.0,11/46,16.41%,FCGR2B;BAX;TYROBP;PICALM;FYN;EIF2S1;CTNNB1;FOS;TNF;WNT5A;TLR4
prerank,protein glycosylation (GO:0006486),0.24992896096784556,0.9989420483619692,0.46720214190093706,0.962001514046767,1.0,29/125,20.16%,PLOD3;ST3GAL5;TET1;B3GNT9;FUT10;B4GAT1;B3GNT6;B3GALT2;DDOST;ALG1;SERP2;ST6GALNAC2;POFUT1;OGT;B3GALNT1;SLC39A8;MGAT5B;ST3GAL6;GAL3ST1;MGAT4B;TMEM258;POMGNT1;PLOD1;ALG5;DPM3;GCNT4;ALG3;ST3GAL3;GALNT2
prerank,positive regulation of metabolic process (GO:0009893),0.2570638035597572,0.9983400306341782,0.4444444444444444,0.9628306723732009,1.0,25/103,18.81%,KSR2;G0S2;ESRRG;KDM6B;PPARGC1A;GATM;PRLR;MFAP2;ADCYAP1;OGT;ACHE;CXCR4;ELOVL6;EPAS1;AGPAT1;PRDM16;INSR;ACLY;ACACB;GNAS;ALMS1;IL18;ZBTB7B;HDAC3;GHRL
prerank,macrophage chemotaxis (GO:0048246),-0.39290687598559404,-0.9982259696279486,0.45076586433260396,0.7359671463649219,1.0,5/10,34.83%,EDNRB;CXCL17;TAFA4;CKLF;EDN2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.40277659362883667,-0.9981097052474155,0.4337078651685393,0.7356481067858953,1.0,7/10,43.69%,SOX6;PKDCC;SOX5;GDF6;ZBTB16;SOX9;ACVRL1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.35474364820802307,-0.998071999883885,0.4436936936936937,0.7351129856285534,1.0,6/15,12.39%,TSEN2;CPSF1;FAM98B;ERN1;CPSF4;CSTF2
prerank,positive regulation of nervous system process (GO:0031646),0.3600809127946636,0.9980671353837826,0.44462540716612375,0.9626622920692371,1.0,4/18,13.56%,TPPP;UNC13B;RIMS1;MYRF
prerank,P-body assembly (GO:0033962),-0.3863652787832079,-0.9979993133578219,0.4618834080717489,0.7346446644508845,1.0,4/12,10.65%,LIMD1;EIF4ENIF1;DDX6;RC3H1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.23515108091483616,-0.9979141342253163,0.4605678233438486,0.7342370935818511,1.0,18/77,16.52%,BCL2;IGF1;BCL2L1;BIRC6;MCL1;SIAH2;THBS1;RIPK1;PLAUR;ACAA2;SH3RF1;ASAH2;PSMD10;RB1;QARS1;TNF;GPX1;SLC35F6
prerank,acidic amino acid transport (GO:0015800),-0.33861777735247356,-0.997704912936996,0.4345679012345679,0.7341519866210359,1.0,3/17,3.14%,ARL6IP5;LRRC8D;SLC6A6
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.37423942530675697,0.9976892369543279,0.46557377049180326,0.962793450658775,1.0,10/15,34.91%,ENTPD6;AK5;AK1;AK4;ENTPD1;ENTPD2;NME2;ENTPD3;ENTPD7;AK7
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3630174991763773,-0.9976455436899416,0.44222222222222224,0.7336622391382396,1.0,6/15,24.69%,CCT6A;CCT3;NOP10;DKC1;NAF1;NHP2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3511292663710168,0.9975895728405979,0.4663299663299663,0.9620400490051285,1.0,6/21,20.34%,HOGA1;CYP26C1;ACOX1;LDHD;AGXT;PLA2G15
prerank,renal absorption (GO:0070293),-0.4106547935231408,-0.9972972129160345,0.4608501118568233,0.7340173811029344,1.0,4/10,24.70%,HAS2;GSN;KCNQ1;SLC15A2
prerank,protein targeting (GO:0006605),0.24885548399613222,0.9972741494555633,0.4531886024423338,0.9619673663868484,1.0,43/118,26.99%,LTBP2;FUT10;SPCS2;GIPC1;CHM;FIS1;FBXO7;PRKCI;ZDHHC22;MYO1C;TOMM34;ZDHHC1;SRPRB;ZDHHC2;SRP14;PITRM1;TIMM13;TSPO;MICALL1;TIMM22;TOMM70;HAP1;RASSF9;ZDHHC23;CACNG3;SRPRA;MFF;PEX6;GOLGA7;AP4E1;TIMM23;GABARAP;ZDHHC15;ZFAND6;TIMM44;HACL1;TOMM22;TAOK2;TIMM10;ZDHHC19;TIMM10B;SEC61G;ZDHHC12
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.35030632202517786,0.9972159960976444,0.4444444444444444,0.9611119201110329,1.0,8/20,20.79%,MRAP;ADA;MGRN1;APLP1;RGS2;BICD1;CCL5;YWHAB
prerank,peptide hormone secretion (GO:0030072),0.3257100054814368,0.9971504930141267,0.45773524720893144,0.9602627166926438,1.0,8/26,21.02%,PTPRN;EXOC3L1;IL6;ADCYAP1;GAL;LTBP4;GHRL;SNX19
prerank,regulation of filopodium assembly (GO:0051489),0.30479096481440154,0.9970425111253163,0.46899841017488075,0.9595632740683524,1.0,13/38,23.06%,AGRN;FSCN1;ARHGAP44;TENM1;TRPM2;RAB5A;RHOQ;PALM;CDC42;GPM6A;PPP1R16B;FXR1;WASL
prerank,diol biosynthetic process (GO:0034312),-0.3666523918323832,-0.9970189215789852,0.48514851485148514,0.7342208170802991,1.0,6/15,20.95%,ACER3;ASAH2;SPHK2;SPTLC2;SPTLC3;DHFR
prerank,regulation of necroptotic process (GO:0060544),-0.31628655614366136,-0.9968619451804974,0.4681372549019608,0.7340423952427793,1.0,7/23,13.04%,FLOT2;SDCBP;ZBP1;RIPK1;BIRC2;PELI1;PDCD6IP
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.32964132862533324,-0.9967781580738334,0.44919786096256686,0.7336456275191007,1.0,6/19,16.65%,GNPDA1;UAP1L1;UGDH;GNPNAT1;GMPPB;NAGK
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.29596773251172614,0.9967472902434108,0.46515151515151515,0.9594441079168728,1.0,9/43,11.06%,WNT4;WWTR1;DNAI3;IL6;MEF2C;FBN2;CCN4;BMP4;NPNT
prerank,ameboidal-type cell migration (GO:0001667),0.28437051034011834,0.9966480421649051,0.4880952380952381,0.958705439974394,1.0,12/51,12.36%,SEMA7A;NANOS1;SRGAP2;PKN1;SOX10;SEMA6C;MEGF8;SEMA6B;SEMA3D;ERBB4;FAT2;SEMA4F
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3474921833906257,-0.9966265927009837,0.44285714285714284,0.733388563976153,1.0,10/16,30.84%,PROX1;NOTCH1;BMP2;HEY2;NOTCH2;ISL1;BMPR2;DLL4;SHOX2;TGFB2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.23293263675550488,-0.9964534678337446,0.4564459930313589,0.7332358274035811,1.0,24/85,19.87%,DAB2;VCP;ARIH1;CBFA2T3;FBXW7;TAF1;BBS7;ARIH2;PSMC6;BAG6;RNF14;SOCS5;LRRK2;PSMD10;TMTC3;RACK1;PLK1;USP5;NOP53;ECSCR;RNF144A;RNFT1;NKD2;HSPA1B
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3402922141272551,-0.9963164316601841,0.4336734693877551,0.732955064140744,1.0,6/17,19.54%,PPP1R12A;S1PR2;IL1B;VCL;TNF;S1PR3
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2401536509947086,0.9962836419160368,0.47661188369152974,0.9587470179782788,1.0,26/150,12.97%,FGF10;F3;FGF16;P2RY12;CD80;FGF9;KLB;NRG4;LRP2;CD86;FGF7;AREG;PIK3CG;TNFAIP8L3;MAZ;TGFBR1;TCF7L2;ERBB4;TGFB1;CX3CR1;ITGB1BP1;FGF2;IRS1;VAV1;PDGFB;TEK
prerank,regulation of cellular pH (GO:0030641),0.3235576328601911,0.9960312740421808,0.46,0.9585026880235755,1.0,6/29,14.06%,LACC1;SLC4A8;SLC9A4;SLC4A10;SLC4A7;SLC9A5
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.25325090901406433,-0.995919062779151,0.46546546546546547,0.733425209156539,1.0,18/54,20.36%,RPL5;MALSU1;RPL35A;RPF1;RPF2;RPL6;RPL10;MRPL1;RPL14;RPL23A;MDN1;RPL3;NPM1;NOP53;GTF3A;RPL26;SDAD1;RPL11
prerank,regulation of chromosome segregation (GO:0051983),-0.3472974836658026,-0.9957628770393688,0.4444444444444444,0.733253040727271,1.0,5/16,14.24%,MKI67;PUM2;RMI2;BUB1;NUMA1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.359341705020082,-0.9957376208211904,0.45153061224489793,0.7326949615519828,1.0,5/14,18.70%,FASTKD1;EARS2;MTERF2;SLC25A33;FASTKD5
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.3246116762200552,-0.9957001743111605,0.45323741007194246,0.7321529451162911,1.0,5/20,11.61%,ITCH;UBQLN1;ZMIZ1;HIF1A;DCUN1D1
prerank,triglyceride biosynthetic process (GO:0019432),0.35881973954477187,0.9956830097103376,0.4744408945686901,0.9585893855595012,1.0,2/18,6.60%,DGAT2;PNPLA3
prerank,bile acid metabolic process (GO:0008206),-0.2952413038794637,-0.9953360333607368,0.45901639344262296,0.7325164931789636,1.0,5/27,9.15%,ACOT8;OSBP;OSBPL9;OSBPL1A;OSBPL2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.2688175136112363,0.9952750306949517,0.4602510460251046,0.9588444148804454,1.0,21/72,17.85%,STMN2;NAV3;CLU;CLASP2;SHANK3;TWF2;PRKN;CAMSAP3;FGF13;CAMSAP1;CORO1A;CHADL;ARFGEF1;APC2;TWF1;SSH1;SSH2;TAOK1;HDGFL3;SSH3;SHANK1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.3904377194283734,-0.9949454665502553,0.46352941176470586,0.7329768860030382,1.0,3/11,15.37%,RFTN1;RIPK1;SCIMP
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.36732914080810675,0.9947623606770307,0.4686971235194585,0.9594847670947163,1.0,6/16,10.73%,ZFPM2;MEF2C;TGFBR3;ERBB4;TBX2;FGF2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.29677859170737686,-0.9945635175987501,0.453551912568306,0.7333854851014555,1.0,6/26,10.05%,CUL4A;CHD1L;UBC;USP45;UBA52;RAD23B
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3117379740887398,0.9941676649482039,0.4840255591054313,0.9603643082705332,1.0,6/33,10.75%,RELA;IL6;TRPM2;RIPK3;SIGMAR1;NFE2L2
prerank,negative regulation of cell migration (GO:0030336),0.24713985874048844,0.9940791560799581,0.476,0.9596044390808741,1.0,28/137,15.95%,ADTRP;SRGAP3;SRGAP2;STK26;LDLRAD4;SLURP1;THY1;PTPRT;DNAI3;PTPRU;NAV3;MAPK15;TRIB1;CLASP2;DAB2IP;EPHA1;ITGB1BP1;ADAM15;FGF2;SFRP1;SCAI;EVL;NDRG4;EPHA4;FLCN;ADORA3;MIA3;PHLDB2
prerank,negative regulation of JNK cascade (GO:0046329),-0.2938497277827938,-0.994027505155825,0.44063324538258575,0.7341293009750901,1.0,9/31,24.31%,ITCH;PTPN22;TAOK3;NCOR1;DUSP19;MECOM;GSTP1;DUSP3;FKTN
prerank,positive regulation of blood coagulation (GO:0030194),0.3625014675979784,0.9939600189809462,0.4616695059625213,0.9589546431437276,1.0,4/17,12.52%,F3;THBD;USF1;ENPP4
prerank,cellular response to drug (GO:0035690),0.33433167122307067,0.9937328808457871,0.4817880794701987,0.9586586606777883,1.0,7/25,16.55%,KCNH2;PPM1E;KCNE2;MEF2C;CRHBP;REST;CERS1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.20583112874175408,-0.9930389891140601,0.45320197044334976,0.7361125130290094,1.0,26/186,7.94%,DAB2;STK3;APOE;PSMA6;MCC;LIMD1;CUL3;DVL3;IGFBP4;PSMB2;SIAH2;RNF213;PSME2;CCDC88C;DKK2;HECW1;HMGXB4;PSMD11;MLLT3;TMEM131L;PSMC6;CAV1;PFDN5;WWOX;ZNRF3;PSMA3
prerank,acylglycerol metabolic process (GO:0006639),0.3009501491783023,0.992943874136266,0.4610492845786963,0.9600890511696182,1.0,12/37,20.69%,DGKI;DGAT2;AWAT2;PNPLA3;ABHD12;DGKQ;DGKZ;DGKE;LMF1;ABHD2;PGS1;DGKH
prerank,sensory perception of smell (GO:0007608),-0.3873778588880007,-0.9928381869253309,0.448512585812357,0.7360190197802389,1.0,2/11,12.73%,DRD2;ADCY3
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.24573918186408666,-0.9928110057078703,0.4603174603174603,0.7354646933231155,1.0,14/61,10.46%,MECP2;PCNA;SMCHD1;RTEL1;ZCWPW1;CEBPG;TOX;NBN;BRCA1;EYA1;ABRAXAS1;EYA3;USP9X;EYA2
prerank,regulation of type I interferon production (GO:0032479),-0.23719080470499707,-0.9927616358127278,0.4859154929577465,0.7349817248865202,1.0,29/84,22.59%,ITCH;PTPN22;TRIM25;IFIH1;IRF7;ZBP1;TBK1;POLR2E;DHX33;NFKB1;CD14;RNF216;DDX41;EP300;CTNNB1;ACOD1;NLRC5;LRRFIP1;POLR2H;UBE2L6;DTX4;POLR3G;TRAF3IP1;MYD88;NPLOC4;TRIM21;RNF125;G3BP1;CRCP
prerank,apoptotic process (GO:0006915),-0.2030239594118403,-0.9926843803730178,0.4976303317535545,0.7345837739720052,1.0,38/203,12.51%,BCL2;STK3;PAEP;HIP1;BCL2L1;PRKCE;RAF1;TLR2;IFIT2;RRAGC;BAX;AHR;CD14;TRPC5;ARHGEF6;PPARD;FAS;HSPD1;RIPK1;DDX41;CIT;CIB1;IL1B;BAG6;PIK3CA;PIDD1;MRPS30;EP300;TNFRSF19;FOXO1;SEMA6A;LIG4;DAPK1;BRAT1;CD2;ESPL1;MCM2;PRUNE2
prerank,regulation of protein localization to nucleus (GO:1900180),-0.26875313755607033,-0.992360984608797,0.459214501510574,0.7347938293718769,1.0,12/43,16.67%,DTX3L;LAMTOR5;CTNNA1;TFRC;YAP1;BYSL;CDK1;PARP9;ORMDL3;KAT7;PLK1;SESN2
prerank,histone lysine methylation (GO:0034968),-0.28156388050284775,-0.9921093103178319,0.45528455284552843,0.734815841629466,1.0,15/33,25.77%,SETDB2;DOT1L;SETD3;PRDM9;WDR82;KDM6A;PAXIP1;DPY30;KMT2D;RBBP5;SMYD3;KMT2B;KMT2A;EZH2;DYDC2
prerank,blood vessel endothelial cell migration (GO:0043534),-0.31599515584380866,-0.9920087812214009,0.4223918575063613,0.7344731129091587,1.0,8/22,16.71%,NRP1;EGR3;ID1;KDR;EMP2;GREM1;MYH9;EPHB4
prerank,positive regulation of organelle organization (GO:0010638),-0.2906544575965573,-0.9918103111794911,0.4971751412429379,0.7343758094692897,1.0,8/32,16.92%,ANXA1;UVRAG;SMCR8;TMED9;SORBS3;LIG4;STX18;RAB3GAP2
prerank,mitotic nuclear division (GO:0140014),-0.23715909484078745,-0.991788623883047,0.4397163120567376,0.7338204014732538,1.0,22/71,19.40%,KPNB1;CHMP4B;EPS8;MIS12;PIBF1;KIF11;KIFC2;CDCA8;NCAPG2;KIFC1;ABRAXAS1;NUSAP1;ESPL1;NUP62;NDC80;PLK1;UBE2C;MZT1;FLNA;KIF18B;TPX2;ZWINT
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2555395205358274,0.9917668046578165,0.48678720445062584,0.9627993590451684,1.0,27/98,21.38%,YWHAE;FIS1;E2F1;PRNP;PDCD5;PRKCI;ZDHHC8;CD81;MYO1C;PRKN;ITGB1BP1;STX3;PPP3CC;MTCL1;PPP1R13B;SPTBN1;BBC3;EPHB2;HRAS;YWHAQ;NMT1;MFF;CASP8;ITGAM;PDPK1;YWHAB;TFDP2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2945712606331884,0.9917354783917387,0.47023809523809523,0.9618567791446223,1.0,15/45,20.89%,SCRIB;BMP4;ZFP36L2;FOXC1;TGFB1;ZW10;PTPN3;BTG3;BTG2;TOM1L1;ANGEL2;PLK2;BTG1;HECA;NABP1
prerank,regulation of chromatin binding (GO:0035561),-0.3931254481072465,-0.9916817148399866,0.4680365296803653,0.7334816741643848,1.0,3/10,14.25%,DTX3L;PARP9;CDT1
prerank,regulation of DNA recombination (GO:0000018),-0.28131147085253877,-0.9915303282853247,0.48097826086956524,0.7332409792731169,1.0,16/32,33.18%,KPNA2;RTEL1;ZCWPW1;ZRANB3;H1-0;PPP4R2;RPA2;SETD2;RAD51AP1;SMARCAD1;THOC1;MSH6;FIGNL1;SPIDR;RAD50;MSH3
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.30847692364401175,0.9912676942128282,0.4802527646129542,0.9623128734745923,1.0,10/33,16.64%,P2RY12;NCKAP1L;ADA;PIK3CG;PDE3B;SNAI2;ITGB1BP1;EFNA1;JAM3;PTK2
prerank,phospholipid translocation (GO:0045332),0.3236656690125742,0.9912571006008956,0.46687211093990755,0.9613019104572286,1.0,8/28,21.52%,ATP8A2;ATP9A;ABCB4;ATP11A;ATP8B1;ATP8A1;ABCA7;PLSCR4
prerank,positive regulation of histone acetylation (GO:0035066),-0.3145928416830484,-0.9911540775777476,0.48641304347826086,0.7335987152119177,1.0,9/23,18.49%,BRCA1;IL1B;PAXIP1;GLYR1;SPHK2;TADA2B;KAT7;SMAD4;TADA2A
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.29670183364756253,0.9909997337749891,0.4844517184942717,0.9610889943316646,1.0,10/39,21.22%,ADTRP;PPARA;SPINT2;MAP2K5;TGFB1;MIA3;PTK2;MBP;WNK1;RDX
prerank,neuronal action potential (GO:0019228),0.3413935808658123,0.9909226253454139,0.45723684210526316,0.9602845548731676,1.0,9/22,31.08%,CACNA1G;SCN2A;KCNMB3;SCN8A;SCN7A;ANK3;CACNA1H;SCN1A;CACNA1I
prerank,regulation of steroid metabolic process (GO:0019218),0.33033742767836133,0.9903473716511834,0.4815436241610738,0.9610658719444938,1.0,10/23,25.70%,STAR;GNB3;DGKQ;ABCA2;TTC39B;RORA;FMO5;NR5A1;STUB1;PANK2
prerank,outer dynein arm assembly (GO:0036158),0.3827760982207393,0.9903246284911359,0.513840830449827,0.9600963652360022,1.0,2/14,2.02%,DNAAF1;ODAD4
prerank,microtubule anchoring (GO:0034453),0.3966493636552435,0.9903123154747556,0.4730639730639731,0.959104290879894,1.0,5/12,17.34%,CLASP2;CAMSAP3;PEX14;BICD2;BICD1
prerank,positive regulation of DNA recombination (GO:0045911),0.33157768720902014,0.9901963913902411,0.4608,0.9584353989255461,1.0,10/27,24.08%,WRAP53;FUS;TIMELESS;PARP1;ERCC6;SHLD3;MRNIP;SHLD2;ERCC2;ARID2
prerank,protein insertion into membrane (GO:0051205),0.3105544350939451,0.9901851747817377,0.4514003294892916,0.9574523345463786,1.0,8/32,15.22%,SGTA;PRNP;OTOF;EMD;TRAM2;CCDC47;TRAM1;OXA1L
prerank,connective tissue development (GO:0061448),-0.2812657948799352,-0.9901339383173157,0.49008498583569404,0.7356763025688876,1.0,6/35,5.28%,SOX6;CD44;ATP7A;NAMPT;SH3PXD2B;COL11A2
prerank,positive regulation of JNK cascade (GO:0046330),-0.23759986823467177,-0.9901219305206359,0.4463087248322148,0.7350878238435645,1.0,18/70,18.72%,FCGR2B;SDCBP;PJA2;NOD2;RIPK1;IL1B;TAOK3;SH3RF1;MAP3K11;TNFRSF19;GADD45G;SLAMF1;AGER;PTK2B;TRAF1;HIPK2;MMP8;TRAF4
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.25723849959426687,-0.9898239640221125,0.4492307692307692,0.7352145565772708,1.0,11/47,15.33%,APOE;EIF2A;VPS35;TCOF1;NFKB1;NR1H2;EDNRB;RPL10;WDR91;NR1H3;EIF2B4
prerank,erythrocyte development (GO:0048821),0.42513430332535207,0.989288910911549,0.49158249158249157,0.959250351261795,1.0,5/10,27.09%,NCKAP1L;SH2B3;ZBTB7A;LYAR;DMTN
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.2896122930317845,-0.9889795993147261,0.46965699208443273,0.7368859300567423,1.0,14/30,24.67%,CHST11;CHST9;IDUA;UGDH;IDS;DSEL;CSPG4;CHST7;CHPF;DSE;CHST12;CHSY3;CHST3;HEXA
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.36941347703218264,-0.9887277659212057,0.4569377990430622,0.7369037040216515,1.0,2/12,8.86%,KPNB1;MBTPS1
prerank,glycolipid biosynthetic process (GO:0009247),0.3018614769020252,0.9881801140303138,0.47473200612557426,0.96169723490902,1.0,17/38,32.36%,ST3GAL5;PIGQ;PIGB;PIGP;MPPE1;SCCPDH;DPM3;PGAP2;LARGE1;PGAP3;DPM1;DPM2;PIGZ;A4GALT;ST8SIA3;PIGG;PIGC
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.2502213912383865,-0.988075778625915,0.4692556634304207,0.7380054797529587,1.0,18/55,16.94%,GALNS;LYVE1;FUCA1;CD44;HGSNAT;IDUA;HMMR;CEMIP2;HPSE2;HPSE;OGN;IDS;STAB2;CSPG4;SDC3;CHP1;SDC1;HYAL3
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.23533755913879859,0.9878967156740979,0.5019059720457433,0.9616136478683827,1.0,43/173,21.43%,ACTR10;RAB1B;KDELR3;CNIH2;SEC16B;TMED2;AREG;COPG1;COG4;SEC31A;GRIA1;NRBP2;TRAPPC3;MPPE1;ZW10;BGLAP;PDCD6;CNIH1;SPTAN1;BET1L;DCTN1;SPTBN2;TMED5;SEC24D;SEC24B;SPTBN1;COPE;IER3IP1;KDELR2;MIA3;SEC24C;TMED3;COPG2;ANK2;PREB;STX17;LMAN2L;DCTN3;TRAPPC8;TMED7;TFG;CNIH4;VTI1B
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.23799678321686998,-0.9878355189717888,0.45544554455445546,0.7380200092448347,1.0,20/76,19.87%,DAB2;VCP;ARIH1;CBFA2T3;FBXW7;TAF1;BBS7;ARIH2;RNF14;CCDC22;SOCS5;LRRK2;PSMD10;RACK1;PLK1;USP5;NOP53;RNF144A;NKD2;HSPA1B
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.2567406815460463,0.9874348089361524,0.4945054945054945,0.9620801935015304,1.0,21/90,18.81%,KSR2;G0S2;ESRRG;KDM6B;PPARGC1A;GATM;PRLR;MFAP2;ADCYAP1;OGT;ACHE;CXCR4;ELOVL6;EPAS1;PRDM16;GNAS;ALMS1;IL18;ZBTB7B;HDAC3;GHRL
prerank,regulation of activated T cell proliferation (GO:0046006),0.3182659262490336,0.987404736322215,0.4880382775119617,0.9611313992723933,1.0,10/30,18.30%,SCRIB;PRNP;IGFBP2;IL2;RIPK3;CRTAM;HMGB1;PRKAR1A;IL18;ICOSLG
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2478962833708373,0.9873922096045147,0.48202396804260983,0.9601315247776273,1.0,14/117,6.43%,HOGA1;CYP2S1;ACSF2;AKR1C1;ALOX12;CPT1B;GATM;BCO2;MECR;PPARA;ACADSB;VDAC1;MTHFD1L;GGT5
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.39543970457168226,0.9872871662542397,0.4800693240901213,0.9573976049118572,1.0,7/11,27.91%,PPCDC;COASY;DCAKD;PPCS;PANK2;SLC25A16;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),0.39543970457168226,0.9872871662542397,0.4800693240901213,0.9573976049118572,1.0,7/11,27.91%,PPCDC;COASY;DCAKD;PPCS;PANK2;SLC25A16;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.39543970457168226,0.9872871662542397,0.4800693240901213,0.9573976049118572,1.0,7/11,27.91%,PPCDC;COASY;DCAKD;PPCS;PANK2;SLC25A16;ACOT7
prerank,regulation of protein processing (GO:0070613),-0.313101755959965,-0.9870656776044966,0.4648910411622276,0.7394091940217419,1.0,6/21,19.35%,CCBE1;NLRC4;ADAM8;LRRK2;CLN3;NKD2
prerank,positive regulation of macrophage migration (GO:1905523),0.34882688313334964,0.9868991147935088,0.4856661045531197,0.957565155876645,1.0,9/19,28.92%,P2RY12;RARRES2;MAPK3;PTK2;CCL5;IL34;MAPK1;CSF1R;MDK
prerank,regulation of transport (GO:0051049),-0.2825522904862951,-0.9866069783565907,0.48333333333333334,0.7400206038464368,1.0,9/36,17.14%,ARL6IP5;NRP1;GAPVD1;ICA1;MBTPS1;LRRK2;YRDC;MUL1;RSC1A1
prerank,melanosome localization (GO:0032400),-0.3121252347329731,-0.9864206490973777,0.47883597883597884,0.7398652750423352,1.0,6/21,26.38%,MYO5A;BBS7;MLPH;SHROOM2;BLOC1S3;MREG
prerank,negative regulation of viral life cycle (GO:1903901),-0.35542419467180913,-0.9861197150477268,0.4753246753246753,0.7400462045448493,1.0,7/15,21.63%,CIITA;IFITM3;BST2;TRIM5;GSN;PTX3;IFITM1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3054883422973492,-0.986076396595784,0.4730077120822622,0.739549723145551,1.0,7/24,14.06%,CCR2;MOSPD2;LYN;CCN3;CXCL17;GREM1;DUSP1
prerank,cellular response to fatty acid (GO:0071398),-0.37544745468790797,-0.9860453374526166,0.45852534562211983,0.7390121385666487,1.0,3/12,9.53%,PID1;ZC3H12A;LPL
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.31024058559766765,0.985897732002705,0.46256239600665555,0.9596474817078458,1.0,10/33,14.20%,MEOX2;MEF2C;MAP2K5;VASH1;HDAC5;TGFB1;ITGB1BP1;FGF2;GADD45A;HMGB1
prerank,post-translational protein modification (GO:0043687),0.22101930990640703,0.985571380847772,0.505166475315729,0.9596765959485439,1.0,80/332,20.52%,KLHL25;KLHL22;FBXW8;PSMB1;C3;OBSL1;RAB1B;CST3;FBXW9;RAB3A;AFP;COPS8;CHM;SOCS3;UBE2M;FSTL1;ELOC;IL6;FBXO7;NUB1;RAB8A;COMMD1;PSMF1;BTRC;ASB2;FBXO11;PSMA1;BMP4;SOCS2;PSMD7;COPS3;PSMA8;HSP90B1;FBXW10;RAB5A;RAB38;FBXL20;PSME3;SENP8;KLHL2;CUL2;SCG3;EPAS1;PSMD14;VCAN;NUCB1;SPSB3;FBXL4;FBXL19;PSMC4;DDB2;DCAF11;LRRC41;SOCS6;COPS6;FBXW5;APLP2;SKP2;UBA3;MIA3;FN3K;KLHL5;KLHL11;COP1;ESCO1;FBXO9;PSMB4;QSOX1;FBXL7;KLHL42;FBXL3;WSB1;FBXL22;RABGGTB;SDC2;SPARCL1;FBXO31;COPS5;PSME1;FBXO6
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2626426393409682,-0.9853530846023038,0.4772117962466488,0.7401954111910981,1.0,11/43,15.18%,CBLB;RAB7A;EPS15;SOCS5;SPRY2;GRB2;CBL;SPRY1;STAM;EGFR;ITGA1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3290630686110336,-0.9852305193984605,0.47596153846153844,0.739899162901232,1.0,8/19,17.30%,SUCO;CIITA;LARP6;VIM;HDAC2;SCX;CREB3L1;RGCC
prerank,regulation of receptor recycling (GO:0001919),0.36819513847211716,0.9852248925759168,0.47107438016528924,0.9597416274145852,1.0,4/16,14.44%,SCRIB;INPP5F;TBC1D16;VAMP3
prerank,negative regulation of translational initiation (GO:0045947),-0.3619729057287311,-0.985121108393177,0.4488778054862843,0.7395796679305249,1.0,7/13,26.59%,EIF4EBP2;AGO2;PAIP2B;LARP1;EIF3E;EIF2AK1;PAIP2
prerank,regulation of cell death (GO:0010941),-0.22541884990745664,-0.9850859101149598,0.4795539033457249,0.7390393250928947,1.0,34/94,25.62%,ACER3;CHMP4B;CELF1;CD36;TBK1;SOX11;VPS35;NCK1;SPEF1;TMEM109;PACRG;ZC3H12A;SNCG;CCN1;TNFRSF1B;LRRK2;CCN3;LRP1;CCN5;CHP1;DUS2;ADNP2;HSPA1B;BMP7;DHCR24;HPR;HP;EPHB1;NOA1;PARP16;CCN6;RAMP3;OLFM4;TRIM13
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3800812587291674,0.9850702375275742,0.4483985765124555,0.9591779739664774,1.0,3/14,6.05%,ZBTB8OS;TSEN54;DDX1
prerank,inner ear morphogenesis (GO:0042472),0.3359927699535315,0.9850085306910874,0.4786184210526316,0.958369203340134,1.0,4/22,15.47%,MYO6;POU3F4;EPHB2;HPN
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.41686875137378254,0.9849847506154158,0.500875656742557,0.9574161808866933,1.0,2/10,8.42%,EMC6;EMC2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.23847933100890628,-0.9849186415062939,0.44966442953020136,0.7388531125560226,1.0,16/70,16.30%,CYBB;PSMA6;CD36;PSMB2;PSME2;TAPBP;PSMD11;PSMC6;PSMA3;SNAP23;CYBA;MFSD6;PSMD10;B2M;PSMB5;FCER1G
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.3063734595875959,-0.9848644642760424,0.47341772151898737,0.738360498979246,1.0,8/24,17.17%,PTPN22;DTX3L;ZC3H12A;STAT1;TRIM44;PARP9;LILRB1;TRAF3IP2
prerank,cilium organization (GO:0044782),-0.19772795406067364,-0.9843702097668189,0.5079365079365079,0.7390269232490275,1.0,37/209,12.56%,EHD4;ATP6V0D1;RAB8B;ACTR3;KIF3A;PTPN23;PCM1;RILPL2;FAM161A;PIBF1;RAB1A;MKS1;RPGR;SCLT1;CDC14B;EXOC4;CPLANE1;GBF1;CEP250;ARL13B;TCTN1;SSX2IP;BBS7;FHDC1;ASAP1;DNAH5;TMEM231;KIF24;CEP164;WDPCP;SNAP29;CCDC28B;TMEM138;NOTCH1;FOXJ1;IFT52;EXOC8
prerank,regulation of lipid kinase activity (GO:0043550),-0.37898863906944197,-0.9843428369963214,0.46543778801843316,0.7384843223640314,1.0,4/11,13.38%,PPP2R5A;WDR91;WDR81;RB1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.25891014188004563,0.9842585587696326,0.4752475247524752,0.95875976572591,1.0,25/84,23.05%,GAPDH;RTN1;NANOS1;GGA3;BIN1;ENC1;PRNP;CLU;ORMDL2;BTG2;CNOT8;HAP1;NTRK2;EPRS1;ROCK1;CHRNA7;PIN1;TOB1;PUS7;DHX36;ABCA7;CNOT10;FXR1;IGF2BP3;RNF139
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3752034235047765,0.9840711965165859,0.4828767123287671,0.9583426831252725,1.0,8/14,28.92%,RARRES2;MAPK3;PTK2;CCL5;IL34;MAPK1;CSF1R;MDK
prerank,regulation of metal ion transport (GO:0010959),-0.3380473312141403,-0.983702228778098,0.46272493573264784,0.7394982348269046,1.0,2/16,3.44%,BCL2;IL16
prerank,negative regulation of hydrolase activity (GO:0051346),0.28365856449071924,0.9836621144987091,0.4817629179331307,0.9586198923014155,1.0,16/49,24.07%,F11R;CST3;GCHFR;TMED2;DAB2IP;ARFGEF1;RCC2;SH3BP4;RRP1B;HRAS;WNK1;GMIP;RDX;MAP2;GPSM1;CST7
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.27517013457715606,0.9830301599899713,0.4903129657228018,0.9596049812990984,1.0,13/61,12.78%,FGF10;F11R;NTRK1;PIK3CG;PRAG1;MAPRE2;RASGEF1A;GPR17;MAP4K4;RASGRF1;LPAR4;AKAP13;VAV1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.21141988839612147,-0.9827917375351889,0.5120772946859904,0.7412870768007092,1.0,27/148,12.77%,PPP2R5C;RBBP8;RBBP7;RPL5;PRKAB1;TOPBP1;RPS20;TAF1;PHF20;RPF2;TAF12;NBN;PRKAG2;BRCA1;RMI1;ATRIP;EP300;HIPK1;RHNO1;BARD1;RPA1;CDK1;HDAC2;RMI2;EHMT1;KAT5;HDAC1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.30923379236184995,0.9826911944392112,0.4959481361426256,0.9596736894204477,1.0,10/34,20.22%,LACC1;CD86;IL6;INAVA;IL2;CLCF1;VAMP3;EPHB2;XBP1;TNFRSF4
prerank,actin cytoskeleton reorganization (GO:0031532),0.27407092734168176,0.9826517568107831,0.49189985272459497,0.9587725453306577,1.0,11/63,12.14%,FGF10;CTTN;MKLN1;THSD7A;PAK1;FGF7;PTK7;CDC42BPA;ATP2C1;MINK1;FARP2
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.2908439936463788,-0.9824524768753431,0.49714285714285716,0.7416007703275318,1.0,8/29,19.58%,ZCWPW1;STAG3;PRDM9;BAG6;RAD21;TEX11;TRIP13;REC8
prerank,positive regulation of kinase activity (GO:0033674),-0.21806767824269901,-0.982264553779616,0.4712230215827338,0.7414931849415716,1.0,23/107,16.71%,IQGAP1;CD74;GAS6;AXL;PTPRC;MET;LMTK2;FLT1;SNX9;NBN;PRKAG2;RET;LCP2;AGAP2;CCN1;KDR;LMO4;EGFR;TNF;PTK2B;RAP1A;EPHA2;EPHB4
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2720844438411384,-0.9821771881933783,0.4594594594594595,0.7411111055966267,1.0,8/36,10.73%,PRPF19;CLSPN;USP28;DOT1L;NBN;ATRIP;HINFP;RHNO1
prerank,positive regulation of myelination (GO:0031643),0.40373091222916685,0.9821662799915779,0.4896551724137931,0.9592940382381017,1.0,1/11,0.01%,TPPP
prerank,neurogenesis (GO:0022008),0.29181812751785996,0.9820513678538864,0.4795763993948563,0.9586705964705278,1.0,11/43,18.59%,ROGDI;DCHS1;SIX4;RYK;BTBD3;CXCR4;HAP1;ERCC6;FAT4;NDUFS2;DAGLA
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.300964673464807,0.9816041864961214,0.4692913385826772,0.9590820447343471,1.0,9/39,13.79%,PIK3C2G;IP6K1;SLA2;SOCS3;PIK3CG;PI4K2A;SOCS2;SOCS6;SOCS4
prerank,organelle fusion (GO:0048284),0.3399704629099824,0.9814933837943842,0.4940374787052811,0.9584081324227897,1.0,5/22,17.61%,CYP26C1;FIS1;USP30;MIGA1;MFF
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3444165001707014,-0.9814461084829859,0.46756152125279643,0.7424356957523063,1.0,5/15,16.27%,STAT2;USP18;NLRC5;OAS3;MUL1
prerank,transition metal ion homeostasis (GO:0055076),0.31817915806295866,0.981380903131405,0.48031496062992124,0.9577628363328099,1.0,5/28,9.79%,IREB2;TMC8;COMMD1;NEO1;PRKN
prerank,activation of protein kinase B activity (GO:0032148),-0.2919291406978172,-0.9807564594915612,0.4708994708994709,0.7436338691112586,1.0,5/29,8.19%,OSBPL8;GAS6;IGF1;FGF1;TXN
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.25929410192779845,-0.9803659073077693,0.5068870523415978,0.7440461147400336,1.0,23/45,36.65%,DAB2;SDCBP;BMP5;RBPMS;BMP2;BMP3;SMAD4;ACVR1;ACVR2A;GDF3;BMP7;GDF10;BMPR2;GDF9;INHBB;BMPR1A;GDF15;TGFB2;BMP8B;LEFTY1;GDF6;BMP15;INHBC
prerank,regulation of wound healing (GO:0061041),-0.26391657663723744,-0.9803473187203835,0.4776536312849162,0.7434866409971621,1.0,6/42,7.33%,PLAU;ALOX5;CRK;PRKCE;CAV1;ANXA1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.32595230963263094,0.9802919243385911,0.49585406301824214,0.9601876927956711,1.0,7/26,18.52%,PAK1;PSRC1;STMN2;NAV3;DCTN1;CLIP1;FES
prerank,positive regulation of cellular process (GO:0048522),-0.18280884679174608,-0.9800793709572031,0.5657894736842105,0.7435868251738021,1.0,148/565,22.56%,FCGR2B;IL15;BCL2;GAS6;ANKRD17;MECP2;ITGAX;ACER3;IGF1;CELF1;GCNT2;DPP4;SDCBP;CUL3;CD47;LIFR;CAPN1;TLR2;FAM98B;LILRA5;P2RX4;CD36;IL12RB2;MEIS1;SLC6A6;RARA;DOCK2;NCBP1;FAM98A;NAMPT;CDCA7L;SOX11;IL6ST;DOT1L;IER5;CXCL16;KITLG;PROX1;PRC1;DDX49;S1PR2;MTLN;THBS1;VHL;CRKL;PDGFD;FLT1;EGR2;CCND1;KIF20B;CAV1;PDCD10;LYN;DHPS;CIB1;GAB2;IL1B;FGF1;HSF1;HCK;H3-3A;BMP5;VIPR1;ZC3H12A;KRAS;PDGFC;ADAM8;BIRC5;NOTCH1;TRPM4;PPP3CA;HDAC2;IGF2;TNFRSF1B;CYBA;BRAT1;SLC11A1;HDAC1;KDR;EMP2;CCND2;PSMD10;LRP1;PTN;SLAMF1;SCX;GREM1;HAS2;EXOSC9;NPM1;KMT2D;NUMA1;LBP;CIAO1;EGFR;SHC1;TNF;PTK2B;WNT5A;TUB;SLC25A33;ECHDC3;BST1;MFSD2A;ACACA;FCER1G;FXR2;TLR4;SLC35F6;MAPK8;ADAM17;AQP11;ADNP2;PTHLH;HMGA2;FN1;LRP6;PDGFRA;HES1;TFAP2B;IRS2;S1PR3;OSMR;CHP2;PA2G4;BAMBI;EPO;TIMP1;MLC1;TRIM21;SIRT2;CXCL12;HDAC4;CDH3;TGFA;CNOT6L;HPR;HP;LMNA;NOXO1;SERPINF2;HMGN5;ISL1;FGF18;SHH;CCAR1;CAPN10;CCKBR
prerank,keratan sulfate catabolic process (GO:0042340),0.41275560894453694,0.9800471453118917,0.49312714776632305,0.9599269387154012,1.0,2/11,2.81%,HEXB;ACAN
prerank,skin development (GO:0043588),-0.24193987349908136,-0.9800222208794278,0.47634069400630913,0.7431234704982475,1.0,28/65,33.26%,ATP7A;MET;ST14;ADAM9;CLIC4;STMN1;ANXA1;TXNIP;ALOXE3;WNT5A;EPHA2;CLDN1;COL3A1;OPN3;DHCR24;BCR;DSP;ASCL4;EVPL;PDGFA;SCEL;KRT10;TMEM79;DLL1;KDF1;ASAH1;ITGA3;UGCG
prerank,apoptotic mitochondrial changes (GO:0008637),0.3123099597703654,0.9791473838883025,0.48244274809160304,0.961810251916505,1.0,12/32,17.61%,FIS1;CLU;BAK1;ERBB4;GGCT;NDUFS1;DNM1L;BIK;BBC3;HK2;CCAR2;MFF
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.32198480672506957,-0.9787730976168745,0.48498845265588914,0.7456370694021458,1.0,5/20,17.30%,ITGA4;THBS1;ECSCR;GSN;RGCC
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4051473400483102,0.9783650301765725,0.49122807017543857,0.9632216481957013,1.0,4/11,21.89%,STK26;PRKN;REST;LANCL1
prerank,actin filament bundle organization (GO:0061572),-0.2774198421336418,-0.9781247812161074,0.46949602122015915,0.7467632552228045,1.0,10/33,22.64%,NEDD9;EPS8;LCP1;PLS1;MICAL1;LIMA1;RFLNA;AIF1L;SHROOM2;BAIAP2L2
prerank,lamellipodium organization (GO:0097581),0.3165615493374377,0.9781207999985465,0.4862236628849271,0.9629979228213542,1.0,4/29,8.02%,CTTN;P2RY12;PTPRO;ABLIM2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.4088669135825401,0.9780366123097155,0.47927927927927927,0.962256018005793,1.0,3/10,9.32%,UBE2B;PDE3B;MGRN1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.307613392882182,0.9780265166827672,0.46919431279620855,0.9612954777939056,1.0,5/32,8.04%,C3;STAR;PPARA;THRSP;EIF6
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.38228533062575376,0.97775469338058,0.4857142857142857,0.9611423084907699,1.0,4/13,12.49%,FSTL1;DAND5;FBN2;GREM2
prerank,tRNA export from nucleus (GO:0006409),-0.27676282877011216,-0.9777523293237693,0.5043731778425656,0.7464993287346857,1.0,7/32,10.32%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.27676282877011216,-0.9777523293237693,0.5043731778425656,0.7464993287346857,1.0,7/32,10.32%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB
prerank,regulation of neuroinflammatory response (GO:0150077),-0.3183274155404332,-0.9776283087449104,0.4708994708994709,0.7461832560497128,1.0,5/19,18.53%,IGF1;IL1B;TNFRSF1B;TNF;MMP8
prerank,proteolysis (GO:0006508),0.2260825324396708,0.9776010869396864,0.5261239368165249,0.9606022938662774,1.0,61/252,21.54%,RNF123;F3;PLAT;CAPN3;MMP16;RNPEPL1;ACAN;PRSS56;CAPN12;ASPRV1;XPNPEP1;CNDP1;PGPEP1;TMPRSS7;BACE1;GGT5;XPNPEP3;UBE3A;SPPL2B;LGMN;ATG4A;OGT;VASH1;PHEX;FBXL6;AEBP1;TRHDE;CAPN11;CASP3;LAP3;CASP4;PSENEN;CASP7;PITRM1;VASH2;MMP1;PSMC4;ENPEP;HM13;HPN;UBA3;ERMP1;THOP1;FBXL2;SUFU;TMPRSS6;LACTB;MMP17;PCSK2;ADAMTS3;DPP8;FOLH1;CTSK;NAALAD2;CASP8;TYSND1;FBXO6;METAP2;APEH;CASP2;CTSS
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.307499034299727,-0.9774604125621558,0.4782608695652174,0.7459920339468796,1.0,10/22,35.20%,HSPD1;IL1B;B2M;CD55;FADD;IL12RB1;MALT1;IL12A;IL23R;IL12B
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.34114409689187264,-0.9772784950631002,0.4696261682242991,0.7458388373161209,1.0,7/16,17.30%,SUCO;LARP6;VIM;HDAC2;SCX;CREB3L1;RGCC
prerank,macrophage activation (GO:0042116),-0.2822360580492491,-0.9769160338975141,0.5231607629427792,0.7461458453110866,1.0,16/34,30.55%,C5AR1;SYK;DYSF;SLC11A1;FOXP1;LBP;AGER;TNF;TLR4;TLR1;APP;FPR2;TMEM106A;CRTC3;CD93;ITGB2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3544940714854568,0.976618765546942,0.5017064846416383,0.9625577666759734,1.0,5/18,12.38%,SLC25A4;HEBP2;SLC25A31;BAK1;SLC25A5
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.24939615128140297,0.9765973441204091,0.5100286532951289,0.9616163710199009,1.0,28/100,19.61%,TSC2;NTRK1;NTRK3;PIK3CG;MAZ;DAB2IP;NEDD4;FGF2;BECN1;PDGFB;TEK;PIK3IP1;INSR;NTRK2;DIPK2A;MAPK3;FBXL2;PTK2;AGT;FLT3;PTPN13;IL18;PLXNB1;DCN;STAMBP;CCL5;PDGFRB;ROR1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.2713027650976164,-0.9765516188979466,0.49868073878627966,0.7464390646145286,1.0,11/38,18.59%,SP100;BCL2L1;THBS1;FAS;RIPK1;BRCA1;BMP5;PMAIP1;GPX1;HMOX1;ARHGEF2
prerank,regulation of kinase activity (GO:0043549),0.25355429340124547,0.9765508077110541,0.5092460881934566,0.9607575310806419,1.0,22/89,20.51%,ANKRD54;MERTK;LDB2;LDB1;NTRK1;FLT4;NTRK3;RYK;EPHA1;ERBB4;TEK;EPHA4;RBL2;RBL1;INSR;EPHB2;NTRK2;VAC14;FLT3;PDGFRB;ROR1;EPHA5
prerank,postsynaptic membrane organization (GO:0001941),0.3556853681375318,0.9765338707653057,0.4925373134328358,0.9598272532309671,1.0,3/17,7.90%,LHFPL4;NRXN1;SHANK3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3199063563896688,-0.9765014551641382,0.48,0.7459771581563029,1.0,4/19,6.71%,GAS6;AXL;SYK;ZMIZ1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.28569575621663296,-0.9761994264527493,0.5049019607843137,0.7461218844102546,1.0,12/29,22.26%,IGF1;SHOC2;RASGRP4;CRKL;LYN;GRB2;NOTCH1;SHC1;IRS2;NOTCH2;EPO;LRRC59
prerank,muscle tissue morphogenesis (GO:0060415),0.3641242648327548,0.9760075208147784,0.5008726003490401,0.9604387541707788,1.0,3/16,8.31%,ZFPM1;TGFBR3;BMP4
prerank,negative regulation of protein phosphorylation (GO:0001933),0.23562645933754195,0.9759838069760223,0.5151915455746368,0.9595277653179882,1.0,24/150,11.53%,TSC2;PPM1E;WWTR1;LDLRAD4;THY1;DMD;CNKSR3;PRKCZ;PRNP;NTRK3;TRIB1;TRIB2;UBASH3B;CACTIN;DAB2IP;DGKQ;EPHA1;SH3GL2;TGFB1;MVP;PRKN;ITGB1BP1;DDIT4;SFRP1
prerank,icosanoid metabolic process (GO:0006690),0.29464112142965837,0.9759821587460196,0.4851190476190476,0.9585489096961796,1.0,5/40,6.43%,CYP2S1;PTGS1;ALOX12;PLA2G4C;GGT5
prerank,protein-containing complex subunit organization (GO:0043933),0.24571554148009614,0.9759346921869232,0.5138504155124654,0.957696007751283,1.0,39/109,27.09%,WDR19;CAPN3;ADD2;NIFK;PARD6B;PPARGC1A;NCKAP1L;MAGI1;IL1RAP;NUP54;TSPAN4;SH3BGR;ZW10;PEX14;RIMS1;DNM1L;WASF3;CHCHD10;VAMP3;NUP133;TUBGCP2;EPRS1;GEMIN5;PPP2R1A;SHANK1;LIN7A;CLDN14;CAPG;MDM4;TEAD2;WASL;LAMC1;IL2RB;CD40;HFE;LLGL1;DLG4;ST13;DMTN
prerank,negative regulation of neuron death (GO:1901215),0.255302778636463,0.9758631458841904,0.4951048951048951,0.9569654348986301,1.0,21/93,16.74%,CD34;NTRK1;SIX4;PPARGC1A;PLA2G3;PM20D1;FBXO7;MEF2C;LGMN;PRKCI;NRBP2;PRKN;CLCF1;KDM2B;MAG;NDNF;SNX6;NTRK2;REST;KIF14;PRKCG
prerank,negative regulation of neurogenesis (GO:0050768),0.3110239975911551,0.9757677403049636,0.4991735537190083,0.9562743553110454,1.0,9/34,15.66%,THY1;OMG;EFNB3;IL6;ARHGDIA;GDI1;MAG;WNT7A;REST
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.26650605843658254,0.9756629407364457,0.480225988700565,0.9556129564943027,1.0,20/69,23.69%,POLR2L;CDK7;POLR2F;POU2F2;GTF2F1;GTF2E2;TAF9;ZC3H8;INTS10;POLR2G;CCNK;INTS8;SNAPC3;INTS5;INTS9;INTS11;NABP1;POLR2C;GTF2B;POLR2D
prerank,secondary alcohol metabolic process (GO:1902652),-0.2628508319417834,-0.9754438852095668,0.4715447154471545,0.7475334977373269,1.0,8/42,9.44%,APOE;IDH3A;IDH1;PPARD;OSBPL1A;LDLRAP1;CLN8;ABCG1
prerank,histone H4 deacetylation (GO:0070933),-0.3908272300144383,-0.9754416201418193,0.5012048192771085,0.7469371601190644,1.0,5/10,21.35%,RCOR1;HDAC2;HDAC1;SIRT2;HDAC4
prerank,regulation of neuron death (GO:1901214),0.2583915586151204,0.975259794858505,0.5222222222222223,0.9558839301216393,1.0,25/82,21.89%,DCC;FAIM2;CD34;PPARGC1A;PM20D1;PRNP;CLU;MEF2C;GRID2;GRIN2B;SIGMAR1;PRKN;DDIT4;SARM1;REST;KIF14;RRAS2;SNCB;INPP5A;CHRNA7;NSMF;CCL5;ITGAM;BTBD10;LANCL1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.30071476613964343,-0.9752426597120687,0.48081841432225064,0.746863478047139,1.0,4/25,3.14%,CHMP4B;CHMP4A;VCP;LYST
prerank,androgen receptor signaling pathway (GO:0030521),0.40130354750506536,0.9752187198264675,0.48695652173913045,0.955015539643698,1.0,2/11,6.30%,DDX5;AR
prerank,regulation of protein dephosphorylation (GO:0035304),-0.27591605884099135,-0.9751368057023851,0.5042016806722689,0.7465441595795064,1.0,13/37,17.80%,ENSA;PPP2R5A;PPP6R1;PTPA;PPP6R3;CDCA2;CALM3;SPPL3;CALM2;ARPP19;PPP1R2;CAMTA1;PPP1R15A
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.3703667677914233,-0.9746566904537537,0.48894348894348894,0.7472053830541517,1.0,6/12,28.49%,RAB1A;CDC14B;PLK1;UBE2C;GORASP1;CDC20
prerank,dopamine metabolic process (GO:0042417),0.3542709086773883,0.974299630586781,0.4872665534804754,0.9568066550339946,1.0,5/18,14.73%,LRTOMT;PRKN;MOXD1;DAO;COMT
prerank,positive regulation of mRNA processing (GO:0050685),0.3397497745692418,0.9741732986522568,0.48330683624801274,0.9562407103020275,1.0,8/21,20.27%,PRDX6;TRA2B;CIRBP;RBMXL1;RBM3;PAF1;TRA2A;DHX36
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2593193814654436,0.9739243115382158,0.49654218533886585,0.956013384039217,1.0,28/80,27.40%,AGRN;P2RY12;FSCN1;EPS8L3;TENM1;NCKAP1;CDC42EP5;TWF2;ARHGAP35;CYFIP1;EPS8L2;HRAS;RHOQ;WASF2;PALM;CDC42EP4;CDC42EP1;CDC42;GPM6A;CEP120;WASL;EPS8L1;CLRN1;FNBP1L;FUZ;BRK1;ENTR1;DEF8
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3711767649278111,0.9738171628667727,0.4835766423357664,0.9553635117834818,1.0,4/14,10.22%,MEOX2;MAP2K5;HDAC5;ITGB1BP1
prerank,regulation of microtubule polymerization (GO:0031113),0.2911574451165402,0.9736377646982014,0.4878048780487805,0.9549346692152241,1.0,15/40,26.15%,PAK1;PSRC1;STMN2;NAV3;CAMSAP3;CAMSAP1;DCTN1;CLIP1;FES;MAP2;MAPRE3;DRG1;GBA2;TBCD;MAPT
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.26653067434210814,-0.9736078451660799,0.47354497354497355,0.7494202073508949,1.0,11/43,15.41%,PID1;PTPN1;NCK1;SLC27A4;PRKCQ;IL1B;IGF2;SORBS1;SIK2;INPP5K;TNS2
prerank,regulation of cellular component organization (GO:0051128),-0.21151649649025686,-0.9735006740809581,0.5185185185185185,0.7491105911969481,1.0,32/135,18.06%,ITCH;APOE;HIP1;ABL2;ATAD3A;CD36;PTPN1;MKI67;ZFYVE16;HIP1R;MLLT3;TFRC;PICALM;NUBP1;PRKCQ;OGFR;RASGRP2;CAMK2D;MAD2L2;ATF5;CEACAM1;PACSIN2;TNF;RAB4B;RAP1B;WNT5A;RAP1A;BCAR1;RAB33B;KLK8;SGK3;SGK2
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.21720514430144908,-0.9733257236980639,0.5284552845528455,0.7489442779723642,1.0,24/110,15.32%,FNIP2;APOE;RAF1;VCP;CD36;GNL3L;BAX;SH3GLB1;MTLN;SYK;TFRC;HSF1;HCK;EP300;AJUBA;ATF7IP;FBLIM1;RB1;RACK1;RALB;CDT1;TNF;BCL2L11;ICE1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.2531941080651414,-0.9732450571859876,0.4843304843304843,0.748559810623097,1.0,6/49,6.83%,IL15;IGF1;PARP14;PIBF1;IL6ST;LYN
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.29159131922448533,0.9731170209527438,0.5097451274362819,0.9555168124887282,1.0,8/41,10.39%,LACC1;AAAS;NUP54;EIF6;OGT;NUP88;RAE1;JMJD8
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3074561913749524,-0.973006319592879,0.47572815533980584,0.7485631034226721,1.0,5/22,10.94%,IGF1;P2RX4;IL6ST;CAMK2D;NOTCH1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.41429278056402574,0.9725719842073891,0.5,0.9562458175834226,1.0,4/10,23.60%,ACADS;ACADM;ETFB;ETFA
prerank,regulation of signal transduction (GO:0009966),0.23158078250082262,0.972530860404636,0.5105853051058531,0.9554032851505574,1.0,26/190,9.35%,TSC2;NUCKS1;ANKRD54;CD80;IFT81;FRRS1L;WWTR1;IGFBPL1;IGFBP6;PRNP;CLU;RGS11;IGFBP2;YJEFN3;MTCH1;UBASH3B;TSPAN15;PRAG1;POFUT1;GNG4;KIF26A;DGKQ;SOCS2;ADCYAP1;OGT;TGFB1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.38788982425102636,0.9719505803964992,0.4958813838550247,0.9561788460675894,1.0,3/13,10.05%,NOP9;EIF6;NUP88
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2373557698613723,-0.9717505479323649,0.5168195718654435,0.7512676177532931,1.0,16/61,15.46%,CDK6;CUL3;CUL4A;GPR132;CDC34;CCND1;CDKN2C;HINFP;MAP3K11;CCNH;CDKN3;CCNA2;RB1;MNAT1;TRIM71;CDC25A
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3562105019119026,-0.9712257032192513,0.48868778280542985,0.7520658509804125,1.0,4/14,15.43%,CD74;GPRC5B;LILRB1;WNT5A
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2417211047008152,-0.9711387761835749,0.496875,0.7516866749810932,1.0,9/63,7.07%,SP100;IGF1;BIRC6;SIAH2;THBS1;FAS;RIPK1;CAV1;WWOX
prerank,pre-replicative complex assembly (GO:0036388),-0.2376175476356851,-0.9709741706521277,0.4812286689419795,0.7515639149873238,1.0,16/64,15.34%,PSMA6;PSMB2;PSME2;ORC5;PSMD11;PSMC6;UBC;PSMA3;UBA52;ORC2;MCM2;ORC4;PSMD10;CDT1;PSMB5;MCM8
prerank,cardiac conduction system development (GO:0003161),0.3281685874552281,0.9708851151956149,0.496742671009772,0.9584423369784617,1.0,4/24,9.90%,BMP4;HEY1;CACNA1G;GJA5
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.30393458723124706,-0.9708704831421843,0.5072463768115942,0.7512283507192596,1.0,9/23,26.08%,ALOX5;LTA4H;GSTM1;ASAH2;CYP1A1;ALOXE3;LTC4S;GSTP1;ALOX15
prerank,RNA 3'-end processing (GO:0031123),0.2678822529405023,0.9706994269022264,0.5048951048951049,0.9579747276647069,1.0,19/69,21.33%,RNPS1;SRSF5;CASC3;SRSF6;SRSF11;MTPAP;SRSF1;CPSF3;CSTF1;NUDT21;CDC40;DDX39B;THOC5;SARNP;SRSF9;CHTOP;ALYREF;SRSF2;LIN28B
prerank,necroptotic process (GO:0070266),0.36654815350769443,0.9705056601161425,0.5016949152542373,0.9575629993794554,1.0,6/16,20.39%,ITPK1;RIPK3;IPMK;DNM1L;TLR3;CYLD
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.27510102703721406,-0.9702722222104289,0.4973958333333333,0.7521713991431874,1.0,11/35,15.24%,ABL2;RIPOR2;CUL3;MET;CCDC125;STMN1;ARHGAP24;SPRY2;SPRY1;MYOC;SPRY4
prerank,cAMP-mediated signaling (GO:0019933),-0.29667317952154765,-0.9701354110271371,0.477088948787062,0.7519209498612479,1.0,7/24,16.18%,ADGRG6;PDE7B;AHR;ADCY1;RIMS2;PDE2A;MAPK7
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.3293536131948387,-0.9700934569698783,0.4813953488372093,0.7514257211862523,1.0,5/16,12.50%,DTX3L;SMCHD1;MAD2L2;SHLD1;PARP9
prerank,histone H3-K4 trimethylation (GO:0080182),-0.3797916149372018,-0.9699907213339931,0.4953051643192488,0.7510750089929938,1.0,7/11,23.38%,TET2;PRDM9;WDR82;TET3;KMT2D;SETD1A;KMT2A
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.31545647733928556,0.9699743175364409,0.5023696682464455,0.9581781547796622,1.0,12/29,29.25%,LDLRAD4;DAB2IP;EFNA1;SFRP1;SDHAF2;HPN;ZNF750;IL17RD;SFRP2;FUZ;PTEN;NKX2-1
prerank,positive regulation of sodium ion transport (GO:0010765),0.3886521245723549,0.9697414154117112,0.5089722675367048,0.9579641090611606,1.0,7/12,33.06%,CNKSR3;SCN1B;SCN3B;ANK3;PKP2;WNK3;SCN4B
prerank,positive regulation of protein export from nucleus (GO:0046827),0.3744295911017181,0.9696418362966974,0.5,0.9573258163706506,1.0,4/15,9.79%,YWHAE;TCF7L2;RAPGEF3;EMD
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2826052613533965,0.9685209373835209,0.5192012288786483,0.9597220019083846,1.0,13/45,18.18%,NANOS1;DDX25;ZC3H10;ZC3H7B;SPOUT1;YTHDC1;METTL16;CYFIP1;NUDT21;RBM3;MAPKAPK5;GEMIN5;ATXN2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3011085247312844,-0.9681093273840956,0.4986737400530504,0.7554324115180296,1.0,9/23,28.41%,PLBD1;PLA2G4E;PLAAT3;LPCAT4;PLA2G4F;PLA2G2D;MBOAT1;ABHD4;PLA2G12A
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.24522718856257958,0.9680749756795546,0.5314207650273224,0.9600790163991111,1.0,34/119,22.29%,INPP4B;PIK3C2G;IP6K1;INPP5D;SLA2;MTMR9;SOCS3;PIGQ;PIK3CG;PIGB;PI4K2A;SACM1L;PIGP;SOCS2;MPPE1;INPP5F;OCRL;RAB5A;FGF2;MTMR1;SOCS6;SOCS4;VAC14;DPM3;PTPN13;SMG1;INPPL1;PLEKHA2;INPP5J;PLEKHA1;PGAP2;PIK3C2A;PIP4K2B;ARF1
prerank,intracellular protein transport (GO:0006886),0.21832310054401366,0.9676222952285141,0.5634458672875436,0.9605730185663168,1.0,71/304,20.36%,CTTN;TSC2;LTBP2;FUT10;STRADB;RAB6B;GGA3;RAB1B;SCFD2;SGSM2;RAB43;SGSM3;GIPC1;HERC2;NAPB;ARL5A;FAM53C;TMED2;STX16;ARL4C;SEC31A;NXT2;ARL4A;MYO6;PRICKLE1;RAB24;ARFRP1;HEATR3;FAM53B;TGFB1;MYO1C;NUP88;ARL4D;RAB5A;CAMSAP3;RAB38;PDCD6;STX3;EHD1;TBC1D16;RAB28;SNX15;PKD1;TBC1D8;IFT27;TMED5;STXBP2;IPO5;SNX6;HAP1;OXA1L;RASSF9;TBC1D25;NUP133;XPO6;TMED3;CACNG3;VPS33B;SRPRA;PREB;BCS1L;SYNRG;STX17;STRADA;AP4E1;IPO8;ERP29;TMED7;SNF8;RANBP3L;GABARAP
prerank,endoderm development (GO:0007492),-0.3544249590210191,-0.9675319676358156,0.5011820330969267,0.7562248413734752,1.0,3/13,14.83%,KIF16B;DUSP1;LHX1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.33953498684640104,-0.9671078030798241,0.47191011235955055,0.7566934013681392,1.0,2/16,1.07%,CHMP4B;CHMP4A
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4090817497307441,0.9665742475492776,0.5187713310580204,0.962797463303549,1.0,4/10,17.14%,SCRIB;PRNP;CRTAM;PRKAR1A
prerank,regulation of viral transcription (GO:0046782),0.29009645991479593,0.9665417747036551,0.5031948881789138,0.9619245310423498,1.0,6/39,6.88%,POLR2L;POLR2F;NELFB;MID2;NELFCD;GTF2F1
prerank,response to metal ion (GO:0010038),0.2646226985564119,0.9664537835721418,0.5242857142857142,0.9612158842602753,1.0,18/67,18.76%,KCNMA1;TRPC3;CAPN3;SEC31A;NEDD4;PDCD6;ITPR3;SLC30A3;PPP5C;KHK;NDRG1;NEDD4L;MT2A;MT1X;MT1A;IL1A;SNCB;TRPV6
prerank,fatty acid metabolic process (GO:0006631),0.24288332205535743,0.9664127580141056,0.5269541778975741,0.96038332335229,1.0,35/115,23.84%,ACSF2;ALOX12;CPT1B;PPARGC1A;MECR;PPARA;ACADSB;GGT5;PNPLA3;CBR4;ACSL6;OXSM;ACOT4;ACOX1;ELOVL4;ACOT11;ACLY;NDUFAB1;ACSF3;PEX2;ACSBG1;ANGPTL3;ACADM;LIPC;XBP1;ABCD2;HPGD;PLA2G15;ALOX5AP;FA2H;ACAD9;PNPLA8;ACSL3;GPAT2;HACL1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3786995006833397,0.9662092828511195,0.5168141592920354,0.9600453694140317,1.0,4/14,13.61%,RELA;CD81;PRKD2;KCNN4
prerank,regulation of hydrolase activity (GO:0051336),0.26460267307312485,0.9659208280561024,0.5252976190476191,0.9599495962088438,1.0,22/71,19.01%,STMN3;PLXNB2;ARHGAP44;CHN1;CHN2;FGD2;DAB2IP;CFAP100;EPHA1;ITGB1BP1;OCRL;RAP1GAP;VAV1;PRKG1;RALBP1;EPHA4;NTRK2;PTK2;SCARB2;ARHGAP12;WRN;PLXNB1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3695363115555308,-0.9658453397959208,0.494199535962877,0.7594100508717171,1.0,4/11,14.06%,STAP1;CCN3;GREM1;DUSP1
prerank,myeloid cell development (GO:0061515),-0.32119096197541486,-0.9652988191666695,0.4909090909090909,0.7602147687369397,1.0,6/18,22.74%,NRROS;TLR2;ALAS1;FOXP1;APP;ALAS2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.24488156332674163,0.9652200553284243,0.5306957708049114,0.9611687972512798,1.0,17/109,10.73%,INPP4B;TPTE;PIK3C2G;INPP5D;PLA2G3;MTMR9;PLCD1;INPP5B;PLA2G4C;PLCG1;PIK3CG;PI4K2A;SACM1L;INPP5F;OCRL;RAB5A;FGF2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.32761544570924983,-0.9650471956738926,0.47665847665847666,0.7602531711119075,1.0,7/18,20.17%,RIPOR2;KIF20B;SHTN1;RACK1;PTK2B;RAP1B;BCAS3
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.21910487733306186,-0.9645770168282919,0.5427509293680297,0.7609000210481844,1.0,23/102,17.41%,MYO5A;RAB8B;DENND4C;PPARG;PRKACA;ADCY9;NFKB1;CAV1;GOT1;ADCY5;RAB15;ADCY6;RAB10;FOXO1;ADCY1;SORBS1;CEACAM1;ADCY3;INPP5K;PRKACB;SLC25A33;CPEB2;RAB31
prerank,regulation of chromatin organization (GO:1902275),-0.3485904142043952,-0.9645053943816662,0.4934782608695652,0.7604747666235445,1.0,7/14,21.06%,MKI67;MLLT3;IGF2;HPF1;HNRNPU;CDK9;SETD1A
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.29468454029560587,0.9642792445013663,0.5402476780185759,0.9630152236237727,1.0,10/41,15.57%,ITPR2;TRPM2;PKD2;GRIN1;GRIN2B;SLC8A1;FGF2;ITPR3;SLC8A3;CACNA2D1
prerank,regulation of glycolytic process (GO:0006110),-0.23306137283599332,-0.9642185176179238,0.4967532467532468,0.7606188124693466,1.0,13/68,10.27%,IGF1;GIT1;CBFA2T3;RANBP2;PRKAG2;HIF1A;PSEN1;NUP153;NDC1;NUP43;NUP210;EP300;PGAM1
prerank,negative regulation of viral transcription (GO:0032897),-0.36185818689583,-0.9640943221994231,0.5196304849884527,0.7603359595037742,1.0,3/13,6.61%,TRIM14;IFITM3;TRIM62
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.299421150709456,0.963948081190609,0.5239616613418531,0.9630469812235493,1.0,6/33,14.81%,ANG;TRIB1;MEF2C;PRKG1;NDRG4;APOD
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.35065745761593,0.9639127404455881,0.5207986688851913,0.96219248922948,1.0,5/18,14.13%,TMEM14A;ZNF205;BAK1;SLC25A5;CHCHD10
prerank,GPI anchor biosynthetic process (GO:0006506),0.3087125798768015,0.9638618985792761,0.513595166163142,0.9613858757989564,1.0,12/30,28.05%,PIGQ;PIGB;PIGP;MPPE1;PIGS;DPM3;PGAP2;PGAP3;PIGX;DPM1;DPM2;PIGZ
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.33945131957789776,-0.9635440452142596,0.48333333333333334,0.7611706524257436,1.0,5/16,21.58%,ZC3H12D;ZC3H12A;RC3H1;TRIM71;CPEB3
prerank,regulation of epithelial cell migration (GO:0010632),-0.2505532836078911,-0.9632016679604445,0.5384615384615384,0.7614248864098768,1.0,11/51,13.42%,SASH1;PTPN23;PRKCE;MCC;CORO1C;GLIPR2;HIF1A;RHOJ;CEACAM1;EMP2;PTN
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.31720220494395057,0.9631579938438382,0.513911620294599,0.962577280019349,1.0,9/26,18.40%,PRKCZ;NRXN1;SHANK3;GRIN1;RIMS1;SLC8A3;WNT7A;SHANK1;CHRNA7
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2341518759032002,-0.9630417507718514,0.49523809523809526,0.761243362600639,1.0,14/67,15.00%,CYBB;PSMA6;CD36;PSMB2;PSME2;TAPBP;PSMD11;PSMC6;PSMA3;SNAP23;CYBA;PSMD10;B2M;PSMB5
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.37532954215262593,0.9623801559954404,0.4906621392190153,0.9639975646943393,1.0,6/14,24.51%,ATP1B1;DMD;WNK1;SLC9A1;GLRX;ANK3
prerank,regulation of ATP metabolic process (GO:1903578),-0.2362860977279702,-0.9623534741966192,0.5295857988165681,0.7623606977944475,1.0,14/54,15.65%,ATP7A;RANBP2;PRKAG2;HIF1A;NUP153;NDC1;NUP43;NUP210;EP300;PGAM1;UQCC2;SPHK2;SLC25A33;NUP62
prerank,ceramide catabolic process (GO:0046514),0.3640735157938461,0.9621976083107071,0.5132890365448505,0.9635856827462878,1.0,3/14,8.81%,HEXB;NEU1;NAGA
prerank,regulation of store-operated calcium entry (GO:2001256),0.40934134364244074,0.9621558878163062,0.492091388400703,0.9627723044544956,1.0,2/10,10.35%,EFHB;HOMER2
prerank,negative regulation of translation (GO:0017148),-0.22472325701551338,-0.9618937949557501,0.5264900662251656,0.7629006555839521,1.0,28/87,23.57%,CELF1;CNOT9;MALSU1;SAMD4A;EIF4EBP2;EIF4ENIF1;DDX6;CAPRIN1;CPEB4;DAPK1;AGO2;PAIP2B;SYNCRIP;TYMS;LARP1;RACK1;TRIM71;FXR2;CPEB2;IGFBP5;MEX3D;PUM1;DHFR;CPEB3;EIF3E;ILF3;EIF2AK2;RIDA
prerank,lysosome organization (GO:0007040),-0.2701425667783441,-0.961619095025074,0.5094850948509485,0.7629946862179414,1.0,11/36,16.03%,TMEM165;TPCN2;NAGPA;HPS1;CLN5;MBTPS1;GNPTAB;AKTIP;LRRK2;GAA;CLN3
prerank,regulation of calcium ion transport (GO:0051924),-0.24123548397254516,-0.961093323134885,0.5141065830721003,0.7637653205994501,1.0,17/54,20.79%,BCL2;LILRA5;P2RX4;IL16;HOMER3;CTNNB1;INPP5K;LILRB1;STIM2;CRACR2A;FFAR1;WFS1;SLC8B1;MYLK;CD33;GRIN3B;HOMER1
prerank,mitochondrial translation (GO:0032543),0.24337543298305436,0.9610355219624644,0.5274725274725275,0.9652591800452304,1.0,31/104,26.26%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;HARS1;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;MRPS10;FASTKD2;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.38052463032770845,0.9608515351742921,0.5034364261168385,0.9648441599526737,1.0,6/13,23.33%,ASPH;LGMN;BAK1;CASP8;CIDEB;RIPK2
prerank,regulation of phospholipase C activity (GO:1900274),0.3629465709567314,0.9608482743133195,0.5232358003442341,0.9639091219084909,1.0,6/15,19.41%,NTRK3;PLCG1;FGF2;HRAS;BICD1;PDGFRB
prerank,aerobic electron transport chain (GO:0019646),0.26406791818282965,0.960444270899652,0.5180897250361794,0.9641951890483543,1.0,21/68,23.98%,NDUFA6;UQCRC1;NDUFA4;CYC1;SDHC;COX7B;UQCC3;COX6C;NDUFS1;UQCR11;NDUFA8;NDUFS6;SDHAF2;COX7C;NDUFAB1;NDUFS2;NDUFB6;COX4I1;COX6B1;UQCR10;COX10
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.382587274380652,-0.9604418493787833,0.533816425120773,0.7648309875572779,1.0,2/11,2.65%,CD274;RUNX3
prerank,B cell homeostasis (GO:0001782),0.411287021306878,0.9602794464190361,0.5257731958762887,0.9637141656645524,1.0,3/10,11.64%,NCKAP1L;MEF2C;DOCK10
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.23050076089850396,-0.9599781485179323,0.5577557755775577,0.7654219950663442,1.0,25/80,25.07%,ARL6IP5;GAS6;RAF1;CD44;SIAH2;LAMTOR5;GRAMD4;THBS1;UACA;SYK;SH3RF1;DAPK1;PMAIP1;TNF;DNAJB6;GPX1;PPM1F;KLF4;CASP1;DHCR24;TNFSF10;NDUFA13;XIAP;RPS6KA3;CTSD
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.387385791579435,-0.9599564962006812,0.5048780487804878,0.7648825292478981,1.0,4/10,15.56%,MECP2;PCGF3;IGF2;PCGF5
prerank,mitochondrion organization (GO:0007005),-0.20067254685940855,-0.9598908975406535,0.5610859728506787,0.7644295786439206,1.0,34/165,17.25%,PID1;VPS13D;TRAK1;BCL2L1;CHCHD2;ATAD3A;YME1L1;IFIT2;ATP7A;BAX;TOMM7;MTX3;HSPD1;NRF1;AGTPBP1;MTX1;FMC1;ALAS1;DNM2;TOMM20;MTM1;WDR81;LRRK2;STOML2;TIMM17A;AIP;TIMM50;WASF1;IMMP2L;SLC25A33;MUL1;MTFP1;MTFR2;MIEF1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2509735676004752,0.9597940205294347,0.5268505079825835,0.9642385856694581,1.0,21/87,17.33%,SH3BP1;ABI3;FSCN1;ARHGAP44;F11R;PAK1;CORO2B;RHOBTB1;TRPM2;TWF2;ARHGDIA;RAPGEF3;GRHL3;ARHGAP35;CORO1A;TWF1;RHOQ;CDK10;ROCK1;TAOK1;RHOBTB2
prerank,cellular amide metabolic process (GO:0043603),-0.2169330579425655,-0.9596881491906563,0.5424354243542435,0.7643379259409118,1.0,22/102,15.04%,NLN;ACOT8;SGPL1;PLA2G4E;MTHFR;CPD;ORMDL1;PLAAT3;MCCC1;CLN8;SLC46A1;ST6GAL1;MCCC2;HLCS;CPE;MTHFD1;CPM;CERK;ASAH2;MTRR;ORMDL3;BTD
prerank,plasma membrane invagination (GO:0099024),-0.2823410055656904,-0.9592667481284256,0.5271739130434783,0.7648483468581276,1.0,4/29,6.79%,FCGR2B;MSR1;CD36;SNX9
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.37682789926364946,0.959211022404552,0.5008264462809917,0.9650066600145807,1.0,2/13,5.65%,RELA;IL6
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.32395011954908987,0.9589063650754011,0.4928,0.9649408819327924,1.0,7/25,18.69%,ABI3;ARHGAP44;LIMK2;RAP1GAP;EVL;CDK10;TCHP
prerank,cellular response to retinoic acid (GO:0071300),-0.25319839847383707,-0.95883873155968,0.5457142857142857,0.7653376686430843,1.0,23/42,36.01%,ABL2;BRINP1;LYN;RET;SNW1;TESC;PTK2B;WNT5A;ADNP2;WNT9A;FZD4;NDUFA13;WNT6;FZD10;LTK;AQP1;CREB1;ATM;FZD7;TBX1;WNT10B;WNT11;WNT2
prerank,neuron cell-cell adhesion (GO:0007158),-0.3415046468728874,-0.9584446825972587,0.49635036496350365,0.765768579502482,1.0,3/14,9.36%,NINJ2;RET;NRXN2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.40204588810171726,0.9582691626986833,0.5107142857142857,0.9659069186816198,1.0,3/10,18.07%,DROSHA;TSN;TSNAX
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.27681343551765103,-0.9581221033290526,0.5276967930029155,0.7659950880325849,1.0,8/33,14.37%,CPSF1;NCBP1;FIP1L1;SNRPB;CPSF4;CSTF2;CPSF2;PCF11
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3740258231144318,0.9579312739762458,0.5111876075731497,0.9659245410580801,1.0,3/14,5.49%,CD80;CD86;PRKCZ
prerank,response to thyroid hormone (GO:0097066),0.3804673482112677,0.9578810188655585,0.5158450704225352,0.9651322769605692,1.0,7/13,25.93%,BRD8;LMO2;HPN;RDX;CTSS;GAS2L1;CTSH
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.30088312066439465,-0.9578525529416951,0.4904632152588556,0.7660784249029146,1.0,5/23,8.85%,VCP;OS9;TECPR2;SEC16A;TMED9
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3956339839530192,0.9578292427974031,0.5089285714285714,0.9643330843751541,1.0,5/10,17.48%,SOCS3;INPP5F;SH2B3;PTPN2;PPP2R1A
prerank,regulation of protein neddylation (GO:2000434),-0.38389751403427735,-0.9576734913430314,0.5229357798165137,0.7659454436902278,1.0,5/10,25.19%,RPL5;HIF1A;DCUN1D1;RPL11;DCUN1D4
prerank,cellular response to growth factor stimulus (GO:0071363),0.23263807793162009,0.9575998800188527,0.5582010582010583,0.9640704501581687,1.0,34/151,16.30%,WNT4;NTRK1;FLT4;RELA;STMN2;LRP2;NTRK3;PDCD5;PLCG1;MEF2C;LGMN;RPS6KB1;TGFBR1;DAB2IP;BMP4;TWF2;ZFP36L2;MAP2K5;PRKD2;FOXC1;TGFB1;EMD;SNAI2;ITGB1BP1;EHD1;SFRP1;ACVR1B;PDGFB;NDNF;AMHR2;NTRK2;WNT7A;PRKD1;SETX
prerank,nuclear body organization (GO:0030575),0.3820087721275571,0.9575436820968138,0.504424778761062,0.9633146090898168,1.0,2/12,7.04%,WRAP53;USP50
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.23823734317769676,-0.9574404347644949,0.5807453416149069,0.7659669694493659,1.0,16/62,15.28%,CDK6;CDC73;MEIS1;PURB;THBS1;PF4;LYN;KMT2C;PRKCQ;H3-3A;EP300;NFE2;HDAC1;DPY30;KMT2D;PTK2B
prerank,protein-containing complex assembly (GO:0065003),0.2182585782806523,0.957337201531357,0.5760479041916168,0.9630112224333717,1.0,52/259,17.90%,BCL9L;TLE3;ADCY8;WDR19;PLEKHA7;CAPN3;TLE2;RAB1B;ADD2;NIFK;CNIH2;PARD6B;SEC16B;PPARGC1A;NCKAP1L;DMD;PDE4DIP;MAGI1;IL1RAP;TMED2;AREG;CDC123;SEC31A;GRIA1;TRAPPC3;TSPAN4;TCF7L2;SH3BGR;BIN2;ZW10;ITGB1BP1;PDCD6;PEX14;CNIH1;RIMS1;FARP2;DNM1L;WASF3;SEC24D;SEC24B;CHCHD10;VAMP3;TRAPPC9;TCF7L1;TUBGCP2;EPRS1;SEC24C;GEMIN5;PYGO2;PPP2R1A;SHANK1;PREB
prerank,endodermal cell differentiation (GO:0035987),0.3046141004812853,0.9571939700588138,0.5259026687598116,0.9624820028323586,1.0,8/31,16.18%,CTR9;RTF1;LAMB3;ITGB5;ITGA5;COL4A2;VTN;PAF1
prerank,Rap protein signal transduction (GO:0032486),0.4017997552714869,0.9571749176602287,0.5148861646234676,0.96158651927011,1.0,5/10,25.08%,SGSM3;RAPGEF3;PLK2;RAP2C;RAPGEF2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.3352803729847234,-0.9569497349642938,0.5220588235294118,0.7666668468869825,1.0,2/16,2.85%,APOE;CD36
prerank,inner mitochondrial membrane organization (GO:0007007),0.276693228611221,0.9569138644862335,0.49842271293375395,0.9614373711052657,1.0,21/47,30.52%,TIMM29;ATP5F1C;UQCC3;MICOS13;HSPA9;APOO;TIMM13;TIMM22;TOMM70;MTX2;ATP5MC3;ATP5ME;ATP5MF;TIMM10;TIMM10B;DNAJC11;APOOL;ATP5F1A;MICOS10;SPG7;TMEM11
prerank,negative regulation of response to wounding (GO:1903035),-0.318943280336796,-0.9568500327544538,0.5050505050505051,0.7663339734359396,1.0,6/19,17.06%,ALOX5;CRK;GIT1;AJAP1;CERS2;KLK8
prerank,regulation of stress fiber assembly (GO:0051492),-0.23497933876385918,-0.9565042582567288,0.5168195718654435,0.7666768229952118,1.0,20/74,17.30%,NRP1;PXN;ARHGEF10L;CD47;MET;CGNL1;PTGER4;ARHGEF18;ARAP1;CARMIL1;STMN1;SORBS3;S100A10;ARHGAP28;GPR65;MYOC;INPP5K;ARHGEF5;PFN2;RGCC
prerank,regulation of heart contraction (GO:0008016),0.2511578149661299,0.956492796713854,0.5372124492557511,0.9617255002043744,1.0,20/90,19.85%,ATP2A3;ATP2A2;ITPR2;ATP1B1;ASPH;ATP1B3;TBX2;SLC8A1;GJA5;ITPR3;ATP2B3;SLC8A3;ADORA3;DMPK;AGT;ANK2;TMEM65;ATP1A4;ATP1A3;ATP1A1
prerank,sterol metabolic process (GO:0016125),0.26705775768338164,0.9564500415954176,0.5578330893118595,0.960930452121529,1.0,7/60,6.99%,STARD3;TM7SF2;CYP26C1;FDX2;SOAT2;NSDHL;CYP39A1
prerank,nucleus organization (GO:0006997),-0.24886611258059022,-0.9560713133204473,0.5467836257309941,0.7671559830566113,1.0,9/47,14.24%,CHMP4B;CHMP4A;ATXN7;CTDNEP1;LEMD3;NDC1;PDCD6IP;CHMP1B;NUMA1
prerank,lipid modification (GO:0030258),0.2927427944476592,0.9560358172883867,0.5463108320251178,0.9612223332023053,1.0,9/37,20.82%,DGKI;PLPP5;ALOX12;DGKQ;DGKZ;DGKE;PLPPR4;DGKH;PLPP1
prerank,regulation of tissue remodeling (GO:0034103),-0.3234656020503261,-0.955326977580703,0.4819277108433735,0.768478146734914,1.0,2/18,0.22%,SUCO;IL15
prerank,peptidyl-tyrosine modification (GO:0018212),0.2673351403336186,0.9551518288261417,0.5288611544461779,0.9628780411403426,1.0,16/56,19.41%,ABI3;NTRK1;FLT4;EPHA1;ERBB4;BTK;PDGFB;TEK;EPHA4;TPST2;INSR;EPHB2;PTK2;FLT3;FES;PDGFRB
prerank,regulation of feeding behavior (GO:0060259),0.390777195790717,0.9541996170176053,0.5166374781085814,0.9647523920884584,1.0,2/11,15.31%,GNB3;EIF2AK4
prerank,calcium ion import into cytosol (GO:1902656),0.35861645468451053,0.9541850278577142,0.5051020408163265,0.9638691452979166,1.0,5/15,18.76%,TRPM2;SLC8A1;SLC8A3;CACNA2D1;TRPV6
prerank,base-excision repair (GO:0006284),0.27576904683582026,0.9541133202506764,0.5481927710843374,0.963139016074777,1.0,14/48,22.96%,POLG;POLD3;OGG1;XRCC1;LIG3;ADPRS;PARP1;APEX1;FEN1;ERCC6;WRN;UNG;MPG;RFC4
prerank,response to purine-containing compound (GO:0014074),0.34621075177638583,0.9537000240995136,0.5288966725043783,0.9633931570824817,1.0,4/17,12.15%,TRPC3;TRPM2;DGKQ;P2RY1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.32435397938082505,-0.9536760800824187,0.5221932114882507,0.7721485341789736,1.0,3/17,8.39%,NRP1;STAP1;HCK
prerank,phospholipid catabolic process (GO:0009395),-0.29207335398884793,-0.9535262950286733,0.5282555282555282,0.7719164095729968,1.0,6/24,12.31%,PLBD1;PLA2G4E;PNPLA6;GDPD3;SMPDL3A;GDE1
prerank,skeletal system morphogenesis (GO:0048705),0.2875669238412501,0.9532915382478977,0.5348101265822784,0.9636642753229661,1.0,7/42,14.95%,HOXD4;MEGF8;HOXB9;TGFBR1;FBN2;SPEF2;DSCAML1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3807205719449759,-0.9532413131327506,0.5056433408577878,0.7720685242035942,1.0,5/10,22.78%,PTPN22;NR1H3;LBP;LTF;TICAM2
prerank,pulmonary valve development (GO:0003177),-0.3227096382775656,-0.9530823159950107,0.5,0.7718685230245738,1.0,13/18,37.84%,NOTCH1;SMAD6;TNFRSF1B;HEY2;NOTCH2;HEYL;BMPR2;SLIT2;ROBO2;TGFB2;STRA6;NFATC1;TNFRSF1A
prerank,negative regulation of nuclear division (GO:0051784),0.38877547074911417,0.9527740029392825,0.5271453590192644,0.9642747608460625,1.0,3/11,19.92%,BMP4;TOM1L1;FBXO5
prerank,regulation of actin filament-based process (GO:0032970),0.25868955424791645,0.9521900060528427,0.5297619047619048,0.9650349057858437,1.0,19/70,20.54%,SH3BP1;FSCN1;ARHGAP44;F11R;PAK1;CORO2B;RHOBTB1;TWF2;GRHL3;ARHGAP35;CORO1A;RHOQ;CDK10;ROCK1;TAOK1;RHOBTB2;PDGFRB;EPHA5;IQGAP3
prerank,regulation of cholesterol transport (GO:0032374),-0.30194745243730514,-0.9521336901101581,0.5278450363196125,0.7737193428458263,1.0,7/20,16.74%,NFKB1;NAXE;NR1H2;APOC1;NR1H3;LRP1;NUS1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.35295322409560426,-0.9520983247784229,0.507177033492823,0.7732176807317364,1.0,4/13,17.07%,ITGA4;SP1;IGF2;ADAM17
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3937363320538517,-0.9513714992841806,0.5068493150684932,0.7744942444055429,1.0,4/10,17.85%,RARA;IRF4;SPHK2;GATA3
prerank,negative regulation of cell cycle (GO:0045786),0.25689018069919733,0.9509971573899608,0.543026706231454,0.9675866977993238,1.0,15/73,15.49%,HHEX;SCRIB;SIPA1;BMP4;FOXC1;TGFB1;PTPN3;BTG3;HEXIM2;BTG2;CHMP1A;INHA;PPP1R13B;IPO5;ANGEL2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2051422777377899,-0.9509942862577374,0.6142322097378277,0.7748987037401036,1.0,30/138,16.71%,NEDD9;MTSS1;STAP1;AXL;CASS4;LIFR;FRS2;MET;IL6ST;LMTK2;RASGRP4;FLT1;SYK;LYN;FYN;BLNK;HCK;RET;LCP2;LCK;FRK;KDR;PTN;EGFR;SHC1;PTK2B;EPHA2;GFRA2;BCAR1;EPHB4
prerank,mitotic recombination (GO:0006312),0.3600173058744276,0.9508945112906911,0.5304054054054054,0.9669865655881713,1.0,4/15,15.95%,SMC5;DMC1;RAD52;XRCC3
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.393638329808083,0.950803720350961,0.5164835164835165,0.966329388516636,1.0,2/11,2.21%,RAB1B;F11R
prerank,import into cell (GO:0098657),0.28682888984283056,0.9505375724488319,0.530827067669173,0.9661604764535651,1.0,7/41,14.80%,SNAP25;SLC29A2;LRP2;SLC12A6;SLC1A3;SLC19A1;SLC22A4
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.19002229063554393,-0.94976231470439,0.6474820143884892,0.7774761756645535,1.0,59/291,16.67%,PID1;PXN;STAP1;CD274;AXL;ABL2;VCP;BRINP1;CDC73;TLR2;HMGB2;GIT1;P2RX4;RRAGC;LAMTOR5;ESR1;AHR;NFKB1;CAPN2;ADAM9;CD14;TAF1;LCOR;PF4;NOD2;TNIP3;ERCC6L2;LYN;IL1B;CPEB4;RET;SNW1;ZC3H12A;LPL;ADCY6;VIM;FOXO1;ACOD1;TNFRSF1B;DAPK1;RRAGA;KAT5;SHPK;NR1H3;INPP5K;FOS;TESC;LBP;EGFR;LILRB1;PTK2B;RAP1B;WNT5A;RAP1A;FAM210B;PDE2A;TLR4;MAPK8;SESN2
prerank,neuron projection regeneration (GO:0031102),0.4018995112515712,0.9495951749608674,0.5275862068965518,0.9679885939976097,1.0,4/10,19.68%,OMG;RTN4RL1;MTR;NREP
prerank,response to X-ray (GO:0010165),0.3683901367746117,0.9495442318988815,0.5267558528428093,0.9672087512459671,1.0,5/14,23.82%,NUCKS1;XRCC6;XRCC5;XRCC4;IKBIP
prerank,inositol phosphate biosynthetic process (GO:0032958),0.39326268632404193,0.9495208114866969,0.5460869565217391,0.9663475789975822,1.0,3/11,12.24%,IP6K1;FGF2;IPMK
prerank,hexose metabolic process (GO:0019318),0.28359998606999115,0.9492129181953571,0.5322085889570553,0.966352292984561,1.0,12/39,20.33%,SLC37A4;GALT;ALDOC;CHST1;FPGT;KHK;APOD;GALK1;GHRL;PGM1;ALDOA;OMA1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.27910338227737896,0.9492068965441475,0.5455950540958269,0.9654469865580112,1.0,11/44,20.27%,NANOS1;GTPBP1;ZFP36L2;METTL16;BTG2;POLR2G;CNOT8;UPF1;ROCK1;TOB1;DHX36
prerank,release of cytochrome c from mitochondria (GO:0001836),0.34963124311174215,0.9490985538362356,0.5326797385620915,0.9648196750342418,1.0,7/17,17.61%,FIS1;CLU;BAK1;GGCT;DNM1L;BBC3;MFF
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.20601440300305918,-0.9485415434883893,0.6147859922178989,0.7800286279442298,1.0,35/128,21.53%,NRROS;PXN;GCNT2;SMURF2;ARHGEF18;ADAM9;ZFYVE16;SMAD3;SMAD9;ZMIZ1;UBC;BMP5;UBA52;USP9X;ID1;SMAD6;CBL;SCX;NLK;BMP2;FOS;PARD6A;SMAD4;HIVEP1;COL3A1;ACVR1;ACVR2A;APPL2;GDF3;BMP7;USP15;CGN;BAMBI;USP9Y;ZMIZ2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.2606160419464129,-0.948299446679681,0.5231607629427792,0.7800463695878243,1.0,16/40,26.25%,DAB2;GCNT2;SDCBP;SMAD3;GLIPR2;IL1B;CTNNB1;NOTCH1;BMP2;RGCC;SMAD4;BAMBI;TWIST1;EZH2;PDPN;LEF1
prerank,positive regulation of protein import (GO:1904591),-0.27117655184917666,-0.9478434447151641,0.5442708333333334,0.7805902203770511,1.0,9/30,19.90%,ZPR1;SMAD3;PSEN1;ZC3H12A;ARHGEF5;FLNA;ECT2;CDH1;CHP2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.25574989275527793,0.9476337002772788,0.5412979351032449,0.9681701934828341,1.0,20/72,19.61%,NTRK1;NTRK3;PIK3CG;MAZ;NEDD4;FGF2;BECN1;PDGFB;TEK;INSR;NTRK2;PTK2;AGT;FLT3;IL18;PLXNB1;DCN;CCL5;PDGFRB;ROR1
prerank,secretion (GO:0046903),0.3613894350615675,0.9474394814381693,0.5212224108658744,0.9678134881412258,1.0,5/14,22.66%,PRKCI;RIMS1;SLC22A4;GUCA1B;NPR1
prerank,regulation of intracellular pH (GO:0051453),-0.2730755716380667,-0.9474336859943695,0.5278592375366569,0.7810429873185697,1.0,17/34,27.16%,TMEM165;SLC9A9;TM9SF4;SLC9A2;LRRK2;SLC4A9;CHP1;CLN3;GPR89B;GPR89A;SLC9A6;SLC26A6;CA2;SLC26A3;SLC9A3;SLC4A1;SLC4A5
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.28240378307899594,-0.9473820209712827,0.5417789757412399,0.7805859598150637,1.0,8/29,17.63%,DTX3L;FBXW7;BMI1;UBE2L3;DCUN1D1;MAGEC2;PLK1;ARRDC4
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.3302328407564542,-0.9472747100927519,0.5,0.7802124080137404,1.0,10/17,28.60%,RBPJ;NOTCH1;BMP2;HEY2;ACVR1;NOTCH2;HEYL;GALNT11;DLL4;BMPR1A
prerank,chemokine-mediated signaling pathway (GO:0070098),0.28784209536707916,0.9472492952328491,0.559748427672956,0.9674522194408849,1.0,9/42,19.31%,ACKR3;CCR1;FOXC1;SH2B3;STK39;THPO;CCL15;WNK1;CCL5
prerank,smooth muscle cell differentiation (GO:0051145),0.38196932260365635,0.9467848066261941,0.5157342657342657,0.9678873939036675,1.0,3/12,9.05%,MEF2C;BMP4;HEY1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3190657615874013,0.9466664343750657,0.5143338954468802,0.9673025839675622,1.0,8/23,23.01%,DGAT2;ACSL6;ELOVL6;TECR;ACSF3;ACSBG1;ELOVL5;ACSL3
prerank,regulation of endopeptidase activity (GO:0052548),0.2665257037229563,0.94664132466589,0.5562043795620438,0.9664464161049371,1.0,11/59,16.94%,GAPDH;SPOCK3;VSIR;SPOCK2;SERPINH1;PSME3;PSENEN;VTN;SERPINE2;AGT;PRELID1
prerank,cellular glucose homeostasis (GO:0001678),0.28460640512974517,0.9464929543814958,0.5398230088495575,0.9659550578917274,1.0,5/41,4.45%,NUCKS1;ADCY8;TRA2B;PPARGC1A;SOX4
prerank,cellular response to organic substance (GO:0071310),-0.20970950137498925,-0.9464885273383284,0.58203125,0.7815899169339611,1.0,33/116,21.41%,PID1;ARL6IP5;PTPN23;STAT5B;TBK1;NCOA1;SMAD3;LDLRAP1;CIB1;IL1B;PTPN7;CTNNB1;GHR;LRRK2;ASAH2;CYP1A1;RACK1;INPP5K;SHC1;TNF;RAMP2;MAPK7;MAPK8;TIPARP;CRNN;IL18R1;IGFBP5;ACVR1;ACVR2A;KLF4;CDK9;CASP1;PTPN4
prerank,leukotriene metabolic process (GO:0006691),-0.314537342488909,-0.9464204334324594,0.5238095238095238,0.7811544456405884,1.0,3/19,3.83%,ALOX5;MGST3;MAPKAPK2
prerank,cellular response to glucose stimulus (GO:0071333),0.30903006549172785,0.9460659355317574,0.5358255451713395,0.9663371025420152,1.0,4/30,4.45%,ADCY8;PTPRN;TRA2B;SOX4
prerank,regulation of developmental growth (GO:0048638),-0.27874536546459244,-0.9458659959152851,0.5240641711229946,0.7820628964339644,1.0,5/29,10.77%,APOE;IGF1;STAT5B;DNM2;GHR
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.3401553711294529,-0.9457781658530333,0.5212264150943396,0.7816945805418568,1.0,6/15,25.07%,NOD2;HIF1A;TNF;TLR4;MYD88;APPL1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.33211684897573535,-0.9456907568050943,0.5153664302600472,0.7813445729601781,1.0,6/15,24.33%,ZDHHC3;DRD2;CLN3;ADRA1A;NPAS4;NLGN2
prerank,peroxisomal membrane transport (GO:0015919),0.3145948198682662,0.9452686492254541,0.5398773006134969,0.9677597934573378,1.0,13/27,27.71%,PEX5;FIS1;ATAD1;PEX26;PEX14;PEX2;PEX6;ABCD2;PEX11B;PEX3;PXMP4;ABCD3;ACBD5
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.2641823655905439,-0.9451845496206702,0.553072625698324,0.782017173319557,1.0,8/40,10.05%,RPL5;FBXW7;TAF1;RPS7;GNA12;CCDC22;XPO1;RAD23B
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.26890927744715465,-0.9447534802173325,0.5506849315068493,0.7825345081913931,1.0,10/31,20.54%,CDK6;CDC73;KANK2;CDKN2C;WEE1;PRMT2;RB1;E2F7;CDKN2A;KLF4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.32022129883641853,-0.9445210444902576,0.5244215938303342,0.781926916806248,1.0,7/20,22.59%,IGF1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;APP
prerank,positive regulation of glycolytic process (GO:0045821),-0.32022129883641853,-0.9445210444902576,0.5244215938303342,0.781926916806248,1.0,7/20,22.59%,IGF1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;APP
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2692604917334269,0.943777229700614,0.5555555555555556,0.971209260996624,1.0,13/48,19.95%,POLR2L;ASF1A;POLR2F;WBP2;SERTAD1;MYO1C;POLR1E;ERCC6;PHF2;POLR1F;ACTB;ELOF1;ATAD2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2517782935298556,-0.9436046082352147,0.5826330532212886,0.7837137011550289,1.0,15/44,24.62%,GAS6;RAF1;CD44;SIAH2;LAMTOR5;THBS1;SH3RF1;TNF;DNAJB6;GPX1;LTF;KLF4;DHCR24;XIAP;RPS6KA3
prerank,negative regulation of cell activation (GO:0050866),-0.34068520507175337,-0.9435896920662189,0.5438202247191011,0.7831518096532727,1.0,2/14,6.67%,APOE;LDLR
prerank,snRNA transcription (GO:0009301),0.2564638863445468,0.9434711872228887,0.5607344632768362,0.9712160260960965,1.0,20/70,23.69%,POLR2L;CDK7;POLR2F;POU2F2;GTF2F1;GTF2E2;TAF9;ZC3H8;INTS10;POLR2G;CCNK;INTS8;SNAPC3;INTS5;INTS9;INTS11;NABP1;POLR2C;GTF2B;POLR2D
prerank,eye development (GO:0001654),0.26843711221050515,0.943224920736811,0.5541795665634675,0.9710112330601276,1.0,8/54,11.74%,COL5A1;PRSS56;MAB21L2;PBX2;FBN2;CRYBA4;FOXC1;PBX3
prerank,antibacterial humoral response (GO:0019731),0.3503524019571653,0.942866849227147,0.5471698113207547,0.971129406605127,1.0,3/16,10.19%,ANG;DEFA6;RNASE7
prerank,regulation of cardiac muscle contraction (GO:0055117),0.29278894544871886,0.9428197457467985,0.5397815912636506,0.9703590543038754,1.0,6/34,9.90%,ATP2A2;ATP1B1;TNNI3;PIK3CG;SLC8A1;GJA5
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2304538358889066,0.9424036173573529,0.6005291005291006,0.9706811662418278,1.0,27/140,16.41%,ACKR4;ADCY8;TRPC3;ACKR3;FIS1;GNA15;CCR1;GPR17;ADCYAP1;GRIN1;CXCR6;CX3CR1;SLC8A1;CXCR4;LPAR4;ITPR3;P2RY1;JPH1;TAC1;CCR6;HMGB1;CACNA2D1;P2RY10;ACKR2;CCR9;PTGER1;CACNA1A
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.2873838379263104,-0.9423522145457943,0.6051948051948052,0.7857633831327402,1.0,11/25,26.36%,SDCBP;MTMR2;ANKRD13A;PICALM;PSEN1;APOC1;ITGB3;WDR54;APP;RAC1;ANKRD13B
prerank,cellular response to organic cyclic compound (GO:0071407),-0.20303831668566774,-0.9422899680197879,0.6607929515418502,0.7853107466816034,1.0,38/141,18.91%,ARL6IP5;NR3C1;HRH1;P2RX4;ESR1;CTNNA1;AHR;MSN;TAF1;LCOR;GABRB2;EPG5;BRCA1;IL1B;ADCY5;UBE2L3;ZC3H12A;ADCY6;CTNNB1;ADCY1;LRRK2;KAT5;ADCY3;CYP1A1;LARP1;INPP5K;EGFR;TNF;RAP1B;RAP1A;FAM210B;PDE2A;TIPARP;NRIP1;IGFBP5;CASP6;CDH1;KCNQ1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.25199294482114354,0.9422043463872017,0.5579710144927537,0.9703134772183333,1.0,10/76,8.07%,CTTN;BIN1;LMOD1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;NTRK3;FCHSD2;LIMK1
prerank,mesoderm development (GO:0007498),0.3398697025078626,0.9421814666253558,0.5471698113207547,0.969487688431237,1.0,4/18,17.12%,GDF11;BTK;TBX6;MEST
prerank,response to light stimulus (GO:0009416),0.26586044961888944,0.9420925142945653,0.5625942684766214,0.9688501835292465,1.0,11/55,15.46%,UBE2B;CPT1B;GTF2H2;CIRBP;COPS3;USF1;DCT;DDB2;MAPK10;ERCC6;CCAR2
prerank,homeostasis of number of cells (GO:0048872),0.37607214061763417,0.9418477542979985,0.531021897810219,0.9686482039199722,1.0,3/12,15.45%,OCIAD2;CX3CR1;NAPEPLD
prerank,establishment of skin barrier (GO:0061436),-0.3347885685954971,-0.9414217742064281,0.5214446952595937,0.7862771357441374,1.0,4/15,17.39%,MET;STMN1;ALOXE3;CLDN1
prerank,regulation of water loss via skin (GO:0033561),-0.3347885685954971,-0.9414217742064281,0.5214446952595937,0.7862771357441374,1.0,4/15,17.39%,MET;STMN1;ALOXE3;CLDN1
prerank,anion transport (GO:0006820),0.29421747104889096,0.9414097094862109,0.5454545454545454,0.9690131392673593,1.0,9/33,22.69%,SLCO2B1;VDAC1;SLC26A4;SLC26A7;TSPO;SLC19A1;SLC13A3;ABCG2;LRRC8B
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.38459109686418425,0.9410134685739318,0.5336879432624113,0.9692132584313153,1.0,3/12,14.38%,CRMP1;ALDH6A1;DPYSL2
prerank,triglyceride homeostasis (GO:0070328),0.31154570935904136,0.9409793705689847,0.5589171974522293,0.9684173448440366,1.0,9/26,22.24%,DGAT2;ANGPTL4;FITM2;ANGPTL3;LIPC;XBP1;IL18;RORA;PNPLA8
prerank,nucleic acid metabolic process (GO:0090304),0.2570671924796872,0.9409470334419185,0.5507868383404864,0.9676185054314718,1.0,17/69,18.55%,POLR2L;POLR2F;HNRNPH1;POLG;DNASE1L2;LSM1;PTBP1;DDX1;GTF2F1;POLR2G;LSM8;RBFOX2;FEN1;HNRNPA1;ATXN2;WRN;DXO
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.24357471724698465,-0.9404518085730199,0.5946745562130178,0.7880845442857135,1.0,18/54,20.41%,EXT1;XYLT1;GCNT2;FUCA1;HGSNAT;CHST9;IDUA;UGDH;HPSE2;HPSE;IDS;SDC3;SDC1;XYLT2;GALNT5;PXYLP1;SDC4;SLC35D2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.20879880691657934,-0.9403781219382533,0.6052631578947368,0.7876739225469263,1.0,26/114,18.00%,PSMA6;TNFSF8;PSMB2;PSME2;LIMS1;BAG4;PSMD11;RIPK1;PSMC6;PSMA3;STAT1;LTB;BIRC2;TNFRSF1B;PSMD10;EDA;TNFRSF17;PSMB5;TNF;PTK2B;TRAF1;ADAM17;PYDC1;TNFRSF9;TNFRSF25;PSMD5
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.23919710867895905,-0.9403562550957995,0.59375,0.7871295788235567,1.0,14/56,20.01%,DAB2;SDCBP;SNX25;BMP5;RBPMS;SMAD6;GREM1;BMP2;BMP3;SMAD4;ACVR1;ACVR2A;GDF3;BMP7
prerank,regulation of ERAD pathway (GO:1904292),0.3859823126518389,0.9397850289982776,0.5180722891566265,0.9699970786819148,1.0,3/11,15.94%,TMEM259;HERPUD1;UBXN1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2511678356370458,0.9397383668045287,0.5643994211287988,0.9692305210018988,1.0,18/80,17.19%,RAB6B;KLC1;RAB1B;ATP9A;KDELR3;TMED2;COPG1;COG4;KIF26A;ZW10;BICD2;KIF1C;KIF2A;COPE;NBAS;KDELR2;TMED3;COPG2
prerank,inhibitory synapse assembly (GO:1904862),0.38834376939276216,0.939209936821141,0.5343915343915344,0.9697540580828155,1.0,4/11,19.01%,GABRG2;GABRA2;FGF13;PLXNB1
prerank,protein localization to vacuole (GO:0072665),-0.3493032044595922,-0.9392008752746983,0.5475638051044084,0.7894031119442108,1.0,6/13,25.35%,LAMTOR5;SH3GLB1;SZT2;LAMTOR4;LMBRD1;ATP13A2
prerank,actin filament polymerization (GO:0030041),-0.27557066403971336,-0.9390709719277548,0.5666666666666667,0.7891100565538237,1.0,17/29,33.44%,PSTPIP2;DIAPH3;GAS7;COBL;WASF1;CORO7;GSN;MSRB1;DIAPH1;TTC17;WASHC3;RAC1;MICALL2;PSTPIP1;WAS;WASHC5;SPIRE1
prerank,response to glucose (GO:0009749),0.27952727669576477,0.9390380854554914,0.5683229813664596,0.9693536522665512,1.0,9/46,15.19%,SELENOS;ADCY8;TRA2B;SOX4;TCF7L2;UNC13B;EIF2B3;KHK;EIF2B1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.30820594830365894,-0.9379488497214346,0.5583126550868487,0.7913642094642404,1.0,14/19,37.82%,HRH1;PPP3R1;PPP3CA;NFATC3;PLCE1;NFATC2;GPR62;NFAT5;PPP3CB;EDN3;NFATC4;EDN2;EDN1;NFATC1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.30322930095180595,0.9379421491446874,0.5448717948717948,0.9716450176378015,1.0,7/28,23.08%,CTTN;SH3BP1;FCHSD2;ARHGAP35;PLEKHG2;LATS1;GBA2
prerank,striated muscle cell differentiation (GO:0051146),0.3437626928683513,0.9378360276699464,0.5439469320066335,0.9710507290962268,1.0,4/16,13.97%,KDM6B;MEF2C;AKAP13;SORT1
prerank,adipose tissue development (GO:0060612),0.38505297005714245,0.9377919826765045,0.5581818181818182,0.9702743339274457,1.0,3/11,6.68%,DGAT2;PGRMC2;DYRK1B
prerank,protein processing (GO:0016485),0.2414005135677304,0.9377167709114791,0.59366391184573,0.9695825061315367,1.0,26/102,21.54%,F3;MMP16;SPCS2;MYRFL;ASPRV1;VSIR;BACE1;XPNPEP3;LGMN;OGT;PHEX;AEBP1;CASP4;PSENEN;PITRM1;MYRF;KLK2;HM13;SEC11C;PCSK2;ADAMTS3;TYSND1;OMA1;METAP2;CASP2;CTSS
prerank,toxin transport (GO:1901998),-0.37641447843358883,-0.937325075702563,0.5117370892018779,0.7923373799007108,1.0,1/10,0.76%,ANTXR2
prerank,regulation of dendrite extension (GO:1903859),0.33157472677530003,0.9371386410167748,0.5436573311367381,0.9704095402271238,1.0,5/18,15.10%,SYT4;SYT1;CPNE6;RIMS1;NEDD4L
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.38978800717828704,0.9371050687062289,0.5363636363636364,0.9687145774948528,1.0,3/10,19.01%,MAP2K5;MBP;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.38978800717828704,0.9371050687062289,0.5363636363636364,0.9687145774948528,1.0,3/10,19.01%,MAP2K5;MBP;WNK1
prerank,cellular response to ATP (GO:0071318),0.35575613606661755,0.9369814852711397,0.5346869712351946,0.9681720429942353,1.0,4/14,16.10%,P2RY12;HSP90B1;P2RY1;SSH1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2584491599056219,0.9369750235614316,0.5754437869822485,0.9673016848711035,1.0,20/67,22.71%,IFT20;FSCN1;SGSM3;TRPM2;MAPK15;TWF2;CDKL5;RAB5A;TBC1D16;RABEP2;TBC1D8;IFT88;TWF1;ATP8B1;CYLD;CDKL1;CDC42;RDX;PPP1R16B;FXR1
prerank,ganglioside biosynthetic process (GO:0001574),-0.3313199703822376,-0.93680361570568,0.5185185185185185,0.7930414031849742,1.0,6/15,22.40%,B4GALT5;ST8SIA6;ST8SIA4;ST8SIA2;ST6GALNAC5;B4GALNT1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.36356469803031677,0.9368034031802698,0.5344262295081967,0.9668992359772344,1.0,5/13,23.35%,GTPBP1;GNAI3;RHOQ;AK4;AK3
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2984349211746896,0.9366948372936156,0.5585443037974683,0.9663236358955809,1.0,10/30,20.59%,ACSL6;ELOVL6;TECR;ACOT4;ACOX1;ELOVL4;PEX2;ACSBG1;ABCD2;ELOVL5
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.31564238137563144,-0.9366370915794117,0.5581947743467933,0.792862731485047,1.0,4/18,8.22%,MSRA;MTHFR;GOT1;MTHFD1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.28607164374132543,-0.9362223929471486,0.5404699738903395,0.793309331559016,1.0,5/24,9.40%,ITCH;NOD2;UBC;TAB1;UBA52
prerank,activin receptor signaling pathway (GO:0032924),0.3538535024757956,0.93618069941084,0.5665529010238908,0.9669036777152578,1.0,5/15,20.58%,TGFBR1;ACVR1B;AMHR2;ACVR1C;SMAD2
prerank,regulation of mitotic spindle organization (GO:0060236),-0.26256838932670173,-0.9360779313172102,0.5835616438356165,0.7931019660839511,1.0,12/35,20.05%,CHMP4B;TACC3;BORA;PDCD6IP;CHMP1B;CCSAP;NUMA1;NUP62;PLK1;TPX2;HSPA1B;HNRNPU
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.34115588884709647,-0.9359867146935008,0.5682382133995038,0.7927296608616926,1.0,6/13,21.65%,GNPDA1;UAP1L1;SLC35A3;GNPNAT1;NAGK;RENBP
prerank,central nervous system neuron differentiation (GO:0021953),0.2894932803186798,0.9359432291623858,0.580952380952381,0.9667211111174046,1.0,5/33,7.91%,MDGA2;FAIM2;SOX4;RYK;GRID2
prerank,myeloid dendritic cell activation (GO:0001773),-0.36027456278813463,-0.935891771396228,0.5456674473067916,0.7923630449608858,1.0,3/12,14.48%,DOCK2;SLAMF1;BATF2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.3192046082181902,0.9353378587901374,0.5477815699658704,0.9676169271186181,1.0,7/23,13.00%,TPTE;MTMR9;INPP5B;SACM1L;INPP5F;OCRL;MTMR1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.25547963936600154,-0.9353028234435748,0.5583333333333333,0.7931960759775152,1.0,13/41,23.69%,GAS6;PTPN22;IGF1;RARA;ZC3H12A;SLAMF1;LBP;LILRB1;TLR4;CD33;NLRC3;NR1H4;GSTP1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.2900631907082022,-0.9351920624039363,0.5564304461942258,0.7928839379392962,1.0,5/25,8.08%,TLR2;CORO1C;SLIT1;THBS1;IL1B
prerank,ganglioside metabolic process (GO:0001573),0.33115940506083735,0.9349129800373185,0.5474209650582362,0.9679270938228675,1.0,4/20,13.96%,ST3GAL5;HEXB;NEU1;ABCA2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.2695453313758509,0.9346065205885321,0.569377990430622,0.9679128605535687,1.0,7/48,12.61%,CAPN3;THY1;DMD;PLCG1;UBASH3B;GSTO1;JPH1
prerank,mitotic DNA replication (GO:1902969),0.3947406092123954,0.9341524998499761,0.5684575389948007,0.9682805568841559,1.0,2/10,7.46%,GINS3;MCM3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3731487122317598,0.9341099324836298,0.5214408233276158,0.9675158752602954,1.0,2/12,10.94%,SNAP25;STX3
prerank,negative regulation of angiogenesis (GO:0016525),0.2445553063189683,0.9339035517627974,0.5737931034482758,0.9672028439783656,1.0,14/84,12.97%,HOXA5;HHEX;IL17F;SLC12A2;YJEFN3;PDE3B;GTF2I;MINAR1;DAB2IP;FOXC1;VASH1;EFNA3;COL4A2;TEK
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.2594490389090023,-0.933848947518273,0.5591715976331361,0.7956494111161614,1.0,8/40,13.84%,DAB2;HIP1;LDLRAP1;HNRNPK;CBL;RAB21;B2M;GREM1
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.29456341193472624,-0.9337164935510752,0.5475,0.7953819139592618,1.0,10/22,31.78%,STAP1;CDKN2C;INPP5K;PRKRIP1;CDKN2A;BMP7;TESK1;PLEK;CDKN2D;CDA
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.29090302463065804,0.933510602500625,0.5515055467511886,0.9674767637920016,1.0,9/35,18.91%,MKLN1;C3;CLU;SNAP91;BMP2K;AAK1;VTN;BICD1;RSPO1
prerank,ureteric bud development (GO:0001657),0.3394952145757748,0.9334685787844351,0.5557377049180328,0.9667127470964378,1.0,4/17,11.06%,BMP4;PKD2;FOXC1;NPNT
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.3164016103816605,-0.9332828380126564,0.526829268292683,0.7958985311174015,1.0,5/17,11.76%,ADAM9;SYK;CIB1;RET;SKAP1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3642542375947726,0.9330105665309004,0.5384615384615384,0.9671867404205263,1.0,6/14,23.35%,PNP;NMNAT2;AK5;AK1;AK4;AK3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.31889868360747353,0.9329842070840848,0.5540765391014975,0.9663863927642254,1.0,5/22,10.75%,PSMB1;ENC1;PSMA1;PSMA8;NFE2L2
prerank,response to muramyl dipeptide (GO:0032495),0.3702336105674608,0.9327543350137888,0.5452930728241563,0.9661588622087265,1.0,6/12,23.33%,TRIM41;INAVA;NOD1;IRF5;CHMP5;RIPK2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.2732730414785214,0.932614993779466,0.5462822458270106,0.9656856650034267,1.0,9/43,12.82%,DDX5;FOSL1;NFIB;RELA;PPARA;BMP4;TGFB1;FGF2;PDGFB
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3395800084330927,-0.9324575001266999,0.533498759305211,0.7973251257827075,1.0,8/14,25.19%,NRP1;GAB1;PIK3CA;KDR;NUS1;PIK3CD;VEGFB;PGF
prerank,serine family amino acid metabolic process (GO:0009069),-0.31835699965754355,-0.9324352974507475,0.49391727493917276,0.7967876259924956,1.0,6/16,21.77%,MTHFD1;GCLC;CBS;THNSL2;CTH;SEPHS2
prerank,endocrine system development (GO:0035270),0.32483119933616006,0.9321481429498985,0.5665024630541872,0.9661710211645969,1.0,2/21,7.62%,WNT4;TGFBR1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.27048669228303224,-0.9317765048160126,0.5469613259668509,0.797887218515205,1.0,10/29,18.66%,CUL4A;CHD1L;UBC;UBA52;RAD23B;CCNH;RPA1;MNAT1;RPA2;XPC
prerank,miRNA metabolic process (GO:0010586),-0.3124416125458125,-0.9316977241900789,0.5495049504950495,0.7975008747376128,1.0,5/20,21.18%,DIS3L2;AGO2;TRIM71;TENT4B;DGCR8
prerank,isotype switching (GO:0045190),0.403059169991665,0.9316251653429033,0.567219152854512,0.9667304742936305,1.0,4/10,15.31%,RNF168;RNF8;CCR6;BATF
prerank,ncRNA export from nucleus (GO:0097064),-0.25983911575628404,-0.9316216916486537,0.5850746268656717,0.7970978034226532,1.0,9/36,15.65%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB;NPM1;NUP62
prerank,muscle cell migration (GO:0014812),0.39568774294374176,0.9315230758462619,0.5535390199637024,0.9661424719926383,1.0,3/10,17.18%,PLAT;ITGB1BP1;ROCK1
prerank,DNA recombination (GO:0006310),-0.2619493057185307,-0.9308625020699657,0.5777777777777777,0.7984266220118545,1.0,8/37,13.72%,RAD51B;RTEL1;IGHMBP2;RHNO1;RPA1;LIG4;RAD21;ENDOG
prerank,hemopoiesis (GO:0030097),0.24236431157436653,0.9308225711409854,0.6017069701280228,0.9672248200409109,1.0,17/87,13.86%,SELPLG;FUT10;ZFPM1;CD34;FLT4;YJEFN3;TGFBR3;PLD4;BMP4;ZFP36L2;TGFB1;SH2B3;KAT8;SFRP1;PDGFB;TEK;FLCN
prerank,endomembrane system organization (GO:0010256),0.2219359288572855,0.9300950726478556,0.6378446115288221,0.9683493657369594,1.0,55/178,25.51%,FBXW8;ANXA8;ANXA8L1;OBSL1;RAB43;SEC16B;ATL1;MAPK15;TMED2;CLASP2;COG4;SEC31A;USP50;PI4K2A;OTOF;TANGO2;ZW10;TLCD2;SYNGR1;DNM1L;HACE1;LYSMD3;TMED5;ARFGEF1;BLZF1;SPTBN1;HOOK2;MIA3;PRKD1;DMPK;ATP8B1;TMED3;VPS33B;ALS2;STX17;LMAN2L;SNX33;HOOK1;CAV2;TRAPPC8;TMED7;SYNGR2;CDC42;LEMD2;VMP1;ATL2;TMED1;SEC31B;VAPA;ANK3;RNF112;ATP8B2;GOLGA8B;GOLGA5;TJAP1
prerank,peptide catabolic process (GO:0043171),0.3240953853314045,0.9299479643156043,0.5765472312703583,0.9678482944013527,1.0,9/23,25.93%,GGT7;XPNPEP1;GGT5;TRHDE;ENPEP;CHAC2;NPEPPS;TPP1;CTSH
prerank,cellular response to organonitrogen compound (GO:0071417),0.23959111745405148,0.9296424959644203,0.6135135135135135,0.9678016388599675,1.0,24/99,19.03%,HCN1;P2RY12;RPTOR;RELA;TRPM2;GABRG2;MEF2C;SLC38A9;RAPGEF3;PKD2;GLRA2;CFTR;HSP90B1;SFRP1;P2RY1;CRHBP;IPO5;GABRB1;AOC1;SH3BP4;SSH1;XBP1;ACTB;NSMF
prerank,acylglycerol homeostasis (GO:0055090),-0.29765146330582987,-0.9296097600063956,0.5717884130982368,0.8010453611713623,1.0,4/20,13.28%,APOE;MTLN;LPL;NR1H3
prerank,regulation of immunoglobulin production (GO:0002637),0.3151373215596897,0.9294493681111167,0.5689381933438986,0.9674795114337994,1.0,9/23,20.22%,CD86;IL6;IL2;CLCF1;VAMP3;EPHB2;CD22;XBP1;TNFRSF4
prerank,regulation of cell population proliferation (GO:0042127),0.1988622887611376,0.9289818308511644,0.7264050901378579,0.967902288545146,1.0,134/691,19.41%,ATP8A2;P3H2;FGF10;TPTE;HHEX;TSC2;TET1;FGF16;SMYD2;AVPR2;MATK;FGF9;ECRG4;NACC2;WWTR1;PAK1;NTRK1;FOSL1;SIX4;AVPR1A;FLT4;SLURP1;RELA;COPS8;TENM1;BEX4;SOX4;IGFBP6;PTPRU;PRLR;STK11;SERTAD1;CD86;HILPDA;FGF7;IL6;NTRK3;CLU;MAPK15;PDCD5;RNF126;XRCC6;CTBP1;GSDME;AR;AREG;RBM5;LGMN;IL2;ADRA2A;CDC123;S100A13;EEF1E1;MAZ;TGFBR1;HOXC10;MINAR1;DAB2IP;TIMELESS;NME1;BMP4;CD81;SSR1;TCF7L2;EPHA1;ERBB4;PKD2;SST;TGFB1;TBX2;NMI;BTG3;CLCF1;CAPNS1;ITGB1BP1;SETD4;SH2B3;THAP12;TRNP1;FGF2;BTG2;STX3;NOP2;IRS1;SFRP1;CGRRF1;TSPAN31;IL13RA1;SLC25A5;TBRG4;TBC1D8;PDGFB;TBX6;TSPO;CNOT8;INHA;RBFOX2;BAP1;THPO;ZBTB49;INSR;PTPN2;NTRK2;IFI35;CADM4;SH3BP4;ADORA3;REST;COL18A1;KIF14;DNAJA3;HRAS;PTK2;IL7;AGT;OPRM1;CDK10;ENG;FLT3;BTG1;FABP3;UTP20;XBP1;POU3F3;IL1A;CHTOP;CHRNA7;FES;GHRL;MCTS1;STAMBP;MAGI2;TOB1;PDGFRB
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.21302008367204495,-0.9289377471421552,0.6518518518518519,0.8021559557321665,1.0,38/101,26.38%,UPF3A;NIBAN1;RPL5;VPS35;BCL3;SAMD4A;ATG7;MSN;THBS1;NR1H2;LARP6;VIM;PTTG1IP;CD28;HDAC2;PIWIL2;PLD1;TBC1D10A;NR1H3;NPM1;ZCCHC4;LARP4B;PLK1;FXR2;UPF3B;HNRNPD;NAT10;RPL26;KLF4;CPEB3;EIF3E;PYM1;PERP;FGFR4;FADD;CSF1;HSP90AA1;PASK
prerank,positive regulation of biomineral tissue development (GO:0070169),0.28071665478828883,0.9285602620065683,0.5487421383647799,0.9682286018346644,1.0,6/40,9.63%,WNT4;MEF2C;FBN2;BMP4;TGFB1;SLC8A1
prerank,positive regulation of wound healing (GO:0090303),0.2858290514634957,0.9282639938397917,0.5928338762214984,0.9682632249728998,1.0,9/36,17.88%,INSL3;SMOC2;ADRA2A;ENPP4;ARFGEF1;VTN;HRAS;PTK2;XBP1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.3418304653523182,0.9282338481015746,0.5618556701030928,0.966590910435069,1.0,10/16,30.39%,CLASP2;ITGB1BP1;APOD;RCC2;PHLDB2;DMTN;PTEN;DLC1;ARHGAP6;FAM107A
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.3418304653523182,0.9282338481015746,0.5618556701030928,0.966590910435069,1.0,10/16,30.39%,CLASP2;ITGB1BP1;APOD;RCC2;PHLDB2;DMTN;PTEN;DLC1;ARHGAP6;FAM107A
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.32893724370917915,0.9281748491224238,0.5492730210016155,0.9658774367998546,1.0,3/20,4.45%,DIP2B;PPARGC1A;SOX4
prerank,regulation of immune effector process (GO:0002697),-0.2561047937733192,-0.9275395770754608,0.5804020100502513,0.8050400100094229,1.0,12/41,20.14%,FCGR2B;C3AR1;C5AR1;IRF4;C4B;SERPING1;CD55;CFHR2;C1QC;CFP;C2;C1QB
prerank,positive regulation of protein acetylation (GO:1901985),0.37199433464891896,0.927287768651071,0.5523156089193825,0.9674321049280225,1.0,7/12,27.65%,DIP2B;RAPGEF3;TAOK1;DDX3X;CAMK1;PRKAA2;DIP2A
prerank,positive regulation of tissue remodeling (GO:0034105),-0.37455235223752137,-0.9271319059731363,0.564625850340136,0.8054867585763202,1.0,1/10,0.22%,IL15
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.27639817676237405,-0.927107978947717,0.5519125683060109,0.8049488104711174,1.0,3/28,3.68%,BCL2;ZDHHC3;BAX
prerank,axonal transport (GO:0098930),0.2870159959793844,0.9269368075288059,0.5815384615384616,0.9675243997274726,1.0,8/36,14.90%,DST;BLOC1S2;SNAPIN;AP3M1;AP3B2;DCTN1;SYBU;HAP1
prerank,recombinational repair (GO:0000725),0.24758622231345406,0.9268066597508908,0.5980253878702397,0.9670177143870582,1.0,19/77,19.41%,NUCKS1;RNF138;SMC5;XRCC1;LIG3;UBE2N;RECQL;FAN1;RAD52;PSMD14;PARP1;FEN1;XRCC3;RFWD3;TONSL;HUS1;WRN;SEM1;RECQL4
prerank,purine nucleotide metabolic process (GO:0006163),0.3160854898733341,0.9266411966754993,0.5795644891122278,0.966616104340554,1.0,7/24,14.21%,FHIT;PNP;GART;PRPSAP2;HPRT1;ADSL;PRPSAP1
prerank,fatty acid oxidation (GO:0019395),0.2591684587439908,0.9265416381539233,0.597667638483965,0.9660450278272917,1.0,12/57,19.93%,ECHDC1;ALOX12;PPARGC1A;MECR;ACAT2;ACADS;ACOX1;PEX2;ACADM;HSD17B10;ABCD2;ECHS1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3206723695068606,0.9265306570840329,0.5478991596638656,0.9652114908797192,1.0,3/22,8.93%,OCIAD2;IL6;ERBB4
prerank,positive regulation of dendrite extension (GO:1903861),0.33158420271221706,0.9264600602687989,0.5528455284552846,0.9645542304984082,1.0,5/17,15.10%,SYT4;SYT1;CPNE6;RIMS1;NEDD4L
prerank,membrane lipid catabolic process (GO:0046466),-0.3802942875235505,-0.9264538997259197,0.5435294117647059,0.8060845880014257,1.0,2/10,1.52%,SGPL1;FUCA1
prerank,protein homotrimerization (GO:0070207),0.3569730924387878,0.9263581985258292,0.5561312607944733,0.9631128753599355,1.0,5/14,21.85%,DISP1;SIGMAR1;ASIC1;ALOX5AP;STEAP4
prerank,protein trimerization (GO:0070206),0.3569730924387878,0.9263581985258292,0.5561312607944733,0.9631128753599355,1.0,5/14,21.85%,DISP1;SIGMAR1;ASIC1;ALOX5AP;STEAP4
prerank,positive regulation of phosphorylation (GO:0042327),0.21230096459070089,0.926134002046951,0.6743902439024391,0.9628967972601317,1.0,56/240,20.51%,FGF10;ADTRP;FGF16;ANG;MERTK;FGF9;C3;PAK1;NTRK1;FLT4;CARD14;NCKAP1L;RARRES2;PFKFB4;FGF7;NTRK3;DSCAM;AR;RYK;LIMK2;CCND3;BMP4;EPHA1;ERBB4;TGFB1;FGF2;EFNA1;P2RY1;TEK;RALBP1;EPHA4;FLCN;THPO;INSR;EPHB2;NTRK2;MAPK3;HRAS;VAC14;PTK2;ITGA6;ENG;FLT3;CHRNA7;PIN1;HDAC3;RSPO1;DVL2;PFKFB2;CCL5;PDGFRB;ROR1;ERP29;IL34;ARRB1;EPHA5
prerank,glycerophospholipid catabolic process (GO:0046475),0.30027942004434033,0.9260979062691145,0.5496794871794872,0.9621571825840345,1.0,5/27,10.37%,PRDX6;PLA2G4C;ABHD12;ENPP2;INPP5F
prerank,dermatan sulfate metabolic process (GO:0030205),-0.3416866046200293,-0.9260306602035918,0.5562913907284768,0.806531587292454,1.0,7/13,32.32%,IDUA;DSEL;CSPG4;DSE;CHST12;NCAN;CHST14
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.2187999682930361,-0.9257763779405028,0.6133333333333333,0.8066078371642297,1.0,21/80,18.25%,CUL3;FBXW7;CAV1;UBQLN1;BRCA1;BMI1;UBE2L3;PTTG1IP;PAXIP1;DCUN1D1;BIRC2;CRY1;LRRK2;PSMD10;FANCI;MAGEC2;PLK1;WFS1;CENPX;ARRDC4;FANCM
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.28495324725444005,-0.9256581574868954,0.5426356589147286,0.8062990071719802,1.0,8/22,17.90%,CIAPIN1;NUBP1;CIAO2A;IBA57;NFU1;CIAO2B;CIAO1;LYRM4
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.2643386600552511,-0.9251071407376753,0.5670391061452514,0.8071053017807156,1.0,4/35,1.20%,IQGAP2;NRP1;STAP1;ABL2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.33461328421853437,0.9250345982863822,0.5855704697986577,0.9642646876715736,1.0,4/19,10.89%,ZFPM1;SOX4;HEY1;EFNA1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.21050220388561655,-0.9249953105082853,0.6501766784452296,0.8067501508836814,1.0,30/94,25.34%,PCM1;CDK5RAP2;PRKACA;MKS1;SCLT1;TUBA4A;CEP250;TCTN1;YWHAG;HAUS2;KIF24;CEP164;MAPRE1;CDK1;HAUS8;PLK1;DCTN2;ODF2;PAFAH1B1;AKAP9;CC2D2A;B9D2;CEP78;OFD1;TUBB4B;MARK4;NDE1;NPHP1;RAB3IP;CEP97
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.36251643446303683,-0.9248102318856667,0.5279187817258884,0.8066354695955378,1.0,5/10,23.92%,GNPDA1;ST6GAL1;NAGK;RENBP;NPL
prerank,autonomic nervous system development (GO:0048483),0.33860725755196,0.9241225851681732,0.5574324324324325,0.9658524528016968,1.0,4/17,8.34%,NTRK1;SOX10;SOX4;KIF26A
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.25903714741785866,-0.9240611785545642,0.6277777777777778,0.8079081748127842,1.0,8/36,14.00%,EPC1;RBBP8;RBBP7;BRCA1;BMI1;EHMT1;RYBP;L3MBTL2
prerank,dephosphorylation (GO:0016311),-0.19689755156127614,-0.9236923890575568,0.6933333333333334,0.8082427901135136,1.0,31/147,15.84%,PPP2R5C;PTPN22;DUSP16;PPP2R1B;PPP2R2A;PTPRC;PPP2R5A;PPP4R1;PTPN1;MTMR2;CDC14B;PTPN21;PPM1H;PPP1R12A;MTMR4;CTDNEP1;SGPP1;PTPN7;TAB1;DUSP18;PPP4R2;PHPT1;PPP3CA;MTM1;CTDSP1;INPP5K;DUSP1;TIMM50;PPP2CB;ACP6;MTMR3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.20982126541387408,0.9235135028556491,0.6697892271662763,0.9666707073359827,1.0,66/308,20.58%,GAPDH;BCL9L;SCAMP5;AVPR2;PPIB;WWTR1;KSR2;G0S2;TXK;ESRRG;KDM6B;SIX4;AVPR1A;IL17F;CADM1;PPARGC1A;GATM;PLA2G3;PRLR;HILPDA;MFAP2;IL6;FOXD1;PIK3CG;IL2;ADRA2A;S100A13;TGFBR1;BMP4;ADCYAP1;OGT;ACHE;FOXC1;TGFB1;FGF2;CRTAM;CFL1;CXCR4;ACVR1B;ELOVL6;EPAS1;AGPAT1;PDGFB;PRDM16;MAP3K13;HAP1;BATF;REST;SHLD3;AGT;GNAS;ITK;ROCK1;XBP1;ALMS1;IL18;IL1A;ZBTB7B;HDAC3;GHRL;BMPR1B;HCAR2;FBXO5;SHLD2;OMA1;SMAD2
prerank,response to axon injury (GO:0048678),0.3314170526592335,0.9235027576843989,0.5594059405940595,0.9658446387696206,1.0,6/18,19.68%,P2RY12;RTN4RL1;APOD;SARM1;MTR;NREP
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.31060691193665113,0.9234122924298642,0.5641838351822503,0.9652533241906157,1.0,8/25,20.72%,GAPDH;PGAM2;ALDOC;PFKM;HK2;ALDOA;PFKP;ENO3
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3126902564868971,0.9233552632096582,0.5918032786885246,0.9645600753923567,1.0,5/24,11.85%,ITPR2;TRPM2;PKD2;FGF2;ITPR3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.33595224050599404,-0.9230534550967544,0.5423340961098398,0.8092036054231142,1.0,5/14,23.88%,CCR2;PTK2B;WNT5A;ADAM17;CCL7
prerank,phospholipid dephosphorylation (GO:0046839),0.28131932701035234,0.9227830691369463,0.5694656488549619,0.9653362645332165,1.0,12/37,21.24%,TPTE;PLPP5;MTMR9;INPP5B;SACM1L;INPP5F;OCRL;MTMR1;PLPPR4;PLPP1;PIP4P1;INPP5J
prerank,chromosome organization (GO:0051276),-0.208816143818374,-0.9227277150220192,0.6807692307692308,0.8094151420355387,1.0,28/99,18.66%,SETD7;HMGB2;CUL4A;MTHFR;SMARCA4;TOP2A;DOT1L;PADI4;CDCA8;UBC;H3-3A;UBA52;RAD23B;HDAC2;LIG4;EHMT1;HMGN3;HDAC1;CDT1;HMGN2;CENPW;NDC80;NUF2;SATB1;HMGA2;COPS4;PHF19;XPC
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.28444369446839357,-0.9226726985645773,0.5889724310776943,0.8089543922924269,1.0,8/27,18.88%,ZC3H12D;ERN1;ZC3H12A;ZC3H12B;PCF11;POP1;TRIR;RNASEH1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.222222412898022,0.9226634419523218,0.6508135168961201,0.96481224826405,1.0,22/166,9.70%,POLR2L;CDK7;WWTR1;POLR2F;ESRRG;NR1I2;NR1I3;TFAM;PPARGC1A;GTF2H2;PPARA;NR2F6;AR;GTF2H4;RXRG;GTF2F1;MAZ;NCOR2;GTF2E2;HDAC5;TAF9;MAML3
prerank,adenine nucleotide transport (GO:0051503),0.33662150148026,0.9226039101848214,0.5656565656565656,0.964121216547868,1.0,5/17,19.64%,SLC25A4;SLC25A5;SLC19A1;SLC35B2;ABCC6
prerank,regulation of actin filament depolymerization (GO:0030834),0.37466112578784594,0.9225666905951959,0.5785837651122625,0.9633842518001116,1.0,1/12,0.33%,SH3BP1
prerank,response to insulin (GO:0032868),0.2453776015981468,0.9225169282824773,0.6130867709815079,0.962668670476324,1.0,19/80,18.40%,SELENOS;RAB8A;PDE3B;RPS6KB1;PRKCI;EIF6;OGT;HDAC5;IRS1;USF1;PARP1;RAB12;KHK;SORT1;INSR;EPRS1;RHOQ;XBP1;ZBTB7B
prerank,nuclear membrane organization (GO:0071763),-0.3058826987772451,-0.9223055880194054,0.5706806282722513,0.8092782156365913,1.0,6/19,16.18%,CHMP4B;TOR1AIP1;TOR1B;NEMP1;UBXN2B;PLK1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.3636584482317173,-0.9222743864231334,0.5375586854460094,0.8087560620237462,1.0,3/10,12.11%,ESR1;PSMC6;ATF7IP
prerank,"transcription, DNA-templated (GO:0006351)",0.2174172672058666,0.9222035649665722,0.6524908869987849,0.9626873093508396,1.0,22/207,7.13%,POLR2L;RNPS1;CDK7;CTR9;IVNS1ABP;DRAP1;RTF1;POLR2F;NELFB;DDX5;TFAM;XAB2;GTF2H2;MED4;NELFCD;E2F1;ELOC;SSRP1;GTF2H4;ARRB2;GTF2F1;FUBP3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.36160473175655244,0.9221443921233821,0.5567567567567567,0.9620123184139027,1.0,4/13,9.35%,SH2B1;TGFBR1;BMP4;TGFB1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.29701208633795095,0.922059906748261,0.5571895424836601,0.9613834192050499,1.0,12/29,25.82%,CBR4;ACSL6;PPT2;ELOVL6;TECR;ACLY;ACSF3;ACSBG1;ELOVL5;ACSL3;SLC25A1;FASN
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.2351871544041248,-0.9219960129470025,0.6158357771260997,0.8088650779932107,1.0,15/54,17.30%,APOE;MECP2;PPARG;P2RX4;THBS1;SP1;HIF1A;PRCP;KDR;TNF;HSPB1;EPHA2;NUS1;ADAM17;RGCC
prerank,nucleosome organization (GO:0034728),0.2600358130970852,0.9211685422100401,0.5964912280701754,0.9629894718743568,1.0,13/55,16.18%,ASF1A;SMARCC2;BPTF;MCM3AP;SMARCE1;ZNHIT1;SMARCD3;VPS72;RNF8;DMAP1;SPTY2D1;NAA60;PAF1
prerank,protein localization to Golgi apparatus (GO:0034067),0.3044487594583146,0.920943735372975,0.5756578947368421,0.9627629184127305,1.0,6/27,12.39%,IFT20;OBSL1;ARL5A;SYS1;ARFRP1;BICD2
prerank,endocardial cushion development (GO:0003197),0.3199376887819552,0.9207935849493644,0.5893155258764607,0.9622948842002701,1.0,6/21,21.45%,BMP4;HEY1;TBX2;CRELD1;ENG;MDM4
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.3478802219735483,-0.9206690390086315,0.5501222493887531,0.8116579245862706,1.0,7/13,24.92%,TLR2;NAMPT;NOD2;KDR;TLR4;GSTP1;TLR9
prerank,lymphocyte migration (GO:0072676),-0.27059248333547475,-0.9206641805348067,0.6011560693641619,0.8110691233112773,1.0,9/32,27.31%,MSN;CCL25;RET;ADAM8;ZAP70;GATA3;CCL7;TBX21;CCL24
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.38173802824465347,0.9205541558782088,0.5711743772241993,0.9621092655339386,1.0,5/11,26.25%,FBXO7;PRKN;REST;NONO;ATF4
prerank,response to histamine (GO:0034776),-0.3722657549553071,-0.9205228321827263,0.5594936708860759,0.810793192745883,1.0,5/10,21.30%,HRH1;GABRB2;DRD2;DRD3;DIAPH1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.23730707522457023,-0.9204934221649379,0.6172839506172839,0.8102698451119705,1.0,12/55,15.24%,BCL2;BCL2L1;BAX;FAS;RIPK1;CAV1;WWOX;LCK;RACK1;PMAIP1;TNF;BCL2L11
prerank,regulation of ruffle assembly (GO:1900027),-0.29149938488549443,-0.9204531453381543,0.5896103896103896,0.8097672364155165,1.0,6/23,8.68%,STAP1;EPS8;P2RX4;FAM98A;CAV1;ARHGAP24
prerank,response to organic cyclic compound (GO:0014070),0.26238807067297654,0.9202645840283269,0.5994277539341917,0.9620636152810066,1.0,15/52,19.31%,GGT7;TRPM2;SLC1A1;GGT5;ABCB4;SOCS2;TGFB1;WNT8B;ALPL;BGLAP;SFRP1;ABCA2;TLR3;IL18;CCL5
prerank,cell proliferation in forebrain (GO:0021846),-0.36637758874978454,-0.920235256733915,0.5347721822541966,0.8096744700837246,1.0,2/10,2.93%,PCM1;DOCK7
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.36952503884261123,-0.9201108907524853,0.5583756345177665,0.8093844164372305,1.0,2/10,1.21%,STAP1;CD300A
prerank,positive regulation of DNA repair (GO:0045739),0.2700945621317339,0.9199066198217611,0.5778443113772455,0.9622469174466618,1.0,11/46,16.74%,FGF10;WRAP53;TIMELESS;XRCC1;UBE2N;RNF168;RNF8;PARP1;HMGB1;ERCC6;PRKCG
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.32009982635037565,0.9196603374674377,0.5642276422764227,0.9620412239370686,1.0,6/21,19.21%,SH3BP1;DAB2IP;RASAL3;EPHB2;ARHGAP12;STAMBP
prerank,regulation of actomyosin structure organization (GO:0110020),0.36207198331213797,0.919569251044878,0.535472972972973,0.9614530384088079,1.0,7/13,26.21%,AKAP13;ROCK1;ALMS1;ASAP3;CDC42;SLC9A1;FHOD1
prerank,regulation of JNK cascade (GO:0046328),-0.20844510284214574,-0.9195591891633336,0.6642599277978339,0.810189783940307,1.0,31/101,24.92%,FCGR2B;ITCH;SDCBP;PJA2;NOD2;RIPK1;IL1B;TAOK3;SH3RF1;MAP3K11;TNFRSF19;GADD45G;MAPK8IP3;SLAMF1;EGFR;AGER;PTK2B;TRAF1;HIPK2;MMP8;RAP2A;TRAF4;NCOR1;DUSP19;SERPINF2;EPHB1;MECOM;APP;DUSP3;FKTN;TLR9
prerank,fibrinolysis (GO:0042730),-0.34871116852314366,-0.9193917597319919,0.5560640732265446,0.8099953580045511,1.0,2/13,6.66%,PLAU;PLAUR
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2857262169301891,0.9193469230375166,0.5986509274873525,0.961238794842292,1.0,6/33,14.64%,HOXA5;ANKRD54;NCKAP1L;MTURN;ACVR1B;THPO
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.24727132725241063,0.9192619203825816,0.613540197461213,0.9606304095987362,1.0,13/78,14.37%,HHEX;CDK7;PSRC1;CCNI;SERTAD1;CCND3;PKD2;HEXIM2;PKD1;PDGFB;GADD45A;CCNK;IPO5
prerank,histone lysine demethylation (GO:0070076),-0.27977932598622735,-0.9190937755637607,0.5741239892183289,0.8101464467756226,1.0,7/25,15.27%,RIOX2;KDM7A;KDM8;KDM6A;HR;RIOX1;KDM5C
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.3900778375106931,0.919039055661419,0.5486238532110091,0.9604097235483818,1.0,3/10,18.40%,NCKAP1L;CD81;ZBTB7B
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.22048166805034058,-0.918776168969585,0.6440129449838188,0.8103629302836326,1.0,15/74,13.89%,DAB2;PHLDB1;GCNT2;SDCBP;SMAD3;GLIPR2;IL1B;DAG1;BMP5;MAD2L2;SPRY2;CTNNB1;SPRY1;GREM1;BMP2
prerank,autophagy of mitochondrion (GO:0000422),-0.25487455199560344,-0.9186967286810157,0.595166163141994,0.8099661403123184,1.0,11/38,17.37%,MAP1LC3B;MARK2;ATG13;ATG7;CISD2;ATG2B;ATG3;AMBRA1;ATG9B;SQSTM1;MAP1LC3A
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.31083593528594833,0.9185345276507668,0.6041308089500861,0.9609203299660275,1.0,8/23,21.56%,IL17F;TGFBR3;TGFB1;ENG;LTBP4;NREP;SMAD2;LATS1
prerank,leukotriene biosynthetic process (GO:0019370),-0.33602550978543466,-0.9184137632280356,0.5633074935400517,0.8100245965054974,1.0,4/14,12.03%,ALOX5;MGST3;GGTA1;LTA4H
prerank,regulation of B cell apoptotic process (GO:0002902),-0.3576616029848424,-0.9181205746810293,0.55,0.8101444714776319,1.0,7/12,28.80%,LYN;FOXP1;ORMDL3;IRS2;BCL6;BLK;FNIP1
prerank,presynaptic endocytosis (GO:0140238),-0.28205803027968473,-0.917967232123151,0.595,0.8099667886221875,1.0,4/24,10.67%,SYNJ2;FCHO2;AMPH;SNCG
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.29784569613281264,0.9178351253836509,0.5799011532125206,0.9619465064202193,1.0,7/30,14.31%,GGA3;RAB26;SYS1;ARFRP1;RAB34;BLZF1;SPTBN1
prerank,phagolysosome assembly (GO:0001845),-0.35898496123208024,-0.9177880844204749,0.5555555555555556,0.8098220527477592,1.0,2/12,3.66%,RAB7A;RAB7B
prerank,response to organophosphorus (GO:0046683),0.3364594830564981,0.9176082794745021,0.5633802816901409,0.9616911271160258,1.0,3/16,8.50%,TRPC3;AKR1C1;DGKQ
prerank,nerve growth factor signaling pathway (GO:0038180),0.38297142199907935,0.9174734781965417,0.5704099821746881,0.9612002312416132,1.0,4/10,25.08%,NTRK1;MAGI2;BDNF;RAPGEF2
prerank,cilium assembly (GO:0060271),-0.17841395247087857,-0.9174236026840368,0.8136645962732919,0.8101566077844297,1.0,47/296,12.56%,EHD4;ATP6V0D1;RAB8B;ACTR3;KIF3A;PTPN23;PCM1;RILPL2;FAM161A;CDK5RAP2;PIBF1;RAB1A;PRKACA;MKS1;RPGR;SCLT1;CDC14B;EXOC4;CPLANE1;GBF1;TUBA4A;CEP250;ARL13B;TCTN1;SSX2IP;TBC1D32;BBS7;FHDC1;ASAP1;DNAH5;YWHAG;HAUS2;TMEM231;KIF24;CEP164;CCDC40;WDPCP;MAPRE1;SNAP29;CCDC28B;TMEM138;NOTCH1;CDK1;HAUS8;FOXJ1;IFT52;EXOC8
prerank,long-term memory (GO:0007616),-0.29689591294631257,-0.9172693651602888,0.5824742268041238,0.8099614994082153,1.0,3/19,6.67%,APOE;PJA2;LDLR
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.25593434646153873,-0.917039187513669,0.6088154269972452,0.809931736852936,1.0,13/38,27.15%,RBBP7;CABIN1;H3-3A;CENPA;HAT1;NPM1;CENPW;CENPX;MIS18BP1;UBN1;CENPH;HJURP;OIP5
prerank,fatty acid biosynthetic process (GO:0006633),0.25091556142689253,0.9170073806675977,0.5939849624060151,0.9616129993612337,1.0,17/63,20.59%,ALOX12;CBR4;ELOVL6;OXSM;TECR;ELOVL4;ACLY;NDUFAB1;ACSF3;ACSBG1;LIPC;XBP1;HPGD;DECR2;FADS3;ABHD2;ELOVL5
prerank,vesicle transport along actin filament (GO:0030050),-0.30508804542692325,-0.916695259386322,0.562962962962963,0.8101815310954921,1.0,3/19,6.67%,MYO5A;MYO1F;MYO15A
prerank,manganese ion transport (GO:0006828),0.35952149381103427,0.9166308354010089,0.5687285223367697,0.9618276281881093,1.0,4/14,11.52%,TRPC3;SLC39A8;ATP2C1;TRPC6
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.23956463610352036,0.9166236942931976,0.6297335203366059,0.9610188723169649,1.0,27/87,22.76%,NDUFA6;DMAC1;NDUFAF8;TIMM21;TTC19;FOXRED1;UQCC3;NDUFS1;NDUFA8;NDUFS6;SDHAF2;NDUFAF2;OXA1L;ECSIT;NDUFAB1;TIMMDC1;NDUFS2;NDUFAF6;BCS1L;NDUFB6;SDHAF4;OMA1;COX17;ACAD9;SMIM20;NUBPL;COX18
prerank,cellular response to reactive oxygen species (GO:0034614),0.25142675350598176,0.916094110129125,0.5910404624277457,0.9615428657179798,1.0,8/59,10.75%,PRDX5;PJVK;RELA;IL6;TRPM2;RIPK3;PKD2;NFE2L2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.18691649452964978,-0.9157854076472267,0.7298578199052133,0.8119272009938224,1.0,67/208,25.13%,CD74;ANKRD17;ALPK1;TRIM25;TRIM14;LGALS1;TBK1;LAMTOR5;SHISA5;ESR1;BST2;NOD2;TNIP3;RIPK1;TFRC;LITAF;TRIM62;PLEKHG5;CLEC6A;IL1B;CCDC22;S100A4;EEF1D;PIDD1;ZC3H12A;GPRC5B;STAT1;TNFRSF19;BIRC2;IRAK4;PELI1;TRIM5;ZDHHC17;SPHK2;DDX21;TNF;GJA1;HSPB1;WNT5A;OPTN;NUP62;TRAF1;MUL1;HMOX1;SQSTM1;TRAF3IP2;FLNA;ECT2;TRAF4;MYD88;LTF;CASP1;NLRC3;TRIM21;NDFIP1;TNIP1;NR1H4;TNFSF10;GPR89A;TICAM2;TMEM101;GSTP1;GOLT1B;PIM2;FADD;TLR9;TAB3
prerank,mitochondrion morphogenesis (GO:0070584),-0.3556857651701537,-0.915557571817981,0.5555555555555556,0.8118763537353492,1.0,3/11,15.02%,PID1;MTM1;WASF1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.24891006132963595,0.9154940891233233,0.6180081855388813,0.9623681234407069,1.0,24/68,27.54%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;MAZ;CPSF3;POLR1E;CSTF1;NUDT21;SETX;POLR1F;SNRPD3;SSU72;PRMT5;SCAF8;POLR1G;GTF2H3;POLR3K;ERCC2;TAF1A;POLR1A;PAPOLA;GTF2H1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3772846676653115,0.9154721238150146,0.5854545454545454,0.9616030524037777,1.0,1/11,2.16%,CD34
prerank,respiratory chain complex IV assembly (GO:0008535),0.3188716230437903,0.9154314732181504,0.5845410628019324,0.9608759002791024,1.0,9/21,26.01%,COA6;TIMM21;OXA1L;BCS1L;COX17;SMIM20;COX18;COX10;FASTKD3
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3236136430662752,0.9150908000388,0.5851239669421487,0.9609877876558172,1.0,6/21,15.58%,FIS1;MICU2;SMDT1;RAP1GDS1;SLC8A3;SLC25A23
prerank,negative regulation of macroautophagy (GO:0016242),-0.2752219505205501,-0.9146593277303543,0.6015424164524421,0.8134034216379107,1.0,6/26,12.18%,CHMP4B;CHMP4A;SMCR8;PIK3CA;MTM1;LRRK2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.2576292995741051,-0.9144685333233503,0.6005089058524173,0.8133151413782579,1.0,13/35,23.84%,PTPRC;DOT1L;BCL3;VHL;CAV1;GHR;NOTCH1;NLK;TNF;HES1;SOCS1;CYP1B1;EGF
prerank,regulation of mRNA stability (GO:0043488),-0.19637711541518363,-0.9140671355565869,0.7136363636363636,0.8136796792818338,1.0,45/145,25.99%,PSMA6;CELF1;NOCT;PSMB2;MAPKAPK2;PSME2;SAMD4A;PUM2;PSMD11;PSMC6;UBC;EIF4ENIF1;PSMA3;EXOSC8;UBA52;VIM;XPO1;FASTKD1;RC3H1;TENT5A;SLC11A1;PSMD10;LARP1;EXOSC9;NPM1;PSMB5;HSPB1;RC3H2;FXR2;PSMD5;HNRNPD;MEX3D;PSMD1;HNRNPU;PUM1;EXOSC1;TENT5C;RIDA;PSMA7;PSMB7;EXOSC7;SERBP1;VIP;GIGYF2;PSMB3
prerank,canonical glycolysis (GO:0061621),0.3109190886630572,0.9136427223600369,0.5841269841269842,0.9632278408826445,1.0,8/24,20.72%,GAPDH;PGAM2;ALDOC;PFKM;HK2;ALDOA;PFKP;ENO3
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3109190886630572,0.9136427223600369,0.5841269841269842,0.9632278408826445,1.0,8/24,20.72%,GAPDH;PGAM2;ALDOC;PFKM;HK2;ALDOA;PFKP;ENO3
prerank,mitotic cytokinetic process (GO:1902410),-0.29719784069133737,-0.9136390561089378,0.6009501187648456,0.8140948271298187,1.0,5/20,16.22%,CHMP4B;CHMP4A;PDCD6IP;CHMP1B;KIF20A
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.34341814861452225,0.913626882694154,0.57166392092257,0.9624355852896429,1.0,8/15,28.50%,GRM3;HOMER2;DAGLA;DAGLB;GRIK3;GRM8;GRM7;GRM1
prerank,striated muscle tissue development (GO:0014706),0.2893835899395327,0.9136034874934761,0.6016,0.9616777581369308,1.0,11/29,23.99%,SIX4;MEF2C;MYL6;TBX2;SGCZ;SGCG;SGCD;IGSF8;CFLAR;RBP4;POPDC3
prerank,regulation of transforming growth factor beta production (GO:0071634),0.32731226010607384,0.9135669030916125,0.5899280575539568,0.9609805720549677,1.0,2/18,4.00%,CD34;ITGB6
prerank,negative regulation of protein modification process (GO:0031400),0.24076589604739077,0.9135446070913384,0.629842180774749,0.9602225865406148,1.0,12/79,9.79%,TPPP;WWTR1;BEX4;DMD;PRNP;NTRK3;CACTIN;DAB2IP;XRCC1;SH3GL2;TGFB1;PRKN
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.3737540397019812,0.9128224353350216,0.5797872340425532,0.9613260330037076,1.0,3/11,17.66%,PLA2G3;AGT;LIPC
prerank,T cell differentiation in thymus (GO:0033077),0.351326321413059,0.912750281246799,0.5696428571428571,0.960698195607946,1.0,4/14,13.66%,MR1;RIPK3;ZFP36L2;CCR6
prerank,protein autophosphorylation (GO:0046777),0.22000998278160508,0.9126161839980504,0.6592689295039165,0.9602226468043871,1.0,35/157,17.59%,TXK;STK26;PAK1;NTRK1;FLT4;STK16;STK11;MAPK15;MAP3K10;RIPK3;EPHA1;ERBB4;CDKL5;PRKD2;AAK1;STK39;VRK2;MINK1;STK25;ACVR1B;TEK;EPHA4;MAP3K13;INSR;NTRK2;EIF2AK4;MAPK3;PRKD1;PTK2;MAPKAPK5;ITK;AATK;TAOK1;FLT3;SMG1
prerank,sulfur compound catabolic process (GO:0044273),0.28079568497170754,0.9125378335281632,0.6075187969924812,0.9596089043461464,1.0,5/38,6.43%,HEXB;GGT7;ACAN;ARSB;GGT5
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3073653304886447,0.9123725676991545,0.5844370860927153,0.9592484796880153,1.0,10/26,23.15%,SHANK3;LIMK1;PRKN;ROCK1;SHANK1;ALMS1;ASAP3;CDC42;RDX;SLC9A1
prerank,RNA methylation (GO:0001510),0.2507826940066868,0.9119648554105564,0.6313497822931785,0.9595147944570848,1.0,13/60,14.72%,METTL2B;METTL2A;TRMT44;METTL1;TRMT61B;DIMT1;MEPCE;FTSJ1;METTL16;NOP2;METTL5;CBLL1;FBLL1
prerank,L-glutamate transmembrane transport (GO:0015813),0.3857823483137317,0.911423473604749,0.5711805555555556,0.9600747003429297,1.0,3/10,11.07%,SLC1A1;SLC25A18;SLC1A3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2973578678747491,0.9112602036481743,0.5935085007727975,0.9597101130785137,1.0,13/26,30.39%,FGF10;RPTOR;CCND3;MTBP;CDK10;KMT2E;RDX;UBE2E2;DDX3X;ADAMTS1;PLCB1;TFDP1;LSM10
prerank,DNA-dependent DNA replication (GO:0006261),-0.19773908193832912,-0.91047316066447,0.7196652719665272,0.821205416164662,1.0,30/128,20.30%,BAZ1A;PSMA6;PSMB2;POLE4;TOPBP1;PSME2;ORC5;PSMD11;CDC34;PSMC6;UBC;PSMA3;UBA52;ORC2;POLD4;RPA1;MCM2;ORC4;PSMD10;CDT1;PRIM2;PSMB5;DDX21;MCM8;RPA2;PSMD5;WDHD1;PSMD1;POLE3;HMGA1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.24803615912194976,-0.9102810894134609,0.6225352112676056,0.8210695364115478,1.0,9/37,17.00%,CUL4A;PCNA;CHD1L;UBC;UBA52;POLD4;RPA1;NTHL1;RPA2
prerank,T cell migration (GO:0072678),-0.3348812156286034,-0.9102180889872201,0.5625,0.8206257332832663,1.0,3/13,6.00%,CXCL16;MSN;GPR183
prerank,mitochondrial membrane organization (GO:0007006),-0.26388139775284897,-0.9101947014012225,0.6102150537634409,0.8200874548634064,1.0,8/32,14.72%,BCL2;BCL2L1;RCC1L;MTX3;MTX1;IMMT;PMAIP1;TIMM50
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.2685548764435462,-0.909792638624716,0.601078167115903,0.8204788576115636,1.0,7/28,9.91%,BCL2;BAX;ERN1;CEBPB;ITPR1;BAG6;DNAJC10
prerank,positive regulation of immunoglobulin production (GO:0002639),0.29336173709188407,0.9096482835799609,0.6266025641025641,0.9631709199455748,1.0,10/31,20.22%,CD86;IL6;IL2;CLCF1;VAMP3;EPHB2;SHLD3;XBP1;SHLD2;TNFRSF4
prerank,heart trabecula morphogenesis (GO:0061384),-0.3108522254418119,-0.9093789762293971,0.5686274509803921,0.8209147382665022,1.0,4/18,10.94%,RBPJ;ADGRG6;BMP5;NOTCH1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.29204784175502696,0.9093380992513206,0.5865384615384616,0.9632305768334373,1.0,10/28,28.50%,KCNE2;CLU;DAB2IP;PRKN;PTK2;AXIN1;RNF139;PSMC5;PTEN;ATP5IF1
prerank,protein localization to lysosome (GO:0061462),-0.2711794075273106,-0.9091549952702911,0.5873417721518988,0.8208969698977103,1.0,7/28,11.69%,RAB7A;LAMTOR5;NAGPA;M6PR;ZFYVE16;AP4M1;SZT2
prerank,"wound healing, spreading of cells (GO:0044319)",-0.28915948177294015,-0.9091441436081225,0.598014888337469,0.82032875549702,1.0,9/24,17.78%,CD44;PDCD10;ARHGAP24;LCP1;CCN1;CEACAM1;ADAM17;CARMIL2;FLNA
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3699910262805777,0.9090193748430917,0.5709156193895871,0.9632560884558187,1.0,3/11,10.56%,PTPRT;SOCS3;SH2B3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.19356542391776813,-0.9086790736626562,0.7433628318584071,0.8208282901595397,1.0,50/158,25.13%,CD74;ANKRD17;ALPK1;TRIM25;TRIM14;LGALS1;TBK1;LAMTOR5;SHISA5;BST2;NOD2;RIPK1;TFRC;LITAF;TRIM62;PLEKHG5;CLEC6A;CCDC22;S100A4;EEF1D;GPRC5B;TNFRSF19;BIRC2;IRAK4;PELI1;TRIM5;ZDHHC17;DDX21;TNF;GJA1;NUP62;MUL1;HMOX1;TRAF3IP2;FLNA;ECT2;MYD88;LTF;CASP1;TRIM21;NDFIP1;TNFSF10;GPR89A;TICAM2;TMEM101;GOLT1B;PIM2;FADD;TLR9;TAB3
prerank,cochlea morphogenesis (GO:0090103),0.3951727857616329,0.9080172614848896,0.5766423357664233,0.9650590359296527,1.0,2/10,15.47%,POU3F4;HPN
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2974309675358605,0.9078422268751509,0.6138763197586727,0.9647017746868293,1.0,5/27,9.90%,SMYD2;DDX5;HIC1;EEF1E1;SNAI2
prerank,regulation of membrane depolarization (GO:0003254),0.3229158053352353,0.9078164606234831,0.5914332784184514,0.9639429455623629,1.0,6/18,22.35%,FHL1;PTPN3;GJA5;NEDD4L;SCN1B;SCN3B
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.32059556965357827,-0.9078131832411153,0.5581947743467933,0.8223649620214981,1.0,6/15,15.40%,P2RX4;MET;THBS1;FGF1;NOTCH1;HSPB1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.2595125116548923,-0.9077517583960935,0.6162162162162163,0.8219237510245719,1.0,10/32,25.11%,OSBPL8;PLA2G4E;PLAAT3;ABHD16A;LPCAT4;PLA1A;PLA2G4F;PLA2G2D;PLSCR1;MBOAT1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3097460718859174,0.9075623491241317,0.5963756177924218,0.96380544110926,1.0,6/23,21.83%,GUCY2F;CNGB1;GUCY2D;NMT1;METAP2;GUCA1B
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2733014190924599,0.9072483507216323,0.6295133437990581,0.9638283667972237,1.0,13/39,23.64%,YWHAE;FGF12;FHL1;PTPN3;NEDD4;STK39;TRPC6;CACNA1D;NEDD4L;ANK2;SCN1B;SCN3B;PDZK1
prerank,ether lipid metabolic process (GO:0046485),-0.3399725948120278,-0.9071068815678072,0.5795724465558195,0.8229368157756267,1.0,5/14,23.40%,NCEH1;PLAAT3;TMEM86B;PAFAH1B1;PLA2G7
prerank,placenta development (GO:0001890),-0.3381519299842981,-0.907029796425203,0.5788235294117647,0.8225309000012619,1.0,4/12,16.06%,ADAM19;PPARG;E2F8;E2F7
prerank,proteasomal protein catabolic process (GO:0010498),0.212197825450779,0.906922473422007,0.6988984088127295,0.9638831337788584,1.0,45/201,16.38%,KLHL22;UBXN6;UBE2B;PSMB1;HECTD3;ENC1;RNF126;UBE2G1;ARRB2;PSMF1;BTRC;PSMA1;PSMD7;FAF1;HECW2;PRKN;PSMA8;NEDD4;NFE2L2;CCDC47;NHLRC1;TRIM9;KCTD10;KCTD13;PSME3;IFI27;GID4;DERL1;PSMD14;APPBP2;HACE1;SPSB3;FBXL19;PSMC4;DCAF11;SOCS6;KCTD5;RFFL;FBXW5;NEDD4L;SKP2;UBXN1;SIAH1;COP1;KIF14
prerank,dendritic cell migration (GO:0036336),-0.3144670860550779,-0.9069068771724657,0.5752427184466019,0.8222677033326998,1.0,5/16,11.40%,EPS8;ALOX5;CCR2;GPR183;TRPM4
prerank,regulation of focal adhesion assembly (GO:0051893),-0.23580606838598267,-0.9065628921859266,0.6770186335403726,0.822565247276142,1.0,6/54,5.53%,PEAK1;SLK;NRP1;CORO1C;LIMS1;THBS1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3310793022110413,0.9061205313180202,0.6037414965986394,0.9651887055059726,1.0,4/17,9.35%,WNT4;VSIR;BMP4;TGFB1
prerank,carboxylic acid transport (GO:0046942),-0.22842185451285477,-0.9060382459629914,0.6555183946488294,0.8232522022665124,1.0,5/55,3.14%,SLC38A6;SLC1A5;SLC7A1;PSAP;SLC6A6
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3376854659722298,0.9059665567601313,0.6024518388791593,0.9647847341020063,1.0,6/15,24.43%,JMJD8;ITGA5;FGF2;SMAD1;PDPK1;PKM
prerank,actin filament-based transport (GO:0099515),-0.28765762499082426,-0.9059580741592599,0.5910224438902744,0.8228452773764859,1.0,3/21,6.67%,MYO5A;MYO1F;MYO15A
prerank,zinc ion transport (GO:0006829),0.3197144719578335,0.9057712101436287,0.5889070146818923,0.9644761773414686,1.0,5/21,17.77%,SLC39A4;TRPM2;SLC39A8;SLC30A3;SLC39A3
prerank,response to estradiol (GO:0032355),0.2865801105666684,0.9057601155680794,0.6121212121212121,0.9636961781987622,1.0,7/31,12.72%,GGT7;GGT5;SOCS2;TGFB1;WNT8B;SFRP1;CRHBP
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.362643468992771,-0.9055732280057869,0.5679611650485437,0.8231912820967974,1.0,4/10,27.33%,OS9;INSIG1;UBE2J1;YOD1
prerank,glucan biosynthetic process (GO:0009250),-0.3447665911549011,-0.9054284375880095,0.5758293838862559,0.8223559927283495,1.0,6/12,30.82%,GYG1;PPP1R3C;PGM2L1;PER2;GBE1;GYS1
prerank,glycogen biosynthetic process (GO:0005978),-0.3447665911549011,-0.9054284375880095,0.5758293838862559,0.8223559927283495,1.0,6/12,30.82%,GYG1;PPP1R3C;PGM2L1;PER2;GBE1;GYS1
prerank,regulation of histone modification (GO:0031056),0.34703507951541646,0.9054202183251153,0.569023569023569,0.9637819113452682,1.0,4/13,13.86%,AKAP8L;UBE2N;AKAP8;FLCN
prerank,focal adhesion assembly (GO:0048041),0.3139814068488646,0.9053313431778803,0.5702054794520548,0.9632245163630052,1.0,4/21,9.00%,CTTN;THY1;TRIP6;ACTN2
prerank,T cell proliferation (GO:0042098),0.35176839878205085,0.9048695707035147,0.5844827586206897,0.9636333746337037,1.0,3/13,11.30%,CADM1;PIK3CG;CRTAM
prerank,histone H2A acetylation (GO:0043968),-0.31711817409383664,-0.9044714744191092,0.6247030878859857,0.824119784031875,1.0,5/16,14.39%,EP400;EPC1;TRRAP;SPHK2;MSL3
prerank,autophagosome assembly (GO:0000045),-0.232109129955217,-0.9043184675810472,0.6905444126074498,0.8238743790547476,1.0,14/52,17.37%,PIK3C3;MAP1LC3B;ATG13;STX12;RAB1A;RAB7A;ATG7;UBQLN1;ATG2B;ATG3;UBXN2B;AMBRA1;ATG9B;MAP1LC3A
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2604241634554252,-0.9042267639543098,0.6426666666666667,0.82350357088841,1.0,7/33,10.88%,UBA5;ESR1;RNF14;H3-3A;RNF6;EP300;PRMT2
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.24224174387086275,-0.9040531062874037,0.6513513513513514,0.8233256500497638,1.0,13/44,19.14%,NRP1;PXN;ARHGEF10L;CD47;CARMIL1;SORBS3;S100A10;GPR65;MYOC;ARHGEF5;PFN2;RGCC;PPM1F
prerank,positive regulation of cation channel activity (GO:2001259),0.27417655113814143,0.9039262380789498,0.6321483771251932,0.9652758886554244,1.0,11/40,24.51%,SHANK3;PKD2;ACTN2;GSTO1;HAP1;EPHB2;GAL;ANK2;CTSS;LRRC55;ANK3
prerank,exit from mitosis (GO:0010458),-0.33771254667734196,-0.9034954564715354,0.579746835443038,0.8240250645370485,1.0,2/12,1.14%,CHMP4B;EPS8
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.27386448750254605,-0.9032958094319036,0.6094527363184079,0.8239030115919088,1.0,7/25,15.43%,NOD2;CD226;B2M;CD55;SPHK2;SCIMP;WNT5A
prerank,regulation of peptidase activity (GO:0052547),-0.3000008859144254,-0.9032326575440813,0.5850515463917526,0.8234956156658096,1.0,7/19,25.35%,NRDC;CAV1;PSMA3;HDAC1;MAPK12;NDUFA13;ATP13A2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.3299103085160115,-0.903209065665934,0.5786924939467313,0.8229634900617215,1.0,6/14,17.85%,THBS1;SPRY2;SPRY1;CREB3L1;SPRY4;GATA3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.21289787230675772,-0.90311578058648,0.7011070110701108,0.8226266872203638,1.0,19/84,16.38%,PSMA6;BUB3;CUL3;PSMB2;PSME2;PSMD11;PSMC6;UBC;PSMA3;UBA52;CDC27;CDK1;MAD2L1;PSMD10;BUB1B;RB1;PSMB5;PLK1;UBE2C
prerank,regulation of mitochondrion organization (GO:0010821),-0.23678111569911547,-0.9030778149427555,0.6366459627329193,0.8221248048230549,1.0,11/47,18.81%,PID1;FBXW7;STAT2;VPS35;PARL;EP300;LRRK2;PDE2A;MUL1;SQSTM1;PISD
prerank,visual perception (GO:0007601),0.2369684574246984,0.902832516936664,0.6653116531165312,0.9673520292560919,1.0,8/84,8.46%,GUCY2F;ROM1;RDH10;COL2A1;CRYGN;CNGB1;CRYBA4;CABP1
prerank,COPII-coated vesicle budding (GO:0090114),0.2480216882240686,0.9026680648308966,0.6260869565217392,0.9669627807401424,1.0,17/68,17.90%,RAB1B;CNIH2;SEC16B;TMED2;AREG;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9;MIA3;SEC24C;SCAP;PREB
prerank,phospholipid metabolic process (GO:0006644),0.24559868491208023,0.9025906353863282,0.6384180790960452,0.9663767601811788,1.0,24/71,26.06%,PLA2G3;PLCD1;PLA2G4C;PNPLA3;LPCAT1;TNFAIP8L3;ABHD12;ENPP2;AGPAT1;ABCA2;FITM2;PLPPR4;ANGPTL3;PLCB2;PLA2G15;PLPP1;PIP4P1;PIP4K2B;GPAT2;PIP4K2A;PLPP2;PLPPR1;PLA2G4A;SMPD2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2520045359657169,0.9025141854646936,0.6394160583941606,0.9657568676193689,1.0,14/59,17.88%,HOGA1;GATM;CYP39A1;CBR4;OXSM;ELOVL4;CYP27A1;ACLY;NDUFAB1;ACSF3;AMACR;LIPC;HSD17B10;XBP1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.24141816090770996,-0.902302720504862,0.6784565916398714,0.8233289994614099,1.0,26/44,40.00%,ACOT8;OSBP;OSBPL9;OSBPL1A;PRKAG2;OSBPL2;HSD17B1;SC5D;PER2;HSD3B7;INSIG1;SRD5A2;PMVK;ALOX15;ABCB11;INSIG2;EBP;BAAT;SLC27A5;AKR1D1;ACOX2;HMGCR;CH25H;LBR;OSBPL3;SLC27A2
prerank,hyaluronan catabolic process (GO:0030214),-0.30145983310261104,-0.9022619223975975,0.5921375921375921,0.8228600099049085,1.0,7/18,16.94%,LYVE1;CD44;HMMR;CEMIP2;STAB2;CHP1;HYAL3
prerank,organelle fission (GO:0048285),-0.2740612373256379,-0.9020283475849398,0.6105527638190955,0.8228143008437149,1.0,9/24,18.91%,TMCC1;ACOT8;CORO1C;DNM2;MUL1;MTFP1;MTFR2;MIEF1;GDAP1
prerank,regulation of cellular response to stress (GO:0080135),0.22899946386626352,0.9019866035760282,0.6751336898395722,0.9663218767222287,1.0,39/115,28.07%,YWHAE;ADCY8;AAAS;RPTOR;DNAJC2;SLC38A2;CORO2B;USP51;MANF;NUP54;VASH1;CHORDC1;PRKN;NUP88;NEK4;RAE1;DNAJC7;CRHBP;CCAR2;MAPK3;NUP133;OPRM1;SMG1;HSP90AB1;POM121;NUAK1;ING2;NPAS2;CAMK2B;CRYAB;MAPK1;FKBP4;MAPT;ATF4;AMFR;HSPA8;PTGES3;NUP107;NUP155
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3711921163627405,0.9019832909130546,0.5904936014625228,0.9655245126588603,1.0,2/11,7.46%,SLC25A4;RIPK3
prerank,negative regulation of chemotaxis (GO:0050922),0.27931402985267034,0.901955259189782,0.6163723916532905,0.9647901272240288,1.0,8/31,16.53%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;SEMA4F;PTPN2;SEMA4B;SEMA3C
prerank,autophagosome organization (GO:1905037),-0.23726816052909655,-0.9019338706518334,0.6837349397590361,0.8224471167733158,1.0,14/50,17.37%,PIK3C3;MAP1LC3B;ATG13;STX12;RAB1A;RAB7A;ATG7;UBQLN1;ATG2B;ATG3;UBXN2B;AMBRA1;ATG9B;MAP1LC3A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.35655253231285927,-0.9013111563017405,0.5835189309576837,0.8233167854709215,1.0,5/11,25.64%,NRP1;STMN1;BCAR1;SIRT2;RAC1
prerank,catecholamine metabolic process (GO:0006584),0.34949253406650926,0.9011244826471342,0.60580204778157,0.9661009617064006,1.0,4/14,14.73%,LRTOMT;RNF180;PRKN;COMT
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2026942183782834,0.9009320297013631,0.730195177956372,0.965790313971801,1.0,79/327,23.78%,ZFHX3;SCRT2;MAGED1;CTR9;DRAP1;DENND4A;LDB1;PQBP1;FUS;WWTR1;ESRRG;NR1I2;SOX21;HIC1;SKOR1;RELA;PPARGC1A;NSD1;UBE2V1;SOX4;HOXB7;E2F1;MEF2C;ZNF35;ZNF205;TGFBR1;OGG1;APBB1;POFUT1;FOXC1;SNAI2;SPIN1;SLC39A8;MLLT6;ACVR1B;WWC1;THAP1;MLF2;TFEB;PLAG1;LMX1B;SPTY2D1;INSR;APBB3;CCAR2;EDF1;REST;TCF3;TCF7L1;SUFU;PAK6;BACH1;ENG;PPP2R1A;BTG1;HMG20A;PHF1;ELAVL2;GCFC2;DVL2;REXO4;RORA;MED23;PRMT5;ZFAT;TEAD2;ING2;ZNF628;NFYB;SKOR2;SSBP2;TULP3;YAF2;SOX13;ACTR5;HES6;NAB2;SMARCA2;MAFB
prerank,glycolytic process (GO:0006096),0.2929069142675619,0.9007344094798827,0.5919003115264797,0.9654985004483285,1.0,9/28,20.72%,GAPDH;PGAM2;ALDOC;PFKM;HK2;PFKFB2;PGM1;ALDOA;ENO3
prerank,organelle organization (GO:0006996),0.1985996275898144,0.9001927626468346,0.7670772676371781,0.9660726817161841,1.0,106/388,23.63%,FBXW8;ARMC2;CFAP126;CNTNAP1;DST;OBSL1;BIN1;RAB43;ROPN1;SEC16B;CATIP;THY1;CYP26C1;TFAM;PPARGC1A;ATL1;SIPA1;BRWD1;FGD2;FMNL3;HILPDA;GABPB1;MAPK15;TMED2;MICAL3;PNPLA3;NDP;PRKCI;CLASP2;COG4;SEC31A;PI4K2A;RHOT1;TANGO2;PKD2;ARAP3;ZW10;PRKN;RAB38;PEX14;CFL1;CAMSAP1;PAK5;GABPA;DNM1L;CHMP1A;RAB34;WASF3;HACE1;LYSMD3;TMED5;PARP1;ARFGEF1;BLZF1;SORT1;CHCHD10;CHMP2A;DPYSL2;FITM2;MSTO1;MIA3;CFAP61;PRKD1;PEX2;DNAJA3;ATP8B1;CXADR;PAK6;TMED3;CDC42BPB;HSD17B10;BCS1L;MAST2;PEX6;STX17;ABCD2;LMAN2L;ZMYM6;RHOU;IQCG;MTX2;ZMYM3;CAV2;PYROXD2;TRAPPC8;TMED7;HPS3;SNX11;CDC42;SSBP1;ARHGAP4;KIF9;PACSIN3;PEX11B;CHMP5;VMP1;PEX3;PEX11A;CHMP7;ATL2;WASL;CHGA;PCLO;FGD5;TMED1;SEC31B
prerank,regulation of protein phosphorylation (GO:0001932),0.20481703285397948,0.8997216091739068,0.7137724550898203,0.9664440833611594,1.0,57/256,20.42%,FGF10;ANKRD54;ADTRP;FGF16;PLXNB2;FGF9;C3;WWTR1;PAK1;NTRK1;ROPN1;FLT4;ROPN1L;CARD14;NSD1;RARRES2;PRNP;FGF7;NTRK3;CACTIN;AKAP8L;DAB2IP;LIMK2;CCND3;BMP4;ERBB4;SH3GL2;TGFB1;PRKN;FGF2;EFNA1;AKAP8;P2RY1;TEK;RALBP1;FLCN;THPO;INSR;EPHB2;BRD4;NTRK2;CADM4;MAPK3;TWF1;HRAS;PTK2;ENG;PTPN13;CHRNA7;PIN1;HDAC3;RSPO1;DVL2;ERP29;PPIL4;IL34;ARRB1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.24500514816232366,-0.8994743531277828,0.6519337016574586,0.8270855518834948,1.0,15/43,21.97%,IGF1;MEF2D;ERN1;THBS1;LDLRAP1;DNMT1;STAT1;HTR1B;FOXP1;TNF;GJA1;HMOX1;IGFBP5;ID2;SERPINF2
prerank,protein phosphorylation (GO:0006468),0.19512924590812744,0.8994383622869446,0.7732749178532311,0.9663456310773602,1.0,122/478,22.52%,CDK7;ABI3;STRADB;DCLK3;MERTK;MATK;CDK15;NIM1K;TXK;STK26;PKN1;PAK1;NTRK1;FLT4;PNCK;COPS8;STK16;STK11;PRKCZ;MAPK15;CTBP1;TRIB1;RYK;TRIB2;GTF2H4;DYRK1B;RPS6KB1;PRKCI;MAP3K10;CDC42BPA;RIPK3;TGFBR3;TGFBR1;NRBP2;PRAG1;DAB2IP;LIMK2;LIMK1;BMP2K;BMP4;STK36;DGKQ;PRKCA;EPHA1;ERBB4;CDKL5;PRKD2;MAP4K4;RNASEL;TGFB1;NEK4;NEK1;AAK1;PRDX4;BTK;STK39;VRK2;CAMKV;MINK1;STK25;ACVR1B;MAP3K7;PAK5;PKD1;STK32B;PRKG1;PDGFB;COQ8A;TEK;EPHA4;MAP3K13;GLYCTK;MAPK10;AMHR2;INSR;EPHB2;NTRK2;EIF2AK4;ERG;MAPK3;PRKD1;DMPK;PTK2;PRKCG;CSNK1G3;MAPKAPK5;PAK6;PLK2;CDK10;ROCK1;AATK;TAOK1;FLT3;CDC42BPB;TLR3;SMG1;AKT3;MAST2;PLK4;FES;MAP4K2;STRADA;WNK1;BMPR1B;PDGFRB;ACVR1C;CDKL1;SBK1;SMAD2;PDK1;PDPK1;NUAK1;ULK2;TOP1;LATS1;SIK3;LIPE;CDK4;CLK3;ULK1;GTF2H3;TLK2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3441079287464247,0.8992605082603975,0.6,0.9660243272094596,1.0,2/14,3.59%,CD80;IL17F
prerank,cardiac ventricle development (GO:0003231),0.31693754804092633,0.8991980491067225,0.5884353741496599,0.9653862490512034,1.0,8/20,26.26%,DAND5;HEY1;GJA5;ENG;TMEM65;MDM4;HECTD1;SALL1
prerank,protein autoprocessing (GO:0016540),0.3306678952440375,0.8991064092413946,0.5946843853820598,0.9648273453376329,1.0,4/17,20.33%,MYRFL;CASP4;MYRF;OMA1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.341475176695696,-0.8989550020856875,0.6022988505747127,0.8277457646550427,1.0,2/12,1.48%,KIF3A;PCM1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.36153080287292944,-0.8986320276815987,0.5790697674418605,0.8279178750692311,1.0,3/11,10.63%,CABIN1;H3-3A;HAT1
prerank,regulation of gene silencing by RNA (GO:0060966),-0.22775251822427436,-0.8983287319900911,0.6498316498316499,0.8274470502790139,1.0,14/50,15.65%,POLR2E;RANBP2;PUM2;NUP153;NDC1;H3-3A;NUP43;NUP210;AGO2;POLR2B;POLR2H;POLR2J;TRIM71;NUP62
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.22775251822427436,-0.8983287319900911,0.6498316498316499,0.8274470502790139,1.0,14/50,15.65%,POLR2E;RANBP2;PUM2;NUP153;NDC1;H3-3A;NUP43;NUP210;AGO2;POLR2B;POLR2H;POLR2J;TRIM71;NUP62
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.20664295459483806,0.8982982151761035,0.7370325693606755,0.9661446851398142,1.0,66/248,22.05%,FGF10;HHEX;TLE3;UBE2B;PSMB1;TLE2;WWTR1;SOX4;IGFBP6;PTPRO;PTPRU;TMEM198;STK11;ANKRD6;IGFBP2;PTK7;PSMF1;BTRC;DAB2IP;PRICKLE1;PSMA1;GPC5;TCF7L2;PSMD7;PPM1A;FAM53B;TGFB1;PRKN;EMD;TPBG;SNAI2;PSMA8;CTNND2;PPM1N;PSME3;SFRP1;PSMD14;AMER2;LRRK1;PSMC4;SDHAF2;TMEM9;CCAR2;APC2;PRDM15;AMER3;CSNK1G3;FRMD8;PSMB4;PIN1;RSPO1;WNK1;DVL2;RBMS3;UBAC2;PSME1;CYLD;GLI3;PSMD2;PSMD4;BICC1;LATS1;FRZB;PSMD8;AXIN1;SFRP2
prerank,cellular response to light stimulus (GO:0071482),-0.2259951464437601,-0.8982365952963602,0.6869009584664537,0.8270812841809171,1.0,28/66,35.08%,PCNA;USP28;TAF1;YY1;EP300;EIF2S1;RHNO1;NPM1;CDC25A;GPR88;PDE6B;RPL26;OPN3;CASP9;TRPM1;PDE6A;RRH;GPR52;AQP1;RHBDD1;USP47;RUVBL2;PTPRK;MAPK13;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.21160635573557116,-0.8981920608451508,0.7132352941176471,0.8266005444849543,1.0,31/83,26.78%,CDK6;CUL3;CDK17;CUL4A;PCNA;GPR132;CDC34;CCND1;CDKN2C;HINFP;CCNH;CDKN3;TYMS;RB1;CDT1;MNAT1;TRIM71;CDK14;CDC25A;KLF11;CDKN2A;ACVR1;CUL5;DHFR;RCC1;CDC45;PIM2;USP26;NPAT;POLE;E2F3
prerank,negative regulation of DNA binding (GO:0043392),-0.26849075617698687,-0.8978132327341329,0.612987012987013,0.826939763404658,1.0,6/28,18.14%,SP100;SOX11;MAD2L2;HEY2;HMGA2;PER2
prerank,positive regulation of ossification (GO:0045778),0.27433995844256504,0.8973893767833663,0.6421875,0.9676801843818306,1.0,6/39,9.63%,WNT4;MEF2C;FBN2;BMP4;TGFB1;SLC8A1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3454588028671802,0.8972521118061683,0.6334459459459459,0.9672558489356865,1.0,7/15,29.65%,REEP2;ATL1;TMEM33;ZFYVE27;ATL2;RTN3;TMEM170A
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3149000575956427,0.8970445277965658,0.6199677938808373,0.9669892382154365,1.0,6/20,12.74%,ATP2A2;FIS1;BAK1;CCDC47;HERPUD1;RAP1GDS1
prerank,positive regulation of ATPase activity (GO:0032781),0.2681637532387414,0.8967468471592418,0.6267496111975117,0.9669577639683814,1.0,5/41,8.57%,FGF10;ATP1B1;MYBPC3;ATP1B3;DNAL4
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.332386074526474,-0.8965567715169588,0.6010230179028133,0.8293629323706737,1.0,6/13,26.56%,CIAO2A;NFU1;CIAO2B;CIAO1;LTO1;GLRX5
prerank,pore complex assembly (GO:0046931),-0.29950777365557146,-0.8964060828164244,0.6185567010309279,0.8290930449209784,1.0,4/19,11.63%,AFDN;NUP153;NDC1;AHCTF1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.2508481126295913,-0.8961294713381978,0.657608695652174,0.8291176302941085,1.0,4/36,5.53%,FCGR2B;MSR1;CD36;THBS1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.2924127744313884,0.8957028962023954,0.6205287713841369,0.9688522675363147,1.0,9/28,20.42%,ADCY8;LGMN;SHANK3;ZDHHC2;EPHA4;EPHB2;EIF2AK4;CHRNA7;CALB1
prerank,AMP metabolic process (GO:0046033),0.3541586530883712,0.8956700927718316,0.6010362694300518,0.9681565078173094,1.0,6/13,23.54%,NUDT2;AMPD3;ADSL;AK4;AK3;AK9
prerank,sulfur compound biosynthetic process (GO:0044272),-0.20444640364362915,-0.8956255947752663,0.7136929460580913,0.829746129683836,1.0,22/104,16.35%,CHST11;B4GALT5;PAPSS2;MGST3;CHST9;GGTA1;GSTA3;UGDH;GSTO2;GCLC;OGN;DSEL;GSTZ1;CSPG4;GSTM1;CHST7;MPST;GSTM5;CHPF;DSE;LIAS;CBS
prerank,positive regulation of intracellular transport (GO:0032388),0.274540313227258,0.8954907086660259,0.6273584905660378,0.9678279455949986,1.0,8/38,11.37%,TENM1;STK11;OAZ1;ACTN2;PLK3;NEDD4;EHD1;EHD2
prerank,adherens junction organization (GO:0034332),0.2574078156220956,0.8953473351305054,0.6251874062968515,0.9673971735371789,1.0,10/48,16.23%,ANG;DCHS1;CADM1;INAVA;CDH18;NECTIN3;CDH4;CADM3;JAM3;CADM2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.36252994276997064,0.8947793008798004,0.5768566493955095,0.9680783306533169,1.0,5/12,12.61%,SGTA;SEC62;SGTB;SEC61A2;GET3
prerank,lytic vacuole organization (GO:0080171),-0.2577783390457754,-0.8945143395245234,0.6334164588528678,0.8317262211848406,1.0,10/32,16.03%,TPCN2;NAGPA;HPS1;CLN5;MBTPS1;GNPTAB;AKTIP;LRRK2;GAA;CLN3
prerank,regulation of myotube differentiation (GO:0010830),0.3018272518608468,0.8941749271527681,0.6026490066225165,0.9688009542327595,1.0,7/24,18.75%,HDAC5;ATP11A;SMYD1;DMPK;BHLHE41;XBP1;HDAC3
prerank,iron ion homeostasis (GO:0055072),-0.22631667684339768,-0.8940327351642288,0.6762820512820513,0.8322731919164411,1.0,18/58,23.20%,ATP6V0D1;TFRC;PICALM;SLC46A1;NUBP1;CP;SLC11A1;ATP6V1A;LCN2;B2M;FTL;HMOX1;SMAD4;CYBRD1;NDFIP1;HEPH;ALAS2;FBXL5
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.1997529734834732,0.8940318795772906,0.7597254004576659,0.9683395008018015,1.0,89/366,23.78%,ZFHX3;NUCKS1;SCRT2;MAGED1;CTR9;DRAP1;DENND4A;LDB1;PQBP1;FUS;WWTR1;ESRRG;NR1I2;SOX21;HIC1;SKOR1;RELA;PPARGC1A;DDX25;NSD1;UBE2V1;SOX4;HOXB7;E2F1;MEF2C;ZNF35;ZNF205;TGFBR1;OGG1;APBB1;POFUT1;FOXC1;SNAI2;SPIN1;SLC39A8;MLLT6;ACVR1B;WWC1;THAP1;MLF2;TFEB;PLAG1;TOM1L1;CYFIP1;LMX1B;SPTY2D1;INSR;APBB3;CCAR2;EDF1;REST;TCF3;TCF7L1;RBM3;SUFU;MAPKAPK5;GEMIN5;PAK6;BACH1;ESCO1;ENG;PPP2R1A;BTG1;HMG20A;PHF1;ELAVL2;ATXN2;GCFC2;DVL2;REXO4;RORA;FBXO5;MED23;PRMT5;ZFAT;TEAD2;ING2;ZNF628;NFYB;SKOR2;SSBP2;TULP3;YAF2;SOX13;ACTR5;HES6;NAB2;SMARCA2;MAFB
prerank,negative regulation of vascular permeability (GO:0043116),-0.3403720097805999,-0.8939732321555988,0.5968992248062015,0.8318503584177903,1.0,7/12,32.02%,CEACAM1;RAMP2;PDE2A;ANGPT1;SLIT2;DDAH1;PDE3A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.27659681057936025,-0.893833413115978,0.635036496350365,0.8316585872580439,1.0,9/25,20.54%,P2RX4;CD36;SMAD3;IL1B;TNF;TLR4;KLF2;MMP8;KLF4
prerank,positive regulation of lipid localization (GO:1905954),0.376396368427265,0.8933503840474124,0.6070796460176991,0.9692649123180922,1.0,2/11,5.43%,C3;HILPDA
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3282661320401169,0.8933197468391368,0.5996705107084019,0.9685521940355305,1.0,4/17,12.61%,SGTA;EMC6;EMC2;GET3
prerank,regulated exocytosis (GO:0045055),0.21317865388980242,0.8932427092471057,0.708171206225681,0.9679518858195876,1.0,30/173,15.49%,SNAP25;SYT4;RAB3A;PCDH7;SYTL4;SYT13;SYT1;SNAPIN;TEX264;RAB26;RARRES2;SYT6;CLU;SYNGR3;MANF;OTOF;ACTN2;TGFB1;ISLR;RIMS1;CPLX2;SYNGR1;SCG3;CRHBP;PDGFB;LY6G6F;SCCPDH;STXBP2;ENDOD1;APLP2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.18709589555905004,-0.893135094973916,0.8,0.8326830954221351,1.0,55/184,24.24%,PSMA6;BUB3;PCM1;CUL3;CDK5RAP2;PSMB2;PRKACA;CDC14B;PSME2;TUBA4A;CEP250;PSMD11;PSMC6;UBC;PSMA3;YWHAG;HMMR;HAUS2;CEP164;UBA52;MAPRE1;CDC27;CDK1;MAD2L1;HAUS8;PSMD10;BUB1B;KNTC1;PSMB5;PLK1;UBE2C;KCNH5;MAD2L1BP;RGCC;DCTN2;PSMD5;ODF2;TPX2;XPC;PAFAH1B1;PSMD1;APPL2;AKAP9;SIRT2;ANAPC10;CEP78;ID2;OFD1;CDC14A;ANAPC7;TUBB4B;CCNB1;NDE1;PSMA7;PSMB7
prerank,positive regulation of filopodium assembly (GO:0051491),0.3031792598738995,0.8930018065289177,0.6110210696920584,0.9677779103882334,1.0,3/24,3.95%,AGRN;FSCN1;TENM1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.1864894511127327,-0.892677111451051,0.8131313131313131,0.833202305262697,1.0,25/151,14.63%,HACD4;APOE;B4GALT5;ACER3;SGPL1;MOCS2;PCYT1A;MGST3;MOCS1;PRKD3;GSTA3;SGPP1;GSTO2;RHD;PCTP;LCMT2;ALAS1;SPTSSB;GSTZ1;GSTM1;PEMT;GSTM5;SPHK2;STARD10;PAM
prerank,regulation of acute inflammatory response (GO:0002673),0.32281283556557316,0.8926444617100486,0.6019900497512438,0.9679021095682265,1.0,2/18,5.65%,DNASE1;IL6
prerank,stem cell differentiation (GO:0048863),0.26927351384539694,0.8925524396864213,0.6455505279034691,0.9673531884317773,1.0,8/39,15.54%,NELFB;SOX21;MEF2C;SETD6;METTL5;SFRP1;BATF;WNT7A
prerank,membrane lipid biosynthetic process (GO:0046467),-0.22120179682563157,-0.8924286557248836,0.6976744186046512,0.8332380932881494,1.0,16/58,22.52%,HACD4;ACER3;SGPL1;PRKD3;ST8SIA6;SGPP1;SPTSSB;SPHK2;CERS2;SPTLC2;HACD1;HACD2;ALDH3A2;SPTLC3;VAPB;ELOVL2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.23404131318801852,0.892339773576787,0.6657223796033994,0.9671012847073877,1.0,18/80,16.02%,PLXNB2;RELA;SOX4;IL6;CLU;CIRBP;RPS6KB1;LRRTM3;EIF6;EFNA1;CASP3;METTL5;PRR16;NSMAF;EPHA4;ABCA2;RBM3;IFNGR1
prerank,positive regulation of response to wounding (GO:1903036),0.2945181291360987,0.8919734553591466,0.6230899830220713,0.9672020342280407,1.0,11/24,28.92%,INSL3;ADRA2A;ARFGEF1;VTN;HRAS;PTK2;GRN;DMTN;KANK1;HBEGF;MDK
prerank,chondroitin sulfate catabolic process (GO:0030207),0.3501083697331949,0.8919656028550775,0.6041666666666666,0.9664368020978157,1.0,4/13,19.11%,HEXB;ARSB;VCAN;DCN
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.26911015299414087,-0.8916947897032055,0.6342710997442456,0.8342811216172433,1.0,7/24,13.59%,CCBE1;IL6ST;HIF1A;BRCA1;IL1B;HPSE;CXCL17
prerank,homotypic cell-cell adhesion (GO:0034109),-0.24624187243807927,-0.8915847085898528,0.6485714285714286,0.8339692387149442,1.0,19/39,33.16%,ACTN1;MEGF11;VCL;HSPB1;MYH9;FLNA;FN1;PDGFRA;ITGB3;FIBP;TLN1;MYL12A;CLIC1;ILK;PLEK;PLPP3;RAP2B;MYL9;PPIA
prerank,reticulophagy (GO:0061709),-0.3323792351475035,-0.8913132581247327,0.6068181818181818,0.8340166985045803,1.0,3/12,11.32%,UBA5;UFC1;ATG2B
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3439646349308153,-0.8902100635731149,0.6085918854415274,0.8359857599494929,1.0,7/11,38.70%,CTNNB1;WNT5A;LRP6;FZD1;LMX1A;WNT2;NR4A2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.350300964093526,0.890056848306825,0.6180327868852459,0.9704728325852474,1.0,5/13,21.56%,PKD2;PKD1;SUFU;YWHAB;LATS1
prerank,histone exchange (GO:0043486),0.272419360311438,0.8900197287108789,0.6483180428134556,0.9697751912319302,1.0,9/37,20.29%,CENPP;ZNHIT1;VPS72;RNF8;DMAP1;SPTY2D1;CENPN;CENPS;CENPC
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.3063201056109334,-0.8896589979924576,0.6186046511627907,0.836722171921146,1.0,3/17,2.93%,NRP1;IGF1;DOCK7
prerank,iron-sulfur cluster assembly (GO:0016226),-0.27036679712820105,-0.889601149473659,0.6229946524064172,0.8362793923384713,1.0,8/24,17.90%,CIAPIN1;NUBP1;CIAO2A;IBA57;NFU1;CIAO2B;CIAO1;LYRM4
prerank,regulation of fibroblast migration (GO:0010762),-0.28823559991158576,-0.8892932393812396,0.625,0.8364437995392442,1.0,4/20,7.14%,PRKCE;CORO1C;THBS1;GNA12
prerank,glucose transmembrane transport (GO:1904659),0.324193654665898,0.8889699652553514,0.6306913996627319,0.9716525929014982,1.0,4/18,13.97%,SLC2A3;SLC2A2;SLC45A1;SORT1
prerank,RNA metabolic process (GO:0016070),0.22164390460920536,0.8887528778440927,0.7076101468624834,0.971406089617643,1.0,24/127,16.30%,POLR2L;ADARB2;POLR2F;RNASE1;HNRNPH1;LSM1;PTBP1;ADAR;RBM5;GTF2F1;RNASEL;MPHOSPH10;DROSHA;POLR2G;LSM8;SND1;TBRG4;RBFOX2;AGO4;NOVA1;DDX39B;HNRNPA1;RBM3;SETX
prerank,nuclear transport (GO:0051169),-0.305356915893692,-0.8885926035520525,0.6264775413711584,0.8374381474030348,1.0,6/16,14.13%,RSRC1;XPO1;NUTF2;BANF1;NXT1;NPM1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.258538655021448,-0.8883054481432322,0.6413043478260869,0.8375140523334996,1.0,9/31,21.33%,RTEL1;PKIB;NBN;PRKCQ;HNRNPA2B1;MAP2K7;SLX4;HNRNPD;NAF1
prerank,copper ion homeostasis (GO:0055070),0.3242992600585319,0.8882693466034144,0.6301369863013698,0.9718355652491679,1.0,4/17,6.63%,ABCB6;PRNP;SLC31A1;COMMD1
prerank,regulation of JUN kinase activity (GO:0043506),-0.25404313765511494,-0.8882041020358964,0.6583333333333333,0.8371612427102426,1.0,7/33,16.04%,SASH1;PTPN22;DVL3;TAOK3;MAP3K11;TNF;ARHGEF5
prerank,stress granule assembly (GO:0034063),-0.2888956838200114,-0.8881699200693652,0.6127450980392157,0.8366623916119263,1.0,4/20,10.22%,RPS23;UBAP2L;DDX6;EIF2S1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3530157187461278,0.8879875362844287,0.6178451178451179,0.9709839398715654,1.0,2/12,10.35%,PRNP;HOMER2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3530157187461278,0.8879875362844287,0.6178451178451179,0.9709839398715654,1.0,2/12,10.35%,PRNP;HOMER2
prerank,neural crest cell migration (GO:0001755),0.27096031098773465,0.8876402536497247,0.6598746081504702,0.971075743688034,1.0,9/36,16.53%,SEMA7A;SOX10;SEMA6C;SEMA6B;SEMA3D;ERBB4;SEMA4F;SEMA4B;SEMA3C
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.281004513599936,-0.8874125872280266,0.6414565826330533,0.8378913208854043,1.0,5/22,10.05%,CUL4A;CHD1L;UBC;UBA52;RAD23B
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.25886328840577555,0.8872591127820761,0.6292466765140325,0.9713097041047971,1.0,9/46,14.37%,YWHAE;CPSF6;TCF7L2;RAPGEF3;TGFB1;EMD;NEDD4;DMAP1;IPO5
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.32953772299992523,0.8871723942296277,0.6082644628099173,0.9707631476931925,1.0,3/16,8.54%,PIGQ;PIGB;PIGP
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2707517562386674,0.886887849581527,0.6552748885586924,0.9706589193222214,1.0,5/39,8.74%,NNAT;SOX4;DOC2B;TCF7L2;ADCYAP1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3117831285754379,-0.8861024270510746,0.628140703517588,0.8403660832587523,1.0,5/17,15.37%,SASH1;CD36;TRIM5;CD55;SCIMP
prerank,positive regulation of positive chemotaxis (GO:0050927),0.33590844068337683,0.8855905346794504,0.621160409556314,0.9730189049476768,1.0,2/15,5.75%,F3;NTRK3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24641153191256782,0.8855644584940446,0.6595744680851063,0.9723196799163708,1.0,20/60,25.50%,WRAP53;SMOC2;MAPK15;PRKD2;FGF2;CCT4;PDGFB;HNRNPA1;MAPK3;MAPKAPK5;PDGFRB;HSP90AB1;CCT7;XRCC5;GRHL2;RFC4;PARM1;TNKS2;MAPK1;ACD
prerank,response to steroid hormone (GO:0048545),-0.2576504219672127,-0.8854437736763762,0.6808510638297872,0.841227079478468,1.0,7/31,9.26%,NR3C1;THBS1;CATSPER3;CAV1;YAP1;CATSPER2;UBE2L3
prerank,positive regulation of phospholipid transport (GO:2001140),-0.34688254146512043,-0.8853955927858443,0.600451467268623,0.8407623980105388,1.0,2/10,5.70%,APOE;TMEM30A
prerank,melanosome organization (GO:0032438),0.29144656217334874,0.8852707385068326,0.6276422764227643,0.9722726661888499,1.0,4/26,10.58%,BLOC1S2;ABCB6;SNAPIN;RAB38
prerank,regulation of Notch signaling pathway (GO:0008593),0.23858139147559798,0.885136024023456,0.6914285714285714,0.9718078215411905,1.0,15/76,13.76%,ENHO;TCIM;YJEFN3;PRKCI;TSPAN15;PRAG1;EGFL7;BMP2K;POFUT1;HEY1;MAML3;ITGB1BP1;AAK1;ARRDC1;BEND6
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.31751435468030226,0.8850009701824275,0.621160409556314,0.9713828883259786,1.0,4/18,9.35%,FSCN1;IL6;CLASP2;TGFB1
prerank,telomere maintenance via telomerase (GO:0007004),-0.2678564902621613,-0.8848823140525782,0.6575342465753424,0.8413692025247658,1.0,13/28,26.30%,RTEL1;PPP6R3;ANKRD28;RPA1;TERF2;NOP10;DKC1;TINF2;PIF1;NHP2;TERT;TNKS1BP1;HSP90AA1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.2944174956359773,-0.8844187605418864,0.6301020408163265,0.8418619881442976,1.0,7/18,19.52%,LYN;F7;PTN;PTK2B;ADAM17;SLC8B1;MTUS1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.2418495723286929,-0.8843920153676823,0.6705202312138728,0.8413426766833038,1.0,14/40,22.15%,RIC1;CTSA;MAD2L2;AGAP2;MAD2L1;TIMP4;EGFR;RGP1;FLNA;RILP;FMN2;TIMP1;SIRT2;ADGRB1
prerank,cellular response to hormone stimulus (GO:0032870),0.23987385530047453,0.8843050210976843,0.689051094890511,0.9723542664131782,1.0,17/69,21.54%,ADTRP;AKR1C1;WBP2;BRD8;MEF2C;AR;ADRA2A;LMO2;SOCS2;SFRP1;CRHBP;XBP1;NSMF;ATP1A3;ATP1A1;RDX;CTSS
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.3569759513403732,-0.8841906540693572,0.5989974937343359,0.8406310442686271,1.0,3/10,15.15%,RACK1;SPHK2;TNF
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3569759513403732,-0.8841906540693572,0.5989974937343359,0.8406310442686271,1.0,3/10,15.15%,RACK1;SPHK2;TNF
prerank,actin crosslink formation (GO:0051764),-0.3418927155612299,-0.8840969925545573,0.6136919315403423,0.8402423771983301,1.0,5/12,22.64%,EPS8;GAS2L3;LCP1;FLNA;BAIAP2L2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.26323116914918326,-0.8835776860968703,0.6739130434782609,0.8408367898849258,1.0,7/28,12.50%,DTX3L;SMCHD1;CYREN;HSF1;MAD2L2;SHLD1;PARP9
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2050232852696518,-0.8834967260922006,0.74822695035461,0.8404401299153166,1.0,14/88,10.43%,APOE;NRP1;NRP2;ALOX5;XDH;HMGB2;AIMP1;PROX1;THBS1;AGGF1;CAV1;HIF1A;STAT1;EGR3
prerank,positive regulation of cell growth (GO:0030307),0.2268396567814571,0.8834099369745939,0.6814516129032258,0.9738198352809788,1.0,15/96,11.53%,KLHL22;SYT4;SEMA7A;RPTOR;SYT1;HDGFL2;LGI1;IL2;TGFBR1;LIMK1;TWF2;CPNE6;CDKL5;RIMS1;SFRP1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.22248988916222562,-0.8834002087552071,0.6996805111821086,0.8400775261547483,1.0,16/59,20.15%,MARK2;TBK1;LMTK2;TAF1;DYRK1A;CIT;CAMK2D;HIPK1;CAD;CDK1;LRRK2;NLK;MAPK8;HIPK2;ACVR1;CDC42BPG
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3047032314173669,0.8832350578232655,0.63915857605178,0.9734806524810141,1.0,6/22,18.33%,LTB4R2;GRM3;CACNA1D;GABBR2;GNAI3;PALM
prerank,positive regulation of macroautophagy (GO:0016239),-0.23059575162582124,-0.8830757946161826,0.7235294117647059,0.8402214994057979,1.0,15/48,18.49%,VPS13D;PAFAH1B2;TBK1;SH3GLB1;UVRAG;SMCR8;KDR;LARP1;RALB;HSPB8;OPTN;WAC;SESN2;RAB3GAP2;SPTLC2
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.2570468262249449,-0.8826447516644397,0.661849710982659,0.8406497522632451,1.0,13/33,26.30%,RTEL1;PPP6R3;ANKRD28;RPA1;TERF2;NOP10;DKC1;TINF2;PIF1;NHP2;TERT;TNKS1BP1;HSP90AA1
prerank,replication fork processing (GO:0031297),-0.2455037098352098,-0.882574892905016,0.632,0.8402320063589699,1.0,12/38,21.87%,ETAA1;PCNA;RTEL1;ZRANB3;EME1;MMS22L;CENPX;FANCM;CDK9;ZGRF1;FBH1;BOD1L1
prerank,retinol metabolic process (GO:0042572),-0.32536188363478047,-0.8824341859654992,0.6658415841584159,0.839977299104817,1.0,6/14,24.41%,RDH11;CYP1A1;DHRS9;DHRS3;CYP1B1;RDH12
prerank,melanocyte differentiation (GO:0030318),0.36649534858516225,0.8823888514981294,0.6321243523316062,0.9748340431852239,1.0,3/11,16.29%,SLC24A5;MEF2C;LRMDA
prerank,regulation of cell morphogenesis (GO:0022604),0.2811193475189723,0.882357506629,0.6571428571428571,0.9741478987744111,1.0,8/30,19.39%,BCL9L;CFL1;CAMSAP1;FITM2;NTNG2;NTNG1;ZMYM6;ZMYM3
prerank,protein maturation (GO:0051604),0.2260329962949273,0.8820556680468402,0.7059639389736477,0.974121732732069,1.0,34/95,28.55%,F3;MMP16;NNAT;ASPRV1;BACE1;XPNPEP3;TSPAN15;TSPAN32;OGT;PHEX;AEBP1;PSENEN;PITRM1;NAA35;NDUFAB1;NAA60;PCSK2;ADAMTS3;LMF1;GALNT2;TYSND1;METAP2;CASP2;CTSS;PCSK7;SDE2;STUB1;TMPRSS4;AANAT;EEF1AKMT4-ECE2;ECE2;LONP2;BOLA2;TSPAN33
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.32947741546620163,0.8818453789941662,0.6273830155979203,0.9738625437759921,1.0,6/17,20.19%,ADTRP;AR;BMP4;ATP1A3;ATP1A1;ABHD2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.2539230150303156,-0.8810993160186773,0.649867374005305,0.84231695587762,1.0,8/33,16.52%,IGF1;BCL2L1;TFRC;ACAA2;PSMD10;GPX1;MUL1;SLC35F6
prerank,endothelial cell development (GO:0001885),0.29713702639648193,0.8810146554371759,0.6377295492487479,0.9751353714316663,1.0,8/25,21.68%,ROBO4;MARVELD2;RAPGEF3;ICAM1;COL15A1;COL18A1;RDX;PPP1R16B
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2832362152360487,0.880831128013981,0.6561514195583596,0.9748212217188301,1.0,6/30,18.81%,TM7SF2;ACAT2;NSDHL;LSS;ACLY;FDPS
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3154815916341374,-0.8805172456220718,0.6205128205128205,0.8430717448316354,1.0,7/14,37.34%,TYROBP;TNF;CSF1;IL23R;IL12B;POU4F2;POU4F1
prerank,negative regulation of secretion by cell (GO:1903531),-0.23969563948588365,-0.8804717628913994,0.6628571428571428,0.8425904859055694,1.0,12/38,20.10%,APOE;ANXA1;DRD2;NOTCH1;HTR1B;TNFRSF1B;STXBP6;LILRB1;SLC30A1;DPH3;DRD3;SERGEF
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.2524761801942004,-0.8804304750362211,0.6816901408450704,0.8421108076200995,1.0,6/32,10.27%,EIF2A;TCOF1;PICALM;RPL10;TMED10;PGAM1
prerank,Ras protein signal transduction (GO:0007265),0.21483420927600608,0.8800866141777132,0.6988265971316818,0.9759490028929957,1.0,36/137,21.40%,KSR2;EPS8L3;ARHGDIG;SGSM3;RGL2;NCKAP1;CDC42EP5;ADRA2A;USP50;CTNNAL1;RIT2;LIMK1;ARHGDIA;RAPGEF3;ARHGAP5;FGF2;GDI1;CFL1;FARP2;HACE1;CYFIP1;EPS8L2;PRKD1;HRAS;MAPKAPK5;PLK2;RRAS2;ROCK1;SETDB1;RIPOR1;CDC42EP4;CDC42EP1;ARHGAP1;ARHGAP4;RAP2C;SHC3
prerank,regulation of coagulation (GO:0050818),0.36210447924691447,0.8799235337549227,0.6448763250883393,0.9755677013957482,1.0,2/11,14.92%,HS3ST5;EPHB2
prerank,positive regulation of immune system process (GO:0002684),-0.3082021643514393,-0.8798398283295985,0.6190476190476191,0.8429049078111435,1.0,2/16,7.33%,IL15;ANXA1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.2987301358205967,-0.8797676518620938,0.6142857142857143,0.8424848426095237,1.0,9/17,27.94%,PTPN22;BCL3;ANXA1;ANXA4;CD33;KLF4;TMSB4X;TLR9;SSC5D
prerank,regulation of integrin activation (GO:0033623),-0.30816383346003495,-0.8793608008794038,0.6142506142506142,0.8429117142399191,1.0,4/15,15.34%,PTGER4;SKAP1;FBLIM1;RAP1B
prerank,regulation of DNA metabolic process (GO:0051052),0.26357977906278174,0.8793521711100981,0.6681481481481482,0.9761887751870123,1.0,15/44,24.50%,NUCKS1;UBE2V1;KDM1B;UBE2N;SUB1;TOM1L1;UPF1;WRNIP1;SMG1;ALYREF;XRCC5;GRHL2;MPHOSPH8;HDAC8;KPNA1
prerank,glial cell development (GO:0021782),0.2955868702848816,0.879332446269805,0.6217105263157895,0.975470269341754,1.0,6/25,15.19%,TPPP;SOX10;SOX4;EIF2B3;MYRF;EIF2B1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.34804629846142654,-0.8789427905164399,0.6323851203501094,0.8433573971030494,1.0,1/10,0.80%,PTPN22
prerank,histone H2A monoubiquitination (GO:0035518),0.32374909467221014,0.8785505070267413,0.6322033898305085,0.9766158302321648,1.0,5/17,14.08%,PCGF6;KDM2B;RNF168;DDB2;RNF2
prerank,long-chain fatty acid import into cell (GO:0044539),-0.3532030880174447,-0.8781850633688375,0.631336405529954,0.8444363897978,1.0,2/10,5.21%,CD36;SLC27A4
prerank,positive regulation of cartilage development (GO:0061036),-0.3045751319235707,-0.878140931164941,0.6342592592592593,0.8439740086631837,1.0,7/17,29.82%,SOX6;SCX;BMP2;PKDCC;BMPR2;TAPT1;SOX5
prerank,rRNA catabolic process (GO:0016075),-0.30088802176844354,-0.8779712238990026,0.6658476658476659,0.843814498602822,1.0,6/16,25.45%,EXOSC8;EXOSC10;EXOSC9;TRIR;EXOSC7;ERN2
prerank,regulation of RNA export from nucleus (GO:0046831),0.3596410020876306,0.8775666075304697,0.6331658291457286,0.9783101497597907,1.0,2/11,7.60%,CPSF6;AKAP8L
prerank,response to tumor necrosis factor (GO:0034612),0.22844263102170764,0.8774673292118162,0.7264833574529667,0.9777675647279492,1.0,14/91,12.72%,GGT7;YTHDC2;RELA;NUB1;GSDME;GGT5;CACTIN;DAB2IP;ZFP36L2;NFE2L2;NPNT;CASP3;SFRP1;CRHBP
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3452804028928562,0.8772968067789146,0.6509274873524452,0.9773947360596655,1.0,5/13,18.33%,LTB4R2;GRM3;GABBR2;GNAI3;PALM
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.2995799960661786,0.8772113077440652,0.6611570247933884,0.9768356702017456,1.0,4/23,10.73%,LBX2;SIX4;BMP4;FGF2
prerank,positive regulation of viral process (GO:0048524),0.24091647759547352,0.8771259562264935,0.6870451237263464,0.976273752583718,1.0,7/60,6.88%,POLR2L;POLR2F;NELFB;PPARA;NELFCD;ADAR;GTF2F1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.2039547185044365,-0.8769065093121101,0.7442748091603053,0.8456230717176119,1.0,21/86,19.16%,PSMA6;LIMD1;ATF3;PSMB2;PSME2;VHL;PSMD11;PSMC6;UBC;HIF1A;PSMA3;UBA52;EP300;PSMD10;PSMB5;MAPK7;HMOX1;KLF2;DNAJB1;PSMD5;PSMD1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3558993251420561,0.876399382442524,0.6318407960199005,0.9772528470592627,1.0,5/12,19.73%,DCK;TK1;TK2;DHODH;UCK1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.3225671985624469,0.8763281962101668,0.6311336717428088,0.9766616643625909,1.0,4/16,20.27%,LTBP3;FOXC1;NUDT21;DHX36
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.18211241254234714,-0.8760221838965475,0.8512820512820513,0.8470132540853695,1.0,41/190,16.88%,PPP2R5C;BCL2;BCL2L1;LIMD1;XDH;DLG5;MCL1;CGNL1;ESR1;THBS1;UACA;TNIP3;RIPK1;CDC34;ITPR1;CAV1;PLAUR;LYN;CIT;CIB1;DAG1;BANK1;CCDC22;RNF157;DRD2;ZC3H12A;STAT1;C1QTNF3;AJUBA;PSMD10;CCN3;RACK1;INPP5K;DUSP1;DEPTOR;SFRP5;EPHA2;PDE2A;MUL1;PEBP1;NOP53
prerank,regulation of complement activation (GO:0030449),0.2622731777679831,0.8753930380004737,0.674457429048414,0.978172173717457,1.0,10/40,21.60%,C3;C9;CLU;CFH;CD81;C8G;VTN;CR1L;CR2;C5AR2
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.2905325179306075,-0.8752153626573469,0.6372315035799523,0.8481882081477233,1.0,9/18,23.38%,SETD7;SETD3;PRDM9;EHMT1;KMT2D;KMT2B;SETD2;SETD1A;KMT2A
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.29141767216847136,-0.8751685030074772,0.6627358490566038,0.847713826879029,1.0,2/18,4.30%,MDFIC;CTNNA1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.3115497053645345,0.8750216343851007,0.6344262295081967,0.977582455963131,1.0,2/19,2.31%,POLR2L;POLR2F
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.3115497053645345,0.8750216343851007,0.6344262295081967,0.977582455963131,1.0,2/19,2.31%,POLR2L;POLR2F
prerank,regulation of mononuclear cell migration (GO:0071675),-0.2786580580868264,-0.8750153057413776,0.672,0.8474963109339152,1.0,6/23,15.15%,MSN;THBS1;LYN;BMP5;CXCL17;TNF
prerank,regulation of lamellipodium assembly (GO:0010591),0.27446141426153814,0.8744713272934349,0.6666666666666666,0.9781392517370554,1.0,11/34,27.09%,ABI3;FSCN1;NCKAP1;TWF2;CYFIP1;TWF1;WASF2;CDC42;CLRN1;BRK1;DMTN
prerank,peripheral nervous system development (GO:0007422),0.2971979621695385,0.8742161941932053,0.6514657980456026,0.9779773140147002,1.0,4/23,10.12%,SOX10;GPC1;NFASC;ASIC2
prerank,muscle cell development (GO:0055001),0.28188074095896154,0.8739756275329262,0.6580645161290323,0.9777692531193775,1.0,8/30,17.90%,NEBL;BIN1;DMD;SLC8A1;SGCZ;CXADR;ENG;ANK2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2616668416311798,-0.8739488574023233,0.7008547008547008,0.8493917497262728,1.0,6/29,12.93%,STAP1;TYROBP;CD226;RAET1E;LAMP1;KLRD1
prerank,spindle assembly (GO:0051225),0.23649163094877615,0.8737941216466806,0.6852122986822841,0.9774447395776407,1.0,22/67,25.18%,CEP192;AAAS;HAUS4;MISP;CLASP2;SMC1A;MAPRE2;SAC3D1;KIF2A;TUBGCP2;MAP9;STAG2;STARD9;HDAC3;ABRAXAS2;HAUS5;TUBGCP6;MAPRE3;TOGARAM2;RHOA;TUBGCP5;GOLGA8B
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.1895885913277477,-0.8737261921209022,0.8110599078341014,0.8493072975193032,1.0,43/145,24.24%,RAD51B;PSMA6;MECP2;PCM1;CDK5RAP2;PSMB2;PRKACA;GPR132;PSME2;TUBA4A;CEP250;PSMD11;CCND1;PSMC6;PSMA3;YWHAG;HMMR;HAUS2;CEP164;MAPRE1;CDK1;HAUS8;PSMD10;PSMB5;CDC25A;PLK1;KCNH5;DCTN2;DTL;PSMD5;ODF2;TPX2;PAFAH1B1;PSMD1;AKAP9;CDC25C;CEP78;OFD1;TUBB4B;CCNB1;NDE1;PSMA7;PSMB7
prerank,regulation of neuroblast proliferation (GO:1902692),0.32457529181666084,0.8737221344759899,0.6333907056798623,0.9768638987188905,1.0,4/15,15.23%,CX3CR1;SMARCD3;DCT;TAFA1
prerank,cellular protein modification process (GO:0006464),0.18448779740581495,0.8735088391267549,0.8947906026557712,0.9766078436230624,1.0,231/982,22.18%,KLHL25;TPTE;KLHL22;SLC35A1;CDK7;FBXW8;ST3GAL5;B3GNT9;HS3ST5;FUT10;STRADB;PSMB1;PLAT;MERTK;MATK;B3GNT6;CDK15;C3;B3GALT2;OBSL1;DDOST;PPM1E;RAB1B;CST3;PTPRD;NIM1K;FBXW9;TXK;RAB3A;STK26;PKN1;PAK1;DUSP29;NTRK1;AFP;COPS8;ALG1;UBA7;CHM;PTPRT;PTPRO;PTPRU;STK11;SOCS3;SERP2;UBE2M;FSTL1;PRKCZ;ELOC;IL6;YES1;FBXO7;NUB1;CTBP1;TRIB1;METAP1D;RYK;TRIB2;RAB8A;COMMD1;DYRK1B;PRKCI;CDC42BPA;PSMF1;ST6GALNAC2;BTRC;RIPK3;TGFBR1;NRBP2;ASB2;PRAG1;FBXO11;LIMK2;LIMK1;BMP2K;PPP1CC;PSMA1;BMP4;STK36;SOCS2;PSMD7;PRKCA;CDKL5;PRKD2;PPM1A;MAP4K4;RNASEL;PHEX;TGFB1;PTPN3;COPS3;PSMA8;B3GALNT1;NEK4;HSP90B1;FBXW10;RAB5A;RAB38;NEK1;AAK1;BTK;FBXL20;PSME3;STK39;VRK2;SENP8;MINK1;STK25;KLHL2;NTAQ1;ACVR1B;CUL2;PAK5;PPP2R3A;SCG3;PPP3CC;EPAS1;TGM4;PSMD14;VCAN;PRKG1;PDGFB;COQ8A;ST3GAL6;NUCB1;SPSB3;FBXL4;PARP1;FBXL19;PPP5C;AGA;PSMC4;DDB2;DCAF11;LRRC41;PGGT1B;SOCS6;COPS6;SDHAF2;MAP3K13;BAP1;GLYCTK;TGM1;MAPK10;AMHR2;INSR;DUSP2;FBXW5;EIF2AK4;ERG;APLP2;SKP2;UBA3;MIA3;MAPK3;FN3K;KLHL5;PDP2;KLHL11;PRKD1;SSH1;PIGS;UBE2I;COP1;DMPK;CTTNBP2NL;FBXL2;PRKCG;CSNK1G3;ALG5;PAK6;PLK2;CDK10;SSH2;ROCK1;AATK;TAOK1;PTPRS;CDC42BPB;PPP2R1A;PTPN13;PARP6;FBXO9;AKT3;PSMB4;MAST2;QSOX1;PLK4;FBXL7;UBL5;KLHL42;MAP4K2;ALG3;FBXL3;STRADA;WNK1;BMPR1B;WSB1;ST3GAL3;FBXL22;RABGGTB;SDC2;SPARCL1;FBXO31;ACVR1C;COPS5;PSME1;CDKL1;FBXO6;UBE2S;PDK1;PDPK1;PSMD2;NUAK1;PPM1L;PSMD4;METAP2;FCGR3A;ABCA7;LATS1;PPP6C;PPP2R5D;SIK3;PSMD8;LIPE;CDK4;OGA;CLK3;LARGE1;PARP10;WDR5
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.2827456182118286,0.8733961084851027,0.6283048211508554,0.9761315075528402,1.0,3/29,1.88%,BCL9L;TLE3;TLE2
prerank,Rac protein signal transduction (GO:0016601),0.3119879678882793,0.8733910596835995,0.626916524701874,0.9753855147355773,1.0,4/18,14.07%,NCKAP1;FARP2;HACE1;CYFIP1
prerank,protein import into mitochondrial matrix (GO:0030150),0.3095839726870105,0.8731824293550162,0.6472602739726028,0.9751416749381985,1.0,5/18,22.81%,TOMM40L;TIMM21;TOMM70;TIMM23;TIMM44
prerank,cellular senescence (GO:0090398),0.2868098447173876,0.8731349223161494,0.6452648475120385,0.974489864433135,1.0,6/27,20.17%,ECRG4;SMC5;TBX2;HRAS;MAPKAPK5;SRF
prerank,regulation of autophagosome assembly (GO:2000785),-0.2519600790770763,-0.8730420831319013,0.6568364611260054,0.8501660523289843,1.0,10/33,16.92%,CHMP4B;CHMP4A;SH3GLB1;SMCR8;MTM1;LRRK2;RALB;ADPRH;MTMR3;RAB3GAP2
prerank,nucleosome disassembly (GO:0006337),0.3341397771971022,0.8727035213797371,0.6412859560067682,0.9739752440065734,1.0,3/14,11.22%,SMARCC2;SMARCE1;SMARCD3
prerank,chromatin disassembly (GO:0031498),0.3341397771971022,0.8727035213797371,0.6412859560067682,0.9739752440065734,1.0,3/14,11.22%,SMARCC2;SMARCE1;SMARCD3
prerank,cellular response to cAMP (GO:0071320),0.2824931810838515,0.8726958940872421,0.6789727126805778,0.973233214797691,1.0,5/30,12.72%,HCN1;RAPGEF3;PKD2;CFTR;CRHBP
prerank,embryonic skeletal system development (GO:0048706),0.26917088474929673,0.8721112886742701,0.6867283950617284,0.9738907623004447,1.0,12/35,27.27%,HOXD4;MEGF8;HOXB9;DSCAML1;KIAA1217;SULF2;UCMA;HOXB3;RBP4;HOXC9;FUZ;SULF1
prerank,canonical Wnt signaling pathway (GO:0060070),0.23872294402917624,0.8720640151531334,0.7144927536231884,0.9732565430935463,1.0,19/68,26.11%,WNT4;BCL9L;FRAT2;WNT3;RYK;TCF7L2;WNT8B;RAB5A;SFRP1;WNT7A;TCF7L1;DVL2;FRZB;AXIN1;SFRP2;PPP1CA;SCYL2;WNT5B;FZD5
prerank,regulation of vesicle-mediated transport (GO:0060627),0.22734779231246285,0.8717617288489368,0.7181571815718157,0.9732697104033781,1.0,20/91,18.52%,LGI3;TSC2;ATP9A;RAB3A;SYT1;RAB26;PLA2G3;RAB8A;RIT2;INPP5F;RAB5A;RAB3D;CPLX2;BET1L;RAB12;HAP1;MAPK3;CD22;STXBP5;FES
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.24539207503700317,0.871726361591225,0.7115666178623719,0.9710916303112782,1.0,15/61,17.90%,RAB1B;CNIH2;SEC16B;TMED2;AREG;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9;SEC24C;PREB
prerank,vesicle coating (GO:0006901),0.24539207503700317,0.871726361591225,0.7115666178623719,0.9710916303112782,1.0,15/61,17.90%,RAB1B;CNIH2;SEC16B;TMED2;AREG;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9;SEC24C;PREB
prerank,COPII vesicle coating (GO:0048208),0.24539207503700317,0.871726361591225,0.7115666178623719,0.9710916303112782,1.0,15/61,17.90%,RAB1B;CNIH2;SEC16B;TMED2;AREG;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9;SEC24C;PREB
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3664677891909696,0.8716762476386706,0.6173469387755102,0.9704638591397933,1.0,1/11,2.27%,NOS1AP
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.2961160595878718,0.8716304418388138,0.6279461279461279,0.9698321801818323,1.0,7/24,17.18%,THY1;MAPRE2;MAP4K4;IQSEC1;SFRP1;TEK;ROCK1
prerank,response to ketone (GO:1901654),0.30159722130392924,0.8716144461309668,0.665,0.9691216601331105,1.0,5/24,9.35%,WBP2;UBE3A;ABCB4;TGFBR3;TGFB1
prerank,regulation of exosomal secretion (GO:1903541),-0.28809607054494746,-0.8716076972236018,0.6262376237623762,0.8527244731765531,1.0,6/19,20.12%,SDCBP;RAB7A;PDCD6IP;STAM;SDC1;SDC4
prerank,microtubule-based transport (GO:0099111),0.3545279591647303,0.8715362172007346,0.6543859649122807,0.9685467851951375,1.0,4/12,15.29%,ROPN1L;SPA17;SPEF2;DNAAF2
prerank,histone deubiquitination (GO:0016578),-0.2943015528390088,-0.8713477961929664,0.6324582338902148,0.8527056809535623,1.0,9/18,33.35%,ATXN7;TRRAP;UIMC1;BRCC3;USP15;ATXN7L3;EPOP;TAF10;USP3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.30840729489997565,-0.8708187722634625,0.6604215456674473,0.8532841912452103,1.0,3/15,7.53%,RNF213;SPEF1;ZNRF3
prerank,response to chemokine (GO:1990868),0.34416563406497047,0.8704010171357411,0.6412078152753108,0.9704791901661284,1.0,4/13,11.27%,SLC12A2;FOXC1;SH2B3;STK39
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.23250868117806311,0.8701431984941309,0.7190684133915575,0.970347906997223,1.0,14/78,10.93%,RNF19A;SGTA;CLU;NUB1;TRIB1;TRIB2;RNF180;PRICKLE1;PLK3;PRKN;SUMO2;NFE2L2;HERPUD1;ZYG11B
prerank,stem cell development (GO:0048864),-0.2969507839628013,-0.8698399805546735,0.6514423076923077,0.8549203970157552,1.0,5/16,15.06%,PTPRC;SOX11;TCOF1;KBTBD8;CDH2
prerank,regulation of secretion (GO:0051046),0.33899669038895414,0.8695719237784585,0.6417391304347826,0.9709177785773664,1.0,2/13,7.80%,FGF10;MYO6
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2533803377129174,-0.8690968972571846,0.6829268292682927,0.8560045163743317,1.0,7/29,16.50%,PLBD1;PLA2G4E;PLAAT3;NR1H2;NR1H3;TMEM86B;LPCAT4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.2988644247715465,0.8688660503358285,0.6435643564356436,0.9718606509622298,1.0,3/22,3.96%,RPP40;ERI3;NOP9
prerank,embryonic hemopoiesis (GO:0035162),0.3501926524755629,0.8684533211751858,0.648506151142355,0.9720955275767209,1.0,5/12,26.25%,ZFPM1;SH2B3;THOC5;FLT3LG;ATF4
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.1834595864436877,0.8679441516925999,0.923391215526047,0.9725494196391445,1.0,179/1082,16.50%,ZFHX3;WNT4;HOXA5;HHEX;AGRN;BCL9L;CDK7;MPND;TET1;CD80;ZFPM1;DRAP1;KCNH2;CAPN3;ASF1A;IL4I1;LDB2;LDB1;SMARCC2;MED24;ONECUT2;MYRFL;WWTR1;BPTF;CSRNP3;POU2F2;USF2;HOXD4;RPTOR;TFCP2;PTPRN;TXK;ESRRG;RAI1;KDM6B;DNAJC2;NR1I2;FOSL1;NRL;SIX4;NR1I3;PSRC1;NFIB;RELA;SOX10;TFAM;PPARGC1A;NSD1;UBE2V1;MEOX2;WBP2;SOX4;BCL11B;MED4;PPARA;PBX2;SERTAD1;BRD8;HOXB7;MLLT11;E2F1;CD86;FGF7;GABPB1;IL6;ZFPM2;CRTC1;XRCC6;RFX6;WDR75;KDM1B;MEF2C;AR;DPF2;RXRG;DYRK1B;BCLAF3;NDP;GTF2F1;TADA3;FUBP3;BTRC;MAZ;AKAP8L;TGFBR1;HOXC10;MYO6;DAB2IP;APBB1;SS18;MACC1;LHX3;LMO2;BMP4;CD81;TCF7L2;ADCYAP1;OGT;MAP2K5;ERBB4;PRKD2;PKD2;FOXC1;PPM1A;HEY1;HDAC5;GRIN1;ZNF462;RNASEL;TGFB1;TAF9;LBH;MAML3;PRKN;ZC3H8;MSANTD1;KLF7;NEK4;SPIN1;SS18L1;ITGB1BP1;AKIRIN2;GRHL3;HSF2;FGF2;NFE2L2;PTOV1;SMARCD3;MLLT6;HOXB2;KAT8;RFXAP;SFRP1;FANK1;USF1;GABPA;EPAS1;HLF;TFEB;PKD1;PHF8;PDGFB;PARP1;PFKM;MYRF;PLAG1;PRDM16;FLCN;GPATCH3;EAF2;CHCHD10;BARX2;HMGB1;CCNK;LMX1B;ZBTB49;RBL1;APEX1;PRDM10;BRD4;GAL;ERCC6;IRF5;ERG;DDX39B;EDF1;WNT7A;REST;THOC5;TCF3;MAPK3;PRKD1;PRDM15;LHX2;MED25;CALCOCO1;SETX;RRP1B;HRAS
prerank,protein lipidation (GO:0006497),0.2451287422385089,0.8678005376148346,0.7171717171717171,0.9721384999766931,1.0,23/59,28.05%,PIGQ;ZDHHC22;PIGB;ZDHHC8;PIGP;MPPE1;ZDHHC1;ZDHHC2;ZDHHC23;DPM3;SELENOK;PGAP2;ZDHHC15;GPLD1;WDR45B;PGAP3;GLUL;WIPI2;ZDHHC12;DPM1;ZDHHC5;DPM2;PIGZ
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.2579407521860069,-0.8675183305034477,0.6684782608695652,0.8588772336409838,1.0,4/28,3.34%,MECP2;CDK5RAP2;GIT1;MET
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.2805425960930761,0.8674058351822044,0.6645569620253164,0.9722879116413321,1.0,6/28,13.76%,TCIM;TSPAN15;EGFL7;HEY1;ARRDC1;BEND6
prerank,renal system development (GO:0072001),0.24614976497991997,0.8668156621692806,0.6839762611275965,0.9729292538519688,1.0,10/52,17.15%,WNT4;TGFBR1;BMP4;FOXC1;C1GALT1;PKD1;IFT27;IFT88;AGT;PYGO2
prerank,anion transmembrane transport (GO:0098656),0.23652976243486948,0.8666912326414465,0.6992592592592592,0.9724851545558841,1.0,20/67,25.62%,SLC25A4;SLC35A1;SLC1A1;SLC25A18;SFXN1;SLC1A3;SLC39A8;SLC25A5;SFXN2;SLC19A1;SLC16A12;SLC13A3;SLC25A38;SLC6A9;SLC25A10;LRRC8B;SLC35B1;SLC16A7;SLC25A1;ABCC5
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2470301646439192,0.86665326806932,0.7049180327868853,0.9718219904377977,1.0,14/50,22.81%,IVNS1ABP;SOX4;NXN;ARRB2;MINAR1;LIMK1;OGT;UBXN1;PRKCG;PRMT3;FBXO5;ARRB1;HDAC8;CAMLG
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.29328983643791434,0.8666077176579715,0.6619496855345912,0.9711803502149088,1.0,7/24,13.79%,NUB1;UBE3A;EFNA1;PSME3;PSMD14;PKD1;EPHA4
prerank,organic acid transport (GO:0015849),-0.197960646155852,-0.8662887104332292,0.7852112676056338,0.8610628515249198,1.0,10/94,6.31%,LRRC8D;SLC1A5;SLC7A1;SLC43A2;SLC6A6;SLC7A11;SLC27A4;PPARD;NCOA1;SLC46A1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.21516851220297867,0.8662741205884992,0.75,0.9712449324283896,1.0,35/129,22.05%,FGF10;HHEX;UBE2B;PSMB1;SOX4;TMEM198;PTK7;PSMF1;PSMA1;GPC5;PSMD7;PPM1A;FAM53B;TGFB1;PSMA8;PPM1N;PSME3;SFRP1;PSMD14;LRRK1;PSMC4;TMEM9;CCAR2;PRDM15;CSNK1G3;PSMB4;PIN1;RSPO1;WNK1;PSME1;PSMD2;PSMD4;PSMD8;AXIN1;SFRP2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.269100752005229,-0.8654548256972233,0.6262886597938144,0.8623065901222484,1.0,10/23,25.73%,UBE2K;S1PR2;PRKAG2;CALM3;CALM2;PLK1;BMP7;APP;EGF;TNKS1BP1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.29153627646446856,0.8653949566541969,0.6645161290322581,0.9726646155274543,1.0,4/23,11.30%,CADM1;SLAMF6;ARRB2;CRTAM
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2645265408593779,-0.8653569359665252,0.6683168316831684,0.8619480487084163,1.0,9/26,20.54%,P2RX4;CD36;SMAD3;IL1B;TNF;TLR4;KLF2;MMP8;KLF4
prerank,linoleic acid metabolic process (GO:0043651),-0.2919151726822714,-0.8653369398684215,0.671264367816092,0.8614097309505011,1.0,7/17,29.76%,ALOX5;ALOXE3;ELOVL2;GSTP1;ALOX15;ABCD1;FADS2
prerank,mitochondrial fission (GO:0000266),0.31889927052746647,0.8651756562316847,0.6395147313691508,0.972460745009344,1.0,5/16,17.61%,FIS1;PRKN;DNM1L;SLC25A46;MFF
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.21263583270486655,0.8650924490133409,0.7576974564926372,0.9719198039506722,1.0,24/142,16.41%,ACKR4;YWHAE;ADCY8;TRPC3;ACKR3;CDH23;FIS1;CCR1;ADCYAP1;CXCR6;CX3CR1;SLC8A1;TRPC6;CXCR4;ITPR3;P2RY1;ATP2B3;TAC1;CCR6;HMGB1;ACKR2;CCR9;PTGER1;CACNA1A
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3083211146222651,-0.8650214207696593,0.6591478696741855,0.8615289906235591,1.0,2/15,1.14%,IGF1;BCL2L1
prerank,mitochondrial gene expression (GO:0140053),0.2594330996541564,0.8648493201100438,0.6818897637795276,0.9717156093640945,1.0,10/42,24.83%,MRPS6;TFAM;MRPS7;GFM2;MRPL23;PTCD3;HARS1;FASTKD2;MRPS34;MRPS2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.34439943919553156,0.8647139987611002,0.6483333333333333,0.9712895489515598,1.0,2/13,3.96%,RPP40;NOP9
prerank,gene silencing by miRNA (GO:0035195),0.27440419622978424,0.8646552821546883,0.6925418569254186,0.9706913305704201,1.0,6/32,14.28%,ZC3H7B;ADAR;SPOUT1;EIF6;CNOT8;AGO4
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2719118942354676,-0.8641819199570338,0.7013333333333334,0.8627963695824402,1.0,12/24,32.49%,PRKACA;CAMK2D;CALM3;CALM2;SELENON;JPH4;PDE4D;CASQ2;CALM1;FKBP1A;SRI;NOS1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.31926648301019483,0.8641768464879481,0.6502546689303905,0.9710503271657608,1.0,7/16,23.72%,TRPC3;PRKCA;PARP1;AGT;ROCK1;SLC9A1;MEF2A
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.25405459336846653,0.8639409872551713,0.6610942249240122,0.970837827202604,1.0,19/42,27.49%,SMARCC2;SMARCE1;ZNHIT1;VPS72;RNF8;DMAP1;SPTY2D1;ERCC6;ACTB;ACTR5;MBD3;SMARCA2;ACTR6;ACTR8;PBRM1;MTA2;CHD8;ACTL6B;CHD4
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.18090577836454988,0.8638645053896675,0.9606458123107972,0.9702874096375144,1.0,302/1668,18.64%,ZFHX3;HOXA5;HHEX;AGRN;NUCKS1;BCL9L;DCAF1;SCRT2;CDK7;MPND;TET1;CTR9;SMYD2;MED12L;HSF4;ZFPM1;ZFP57;SALL3;IKZF4;DRAP1;IL4I1;NACC2;RTF1;LDB2;LDB1;SMARCC2;MED24;ONECUT2;BRD9;FUS;WWTR1;BPTF;CSRNP3;POU2F2;USF2;HOXD4;TFCP2;CNOT2;ZNF394;PTPRN;TXK;ESRRG;PKN1;DDX5;RAI1;KDM6B;LBX2;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;ELP2;SP2;KCNIP3;SOX10;TFCP2L1;SLA2;PPARGC1A;NSD1;MEOX2;RIPPLY2;WBP2;SOX4;GTF2H2;BCL11B;MED4;ZBTB12;PPARA;HOXB9;HOXC6;BRWD1;PBX2;BRD8;HOXB7;TCF25;E2F1;ELOC;GABPB1;IL6;HDGFL2;ZFPM2;CRTC1;SMARCE1;XRCC6;CBX2;FOXD1;NR2F6;RFX6;CTBP1;KDM1B;MEF2C;AR;GTF2H4;DPF2;RXRG;BCLAF3;MED31;GTF2F1;PCGF6;TADA3;FUBP3;ZNF35;ZNF205;MAZ;AKAP8L;HOXC10;REPIN1;MYO6;PHF6;NCOR2;DAB2IP;APBB1;SS18;CBX6;MACC1;LHX3;LMO2;BMP4;SP4;EBF1;DGKQ;CD81;ZBTB22;TCF7L2;PRDM6;ADCYAP1;OGT;MAP2K5;PRKD2;PKD2;FOXC1;PPM1A;HEY1;HDAC5;GRIN1;ZNF462;ZFP82;RNASEL;HTATSF1;TGFB1;TAF9;ZFP91;TSHZ2;TBX2;ZNF23;MAML3;PLK3;AEBP1;PRKN;ZKSCAN8;SNAI2;HEXIM2;KLF7;SS18L1;ITGB1BP1;AKIRIN2;DMRTA1;GBX1;GRHL3;NKAP;HSF2;FGF2;NFE2L2;PTOV1;EFNA1;ZNF32;ZFP1;ZFP69;KDM2B;CBX4;SMARCD3;MLLT6;ZFP41;HOXB2;VPS72;IFI27;NOP2;KAT8;RFXAP;POU3F4;SUV39H2;PBX3;ZNF383;WWC1;THAP1;USF1;GABPA;EPAS1;HLF;TFEB;HOXB5;PKD1;PHF8;SAP130;TBX6;PARP1;PFKM;TEF;FBXL19;SMARCAL1;GADD45A;LHX5;SUB1;PLAG1;PRDM16;ZSCAN12;FLCN;ABCA2;ZBTB32;MYNN;DMAP1;EAF2;RNF2;BARX2;HMGB1;CCNK;AGO4;PPP1R13L;LMX1B;TAF3;ZBTB49;OTUD7B;RBL1;NKX2-2;IKZF2;APEX1;PRDM10;BRD4;GAL;ZNF740;NEDD4L;IRF5;HMGB3;PRDM1;BATF;ERG;BHLHA9;WNT7A;REST;UXT;TCF3;TCF7L1;MAPK3;PRKD1;PRDM15;LHX2;UBE2I;MED25;CALCOCO1;PEX2;PAF1;SETX;DNAJA3;RRP1B;HRAS;BHLHE41;EN2;SUFU;KLF16;IRF2BP1;BRIP1;BACH1;RHOQ;ITGA6;PRKAR1A;ENG;TMPRSS6;HDGFL3;KLF12;ZIC5;TLR3;ZNF750;ZFP30;ZEB1;BACH2;ZBTB34;PHF2;XBP1;RGMA;POU3F3;IL18;TEAD3;MAX;ZFP92;PSIP1;ZBTB7B;FOSL2;ECD;PIN1;UBE2D1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2266317609916897,0.8632828253068681,0.7535211267605634,0.9708624447450495,1.0,28/88,21.80%,PSMB1;PSMF1;BTRC;PSMA1;PSMD7;FBXL6;PSMA8;FBXL20;PSME3;CUL2;PSMD14;FBXL4;PSMC4;FBXW5;SKP2;KIF14;FBXL2;FBXO9;PSMB4;FBXL7;FBXL3;FBXL22;FBXO31;PSME1;FBXO6;PSMD2;PSMD4;PSMD8
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.20826061184753503,-0.862697551343912,0.7898550724637681,0.8654467028473796,1.0,10/70,7.94%,ITCH;PSMA6;TCF12;PSMB2;N4BP2L2;PSME2;PSMD11;PSMC6;YAP1;PSMA3
prerank,nitrogen compound transport (GO:0071705),-0.18390101835991562,-0.8625071922708936,0.8547008547008547,0.8652688534677204,1.0,29/141,18.65%,ARL6IP5;LRRC8D;KIF3A;SLC1A5;SLC7A1;SLC43A2;SLC6A6;RAB7A;SLC15A3;SLC7A11;TMEM30A;TXNIP;NDC1;SLC52A2;HIKESHI;SLC11A1;CHMP1B;SLC6A8;RAMP2;SLC25A47;CALCRL;MYH9;SLC16A10;SLC7A6;SLC3A2;ARRDC4;RILP;SLC52A1;TOM1
prerank,negative regulation of receptor internalization (GO:0002091),0.34943870953176903,0.8624583086968542,0.6474576271186441,0.9719859389264133,1.0,2/12,1.59%,RIN3;ANKRD13D
prerank,cellular response to BMP stimulus (GO:0071773),0.23858924696467182,0.8623082029302686,0.7170953101361573,0.9715888098687736,1.0,15/66,20.62%,DDX5;MEGF8;SLC33A1;TGFBR3;BMP4;TGFB1;SFRP1;AMHR2;MAPK3;GDF1;ENG;RGMA;BMPR1B;SMAD2;SMAD1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.3458468922520609,0.8621588538010989,0.6593220338983051,0.971217349043237,1.0,3/12,18.65%,GSS;GGCT;CHAC2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.25798972956073873,-0.8620208824250799,0.7,0.865762679640607,1.0,13/29,26.30%,RTEL1;PPP6R3;ANKRD28;RPA1;TERF2;NOP10;DKC1;TINF2;PIF1;NHP2;TERT;TNKS1BP1;HSP90AA1
prerank,regulation of mitochondrial fission (GO:0090140),-0.2656823735332283,-0.8616543893097534,0.67828418230563,0.8659847311460435,1.0,7/24,17.25%,DDHD1;STAT2;VPS35;LRRK2;KDR;MUL1;MIEF1
prerank,negative regulation of cellular process (GO:0048523),0.18815937690139786,0.8615867577154982,0.8705114254624592,0.9718543530576066,1.0,95/521,17.81%,ATP8A2;P3H2;TPTE;TSC2;WFDC1;SMYD2;AVPR2;SRGAP2;PLXNB2;NACC2;CD34;NTRK1;PSRC1;SUSD2;SLURP1;ARHGDIG;COPS8;TENM1;SOX4;IGFBP6;PTPRU;JAM2;SIPA1;STK11;IL6;SRSF6;DSCAM;CLU;PDCD5;CTBP1;GSDME;AR;RBM5;PDE3B;EEF1E1;TGFBR3;ADAM22;MINAR1;DAB2IP;APBB1;CCN4;FHL1;NME1;BMP4;GNG4;ARHGDIA;ERBB4;PKD2;SST;TGFB1;NMI;PRKN;BTG3;ITGB1BP1;ADAM15;SH2B3;THAP12;FGF2;BTG2;SFRP1;BECN1;CGRRF1;ACVR1B;CHMP1A;DCBLD2;INHA;PPP1R13B;FLCN;BAP1;TXNDC12;CHMP2A;VAMP3;CBLL1;ZBTB49;EI24;EPHB2;PTPN2;IFI35;CCAR2;SH3BP4;ADORA3;REST;MIA3;COL18A1;PRKD1;CTTNBP2NL;DNAJA3;HRAS;OPRM1;CDK10;NDRG3;PPP2R1A;BTG1;FABP3;UTP20
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.19324467425653244,-0.8615392421825006,0.83,0.8656709576293533,1.0,27/104,20.27%,UBE2D3;PPARG;SMURF2;SMAD3;MTMR4;SMAD9;CAV1;UBC;LEMD3;SNX25;UBA52;SPRY2;NOTCH1;SMAD6;SPRY1;CCN3;GREM1;BMP2;FAM89B;ASPN;ADAM17;HIPK2;SMAD4;ACVR1;ACVR2A;GDF3;BAMBI
prerank,regulation of primary metabolic process (GO:0080090),-0.1917448776936509,-0.8608711597329257,0.8146551724137931,0.8664714135544804,1.0,38/126,24.41%,APOE;PSMA6;PSAP;SIN3B;PPARG;PSMB2;PRKAB1;PSME2;PPARD;NCOA1;PSMD11;SP1;PSMC6;LDLR;TBL1X;PSMA3;IDI1;PSMD10;PSMB5;PRKAB2;ACACA;ODC1;GPAM;SC5D;GGPS1;CERS2;HELZ2;PSMD5;PSMD1;IRS2;NCOR1;MVK;ID2;TBL1XR1;PMVK;PSMA7;PSMB7;FGFR4
prerank,cellular response to interleukin-4 (GO:0071353),-0.3474547227295747,-0.860469172244131,0.6382978723404256,0.8668065728481115,1.0,6/10,36.28%,TCF7;SHPK;GATA3;LEF1;DCSTAMP;RUFY4
prerank,plasma membrane repair (GO:0001778),0.34123115424858197,0.8604409320190441,0.6719298245614035,0.9738217293381605,1.0,2/13,3.45%,RAB3A;SYTL4
prerank,extracellular matrix assembly (GO:0085029),0.28722313875617533,0.8603289904526205,0.6672413793103448,0.9733618869703374,1.0,7/23,18.42%,LTBP3;LAMB3;TGFB1;PXDN;NTNG2;NTNG1;QSOX1
prerank,regulation of response to interferon-gamma (GO:0060330),0.3218036893019859,0.8600936827595262,0.6395759717314488,0.9731746729135489,1.0,6/14,28.54%,SOCS3;PTPN2;IFNGR1;HSP90AB1;SUMO1;CDC37
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.22662595584383327,-0.860014213534988,0.7027027027027027,0.8671602777774405,1.0,9/41,10.27%,RANBP2;PRKAG2;HIF1A;NUP153;NDC1;NUP43;NUP210;EP300;PGAM1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.3423299544572799,-0.8595097510264319,0.6574712643678161,0.8676725702122386,1.0,3/10,11.12%,XDH;SPRY2;SEMA6A
prerank,histone monoubiquitination (GO:0010390),0.2916057704462923,0.8594818303769062,0.6416938110749185,0.9738409845082625,1.0,6/24,16.18%,CTR9;KDM2B;RNF168;DDB2;RNF2;PAF1
prerank,alanine transport (GO:0032328),-0.335029654066895,-0.8594667314766332,0.6567901234567901,0.867188928447061,1.0,2/10,9.21%,SLC6A6;SLC6A17
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2689621734967908,-0.859000322569832,0.6919060052219321,0.8676165866303943,1.0,7/22,23.79%,PTPA;BOD1;CRY2;TNF;PPP1R15A;BOD1L1;MASTL
prerank,interstrand cross-link repair (GO:0036297),-0.22330395617539117,-0.8589792997749197,0.7056962025316456,0.8670921338454612,1.0,16/53,19.68%,VCP;ERCC6L2;UBC;ATRIP;UBA52;RPA1;FAAP20;FANCI;MCM9;MCM8;EME1;RPA2;CENPX;SLX4;FANCM;NEIL3
prerank,response to reactive oxygen species (GO:0000302),-0.22046616265091842,-0.8589723710291789,0.7319277108433735,0.866530519408174,1.0,13/54,16.53%,APOE;PXN;ADAM9;STK24;ERCC6L2;PDCD10;FYN;HIF1A;FOS;EGFR;GPX1;HMOX1;MAPK8
prerank,glycerolipid catabolic process (GO:0046503),0.3057353889909569,0.8588526745088417,0.660377358490566,0.9745823434414519,1.0,3/19,7.16%,PRDX6;PLA2G4C;ABHD12
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.30020382055203587,-0.8587419948173277,0.6548223350253807,0.8664767670767864,1.0,4/16,15.15%,APOE;HDAC1;LRP1;TNF
prerank,long-term synaptic potentiation (GO:0060291),0.2987576352618859,0.8586401261161704,0.6830508474576271,0.9743168589672427,1.0,5/21,16.99%,MPP2;PRKCZ;GRIN2B;SLC8A3;PLK2
prerank,glucose metabolic process (GO:0006006),0.24037111080891127,0.8586380902869172,0.7241379310344828,0.9735884426753781,1.0,19/58,28.06%,GAPDH;PPARGC1A;SLC37A4;PGAM2;ALDOC;MDH1;APOD;GHRL;PGM1;ALDOA;OMA1;ENO3;SLC25A10;RBP4;SLC25A1;CRTC2;ATF4;PFKFB1;DCXR
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.30972046064206527,0.8584123998677857,0.6540362438220758,0.9733792349888942,1.0,3/19,5.82%,FIS1;PRNP;TRPM2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3269118694426031,0.8583463601410485,0.6377551020408163,0.9728001146753666,1.0,5/15,17.19%,TXK;NTRK1;MAPK3;ITK;AATK
prerank,cell differentiation in hindbrain (GO:0021533),-0.3396846059244222,-0.85825770349754,0.6575342465753424,0.8669235681521661,1.0,4/11,14.83%,ATP7A;PROX1;AGTPBP1;LHX1
prerank,cellular response to fluid shear stress (GO:0071498),0.3421702445178973,0.8581005737278825,0.6718213058419243,0.9726616586464254,1.0,4/12,10.75%,MEF2C;MAP2K5;PKD2;NFE2L2
prerank,DNA methylation (GO:0006306),0.2952339666353774,0.8579571328854678,0.6644844517184942,0.9722258984215439,1.0,6/23,18.71%,ZFP57;METTL4;DMAP1;N6AMT1;KMT2E;SPOCD1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.27137580775343656,-0.857767209745281,0.7100737100737101,0.8673643812929144,1.0,8/21,23.79%,ENSA;PTPA;BOD1;CRY2;ARPP19;PPP1R15A;BOD1L1;MASTL
prerank,regulation of myoblast differentiation (GO:0045661),0.26642943450526985,0.8573435567677069,0.6784565916398714,0.9729184794128883,1.0,7/32,20.28%,BOC;MEF2C;BMP4;TGFB1;SMYD1;BTG1;RANBP3L
prerank,synaptic vesicle membrane organization (GO:0048499),0.315273001858118,0.8572230738261956,0.6568144499178982,0.9724524686508851,1.0,3/17,12.12%,SNAP25;STX3;SYNGR1
prerank,negative regulation of lyase activity (GO:0051350),-0.29784982015082695,-0.8569841345027857,0.6791044776119403,0.8684284896171867,1.0,7/16,19.73%,CCR2;EDNRB;DRD2;PHPT1;MTRR;AKAP5;DRD3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3119788548791212,0.856822343833632,0.6511627906976745,0.9726481202280874,1.0,5/17,12.82%,PSRC1;CCND3;PKD2;PKD1;PDGFB
prerank,cellular response to interleukin-1 (GO:0071347),-0.1862008887010791,-0.8568219269321431,0.8443396226415094,0.8681526284926062,1.0,34/143,19.82%,PSMA6;CD47;MAP3K8;PSMB2;PSME2;NFKB1;CCL25;PSMD11;NOD2;PSMC6;GBP3;UBC;HIF1A;PSMA3;IL1B;TAB1;UBA52;ZC3H12A;PTGIS;RC3H1;ACOD1;IRAK4;PELI1;PSMD10;HAS2;PSMB5;RBMX;SQSTM1;HYAL3;PSMD5;ADAMTS12;IL1R2;PSMD1;MYD88
prerank,regulation of protein ubiquitination (GO:0031396),0.21569672606848314,0.8567653684538787,0.7810413885180241,0.9720544520961603,1.0,29/108,23.33%,IVNS1ABP;MYCBP2;SOX4;INAVA;NXN;UBE3A;COMMD1;ARRB2;TGFBR1;MINAR1;PRICKLE1;OGT;PRKN;UBE2N;DERL1;NSMCE3;HSPBP1;UBXN1;PRKCG;CENPS;PRMT3;UBE2D1;HDAC3;ARRB1;HSP90AB1;AXIN1;HDAC8;CAMLG;RIPK2
prerank,Wnt signaling pathway (GO:0016055),-0.1931683712212226,-0.8566512502372251,0.8222996515679443,0.8679265088143264,1.0,15/92,12.55%,CSNK1G1;VPS26A;DVL3;DIXDC1;VPS35;CCDC88C;CD24;UBC;CPE;WNT2B;UBA52;CTNNB1;FZD2;LRRK2;TCF7
prerank,positive regulation of vacuole organization (GO:0044090),-0.34260914237672735,-0.8566080739730171,0.636150234741784,0.867462037060941,1.0,3/10,16.92%,SH3GLB1;RALB;RAB3GAP2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.22843085832203383,0.8564541994930873,0.7557803468208093,0.9720197056573492,1.0,15/75,14.20%,F3;ANG;FLT4;PLCG1;TGFBR1;EGFL7;BMP4;PRKCA;PRKD2;FGF2;PDCD6;PDGFB;VASH2;TEK;HMGB1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.20921704505515473,-0.8563733236511311,0.7361563517915309,0.8673792280670278,1.0,22/72,23.05%,SP100;CNOT9;BAX;PCNA;BCL3;RPS6KA6;NBN;PIDD1;EP300;PAXIP1;CDK1;KAT5;E2F8;E2F7;SESN2;HIPK2;RGCC;RPL26;CDC25C;CNOT6L;GTSE1;CCNB1
prerank,central nervous system neuron development (GO:0021954),-0.30382431590782866,-0.8561926092300473,0.6381418092909535,0.8671997601165325,1.0,2/15,2.62%,B4GALT5;ATP7A
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.21761898753950573,0.8561325085452093,0.7796143250688705,0.9719891328630641,1.0,16/100,10.93%,FHIT;RNF19A;GIPC1;CLU;NUB1;TRIB1;TRIB2;COMMD1;RNF180;PRICKLE1;OGT;TAF9;PRKN;SUMO2;HERPUD1;ZYG11B
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.24447668462458788,-0.856011545647088,0.6797900262467191,0.8670393319267042,1.0,7/35,11.91%,CCT6A;RTEL1;PKIB;PRKCQ;CTNNB1;CCT3;HNRNPA2B1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.28529615727015517,0.8559861916755171,0.6870967741935484,0.9715955707541155,1.0,5/26,11.85%,ITPR2;TRPM2;PKD2;FGF2;ITPR3
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.22356261400715763,0.8559350336624095,0.7454031117397454,0.9709785866928042,1.0,15/86,13.88%,FGF10;CD80;PRKCZ;PRNP;FGF7;IL6;DGKQ;CD81;ENPP2;TGFB1;ITGA5;EFNA1;SFRP1;PDGFB;VTN
prerank,JNK cascade (GO:0007254),0.25822732500975876,0.8558299558924319,0.6905109489051094,0.9705082241709193,1.0,10/40,14.69%,UBE2V1;TRIB1;MAP3K10;NOD1;SH2D3C;UBE2N;MINK1;MAP3K7;MAP3K13;MAPK10
prerank,tRNA wobble base modification (GO:0002097),0.3304170377994199,0.8556912458185677,0.6763698630136986,0.9700972689783343,1.0,2/14,4.06%,ADAT2;CTU1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.29983694064249633,0.8554242015686997,0.6565656565656566,0.9699714439933558,1.0,4/20,11.82%,PRKCZ;IL6;CD81;MAP3K7
prerank,intracellular lipid transport (GO:0032365),-0.27002701869368445,-0.8550565692160192,0.693069306930693,0.8684862144831026,1.0,10/21,26.70%,NPC2;PRKAG2;SGPP1;MID1IP1;PRKAB2;ACACA;SLC25A20;ABCD4;CERT1;ABCD1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.3266089365134716,-0.8547294198182942,0.645933014354067,0.8685934220024296,1.0,6/12,21.63%,CIITA;IFITM3;TRIM5;GSN;PTX3;IFITM1
prerank,regulation of bone mineralization (GO:0030500),0.24290683870977262,0.8545075802580682,0.7337192474674384,0.9713382750574829,1.0,8/55,9.63%,WNT4;MEF2C;CCR1;FBN2;BMP2K;BMP4;TGFB1;SLC8A1
prerank,amino sugar biosynthetic process (GO:0046349),-0.3206363444018545,-0.8544752481829793,0.6675062972292192,0.8685610798621075,1.0,5/12,21.65%,GNPDA1;UAP1L1;GNPNAT1;NAGK;RENBP
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.18375067547837012,-0.854370658789996,0.8625,0.8681867380889333,1.0,73/152,36.93%,ADGRE5;ADGRG6;AKAP12;PSAP;ADCY9;PTGER4;S1PR2;CHRM2;PF4;GNA12;ADCY5;VIPR1;GNA13;NPY1R;ADCY6;ADCY1;HTR1B;GPR65;ADCY3;GNA14;PRKACB;RAMP2;CALCRL;PDE2A;AKAP5;PTHLH;OPRK1;ADGRG5;GPR37;S1PR3;LPAR2;ADGRL2;ADGRB1;VIPR2;RXFP2;PTH1R;CALCA;GLP1R;RAMP3;GRK5;SCTR;S1PR4;ADORA2A;VIP;LPAR3;ADGRG7;FPR2;GPR4;PTGIR;TBXA2R;ADGRG1;OPRL1;GPR26;ADGRG2;GIPR;LGR4;HTR1D;PTGFR;MC2R;CORT;CXCL9;CRHR2;ADGRD1;DRD1;GPER1;GPR3;CALCR;FPR1;FSHR;LHCGR;GHRH;CALCB;ADCY4
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3155137231341457,-0.8542586775440825,0.6587982832618026,0.8678637583102099,1.0,5/13,21.95%,METRNL;PIM1;BMP7;HNRNPU;RREB1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.2872916667130354,-0.8539994374690065,0.6862745098039216,0.8678382011350804,1.0,9/18,25.06%,RPS26;ESR1;RPS13;ZC3H12A;TNF;NCOR1;PTBP3;KAT2B;TERT
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.28606162472174473,0.853820940055455,0.6775244299674267,0.9721483559560968,1.0,5/25,12.77%,TRA2B;BCAS2;LSM1;MPHOSPH10;SF3B3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.30510746259661253,-0.8537726074578579,0.6485849056603774,0.8677208729451745,1.0,4/15,14.72%,CCR2;SYK;CD55;EBI3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.2709511172916013,0.8537523029901974,0.7054009819967266,0.9715992651972819,1.0,9/30,21.56%,IL17F;FSTL1;TGFBR3;TGFB1;ENG;LTBP4;NREP;SMAD2;LATS1
prerank,blood circulation (GO:0008015),0.24768105392756048,0.8537185582086516,0.700920245398773,0.9709386881141452,1.0,10/49,17.18%,AVPR1A;TNNI3;MEOX2;SGCZ;ITGB1BP1;HOXB2;SGCG;TBC1D8;SGCD;ROCK1
prerank,negative regulation of cell aging (GO:0090344),-0.30544275342207866,-0.8536099026287829,0.672289156626506,0.8674977023608156,1.0,6/16,27.88%,CDK6;TERF2;HMGA2;TWIST1;TERT;SLC30A10
prerank,negative regulation of cyclase activity (GO:0031280),0.3296111500533867,0.8535654711858951,0.6850921273031826,0.9705795044853915,1.0,5/14,18.33%,LTB4R2;GRM3;GABBR2;GNAI3;PALM
prerank,positive regulation of T cell migration (GO:2000406),-0.27755933171005936,-0.8535212617380667,0.6755447941888619,0.8671110379618577,1.0,6/20,22.59%,CCR2;WNT5A;SPN;ADAM17;CXCL12;APP
prerank,T cell mediated immunity (GO:0002456),0.33169878958041266,0.8534480460496316,0.6666666666666666,0.9701297435919619,1.0,2/13,11.30%,CADM1;CRTAM
prerank,regulation of protein localization to centrosome (GO:1904779),-0.3469878797089563,-0.8533832829626804,0.6252927400468384,0.8668574231567784,1.0,5/10,23.41%,CEP250;UBXN2B;NUP62;PARD6A;MARK4
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3001682464302292,0.8532608987568113,0.6754530477759473,0.9698674000383988,1.0,5/20,13.84%,PFAS;GART;AMPD3;HPRT1;ADSL
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.23980425570451575,0.8531054147762689,0.7077826725403817,0.9694899768769625,1.0,7/54,8.76%,IVNS1ABP;CAPN3;SOX4;NXN;ARRB2;MINAR1;OGT
prerank,folic acid metabolic process (GO:0046655),0.3164774954851739,0.8528660574222067,0.6858108108108109,0.969289098085865,1.0,5/18,14.50%,FPGS;MTHFD1L;MTHFD2L;ALDH1L1;SLC19A1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.20177242883102572,-0.8527465856758809,0.794425087108014,0.86761312858051,1.0,26/82,23.70%,PCM1;CDK5RAP2;PRKACA;TUBA4A;CEP250;YWHAG;HMMR;HAUS2;CEP164;MAPRE1;ATF5;CDK1;HAUS8;NPM1;PLK1;KCNH5;DCTN2;ODF2;TPX2;PAFAH1B1;AKAP9;CEP78;OFD1;TUBB4B;GTSE1;NDE1
prerank,neural crest cell differentiation (GO:0014033),-0.2835673152718716,-0.8526941895277022,0.681704260651629,0.8671738422086495,1.0,6/18,18.47%,FBXL17;SOX11;TCOF1;KBTBD8;CDH2;LRP6
prerank,programmed necrotic cell death (GO:0097300),0.3077866458420314,0.8521437322262265,0.6898839137645107,0.9702048001110719,1.0,6/18,20.39%,ITPK1;RIPK3;IPMK;DNM1L;TLR3;CYLD
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.2661737700792874,-0.8520401259735596,0.674863387978142,0.867964755816922,1.0,6/23,16.04%,SASH1;DVL3;TAOK3;MAP3K11;TNF;ARHGEF5
prerank,positive regulation of viral genome replication (GO:0045070),-0.2552621625160282,-0.8519329199366649,0.7024793388429752,0.8676127623266121,1.0,8/29,22.05%,TOP2A;IFIT1;CD28;PPIH;LARP1;STAU1;TOP2B;VAPB
prerank,positive regulation of cell cycle (GO:0045787),0.2325520490211376,0.8518957541739871,0.7276785714285714,0.9700426763055621,1.0,11/62,14.65%,PSRC1;SMOC2;LGMN;RPS6KB1;CCND3;PRKCA;CCDC57;PKD2;PKD1;PDGFB;TGM1
prerank,coenzyme A metabolic process (GO:0015936),0.32051427220854667,0.8516915339935529,0.6615120274914089,0.9697895038401559,1.0,5/14,16.09%,PPCDC;COASY;DCAKD;ACLY;PPCS
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.22247953663361317,-0.8515814371222231,0.7364130434782609,0.8678056369895043,1.0,15/51,21.24%,UBE2D3;PPARG;SMURF2;SMAD9;LEMD3;NOTCH1;SMAD6;GREM1;BMP2;HIPK2;SMAD4;ACVR2A;GDF3;BAMBI;TRIM33
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.29510366793328613,0.8513475862674665,0.6737704918032786,0.9698795069458757,1.0,4/20,10.73%,SMOC2;GPC1;PRKD2;FGF2
prerank,regulation of viral release from host cell (GO:1902186),0.29541899714251213,0.851277029429819,0.6867088607594937,0.9693417554752545,1.0,4/21,14.26%,MID2;TRIM26;TRIM8;CHMP2A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.2664009087537925,0.8511255177157531,0.6806020066889632,0.9689567985956945,1.0,6/32,10.73%,SRPX2;MEOX2;MAP2K5;HDAC5;ITGB1BP1;FGF2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.23793681230619457,-0.8507983960983664,0.7264437689969605,0.8688409256547944,1.0,14/38,24.10%,NDUFS4;NDUFV2;NDUFA5;NDUFS8;NDUFB3;NDUFB11;NDUFB10;NDUFS7;NDUFA7;NDUFB2;NDUFB8;NDUFAF1;NDUFA13;NDUFA11
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.30235596127862374,0.8505194033072524,0.6807131280388979,0.9695539086206683,1.0,1/20,0.24%,WNT4
prerank,negative regulation of cation channel activity (GO:2001258),-0.25927273341912194,-0.850438151038733,0.6865284974093264,0.869015040142578,1.0,15/26,32.62%,UBQLN1;DRD2;CALM3;CALM2;KCNAB1;DRD3;EPO;GNB5;KCNE3;CASQ2;CALM1;FKBP1A;SRI;MMP9;GPR35
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3435748475428538,0.850315202034813,0.658703071672355,0.9692574171621269,1.0,3/13,15.88%,STK11;ITFG2;RNF152
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.19898694552157267,-0.8501850663855027,0.8215613382899628,0.8689880488845126,1.0,21/87,19.16%,PSMA6;CDK6;CDC73;KANK2;PSMB2;GPR132;PSME2;PSMD11;PSMC6;PSMA3;CDKN2C;WEE1;PRMT2;PSMD10;RB1;PSMB5;E2F7;RGCC;PSMD5;CDKN2A;PSMD1
prerank,pharyngeal system development (GO:0060037),0.32142824676107584,0.8497633774944978,0.6795096322241682,0.9697318635317521,1.0,3/15,8.31%,SIX4;TGFBR1;BMP4
prerank,regulation of hormone secretion (GO:0046883),-0.301813660901218,-0.849672952117825,0.676056338028169,0.8695005498391849,1.0,2/15,7.33%,SOX11;ANXA1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.22592155257451024,-0.8495413927359184,0.7543352601156069,0.8692267032732044,1.0,14/47,18.30%,RABEP1;GOLPH3L;EXOC4;GGA2;CCDC22;RAB10;EXOC8;STXBP6;OPTN;EXOC6;RAB31;GCC2;GOPC;CCDC93
prerank,negative regulation of transposition (GO:0010529),-0.2984731520095698,-0.8494367249037199,0.6868686868686869,0.8688896211314776,1.0,9/16,41.69%,PIWIL2;TDRD9;MYBL1;AICDA;PIWIL4;PIWIL1;TUT7;MOV10;UBR2
prerank,wound healing (GO:0042060),0.23360258416015509,0.8490113181738113,0.7503628447024674,0.9707250764575112,1.0,6/62,3.45%,FGF10;FUT10;DST;RAB3A;PAK1;SYTL4
prerank,transcription by RNA polymerase III (GO:0006383),0.27706952856233824,0.8489796801273903,0.6962233169129721,0.9700821315048913,1.0,2/27,1.03%,POLR2L;IVNS1ABP
prerank,cellular component disassembly (GO:0022411),-0.2180405756532648,-0.8480537882531489,0.7655786350148368,0.8711073231091482,1.0,16/53,21.94%,CD44;CAPN1;SH3PXD2B;CAPN2;CTSL;SCUBE1;LCP1;ADAM8;EXOC8;GSN;TLL2;HTRA1;MMP8;MMP11;TIMP1;NOXO1
prerank,regulation of cytoplasmic transport (GO:1903649),0.3489881289245886,0.8480263982182326,0.6852173913043478,0.9714872088676982,1.0,4/11,25.08%,ATP9A;MAPK3;USP7;MAPK1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.3252282309438269,-0.847959115666522,0.6572104018912529,0.8707209455909503,1.0,4/12,15.15%,UVRAG;SMCR8;JMJD4;TNF
prerank,spliceosomal snRNP assembly (GO:0000387),-0.23437951210303284,-0.8476095150279135,0.7520215633423181,0.8708833566568303,1.0,11/38,18.66%,PRPF19;CLNS1A;SNRPD1;PRPF6;SNRPB;LSM2;CD2BP2;DDX20;SNRPC;PRPF3;USP4
prerank,reverse cholesterol transport (GO:0043691),-0.31134308419937406,-0.8475669105829787,0.68,0.8703919136775062,1.0,2/13,9.44%,APOE;ABCG1
prerank,fatty acid catabolic process (GO:0009062),-0.2043024186992888,-0.847356227567937,0.8078175895765473,0.8702638113848662,1.0,10/67,10.07%,ACOT8;AIG1;SLC27A4;MTLN;PPARD;DECR1;ACAA2;CROT;PEX13;ACAD10
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.254478525710697,0.8472255785095996,0.711864406779661,0.9725502619378001,1.0,7/39,12.51%,FGF10;PAK1;BMP4;PKD2;FGF2;NPNT;PKD1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.27538127330160583,-0.8471167995893821,0.7037974683544304,0.870168426665651,1.0,4/20,17.21%,AKAP12;PJA2;LRRK2;AKAP5
prerank,ATP transport (GO:0015867),0.36716296991538316,0.8471058369185,0.6587591240875912,0.9720988818230125,1.0,3/10,19.64%,SLC25A4;SLC25A5;ABCC6
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2326663094152335,0.8467476118868917,0.7485549132947977,0.9721726423675383,1.0,23/65,27.52%,PSMB1;PSMF1;PSMA1;FHL1;PSMD7;PSMA8;ZFYVE19;PSME3;PSMD14;PSMC4;PSMB4;FBXL7;PSME1;PSMD2;NABP1;PSMD4;PSMD8;AURKA;PABIR1;PSMC5;PSMD3;PSMB8;PSMA4
prerank,cellular biogenic amine catabolic process (GO:0042402),0.357857652344509,0.8465455847372882,0.6625659050966608,0.9718955524598024,1.0,2/10,14.73%,LRTOMT;COMT
prerank,urogenital system development (GO:0001655),-0.3267030550889102,-0.8465111178517751,0.6722488038277512,0.8708881968913077,1.0,6/11,40.85%,ANXA1;LHX1;SHH;PAX8;OSR1;SOX9
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.28858441693813985,0.8460755706200548,0.673202614379085,0.9722047382090788,1.0,5/23,14.04%,MEF2C;ATP11A;TGFB1;LMOD3;SMYD1
prerank,glutathione biosynthetic process (GO:0006750),0.34585859526367135,0.8460628366386611,0.6468590831918506,0.9715266140883242,1.0,3/11,18.65%,GSS;GGCT;CHAC2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.17713415156461845,0.8458092090879281,0.9768611670020121,0.9713563401405206,1.0,281/1646,17.97%,ZFHX3;POLR2L;WNT4;HOXA5;HHEX;NUCKS1;SCRT2;MAGED1;TSC22D4;CTR9;MED12L;CD80;HSF4;ZFP57;SALL3;IKZF4;DRAP1;CDK15;DENND4A;KCNH2;CAPN3;TLE2;NACC2;LDB1;SMARCC2;MED24;PQBP1;ONECUT2;BRD9;MYRFL;FUS;WWTR1;BPTF;CSRNP3;POU2F2;USF2;HOXD4;TFCP2;CNOT2;ZNF394;ESRRG;PKN1;DDX5;RAI1;DNAJC2;LBX2;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;PSRC1;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;ELP2;SP2;SOX10;TENM1;TFCP2L1;TFAM;PPARGC1A;NSD1;UBE2V1;MEOX2;WBP2;SOX4;GTF2H2;BCL11B;MED4;ZBTB12;PPARA;HOXB9;SPINDOC;HOXC6;BRWD1;PBX2;HOXB7;MLLT11;E2F1;CD86;ELOC;FGF7;TCIM;IL6;HDGFL2;ZFPM2;SMARCE1;XRCC6;FOXD1;NR2F6;RFX6;ZMYND15;CTBP1;MEF2C;AR;DPF2;RXRG;DYRK1B;NDP;MED31;PCGF6;MAP3K10;TADA3;FUBP3;ZNF35;ZNF205;BTRC;MAZ;TGFBR1;OGG1;HOXC10;REPIN1;PHF6;NCOR2;DAB2IP;TIMELESS;APBB1;PRICKLE1;LHX3;POFUT1;BMP4;SP4;EBF1;DGKQ;ZBTB22;TCF7L2;PHC1;OGT;ERBB4;FOXC1;PPM1A;HEY1;HDAC5;ZFP82;HTATSF1;TGFB1;ZFP91;TSHZ2;LBH;TBX2;ZNF23;ZC3H8;ZKSCAN8;SNAI2;HEXIM2;MSANTD1;KLF7;NEK4;SPIN1;SS18L1;DMRTA1;GBX1;GRHL3;NKAP;HSF2;FGF2;NFE2L2;PEX14;ZNF32;ZFP1;ZFP69;SLC39A8;KDM2B;CBX4;SMARCD3;MLLT6;ZFP41;HOXB2;NOP2;KAT8;RFXAP;POU3F4;SFRP1;ACVR1B;SUV39H2;PBX3;ZNF383;POLR3F;METTL4;FANK1;WWC1;THAP1;MLF2;USF1;GABPA;EPAS1;HLF;TFEB;HOXB5;SAMD1;PHF8;CHMP1A;PDGFB;TBX6;SCML2;TEF;FBXL19;SMARCAL1;LHX5;SUB1;RBFOX2;MYRF;KDM4A;PLAG1;PRDM16;ZSCAN12;GPATCH3;ABCA2;ZBTB32;MYNN;DMAP1;BAP1;BARX2;HMGB1;CCNK;PPP1R13L;LMX1B;SPTY2D1;ZBTB49;SNX6;NKX2-2;INSR;IKZF2;BRD4;ZNF740;APBB3;ERCC6;IRF5;HMGB3;PRDM1;BATF;ERG;CCAR2;BHLHA9;EDF1;WNT7A;REST;UXT;TCF3;TCF7L1;PRDM15;LHX2;UBE2I;CALCOCO1;ATP8B1;BHLHE41;EN2;SUFU;KLF16;YWHAQ;IRF2BP1;AGT;PAK6;BRIP1;BACH1;PRKAR1A;ENG;TMPRSS6;HDGFL3;KMT2E;PPP2R1A;KLF12;ZIC5;BTG1;ZFP30;ZEB1;BACH2;HMG20A;ZBTB34;PHF1;PHF2;ELAVL2;POU3F3
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2016208664918923,-0.8457762586667217,0.7980132450331126,0.8718214275899817,1.0,23/79,21.24%,UBE2D3;PPARG;PTPN1;SMURF2;THBS1;SMAD9;LEMD3;SPRY2;NOTCH1;SMAD6;SPRY1;GREM1;BMP2;CREB3L1;SPRY4;HIPK2;SMAD4;NIBAN2;ADAMTS12;ACVR2A;GDF3;BAMBI;TRIM33
prerank,acetyl-CoA metabolic process (GO:0006084),0.3163126548920516,0.84567639112797,0.6523887973640856,0.9709635028541577,1.0,8/15,32.37%,ACLY;PPCS;ACACB;ACSS1;HMGCS1;DIP2A;ACAT1;MLYCD
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.3437670895044916,0.8455303715377969,0.7015985790408525,0.9705792706995382,1.0,6/12,25.93%,BRD8;LMO2;RDX;CTSS;GAS2L1;CTSH
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3103936293277696,-0.8451381446606427,0.6828703703703703,0.8725471053466345,1.0,1/13,0.97%,IGF1
prerank,negative regulation of cellular component organization (GO:0051129),0.22678379815840088,0.8450871792292346,0.7542134831460674,0.9708544577169455,1.0,24/74,25.30%,SCAMP5;HSPA2;TMC8;PEX5;PRKCZ;CLU;AR;RAPGEF3;PRKD1;SNX33;OPRD1;XRCC5;CDC42;RDX;ABCA7;PACSIN3;ULK1;IMPACT;WASL;AIDA;SYT11;TMEFF2;CRYAB;DDX3X
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.21519346677798298,-0.8445184705455112,0.7857142857142857,0.873263949724865,1.0,8/53,10.05%,APOE;FBXW7;PRKACA;PSME2;PSMC6;GNA12;XPO1;RAD23B
prerank,fatty acid beta-oxidation (GO:0006635),-0.2164936782996059,-0.8444933776041693,0.7730061349693251,0.8727530196062535,1.0,8/51,10.07%,ACOT8;ACOX3;MTLN;PPARD;DECR1;ACAA2;CROT;ACAD10
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.23120693967136963,-0.8442247540832151,0.7352941176470589,0.8727300167938923,1.0,5/39,6.67%,MYO5A;TRAK1;RAB1A;MYO1F;MYO15A
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2829937575659778,0.8439293888923908,0.6853932584269663,0.9726992774908014,1.0,8/25,22.78%,MLLT11;PDCD5;DNM1L;BIK;BBC3;MFF;CIDEB;HRK
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.23420556997997433,-0.8438137758345426,0.7282321899736148,0.873001319007673,1.0,10/33,20.54%,CDK6;CDC73;KANK2;CDKN2C;WEE1;PRMT2;RB1;E2F7;CDKN2A;KLF4
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3446937467514055,-0.8435447438921092,0.6621315192743764,0.8729913149500313,1.0,5/10,20.95%,MTHFR;MTHFD1;TYMS;MTHFD2;DHFR
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3003842488692118,-0.8434461672787137,0.6760925449871465,0.8725973330962468,1.0,4/15,19.66%,PRKCH;NUMA1;TRIM16;SULT2B1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.19067183590424336,-0.8433549140131144,0.876,0.8722309554186113,1.0,55/116,36.93%,FCGR2B;CD163;PRKACA;ADCY9;PTGER4;SYK;LYN;FYN;HCK;ADCY5;VIPR1;ADCY6;ADCY1;ADCY3;NPSR1;PRKACB;RAMP2;CALCRL;GPR27;MYH9;ADAM17;PTHLH;CD247;VIPR2;RXFP2;PTH1R;CRH;CALCA;GLP1R;RAMP3;SCTR;ADORA2A;VIP;CREB1;GPR83;PTGDR;PTGIR;GPR15;RHBDF2;FGR;GGT1;GIPR;MC2R;CRHR2;CYSLTR2;DRD1;CALCR;CD3G;FSHR;LHCGR;POMC;NPS;GHRH;CALCB;ADCY4
prerank,mRNA stabilization (GO:0048255),-0.22939846741246772,-0.843136577160985,0.7300771208226221,0.8721183836873384,1.0,18/40,33.40%,NOCT;MAPKAPK2;EIF4ENIF1;TENT5A;SLC11A1;SYNCRIP;LARP1;MYD88;HNRNPC;HNRNPU;TENT5C;VIP;PAIP1;DAZL;THRAP3;HNRNPA0;YBX3;AXIN2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.2691702038976245,-0.8430900043360916,0.6919060052219321,0.8716445299035696,1.0,9/21,27.72%,DLG5;TUBD1;TEDC2;UCHL5;KIF7;SHH;ULK3;TEDC1;EVC
prerank,glutamate metabolic process (GO:0006536),0.3026260375994633,0.8430866479189881,0.6832797427652733,0.9738010625181277,1.0,10/19,32.90%,FPGS;ALDH5A1;PRODH;GLUL;GLS2;DGLUCY;GAD1;MTHFS;GCLM;ALDH18A1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2430744506047041,0.8429209675685797,0.7354260089686099,0.9734439236952463,1.0,10/52,15.55%,HOGA1;FPGS;MTHFD1L;MTHFD2L;ALDH1L1;MDH1;ACOT4;ALDH5A1;SLC19A1;ACLY
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.27210427096577383,-0.8428992596738518,0.7109375,0.8714679170222783,1.0,4/20,12.50%,CELF1;LIMD1;AJUBA;AGO2
prerank,negative regulation of calcium ion transport (GO:0051926),0.3144824238660632,0.8428930996248778,0.6893542757417103,0.972808855889966,1.0,2/15,6.94%,CBARP;ADRA2A
prerank,regulation of centrosome cycle (GO:0046605),-0.27421299568340307,-0.8428403827783575,0.7178841309823678,0.8710386816660897,1.0,8/21,24.26%,CHMP4B;ATF5;PDCD6IP;CHMP1B;NPM1;NAT10;MARK4;PKHD1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.34194987516844955,0.8426628203697103,0.6695352839931153,0.9726340690759336,1.0,6/12,28.16%,IL5RA;MAPK3;PTK2;IL34;MAPK1;CSF1R
prerank,tRNA wobble uridine modification (GO:0002098),-0.30463450609601717,-0.8425872304527494,0.684863523573201,0.8709750848842533,1.0,7/14,24.58%,ALKBH8;MTO1;TRMT9B;KTI12;DPH3;URM1;CTU2
prerank,positive regulation of cellular component organization (GO:0051130),0.21329655157827382,0.8423465618741949,0.7906040268456376,0.9726233925339086,1.0,21/107,15.58%,TPPP;NEUROD2;FRMPD4;NRXN1;CLU;AR;ABCB4;TGFBR1;DAB2IP;SHANK3;RAPGEF3;BAK1;FAF1;TGFB1;DCTN1;MMP1;BIK;CBLL1;INSR;NEDD4L;ANAPC2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2019910439192456,-0.8422792012100995,0.8184523809523809,0.8710648261616997,1.0,18/75,20.01%,APOE;CD300A;STK38;PTPN1;PKIB;LYN;IL1B;SPRY2;SPRY1;RB1;INPP5K;DUSP1;SPRY4;PLK1;IPO7;LRP6;CDKN2A;BMP7
prerank,cellular copper ion homeostasis (GO:0006878),-0.30585557142093167,-0.8416511554600972,0.6917808219178082,0.8716983400783391,1.0,4/14,8.48%,COX19;ATP7A;SLC31A2;CCDC22
prerank,regulation of double-strand break repair (GO:2000779),0.25835520619588404,0.8411700299858028,0.7237654320987654,0.9744686285115831,1.0,4/39,7.90%,WRAP53;PPP4C;USP51;TIMELESS
prerank,glucose import (GO:0046323),0.32362778330282105,0.8410544728755085,0.6803418803418804,0.9740433147105394,1.0,1/13,0.51%,SLC2A3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.32449597226124777,0.8409494153845934,0.6775300171526587,0.9735485426244372,1.0,4/14,14.26%,PFAS;GART;ADSL;RFK
prerank,DNA catabolic process (GO:0006308),0.3428660579883266,0.840766539491756,0.6614035087719298,0.9732326703039175,1.0,2/11,5.22%,DNASE1;DNASE1L2
prerank,peptidyl-threonine modification (GO:0018210),0.22893453813886297,0.8405812188610957,0.7540263543191801,0.9729434216303964,1.0,18/66,20.74%,DYRK1B;MAP3K10;CDC42BPA;TGFBR1;GALNTL6;PRKCA;PRKD2;STK39;ACVR1B;PRKD1;CDK10;ROCK1;CDC42BPB;WNK1;GALNT4;GALNT2;SBK1;PDPK1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.1788781283732402,0.8404947089059118,0.952232606438214,0.9724073081451095,1.0,167/834,20.62%,ZFHX3;HOXA5;HHEX;AGRN;BCL9L;CDK7;MPND;TET1;ZFPM1;DRAP1;IL4I1;LDB2;LDB1;MED24;ONECUT2;WWTR1;BPTF;CSRNP3;POU2F2;USF2;HOXD4;TFCP2;PTPRN;TXK;KDM6B;NR1I2;FOSL1;NRL;NR1I3;NFIB;RELA;PPARGC1A;MEOX2;WBP2;SOX4;BCL11B;MED4;PPARA;PBX2;BRD8;HOXB7;E2F1;GABPB1;IL6;ZFPM2;CRTC1;XRCC6;RFX6;KDM1B;MEF2C;AR;DPF2;RXRG;BCLAF3;GTF2F1;FUBP3;AKAP8L;HOXC10;MYO6;DAB2IP;APBB1;SS18;MACC1;LHX3;LMO2;BMP4;CD81;TCF7L2;ADCYAP1;OGT;MAP2K5;PRKD2;PKD2;FOXC1;HEY1;HDAC5;GRIN1;ZNF462;RNASEL;TGFB1;TAF9;MEPCE;MAML3;PRKN;KLF7;SS18L1;ITGB1BP1;AKIRIN2;GRHL3;HSF2;FGF2;NFE2L2;PTOV1;SMARCD3;MLLT6;HOXB2;KAT8;RFXAP;WWC1;USF1;GABPA;EPAS1;HLF;TFEB;PKD1;PDGFB;PARP1;PFKM;SUB1;PLAG1;FLCN;EAF2;BARX2;HMGB1;CCNK;LMX1B;ZBTB49;RBL1;APEX1;PRDM10;BRD4;GAL;IRF5;ERG;WNT7A;REST;TCF3;MAPK3;PRKD1;PRDM15;MED25;CALCOCO1;SETX;RRP1B;HRAS;RHOQ;ITGA6;ENG;TMPRSS6;TLR3;ZNF750;XBP1;RGMA;IL18;MAX;FOSL2;ECD;PIN1;HDAC3;ZBED4;DVL2;DCN;BMPR1B;REL;RORA;TNIP2;ATAD2;EIF5A;COPS5;SRF;DHX36;ARRB1;IRF2BPL;RNF10;SMAD2;SMAD1;GLI3
prerank,regulation of humoral immune response (GO:0002920),-0.22695038796493328,-0.8400782232375658,0.7590673575129534,0.8742669159791906,1.0,11/44,20.14%,FCGR2B;C3AR1;C5AR1;C4B;SERPING1;CD55;CFHR2;C1QC;CFP;C2;C1QB
prerank,smooth muscle tissue development (GO:0048745),-0.3506499792614173,-0.8399314584947181,0.6768867924528302,0.8740163000902125,1.0,5/10,22.33%,PROX1;EFEMP2;MYLK;PTCH1;SHH
prerank,nucleocytoplasmic transport (GO:0006913),-0.23213081976067057,-0.8398581335035624,0.7540983606557377,0.8736183499202061,1.0,10/40,15.90%,RSRC1;NCBP1;SNRPD1;ATXN1;SNRPB;XPO1;NUTF2;NXT1;NPM1;DDX20
prerank,cellular response to virus (GO:0098586),0.27081455298898793,0.8394245600292667,0.7272727272727273,0.9740135308582729,1.0,13/30,27.28%,POU2F2;IL6;GSDME;TOMM70;RRP1B;CCL5;EIF5A;ARF1;IRF3;IRGM;POU2AF1;DDX3X;LGALS8
prerank,endoplasmic reticulum organization (GO:0007029),0.22598512598156076,0.8393096964389224,0.764367816091954,0.9735778921513601,1.0,15/72,15.73%,SEC16B;REEP2;ATL1;SGTA;PRNP;MAPK15;SEC31A;OTOF;EMD;TRAM2;CCDC47;DNM1L;MOSPD3;TRAM1;MIA3
prerank,import into nucleus (GO:0051170),0.22637815681635715,0.8389975432719489,0.7618364418938307,0.9735586648431438,1.0,18/73,20.68%,TSC2;FAM53C;NXT2;PRICKLE1;HEATR3;FAM53B;SNUPN;SNRPD2;NUP88;IPO5;HNRNPA1;NUP133;GEMIN5;GEMIN6;BACH2;SNRPD3;IPO8;POM121
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.35221223925942496,0.8388834100457793,0.6937716262975778,0.9730990383087839,1.0,4/10,15.10%,HECW2;NEDD4;STK39;NEDD4L
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.22100514279480252,-0.8378489846908462,0.7777777777777778,0.877033162847857,1.0,16/46,26.81%,PTPRC;PTPN1;RANBP9;RPS6KA6;LYN;SPRY2;SEMA6A;SPRY1;TLR4;SMAD4;TNIP1;GSTP1;DUSP3;TIMP3;FBLN1;SPRED1
prerank,endosome organization (GO:0007032),0.2532078206067396,0.8377350472530805,0.7401215805471124,0.9748219331245205,1.0,10/41,18.73%,ANXA8;ANXA8L1;USP50;PI4K2A;TMEM9;HOOK2;VPS33B;ALS2;SNX33;HOOK1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.32517985425432483,0.8376915726145047,0.6894824707846411,0.9742075372530558,1.0,2/13,8.53%,BLOC1S2;RHOT1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.25513037159650803,-0.8374261897753212,0.720626631853786,0.8773338266127629,1.0,7/25,12.84%,PTPRC;CCR2;IRF4;ANXA1;IL1B;CD28;STOML2
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.27415746189384227,-0.8370934430462168,0.7355769230769231,0.8774650630061473,1.0,9/19,38.82%,GOT1;ALDH7A1;PIPOX;AASS;SDS;HYKK;PHYKPL;CRYM;GOT2
prerank,TOR signaling (GO:0031929),0.27858538482180495,0.8370264471758802,0.7014681892332789,0.9749509228707184,1.0,9/26,28.38%,RPTOR;RPS6KB1;PRR5;FLCN;SMG1;RHEBL1;MEAK7;EIF4EBP1;TIPRL
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2530815763649903,-0.8369140671677268,0.7090909090909091,0.877263456865249,1.0,10/27,21.75%,FBXL17;FBXL8;CRY2;CRY1;SIK1;PDE6B;PER2;FBXL12;BHLHE40;ID2
prerank,DNA double-strand break processing (GO:0000729),-0.2878298995750223,-0.8361826260208989,0.6909090909090909,0.8781452120580734,1.0,5/18,12.58%,RBBP8;NBN;BRCA1;BARD1;KAT5
prerank,regulation of cilium assembly (GO:1902017),0.23554768158982717,0.8361696263181508,0.7514204545454546,0.9760578011878558,1.0,22/62,28.99%,IFT20;SGSM3;MAPK15;LIMK2;CDKL5;TBC1D16;RABEP2;ARHGAP35;TBC1D8;IFT88;CDK10;TCHP;CYLD;CDKL1;CEP120;TBC1D30;FUZ;TBC1D22B;TBC1D24;ENTR1;TBC1D9B;DCDC2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.321536133012876,-0.8361594548686536,0.6890547263681592,0.8776345388847003,1.0,5/11,21.65%,GNPDA1;UAP1L1;GNPNAT1;NAGK;RENBP
prerank,cell-cell junction maintenance (GO:0045217),-0.322953566136584,-0.8359198295175493,0.6613995485327314,0.8775750186712139,1.0,6/11,27.57%,PARD6A;MYADM;NLGN2;PRTN3;TJP1;CD177
prerank,modulation by host of symbiont process (GO:0051851),0.2626080865033565,0.8358440343651637,0.7112903225806452,0.9760713341640985,1.0,8/31,19.31%,NUCKS1;CX3CR1;SAP30BP;NAPEPLD;HPN;REST;RRP1B;CCL5
prerank,negative regulation of cellular senescence (GO:2000773),-0.3138444851216313,-0.8357523308784301,0.6712962962962963,0.8773548436063549,1.0,6/13,27.88%,CDK6;TERF2;HMGA2;TWIST1;TERT;SLC30A10
prerank,regulation of cell-substrate adhesion (GO:0010810),0.2500722819709573,0.8356675578988373,0.7585139318885449,0.9757834596866142,1.0,10/42,16.64%,THY1;CORO2B;PTPRO;NPNT;MINK1;PDGFB;NDNF;FBLN2;RSU1;PTK2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.23778764180221648,-0.8356563799088292,0.739946380697051,0.8769915913811392,1.0,5/31,11.65%,ALOX5;MOCS2;MOCS1;PYCR2;HSD17B1
prerank,protein kinase B signaling (GO:0043491),0.28438576286092937,0.8355895098791037,0.7075928917609047,0.97525235145262,1.0,4/23,9.71%,TSC2;ADTRP;TGFB1;PLK3
prerank,response to hydroxyurea (GO:0072710),0.34369696078461576,0.8354720970805556,0.6970740103270223,0.9748110493063499,1.0,2/11,14.43%,TIMELESS;NSMCE3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.288526468219958,0.8353363613384733,0.6995153473344103,0.974427259192259,1.0,7/21,20.27%,MED24;FOSL1;MED4;SUB1;SETX;SRF;DHX36
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.3184116533709116,0.8352695719028825,0.701048951048951,0.9738723665584433,1.0,2/15,9.00%,ROGDI;FOXC1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3510170260893114,0.8348528612793605,0.7013888888888888,0.9740302453362765,1.0,1/10,7.88%,CNGB1
prerank,glutathione metabolic process (GO:0006749),0.25524972399971385,0.8342110999701139,0.7201210287443268,0.9746830081984468,1.0,5/38,11.22%,GGT7;GSS;GGT5;GGCT;CTNS
prerank,cell-matrix adhesion (GO:0007160),0.21450197818536793,0.8341893407736573,0.8097222222222222,0.9740381415529075,1.0,17/95,15.05%,CTTN;MKLN1;CD34;STRC;THY1;ITGB6;ITGB5;TRIP6;SGCE;ACTN2;ITGB1BP1;ADAM15;ITGA10;NPNT;PKD1;VTN;RCC2
prerank,regulation of neuron differentiation (GO:0045664),0.22378805360157503,0.833900872385983,0.7967836257309941,0.9739565004003652,1.0,20/76,25.64%,ZFHX3;BIN1;NEUROD2;MEF2C;HEY1;NRCAM;BEND6;EIF2AK4;VWC2;REST;TCF3;ROCK1;ZEB1;NREP;IMPACT;ZC4H2;BDNF;TIAM1;RHOA;DISP3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.27490997931549327,0.8334861187539472,0.7425742574257426,0.9741564903526501,1.0,6/28,15.22%,C3;NOS1AP;EIF6;CX3CR1;CTNS;FITM2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.31293577114371707,0.8332239435959571,0.706081081081081,0.9740244461322978,1.0,3/16,11.30%,CADM1;SLAMF6;CRTAM
prerank,respiratory electron transport chain (GO:0022904),-0.3096286304676667,-0.8330574092848967,0.6708860759493671,0.8814877498317955,1.0,3/14,6.35%,GPD2;NDUFA5;SDHB
prerank,regulation of mRNA catabolic process (GO:0061013),-0.18301128176524223,-0.8328712286418043,0.9159663865546218,0.8813026012678762,1.0,25/121,18.03%,PSMA6;PSMB2;MAPKAPK2;PSME2;SAMD4A;PUM2;PSMD11;PSMC6;UBC;PSMA3;EXOSC8;UBA52;ZC3H12A;VIM;XPO1;RC3H1;PSMD10;EXOSC9;PSMB5;HSPB1;RC3H2;FXR2;PSMD5;ZC3HAV1;HNRNPD
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3380256206438167,-0.8328427165160414,0.6607538802660754,0.8807927309277236,1.0,4/10,23.05%,RACGAP1;ECT2;SIRT2;CCNB1
prerank,cellular response to interleukin-2 (GO:0071352),-0.3297941909552238,-0.8328272636046822,0.6921397379912664,0.8797086388164007,1.0,4/11,15.28%,STAT5B;SYK;SHC1;PTK2B
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.3297941909552238,-0.8328272636046822,0.6921397379912664,0.8797086388164007,1.0,4/11,15.28%,STAT5B;SYK;SHC1;PTK2B
prerank,dicarboxylic acid transport (GO:0006835),0.27053490072581077,0.8327857182523005,0.7274193548387097,0.9742941028562522,1.0,6/28,14.50%,GIPC1;SLC1A1;SLC25A18;SLC26A7;SLC1A3;SLC19A1
prerank,O-glycan processing (GO:0016266),0.2389964332827498,0.8327579352153857,0.7702312138728323,0.9736596331044326,1.0,13/54,22.98%,B3GNT6;ST6GALNAC2;POFUT1;GXYLT1;C1GALT1;POMGNT1;GCNT4;ST3GAL3;GALNT4;GALNT2;GCNT1;ST6GALNAC4;GALNT9
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.26525593310489126,-0.8324872728845113,0.7412935323383084,0.8797866198023488,1.0,2/22,1.32%,VPS37C;PTPN23
prerank,cellular response to leucine starvation (GO:1990253),0.3560659599739129,0.83231064931457,0.6818980667838312,0.9738889039582201,1.0,6/10,31.34%,EIF2AK4;IMPACT;RRAGD;GCN1;SESN3;RRAGB
prerank,regulation of superoxide anion generation (GO:0032928),-0.296813457784035,-0.8321621134360246,0.675609756097561,0.8799031921402405,1.0,7/14,34.55%,TYROBP;SYK;GSTP1;CD177;FPR2;ITGB2;CRP
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.30883602245275127,-0.8320505355135791,0.7099056603773585,0.8795685203793389,1.0,5/13,21.01%,SEC16A;TMEM30A;TM9SF4;GCC2;INSIG1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.35364052705376786,0.8319145408647933,0.6967370441458733,0.9740049722289422,1.0,2/10,10.80%,WRAP53;CCT4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.30872670507636285,0.8318076920043816,0.7105719237435009,0.9735311997932288,1.0,2/17,6.72%,PLA2G3;LPCAT1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.27285168943140325,-0.831714140431098,0.7142857142857143,0.8797142786886984,1.0,10/20,38.10%,ADCY9;DRD2;ADRA1A;DRD3;GPR101;ZDHHC21;PDE4D;DRD1;ADRA2C;ADRB2
prerank,protein destabilization (GO:0031648),0.26197923133008616,0.8314403196151191,0.733652312599681,0.9735993679392431,1.0,9/32,18.76%,GGA3;CAPN3;PRNP;BTRC;PRKN;DERL1;SERF2;PEX2;FBXL3
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.21497845738272572,0.8313611047758056,0.8102288021534321,0.9730724629985064,1.0,24/94,21.80%,PSMB1;RELA;UBE2V1;IL1RAP;PSMF1;BTRC;PSMA1;NOD1;PSMD7;PELI3;PSMA8;UBE2N;PSME3;MAP3K7;PSMD14;PSMC4;MAPK3;IL1A;PSMB4;TNIP2;PSME1;PSMD2;PSMD4;PSMD8
prerank,positive regulation of transporter activity (GO:0032411),0.3267388451462129,0.8309875251143934,0.6928571428571428,0.9731926805338217,1.0,3/13,11.52%,SYNGR3;STK39;TRPC6
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.18690715034724958,-0.830772744204087,0.8951612903225806,0.8809557090706597,1.0,55/117,36.93%,CD163;PRKACA;ADCY9;PTGER4;SYK;LYN;FYN;HCK;ADCY5;VIPR1;ADCY6;ADCY1;ADCY3;NPSR1;PRKACB;RAMP2;CALCRL;GPR27;MYH9;ADAM17;PTHLH;CD247;VIPR2;PLA2G2D;RXFP2;PTH1R;CRH;CALCA;GLP1R;RAMP3;SCTR;ADORA2A;VIP;CREB1;GPR83;PTGDR;PTGIR;GPR15;RHBDF2;FGR;GGT1;GIPR;MC2R;CRHR2;CYSLTR2;DRD1;CALCR;CD3G;FSHR;LHCGR;POMC;NPS;GHRH;CALCB;ADCY4
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.2778573463620253,0.8305134552960106,0.7142857142857143,0.9734842318444215,1.0,10/25,25.24%,SGTA;PSMF1;EFNA1;EPHA4;PRKCG;ALAD;HSP90AB1;OPHN1;TRIM39;HFE
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.3093876351962726,-0.830121593361952,0.6953488372093023,0.8816081135039877,1.0,2/12,8.08%,PAEP;IL1B
prerank,positive regulation of dendrite development (GO:1900006),-0.3396330059576409,-0.8300188479956943,0.6690647482014388,0.8812594980305479,1.0,6/10,31.18%,BMP5;COBL;PTN;BMP7;VLDLR;PACSIN1
prerank,macrophage differentiation (GO:0030225),-0.29944112747152873,-0.8299480519769296,0.6666666666666666,0.8808188162625273,1.0,1/13,0.22%,IL15
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.294603881414227,0.8299299539345217,0.7152899824253075,0.9739812535230459,1.0,5/20,9.90%,TGFBR3;TGFBR1;BMP4;HEY1;SNAI2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.25397917406047554,-0.8298005076399471,0.7255936675461742,0.88056272662393,1.0,7/24,13.79%,IGF1;PPP1R3C;IGF2;SORBS1;PPP1R3F;PPP1R3E;INPP5K
prerank,protein localization to nucleus (GO:0034504),0.21486358041876244,0.8297421954790516,0.8222523744911805,0.9737224661416806,1.0,17/102,16.18%,HHEX;TSC2;YWHAE;SIX4;FAM53C;NXT2;PRICKLE1;BMP4;HEATR3;FAM53B;NUP88;ARL2BP;CHCHD10;IPO5;TAF3;NUP133;PAF1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.20156071897090538,-0.8294678538166523,0.8537414965986394,0.8806149215585968,1.0,20/66,21.75%,ANKRD17;CDK6;CDC73;KANK2;PSME2;CCND1;ANXA1;CDKN2C;WEE1;PRMT2;CCND2;RB1;EGFR;E2F7;ADAM17;RGCC;CDKN2A;APPL2;KLF4;ID2
prerank,activation of GTPase activity (GO:0090630),-0.19295072707968103,-0.8291048342657129,0.8679245283018868,0.880746557966756,1.0,22/89,18.94%,TBC1D1;DOCK7;CORO1C;CCDC125;SLC27A4;RABGAP1;TBC1D2;ARHGAP24;ABR;RALGAPA2;FOXJ1;ARHGEF26;TBC1D10C;TBC1D10A;GPR65;USP6NL;ADPRH;EPHA2;ARHGEF5;TBCK;ECT2;TBC1D22A
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3292142187986675,-0.8284884818885971,0.6867469879518072,0.8808479591888079,1.0,1/10,4.69%,CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3292142187986675,-0.8284884818885971,0.6867469879518072,0.8808479591888079,1.0,1/10,4.69%,CEP250
prerank,cholesterol biosynthetic process (GO:0006695),0.2637649169519604,0.8281234897556476,0.7383177570093458,0.9764601242079357,1.0,6/31,18.81%,TM7SF2;ACAT2;NSDHL;LSS;ACLY;FDPS
prerank,negative regulation of protein secretion (GO:0050709),0.2529433084877422,0.828074745631911,0.7533632286995515,0.9758767941393521,1.0,11/38,23.25%,ADTRP;RAB11FIP3;ADRA2A;PRKN;IRS1;SFRP1;REST;OPRM1;ERP29;MIDN;CHGA
prerank,tetrapyrrole metabolic process (GO:0033013),0.30378341951291415,0.82771642553948,0.7013201320132013,0.9759334964605736,1.0,5/18,24.28%,ABCB6;MTR;MMAA;TCN2;MMAB
prerank,macrophage activation involved in immune response (GO:0002281),-0.31449022528863374,-0.8274769693517624,0.6810551558752997,0.8822608682222972,1.0,4/13,14.57%,TYROBP;SYK;DYSF;LBP
prerank,positive regulation of isotype switching (GO:0045830),-0.2931166339603013,-0.8267870340654673,0.7004830917874396,0.8830000224990837,1.0,4/15,12.44%,TFRC;MAD2L2;PAXIP1;SHLD1
prerank,response to hexose (GO:0009746),0.2749956435947385,0.8265124834674782,0.7093023255813954,0.977692931948727,1.0,5/25,15.19%,SELENOS;TCF7L2;EIF2B3;KHK;EIF2B1
prerank,regulation of spindle organization (GO:0090224),0.2944708267139662,0.8265026699185198,0.7096774193548387,0.9770285135205424,1.0,5/18,16.27%,PSRC1;FSD1;RAE1;DCTN1;MAP9
prerank,protein deacylation (GO:0035601),0.2796840531954275,0.8260405530475113,0.7313195548489666,0.9772764233022989,1.0,5/23,18.86%,LYPLA1;HDAC5;LYPLAL1;HDAC3;ABHD17C
prerank,regulation of phosphatase activity (GO:0010921),-0.2584072291574556,-0.8257617838275698,0.7397959183673469,0.8843356698205501,1.0,12/24,28.04%,PPP6R1;PTPA;PPP6R3;PPP1R35;BMP2;PPP1R2;CHP1;CHP2;SH2D4A;PPP1R26;PPP1R17;TSC1
prerank,regulation of protein metabolic process (GO:0051246),0.2456573715785557,0.8257561191637204,0.76049766718507,0.977148284468384,1.0,14/44,21.35%,IL17F;CNDP1;MAP2K5;FAF1;CENATAC;ZDHHC2;TMEM9;NEDD4L;SSH1;CHRNA7;LTBP4;SNF8;HSP90AB1;ABCA7
prerank,positive regulation of lipid catabolic process (GO:0050996),0.29674683393695456,0.8257144502988027,0.7058823529411765,0.9765580780046115,1.0,6/19,22.69%,PPARA;IRS1;ABHD5;ANGPTL3;ABCD2;DAGLB
prerank,regulation of fat cell differentiation (GO:0045598),0.22444022243613598,0.8256206756746898,0.7785714285714286,0.9760642875969342,1.0,10/74,9.35%,ZFPM1;WWTR1;GNB3;RARRES2;E2F1;IL6;ZFPM2;TRIB2;ZFP36L2;TGFB1
prerank,spinal cord development (GO:0021510),0.32939472536251446,0.825200561210088,0.7033898305084746,0.976224937952834,1.0,3/12,12.51%,SOX4;PKD2;PKD1
prerank,response to retinoic acid (GO:0032526),-0.2035321102450277,-0.8251880363047868,0.85,0.8849039631290112,1.0,24/59,31.60%,ABL2;BRINP1;RARA;LYN;RET;SNW1;OVCA2;RXRB;TESC;PTK2B;WNT5A;ADNP2;TRIM16;WNT9A;FZD4;NDUFA13;WNT6;FZD10;LTK;AQP1;CREB1;CDKN2D;ATM;FZD7
prerank,transcription by RNA polymerase II (GO:0006366),0.18767815301685348,0.8250460800306018,0.9013921113689095,0.9758567705385667,1.0,72/305,22.53%,POLR2L;CDK7;CTR9;DRAP1;RTF1;WWTR1;POLR2F;POU2F2;NELFB;TFCP2;ESRRG;DDX5;NR1I2;NR1I3;ELP2;PPARGC1A;GTF2H2;MED4;PPARA;NELFCD;ELOC;SSRP1;NR2F6;AR;GTF2H4;RXRG;ARRB2;GTF2F1;GTF2I;MAZ;NCOR2;GTF2E2;HDAC5;TAF9;MAML3;ZC3H8;CPSF3;INTS10;POLR2G;PARP1;EAF2;CSTF1;CCNK;NUDT21;TAF3;ERCC6;PAF1;SETX;INTS8;XBP1;TEAD3;ZBTB7B;HDAC3;SNAPC3;TAF9B;SNRPD3;INTS5;ELOF1;RORA;INTS9;SSU72;MED23;INTS11;NABP1;NFE2L3;RPAP1;TEAD2;POLR2C;TAF4;SCAF8;GTF2H3;MAML2
prerank,regulation of translational initiation (GO:0006446),-0.20319663649733027,-0.825009766588395,0.8758169934640523,0.8846952768787014,1.0,14/63,15.40%,ATF3;EIF4B;NCBP1;NCK1;CEBPB;EIF4EBP2;EIF2B2;UHMK1;AGO2;PAIP2B;LARP1;MIF4GD;NPM1;HSPB1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.22437015905520485,0.8247807933895992,0.7965616045845272,0.9757438560430983,1.0,17/70,21.53%,DCC;BLOC1S2;G0S2;MLLT11;DAB2IP;BAK1;TGFB1;CASP3;IFI27;ACVR1B;SORT1;DDX47;TLR3;CASP8;GABARAP;PDPK1;CASP2
prerank,cholesterol homeostasis (GO:0042632),0.22491154635889166,0.8244744689420482,0.7846820809248555,0.9756658120407014,1.0,15/64,19.60%,DGAT2;ABCG8;AKR1C1;SOAT2;CYP39A1;EHD1;MTTP;ABCA2;ANGPTL3;FABP3;LIPC;XBP1;IL18;TTC39B;RORA
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.21551170449857737,-0.8244575086744002,0.7962466487935657,0.885220103071603,1.0,17/48,24.86%,P2RX4;THBS1;SP1;ANXA1;CIB1;HIF1A;RHOJ;KDR;HSPB1;HMOX1;NUS1;ADAM17;TMSB4X;FGF18;FGFBP1;MAP2K3;ANGPT1
prerank,cardiocyte differentiation (GO:0035051),0.34890014304370937,0.8243947894795176,0.7233273056057866,0.9751380268103783,1.0,2/10,12.51%,KDM6B;AKAP13
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.19659949440414648,-0.8240814995370834,0.8921933085501859,0.8853999796697076,1.0,10/73,7.94%,ITCH;PSMA6;TCF12;PSMB2;PSME2;KITLG;PSMD11;PSMC6;YAP1;PSMA3
prerank,myotube cell development (GO:0014904),-0.3317545500732077,-0.8240506195530186,0.6753554502369669,0.8849042172580754,1.0,1/10,0.97%,IGF1
prerank,DNA modification (GO:0006304),0.2819269435542427,0.8238969017185446,0.72,0.975453927302273,1.0,10/22,30.27%,OGG1;EXOSC5;PARP1;UNG;MPG;EXOSC3;ACD;TERF1;PARP3;NEIL1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.25214965005773293,-0.8236377152904123,0.7634146341463415,0.8851409527013779,1.0,7/25,19.91%,STAT5B;HMGB2;HIF1A;STAT1;FAM210B;HSPA1B;ACVR2A
prerank,synaptic vesicle transport (GO:0048489),0.34097985199227715,0.8234458903242032,0.7089678510998308,0.9756863609533717,1.0,3/11,20.99%,SNAPIN;SPG11;TMEM230
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.23200814255088328,0.8227498626553011,0.76793893129771,0.9764250747313037,1.0,10/57,10.77%,FIS1;ASPH;PDCD5;LGMN;USP50;NOD1;BAK1;GRIN1;GRIN2B;PDCD6
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3066545646515309,0.8225139299992297,0.7084805653710248,0.9762188926988625,1.0,2/15,7.62%,MTHFD1L;TGFBR1
prerank,histone H3 acetylation (GO:0043966),0.24904734945966617,0.8224169174933201,0.7355623100303952,0.9757501712427437,1.0,6/40,11.82%,LDB1;JADE2;MEAF6;TADA3;TAF9;MAP3K7
prerank,keratan sulfate metabolic process (GO:0042339),0.2634869860320726,0.8223847182312235,0.7443267776096822,0.9751263793921787,1.0,3/31,2.81%,HEXB;B4GAT1;ACAN
prerank,negative regulation of signal transduction (GO:0009968),0.18871278629179844,0.8222259877453493,0.9006060606060606,0.9747675588754895,1.0,65/249,24.72%,HHEX;TSC2;DCC;HIC1;CYP26C1;MEGF8;PTPRT;GPC1;PRKCZ;TCIM;NXN;TRIB1;LGMN;RPS6KB1;UBASH3B;TSPAN15;CACTIN;BTRC;MAZ;DAB2IP;EGFL7;KIF26A;HEY1;MGRN1;CX3CR1;SNAI2;NEDD4;FGF2;DDIT4;PDCD6;IRS1;SFRP1;CRHBP;NDRG4;ARRDC1;BEND6;APOD;PTPN2;CADM4;SIAH1;CARD16;RGS2;SUFU;AGT;PALM;LRRC14;DCN;CCL5;SULF2;ARRB1;GLI3;RNF43;YWHAB;FRZB;SFRP2;PIP4K2B;TULP3;TMEM25;HIF1AN;BDNF;GPS2;CXXC4;TMBIM6;ASXL1;PIP4K2A
prerank,regulation of transmembrane transport (GO:0034762),0.26338817085420596,0.8222258639177061,0.7384105960264901,0.9740916542733936,1.0,8/31,18.99%,KCNJ3;KCNJ8;KCNJ13;NEDD4;NEDD4L;KCNJ5;CTTNBP2NL;ACTB
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.2931784815486932,0.822047949299407,0.7377326565143824,0.9737789173913027,1.0,7/18,23.01%,ACSL6;ELOVL6;TECR;ACSF3;ACSBG1;ELOVL5;ACSL3
prerank,axonal transport of mitochondrion (GO:0019896),0.3457237802819414,0.821915313618919,0.6923076923076923,0.9733583482688822,1.0,6/11,26.15%,ACTR10;SYBU;HAP1;NEFL;SPAST;MAPT
prerank,BMP signaling pathway (GO:0030509),0.22918058943673306,0.8216296857936765,0.7846385542168675,0.9732296023219105,1.0,14/62,20.62%,DDX5;MEGF8;SLC33A1;TGFBR3;BMP4;TGFB1;AMHR2;MAPK3;GDF1;ENG;RGMA;BMPR1B;SMAD2;SMAD1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3120129325301423,-0.8214718812707311,0.7159353348729792,0.8886424925121514,1.0,1/12,1.06%,ACOT8
prerank,actin filament bundle assembly (GO:0051017),-0.23180861250251,-0.8209927231627053,0.7684210526315789,0.8889707306958704,1.0,9/33,22.64%,NEDD9;EPS8;LCP1;PLS1;MICAL1;LIMA1;AIF1L;SHROOM2;BAIAP2L2
prerank,ruffle organization (GO:0031529),-0.29125804798962984,-0.8205450569561359,0.7039800995024875,0.8892697464098526,1.0,10/16,38.85%,CARMIL1;INPP5K;LIMA1;AIF1L;RAC1;PLEK;ARF6;CCR7;TPM1;PIP5K1A
prerank,retina homeostasis (GO:0001895),0.28137167269694857,0.8205164377111746,0.6977928692699491,0.9747511663109716,1.0,4/23,18.99%,WHRN;CNGB1;POTEF;ACTB
prerank,extracellular matrix disassembly (GO:0022617),-0.20982419622510318,-0.8202396106652146,0.8011695906432749,0.8892465548527074,1.0,16/53,21.94%,CD44;CAPN1;SH3PXD2B;CAPN2;CTSL;SCUBE1;LCP1;ADAM8;EXOC8;GSN;TLL2;HTRA1;MMP8;MMP11;TIMP1;NOXO1
prerank,regulation of phospholipase activity (GO:0010517),0.3439200099450553,0.820091076028405,0.7073608617594255,0.974866091791558,1.0,5/10,33.91%,RGS2;ANGPTL3;PDPK1;FGFR3;RASGRP1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.31084222572594805,-0.8200540730420991,0.7166276346604216,0.8890439536763709,1.0,5/12,28.31%,TAF1;TAF12;TAF7;GTF2A2;TBP
prerank,response to peptide hormone (GO:0043434),-0.21872272178327068,-0.8200492041722989,0.8328912466843501,0.8885100186673346,1.0,11/43,18.58%,STAT5B;STAT4;STAT2;CAV1;ANXA1;EIF2B2;STAT1;CRY1;EIF2B4;IGFBP5;TRIM16
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.28677596635848535,0.8199762736160823,0.7314662273476112,0.9744241225391275,1.0,5/20,12.82%,PSRC1;CCND3;PKD2;PKD1;PDGFB
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.26270455322684827,0.8199728713957369,0.7552334943639292,0.9737609860529791,1.0,7/30,17.38%,FLT4;PLD4;BMP4;TGFB1;SFRP1;BATF;FLT3
prerank,positive regulation of glial cell differentiation (GO:0045687),0.3044662584780875,0.8198769377169328,0.7214765100671141,0.973276826920504,1.0,6/17,20.15%,BIN1;TGFB1;CLCF1;CXCR4;SERPINE2;IL34
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.20842422875504868,-0.8198615929144706,0.8224852071005917,0.8883030545068934,1.0,6/57,6.83%,IL15;IGF1;PARP14;PIBF1;IL6ST;LYN
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.30107735961720844,-0.8189408536701618,0.7111111111111111,0.8894683539213464,1.0,7/13,34.55%,TYROBP;SYK;GSTP1;CD177;FPR2;ITGB2;CRP
prerank,protein-DNA complex disassembly (GO:0032986),0.30103245854585736,0.8186265587609082,0.7057851239669422,0.9750766172236993,1.0,3/16,11.22%,SMARCC2;SMARCE1;SMARCD3
prerank,positive regulation of phosphatase activity (GO:0010922),-0.26735533836936903,-0.8186117546908573,0.7610837438423645,0.8895599369239986,1.0,8/21,19.90%,CD300A;PTPA;CALM3;CALM2;BMP2;ITGA1;PPP1R15A;CHP2
prerank,protein import into nucleus (GO:0006606),-0.20264643658959652,-0.8185859705697278,0.8695652173913043,0.8890624450379712,1.0,19/66,22.22%,CBLB;KPNB1;RANBP2;KPNA2;SYK;EIF4ENIF1;NUP153;PTTG1IP;NUTF2;HIKESHI;NXT1;RGPD1;NUP62;IPO7;IPO13;KPNA3;APPL2;RANBP6;SPRN
prerank,"phototransduction, visible light (GO:0007603)",0.31085750088150516,0.8182107643823862,0.7208121827411168,0.9751969039871895,1.0,5/14,31.75%,CNGB1;GNA11;GNAQ;ABCA4;PDE6G
prerank,regulation of actin filament-based movement (GO:1903115),0.3502522536801932,0.8177787427851879,0.6906474820143885,0.9753838641521131,1.0,2/10,17.90%,MYBPC3;ANK2
prerank,regulation of organelle assembly (GO:1902115),0.22405285927607768,0.8177662849621754,0.8155197657393851,0.9747408122272171,1.0,18/72,21.22%,IFT20;RAB1B;SGSM3;MAPK15;CDKL5;RAB5A;TBC1D16;RABEP2;TBC1D8;IFT88;UBQLN2;PLK2;ALMS1;ATXN2;CYLD;CDKL1;KIF9;RDX
prerank,regulation of stem cell population maintenance (GO:2000036),-0.27340403899490495,-0.8176629724139103,0.7544757033248082,0.8902082427391265,1.0,6/18,25.97%,WDR43;PTN;HMGA2;ESRRB;TAF6L;ZC3H13
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3211581994578995,-0.8174684198256249,0.7214285714285714,0.8900042387595077,1.0,4/11,21.53%,ARID1B;ZMIZ1;SERTAD2;ZMIZ2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.1993972340794729,0.8170193348349974,0.878748370273794,0.9755285532333406,1.0,39/152,22.05%,FGF10;HHEX;UBE2B;PSMB1;LBX2;SOX4;TMEM198;PTK7;PSMF1;PSMA1;GPC5;PSMD7;PPM1A;FAM53B;TGFB1;PSMA8;SPIN1;PPM1N;PSME3;SFRP1;PSMD14;LRRK1;PSMC4;TMEM9;CCAR2;PRDM15;CSNK1G3;PSMB4;PIN1;RSPO1;WNK1;SULF2;PSME1;PSMD2;PSMD4;RSPO2;PSMD8;AXIN1;SFRP2
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.27159452527582717,-0.8169191757535604,0.7518072289156627,0.8904818413899772,1.0,5/19,13.52%,NRP1;LIMS1;S100A10;KDR;MYOC
prerank,hepaticobiliary system development (GO:0061008),0.28148506359104764,0.8167660968475351,0.7293354943273906,0.9753597021391603,1.0,5/20,17.88%,WNT4;TGFBR3;PKD2;PHF2;XBP1
prerank,negative regulation of cell communication (GO:0010648),-0.25714791490754807,-0.8167416620573286,0.7725,0.8902509862334429,1.0,3/21,8.89%,PTPN1;IL1B;SOCS5
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.28825148874007545,0.8167300834899407,0.7112211221122112,0.9747645964105197,1.0,8/21,22.46%,HS3ST5;GPC1;HS6ST3;HS6ST1;B3GAT3;SULF2;SGSH;EXT2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.27606656822122344,0.8166946629347731,0.7385103011093502,0.9741686829465951,1.0,7/24,17.88%,SELENOS;CLU;PRKN;HERPUD1;TXNDC12;UBXN1;XBP1
prerank,regulation of proteolysis (GO:0030162),0.2346164098549923,0.8165443661237681,0.7917304747320061,0.9737911376469912,1.0,7/48,8.78%,PLAT;CAPN3;CST3;ASPH;BTRC;OGT;BAK1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.3226587981990201,-0.8164171643393697,0.6760869565217391,0.8902904341411526,1.0,3/10,9.65%,RUNX3;IRF4;SH3RF1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.29440502728582696,0.8151858714478762,0.7115716753022453,0.9757492844510263,1.0,3/18,10.75%,NME5;PRKN;NFE2L2
prerank,GTP metabolic process (GO:0046039),0.3042804788286151,0.8151652659964606,0.6996753246753247,0.9751231165342225,1.0,7/15,29.94%,GTPBP1;GNAI3;RHOQ;AK4;AK3;IMPDH2;MFN1
prerank,cellular response to oxidative stress (GO:0034599),-0.1791947894868205,-0.8151469167731396,0.9259259259259259,0.8920019002643818,1.0,28/118,21.17%,CYBB;MSRA;PXN;CHCHD2;ETV5;ERCC6L2;PYCR2;HIF1A;ZC3H12A;EIF2S1;FOXO1;DAPK1;CYBA;LRRK2;TXNRD1;FOS;EGFR;GPX1;HMOX1;MAPK8;SESN2;ADNP2;CPEB2;PDGFRA;HSPA1B;SOD3;GSR;SIRT2
prerank,phosphate ion homeostasis (GO:0055062),-0.32096266754463343,-0.815066921972629,0.7004830917874396,0.8915848637753792,1.0,4/10,42.72%,TFAP2B;FGFR4;FGF23;ENPP1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.2937150540554359,0.8147616985257885,0.7491166077738516,0.9752393077943058,1.0,3/18,10.80%,WRAP53;CORO2B;CCT4
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.22659081273173817,-0.8146805146117094,0.8278688524590164,0.8917325663875353,1.0,10/37,18.88%,RNASE3;DNASE1L1;NCBP1;XRN2;NUDT5;ENTPD5;RNASEH2A;ADPRM;HNRNPD;RNASEH1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.2401737239869324,-0.8143508925400514,0.8311345646437994,0.8917911420387722,1.0,11/30,25.80%,BCL2L1;FAS;RIPK1;BRCA1;BMP5;GPX1;HMOX1;ARHGEF2;TNFSF10;FADD;TMBIM1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.2928263234003487,-0.8140261763567392,0.75,0.8918697715535228,1.0,3/15,9.61%,IGF1;IL6ST;CAMK2D
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.30854760753818605,-0.8138812114703026,0.7418604651162791,0.8915837442809302,1.0,3/12,16.28%,ATP7A;DDC;ODC1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.2669937227239336,0.813817135775582,0.7572156196943973,0.9763532275171974,1.0,8/27,17.93%,F11R;RHPN2;CLASP2;SHANK3;PRKN;PHLDB2;SHANK1;WASF2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.29993912212553764,0.8136868106295764,0.7325581395348837,0.975919389905475,1.0,3/17,11.30%,CADM1;SLAMF6;CRTAM
prerank,positive regulation of histone methylation (GO:0031062),0.2768933079689494,0.8135257026900029,0.7592295345104334,0.9755734553610959,1.0,6/24,18.32%,TET1;CTR9;OGT;PAF1;PHF1;CHTOP
prerank,cellular response to chemokine (GO:1990869),0.24139904186328293,0.8122949042318033,0.7981651376146789,0.9772837726274796,1.0,9/46,19.31%,ACKR3;SLC12A2;CCR1;FOXC1;SH2B3;STK39;CCL15;WNK1;CCL5
prerank,positive regulation of phospholipase activity (GO:0010518),0.2799965509065945,0.8121545305616774,0.7631133671742809,0.9768900161785274,1.0,7/22,20.74%,NTRK3;PLCG1;FGF2;HRAS;CCL5;PDGFRB;PDPK1
prerank,regulation of angiogenesis (GO:0045765),0.19183191859559906,0.8120741304444652,0.9039900249376559,0.9763924534755599,1.0,29/192,12.97%,HOXA5;HHEX;F3;FGF16;CD34;ANGPTL4;IL17F;SMOC2;IL6;PLCG1;YJEFN3;PDE3B;GTF2I;MINAR1;DAB2IP;RAPGEF3;PRKCA;EPHA1;PRKD2;FOXC1;VASH1;FGF2;PDCD6;SFRP1;ADAM12;EFNA3;COL4A2;VASH2;TEK
prerank,lysine metabolic process (GO:0006553),-0.30259376078915634,-0.8119630655918276,0.7435897435897436,0.8940118524211559,1.0,6/12,35.05%,ALDH7A1;PIPOX;AASS;HYKK;PHYKPL;CRYM
prerank,lysine catabolic process (GO:0006554),-0.30259376078915634,-0.8119630655918276,0.7435897435897436,0.8940118524211559,1.0,6/12,35.05%,ALDH7A1;PIPOX;AASS;HYKK;PHYKPL;CRYM
prerank,protein O-linked glycosylation via serine (GO:0018242),0.34070597237128153,0.8113664525321618,0.6972477064220184,0.9771102836353319,1.0,5/10,30.67%,MGAT5B;GALNT4;GALNT2;GALNT3;GALNT13
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.260537540804971,0.8111542482942261,0.7483552631578947,0.976853877547985,1.0,9/32,17.39%,STMN2;NAV3;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,gland development (GO:0048732),0.22428859201775864,0.8110500351183942,0.8132530120481928,0.9763986848622975,1.0,6/59,8.98%,FGF10;WNT4;RIPK3;TGFBR3;TGFBR1;PKD2
prerank,photoperiodism (GO:0009648),-0.24381717577462264,-0.8108742542125656,0.7553191489361702,0.8953545838522454,1.0,10/28,21.75%,FBXL17;FBXL8;CRY2;CRY1;SIK1;PDE6B;PER2;FBXL12;BHLHE40;ID2
prerank,histone mRNA metabolic process (GO:0008334),-0.24543961379726897,-0.8108408986346491,0.7340720221606648,0.8948740005559146,1.0,6/27,13.61%,NCBP1;TENT2;SNRPB;EXOSC10;SSB;CPSF2
prerank,negative regulation of synaptic transmission (GO:0050805),0.2748317068862632,0.8108400897431125,0.7563025210084033,0.9761484750247817,1.0,11/23,28.40%,ATAD1;PNKD;ACHE;PLK2;ARF1;GRIK3;TMEM25;SYT11;PRRT1;CBLN1;PTEN
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.25136158014448984,-0.8105952625863622,0.7639257294429708,0.8947390673553921,1.0,5/23,13.26%,PRCC;ZWILCH;WEE1;BUB1;BUB1B
prerank,protein import (GO:0017038),0.214575650749103,0.8103036761133022,0.8114754098360656,0.9765000240189099,1.0,35/84,30.92%,TSC2;PEX5;FIS1;FAM53C;CLU;ATAD1;NXT2;PRICKLE1;PEX26;HEATR3;FAM53B;NUP88;PEX14;IPO5;NUP133;PEX2;ABCD2;SNX33;IPO8;POM121;PEX11B;PEX3;RANBP17;TOMM22;IPO9;PXMP4;ABCD3;ACBD5;NUP107;NUP155;NUP85;MMP12;TPR;SEC13;PEX12
prerank,protein polymerization (GO:0051258),0.22765814232786255,0.8094125272502235,0.8175074183976261,0.9775726297781235,1.0,15/55,23.06%,TPPP;ANG;CATIP;CKAP5;PRKN;FGF13;WASF3;CHMP2A;RNF135;HDGFL3;PIN1;UBE2S;MAP7D3;TPPP3;WASL
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.2945991482595861,-0.8092102001625453,0.7374701670644391,0.896595736417205,1.0,7/14,28.26%,LIMS1;EMP2;BST1;FLNA;TIMP1;CD177;PHACTR4
prerank,organonitrogen compound catabolic process (GO:1901565),-0.20588304616875036,-0.8089414180632596,0.8246153846153846,0.8965024711171021,1.0,18/57,23.92%,SGPL1;ANPEP;CPQ;GNPDA1;CLN8;CLN5;ERAP1;LTA4H;UCHL3;MPST;NAGK;GADL1;CTH;ADO;RENBP;PLA2G7;RIDA;NPL
prerank,peptidyl-serine modification (GO:0018209),0.19300425594325907,0.808717556701498,0.8972332015810277,0.978211260480456,1.0,44/166,23.42%,DCLK3;PKN1;PNCK;PRKCZ;DYRK1B;RPS6KB1;PRKCI;MAP3K10;TGFBR1;DGKQ;PRKCA;PRKD2;STK39;VRK2;CAMKV;PKD1;MGAT5B;STK32B;PDGFB;PARP1;MAP3K13;NDNF;PRKD1;DMPK;PRKCG;CSNK1G3;MAPKAPK5;PLK2;ROCK1;SMG1;AKT3;MAST2;WNK1;GALNT4;GALNT2;SBK1;PDPK1;ULK2;TOP1;LATS1;ULK1;TLK2;AURKA;STK32A
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.30063259252298435,-0.8086967228573263,0.7263922518159807,0.8963726258429346,1.0,2/13,7.28%,ACOT8;GOT1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.30757051119545986,-0.8084981948115737,0.7272727272727273,0.8961520935471431,1.0,5/12,29.23%,MTLN;PTK2B;DIAPH1;RYR2;CASQ2
prerank,sterol homeostasis (GO:0055092),0.21996084866102106,0.8082168341282313,0.8134110787172012,0.978525925268458,1.0,15/65,19.60%,DGAT2;ABCG8;AKR1C1;SOAT2;CYP39A1;EHD1;MTTP;ABCA2;ANGPTL3;FABP3;LIPC;XBP1;IL18;TTC39B;RORA
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.3372806898289381,0.8081186587125688,0.7309027777777778,0.9780425832850772,1.0,1/11,3.67%,NEUROD2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.20580930260889385,-0.8081069754339257,0.8228228228228228,0.8962783341862012,1.0,12/52,17.21%,PRKCH;PRKCE;CIB1;SORBS1;LRP1;NUMA1;EGFR;TNF;EPHA2;PLS1;SQSTM1;AKAP5
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.30620102617826384,-0.8080769848346779,0.7037037037037037,0.8957867569910166,1.0,4/12,18.76%,XDH;SPRY2;SEMA6A;ADAMTS12
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.27591973869788766,-0.807824783855892,0.7338308457711443,0.8956884477661925,1.0,5/17,22.93%,ADCY9;DRD2;ADRA1A;DRD3;GPR101
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.21086152240345618,-0.8076032820489718,0.8390092879256966,0.8955370481893142,1.0,16/52,25.73%,CNOT9;SAMD4A;EXOSC8;DDX6;DCP1B;RC3H1;LSM2;LSM5;EXOSC9;RC3H2;LSM7;PAN3;CNOT6L;EXOSC1;EXOSC7;TNKS1BP1
prerank,endothelial cell differentiation (GO:0045446),0.32052754720584353,0.8075792446234248,0.7439703153988868,0.978403946614779,1.0,2/12,5.48%,KDM6B;FSTL1
prerank,regulation of cell-cell adhesion (GO:0022407),0.24614035433020465,0.8075199351127063,0.7792998477929984,0.9778514071294828,1.0,7/39,11.50%,MAGI1;ADA;SPINT2;TGFB1;TENM3;ZDHHC2;MINK1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.2694126578367806,0.80746733803816,0.7472527472527473,0.9772900120582328,1.0,4/25,6.30%,ANG;NCKAP1L;DSCAM;AR
prerank,endocardial cushion morphogenesis (GO:0003203),0.29249380313370205,0.8069311498291867,0.7409948542024014,0.9776212963034333,1.0,5/18,21.45%,BMP4;HEY1;TBX2;ENG;MDM4
prerank,centromere complex assembly (GO:0034508),-0.2252100625783447,-0.806904797020777,0.7914285714285715,0.896260777358622,1.0,7/36,17.98%,MIS12;RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1
prerank,lipid biosynthetic process (GO:0008610),0.21754025078846362,0.8068574715930542,0.8307475317348378,0.9770949117962017,1.0,15/77,17.88%,STAR;PRLR;LPCAT1;CBR4;ACSL6;LSS;OXSM;PDSS1;ELOVL4;FITM2;ACLY;NDUFAB1;ACSF3;LIPC;XBP1
prerank,negative regulation of cell cycle process (GO:0010948),-0.20530916643562394,-0.8062561577433263,0.8598726114649682,0.8968183740084693,1.0,15/61,20.01%,EPC1;RBBP8;RBBP7;BRCA1;BMI1;EHMT1;ESPL1;RYBP;E2F8;L3MBTL2;TERF2;E2F7;NME6;EED;BMP7
prerank,platelet aggregation (GO:0070527),-0.23069089606616736,-0.8059966046705999,0.7955801104972375,0.8967055673536858,1.0,17/33,33.16%,ACTN1;VCL;HSPB1;MYH9;FLNA;FN1;PDGFRA;ITGB3;FIBP;TLN1;MYL12A;CLIC1;ILK;PLEK;RAP2B;MYL9;PPIA
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.28153709161213514,-0.8058725371932405,0.7892030848329049,0.8963623286392589,1.0,3/17,8.49%,MPDU1;ALG12;ALG13
prerank,neutrophil migration (GO:1990266),-0.20396949646167445,-0.8049621147061548,0.8761904761904762,0.8975189550745137,1.0,24/58,37.82%,GBF1;CCL25;PF4;SYK;JAML;IRAK4;FCER1G;PIK3CD;CCL7;PRTN3;CCL24;CD177;CXCR2;ITGB2;TGFB2;CKLF;PPIA;EDN3;CCL8;CXCL9;EDN2;EDN1;CXCL1;PECAM1
prerank,carnitine metabolic process (GO:0009437),0.32469821883608085,0.8047513069000661,0.7135506003430532,0.980296619450734,1.0,2/12,6.94%,CPT1B;ALDH9A1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.29619847867908045,0.8046680225031112,0.7230769230769231,0.9797941470991792,1.0,5/17,19.96%,ANGPTL4;SORT1;ANGPTL3;LIPC;LMF1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2514844131702802,0.8042951496690296,0.7641653905053599,0.9798272315964028,1.0,16/33,32.90%,FPGS;SLC39A8;KYAT1;ALDH5A1;ALDH4A1;DDAH2;PRODH;PYCR3;ART4;GLUL;GLS2;DGLUCY;RIMKLB;MTHFS;GCLM;ALDH18A1
prerank,telomere maintenance (GO:0000723),-0.2052642982333557,-0.8042946169336592,0.843558282208589,0.8981092202796318,1.0,7/50,11.08%,SP100;NSMCE2;PCNA;RTEL1;NBN;POLD4;RPA1
prerank,positive regulation of RNA splicing (GO:0033120),0.2584724839854999,0.8041957361488664,0.751937984496124,0.9793374413540568,1.0,9/29,20.59%,PRDX6;TRA2B;SLC38A2;CIRBP;RBMXL1;RBM3;SETX;TRA2A;RBM20
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2337335830892071,-0.8040931758854356,0.7935103244837758,0.89791063194993,1.0,10/31,19.87%,PTPN1;BAX;ERN1;HSF1;PACRG;HSPB8;TM7SF3;OPTN;HSPA13;HSPA1B
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.23330495633698933,-0.8040571009350614,0.7924528301886793,0.8974127770866264,1.0,11/29,26.15%,UTP6;RPS16;RPS14;UTP4;TSR1;TBL3;KRI1;ABT1;HEATR1;TSR2;RPS21
prerank,Golgi organization (GO:0007030),0.2029442181349691,0.803925126863174,0.8758434547908233,0.979154682273772,1.0,35/112,25.51%,FBXW8;OBSL1;RAB43;SEC16B;TMED2;STX16;CLASP2;COG4;PI4K2A;TANGO2;ZW10;PLK3;STK25;HACE1;LYSMD3;TMED5;ARFGEF1;BLZF1;PRKD1;ATP8B1;TMED3;STX17;LMAN2L;TRAPPC8;TMED7;CDC42;PRMT5;VTI1B;VMP1;ATL2;TMED1;ATP8B2;GOLGA8B;GOLGA5;TJAP1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.34310480515371344,0.8033179136140145,0.7279411764705882,0.9796386237657015,1.0,3/10,13.79%,DAB2IP;EFNA1;EPHA4
prerank,aminoglycan catabolic process (GO:0006026),0.2629928838552233,0.8030782924572404,0.7551342812006319,0.9794278041284377,1.0,5/28,8.56%,AGRN;OVGP1;GPC1;GPC2;GPC5
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.29212198470978423,0.8030408725508296,0.7478411053540587,0.9788320273552663,1.0,4/17,18.18%,SLA2;BACH2;IL18;IL18BP
prerank,dopaminergic neuron differentiation (GO:0071542),0.289104479659287,0.8026694058075275,0.7222222222222222,0.9788592697623533,1.0,3/19,14.40%,RYK;MANF;LMX1B
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3118557913669519,-0.8026653849865897,0.7367256637168141,0.8992282754107999,1.0,3/11,17.07%,CCR2;WNT5A;ADAM17
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.2473270065297295,-0.8024099396594183,0.767379679144385,0.8991070477060842,1.0,6/24,16.30%,TAPBP;ERAP1;SEC23A;MFSD6;B2M;FCER1G
prerank,regulation of macrophage differentiation (GO:0045649),-0.28607702069899743,-0.8020523427672243,0.7121212121212122,0.8991379260930553,1.0,7/15,25.83%,PF4;RIPK1;HSF1;C1QC;ID2;FADD;CSF1
prerank,cellular response to acid chemical (GO:0071229),-0.23480775182462443,-0.8012382080870991,0.7722513089005235,0.8999693692786309,1.0,10/27,22.17%,RRAGC;LAMTOR5;CAPN2;CPEB4;RRAGA;SESN2;KLF2;CPEB3;LARS1;LAMTOR4
prerank,negative regulation of cartilage development (GO:0061037),0.31223559077853463,0.8006541650135205,0.7435008665511266,0.981897585675905,1.0,3/13,13.30%,TGFBR1;SNAI2;CHADL
prerank,positive regulation of telomerase activity (GO:0051973),0.2532424459886158,0.8005494490639136,0.7643207855973814,0.9814335611564936,1.0,13/33,29.02%,WRAP53;MAPK15;CCT4;MAPK3;MAPKAPK5;HSP90AB1;XRCC5;GRHL2;PARM1;MAPK1;ACD;PTGES3;MYC
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.22206455799292624,-0.8004495283791586,0.8152492668621701,0.9007808328070355,1.0,19/36,39.15%,PPP3R1;CTNNB1;PPP3CA;FZD2;AGO2;NLK;WNT5A;PDE6B;FZD4;PDE6A;LEF1;TNRC6A;CALM1;PPP3CB;WNT11;NFATC1;FZD6;AGO3;MOV10
prerank,regulation of phospholipid metabolic process (GO:1903725),0.34241150478585597,0.8003295081859609,0.712430426716141,0.9811630550545253,1.0,3/10,13.00%,GNB3;MTMR9;MTMR1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.34171277556894286,0.8001574554632117,0.7217235188509874,0.9808538294045703,1.0,2/10,6.94%,AREG;ADRA2A
prerank,negative chemotaxis (GO:0050919),0.2488242542678842,0.8001128514804255,0.7573415765069552,0.9802795453879649,1.0,7/33,16.53%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;SEMA4F;SEMA4B;SEMA3C
prerank,modified amino acid transport (GO:0072337),0.2989435958377875,0.7996438765572141,0.7470489038785835,0.9805135162483496,1.0,4/15,18.22%,CTNS;SLC1A4;SLC19A1;SLC16A12
prerank,phospholipid homeostasis (GO:0055091),0.32281154696310954,0.7994811635419451,0.7309734513274336,0.9801510557343028,1.0,3/11,17.65%,TLCD2;ANGPTL3;FABP3
prerank,cellular iron ion homeostasis (GO:0006879),-0.20658727107512861,-0.7994466300651119,0.879746835443038,0.9019705204615267,1.0,16/55,23.20%,ATP6V0D1;TFRC;SLC46A1;NUBP1;CP;SLC11A1;ATP6V1A;LCN2;FTL;HMOX1;SMAD4;CYBRD1;NDFIP1;HEPH;ALAS2;FBXL5
prerank,carnitine shuttle (GO:0006853),0.32390463985527596,0.7990080739773177,0.7223140495867768,0.9803732121409595,1.0,2/11,5.42%,CPT1B;THRSP
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2548818952443206,0.7988796096005418,0.7611202635914333,0.9799534282293455,1.0,7/32,14.58%,SNAPIN;MEF2C;PNKD;RAB5A;RIMS1;CPLX2;BAIAP3
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2488959734599484,0.798651292596225,0.7604501607717041,0.9797304088071113,1.0,8/36,14.31%,GGA3;RAB26;SYS1;ARFRP1;NECTIN3;RAB34;BLZF1;SPTBN1
prerank,superoxide anion generation (GO:0042554),-0.2977875081079655,-0.798647056512765,0.723404255319149,0.902717176551133,1.0,4/13,24.23%,CYBB;CYBA;TAFA4;NOX4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3316753078185859,0.7986417513230368,0.7509363295880149,0.9790955630495329,1.0,2/11,10.80%,WRAP53;CCT4
prerank,response to cAMP (GO:0051591),0.24948560679796503,0.7986319976142138,0.7911908646003263,0.9784615626258528,1.0,6/37,12.72%,HCN1;DGKQ;RAPGEF3;PKD2;CFTR;CRHBP
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.24162035310781949,0.7986091173835744,0.7996918335901386,0.977849929546362,1.0,12/41,25.79%,PTGS1;ALOX12;PLA2G4C;ACOX1;DAGLA;DECR2;FADS3;ELOVL5;PNPLA8;DAGLB;PLA2G4A;EPHX1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.18380859429480279,-0.7983841125011959,0.9136690647482014,0.9026132156419705,1.0,29/88,25.99%,PSMA6;AP2A2;DVL3;PSMB2;SMURF2;PSME2;AP2B1;SPEF1;PSMD11;PSMC6;PSMA3;FZD2;PSMD10;PSMB5;WNT5A;PARD6A;PSMD5;NPHP3;PSMD1;DAAM1;FZD4;ARHGEF19;PSMA7;PSMB7;PKHD1;AP2A1;FZD1;RAC1;PSMB3
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2613723576208219,-0.7983254077840892,0.7557840616966581,0.902162952974491,1.0,9/19,35.54%,APOE;CHRNB2;COLQ;CHRNA4;CHRNA5;CHRNA3;RAPSN;CHRNB4;CHRNB3
prerank,primary miRNA processing (GO:0031053),-0.32398969467030325,-0.7981626785160287,0.7303102625298329,0.9018925112852927,1.0,3/10,11.91%,SMAD3;SRRT;HNRNPA2B1
prerank,regulation of lipid metabolic process (GO:0019216),0.20819415503974653,0.7980229485002878,0.8371104815864022,0.9782642156976673,1.0,23/88,22.04%,TM7SF2;GNB3;PPARA;RARRES2;THRSP;TNFAIP8L3;CHD9;NCOR2;LSS;ZFP69;SMARCD3;ELOVL6;CCDC3;EDF1;ACACB;LACTB;HDAC3;FDPS;RORA;RUBCNL;PLPP1;ABCA7;NFYB
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3037240314297619,0.7976535764262428,0.7327586206896551,0.9783125346933027,1.0,4/14,25.08%,PKIA;PRKAR1A;PRKAR2B;RAPGEF2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.22798852698573582,-0.7976065368512676,0.8169398907103825,0.902291401888633,1.0,5/33,7.90%,NR3C1;PPARG;SMARCA4;SMAD3;HIF1A
prerank,vitamin transport (GO:0051180),-0.2305574794956623,-0.7974145694740626,0.8042328042328042,0.9020663849096378,1.0,10/29,29.22%,SLC46A1;SLC2A8;SLC52A2;SLC52A1;AFM;PDPN;AMN;CD320;FOLR2;FOLR1
prerank,glycoprotein catabolic process (GO:0006516),-0.27712861321378435,-0.797055651109955,0.7674418604651163,0.902109247183184,1.0,5/17,24.73%,CTSL;EDEM1;FBXO2;ADAMTS12;NEU4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.27791161615344356,0.7969225854696854,0.7559322033898305,0.97834248630408,1.0,9/22,26.99%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;ZDHHC19;ZDHHC12
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.27791161615344356,0.7969225854696854,0.7559322033898305,0.97834248630408,1.0,9/22,26.99%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;ZDHHC19;ZDHHC12
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.2806508820616211,0.7968884674049883,0.75,0.9777606912128207,1.0,7/21,24.38%,SELENOS;PRKN;HERPUD1;TXNDC12;XBP1;CREB3;TMBIM6
prerank,regulation of protein modification process (GO:0031399),0.22821663015272212,0.7965734294092149,0.8157503714710252,0.9776957506551699,1.0,5/50,3.64%,PPP1R16A;PLXNB2;PPIB;ROPN1;ROPN1L
prerank,positive regulation of embryonic development (GO:0040019),-0.2608388027345695,-0.7964717478408171,0.77,0.9025113877632658,1.0,5/19,18.41%,B4GALT5;RACK1;SCX;LHX1;NIBAN2
prerank,telomere capping (GO:0016233),-0.2758394111700587,-0.7963949475905363,0.7579462102689487,0.9020964295419818,1.0,5/16,32.63%,NBN;TERF2;TINF2;DCLRE1C;RAD50
prerank,heme catabolic process (GO:0042167),0.3105758108632791,0.7958512232346165,0.7318339100346021,0.9776909305308508,1.0,1/14,0.83%,SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.3105758108632791,0.7958512232346165,0.7318339100346021,0.9776909305308508,1.0,1/14,0.83%,SLCO2B1
prerank,sphingolipid metabolic process (GO:0006665),0.20195930280159635,0.7958090202702908,0.8840381991814461,0.977117889467672,1.0,29/108,21.75%,HEXB;ESYT2;TEX2;NEU1;ORMDL2;CERS4;ENPP2;PRKD2;B3GALNT1;SPTSSA;NSMAF;ELOVL6;TECR;ABCA2;GAL3ST1;SPNS2;ELOVL4;CERS5;CERS6;PRKD1;KDSR;CERS1;SERINC1;PPP2R1A;PLA2G15;ELOVL5;PLPP1;PPM1L;FA2H
prerank,positive regulation by host of viral transcription (GO:0043923),-0.2822205493685981,-0.7956023074172772,0.7309523809523809,0.9028807535431821,1.0,4/15,10.19%,SMARCA4;SP1;SNW1;EP300
prerank,negative regulation of cell division (GO:0051782),0.34127402078232144,0.7955791197568814,0.7335640138408305,0.9768913594107225,1.0,2/11,11.23%,SUSD2;ZFYVE19
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.2441707506433486,0.7953728769082088,0.7984732824427481,0.9765984208804762,1.0,13/37,25.24%,FHIT;GIPC1;SGTA;OGT;TAF9;CCAR2;UBXN1;HSP90AB1;TLK2;CAMLG;USP7;TRIM39;HFE
prerank,negative regulation of bone remodeling (GO:0046851),0.33200452487824855,0.7940134976803562,0.740484429065744,0.9783568191216077,1.0,3/11,11.53%,IL6;UBASH3B;SFRP1
prerank,embryonic organ development (GO:0048568),0.2204321079317831,0.793917779108081,0.8293413173652695,0.9778941487703589,1.0,19/61,26.26%,ZFPM1;COL2A1;RARRES2;PBX2;HEY1;TGFB1;TBX2;SH2B3;PBX3;NDRG4;TEAD3;GLI3;TEAD2;RBP4;FLT3LG;COL13A1;RNF112;ATF4;SALL1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2958249384581364,-0.7933645077843139,0.7393483709273183,0.9061274066754338,1.0,4/13,27.33%,OS9;EDEM1;UBE2J1;YOD1
prerank,neuromuscular process (GO:0050905),0.29532458616348667,0.7932301344854837,0.7525597269624573,0.9784546510787837,1.0,4/16,17.85%,MYCBP2;NRXN1;DCTN1;SHANK1
prerank,response to laminar fluid shear stress (GO:0034616),-0.32346199455730823,-0.7930638864334308,0.7346491228070176,0.9060776724644234,1.0,4/10,20.54%,SMAD6;MAPK7;KLF2;KLF4
prerank,morphogenesis of an epithelium (GO:0002009),-0.2443998252604813,-0.7930464492301537,0.8108108108108109,0.9055576923215555,1.0,10/25,23.71%,DAG1;PRKX;VCL;RIPK4;LHX1;LRP6;TRAF3IP1;LAMA5;LIN7C;LAMA3
prerank,cardiac muscle cell development (GO:0055013),0.28053178728393025,0.792726967119829,0.7670549084858569,0.9787113827057281,1.0,4/20,19.41%,OBSL1;SLC8A1;CXADR;PDGFRB
prerank,cellular component assembly (GO:0022607),0.1808455803475291,0.792621348162847,0.9388753056234719,0.9782649758601608,1.0,75/253,27.26%,SH3BP1;FSCN1;WDR19;CAPN3;ADD2;NIFK;RHOV;PARD6B;RAD21L1;PPARGC1A;NCKAP1;NCKAP1L;MAGI1;IL1RAP;LRRTM3;TSPAN4;SH3BGR;TGFB1;ZW10;PEX14;RIMS1;STK25;TLCD2;LRGUK;DNM1L;WASF3;CYFIP1;CHCHD10;SPTBN1;VAMP3;SPAG16;WNT7A;PAWR;TUBGCP2;EPRS1;GEMIN5;RHOQ;PPP2R1A;SHANK1;QSOX1;RHOU;ACTB;LIN7A;ESPN;CLDN14;HORMAD1;CAPG;CDC42;TEX12;GRHL2;MDM4;TEAD2;ZFYVE27;VMP1;DNAJB13;OPHN1;LIMS2;WASL;PCLO;LAMC1;IL2RB;ANK3;CD40;RHOA;HFE;SHROOM1;ACD;LLGL1;DLG4;ADD1;ST13;ABCA3;DMTN;MYO9A;CFAP74
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.24842196952951612,-0.7923801062728653,0.796875,0.906092823706476,1.0,5/25,15.15%,CBLB;PPARG;SOCS5;CBL;TNF
prerank,skeletal muscle tissue development (GO:0007519),0.24758341536133757,0.7923563093898721,0.8060413354531002,0.9780527499873567,1.0,9/32,23.99%,SIX4;MEF2C;MYL6;LMOD3;CAV2;IGSF8;LEMD2;CFLAR;POPDC3
prerank,ribonucleoprotein complex assembly (GO:0022618),0.19464270369192266,0.7920538722704371,0.9004037685060565,0.9779523356277976,1.0,40/132,25.49%,SRSF5;XAB2;CPSF6;ISY1;SRSF6;DDX1;RBM5;EIF6;SNUPN;SRSF1;SNRPD2;YTHDC1;MRPS7;NOP2;CELF6;RAMAC;CRNKL1;NUDT21;RPS27;TRAF7;RSL24D1;DDX39B;SETX;GEMIN5;GEMIN6;SRSF9;PUF60;GCFC2;MCTS1;SNRPD3;HSP90AB1;XRCC5;PRMT5;LSM4;SART1;POLR2D;COIL;CELF4;RRS1;SF1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.28973848893019444,-0.7919004754612557,0.7394366197183099,0.9063626237697419,1.0,2/13,4.28%,NR3C1;ESR1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.21624718656172304,0.7918780771895184,0.8232695139911634,0.9776369110959313,1.0,19/64,25.79%,ADTRP;ALOX12;PLA2G4C;PNPLA3;ACSL6;ELOVL6;ACOT4;ACOX1;ACSBG1;DAGLA;HPGD;ELOVL5;ACAD9;PNPLA8;DAGLB;ACSL3;HACL1;PLA2G4A;EPHX1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.22774367057477726,-0.7917589145204016,0.8315217391304348,0.9060352744534237,1.0,5/32,9.16%,ACTR3;CORO1C;ARPC2;CARMIL1;PIK3CA
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3003805340078435,-0.7912678045084008,0.7353629976580797,0.9062892822483817,1.0,4/12,13.71%,GMPS;ATIC;PAICS;IMPDH1
prerank,T-helper cell differentiation (GO:0042093),0.30663055836266306,0.7909357895517284,0.7445008460236887,0.9786486892233034,1.0,4/14,15.31%,ZFPM1;IL6;HMGB1;BATF
prerank,sensory perception of taste (GO:0050909),0.33504648438237616,0.790795222084284,0.718132854578097,0.9782477955302396,1.0,3/10,17.24%,ASIC1;ASIC2;ASIC3
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2358591340934833,0.7907136293146895,0.8207547169811321,0.9777444660100094,1.0,10/40,19.89%,NUCKS1;DONSON;TIMELESS;SMARCAL1;TRAIP;RFWD3;CENPS;TONSL;WRN;ALYREF
prerank,cytoskeleton organization (GO:0007010),0.1964305868455319,0.790650220463712,0.8711819389110226,0.9772293868206519,1.0,26/114,19.39%,CNTNAP1;DST;OBSL1;BIN1;THY1;SIPA1;RHOBTB1;BRWD1;FGD2;FMNL3;MICAL3;PRKCI;ARAP3;CFL1;CAMSAP1;PAK5;WASF3;DPYSL2;FITM2;PAK6;RHOBTB2;CDC42BPB;MAST2;ZMYM6;RHOU;ZMYM3
prerank,positive regulation of cell development (GO:0010720),0.2541793628555482,0.7902490914517154,0.7621359223300971,0.9772885384183405,1.0,6/31,16.91%,NUMB;LRP2;BMP4;CX3CR1;LMOD3;OPRM1
prerank,transition metal ion transport (GO:0000041),0.24796726013809925,0.7901133584914126,0.776,0.976891133473538,1.0,6/35,11.52%,IREB2;TRPC3;SLC31A1;SLC39A8;ATP2C1;TRPC6
prerank,granulocyte chemotaxis (GO:0071621),-0.20102403541942332,-0.78978226397659,0.8848484848484849,0.9082171509755825,1.0,6/55,9.11%,GBF1;CCL25;PF4;SYK;ANXA1;JAML
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.27184584957448277,0.7897179444694684,0.765089722675367,0.9769375278892568,1.0,3/22,7.53%,DDX5;HIC1;EEF1E1
prerank,cellular response to hexose stimulus (GO:0071331),0.2749757922247237,0.7896436074457378,0.7571428571428571,0.9764253541308725,1.0,3/23,4.45%,ADCY8;TRA2B;SOX4
prerank,cellular macromolecule catabolic process (GO:0044265),-0.2073447637118099,-0.7895465182649768,0.8666666666666667,0.9080620558937056,1.0,11/49,18.88%,RNASE3;DNASE1L1;NCBP1;SIAH2;RIPK1;XRN2;FBXO2;MAGEC2;RNASEH2A;HNRNPD;RNASEH1
prerank,positive regulation of TOR signaling (GO:0032008),0.2402329790189076,0.7885100810633904,0.8111782477341389,0.9777552566173541,1.0,11/40,21.77%,KLHL22;RPTOR;NCKAP1L;SLC38A9;FLCN;WDR59;HTR6;WDR24;HDAC3;PIP4P1;SIK3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.26701828735753214,0.7882540600689898,0.7980295566502463,0.977530089908591,1.0,9/24,29.90%,PLA2G3;LPCAT1;PGS1;PLA2G15;PNPLA8;PLA2G4A;ABCA3;CDS2;CRLS1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.26754827018142635,0.7877555487643355,0.7803660565723793,0.9777756480822867,1.0,9/24,28.85%,FSCN1;NCKAP1;TWF2;CYFIP1;WASF2;CDC42;CLRN1;BRK1;AUTS2
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.31353583162561843,-0.7877005031534628,0.7472766884531591,0.9104255699412265,1.0,3/10,17.07%,CCR2;WNT5A;ADAM17
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.20174562120588685,-0.7874448695385193,0.8543689320388349,0.9102725955928996,1.0,6/50,7.26%,MOSMO;FBXL17;VCP;DLG5;TUBD1;TEDC2
prerank,cellular response to amino acid stimulus (GO:0071230),0.24670016085129445,0.787150459903807,0.8027522935779816,0.9781916534088047,1.0,8/33,19.03%,KLHL22;RPTOR;SLC38A9;GLRA2;IPO5;SH3BP4;XBP1;NSMF
prerank,purine ribonucleotide transport (GO:0015868),0.2902362104445626,0.7871335195809268,0.7537437603993344,0.9775759840220398,1.0,4/16,19.64%,SLC25A4;SLC19A1;SLC35B2;ABCC6
prerank,regulation of stem cell differentiation (GO:2000736),-0.18136876134282112,-0.7867136947418701,0.9411764705882353,0.9109007861101588,1.0,30/89,26.41%,ITCH;PSMA6;TCF12;PSMB2;PSME2;PSMD11;PSMC6;YAP1;PSMA3;NOTCH1;NSUN2;PSMD10;PTN;PSMB5;GATA3;PSMD5;PDGFRA;HES1;PSMD1;LMO1;HNRNPU;ESRRB;SETD1A;EIF2AK2;KMT2A;PSMA7;PSMB7;PSMB3;MYB;CBFB
prerank,regulation of lipid storage (GO:0010883),0.2717683178801974,0.786512128171552,0.759016393442623,0.9779920913541977,1.0,3/22,5.65%,C3;HILPDA;IL6
prerank,histone mRNA catabolic process (GO:0071044),0.3044778868195801,0.7863874932460532,0.7562604340567612,0.9775791016110122,1.0,3/15,14.65%,LSM1;MTPAP;UPF1
prerank,vasoconstriction (GO:0042310),-0.30812361968888463,-0.7863516132431008,0.7537688442211056,0.9109127571434817,1.0,8/11,36.51%,EDNRB;EDNRA;ACTA2;KEL;EDN3;CRP;EDN2;EDN1
prerank,response to interleukin-1 (GO:0070555),-0.1914508913264129,-0.7856645609575225,0.897196261682243,0.9114544974851304,1.0,20/73,23.88%,CD47;NFKB1;CCL25;ANXA1;GBP3;HIF1A;IL1B;ZC3H12A;PTGIS;RC3H1;ACOD1;HAS2;RBMX;HYAL3;ADAMTS12;MYD88;HDAC4;APP;MAPK11;CCL7
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.319639915504714,0.7852109631440898,0.7679558011049724,0.9790207090591979,1.0,3/12,9.35%,ZC3H10;NCOR2;TGFB1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.2629442022954399,0.7851226493020972,0.7945859872611465,0.978525557523241,1.0,6/26,19.53%,B4GAT1;ACAN;CHST1;ST3GAL6;B4GALT2;ST3GAL3
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2612641251831204,0.7848594095937348,0.7891268533772653,0.9783410240344012,1.0,5/26,15.66%,NME5;FBXO7;PRKN;NFE2L2;REST
prerank,PERK-mediated unfolded protein response (GO:0036499),0.33586837351218907,0.7847537516608748,0.7438162544169611,0.9778899661243667,1.0,5/10,31.07%,NFE2L2;HERPUD1;ATF4;DDIT3;CCL2
prerank,positive regulation of ruffle assembly (GO:1900029),0.31330151959917873,0.7840046223515285,0.7607573149741824,0.9785785170251196,1.0,4/13,16.50%,P2RY12;EPS8L3;EPS8L2;HRAS
prerank,mitochondrion distribution (GO:0048311),-0.3034472995522174,-0.7836049453678258,0.7651715039577837,0.9141832991049791,1.0,3/12,12.18%,TRAK1;MTM1;LRRK2
prerank,positive regulation of transferase activity (GO:0051347),0.19067866532077354,0.7835285799810842,0.9096945551128818,0.9787369186639857,1.0,33/142,21.10%,WRAP53;MERTK;NTRK1;FLT4;NTRK3;MAPK15;RYK;DCUN1D2;EPHA1;ERBB4;TGFB1;UBE2N;CCT4;TEK;DBI;EPHA4;INSR;EPHB2;NTRK2;MAPK3;UBE2I;VAC14;MAPKAPK5;SERINC1;FLT3;CHRNA7;PIN1;PDGFRB;ROR1;EPHA5;HSP90AB1;XRCC5;GRHL2
prerank,vasculature development (GO:0001944),0.29302196411550857,0.7831114718817562,0.7596491228070176,0.9788021080206293,1.0,2/16,5.03%,FLT4;STK11
prerank,regulation of cellular localization (GO:0060341),0.2285360941587039,0.7824590854153226,0.8306188925081434,0.9792992628655023,1.0,13/46,21.28%,PARD6B;PARD6G;PRKN;WWC1;PARP1;STXBP2;STXBP4;FES;TRIM67;MAD1L1;EPHA5;HSP90AB1;MAP2
prerank,positive regulation of double-strand break repair (GO:2000781),0.23611250916948606,0.7824590559657576,0.8055130168453293,0.9786658222038817,1.0,8/39,20.00%,WRAP53;FUS;TIMELESS;PARP1;ERCC6;SHLD3;MRNIP;SHLD2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.22657359465333418,0.7822657732085598,0.8393393393393394,0.9783677847490059,1.0,10/48,15.89%,AAAS;NUP54;EIF6;OGT;NUP88;RAE1;JMJD8;PRDM16;KHK;NUP133
prerank,pseudouridine synthesis (GO:0001522),-0.28677793413723845,-0.7816013226308931,0.7857142857142857,0.9168106448595966,1.0,5/13,24.69%,TRUB2;NOP10;DKC1;PUS3;NHP2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2312032170815646,-0.7815202393008401,0.830945558739255,0.9163851275204886,1.0,7/31,14.09%,DIS3L2;EXOSC8;DDX6;DCP1B;LSM2;LSM5;EXOSC9
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.2998038319447836,0.7812312848053332,0.7732656514382402,0.9794845707492409,1.0,4/14,16.62%,PKD2;FAF1;PKD1;SUFU
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.31533463475847145,-0.7811965986293454,0.7477064220183486,0.9163305684436981,1.0,5/10,33.02%,CARMIL1;CFL2;CARMIL2;PLEK;PDXP
prerank,aortic valve morphogenesis (GO:0003180),0.2502427700109119,0.7811575935359784,0.8070175438596491,0.9789744880962616,1.0,5/30,10.89%,BMP4;HEY1;TGFB1;SNAI2;EFNA1
prerank,cellular response to inorganic substance (GO:0071241),0.2702283844952975,0.7809121658543287,0.8078175895765473,0.9787328238314252,1.0,4/21,17.76%,TIMELESS;NSMCE3;AOC1;MTR
prerank,regulation of cellular response to heat (GO:1900034),0.20761788545199453,0.7804415964353999,0.8715846994535519,0.9788903089519695,1.0,13/77,15.89%,YWHAE;AAAS;CD34;RPTOR;DNAJC2;NUP54;CHORDC1;NUP88;RAE1;DNAJC7;CCAR2;MAPK3;NUP133
prerank,positive regulation of telomere capping (GO:1904355),-0.268354975274429,-0.7801476938091872,0.7849740932642487,0.9173997291065525,1.0,5/17,18.03%,RTEL1;PKIB;PRKCQ;MAP2K7;HNRNPD
prerank,intermediate filament organization (GO:0045109),0.28493300342014954,0.7795985640598553,0.7635135135135135,0.9796195342091312,1.0,8/17,31.29%,BFSP2;TCHH;NEFL;KLHL24;GFAP;PKP2;BFSP1;DES
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2049932663014963,0.7794327545935248,0.8741542625169147,0.9792549693331463,1.0,32/85,28.30%,VANGL2;PSMB1;RYK;ARRB2;PSMF1;PRICKLE1;PSMA1;PSMD7;PSMA8;PSME3;VANGL1;PSMD14;PSMC4;WNT7A;PSMB4;DVL2;MAGI2;PSME1;CDC42;PSMD2;PSMD4;PSMD8;TIAM1;RHOA;PSMC5;FZD5;PSMD3;PSMB8;PSMA4;CLTC;ROR2;CELSR2
prerank,rRNA modification (GO:0000154),-0.2506820449961441,-0.7793838863437061,0.7930174563591023,0.917998829617321,1.0,7/21,19.48%,FTSJ3;MRM2;ZCCHC4;NOP10;FBL;NAT10;DKC1
prerank,regulation of myelination (GO:0031641),0.2639942235705325,0.779275800195528,0.7904,0.9788644711962048,1.0,2/25,4.67%,TPPP;JAM2
prerank,regulation of cell growth (GO:0001558),0.18333382424008487,0.7787406446006196,0.9381188118811881,0.9791056971119526,1.0,41/204,19.17%,KLHL22;WFDC1;RPTOR;PSRC1;TMC8;SIPA1;STK11;HDGFL2;LGI1;EBAG9;IL2;TGFBR1;MINAR1;APBB1;FHL1;GNG4;KIF26A;SOCS2;TGFB1;ADAM15;NRG3;SFRP1;CGRRF1;ACVR1B;PAK5;DCBLD2;FLCN;BAP1;EI24;CCAR2;HPN;SH3BP4;KIF14;AGT;N6AMT1;NDRG3;PPP2R1A;BTG1;LTBP4;TCHP;TAF9B
prerank,protein palmitoylation (GO:0018345),0.2521702913175554,0.7786148049649755,0.7956656346749226,0.9786909495746144,1.0,12/30,27.25%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;SELENOK;GOLGA7;ZDHHC15;GLUL;ZDHHC19;ZDHHC12;ZDHHC5
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.19765311300466773,0.7784092694870831,0.8936742934051144,0.9784034251001619,1.0,11/104,9.63%,CDK7;FGF16;RPTOR;THY1;CCNI;SERTAD1;TRIB1;TRIB2;DAB2IP;CCND3;SLC8A1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.2322634204786424,-0.7780676982890463,0.8333333333333334,0.9194727396268912,1.0,4/29,9.19%,MCTP1;APOE;SLC8A2;DRD2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.22386396996965302,0.777814994622493,0.8531976744186046,0.9787315894345678,1.0,14/50,21.80%,PSMB1;PSMF1;PSMA1;PSMD7;OAZ1;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;PSME1;PSMD2;PSMD4;PSMD8
prerank,regulation of phosphate metabolic process (GO:0019220),0.28939990145531647,0.7778070016645944,0.7701543739279588,0.9781134110692165,1.0,2/16,3.26%,SRPX2;GNB3
prerank,cellular response to chemical stress (GO:0062197),0.20104921563706485,0.7776971215016524,0.8875338753387534,0.9776684985056636,1.0,16/96,16.30%,SELENOS;PRDX5;PRDX6;NUDT2;PPARGC1A;VKORC1L1;PRDX2;PKD2;NFE2L2;PYROXD1;VRK2;RAD52;PARP1;PRKD1;ERMP1;SETX
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3082325801974697,-0.777083650310621,0.7535885167464115,0.9204273370591364,1.0,4/10,16.55%,CEACAM1;KDR;RAP1A;ASB4
prerank,protein localization to synapse (GO:0035418),0.3129130486457973,0.7770411836046656,0.7535211267605634,0.978109221143423,1.0,6/12,26.99%,NRXN1;SHANK1;ZDHHC15;PCLO;DLG4;ZDHHC12
prerank,histone H4-K16 acetylation (GO:0043984),0.2782675878217627,0.7768196083110775,0.7726495726495727,0.9778618851769509,1.0,8/19,25.67%,JADE2;MEAF6;OGT;KAT8;WDR5;JADE1;MSL1;MCRS1
prerank,protein export from nucleus (GO:0006611),0.2552888933123694,0.7765939859033099,0.7849462365591398,0.9775876056405134,1.0,9/27,25.04%,STRADB;STYX;TGFB1;PKD1;XPO6;STRADA;RANBP3L;RANBP17;CCHCR1
prerank,negative regulation of cell death (GO:0060548),0.20191225072371122,0.7765022122299081,0.8943850267379679,0.977114402058813,1.0,14/88,14.26%,SRGAP2;CD34;PPARGC1A;SOX4;PM20D1;SRSF6;CLU;CCN4;BMP4;PRKN;FGF2;BECN1;TXNDC12;CHMP2A
prerank,acylglycerol catabolic process (GO:0046464),0.2526244118762271,0.7764504796924095,0.7840909090909091,0.9765742443269183,1.0,10/30,29.71%,PNPLA3;ABHD12;FABP3;LIPC;DAGLA;ABHD2;LIPE;FABP5;MGLL;FAAH
prerank,muscle tissue development (GO:0060537),-0.289813151641256,-0.7764130088395022,0.7655172413793103,0.9209370940671162,1.0,5/13,22.33%,PGM5;CSRP2;POGLUT1;PTCH1;SHH
prerank,carbohydrate biosynthetic process (GO:0016051),-0.24959274598931913,-0.7760372952069987,0.8181818181818182,0.920985032607588,1.0,6/21,22.47%,MPDU1;ST8SIA6;FUT8;B3GALT5;ST6GALNAC5;FUT4
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.21149101386146027,0.775568919294303,0.8682634730538922,0.9773588911560257,1.0,19/65,25.67%,BCL9L;LDLRAD4;PPARA;DAND5;TGFBR1;FBN2;PPM1A;TGFB1;PRDM16;SNX6;PIN1;IL17RD;SMAD2;PDPK1;SKOR2;HTRA3;FBN1;ZBTB7A;STUB1
prerank,pyroptosis (GO:0070269),-0.2758044349341846,-0.7753968874248489,0.7879518072289157,0.9214260451251678,1.0,2/15,4.17%,ZBP1;NLRC4
prerank,limb development (GO:0060173),0.24799194797794868,0.7741689732278401,0.8113821138211382,0.9790498926886978,1.0,2/28,4.52%,FGF10;MEGF8
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.2731723000808303,-0.773931332368157,0.766109785202864,0.9230597501212654,1.0,6/15,30.91%,LEMD3;ACVR1;ACVR2A;FST;IGSF1;FKBP1A
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3047539876237939,-0.7739033427865716,0.7572115384615384,0.9225588725192926,1.0,6/11,25.83%,PF4;RIPK1;HSF1;ID2;FADD;CSF1
prerank,serine family amino acid catabolic process (GO:0009071),0.32407841052403413,0.7732449362214876,0.7779816513761468,0.9798983830482174,1.0,3/10,15.60%,AMT;DAO;DLD
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.2517655440710725,0.7730095402177399,0.807936507936508,0.9796349179024524,1.0,8/30,20.42%,F11R;PRAG1;GPR17;LPAR4;AKAP13;P2RY10;GPR174;ARRB1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.23634447248750387,-0.7729769332625039,0.8252688172043011,0.9234131653163894,1.0,7/27,21.10%,RRM1;CMPK1;TXNRD1;TYMS;NME4;GSR;AK2
prerank,glucan catabolic process (GO:0009251),-0.2740595454366495,-0.772858514030075,0.7972350230414746,0.9230326669391768,1.0,4/15,14.84%,PHKB;AGL;GAA;PGM2L1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.21273752920911604,0.7726766650461866,0.8762169680111266,0.979552711828164,1.0,11/61,13.54%,PSMB1;PPARA;PSMF1;NCOR2;PSMA1;PSMD7;OAZ1;PSMA8;PSME3;PSMD14;PSMC4
prerank,regulation of calcium-mediated signaling (GO:0050848),0.25831319187141666,0.772464894993208,0.8205128205128205,0.9792742325236437,1.0,3/25,7.77%,NEUROD2;SLA2;RIT2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.23302740497741609,0.7723726666435655,0.8330757341576507,0.9787847967840763,1.0,7/39,13.57%,GTF2H2;POLD3;GTF2H4;OGG1;FAN1;PARP1;DDB2
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.19727219106147534,-0.772361077175256,0.8962264150943396,0.9232144131664524,1.0,16/52,25.45%,ATP6V0D1;ERN1;DNAJB9;EDEM1;SHC1;WFS1;PDIA5;YIF1A;TLN1;LMNA;GOSR2;VAPB;PARP16;EXTL1;HYOU1;ERN2
prerank,positive regulation of cilium assembly (GO:0045724),0.28091386608115304,0.7722974245791324,0.7601351351351351,0.9782814367476708,1.0,6/18,27.01%,SEPTIN9;ARHGAP35;HAP1;CEP120;FUZ;ENTR1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.23037189494614407,-0.7721881355489593,0.8232323232323232,0.9229261822034753,1.0,14/27,31.63%,PARP4;TERF2;DACH1;RGCC;SMG6;NIBAN2;FGFR4;BMPR2;PDGFA;TNKS;PINX1;SMG5;ATM;HGF
prerank,regulation of vasoconstriction (GO:0019229),0.25359419667847527,0.7720678356520787,0.8186274509803921,0.978003794600545,1.0,2/27,3.31%,AVPR2;AVPR1A
prerank,ERBB2 signaling pathway (GO:0038128),0.2472927935732534,0.772062575099211,0.8093023255813954,0.9773923582343552,1.0,4/31,8.93%,MATK;NRG4;PRKCA;ERBB4
prerank,carboxylic acid catabolic process (GO:0046395),0.3133491663832296,0.7720602442558195,0.7966942148760331,0.9767751893290872,1.0,2/12,3.74%,IL4I1;GNPDA2
prerank,activation of adenylate cyclase activity (GO:0007190),-0.220240562458428,-0.7720421532893529,0.8376811594202899,0.9225820178643719,1.0,7/35,12.73%,RAF1;ADCY9;ADCY5;ADCY6;EDNRA;ADCY1;ADCY3
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3154957400522904,0.7719670584466486,0.7767695099818511,0.9763079027699865,1.0,3/12,18.40%,PRKCZ;IRS1;ZBTB7B
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.23329421132075218,-0.771713095351345,0.8097982708933718,0.9225395490759355,1.0,2/27,1.35%,ARL6IP5;SLC7A1
prerank,mitochondrion disassembly (GO:0061726),0.23965440340316704,0.7715905935221569,0.8069381598793364,0.9763057245083129,1.0,12/34,24.55%,FUNDC1;FIS1;FBXO7;USP30;PRKN;BECN1;CTSK;GABARAP;ULK2;ULK1;ATG2A;WDR45B
prerank,mitochondrial fusion (GO:0008053),0.282402490654438,0.7710297811347511,0.8048359240069085,0.976596873260835,1.0,4/18,17.61%,FIS1;USP30;MIGA1;MFF
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.29182713505438357,0.7709557445622247,0.7543859649122807,0.976105617596024,1.0,4/15,17.52%,SPCS2;SRPRB;SRP14;SRPRA
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.25961097249864246,0.7708930858327555,0.797716150081566,0.9755785513819965,1.0,5/23,13.86%,COPS8;COPS3;PARP1;DDB2;COPS6
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.21513518322588665,-0.7704310724922521,0.8525469168900804,0.9238493216195784,1.0,9/33,17.30%,ANKRD17;CDC73;CCND1;ANXA1;CCND2;EGFR;CRNN;ADAM17;RGCC
prerank,regulation of Wnt signaling pathway (GO:0030111),0.19405162527167868,0.7703550833202518,0.9072847682119205,0.9757893084396749,1.0,36/108,29.15%,HHEX;TSC2;HIC1;NXN;PTK7;BTRC;FAM53B;PRKN;EMD;SPIN1;CTNND2;SFRP1;AMER2;TCF7L1;AMER3;PPP2R1A;RSPO1;SULF2;RNF43;FRZB;RSPO2;AXIN1;SFRP2;PPP1CA;RUNX1;CXXC4;TIAM1;SALL1;GNAQ;NKD1;SULF1;SENP2;KANK1;SOX7;DCDC2;DAAM2
prerank,regulation of dephosphorylation (GO:0035303),0.29480035309955543,0.7701612872724827,0.7773851590106007,0.9754884018977912,1.0,5/15,21.68%,PPP1R16A;MTMR9;MTMR1;SMG7;PPP1R16B
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.22301651362063535,-0.7695519265560212,0.873015873015873,0.924620683500713,1.0,12/37,26.70%,ALOX5;NOD2;HIF1A;ZC3H12A;TNF;TLR4;MYD88;APPL2;NLRC3;MEFV;APPL1;ABCD1
prerank,L-serine metabolic process (GO:0006563),0.32159119384875234,0.7691269857435654,0.7756849315068494,0.9765701673550777,1.0,6/10,33.75%,SERINC3;PSPH;PHGDH;SRR;SERINC5;PSAT1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.285243574387673,0.7690237840017118,0.788034188034188,0.9755008625319597,1.0,4/17,16.72%,BRWD1;SOCS2;IRS1;IL7
prerank,cellular response to interleukin-7 (GO:0098761),0.285243574387673,0.7690237840017118,0.788034188034188,0.9755008625319597,1.0,4/17,16.72%,BRWD1;SOCS2;IRS1;IL7
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.29911758370484454,-0.7690135969428695,0.7665198237885462,0.9248561905706278,1.0,4/11,19.51%,ITM2B;NECAB1;AGO2;ITM2A
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.1966080433077118,-0.76881161382741,0.8885630498533724,0.9246120961911115,1.0,17/54,24.60%,GAS6;UBE2K;SYK;RIPK1;HIPK1;BIRC2;RACK1;TNF;OTULIN;TRAF1;ADAM17;PYDC1;HSPA1B;CASP1;CLIP3;GSTP1;FADD
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2291085301087925,-0.7686796525382158,0.8337950138504155,0.923727670225827,1.0,9/29,27.15%,RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1;CENPH;HJURP;OIP5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2291085301087925,-0.7686796525382158,0.8337950138504155,0.923727670225827,1.0,9/29,27.15%,RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1;CENPH;HJURP;OIP5
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.30953220239486257,-0.768638527930582,0.7517564402810304,0.9232662338706616,1.0,2/10,14.60%,RTEL1;TERF2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.27024423619791055,0.7685493197156822,0.7885532591414944,0.9750235372706425,1.0,9/21,29.79%,GTF2H2;GTF2H4;PARP1;DDB2;GTF2H3;ERCC2;ERCC4;GTF2H1;RBX1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.27024423619791055,0.7685493197156822,0.7885532591414944,0.9750235372706425,1.0,9/21,29.79%,GTF2H2;GTF2H4;PARP1;DDB2;GTF2H3;ERCC2;ERCC4;GTF2H1;RBX1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.221121830692373,0.7683699626117088,0.8310708898944194,0.9746909796175641,1.0,16/54,24.34%,CNOT2;SOX4;E2F1;PLK3;BTG2;CNOT8;GADD45A;RBL2;PLK2;TFDP2;MDM4;CASP2;CNOT10;AURKA;TRIAP1;CNOT4
prerank,homologous chromosome segregation (GO:0045143),0.27125801811655204,0.7683025904816654,0.7807570977917981,0.9741841625439968,1.0,5/20,21.67%,SGO1;TERB1;FANCD2;CENPC;IHO1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.29280028282141024,0.7682428733800477,0.8165784832451499,0.9736700476690854,1.0,9/14,35.30%,NUDT9;ENTPD6;ENTPD1;ENTPD2;NUDT16;ENTPD3;ENTPD7;NUDT1;NUDT18
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.21283793308004545,0.7682035407146083,0.845360824742268,0.9731322932805039,1.0,19/63,24.62%,CNOT2;SOX4;E2F1;PLK3;BTG2;CNOT8;GADD45A;RBL2;RFWD3;PLK2;FBXO31;TFDP2;MDM4;CASP2;CNOT10;AURKA;TRIAP1;CNOT4;SDE2
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.3023940626954162,-0.7681378929647222,0.7694174757281553,0.9234882506404972,1.0,1/11,0.36%,VCPIP1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2103887106344801,-0.7678656914465917,0.8823529411764706,0.9233335872841825,1.0,14/37,26.81%,UBE2K;S1PR2;PRKAG2;SPRY2;CALM3;CALM2;INPP5K;PLK1;BMP7;SIRT2;APP;EGF;TNKS1BP1;SPRED1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.26765573017128685,0.7678451470289982,0.792332268370607,0.9730697200717117,1.0,9/21,28.62%,DMD;CNKSR3;DDIT4;GADD45A;INPP5J;PAQR3;DMTN;PTEN;NLRP2B
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.26200778238428213,-0.7677693967028288,0.7952380952380952,0.9229275077436101,1.0,5/18,16.51%,ANXA1;CIB1;RHOJ;KDR;HMOX1
prerank,cartilage development (GO:0051216),0.2216349644719496,0.7666197867173515,0.8376811594202899,0.9743273857816408,1.0,15/49,25.61%,COL2A1;IL17F;NFIB;MEF2C;BMP4;TGFB1;FGF2;PKD1;WNT7A;GHRL;SULF2;SNX19;GPLD1;RUNX1;WNT5B
prerank,cellular defense response (GO:0006968),0.23115446152883756,0.7666105495105469,0.8593508500772797,0.9737318575428535,1.0,9/40,18.87%,FOSL1;RELA;CX3CR1;BECN1;CCR6;CLEC5A;CCR9;ITK;NCF2
prerank,response to hydrogen peroxide (GO:0042542),0.22445042222435846,0.766454645522524,0.8544303797468354,0.9733704219863994,1.0,7/45,11.54%,STK26;RELA;IL6;TRPM2;RIPK3;NFE2L2;STK25
prerank,negative regulation of leukocyte migration (GO:0002686),-0.30554368054975384,-0.7663576975924923,0.7616926503340757,0.9244049867724524,1.0,3/10,16.51%,CD300A;BMP5;HMOX1
prerank,sphingoid metabolic process (GO:0046519),-0.2896545484735028,-0.7661150307351332,0.7969543147208121,0.9241958085473672,1.0,4/12,20.33%,SGPP1;ASAH2;SPHK2;SPTLC3
prerank,mesenchymal cell development (GO:0014031),0.28106321528497724,0.7660032664481948,0.7986230636833046,0.9734531125078533,1.0,4/18,10.77%,CYP26C1;FOXC1;SNAI2;PDCD6
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.2761836864938582,-0.7655445267464327,0.7848970251716247,0.9244724427801099,1.0,5/15,18.88%,ZC3H12D;ZC3H12A;ZC3H12B;POP1;RNASEH1
prerank,regulation of blood circulation (GO:1903522),-0.21564377982211844,-0.7654380345804489,0.8626373626373627,0.9240754128441832,1.0,17/34,39.39%,CAMK2D;S100A1;FXYD1;AGER;PER2;KCNQ1;CELF2;KCNG2;ACE2;SRI;TNNT2;MYH6;TH;AGTR1;TPM1;KCNMB4;ECE1
prerank,negative regulation of innate immune response (GO:0045824),-0.21818301384531147,-0.765207950058682,0.8740157480314961,0.9238604235705364,1.0,14/34,30.00%,STAT2;USP18;ACOD1;SERPING1;NLRC5;OAS3;MUL1;USP15;NLRC3;TRIM21;DHX58;RPS19;VSIG4;TNFAIP3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.29409249578696817,-0.7651425179828124,0.773542600896861,0.9234021341145967,1.0,5/11,25.05%,LYN;ANXA1;CDKN2A;PIK3CD;BLK
prerank,inositol phosphate catabolic process (GO:0071545),0.30885614774911047,0.7648473828991093,0.7577319587628866,0.9745745689643621,1.0,5/12,21.24%,INPP5B;NUDT3;OCRL;INPP5A;INPP5J
prerank,zinc ion transmembrane transport (GO:0071577),0.2660618537819533,0.7640926998617715,0.7916666666666666,0.9750940935367705,1.0,5/22,17.77%,SLC39A4;TRPM2;SLC39A8;SLC30A3;SLC39A3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.2989861700474564,0.7640386812255218,0.766497461928934,0.9745640555958799,1.0,2/12,16.81%,SIX4;AGT
prerank,anterograde axonal transport (GO:0008089),0.235323366811346,0.7635814196513523,0.8353846153846154,0.9746689571637462,1.0,7/37,14.90%,DLG2;BLOC1S2;SNAPIN;AP3M1;AP3B2;KIF1C;HAP1
prerank,odontogenesis (GO:0042476),0.2355271972465089,0.7632875319577125,0.8211382113821138,0.9745043158403431,1.0,3/35,9.00%,ROGDI;BMP4;FOXC1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2299711013210351,-0.763104492753192,0.8440860215053764,0.9258040417525479,1.0,15/27,36.46%,C3AR1;GPR157;DRD2;GPR65;GPR18;DRD3;CALCA;GPR4;HTR2C;OPRL1;F2RL2;GPR35;GPR55;DRD1;AGTR1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.2126159027416508,-0.7631024918926862,0.8597883597883598,0.9252656533353286,1.0,7/34,17.88%,RIPOR2;CTNNA1;ANKRD13A;PICALM;CDT1;UBXN2B;GOPC
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.25358419279121713,-0.7630083670373218,0.8226600985221675,0.9248510451105304,1.0,4/19,10.02%,EXT1;XYLT1;UGDH;NDST3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2265727491690095,-0.7628282886827275,0.8174386920980926,0.9245401488540065,1.0,3/27,8.20%,FCGR2B;VPS35;PSEN1
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.231289446294905,-0.7627941348332965,0.8612565445026178,0.9240391511832878,1.0,5/24,18.58%,PRKCH;CTSL;SGPP1;NUMA1;TRIM16
prerank,'de novo' posttranslational protein folding (GO:0051084),0.24436130457497424,0.7626480501500362,0.8375796178343949,0.974895103105015,1.0,12/30,27.64%,HSPA2;SDF2;SDF2L1;HSPA9;DNAJC7;HSPE1;HSPA14;DNAJB4;DNAJB13;ST13;HSPA8;PTGES3
prerank,regulation of cellular protein localization (GO:1903827),-0.20346056049952696,-0.7625506248882931,0.8753623188405797,0.9238187149376019,1.0,9/45,14.71%,VCPIP1;VCP;DVL3;PTPN1;GBF1;LCP1;CTNNB1;RALB;RAB11FIP5
prerank,regulation of DNA repair (GO:0006282),0.2282656541447533,0.7624168395081691,0.8601503759398497,0.9746380465775593,1.0,9/44,16.30%,FGF10;WRAP53;UBE2V1;UBE2N;RAD52;RNF168;RNF8;ERCC6;WRNIP1
prerank,phospholipid biosynthetic process (GO:0008654),-0.21263698712362963,-0.7623922853523496,0.8931750741839762,0.9234883535672213,1.0,8/36,16.74%,AGPAT4;AGPAT5;IDI1;SPHK2;CPNE7;CLN3;GPAM;NUS1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2654828811169384,-0.7622123149802512,0.8103896103896104,0.9232019485606842,1.0,4/16,14.25%,CLSPN;TOPBP1;TICRR;CDT1
prerank,regulation of axon guidance (GO:1902667),-0.3069701799738037,-0.7621601996216609,0.7733990147783252,0.922726647751925,1.0,1/10,0.66%,NRP1
prerank,replicative senescence (GO:0090399),-0.29591964846202135,-0.762070664148345,0.7695852534562212,0.9223231159814296,1.0,12/12,70.44%,CDKN2A;TERT;PLA2R1;ATM;ROMO1;WNT16;CHEK2;ATR;SERPINE1;CHEK1;TP53;MME
prerank,establishment of spindle localization (GO:0051293),-0.2759925607729663,-0.7613250546984676,0.817283950617284,0.9228540270930744,1.0,3/14,12.30%,KPNB1;NUSAP1;ESPL1
prerank,positive regulation of protein depolymerization (GO:1901881),0.30966861446851024,0.7607759390311314,0.7799295774647887,0.9763959108011862,1.0,1/11,4.03%,STMN2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.2732153851667391,0.7606897669235387,0.7980456026058632,0.9759205941437415,1.0,7/18,23.35%,FIS1;PRKN;DNM1L;RALBP1;MFF;DCN;AURKA
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.26434585401066696,0.7605551742986367,0.8201680672268907,0.9755209911162805,1.0,7/22,29.92%,HHEX;HEXIM2;IPO5;LATS1;HEXIM1;PTEN;CDK5RAP1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.25470046113789674,0.7601485026860999,0.813953488372093,0.9755419145419515,1.0,10/23,29.48%,MAP6;KIF1C;HOOK2;HOOK1;KIF1B;CCDC186;TUBA1B;DYNC1I1;TUBA1A;TUBA1C
prerank,aerobic respiration (GO:0009060),-0.2441755532196093,-0.7600522435759881,0.826302729528536,0.9240513971394315,1.0,5/20,17.36%,NDUFS8;SDHB;NDUFS7;MTFR2;SURF1
prerank,negative regulation of heart contraction (GO:0045822),-0.29767041461276134,-0.7600042818838211,0.7658643326039387,0.9235846059028721,1.0,6/11,31.01%,ZC3H12A;SPX;GRK2;PDE4D;AGTR2;SRI
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.2798576534456249,0.7598775939064383,0.8181818181818182,0.9753519470001566,1.0,3/18,11.61%,OPALIN;SLC45A3;CXCR4
prerank,regulation of mitotic cell cycle (GO:0007346),0.18253810581622046,0.7590108534106271,0.9623115577889447,0.9760115224202304,1.0,40/171,21.20%,PSMB1;OBSL1;SCRIB;SMOC2;LGMN;RPS6KB1;PSMF1;BTRC;PSMA1;PSMD7;PRKCA;CCDC57;FOXC1;TGFB1;PTPN3;BTG3;PSMA8;BTG2;PSME3;TTC28;THAP1;PSMD14;PSMC4;TTLL12;ANGEL2;ANAPC2;CDK10;BTG1;PSMB4;PIN1;UBE2D1;CAV2;FBXO5;PSME1;CYLD;HECA;UBE2S;PSMD2;PRMT5;PSMD4
prerank,cellular transition metal ion homeostasis (GO:0046916),0.1980590259110702,0.7585105405055332,0.9033613445378151,0.976108997042369,1.0,24/91,20.97%,IREB2;SLC39A4;ABCB6;PRNP;SLC31A1;FLVCR1;SLC39A8;FRRS1;ATOX1;CYB561A3;MT2A;TMPRSS6;ISCU;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;ABCG2;ABCB7;ATP6V1G1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.2657186893359687,0.7584044635538456,0.8203389830508474,0.9756444380178647,1.0,6/22,17.43%,TWF2;ARFGEF1;TWF1;SSH1;SSH2;SSH3
prerank,relaxation of cardiac muscle (GO:0055119),0.2964616191807427,0.7583853551943066,0.7944732297063903,0.9750674573083403,1.0,5/13,23.25%,ATP1B1;SLC8A1;RGS2;ATP1A1;CHGA
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.32046073634459626,0.757862803662492,0.7667785234899329,0.9752342655638433,1.0,1/10,1.25%,CBARP
prerank,regulation of T cell differentiation (GO:0045580),0.2375250477102997,0.7577595481956797,0.8161290322580645,0.9747877222267903,1.0,7/33,17.88%,IL2RA;IL2;CRTAM;PRDM1;IL7;PRELID1;XBP1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.26024061179547375,0.7571603621897272,0.8140293637846656,0.9750575198817054,1.0,7/22,22.17%,CCNK;BRD4;ERCC6;DDX39B;THOC5;ALYREF;SCAF8
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.3186472584329675,0.7570786770016663,0.7749546279491834,0.974573089518792,1.0,3/10,13.88%,PRKD2;ITGA5;VTN
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.3180935887447509,0.7568677550586334,0.7877758913412564,0.9742667647069748,1.0,3/10,12.12%,SHANK3;RAB5A;SYNGR1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2838501886571606,-0.756574493880795,0.8063063063063063,0.9276885226140811,1.0,3/12,17.92%,HDAC1;INPP5K;HMGA2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.27046961312134143,0.7563455562410876,0.8245315161839863,0.97443160294537,1.0,7/20,29.92%,HHEX;HEXIM2;IPO5;LATS1;HEXIM1;PTEN;CDK5RAP1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.2662078362948545,0.7563281356811731,0.8148760330578513,0.9738607863491613,1.0,9/19,28.92%,RARRES2;MAPK3;JAM3;PTK2;CCL5;IL34;MAPK1;CSF1R;MDK
prerank,microvillus assembly (GO:0030033),0.28943565177938235,0.7557392708840863,0.7911714770797963,0.9741181548037179,1.0,6/14,25.08%,STK26;MAP4K4;MINK1;ESPN;RAP2C;RAPGEF2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3089579658499909,-0.7556226670735204,0.7949308755760369,0.9284202320696482,1.0,3/10,19.34%,BRCA1;THAP7;TAF7
prerank,positive regulation of hemostasis (GO:1900048),-0.29737620657240615,-0.7556020298251533,0.804932735426009,0.9273765728275157,1.0,2/10,9.54%,THBS1;HPSE
prerank,positive regulation of coagulation (GO:0050820),-0.29737620657240615,-0.7556020298251533,0.804932735426009,0.9273765728275157,1.0,2/10,9.54%,THBS1;HPSE
prerank,positive regulation of heart contraction (GO:0045823),0.2710768853680032,0.7555717610878511,0.7986577181208053,0.9737681121907108,1.0,5/19,23.25%,ATP2A2;ADM;RGS2;SCN3B;CHGA
prerank,polyol biosynthetic process (GO:0046173),0.28820990472723373,0.7550789295757303,0.8226086956521739,0.9738793745212034,1.0,4/16,15.41%,IP6K1;FGF2;IPMK;CYP27A1
prerank,positive regulation of vasculature development (GO:1904018),0.19564092115516754,0.7543162619710171,0.9174964438122333,0.9743869568736826,1.0,21/94,18.40%,F3;CD34;ANGPTL4;SMOC2;PLCG1;RAPGEF3;PRKCA;EPHA1;PRKD2;FGF2;PDCD6;ADAM12;VASH2;TEK;HK2;PRKD1;ANGPTL3;BTG1;XBP1;IL1A;CHRNA7
prerank,tRNA 5'-leader removal (GO:0001682),0.29508983785455845,0.7538144146606982,0.8096118299445472,0.9744918747756162,1.0,3/13,13.22%,RPP40;PRORP;RPP30
prerank,cellular component maintenance (GO:0043954),-0.28554017870545434,-0.7535290642995145,0.7828054298642534,0.9296257422106711,1.0,2/12,6.99%,MTMR2;FYN
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.24429486254083177,0.7533588518871215,0.834108527131783,0.974552020018696,1.0,8/29,21.33%,ZC3H7B;ADAR;SPOUT1;DROSHA;AGO4;SMAD2;SMAD1;LIN28B
prerank,signal peptide processing (GO:0006465),0.30696366836990524,0.7533368947125227,0.7918871252204586,0.9739845552071282,1.0,3/11,16.04%,SPCS2;HM13;SEC11C
prerank,vasculogenesis (GO:0001570),-0.219734147193019,-0.7529023879686716,0.8698979591836735,0.9298744623138345,1.0,14/32,30.89%,RASA1;AGGF1;CAV1;NOTCH1;KDR;HAS2;RAMP2;HEY2;SHH;APLNR;SPRED1;ITGB8;WT1;RASIP1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.28334340534636304,-0.7527510858790136,0.7871853546910755,0.9295438697147044,1.0,4/13,15.43%,CD74;GPRC5B;LILRB1;WNT5A
prerank,positive regulation of peptidase activity (GO:0010952),0.2638156256000712,0.7527078858410982,0.8413461538461539,0.9742615814159482,1.0,7/20,25.93%,VSIR;PSME3;PSENEN;PRELID1;PSME1;GRN;CTSH
prerank,regulation of cell junction assembly (GO:1901888),-0.22979954787622597,-0.7526955212509384,0.8578947368421053,0.9290870705005938,1.0,3/27,3.29%,PRKCH;PDLIM5;PRKACA
prerank,synaptic vesicle localization (GO:0097479),0.29673669044711004,0.7524081637179098,0.8061749571183533,0.9740786070613875,1.0,3/13,20.99%,SNAPIN;SPG11;TMEM230
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.21368378778286035,0.7522025783907336,0.8928571428571429,0.9737637072516109,1.0,14/53,21.80%,PSMB1;PSMF1;PSMA1;PSMD7;OAZ1;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;PSME1;PSMD2;PSMD4;PSMD8
prerank,steroid biosynthetic process (GO:0006694),-0.19108261382646138,-0.752155443712215,0.9421221864951769,0.929288522175314,1.0,29/56,40.00%,ACOT8;OSBP;OSBPL9;OSBPL1A;PRKAG2;OSBPL2;HSD17B1;HSD11B1;SC5D;HSD3B7;INSIG1;SRD5A2;PMVK;HSD3B2;ABCB11;INSIG2;EBP;BAAT;HSD17B3;SLC27A5;AKR1D1;CYP19A1;ACOX2;HMGCR;CH25H;FDFT1;LBR;OSBPL3;SLC27A2
prerank,positive regulation of angiogenesis (GO:0045766),0.19058581063619712,0.752104433222663,0.9195561719833565,0.9733035791130537,1.0,23/108,18.40%,F3;CD34;ANGPTL4;SMOC2;PLCG1;RAPGEF3;PRKCA;EPHA1;PRKD2;JMJD8;ITGA5;FGF2;PDCD6;ADAM12;VASH2;TEK;HK2;PRKD1;ANGPTL3;BTG1;XBP1;IL1A;CHRNA7
prerank,cellular response to osmotic stress (GO:0071470),0.26454436561617733,0.7516191622469732,0.8292682926829268,0.9733743842805,1.0,4/21,14.12%,CAPN3;PKD2;STK39;SCN2A
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2691223759132839,0.7512579700236542,0.8140703517587939,0.9732663274180539,1.0,5/18,16.18%,DAB2IP;EMD;SFRP1;MED25;PEX2
prerank,membrane lipid metabolic process (GO:0006643),0.2561346669828038,0.7505533208522771,0.8330683624801272,0.9736596331044327,1.0,5/22,17.07%,TEX2;TECR;ST3GAL6;GAL3ST1;SERINC1
prerank,sensory perception (GO:0007600),0.21902729955373323,0.7501441118818468,0.8814589665653495,0.9736248869500684,1.0,8/45,18.40%,WHRN;CDH23;NTSR2;NIPSNAP1;OPRM1;GNAS;ASIC3;CHRNA7
prerank,regulation of transposition (GO:0010528),-0.27983829806871,-0.7500961235568262,0.8213399503722084,0.9314869044225168,1.0,6/13,35.60%,PIWIL2;TDRD9;MYBL1;AICDA;PIWIL4;PIWIL1
prerank,mRNA catabolic process (GO:0006402),0.22156471781340442,0.749984510255381,0.8883720930232558,0.9732549913762906,1.0,8/44,15.17%,NUDT12;DDX5;ZFP36L2;METTL16;NBDY;AGO4;UPF1;NBAS
prerank,negative regulation of cell differentiation (GO:0045596),0.17972212274051524,0.7496967511456095,0.9631043256997456,0.9730600302298706,1.0,28/181,16.62%,CTR9;COL5A1;ZFPM1;WWTR1;NELFB;LDLRAD4;PPARA;E2F1;IL6;ZFPM2;PTBP1;TRIB2;TGFBR1;DAB2IP;BMP4;ZFP36L2;HEY1;TGFB1;SNAI2;EFNA1;SFRP1;CHADL;SDHAF2;EIF2AK4;HPN;REST;PAF1;SUFU
prerank,cholesterol metabolic process (GO:0008203),0.20562817366701092,0.7494712382661589,0.9074889867841409,0.9727680034037874,1.0,14/68,21.11%,STARD3;TM7SF2;SOAT2;ACAT2;NSDHL;LSS;CYP27A1;ACLY;SCAP;ANGPTL3;FDPS;CLN6;PIP4P1;FDX1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.26195684042115985,0.7493182608995963,0.8084033613445378,0.9723762001192169,1.0,5/20,15.39%,RELA;SPPL2B;TGFB1;PSENEN;HM13
prerank,negative regulation of DNA replication (GO:0008156),-0.27967857367066357,-0.7489047947661974,0.8120481927710843,0.932483417483915,1.0,13/13,72.06%,PDS5A;WAPL;S100A11;TSPYL2;RAD17;CDC6;MCIDAS;GMNN;ATR;GMNC;CDAN1;GTPBP4;TERF1
prerank,UV protection (GO:0009650),0.32653451938389844,0.7486996819899819,0.8141135972461274,0.9726646889800009,1.0,5/10,28.99%,FEN1;SDF4;ERCC2;CAT;SCARA3
prerank,outflow tract septum morphogenesis (GO:0003148),0.24998372766872695,0.7480752853295835,0.826580226904376,0.9729249386216917,1.0,6/24,17.25%,LRP2;ZFPM2;BMP4;TBX2;SEMA3C;ENG
prerank,regulation of fatty acid oxidation (GO:0046320),0.2786828553372053,0.7480699041998979,0.8221859706362153,0.9723396222210877,1.0,2/16,4.80%,PPARGC1A;PPARA
prerank,sensory organ development (GO:0007423),-0.19519966075340486,-0.7469524574793335,0.9369627507163324,0.9345142581661154,1.0,27/51,39.39%,MEIS1;SMCHD1;SH3PXD2B;PBX4;HIPK1;SMOC1;HIPK2;GATA3;GDF3;SHROOM2;PAX6;BLOC1S3;CPAMD8;SIPA1L3;ADAMTS18;SALL2;MAB21L1;PAX8;TGFB2;RAB18;SOX3;NTF4;STRA6;MEIS3;AHI1;FREM2;ECE1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.18026680002544648,-0.7463365491437866,0.9339622641509434,0.9347724873985055,1.0,12/69,13.69%,VCP;TRIM25;OS9;PSMC6;UBQLN1;DNAJB9;ERLIN2;BAG6;DNAJC10;RNF103;EDEM1;FBXO2
prerank,regulation of sodium ion transport (GO:0002028),0.2341699700122994,0.7462934315288636,0.8525345622119815,0.9741609991753927,1.0,16/34,33.33%,FGF12;CNKSR3;NKAIN2;NEDD4;WNK1;ATP1A1;SCN1B;SCN3B;SNTA1;ANK3;PKP2;WNK4;P2RX7;WNK3;SCN4B;SPTBN4
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2792186039672403,-0.7458858252706243,0.8253588516746412,0.9348415841034653,1.0,8/12,40.92%,CTDNEP1;CDK1;PLK1;CCNB1;LPIN1;PRKCB;CNEP1R1;VRK1
prerank,tRNA 5'-end processing (GO:0099116),-0.26584008730703923,-0.7458230018643216,0.8198198198198198,0.9343733962647246,1.0,4/15,10.32%,TRMT10C;RPP38;RPP21;SSB
prerank,regulation of glycogen metabolic process (GO:0070873),-0.28738651803093007,-0.7455933603834031,0.8160919540229885,0.9341131484427434,1.0,4/12,13.79%,PPP1R3C;PPP1R3F;PPP1R3E;INPP5K
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.28340405978538064,0.7452755711663959,0.8195876288659794,0.9749190050740456,1.0,3/14,13.30%,TGFBR1;SNAI2;CHADL
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.1788550381032474,0.7452532124985727,0.9717223650385605,0.9743541689498731,1.0,39/172,22.45%,INPP4B;PIK3C2G;INPP5D;MTMR9;PLA2G4C;PIK3CG;PNPLA3;LPCAT1;PI4K2A;SACM1L;DGKQ;CPNE6;ACHE;CHAT;PTDSS2;INPP5F;OCRL;RAB5A;FGF2;LPCAT2;SLC44A2;AGPAT1;MTMR1;ABHD5;DGKZ;DGKE;VAC14;PTPN13;ABHD8;INPPL1;PGS1;DGKH;PLEKHA2;INPP5J;PLEKHA1;PIK3C2A;PIP4K2B;ARF1;SELENOI
prerank,histone acetylation (GO:0016573),-0.185721940172434,-0.7452001635269715,0.9586206896551724,0.934072997281855,1.0,22/69,26.43%,EP400;EPC1;KAT6B;PHF20;TAF12;TRRAP;EP300;HAT1;KAT5;CHD5;MSL3;KAT7;TADA2A;TRIM16;YEATS2;POLE3;KAT2B;TAF6L;NAA40;ACTL6A;LEF1;ATF2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.2398125860672651,-0.7447545829878309,0.8463356973995272,0.9340954321107853,1.0,4/21,12.11%,DVL3;CAV1;CTNNB1;FZD2
prerank,regulation of smooth muscle contraction (GO:0006940),0.2568366238206199,0.744491027853698,0.8652037617554859,0.9747942792243708,1.0,1/20,0.21%,CTTN
prerank,divalent inorganic cation homeostasis (GO:0072507),0.24818480612002422,0.7444012705374956,0.835820895522388,0.9743245813924888,1.0,4/25,9.79%,TMC8;GRIN1;SLC8A1;PRKN
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.20472571014375326,-0.7442604593604278,0.9015151515151515,0.934219410124282,1.0,8/39,15.24%,GCNT2;CORO1C;RASA1;THBS1;NOTCH1;MYOC;AJAP1;SPRY4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.30752272814414916,0.7434337022053258,0.8413547237076648,0.9750811269886196,1.0,1/10,0.98%,ADTRP
prerank,mitochondrial transcription (GO:0006390),0.3170718382155537,0.7432652741849329,0.7735849056603774,0.97472331266092,1.0,1/10,4.02%,TFAM
prerank,neural tube development (GO:0021915),0.2830818201653433,0.7430816538608248,0.8234295415959253,0.9743716704275958,1.0,4/15,12.51%,SOX4;PKD2;TGFB1;PKD1
prerank,regulation of cell communication (GO:0010646),-0.21298870403775086,-0.7430273319065114,0.8991596638655462,0.9352248270027966,1.0,15/35,29.23%,CRK;PTPN1;ANXA1;YWHAG;CAMK2D;NUP62;IGFBP7;CDC42SE2;VEPH1;GLRX2;GRK5;RYR2;GRK2;GRK4;CASQ2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.23580816644884212,0.7427254677206461,0.861198738170347,0.9742426817122639,1.0,9/33,22.39%,PPARA;TCF7L2;NFE2L2;ICAM1;TEK;NDNF;TNIP2;PDPK1;CAST
prerank,pulmonary valve morphogenesis (GO:0003184),0.27228253899911503,0.7426292159453557,0.8357963875205254,0.9737728289031726,1.0,3/17,9.90%,BMP4;HEY1;GJA5
prerank,peptidyl-amino acid modification (GO:0018193),0.3050458729336589,0.742025392899941,0.7907407407407407,0.9739722845577027,1.0,3/10,21.27%,METAP1D;FKBP10;METAP2
prerank,cellular respiration (GO:0045333),-0.19659151030683733,-0.7419206038896546,0.9069767441860465,0.9360776925879101,1.0,5/41,6.35%,NDUFS4;NDUFA5;MTLN;NDUFS8;SDHB
prerank,regulation of lymphocyte activation (GO:0051249),0.30224487117244264,0.741844716014846,0.8161764705882353,0.9736219467965892,1.0,3/12,19.31%,PAG1;CRTAM;CCL5
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.24386390777057815,0.7418376860728135,0.8593996840442338,0.9730408068944949,1.0,5/27,17.90%,ATP2A2;GJA5;FGF13;CTNNA3;ANK2
prerank,organophosphate catabolic process (GO:0046434),0.3033272011825354,0.7410382307209075,0.8211678832116789,0.9735047817409125,1.0,3/11,16.97%,ABHD12;ENPP2;ANGPTL3
prerank,response to nitric oxide (GO:0071731),-0.2741419005517022,-0.7407037282881261,0.8317073170731707,0.9370574935174546,1.0,4/13,27.78%,TXN;FOXO1;EGLN1;AQP1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.25947907404886394,-0.740548264402085,0.8317307692307693,0.9367102262183783,1.0,4/16,16.03%,ETF1;SHFL;TNF;CLN3
prerank,monocyte differentiation (GO:0030224),0.3126063239045641,0.7392623164983221,0.8230240549828178,0.9752534014952976,1.0,5/10,28.16%,BMP4;THOC5;MT1G;PDE1B;CSF1R
prerank,engulfment of apoptotic cell (GO:0043652),0.2782905470914793,0.7392304588229812,0.84375,0.97470802094734,1.0,3/15,17.33%,RHOBTB1;XKR6;RHOBTB2
prerank,regulation of protein localization to cell surface (GO:2000008),-0.21295680024605032,-0.7390530031457243,0.8954423592493298,0.9380297731694455,1.0,13/33,28.53%,TYROBP;GBF1;PICALM;TM9SF4;CTNNB1;RAB11FIP5;TNF;GOPC;EGF;GPD1L;KCNAB2;RANGRF;TAX1BP3
prerank,negative regulation of binding (GO:0051100),0.19452696319734847,0.7385643473921526,0.9280677009873061,0.9750046415903492,1.0,16/81,18.99%,ZFPM1;TMC8;EFHB;E2F1;GTF2F1;STYX;SUMO3;ITGB1BP1;PEX14;USP33;PDGFB;MITD1;CARD16;ROCK1;PIN1;ACTB
prerank,negative regulation of cholesterol transport (GO:0032375),0.3083027246879318,0.7385473000494162,0.8135283363802559,0.9744396293249343,1.0,2/10,13.96%,ABCG8;ABCA2
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.20322805085975687,-0.7384540656122595,0.8879551820728291,0.938255409640225,1.0,14/42,22.90%,AIMP1;FARS2;IARS2;YARS2;PARS2;EARS2;QARS1;NARS1;WARS2;VARS2;WARS1;FARSA;LARS1;PPA2
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.1819962281358521,-0.7384448446506926,0.927797833935018,0.9377290733909838,1.0,10/68,10.11%,MTHFR;FLAD1;MCCC1;SLC46A1;MCCC2;HLCS;GSTO2;MTHFD1;SLC52A2;SLC25A19
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.28172824100650556,-0.7379290813294619,0.8054919908466819,0.9378574078324985,1.0,6/12,32.32%,DSEL;CSPG4;DSE;CHST12;NCAN;CHST14
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.21909343730127856,-0.7377887583691649,0.8759493670886076,0.93750601162379,1.0,6/29,15.15%,GAS6;CCR2;MOSPD2;CXCL17;AGER;TNF
prerank,embryonic digit morphogenesis (GO:0042733),-0.2499099598508921,-0.7377741859895873,0.8357843137254902,0.9369872190945028,1.0,7/18,27.37%,WDPCP;HDAC2;HDAC1;MAP3K20;SHH;TWIST1;MSX1
prerank,positive regulation of neuron migration (GO:2001224),-0.29200504556723794,-0.7377526516780024,0.8106382978723404,0.9364783352194946,1.0,4/11,18.59%,KIF20B;SEMA6A;SHTN1;ARHGEF2
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.28678324930440147,-0.7375988692246519,0.8,0.9361539327664559,1.0,5/11,25.75%,EXOSC10;FBL;TENT4B;DKC1;LARP7
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.28937301548228594,0.7375700144514147,0.79182156133829,0.9750966032714645,1.0,2/12,12.70%,SOAT2;MTTP
prerank,epidermis development (GO:0008544),-0.18422399430366931,-0.737308517335667,0.953125,0.9359679411656392,1.0,30/56,36.79%,FLOT2;EMP1;HDAC2;HDAC1;PTHLH;ALDH3A2;LAMA3;DSP;EVPL;SCEL;FOXN1;CRABP2;SPINK5;KRTDAP;POU2F3;DLL1;SVEP1;WAS;COL7A1;GRHL1;UGCG;OVOL2;TGM5;EDAR;OVOL1;EDA2R;GLI1;RBP2;SPRR1A;NTF4
prerank,regulation of mRNA processing (GO:0050684),0.2355481036985938,0.7369705318462381,0.8784440842787682,0.9752813642141093,1.0,6/32,12.24%,CWC22;SON;YTHDC1;METTL16;KHDRBS2;QKI
prerank,angiogenesis involved in wound healing (GO:0060055),-0.2867628933917713,-0.7369175097532088,0.8329519450800915,0.9358922214134942,1.0,5/11,19.22%,HPSE;PRCP;KDR;ADIPOR2;ITGB3
prerank,stress-activated MAPK cascade (GO:0051403),0.2041572565972192,0.7367187158590697,0.914804469273743,0.9750194359389719,1.0,19/61,25.08%,UBE2V1;TRIB1;MAP3K10;BTRC;NOD1;SH2D3C;UBE2N;MINK1;MAP3K7;MAP3K13;MAPK10;MAPK3;MAP4K2;TNIP2;RIPK2;GPS2;ADORA2B;TAOK2;MAPK1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.3071122466616656,0.736383720064729,0.8101933216168717,0.9748436481624939,1.0,1/10,3.98%,HSPA2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.20688631939254962,0.7358028792445526,0.9077809798270894,0.9749997947129224,1.0,20/55,27.52%,PSMB1;PSMF1;PSMA1;FHL1;PSMD7;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;FBXL7;PSME1;PSMD2;PSMD4;PSMD8;AURKA;PSMC5;PSMD3;PSMB8;PSMA4
prerank,cellular response to hypoxia (GO:0071456),0.18293829960383018,0.7355706023978268,0.9500640204865557,0.9747006186430064,1.0,38/126,26.14%,PSMB1;KCND2;HILPDA;ELOC;PSMF1;PSMA1;PSMD7;PLK3;PSMA8;PSME3;SFRP1;SUV39H2;CUL2;EPAS1;PSMD14;PSMC4;NDNF;SCN2A;SLC8A3;NDRG1;CARD16;BACH1;PSMB4;OPRD1;RORA;PSME1;PSMD2;TBL2;PSMD4;MDM4;PSMD8;AK4;HIF1AN;NPEPPS;HIGD1A;STUB1;PSMC5;PSMD3
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.2078083105072397,-0.7352740079214392,0.9104477611940298,0.9373302136661251,1.0,8/36,16.08%,BCL2;FAS;ASAH2;RB1;QARS1;DEPTOR;TNF;TRAF1
prerank,insulin secretion (GO:0030073),0.25923893114204166,0.7348358294380121,0.8470394736842105,0.9750351059322988,1.0,5/19,22.19%,PTPRN;ADCYAP1;GAL;SNX19;RAB11FIP2
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.18054486292051095,-0.7346564802404743,0.9490445859872612,0.9375301905421461,1.0,25/65,28.26%,UBQLN1;ACAA2;HIF1A;CPEB4;ADAM8;PTGIS;PMAIP1;HP1BP3;HMOX1;NOP53;HIPK2;CPEB2;RGCC;BMP7;FMN2;SIRT2;LMNA;TWIST1;HYOU1;TERT;EGLN1;FAM162A;AQP1;TSC1;MDM2
prerank,negative regulation of myotube differentiation (GO:0010832),0.2928693063564715,0.7345636734523079,0.8152173913043478,0.9747849903229473,1.0,5/12,23.80%,HDAC5;BHLHE41;XBP1;HDAC3;BDNF
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.18486748629105465,0.7344651815843936,0.952258064516129,0.9743351992805249,1.0,41/124,28.30%,WNT4;VANGL2;PSMB1;RYK;ARRB2;PSMF1;PRICKLE1;PSMA1;TCF7L2;PSMD7;PSMA8;PSME3;SFRP1;MAP3K7;VANGL1;PSMD14;PSMC4;AGO4;WNT7A;PSMB4;DVL2;PLCB2;PSME1;CDC42;PSMD2;PSMD4;FRZB;PSMD8;SFRP2;TIAM1;GNG2;RHOA;PSMC5;FZD5;PSMD3;PSMB8;PSMA4;PLCB1;CLTC;ROR2;CELSR2
prerank,neuron migration (GO:0001764),0.2110635976622254,0.734375317343618,0.9007299270072993,0.9738623233394901,1.0,10/48,16.00%,MEF2C;ADGRL3;CDKL5;FGF13;DDIT4;NRCAM;TUBB2A;NDNF;NTRK2;TUBGCP2
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.22222724787049059,-0.7329826199285676,0.8691358024691358,0.9390236477369013,1.0,13/26,30.00%,ITCH;ACOD1;MUL1;TRAF3IP1;LTF;NLRC3;TRIM21;SIRT2;DHX58;RNF26;SIGIRR;C1QBP;TNFAIP3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.2863288856677089,-0.7329113436505295,0.8288288288288288,0.9385720823264753,1.0,6/11,40.85%,STAT1;WNT5A;PDGFA;TBX1;CTNNBIP1;SOX9
prerank,sterol biosynthetic process (GO:0016126),0.23035007292792306,0.7328704191701432,0.8857589984350548,0.975190468748868,1.0,6/33,18.81%,TM7SF2;ACAT2;NSDHL;LSS;ACLY;FDPS
prerank,cell junction maintenance (GO:0034331),0.27952476521884073,0.7328147930261657,0.8194444444444444,0.9746737596425615,1.0,3/14,14.13%,CBLN2;DCTN1;CHCHD10
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.2198137285946301,0.7327769520623404,0.9024024024024024,0.9741421046419252,1.0,12/40,23.56%,MLLT11;CLU;PDCD5;PRKN;DNM1L;BIK;BBC3;PRELID1;MFF;CIDEB;HRK;TRIAP1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.19028624653203352,0.7320589812739074,0.9464285714285714,0.9744576158662671,1.0,20/95,19.82%,AGRN;HS3ST5;HS3ST6;B4GAT1;ACAN;GPC1;GPC2;GPC5;CHST1;HS6ST1;VCAN;CSGALNACT1;ST3GAL6;GPC4;B3GAT3;B4GALT2;DCN;ST3GAL3;CHSY1;SDC2
prerank,fatty acid elongation (GO:0030497),-0.26699821379217664,-0.7307992921279319,0.8325581395348837,0.9404635983144546,1.0,5/13,26.70%,HACD4;HACD1;HACD2;ELOVL2;ABCD1
prerank,regulation of transferase activity (GO:0051338),0.26528979065848685,0.7304848485930882,0.8549222797927462,0.9758604303205547,1.0,2/17,1.96%,LDB2;LDB1
prerank,estrogen metabolic process (GO:0008210),0.2766701960039914,0.7304280276275331,0.8411669367909238,0.9753530287115337,1.0,5/15,24.76%,HSD17B2;HSD17B11;HSD17B10;SULT1A1;HSD17B14
prerank,glycosphingolipid metabolic process (GO:0006687),0.21692803229761878,0.729923729834131,0.8789308176100629,0.9754221233241993,1.0,5/42,10.07%,ST3GAL5;HEXB;ESYT2;NEU1;B3GALNT1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.24497080138644106,0.7299141079924009,0.8453947368421053,0.9748478761761099,1.0,9/23,27.07%,APLP1;PRKN;GABPA;MAPK3;SLC9A1;GNG2;MAPK1;ATF4;TGM2
prerank,regulation of striated muscle contraction (GO:0006942),-0.2230978846547929,-0.7298638031828188,0.8555858310626703,0.9410228407169622,1.0,12/27,32.49%,P2RX4;PRKACA;CALM3;ASB3;CALM2;RNF207;RYR2;SCN10A;GRK2;CALM1;SRI;NOS1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.25679596959905787,-0.729813789782229,0.8459595959595959,0.9405585578488279,1.0,5/15,21.58%,EIF4ENIF1;AGO2;TENT4B;TENT4A;CPEB3
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.19564669005322827,-0.7297528709306561,0.9014492753623189,0.9401040600439757,1.0,16/46,28.41%,DDHD1;AGPAT4;AGPAT5;PLD1;DGKA;ACP6;LPCAT4;GPAM;PLD2;AGPAT2;PLA2G2D;GPD1L;ABHD4;GPAT3;AGPAT3;PLA2G12A
prerank,histone H2B ubiquitination (GO:0033523),-0.29214335696902716,-0.7292265735672562,0.8086560364464692,0.940186775597421,1.0,5/10,23.56%,CDC73;DTX3L;WAC;RNF20;LEO1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.23937473822505745,-0.7284812916301546,0.8663101604278075,0.9405337412871426,1.0,9/21,31.01%,PRKACA;CAMK2D;CALM3;CALM2;RYR2;PDE4D;CASQ2;CALM1;SRI
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.2299118654785638,-0.7284267841927025,0.8825065274151436,0.9400700159781924,1.0,9/23,27.10%,MOSMO;VCP;RACK1;KCTD21;GLIS2;KIF7;PTCH1;ULK3;PTCH2
prerank,chondrocyte differentiation (GO:0002062),0.2283707488200524,0.7283082219297544,0.8672839506172839,0.9762264388630585,1.0,12/32,27.27%,NFIB;MEF2C;BMP4;TGFB1;WNT7A;BMPR1B;SULF2;SNX19;GPLD1;RUNX1;WNT5B;SULF1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.3069887688871641,0.7262540576744755,0.8315412186379928,0.9781401807330388,1.0,1/10,3.05%,KCNE2
prerank,regulation of centrosome duplication (GO:0010824),0.23510694489606193,0.7260880357615421,0.8564273789649416,0.9777559096406951,1.0,9/29,21.90%,CENATAC;CHMP1A;CHMP2A;FBXW5;XRCC3;PLK2;ALMS1;CHMP5;CEP120
prerank,myelination in peripheral nervous system (GO:0022011),0.28644375427790597,0.7255698726483306,0.8301886792452831,0.9778135191604032,1.0,1/13,1.12%,CNTNAP1
prerank,lipoxygenase pathway (GO:0019372),-0.2702390566066901,-0.7251791132773749,0.8175182481751825,0.9431941291716995,1.0,4/14,18.56%,ALOX5;ALOXE3;GPX1;LTC4S
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.26909939189065,-0.7250179167694519,0.8704156479217604,0.9428232879607202,1.0,4/13,21.53%,ARID1B;ZMIZ1;SERTAD2;ZMIZ2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.2949561454153673,-0.7249178967880386,0.8148148148148148,0.9424067293785306,1.0,4/10,19.49%,RIPK1;TXN;LRRK2;GPR37
prerank,atrioventricular valve development (GO:0003171),-0.26090626870809824,-0.7247984434960969,0.8589108910891089,0.9420037058173345,1.0,9/14,30.84%,NOTCH1;BMP2;ACVR1;HEYL;APLNR;BMPR2;BMPR1A;SLIT3;TGFB2
prerank,muscle organ development (GO:0007517),-0.1833526388066275,-0.7243943013091011,0.946875,0.94191220635095,1.0,21/54,29.18%,IGF1;SOX6;TCF12;MEF2D;UTRN;EGR3;MEF2B;CHODL;NEB;MKX;TAGLN;MAPK12;TEAD4;ITGA11;TRIM72;FKTN;CHD2;LAMA2;EVC;ZBTB42;ITGA7
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.28720890745559,0.7242831445538415,0.846551724137931,0.9787711982649219,1.0,2/13,5.65%,PTPRT;IL6
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.26444727014520397,0.7240285989900025,0.8453427065026362,0.9784823513581966,1.0,4/16,21.76%,PPARA;APOD;ABCD2;CUEDC2
prerank,mesenchyme morphogenesis (GO:0072132),0.26362661804611376,0.7234707379048229,0.831081081081081,0.978561903927151,1.0,5/17,21.45%,HEY1;TBX2;ENG;SMAD2;MDM4
prerank,telomere maintenance via telomere trimming (GO:0090737),0.30679319631700425,0.7224317586819686,0.8261589403973509,0.9780488309289326,1.0,5/10,31.19%,SMARCAL1;XRCC3;WRN;TERF1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.30679319631700425,0.7224317586819686,0.8261589403973509,0.9780488309289326,1.0,5/10,31.19%,SMARCAL1;XRCC3;WRN;TERF1;DNA2
prerank,t-circle formation (GO:0090656),0.30679319631700425,0.7224317586819686,0.8261589403973509,0.9780488309289326,1.0,5/10,31.19%,SMARCAL1;XRCC3;WRN;TERF1;DNA2
prerank,negative regulation of signaling (GO:0023057),-0.21905413687200379,-0.7222103325225333,0.9051282051282051,0.9438197418747983,1.0,5/25,19.81%,PTPN1;IL1B;SOCS5;OPTN;ACVR1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.2825388926165657,-0.7220598897330134,0.8183962264150944,0.9429219061915993,1.0,6/11,31.01%,CALM3;CALM2;CASQ2;CALM1;FKBP1A;SRI
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.2825388926165657,-0.7220598897330134,0.8183962264150944,0.9429219061915993,1.0,6/11,31.01%,CALM3;CALM2;CASQ2;CALM1;FKBP1A;SRI
prerank,regulation of axon regeneration (GO:0048679),0.29112073166897906,0.7219311913045482,0.8462897526501767,0.9780499694844199,1.0,5/12,23.28%,RTN4RL1;INPP5F;EPHA4;PTPRS;GRN
prerank,regulation of sensory perception of pain (GO:0051930),-0.28033394011675344,-0.7215072480424548,0.8,0.94294734616363,1.0,11/11,71.99%,CCN3;VIP;SPX;ATPSCKMT;ACP3;TMEM100;CCL3;SCN11A;F2R;ZFHX2;MGLL
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.26891442287852796,-0.7201591502822804,0.8505747126436781,0.9438903188659324,1.0,5/13,27.37%,ENPP3;SMPDL3A;ENTPD5;NUDT15;DCTPP1
prerank,glycolipid metabolic process (GO:0006664),0.20904649804175973,0.7201172662345824,0.9286775631500743,0.9795946120807848,1.0,8/47,13.96%,HEXB;ESYT2;NEU1;NAGA;B3GALNT1;ST3GAL6;SCCPDH;ABCA2
prerank,positive regulation of dephosphorylation (GO:0035306),0.2379405340079403,0.720084557795798,0.8723747980613893,0.9790531079977587,1.0,8/27,21.68%,MTMR9;PTBP1;RIPK3;TGFB1;PPP1R7;PIN1;NSMF;PPP1R16B
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.22411816786669386,0.7198956482966783,0.8892455858747994,0.9787020395536771,1.0,7/32,15.95%,CLASP2;MAP4K4;ITGB1BP1;ADAM15;APOD;RCC2;PHLDB2
prerank,embryonic axis specification (GO:0000578),0.2713423049851806,0.719551361873368,0.8604269293924466,0.9785373408743763,1.0,5/15,26.11%,RIPPLY2;WNT7A;SMAD2;CXXC4;FZD5
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.27905876796239243,-0.7194093539565766,0.8090452261306532,0.9441746833508172,1.0,4/11,15.43%,ETV6;ARIH2;WNT2B;WNT5A
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.23311973392912055,-0.7190742002602384,0.8969072164948454,0.9439736864902032,1.0,4/21,12.88%,IGF1;PTGER4;CDK1;KDR
prerank,protein K11-linked ubiquitination (GO:0070979),-0.21662708559904387,-0.7188902618468337,0.9045346062052506,0.9436337546058136,1.0,13/27,33.36%,UBE2D3;UBE2L3;CDC27;UBE2E3;UBE2C;ANAPC10;ANAPC7;RNF26;CDC23;UBE2T;ANAPC11;UBE2A;ANAPC1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.23873136917865556,0.718782892061574,0.8805237315875614,0.9788283671378692,1.0,6/26,18.94%,GCHFR;PM20D1;ABCA2;DDAH2;CYB5B;ARG2
prerank,ceramide metabolic process (GO:0006672),0.2093233303057379,0.7181795297012974,0.9107692307692308,0.9789407624330279,1.0,14/49,21.75%,TLCD3B;ORMDL2;CERS4;SPTSSA;NSMAF;ABCA2;CERS5;CERS6;CERS1;PPP2R1A;CLN6;PLA2G15;PLPP1;FA2H
prerank,smooth muscle contraction (GO:0006939),-0.25656506255175604,-0.7180670764984883,0.8530120481927711,0.9439468234007113,1.0,5/14,19.19%,TPCN2;EDNRA;CHRNB2;ADRA1A;MYLK
prerank,cellular response to nutrient levels (GO:0031669),-0.17610172324608664,-0.717917415693356,0.9413793103448276,0.9435759738676449,1.0,13/62,17.56%,MAP1LC3B;RRAGC;STK24;ATG7;LAMP2;LPL;FOXO1;LRRK2;RRAGA;RALB;MFSD2A;MAP1LC3A;NUPR2
prerank,bone morphogenesis (GO:0060349),-0.25947278134998825,-0.7176634787205475,0.851063829787234,0.9432979036850097,1.0,6/14,36.80%,LRP6;LTF;BMPR2;CYP26B1;TFAP2A;MMP13
prerank,endoderm formation (GO:0001706),-0.20698228646757652,-0.7174424068278372,0.9285714285714286,0.9430117532772047,1.0,15/35,32.09%,ITGA4;COL11A1;DUSP1;LHX1;HMGA2;FN1;MMP8;SETD2;LAMA3;COL12A1;ITGA7;ITGB2;DUSP4;COL7A1;MMP9
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.2923831116463289,-0.7170177929420442,0.8306997742663657,0.94293865494101,1.0,5/10,27.67%,NOP10;DKC1;NAF1;NHP2;RPUSD3
prerank,establishment of epithelial cell polarity (GO:0090162),0.24996653796099588,0.7167035886961368,0.8592964824120602,0.9800560574757977,1.0,6/19,27.15%,SH3BP1;CAMSAP3;CDC42;OPHN1;RHOA;MYO9A
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.22810339312862463,0.7164222852398876,0.9043887147335423,0.9798212059906585,1.0,5/29,17.19%,RAB6B;COPG1;TRAPPC3;COPE;COPG2
prerank,cristae formation (GO:0042407),0.23121594497119027,0.7154118984496243,0.8951747088186356,0.9803315137477453,1.0,11/27,30.51%,ATP5F1C;UQCC3;MICOS13;APOO;ATP5MC3;ATP5ME;ATP5MF;DNAJC11;APOOL;ATP5F1A;SPG7
prerank,microvillus organization (GO:0032528),0.28167740888996173,0.7152876075993444,0.8321799307958477,0.979882220623245,1.0,3/13,11.50%,STK26;MAP4K4;MINK1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2526014976258146,0.7152621972184097,0.8655172413793103,0.9793369162735304,1.0,4/21,20.71%,PPARA;PRKN;ABCD2;ABCB7
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.2470812791404664,0.7150476387780393,0.8620689655172413,0.979007948362639,1.0,4/21,13.17%,LRP2;CX3CR1;SMARCD3;DCT
prerank,negative regulation of interferon-beta production (GO:0032688),-0.29177357271720405,-0.7145096547124092,0.8400900900900901,0.9450268162703721,1.0,4/10,20.73%,YY1;LILRB1;RELB;NLRC3
prerank,negative regulation of chemokine production (GO:0032682),0.2774251728155921,0.7143594176881995,0.8436944937833037,0.9792505077810164,1.0,3/14,14.81%,IL6;MAP2K5;APOD
prerank,response to UV-A (GO:0070141),-0.2578595242022796,-0.7140472514868581,0.8841607565011821,0.9449450558723057,1.0,4/14,20.53%,CCND1;EGFR;OPN3;TIMP1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.2960504310744158,0.7134279594923704,0.8378870673952641,0.9796850585042292,1.0,4/11,29.33%,GCHFR;QDPR;SPR;PTS
prerank,RNA interference (GO:0016246),0.2608877208761014,0.7125912472880929,0.8648180242634316,0.9800084316362002,1.0,4/17,18.07%,DROSHA;TSN;AGO4;TSNAX
prerank,actin polymerization or depolymerization (GO:0008154),-0.1867603588428789,-0.7125487917316525,0.9467455621301775,0.9459496179117234,1.0,13/50,17.61%,SVIL;PSTPIP2;DIAPH3;GAS7;COBL;VILL;WASF1;CORO7;CFL2;MICAL1;GSN;MICAL2;MSRB1
prerank,gliogenesis (GO:0042063),-0.24969651669010934,-0.7125472620566343,0.8758782201405152,0.94542238058905,1.0,3/15,15.06%,CDK6;ANXA1;CDH2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.19857710488785213,0.7124127008722806,0.9376899696048632,0.9796418942950108,1.0,18/62,25.30%,SELENOS;ACKR3;NME5;CLU;PRKN;SNAI2;NFE2L2;HERPUD1;TXNDC12;CCAR2;XBP1;ARMC10;SFRP2;RTKN2;CREB3;TMBIM6;SOD2;DDX3X
prerank,lipoprotein catabolic process (GO:0042159),-0.2727122079250249,-0.7124116120044139,0.8275862068965517,0.9450295536952819,1.0,1/11,0.52%,APOE
prerank,visual system development (GO:0150063),0.22089554534836664,0.7122730164077848,0.9244372990353698,0.9792290740240981,1.0,5/37,11.74%,C3;MAB21L2;PBX2;FOXC1;PBX3
prerank,negative regulation of stem cell differentiation (GO:2000737),0.280324725664463,0.7122517923561276,0.8280701754385965,0.978676681627919,1.0,3/12,15.66%,NELFB;ZFP36L2;REST
prerank,N-terminal protein amino acid modification (GO:0031365),0.2702986260808954,0.711562462489744,0.8526863084922011,0.9788543705086677,1.0,4/14,21.27%,METAP1D;NAA35;NAA60;METAP2
prerank,chromatin organization (GO:0006325),0.17629495488973965,0.7114302080868957,0.9752925877763329,0.9784247298291188,1.0,22/132,18.75%,NUCKS1;MPND;SMARCC2;BPTF;FAM50A;PAK1;KDM6B;MCM3AP;BRWD1;SMARCE1;PWWP3A;HDAC5;SMARCD3;SUV39H2;KDM4A;PRDM16;NPM2;TCF7L1;HMG20A;PHF1;SETDB1;HDAC3
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.22974132064484726,-0.7112531038949467,0.902200488997555,0.9456577433564904,1.0,5/22,15.15%,PPP2R5A;IL1B;CEACAM1;APOC1;TNF
prerank,regulation of dendritic spine development (GO:0060998),0.2531072433697572,0.7108666803825074,0.8591772151898734,0.9784708536842898,1.0,5/19,17.85%,TANC2;MEF2C;SHANK3;PTPRS;SHANK1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.27345679630132463,-0.7104198381644167,0.8430493273542601,0.9459730774534396,1.0,6/12,29.12%,SNW1;KLF2;TRIM16;DHRS3;EZH2;CYP26B1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.26946022708278355,0.7104103546610232,0.8606271777003485,0.9783836513416193,1.0,2/16,5.65%,RELA;IL6
prerank,androgen metabolic process (GO:0008209),-0.23995288874203846,-0.7092660561265407,0.8871794871794871,0.9466516573639392,1.0,8/18,36.18%,DHRS9;SHH;SRD5A2;HSD17B7;HSD3B2;HSD17B3;AKR1D1;CYP19A1
prerank,relaxation of muscle (GO:0090075),0.27802705826276125,0.7083447679925986,0.8611111111111112,0.9800478964142659,1.0,4/13,19.85%,ATP1B1;SLC8A1;RGS2;ATP1A1
prerank,regulation of intracellular protein transport (GO:0033157),0.22684007218427787,0.7078948549999551,0.9003164556962026,0.9800008696627698,1.0,6/32,11.36%,TENM1;BMP4;OAZ1;TGFB1;PLK3;IFI27
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.2620787631788572,0.7077267374853476,0.8697183098591549,0.9795957512244821,1.0,4/16,17.90%,DMD;SLC8A1;GSTO1;ANK2
prerank,nuclear membrane disassembly (GO:0051081),0.2771178305771973,0.7065298187479376,0.8568965517241379,0.9803196672434858,1.0,3/14,12.68%,AKAP8L;PRKCA;DCTN1
prerank,negative regulation by host of viral process (GO:0044793),0.29600300806336544,0.7052837951486577,0.8371681415929203,0.9811365399804697,1.0,3/10,15.31%,PRKN;CCNK;EIF2AK4
prerank,response to cholesterol (GO:0070723),0.2600658571602964,0.7052760136149875,0.8639455782312925,0.9805752249307536,1.0,6/17,27.36%,TGFBR1;TGFB1;ABCA2;SMAD2;GPLD1;CCR5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.25291426629870256,0.7052713635516926,0.8773109243697479,0.9800095113538491,1.0,6/19,19.11%,SMOC2;DAB2IP;MYO1C;CADM4;ADAMTS3;DCN
prerank,myeloid cell differentiation (GO:0030099),0.20382031232474454,0.7048761672370506,0.9330289193302892,0.9798575592411508,1.0,11/47,21.62%,ZFPM1;FLVCR1;HSPA9;CASP3;KAT8;SLC25A5;INHA;PTPN2;KMT2E;SLC25A38;TIRAP
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.20141942882267094,0.7044605197933906,0.9366715758468336,0.979725968235116,1.0,17/51,28.92%,PRSS56;RARRES2;IL6;LGMN;CCR1;CCR6;HMGB1;MAPK3;PTK2;CCL5;IL34;IL6R;CREB3;MAPK1;CSF1R;VEGFD;MDK
prerank,positive regulation of lipid transport (GO:0032370),0.28152178792513627,0.7043977514345465,0.8573883161512027,0.9792185845693621,1.0,5/12,27.08%,ABCB4;DBI;PRELID1;TRIAP1;ABCA3
prerank,calcium import into the mitochondrion (GO:0036444),0.3032747827928218,0.7041813981910232,0.8483754512635379,0.9788684959609031,1.0,3/10,15.58%,MICU2;SMDT1;SLC25A23
prerank,dorsal/ventral pattern formation (GO:0009953),0.24709983670175076,0.7037937154699409,0.8780068728522337,0.9786795499780072,1.0,6/20,23.41%,WNT8B;SFRP1;LMX1B;DSCAML1;BMPR1B;AIDA
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.2289813534251879,-0.7035791861791912,0.8888888888888888,0.9517964307628864,1.0,3/19,19.66%,PAPSS2;BPNT2;SULT2B1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.25363352531423183,0.7028966307019073,0.8556876061120543,0.9790198925097012,1.0,7/18,26.01%,TIMM21;OXA1L;BCS1L;COX17;SMIM20;COX18;FASTKD3
prerank,regulation of fibrinolysis (GO:0051917),-0.26540108535546003,-0.7018149548863235,0.8710407239819005,0.9529342892491971,1.0,8/13,34.37%,THBS1;APOH;SERPINF2;F11;KLKB1;PLG;F12;HRG
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.2263982732563048,-0.70125689978122,0.8717948717948718,0.9529637226105478,1.0,2/21,4.59%,CNOT9;SAMD4A
prerank,establishment of protein localization to organelle (GO:0072594),0.18783243390231086,0.700960620488507,0.9583333333333334,0.9804246841807555,1.0,11/72,15.89%,TSC2;LAMP5;FAM53C;NXT2;PRICKLE1;HEATR3;FAM53B;NUP88;IPO5;HK2;NUP133
prerank,regulation of telomere maintenance (GO:0032204),-0.212526008287708,-0.7007053064758808,0.916010498687664,0.9529855493469866,1.0,8/26,24.04%,RTEL1;NBN;YLPM1;TERF2;HNRNPD;SMG6;TINF2;PIF1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.23602065631913074,0.6995940605565243,0.8979591836734694,0.9812449918808269,1.0,6/23,20.39%,RELA;PPM1A;NMI;IFI35;TSPAN6;CYLD
prerank,rRNA methylation (GO:0031167),0.24439143173707292,0.6993401083099774,0.8881239242685026,0.980934491811422,1.0,5/22,14.72%,DIMT1;METTL16;NOP2;METTL5;FBLL1
prerank,gas transport (GO:0015669),-0.2739514632954313,-0.6992660325490829,0.8344988344988346,0.9538263883885053,1.0,5/10,36.42%,CA2;CYGB;AQP1;RHAG;NGB
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.25370041930950876,-0.6990234095748707,0.883177570093458,0.953520127501143,1.0,4/13,22.52%,HACD4;HACD1;HACD2;ELOVL2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.2611473318918246,-0.69883658959314,0.8909090909090909,0.9531816935567392,1.0,3/12,13.88%,FUT8;SLC35A3;GMDS
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.27710554121155584,0.6975704183322171,0.8747697974217311,0.9821617670712469,1.0,2/12,10.80%,WRAP53;CCT4
prerank,cranial nerve development (GO:0021545),0.29095482728865424,0.6975508005903172,0.8473684210526315,0.9816042111775523,1.0,1/11,3.49%,ATOH7
prerank,C4-dicarboxylate transport (GO:0015740),-0.24859844241737813,-0.6972411917106233,0.8687350835322196,0.9541026391566704,1.0,4/14,22.11%,LRRC8D;SLC25A11;SLC25A22;SLC13A5
prerank,regulation of monooxygenase activity (GO:0032768),-0.22232463213530884,-0.6969456164807718,0.9170854271356784,0.9538496047951698,1.0,12/23,31.51%,CAV1;IL1B;NOSIP;DNM2;EGFR;POR;NOSTRIN;CYGB;HSP90AA1;ZDHHC21;CALM1;DDAH1
prerank,nuclear pore organization (GO:0006999),-0.25238908076022953,-0.6963866184649943,0.871536523929471,0.9538633188966406,1.0,3/14,11.63%,NUP153;NDC1;AHCTF1
prerank,monocyte chemotaxis (GO:0002548),0.22035750132093812,0.6956322443025618,0.9076175040518638,0.9829245462057168,1.0,7/32,25.13%,PTPRO;IL6;PDGFB;CCL15;CCL5;IL6R;CCL14
prerank,regulation of brown fat cell differentiation (GO:0090335),0.26227893176299377,0.6955331374565714,0.8927272727272727,0.9824560790742674,1.0,6/16,25.06%,FNDC5;FLCN;NAPEPLD;ZBTB7B;SOX13;FTO
prerank,zymogen activation (GO:0031638),0.21066350132500916,0.6953530514020382,0.9309815950920245,0.9820560311087014,1.0,5/39,8.78%,PLAT;VSIR;ASPH;LGMN;BAK1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.22733936120407688,0.6946305304581866,0.9049919484702094,0.9821845877087094,1.0,3/29,6.26%,FUS;E2F1;CIRBP
prerank,quinone biosynthetic process (GO:1901663),0.264134030191234,0.693729095103114,0.8747940691927513,0.9824758978520945,1.0,3/14,13.74%,COQ7;COQ8A;PDSS1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.28766533542150663,0.6936078658089045,0.8824593128390597,0.9820296888016974,1.0,3/11,20.71%,PPARA;ABCD2;ABCB7
prerank,secretory granule organization (GO:0033363),-0.2843563723599505,-0.6934754427812059,0.8735632183908046,0.9559464680990756,1.0,2/10,7.63%,LYST;SRGN
prerank,histone H4 acetylation (GO:0043967),0.20324948658987896,0.69284612053943,0.9305555555555556,0.9822071253648882,1.0,16/47,25.67%,JADE2;MEAF6;BRD8;TADA3;APBB1;OGT;KAT8;DMAP1;NAA60;MORF4L2;ING3;WDR5;JADE1;YEATS4;MSL1;MCRS1
prerank,lymphocyte mediated immunity (GO:0002449),0.2758542430546995,0.6923423665660429,0.8886925795053003,0.9821158975751486,1.0,1/12,4.03%,SLA2
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.16462001594210396,-0.6913195962367972,0.9867986798679867,0.957354714503852,1.0,12/70,16.50%,PLBD1;PCYT1A;PLA2G4E;PLAAT3;NR1H2;PCTP;PEMT;NR1H3;TMEM86B;STARD10;MFSD2A;LPCAT4
prerank,defense response to Gram-negative bacterium (GO:0050829),0.20669396656472747,0.6911486031192028,0.9239302694136292,0.9826971276799753,1.0,6/42,11.55%,RARRES2;DEFA6;IL6;MR1;RNASE7;DROSHA
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.26042955180270533,0.6895460278181641,0.8756388415672913,0.9835943891614702,1.0,4/14,20.22%,PPARA;IRS1;ABCD2;TYSND1
prerank,secondary palate development (GO:0062009),0.2664180074353677,0.6888454084805317,0.8775510204081632,0.9837346949201864,1.0,3/14,20.58%,TGFBR3;WNT7A;SMAD2
prerank,ERAD pathway (GO:0036503),0.1830477608903948,0.6886304869260117,0.9732394366197183,0.983372690046825,1.0,13/83,17.16%,SELENOS;UBXN6;FOXRED2;SGTA;PRKN;HSP90B1;CCDC47;HERPUD1;SGTB;DERL1;JKAMP;UBQLN2;UBXN4
prerank,bone development (GO:0060348),-0.1868379800706702,-0.6883367098596254,0.9593023255813954,0.9594419133010028,1.0,4/39,5.41%,PTPRC;PTGER4;SH3PXD2B;DYM
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.19571064538742827,0.6862337015321506,0.9302325581395349,0.9850366632995721,1.0,6/50,14.23%,CDK7;CCNI;SERTAD1;CCND3;GADD45A;CCNK
prerank,regulation of DNA damage checkpoint (GO:2000001),0.29081035380615294,0.685842571694747,0.847457627118644,0.9848273338442691,1.0,4/10,16.47%,DDX39B;CCAR2;THOC5;RFWD3
prerank,chromatin remodeling at centromere (GO:0031055),-0.19845790741133876,-0.6849981035021424,0.9382022471910112,0.9617173603715239,1.0,9/31,27.15%,RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1;CENPH;HJURP;OIP5
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.274479035902586,-0.6848323138965966,0.8697674418604651,0.9613262066628913,1.0,10/10,72.58%,STAT1;SHH;PDGFA;TBX1;SOX9;TGFBR2;FGFR2;LRP5;MYC;CHRD
prerank,negative regulation of biosynthetic process (GO:0009890),0.257037633798481,0.683730046022041,0.9130434782608695,0.9861420080901913,1.0,2/16,5.65%,PPARA;IL6
prerank,positive regulation of vascular permeability (GO:0043117),-0.25914051625334444,-0.683232161102473,0.8787185354691075,0.9621776359512234,1.0,5/12,32.32%,PDE2A;ANGPT1;TJP1;PDE3A;TRPV4
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.2533697819470496,0.6830837149739751,0.8935779816513761,0.9861344027020874,1.0,4/16,19.74%,CRMP1;NT5C3A;DPYSL2;NT5C
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.2744720282024693,0.6829721795225479,0.8758620689655172,0.9856735446643032,1.0,1/12,1.87%,BIN1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.2291400858791951,-0.6817971733676661,0.9207920792079208,0.9628378818770414,1.0,5/18,16.34%,IGF1;CD24;IGF2;AGER;IL27RA
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2531376358731065,0.6808681910477449,0.901060070671378,0.9870039944591159,1.0,3/16,15.67%,NAA30;NAA35;NAA60
prerank,regulation of cellular component biogenesis (GO:0044087),-0.18796690478892908,-0.6807384180813949,0.9481268011527377,0.963162967066409,1.0,6/39,15.67%,APOE;CD36;MSN;NOTCH1;RAP1B;RAP1A
prerank,maintenance of protein localization in organelle (GO:0072595),0.24657194556914142,0.6807222847246029,0.8897893030794165,0.9865612217843367,1.0,4/19,14.60%,ARL2BP;CHCHD10;TAF3;HK2
prerank,motor neuron axon guidance (GO:0008045),0.2610999771858588,0.6804921429961134,0.8659966499162479,0.9861938430888244,1.0,4/15,24.05%,CHN1;EPHA4;LAMC2;SEMA3A
prerank,ubiquinone metabolic process (GO:0006743),0.2567815713307106,0.680236740527973,0.8828382838283828,0.9858701680355436,1.0,3/15,13.74%,COQ7;COQ8A;PDSS1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.2571703987430124,-0.6794772093225471,0.847255369928401,0.9636844860701337,1.0,2/13,5.56%,BRAF;ACSL5
prerank,regulation of myoblast fusion (GO:1901739),-0.27060333600353204,-0.6792597013269727,0.8857142857142857,0.9633481273874394,1.0,2/11,11.99%,RIPOR2;CD53
prerank,anterior/posterior axis specification (GO:0009948),0.255842665197704,0.6782019012285637,0.8873949579831932,0.9871005839740162,1.0,1/15,4.34%,RIPPLY2
prerank,regulation of protein acetylation (GO:1901983),-0.2608839462222516,-0.6776825749914466,0.9138381201044387,0.964067045559474,1.0,3/12,18.79%,FAM161A;KAT5;CEP295
prerank,regulation of acrosome reaction (GO:0060046),-0.2751067034898318,-0.6766460475065922,0.8489702517162472,0.964402735088649,1.0,10/10,72.51%,GLRA1;PLA2G10;SERPINA10;CCDC87;FAM170B;PRSS37;ZP3;SPINK13;PLCB1;CACNA1H
prerank,regulation of cell cycle phase transition (GO:1901987),0.17576109482567287,0.6763807384876508,0.9849108367626886,0.9880701891071467,1.0,30/91,28.31%,MN1;PSMB1;TCIM;PSMF1;BTRC;PSMA1;PSMD7;PSMA8;PSME3;PSMD14;PSMC4;ANAPC2;PSMB4;UBE2D1;FBXO5;PSME1;UBE2S;PSMD2;PSMD4;PSMD8;ERCC2;TRIM39;PSMC5;DBF4;PSMD3;NEK10;PSMB8;PSMA4;NEK11;ANAPC4
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.2451034647281285,-0.6749678431803053,0.8804597701149425,0.965199723790057,1.0,6/13,28.21%,CHST7;NAGK;RENBP;CHST3;CHST5;CHST2
prerank,regulation of TORC1 signaling (GO:1903432),0.212714976720746,0.6745808223340239,0.9244094488188976,0.989085048431398,1.0,6/33,15.88%,KLHL22;STK11;DGKQ;ITFG2;FLCN;RNF152
prerank,sphingolipid biosynthetic process (GO:0030148),0.1829942258120023,0.6741142464431127,0.9588652482269504,0.9889242065684356,1.0,18/71,22.16%,ST3GAL5;TLCD3B;CERS4;PRKD2;SPTSSA;ELOVL6;SPNS2;ELOVL4;CERS5;CERS6;PRKD1;KDSR;CERS1;ELOVL5;PLPP1;PPM1L;FA2H;LARGE1
prerank,regulation of histone acetylation (GO:0035065),0.21170684713392554,0.6738845915514448,0.9379968203497615,0.9885639308492621,1.0,8/33,21.92%,PPARGC1A;CTBP1;RAPGEF3;HDAC5;FLCN;MAPK3;ARRB1;BRD7
prerank,regulation of inclusion body assembly (GO:0090083),0.2756877059277372,0.6738078245614366,0.8892857142857142,0.9880580325181575,1.0,1/11,3.98%,HSPA2
prerank,cellular response to superoxide (GO:0071451),0.2897637668572952,0.6724589037483029,0.8831385642737897,0.9886111831554806,1.0,2/10,10.84%,PRDX2;ADPRS
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.2771061441060331,0.6716646325988919,0.8921739130434783,0.9886955842315936,1.0,2/10,9.06%,RAPGEF3;HDAC5
prerank,positive regulation of neuron differentiation (GO:0045666),0.20274769933035106,0.6704622099135523,0.9426751592356688,0.9891517503972659,1.0,11/40,24.68%,NEUROD2;MEF2C;NRCAM;BEND6;VWC2;REST;TCF3;ZEB1;IMPACT;ZC4H2;RHOA
prerank,response to acidic pH (GO:0010447),-0.2475981475439361,-0.6687922532889417,0.8987654320987655,0.9694624385684834,1.0,4/13,16.94%,GPR65;RAB11FIP5;CHP1;PKD1L3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.1796812207171679,0.6686333086668147,0.9711399711399712,0.9900171543919498,1.0,15/76,19.03%,P2RY12;NMUR1;ADRA2A;GNA15;GPR17;ACTN2;CX3CR1;LPAR4;P2RY1;GNA11;P2RY10;AGT;OPRM1;OPRD1;GPR174
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.26646827703694365,0.6686123094338366,0.9028776978417267,0.9894666135368942,1.0,3/13,18.40%,PRKCZ;IRS1;ZBTB7B
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2607898964776156,0.6685669038088086,0.9111498257839721,0.9889390876900553,1.0,3/13,21.14%,OGG1;NT5C;UNG
prerank,regulation of nuclear division (GO:0051783),-0.21844338026626553,-0.6675153282161742,0.9333333333333333,0.9698904320514138,1.0,3/20,6.57%,MKI67;BORA;KIF20B
prerank,cellular response to nitrogen compound (GO:1901699),0.2348576281064019,0.6667968501607672,0.9208400646203554,0.9897310844599018,1.0,3/20,14.70%,TIMELESS;NSMCE3;AOC1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.23573703443173466,-0.6653796410639398,0.917910447761194,0.9710018338842838,1.0,7/16,25.96%,GBF1;SEC16A;LRRK2;PPP1R15A;GABARAPL2;TAPT1;RYR2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.22517306275590476,-0.6652410844338977,0.9113300492610837,0.970581984316935,1.0,5/17,16.71%,NRP1;EGR3;KDR;GREM1;EPHB4
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.23816622022582237,-0.6651648269064996,0.927570093457944,0.9700960768576382,1.0,5/14,23.14%,NT5E;CAD;DPYS;UMPS;UPB1
prerank,neuron maturation (GO:0042551),0.24059395636689207,0.6636440591593062,0.9081632653061225,0.9916753081406087,1.0,3/18,12.14%,C3;MTCH1;FARP2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.24067559871312452,-0.6627431784891554,0.9122401847575058,0.9714005013951541,1.0,6/14,33.35%,MAPKAPK2;MYD88;HNRNPC;DAZL;HNRNPA0;YBX3
prerank,protein acylation (GO:0043543),-0.1855092221843273,-0.6618156109888048,0.9681159420289855,0.9715171718426786,1.0,13/38,27.99%,ZDHHC14;ZDHHC3;NAA10;EP300;FOXO1;ZDHHC17;NAT10;ZDHHC7;KAT2B;HHAT;NAT9;ZDHHC13;ZDHHC21
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.2821668921409872,0.6601229240505393,0.8842832469775475,0.9937778164316895,1.0,3/10,20.10%,PFKM;HK2;PFKP
prerank,negative regulation of protein processing (GO:0010955),0.2651730823663462,0.6596564142068461,0.8981636060100167,0.9935586681547551,1.0,4/12,24.12%,PRNP;SERPINE2;TMEM59;ACP4
prerank,neutrophil chemotaxis (GO:0030593),0.18979440083563337,0.6594749199877586,0.9700149925037481,0.9931290034273556,1.0,7/53,19.31%,PPIB;NCKAP1L;PIK3CG;BSG;CXADR;CCL15;CCL5
prerank,carboxylic acid transmembrane transport (GO:1905039),0.19840569972991648,0.6585301853450221,0.9386503067484663,0.9932411652781215,1.0,10/40,25.62%,SLC38A2;SLC38A9;SLC38A7;SLC19A1;SLC13A3;SLC38A3;SLC25A10;SLC38A10;SLC16A7;ABCC5
prerank,somite development (GO:0061053),-0.2634798422924784,-0.6583047664231063,0.8914549653579676,0.973554369693231,1.0,4/11,22.33%,SOX11;MTHFD1;PTCH1;SHH
prerank,hematopoietic stem cell differentiation (GO:0060218),0.27502570650394514,0.6569564099424837,0.8920353982300885,0.9938362509241644,1.0,2/10,15.31%,SFRP1;BATF
prerank,response to muscle stretch (GO:0035994),0.2504778937061189,0.6569389816746879,0.9059233449477352,0.9932890264163944,1.0,4/15,23.15%,DMD;SLC8A1;PTK2;SLC9A1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.27611840884461386,0.656616170676479,0.8842676311030742,0.99295939124932,1.0,2/10,10.56%,MAP2K5;SH2B3
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.2782833858730681,0.6563225010514548,0.9037433155080213,0.9926025210825291,1.0,3/10,20.59%,SLC45A3;ABCD2;ELOVL5
prerank,negative regulation of histone acetylation (GO:0035067),-0.25639356768361854,-0.655725295223358,0.8956916099773242,0.9747749580029882,1.0,3/11,19.34%,BRCA1;THAP7;TAF7
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.2627769565194709,-0.6555474943658877,0.903755868544601,0.9743670927611051,1.0,4/10,31.70%,ZNHIT3;NAF1;PIH1D2;RUVBL2
prerank,response to prostaglandin E (GO:0034695),0.2805823779631007,0.6552399566514295,0.8909090909090909,0.9928245844590496,1.0,2/10,11.53%,TGFBR3;SFRP1
prerank,ceramide biosynthetic process (GO:0046513),0.1971295418711623,0.6537393223377231,0.9584615384615385,0.9933564042449432,1.0,7/40,16.55%,ST3GAL5;TLCD3B;CERS4;SPTSSA;CERS5;CERS6;CERS1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.24056596327855295,0.6536866774286151,0.9162303664921466,0.9928314395810967,1.0,5/17,28.40%,MEF2C;PRKG1;TAFA5;SOD2;PTEN
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.241182827088549,0.6535799097394369,0.9189627228525121,0.9923474948550682,1.0,3/17,17.56%,BMP4;FGF2;BTG1
prerank,artery development (GO:0060840),0.2219170704970002,0.6525191175166952,0.9357495881383855,0.9925456687145306,1.0,5/23,17.25%,TGFBR1;PKD2;GJA5;ANGPTL3;ENG
prerank,ribosomal small subunit assembly (GO:0000028),-0.2299509903242198,-0.6523053503235408,0.9168704156479217,0.9759628448122207,1.0,2/16,6.04%,RPS14;RPS5
prerank,phosphatidic acid metabolic process (GO:0046473),0.19095730974904346,0.6519544074715057,0.9652042360060514,0.9923752885978057,1.0,9/48,18.15%,PLA2G3;PNPLA3;LPCAT1;DGKQ;AGPAT1;ABHD5;DGKZ;DGKE;ABHD8
prerank,negative regulation of protein polymerization (GO:0032272),0.21578626400166923,0.6516535340658338,0.9466019417475728,0.9920423271193717,1.0,12/27,29.63%,STMN2;TWF2;ARFGEF1;TWF1;SSH1;SSH2;SSH3;MAP2;TBCD;CYRIB;KANK1;PFN1
prerank,ubiquinone biosynthetic process (GO:0006744),0.24499992664236991,0.6515275717744695,0.9165302782324058,0.9915834067393541,1.0,3/15,13.74%,COQ7;COQ8A;PDSS1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.24101935305776961,0.651011410657811,0.9363166953528399,0.99134917228408,1.0,2/17,6.94%,PDE3B;ADRA2A
prerank,aortic valve development (GO:0003176),0.20356639255450726,0.6505495657982734,0.9605678233438486,0.9911311406627584,1.0,5/34,10.89%,BMP4;HEY1;TGFB1;SNAI2;EFNA1
prerank,oogenesis (GO:0048477),0.24221435035850894,0.6500209168088831,0.9246231155778895,0.9909416753945411,1.0,1/15,1.00%,NANOS1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.24401287492619897,0.649730116179962,0.9232111692844677,0.9905817025085946,1.0,1/16,0.65%,ST3GAL5
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.20477847609290079,-0.6495613069984267,0.9356435643564357,0.9772381867424677,1.0,8/21,31.59%,CTSL;SGPP1;MAFG;SULT2B1;GDF3;CBFB;DLL1;KDF1
prerank,I-kappaB phosphorylation (GO:0007252),0.2790454977324609,0.6491849973326841,0.890652557319224,0.9903971776556402,1.0,4/10,17.55%,DAB2IP;PRDX4;MAP3K7;TLR3
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.18931105461921188,-0.6490330875547645,0.9454545454545454,0.9770670229587427,1.0,5/32,11.33%,CCT6A;PKIB;PRKCQ;CTNNB1;CCT3
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.166107739634397,-0.6488859343793584,0.9905660377358491,0.9766424346960262,1.0,21/53,37.65%,HRH1;CHRM2;ANXA1;VIPR1;NPY1R;HTR1B;CALCRL;NPY;LPAR3;XCR1;HRH3;HTR1A;PTGIR;AGTR2;HTR2C;HTR1D;MC2R;CHRM1;DRD1;LHCGR;HRH2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.20275067693692533,0.648662217917212,0.9364341085271318,0.9901996059001356,1.0,4/32,11.38%,LPCAT1;ACHE;CHAT;SLC44A2
prerank,regulation of osteoblast proliferation (GO:0033688),0.23829128732036609,0.648501166769969,0.9395973154362416,0.9897523451222369,1.0,1/17,0.19%,MN1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.1827399466831692,-0.6484108509154457,0.9783783783783784,0.976427183883437,1.0,3/34,3.44%,PTPN22;DUSP16;PTPN1
prerank,epithelial structure maintenance (GO:0010669),-0.25008978804528464,-0.6480707197905924,0.9101941747572816,0.9761207892778475,1.0,4/11,35.22%,NOD2;TLR9;PIWIL4;MUC6
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.22025684345134722,0.6467525250590793,0.912828947368421,0.9903417345216996,1.0,8/23,26.73%,TIMM29;TIMM13;TIMM22;TOMM70;COX18;TOMM22;TIMM10;TIMM10B
prerank,ovarian follicle development (GO:0001541),0.25689843244233124,0.6454079194601148,0.9013605442176871,0.990668926078109,1.0,2/13,13.42%,ANG;INHA
prerank,protein localization to mitochondrion (GO:0070585),0.2695833243178001,0.6453489949528225,0.8868940754039497,0.990153388322736,1.0,4/11,27.42%,MTCH2;HK2;COX18;DNAJA1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.21990795109898958,-0.6453066815961106,0.9441624365482234,0.9773272251793633,1.0,4/17,13.79%,SPRY2;CALM3;CALM2;INPP5K
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.20797504846971376,-0.6441078753584829,0.9483204134366925,0.9775245644476485,1.0,5/21,19.52%,STAP1;THBS1;CXCL17;PTK2B;MTUS1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.2248081262474061,-0.6422595010599605,0.9209876543209876,0.9780799308705117,1.0,7/15,28.21%,GNPDA1;CHST7;NAGK;RENBP;CHST3;CHST5;CHST2
prerank,ear morphogenesis (GO:0042471),0.2249717372189425,0.6417512937452594,0.9437086092715232,0.9918856780967106,1.0,20/20,77.53%,MYO6;EPHB2;CHD7;PAX2;TIFAB;FGFR2;SIX1;HOXA1;USH1C;OSR2;NIPBL;NOG;ZIC1;OSR1;ATP6V1B1;TFAP2A;TBX1;TMIE;PAX8;TWIST1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.2732432637940511,0.6411606728747101,0.9252971137521222,0.9916901387443134,1.0,4/10,27.95%,CORO2B;MAPT;DNAJA1;TERF1
prerank,histone H3-K9 demethylation (GO:0033169),-0.25288591019777545,-0.6409907367822868,0.9200968523002422,0.978306297137026,1.0,2/11,11.59%,KDM7A;HR
prerank,mRNA modification (GO:0016556),-0.20415868972351076,-0.6399730577547634,0.9528535980148883,0.9783842379830645,1.0,4/22,12.70%,TRUB2;TRMT10C;METTL8;NSUN2
prerank,regulation of telomerase activity (GO:0051972),0.18865488063191826,0.639738394726265,0.9717425431711146,0.9920418118610226,1.0,16/45,29.02%,WRAP53;MAPK15;CCT4;MAPK3;CERS1;MAPKAPK5;HSP90AB1;XRCC5;GRHL2;PARM1;ERCC4;MAPK1;ACD;PTGES3;TERF1;MYC
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.22169170976540656,0.6395544483950482,0.9623567921440261,0.9916045054821466,1.0,6/24,20.74%,NFE2L2;ICAM1;TEK;NDNF;TNIP2;PDPK1
prerank,cardiac cell development (GO:0055006),0.2624484552242796,0.6391701209562417,0.9169675090252708,0.9913030737592073,1.0,2/11,16.52%,SLC8A1;CXADR
prerank,regulation of cell killing (GO:0031341),-0.2235852673479261,-0.6387661389899307,0.9417249417249417,0.978542067126896,1.0,8/16,31.60%,CYBA;CD55;WNT5A;MAPK8;NOXO1;RAC1;TGFB2;FZD7
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.24970425902992163,-0.6381341985121435,0.9336609336609336,0.9778527159969476,1.0,3/11,15.12%,AGO2;NOTCH4;TRIM71
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.24970425902992163,-0.6381341985121435,0.9336609336609336,0.9778527159969476,1.0,3/11,15.12%,AGO2;NOTCH4;TRIM71
prerank,regulation of osteoclast differentiation (GO:0045670),0.20044129801082824,0.6373119354334968,0.9684542586750788,0.9918735980151457,1.0,4/33,10.01%,LRRC17;UBASH3B;CCR1;BGLAP
prerank,plasma membrane tubulation (GO:0097320),0.2508988348790281,0.6369570165726228,0.924114671163575,0.9915161497547705,1.0,7/13,28.05%,BIN2;EHD2;MICALL1;SNX33;PACSIN3;FNBP1L;WHAMM
prerank,positive regulation of heart rate (GO:0010460),0.23155278175011068,0.6367176870645677,0.9214046822742475,0.991105122264202,1.0,1/17,1.44%,ATP2A2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.24594704531287442,-0.6358682039825069,0.8953488372093024,0.9780877276038079,1.0,3/11,13.79%,SYNJ2;IMPA2;INPP5K
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.24594704531287442,-0.6358682039825069,0.8953488372093024,0.9780877276038079,1.0,3/11,13.79%,SYNJ2;IMPA2;INPP5K
prerank,regulation of neutrophil migration (GO:1902622),-0.25261384026307915,-0.6355999583762798,0.9017199017199017,0.9777047200277238,1.0,4/10,25.64%,MPP1;BST1;OLFM4;RAC1
prerank,gastrulation (GO:0007369),0.23718969999264256,0.6343060130051583,0.9253996447602132,0.9919927844516897,1.0,2/15,9.76%,MEGF8;WNT8B
prerank,fatty acid transmembrane transport (GO:1902001),-0.2068168579953944,-0.6341070818600978,0.9695431472081218,0.9780100205967036,1.0,8/19,26.70%,CD36;PRKAG2;MID1IP1;PRKAB2;ACACA;SLC25A20;ABCD4;ABCD1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.26682437742761295,0.6328723791488823,0.9097472924187726,0.9922890049517697,1.0,3/10,20.60%,GPATCH3;TSPAN6;SEC14L1
prerank,regulation of lipase activity (GO:0060191),0.2518045164180478,0.632629442438821,0.9168141592920354,0.9918720995298852,1.0,4/13,24.68%,ANGPTL3;LIPC;LMF1;RHOA
prerank,eye photoreceptor cell differentiation (GO:0001754),0.25152733183582476,0.6302440003489195,0.9178082191780822,0.9927206400300628,1.0,1/12,5.79%,DSCAM
prerank,Golgi localization (GO:0051645),0.260915680670985,0.6301697178179738,0.9178571428571428,0.9922116200351812,1.0,4/11,20.77%,COPG1;STK25;RIPOR1;CDC42
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24137772309848293,0.6301158288357341,0.9300699300699301,0.9916896056916708,1.0,3/15,18.34%,RAD9B;FANCD2;HUS1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.24609203339820446,0.6294055410268133,0.9168081494057725,0.9915607162811206,1.0,13/13,75.41%,MR1;CYRIB;PVR;NECTIN2;STX7;XCL1;IL23A;SLC22A13;IL12B;IL23R;IL12A;IL12RB1;FADD
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.22619528850518814,0.6293949373211154,0.9454545454545454,0.9910173589378419,1.0,3/19,9.90%,F11R;MYO1C;SNAI2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.257611288856907,0.6288752611507856,0.9098639455782312,0.9907501293825064,1.0,4/12,21.42%,KDELR3;KDELR2;RER1;ANKRD13C
prerank,amino sugar metabolic process (GO:0006040),-0.2527529552155652,-0.6276205822155048,0.9202733485193622,0.9809809740113533,1.0,7/10,39.64%,ST6GAL1;SLC35A3;B4GALNT2;GFPT1;ST3GAL1;GNE;GFPT2
prerank,rRNA 3'-end processing (GO:0031125),-0.24995861654484508,-0.6269683091293011,0.9084507042253521,0.9807850286517069,1.0,5/10,26.15%,EXOSC8;EXOSC10;EXOSC9;EXOSC7;RPS21
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.20748955924003398,-0.6244657356262456,0.9615384615384616,0.9815037678923886,1.0,6/17,24.74%,TERF2;NTHL1;MUTYH;NEIL3;TINF2;TDG
prerank,tRNA aminoacylation (GO:0043039),-0.17996407606402445,-0.6242650637112488,0.9830028328611898,0.9810779684546167,1.0,11/37,22.90%,AIMP1;FARS2;IARS2;YARS2;QARS1;NARS1;WARS2;WARS1;FARSA;LARS1;PPA2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.22932602357193282,0.6241938367453997,0.9441624365482234,0.9928035814509639,1.0,5/17,23.59%,LGMN;CCR1;HMGB1;CCL5;CREB3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.2504927075211243,0.6241266122741926,0.9155405405405406,0.9922992570720777,1.0,4/12,20.64%,MYCBP2;ARHGAP35;EPHB2;HSP90AB1
prerank,male meiosis I (GO:0007141),0.23116837731052126,0.6229248501514332,0.9333333333333333,0.9923922735558073,1.0,5/16,29.30%,SLC25A31;ING2;FOXJ2;DDX4;ZSCAN21
prerank,regulation of T cell migration (GO:2000404),-0.20967903792415593,-0.622760045934304,0.9570405727923628,0.9812893443586435,1.0,4/18,22.59%,RIPOR2;SPN;CXCL12;APP
prerank,eosinophil chemotaxis (GO:0048245),0.23888749372174783,0.6207718491819696,0.9166666666666666,0.9924617345717871,1.0,14/14,76.13%,CCL5;CCL2;CCL1;CCL11;CCL26;LGALS3;CCL4;CCL3;CX3CL1;SCG2;CCL13;CCL8;CCL24;CCL7
prerank,eosinophil migration (GO:0072677),0.23888749372174783,0.6207718491819696,0.9166666666666666,0.9924617345717871,1.0,14/14,76.13%,CCL5;CCL2;CCL1;CCL11;CCL26;LGALS3;CCL4;CCL3;CX3CL1;SCG2;CCL13;CCL8;CCL24;CCL7
prerank,embryonic digestive tract development (GO:0048566),-0.20567433870272578,-0.6200050100829241,0.9477611940298507,0.9821368623471579,1.0,5/18,21.75%,SOX11;TNF;PDGFRA;PKDCC;ID2
prerank,snRNA 3'-end processing (GO:0034472),0.2241812695418403,0.6193418359151988,0.9395424836601307,0.9926615680317251,1.0,4/19,19.45%,INTS6L;EXOSC5;INTS8;INTS5
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.24842802435883488,0.6180897034154037,0.9394463667820069,0.9927306915448464,1.0,1/12,0.98%,ADTRP
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.26223043122907796,0.6179628837852363,0.9228130360205832,0.9922385079319701,1.0,2/10,15.22%,PRKN;OXA1L
prerank,regulation of plasminogen activation (GO:0010755),-0.23892366402553694,-0.6177219256791029,0.9218009478672986,0.9826665541312987,1.0,2/12,5.53%,ENO1;THBS1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.25206121985499685,-0.6169479760791026,0.9322799097065463,0.9824967896300305,1.0,2/10,11.76%,DPP4;SKAP1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.24124307685613067,-0.6152793812627783,0.9398148148148148,0.9827855347863076,1.0,2/11,16.23%,ATG13;ATG9B
prerank,SNARE complex assembly (GO:0035493),-0.24811697740562336,-0.6148300421370577,0.9221967963386728,0.9824690689816235,1.0,2/10,14.90%,UVRAG;STXBP6
prerank,amyloid-beta metabolic process (GO:0050435),0.2300486047498473,0.6134212198851016,0.9504,0.9939045257052744,1.0,4/16,21.47%,BACE1;PSENEN;ABCA7;APEH
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.23811378630081506,0.6107818732178796,0.9384615384615385,0.9946372493133192,1.0,4/12,24.62%,PLK3;RFWD3;FBXO31;SDE2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.22230375611676167,-0.6099719435435915,0.9357798165137615,0.9840693833176156,1.0,3/13,15.15%,TYROBP;TM9SF4;TNF
prerank,cellular response to UV-A (GO:0071492),0.24701990277315677,0.6095346165675508,0.9362831858407079,0.9946704133348221,1.0,4/11,29.82%,MMP1;CERS1;MME;PPID
prerank,negative regulation of cilium assembly (GO:1902018),0.25053183416309577,0.608755596392572,0.9431438127090301,0.9944927287724086,1.0,4/12,24.42%,LIMK2;CDK10;TCHP;TBC1D30
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.238606741358942,0.6062831164873251,0.9565943238731218,0.995048774696358,1.0,3/13,19.29%,BTG2;POLR2G;TOB1
prerank,chromatin assembly or disassembly (GO:0006333),0.24547943782617015,0.6056636175184378,0.9256055363321799,0.9947597211076609,1.0,4/11,32.34%,SUV39H2;HDAC8;MTA2;TP53
prerank,regulation of calcium ion import (GO:0090279),0.21295696548981857,0.6052626582748551,0.9630872483221476,0.99440645953111,1.0,3/21,12.82%,PRNP;PKD2;PDGFB
prerank,positive regulation of lymphocyte migration (GO:2000403),0.2437257933247956,0.6049893626417145,0.9494773519163763,0.993977409543265,1.0,5/12,33.48%,JAM2;CCL5;RHOA;AIF1;PYCARD
prerank,negative regulation of complement activation (GO:0045916),-0.24473250097974775,-0.6021089973664394,0.95662100456621,0.9869234003253262,1.0,7/10,41.90%,SERPING1;CD55;VSIG4;C4BPB;C4BPA;SUSD4;CD46
prerank,oligosaccharide metabolic process (GO:0009311),0.1764466519741774,0.6019694499404507,0.985981308411215,0.9947639492814395,1.0,6/46,13.03%,B3GALT2;NEU1;NAGA;MAN2B2;GAL3ST4;ST3GAL6
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.25256094411731317,0.600960955684505,0.9366197183098591,0.9946477580967972,1.0,2/10,11.46%,SLC45A3;IRS1
prerank,telomere maintenance via recombination (GO:0000722),0.24810245130685618,0.6004298766701085,0.9424083769633508,0.9943303323455476,1.0,3/11,24.18%,SMC5;XRCC3;ERCC4
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.2203162700013515,0.6002652515353385,0.9587458745874587,0.993850438929402,1.0,2/17,10.75%,NME5;NFE2L2
prerank,vascular process in circulatory system (GO:0003018),-0.22135077142728712,-0.5993527075422795,0.9579439252336449,0.9869920623189917,1.0,2/13,9.75%,GCLC;ADCY6
prerank,regulation of tube diameter (GO:0035296),-0.22135077142728712,-0.5993527075422795,0.9579439252336449,0.9869920623189917,1.0,2/13,9.75%,GCLC;ADCY6
prerank,regulation of autophagosome maturation (GO:1901096),-0.22200086972139071,-0.5966213155589657,0.9476082004555809,0.9874839171981604,1.0,4/13,22.86%,UVRAG;SMCR8;CLN3;PHF23
prerank,smoothened signaling pathway (GO:0007224),0.1883018198541334,0.5965382554592868,0.9779527559055118,0.9948325838466558,1.0,9/32,26.30%,MAP3K10;GPC2;STK36;IFT27;GLI3;TCTN2;EVC2;DISP3;TMEM17
prerank,positive regulation of TORC1 signaling (GO:1904263),0.22141860662254373,0.5957643386601195,0.9634782608695652,0.9946040143222249,1.0,1/16,0.40%,KLHL22
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.24916943074719827,0.5955095284515386,0.9523809523809523,0.9941601133832435,1.0,2/11,12.55%,NT5C3A;DCK
prerank,tRNA metabolic process (GO:0006399),0.2211721969286679,0.5936971056381966,0.943801652892562,0.9943523145761693,1.0,10/17,33.15%,ADAT1;DTD1;RPP30;DTD2;DARS2;POP7;AARS1;SARS1;TRPT1;POP5
prerank,regulation of cytoplasmic translation (GO:2000765),-0.21574320178329434,-0.5931264050480658,0.9586374695863747,0.9883396463541008,1.0,6/14,36.27%,CPEB4;CPEB2;CPEB3;CPEB1;YBX3;RBM24
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.19262585879226454,-0.5930925993664413,0.9732360097323601,0.9878217306004657,1.0,5/20,22.47%,MPDU1;FUT8;B3GALT5;ST6GALNAC5;FUT4
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.23775663105389763,0.5924731662457458,0.9439728353140917,0.9942897671281025,1.0,1/12,5.65%,INAVA
prerank,RNA destabilization (GO:0050779),-0.20095342116765152,-0.5918329652249947,0.9686746987951808,0.9877370919335949,1.0,6/18,25.86%,CELF1;ZC3H18;MEX3D;PUM1;RIDA;GIGYF2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.24073015569724432,-0.5916941900031836,0.9505882352941176,0.9872565833603936,1.0,6/10,34.51%,GATA3;BASP1;WT1;PAX8;FZD7;CITED1
prerank,water transport (GO:0006833),0.23281417415522818,0.5913065220787014,0.9495495495495495,0.9942221224448102,1.0,1/12,9.94%,CFTR
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.24912547049259146,0.591111201372366,0.9245283018867925,0.9937475614615199,1.0,3/10,22.40%,MVP;ENG;IMPACT
prerank,synaptic vesicle recycling (GO:0036465),-0.17310473735162304,-0.5908805089749198,0.9835164835164835,0.9870241156099495,1.0,4/31,10.67%,SYNJ2;FCHO2;AMPH;SNCG
prerank,negative regulation of transferase activity (GO:0051348),-0.17642276970052534,-0.5904168026061954,0.9794871794871794,0.9866656466873226,1.0,7/28,24.80%,DTX3L;PHPT1;INPP5K;IRS2;HNRNPU;PIF1;EIF4A2
prerank,microglial cell activation (GO:0001774),-0.18793352429305155,-0.5884683245522802,0.9757281553398058,0.9868633498397449,1.0,4/21,15.15%,TYROBP;C5AR1;AGER;TNF
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.22015466367560899,0.5855274629429946,0.9633699633699634,0.9952652202977157,1.0,5/15,25.01%,VCAN;CSGALNACT1;B3GAT3;DCN;BCAN
prerank,response to UV (GO:0009411),0.15059741075704294,0.5806640741999349,0.9986263736263736,0.9964430099794266,1.0,14/95,15.46%,UBE2B;RELA;GTF2H2;CIRBP;BAK1;NEDD4;USF1;PARP1;DDB2;NSMCE3;FEN1;ERCC6;EIF2AK4;CCAR2
prerank,cellular response to UV (GO:0034644),-0.14260681040354417,-0.5803227019426302,1.0,0.9890677499296507,1.0,16/76,21.80%,PCNA;USP28;TAF1;YY1;EP300;EIF2S1;RHNO1;NPM1;CRIP1;CDC25A;HYAL3;XPC;RPL26;OPN3;TIMP1;CASP9
prerank,presynapse organization (GO:0099172),-0.23144756025945845,-0.5787190323345991,0.9430523917995444,0.9890657764280123,1.0,4/10,25.50%,C5AR1;WNT5A;NLGN2;FZD1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.18939130449025815,0.5778108394885796,0.9798136645962733,0.9969155349627785,1.0,4/29,13.34%,PATL1;LSM1;EXOSC5;CNOT8
prerank,cellular response to ionizing radiation (GO:0071479),0.16960327682700505,0.5771346143586515,0.9939759036144579,0.9966053870901903,1.0,9/47,22.52%,NUCKS1;RAD9B;XRCC6;GADD45A;HRAS;HUS1;WRN;XRCC5;TLK2
prerank,catecholamine biosynthetic process (GO:0042423),0.2361763640635244,0.5752822671645631,0.9502664298401421,0.9966787202588062,1.0,2/11,14.71%,MOXD1;DAO
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2069939728779508,-0.5736484041773333,0.9654320987654321,0.9901291757471912,1.0,14/14,79.33%,TERF2;TINF2;TERT;TNKS;PINX1;TERF2IP;ATRX;ATR;NABP2;BRCA2;TPP1;ACD;TNKS2;XRCC5
prerank,mRNA methylation (GO:0080009),0.21681704637816174,0.5727386928880015,0.9810017271157168,0.9969157826367738,1.0,3/15,14.63%,TRMT61B;METTL16;CBLL1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.23094490392884964,0.572339270746799,0.9595278246205734,0.9964917075065889,1.0,5/12,29.88%,PARP1;PARP6;PARP10;TNKS2;PARP3
prerank,positive regulation of bone resorption (GO:0045780),0.23549482207048245,0.571841612536214,0.9476439790575916,0.9961147833650543,1.0,2/11,11.75%,PRKCA;MC4R
prerank,cellular response to gamma radiation (GO:0071480),0.20897143000751245,0.5714565781698905,0.97,0.9956907468105729,1.0,6/17,24.55%,XRCC6;HRAS;WRN;XRCC5;TLK2;CRYAB
prerank,RNA biosynthetic process (GO:0032774),-0.16322041355037395,-0.5658325010988563,0.9945054945054945,0.9918675827317358,1.0,31/31,83.72%,TAF12;PRIM2;NAT14;TAF7;BRF2;TERT;TBP;TAF10;NCOA6;HELB;TAF13;POLR2A;RSF1;TCEA2;POLA2;SMARCA5;BRF1;TTF2;ELL3;TBPL2;TAF6;SMN1;TAF5;TBPL1;TTF1;GTF2B;POLA1;TAF4;PRMT5;PRIM1;SETX
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.19557358866698296,0.5645946154775933,0.9831081081081081,0.9972277574128876,1.0,4/22,15.00%,PPM1E;PPM1A;PPP5C;DUSP2
prerank,mesoderm formation (GO:0001707),0.20859251309245594,0.5642943986570488,0.9786184210526315,0.9967821944282129,1.0,1/17,2.85%,KDM6B
prerank,meiosis I (GO:0007127),0.19292503054931048,0.5637700711428023,0.9805825242718447,0.9963708807821852,1.0,2/23,8.49%,SGO1;SLC25A31
prerank,glycine metabolic process (GO:0006544),0.2271186440677967,0.5637656426147375,0.9656419529837251,0.9958322815259473,1.0,12/12,77.31%,AMT;DLD;GLYAT;GCSH;SHMT1;SDSL;BAAT;SHMT2;GCAT;SDS;RIDA;GLDC
prerank,negative regulation of ATPase activity (GO:0032780),-0.1931813120255914,-0.5631578963084184,0.988558352402746,0.9921019859688912,1.0,6/16,28.04%,IFIT1;VCPKMT;LTF;PPIF;TLR9;TSC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.22304127745067936,-0.5613191897025279,0.9464668094218416,0.9914880530443969,1.0,4/11,25.75%,CCT6A;CCT3;DKC1;LARP7
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.22304127745067936,-0.5613191897025279,0.9464668094218416,0.9914880530443969,1.0,4/11,25.75%,CCT6A;CCT3;DKC1;LARP7
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2139735278429867,0.5606862274094475,0.9777015437392796,0.9961251347791398,1.0,4/16,20.88%,RECQL;WRN;RECQL4;SSBP1
prerank,epithelial cell development (GO:0002064),0.19686549659265545,0.5606260600663965,0.9751243781094527,0.9956017598988877,1.0,5/20,25.61%,LRTOMT;SLC4A7;WNT7A;GRHL2;WNT5B
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.23276726798353542,-0.5602817133041024,0.9453302961275627,0.9912233383267017,1.0,1/10,5.12%,PRKD3
prerank,female gonad development (GO:0008585),0.2005934993246905,0.5577918302080404,0.9707317073170731,0.9958351374907972,1.0,1/19,1.37%,ANG
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.2151788099717314,-0.5570053274164265,0.9925187032418953,0.9915200107267131,1.0,4/12,21.77%,MTHFD1;CBS;CTH;SEPHS2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.18963610401241981,-0.5559268989475895,0.9924050632911392,0.991262090617852,1.0,8/17,36.98%,ZDHHC17;TFAP2B;XIAP;FST;SLIT2;PCSK6;ITGA3;FSTL3
prerank,detection of calcium ion (GO:0005513),0.21797598095800597,0.5530675390128957,0.9824561403508771,0.9965184048863094,1.0,1/13,3.85%,SYT1
prerank,genitalia development (GO:0048806),-0.20809455116801212,-0.5500663094969142,0.9783653846153846,0.9921225586695926,1.0,6/12,39.43%,WNT5A;SHH;WT1;LHCGR;STRA6;PTPN11
prerank,response to gamma radiation (GO:0010332),-0.1676384217897197,-0.5483047357008695,0.9948051948051948,0.991989968919569,1.0,4/24,11.57%,YAP1;HSF1;TMEM109;LIG4
prerank,positive regulation of lyase activity (GO:0051349),0.2119332770437512,0.5482251734072867,0.9739130434782609,0.9971383064387718,1.0,2/14,17.67%,CACNA1D;ISCU
prerank,positive regulation of calcium ion import (GO:0090280),-0.20557108033574012,-0.5430201964252078,0.9742388758782201,0.9927115102331289,1.0,6/12,38.40%,SPHK2;CXCL12;RAMP3;ATP2A1;CALCR;STC1
prerank,oxoacid metabolic process (GO:0043436),0.17742566008172056,0.5403041459496777,0.9907407407407407,0.998336641485122,1.0,5/27,22.22%,PPA1;TPST2;DAO;AGXT;SULT1A1
prerank,regulation of establishment of protein localization (GO:0070201),-0.20109722435575061,-0.538759576193183,0.9796839729119639,0.9930587263466779,1.0,6/13,32.56%,GAPVD1;CEP295;PTP4A3;CTSD;SCFD1;SPIDR
prerank,negative regulation of ion transport (GO:0043271),0.1829768403847677,0.5383456574247749,0.9966044142614601,0.9982126802689557,1.0,6/24,23.96%,ADRA2A;ACTN2;NEDD4;WNK1;PACSIN3;SYT11
prerank,positive regulation of behavior (GO:0048520),0.22961775367977083,0.5373247366244089,0.9716312056737588,0.997877452948489,1.0,4/10,32.25%,MEF2C;NPAS2;CFAP20;NLGN1
prerank,regulation of neuron projection arborization (GO:0150011),0.20318293749763439,0.5352955457876173,0.9796954314720813,0.9977211382906777,1.0,6/15,27.15%,MAP3K13;NTNG2;NTNG1;DVL2;DLG4;MYO9A
prerank,regulation of tau-protein kinase activity (GO:1902947),0.22309350182604448,0.5340011433191983,0.9806338028169014,0.9974362492499607,1.0,3/10,23.73%,CLU;HSP90AB1;NAB2
prerank,regulation of actin nucleation (GO:0051125),0.21306737324272615,0.5331215885386447,0.9819819819819819,0.9970573912788847,1.0,6/12,37.40%,CORO1A;ARF1;WHAMM;ARFIP1;ARFIP2;ARPIN
prerank,detection of visible light (GO:0009584),0.1904830155019861,0.5290734634610516,0.9818181818181818,0.9972659364331956,1.0,2/16,15.42%,CNGB1;GNA11
prerank,receptor recycling (GO:0001881),-0.2142397006790654,-0.5278545719744626,0.9684684684684685,0.994585706110082,1.0,1/10,4.57%,LMTK2
prerank,steroid catabolic process (GO:0006706),0.22316362674085571,0.5268708594877938,0.9761092150170648,0.9971314971183489,1.0,2/10,24.76%,HSD17B11;HSD17B14
prerank,aorta development (GO:0035904),-0.19159085351619287,-0.5265953991314445,0.9821826280623608,0.9942872044469846,1.0,5/14,22.54%,EFEMP2;LRP1;PDE2A;TFAP2B;APLNR
prerank,DNA biosynthetic process (GO:0071897),0.19630210247955265,0.5236298323607358,0.9858657243816255,0.9971578908010349,1.0,4/16,22.60%,POLD3;WRNIP1;WRN;POLA1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.2157876678586196,0.5221050132905776,0.987012987012987,0.9968855105834047,1.0,1/10,4.94%,NT5C3A
prerank,regulation of protein kinase C signaling (GO:0090036),0.20250850201513085,0.5214341095096724,0.9893617021276596,0.996455871440087,1.0,1/14,3.55%,FLT4
prerank,nucleoside catabolic process (GO:0009164),0.2071834995840564,0.5149599733221224,0.9764065335753176,0.9969329740521317,1.0,1/11,4.94%,NT5C3A
prerank,cobalamin metabolic process (GO:0009235),-0.17777080062794348,-0.5123278724821659,0.9899244332493703,0.9959680337634659,1.0,17/17,82.25%,MTRR;LMBRD1;ABCD4;AMN;CD320;CUBN;ABCC1;MMADHC;MMUT;CBLIF;TCN1;CTRC;MMACHC;MMAB;TCN2;MMAA;MTR
prerank,glycine transport (GO:0015816),-0.2081345719307055,-0.511290158811031,0.9821428571428571,0.9955621983156874,1.0,10/10,79.21%,SLC6A17;SLC36A2;SLC38A5;SLC7A8;SLC6A20;SLC36A1;SLC36A3;SLC6A5;SLC6A9;SLC25A38
prerank,regulation of microtubule-based movement (GO:0060632),0.20432986254555438,0.5092945289288309,0.9825783972125436,0.9972306060291962,1.0,3/11,21.28%,CCDC65;HAP1;MAP2
prerank,positive regulation of chromatin organization (GO:1905269),-0.19331298122389942,-0.5062704563904701,0.9903147699757869,0.9957055351636347,1.0,4/12,29.19%,H3-3A;TERF2;TINF2;MIER1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.19745493702663647,0.5024869936836424,0.9831365935919055,0.997073499200316,1.0,5/12,28.60%,ITGB1BP1;RCC2;DMTN;AP1AR;KANK1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.19745493702663647,0.5024869936836424,0.9831365935919055,0.997073499200316,1.0,5/12,28.60%,ITGB1BP1;RCC2;DMTN;AP1AR;KANK1
prerank,positive regulation of hormone secretion (GO:0046887),-0.1712260408548359,-0.5007696422168232,0.9873417721518988,0.9958227407648301,1.0,8/17,36.51%,SOX11;C1QTNF3;RASL10B;VAMP7;NMB;EDN3;CYP19A1;EDN1
prerank,piRNA metabolic process (GO:0034587),0.17480921246832326,0.5005863197076896,0.9933333333333333,0.9967674029430539,1.0,4/19,29.12%,EXD1;TDRKH;GPAT2;DDX4
prerank,negative regulation of neuron differentiation (GO:0045665),0.17271497112514056,0.49990382220929125,0.9901153212520593,0.9963176758128327,1.0,3/22,15.66%,HEY1;EIF2AK4;REST
prerank,regulation of cell projection organization (GO:0031344),-0.18171410038380909,-0.49292410392661046,0.9926289926289926,0.9961547586015687,1.0,3/13,22.12%,SPRY2;MFSD2A;SEMA4D
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.1621070525553105,0.48992330792413485,0.9968152866242038,0.9969215911872207,1.0,2/27,4.62%,PLAAT5;PLA2G3
prerank,diol metabolic process (GO:0034311),-0.160997734617758,-0.4878296901260494,0.9924050632911392,0.9961231005679824,1.0,7/19,30.36%,SGPP1;ASAH2;SPHK2;HSP90AA1;GCH1;PLPP3;CALM1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.18927741854479246,0.48713362487561407,0.9853181076672104,0.9966729983378997,1.0,13/13,81.09%,TPST2;SULT1A1;ABHD14B;SULT1C4;SULT1C2;BPNT1;TPST1;ENPP1;SULT6B1;SULT4A1;SULT2A1;SULT2B1;BPNT2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.1799334005644301,0.4797039317072487,0.9864864864864865,0.9968073830171886,1.0,3/15,25.24%,TGFB1;CUEDC2;HFE
prerank,positive regulation of cyclase activity (GO:0031281),0.18288860012665673,0.47365086428093334,0.9947552447552448,0.9967680634794122,1.0,2/14,15.76%,CACNA1D;MAPK3
